<SEC-DOCUMENT>0001193125-21-150256.txt : 20210504
<SEC-HEADER>0001193125-21-150256.hdr.sgml : 20210504
<ACCEPTANCE-DATETIME>20210504171952
ACCESSION NUMBER:		0001193125-21-150256
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		21
FILED AS OF DATE:		20210504
DATE AS OF CHANGE:		20210504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			II-VI INC
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-255547
		FILM NUMBER:		21889903

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>d150472ds4a.htm
<DESCRIPTION>S-4/A
<TEXT>
<HTML><HEAD>
<TITLE>S-4/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on May 4, 2021 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-255547</FONT> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No. 1 </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-4</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top" ALIGN="center"><B>Pennsylvania</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>3827</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">25-1214948</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>375 Saxonburg Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Saxonburg, PA 16056 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code and telephone number, including area code, of registrant&#146;s principal executive offices)<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Jo Anne Schwendinger </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Chief Legal and Compliance Officer and Secretary </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>375 Saxonburg Boulevard </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Saxonburg, PA 16056 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="21%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Andrew J. Nussbaum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Karessa L. Cain</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Wachtell, Lipton, Rosen&nbsp;&amp; Katz</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>51 West 52nd Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>New
York, NY 10019</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">403-1000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>D. Mark McMillan</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Jeffrey W. Acre</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>K&amp;L
Gates LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>70 West Madison Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Chicago, IL 60602-4207</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(312) <FONT STYLE="white-space:nowrap">372-1121</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Bret DiMarco</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Coherent, Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>5100
Patrick Henry Drive</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Santa Clara, CA 95054</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(408) <FONT STYLE="white-space:nowrap">764-4000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Michael S. Ringler</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Sonia K. Nijjar</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>525 University Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>Palo Alto, CA 94301</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">470-4500</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale of the securities to the public: </B>As soon as practicable after this Registration
Statement is declared effective and upon completion of the merger described herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If the securities being registered on this Form are
being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
<FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting
company,&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">Exchange Act Rule <FONT STYLE="white-space:nowrap">13e-4(i)</FONT> (Cross-Border Issuer Tender Offer) &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">Exchange Act Rule <FONT STYLE="white-space:nowrap">14d-1(d)</FONT> (Cross-Border Third-Party Tender Offer) &#9744; </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>     <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman"><B>THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL
THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION ACTING PURSUANT TO SAID SECTION 8(a) MAY DETERMINE. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial Narrow"><FONT COLOR="#eb0029"><B>The information in this joint proxy statement/prospectus is not complete and may be
changed. A registration statement relating to the securities described in this joint proxy statement/prospectus has been filed with the U.S. Securities and Exchange Commission. These securities may not be issued until the registration statement
filed with the U.S. Securities and Exchange Commission is effective. This joint proxy statement/prospectus does not constitute an offer to sell or the solicitation of offers to buy these securities in any jurisdiction where the offer or sale is not
permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>PRELIMINARY&#151;SUBJECT TO COMPLETION&#151;DATED MAY 4, 2021 </B></FONT></P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g03a01.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g150472g03a02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>To the shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and the stockholders of
Coherent, Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MERGER PROPOSED&#151;YOUR VOTE IS VERY IMPORTANT </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On behalf of the boards of directors of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (which we refer to as <FONT
STYLE="white-space:nowrap">&#147;II-VI&#148;)</FONT> and Coherent, Inc. (which we refer to as &#147;Coherent&#148;), we are pleased to enclose the accompanying joint proxy statement/prospectus relating to the proposed acquisition of Coherent by <FONT
STYLE="white-space:nowrap">II-VI</FONT> in a merger transaction. We are requesting that you take certain actions as a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder or a Coherent stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, 2021, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Watson Merger Sub Inc., a newly formed wholly owned
subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> (which we refer to as &#147;Merger Sub&#148;), entered into an Agreement and Plan of Merger (which we refer to as the &#147;merger agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the merger agreement, Merger Sub will merge with and into Coherent (which we refer to as the &#147;merger&#148;) on the terms and
subject to the conditions of the merger agreement, with Coherent continuing as the surviving corporation and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed merger of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent would create a uniquely strategic global leader capable of
delivering to the market the most attractive combination of photonic solutions, compound semiconductors, as well as laser technology&nbsp;&amp; systems. The combined company would benefit from significant market megatrends, with the main
applications in communications, semiconductor capital equipment, and consumer electronics, including those that enable the Cloud, 5G wireless, 3D sensing and consumer displays. Moreover, the combined company will be in a better position to
accelerate its growth in industrial, aerospace&nbsp;&amp; defense, life sciences and laser additive manufacturing by utilizing its expertise in engineered materials imparting differentiated performance in compelling integrated solutions in lasers,
optics and electronics.<B><I> </I></B>With its expanded capabilities, the combined company will be able to collaborate even more broadly across its customer base as the <FONT STYLE="white-space:nowrap">design-in</FONT> leader of choice. In addition,
with a common culture of innovation and a strong track record of merger integration, the combined company will be in a strong position to deliver significant value to all stakeholders, including both companies&#146; shareholders or stockholders (as
applicable), customers, employees and business partners. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the merger, Coherent stockholders will be entitled to receive
$220.00&nbsp;in cash (which we refer to as the &#147;cash consideration&#148;) and 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (together with the cash consideration, the &#147;merger consideration&#148;) for each
share of Coherent common stock they own (and, if applicable, cash in lieu of fractional shares). Although the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock that Coherent stockholders will receive per share of
Coherent common stock is fixed, the market value of the merger consideration will fluctuate with the market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and will not be known at the time Coherent stockholders vote on the
merger. Based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on the Nasdaq Global Select Market (which we refer to as &#147;Nasdaq&#148;) on March&nbsp;24, 2021, the last trading day before public announcement of
the merger, of $67.26, the merger consideration represented approximately $281.21 in value for each share of Coherent common stock. Based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on Nasdaq on April 30, 2021
of $67.14, the merger consideration represented approximately $281.10 in value for each share of Coherent common stock. The value of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock at the time of completion of the merger could be
greater than, less than or the same as the value of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on the date of the accompanying joint proxy statement/prospectus. <B>We urge you to obtain current market quotations of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock (trading symbol &#147;IIVI&#148;) and Coherent common stock (trading symbol &#147;COHR&#148;).</B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement,
<FONT STYLE="white-space:nowrap">II-VI</FONT> entered into an Amended and Restated Investment Agreement (which we refer to as the &#147;investment agreement,&#148; including as it may be amended from time to time), dated as of March&nbsp;30, 2021,
with BCPE Watson (DE) SPV, LP, an affiliate of Bain Capital, LP (which we refer to as &#147;BCPE&#148; and, together with its successors and any respective affiliates thereof that become an investor party to the investment agreement, as the
&#147;investors&#148;). On March&nbsp;31, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> issued and sold to BCPE 75,000 shares of newly designated Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock (which we refer to
as <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock&#148;) for an aggregate purchase price of $750.0&nbsp;million pursuant to the investment agreement (which we refer
to as the &#147;initial investment&#148;). In addition, pursuant to the investment agreement and subject to the terms and conditions set forth therein, the investors (i)&nbsp;committed to purchase 105,000 shares of
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> newly designated Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock (which we refer to as <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock&#148; and, together with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock, as the <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> Series B convertible preferred stock&#148;) immediately prior to the closing of the merger for an aggregate purchase price of $1.05&nbsp;billion and (ii)&nbsp;have the option to purchase up to 35,000
additional shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock immediately prior to the closing of the merger for an aggregate purchase price of up to
$350.0&nbsp;million. The issuance and sale of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock pursuant to the investment agreement (which we refer to as the
&#147;subsequent investment&#148; and, together with the initial investment, as the &#147;equity financing&#148;) is contingent upon the closing of the merger in accordance with the merger agreement and is subject to certain other closing conditions
customary for transactions of this type. The terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock are set forth in the Statement with Respect to Shares, filed with the Pennsylvania Department of State
Corporations Bureau and effective March&nbsp;30, 2021. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of Coherent common stock outstanding and
reserved for issuance as of April&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to issue approximately 22.3&nbsp;million shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to Coherent stockholders and certain
equity holders in the aggregate in the merger, representing total aggregate consideration of approximately $6.9&nbsp;billion in value, based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock as on Nasdaq on
April&nbsp;30, 2021 of $67.14. Upon completion of the merger, we estimate that Coherent stockholders and holders of Coherent equity awards entitled to receive merger consideration as of immediately prior to the merger will collectively own
approximately 15.0%, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders as of immediately prior to the merger (excluding as a result of the equity financing) will own approximately 70.7%, and the investors will own approximately 14.3% of the
outstanding shares of common stock of the combined company (in each case, on an as-converted and fully diluted basis and without regard to the fact that immediately prior to the merger, certain holders may own both
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent stock). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will
each hold a special meeting of its shareholders or stockholders, respectively, in connection with the merger, and in the case of <FONT STYLE="white-space:nowrap">II-VI,</FONT> in connection with the subsequent investment. <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders will be asked to vote to approve the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the merger agreement in the amounts necessary to complete the
merger, the issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the subsequent investment pursuant to the investment agreement, and the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock issued in the equity financing (which we refer to collectively as the <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> share issuance proposal&#148;), which requires the affirmative vote of at least a majority of the votes cast by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy, and to approve certain other matters related to the merger. Coherent stockholders will be asked to adopt the merger agreement (which we refer to as the &#147;Coherent
merger proposal&#148;), which requires the approval of the holders of a majority of the outstanding shares of Coherent common stock entitled to vote on the proposal, and to approve certain other matters related to the merger. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>The special meeting of Coherent stockholders will be held virtually via a live webcast at www.virtualshareholdermeeting.com/COHR2021SM
on June&nbsp;24, 2021, at 8:30&nbsp;a.m., Pacific Time. The special meeting of <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will be held virtually via a live webcast at www.virtualshareholdermeeting.com/IIVI2021SM on June&nbsp;24,
2021, at 11:30 a.m., Eastern Time. Information about these meetings and the merger is contained in this joint proxy statement/prospectus. In particular, see &#147;<A HREF="#tx150472_34">Risk Factors</A>&#148; beginning on page 42 of the accompanying
joint proxy statement/prospectus. We urge you to read the joint proxy statement/prospectus carefully and in its entirety.<B> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is very important regardless of the number of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock that you own. The merger cannot be completed without the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders and the approval of the Coherent merger proposal by Coherent stockholders. Whether or not you plan to attend your special meeting, please vote as soon as possible to make sure that your shares are
represented at the meeting. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Each of our boards of directors recommends that holders of common stock vote &#147;FOR&#148; each of
the proposals to be considered at the respective meetings. We strongly support this combination of our companies and join our boards in their recommendations. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dr. Vincent D. Mattera, Jr.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Andreas W. Mattes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Member of the Board and</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Member of the Board,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Coherent, Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or
disapproved of the securities to be issued in connection with the merger or determined if this joint proxy statement/prospectus is accurate or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying joint proxy statement/prospectus is
dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021, and is first being mailed to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and Coherent stockholders on or
about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying joint proxy statement/prospectus incorporates important business and financial information about <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent from other documents that are not included in or delivered with this joint proxy statement/prospectus. This information is available to you without charge upon your written or oral request. You
can obtain the documents incorporated by reference in this joint proxy statement/prospectus through the Securities and Exchange Commission website at <I>https://www.sec.gov</I> or by requesting them in writing, by
<FONT STYLE="white-space:nowrap">e-mail</FONT> or by telephone at the appropriate address below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>if you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375
Saxonburg Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Mark
Lourie</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: investor.relations@ii-vi.com</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Tel: (724) <FONT
STYLE="white-space:nowrap">352-4455</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>if you are a Coherent stockholder:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, California 95054</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Investor Relations</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: investor.relations@coherent.com</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Tel: (408)
764-4110</P></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You will not be charged for any of these documents that you request. To obtain timely delivery of these
documents, you must request them <U>no later than five </U><U></U><U>business days</U> before the date of the applicable special meeting. This means that <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders requesting documents must do so by
June&nbsp;17, 2021 in order to receive them before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, and Coherent stockholders requesting documents must do so by June&nbsp;17, 2021 in order to receive them before the Coherent
special meeting. </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No one has been authorized to provide you with information that is different from that contained in, or
incorporated by reference into, this joint proxy statement/prospectus. This joint proxy statement/prospectus is dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021, and you should assume that
the information in this joint proxy statement/prospectus is accurate only as of such date. You should assume that the information incorporated by reference into this joint proxy statement/prospectus is accurate as of the date of such incorporated
document. Neither the mailing of this joint proxy statement/prospectus to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or Coherent stockholders nor the issuance by <FONT STYLE="white-space:nowrap">II-VI</FONT> of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock in connection with the merger or the issuance and sale of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in connection with the equity financing will
create any implication to the contrary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The joint proxy statement/prospectus does not constitute an offer to sell, or a solicitation
of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction. Except where the context otherwise indicates,
information contained in, or incorporated by reference into, this joint proxy statement/prospectus regarding <FONT STYLE="white-space:nowrap">II-VI</FONT> has been provided by <FONT STYLE="white-space:nowrap">II-VI,</FONT> and information contained
in, or incorporated by reference into, this document regarding Coherent has been provided by Coherent. </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Where You Can
Find More Information&#148; beginning on page 245 of the accompanying joint proxy statement/prospectus for further information. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g08a08.jpg" ALT="LOGO">
 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g150472g07a01.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d"><B>II-VI Incorporated</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d">375 Saxonburg Boulevard</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d">Saxonburg, PA 16056</FONT></P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>PRELIMINARY&#151;SUBJECT TO COMPLETION&#151;DATED MAY 4, 2021
</B></FONT></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Notice of Special Meeting of Shareholders </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To <FONT STYLE="white-space:nowrap">II-VI</FONT> Shareholders: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (which we refer to as
<FONT STYLE="white-space:nowrap">&#147;II-VI&#148;),</FONT> Coherent, Inc. (which we refer to as &#147;Coherent&#148;) and Watson Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT>
(which we refer to as &#147;Merger Sub&#148;), entered into an Agreement and Plan of Merger (which we refer to as the &#147;merger agreement,&#148; including as it may be amended from time to time). Pursuant to the merger agreement, Merger Sub will
merge with and into Coherent (which we refer to as the &#147;merger&#148;) on the terms and subject to the conditions of the merger agreement, with Coherent continuing as the surviving entity in the merger and a wholly owned subsidiary of <FONT
STYLE="white-space:nowrap">II-VI.</FONT> A copy of the merger agreement is attached as <B>Annex A</B> to the accompanying joint proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into an Amended and Restated
Investment Agreement (which we refer to as the &#147;investment agreement,&#148; including as it may be amended from time to time, in accordance with its terms), dated as of March&nbsp;30, 2021, with BCPE Watson (DE) SPV, LP, an affiliate of Bain
Capital, LP (which we refer to as &#147;BCPE&#148; and together with its successors and any respective affiliates thereof that become an investor party to the investment agreement, as the &#147;investors&#148;). On March&nbsp;31, 2021, <FONT
STYLE="white-space:nowrap">II-VI</FONT> issued and sold to BCPE 75,000 shares of newly designated <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock (which we refer to as <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock&#148;) for an aggregate purchase price of $750.0&nbsp;million pursuant to the investment agreement (which we refer to as the
&#147;initial investment&#148;). In addition, pursuant to the investment agreement and subject to the terms and conditions set forth therein, the investors (i)&nbsp;committed to purchase 105,000 shares of
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> newly designated Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock (which we refer to as <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock&#148; and, together with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock, the <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> Series B convertible preferred stock&#148;) immediately prior to the closing of the merger for an aggregate purchase price of $1.05&nbsp;billion and (ii)&nbsp;have the option to purchase up to 35,000
additional shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock immediately prior to the closing of the merger for an aggregate purchase price of up to
$350.0&nbsp;million. The issuance and sale of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock pursuant to the investment agreement (which we refer to as the
&#147;subsequent investment&#148; and, together with the initial investment, as the &#147;equity financing&#148;) is contingent upon the closing of the merger in accordance with the merger agreement and is subject to certain other closing conditions
customary for transactions of this type. The terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock are set forth in a Statement with Respect to Shares, filed with the Pennsylvania Department of State
Corporations Bureau and effective March&nbsp;30, 2021 (which we refer to as the &#147;statement with respect to shares&#148;). A copy of each of the investment agreement and the statement with respect to shares is attached as <B>Annex B</B> and
<B>Annex C</B>, respectively, to the accompanying joint proxy statement/prospectus. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOTICE IS HEREBY GIVEN that a special meeting of <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> special meeting,&#148; including any adjournments or postponements thereof) will be held virtually via a live webcast
on June&nbsp;24, 2021, at 11:30&nbsp;a.m., Eastern Time. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of ongoing developments related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting will be held solely in a virtual meeting format via live webcast. You will be able to virtually attend and vote at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting by visiting www.virtualshareholdermeeting.com/IIVI2021SM. We are pleased to notify you of and invite you to the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g08a08.jpg" ALT="LOGO">
 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g150472g07a01.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d"><B>II-VI Incorporated</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d">375 Saxonburg Boulevard</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><FONT COLOR="#b3282d">Saxonburg, PA 16056</FONT></P></TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting you will be asked to
vote on the following matters: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal to approve the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant
to the terms of the merger agreement in the amounts necessary to complete the merger, the issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the subsequent
investment pursuant to the investment agreement, and the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock
issued in the equity financing (which we refer to collectively as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> share issuance proposal&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal to adjourn the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to a later date or dates,
if necessary or appropriate, including to solicit additional proxies in the event there are not sufficient votes at the time of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to approve the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors of <FONT
STYLE="white-space:nowrap">II-VI</FONT> has fixed the close of business on May&nbsp;17, 2021 as the record date for the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. Only holders of record of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock as of the close of business on the record date for the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting are entitled to notice of, and to vote at, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting or any adjournment or postponement thereof. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is very important
regardless of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock that you own. </B>The merger cannot be completed without the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> board of directors
recommends that holders of common stock vote &#147;FOR&#148; each of the proposals to be considered at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether or not you plan to attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, we urge you to please promptly complete,
sign, date and return the accompanying proxy card in the enclosed postage-paid envelope or authorize the individuals named on the accompanying proxy card to vote your shares by calling the toll-free telephone number or by using the Internet as
described in the instructions included with the accompanying proxy card. If your shares are held in the name of a bank, broker or other nominee, please follow the instructions on the voting instruction card furnished by such bank, broker or other
nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dr.
Vincent D. Mattera, Jr. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director and Chief Executive Officer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">, 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>PRELIMINARY&#151;SUBJECT TO COMPLETION&#151;DATED MAY 4, 2021
</B></FONT></P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g09a01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5100 Patrick Henry Drive </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Santa Clara, California 95054
</B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Notice of Special Meeting of Stockholders </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Coherent Stockholders: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;25,
2021, Coherent, Inc. (which we refer to as &#147;Coherent&#148;), <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (which we refer to as <FONT STYLE="white-space:nowrap">&#147;II-VI&#148;)</FONT> and Watson Merger Sub Inc., a Delaware
corporation and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> (which we refer to as &#147;Merger Sub&#148;), entered into an Agreement and Plan of Merger (which we refer to as the &#147;merger agreement,&#148; including
as it may be amended from time to time). Pursuant to the merger agreement, Merger Sub will merge with and into Coherent (which we refer to as the &#147;merger&#148;) on the terms and subject to the conditions of the merger agreement, with Coherent
continuing as the surviving entity in the merger and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI.</FONT> A copy of the merger agreement is attached as <B>Annex A</B> to the accompanying joint proxy statement/prospectus. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOTICE IS HEREBY GIVEN that a special meeting of Coherent stockholders (which we refer to as the &#147;Coherent special meeting,&#148;
including any adjournments or postponements thereof) will be held virtually via live webcast on June&nbsp;24, 2021, at 8:30&nbsp;a.m., Pacific Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of ongoing developments related to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the Coherent special meeting will
be held solely in a virtual meeting format via live webcast. You will be able to virtually attend and vote at the Coherent special meeting by visiting www.virtualshareholdermeeting.com/COHR2021SM. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will make available a list of stockholders of record entitled to vote at the Coherent special meeting available for viewing by Coherent
stockholders for any purpose germane to the meeting beginning on June&nbsp;14, 2021 at www.virtualshareholdermeeting.com/COHR2021SM. The list of our stockholders of record will remain available for viewing by Coherent stockholders during the
Coherent special meeting. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are pleased to notify you of and invite you to the Coherent special meeting. The purpose of the
Coherent special meeting is to consider and vote upon the following matters: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal to adopt the merger agreement (which we refer to as the &#147;Coherent merger proposal&#148;).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal to approve, on an advisory <FONT STYLE="white-space:nowrap">(non-binding)</FONT> basis, the executive
officer compensation that will or may be paid to Coherent&#146;s named executive officers in connection with the transactions contemplated by the merger agreement (which we refer to as the &#147;Coherent compensation proposal&#148;).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal to adjourn the Coherent special meeting, if necessary or appropriate, to solicit additional proxies if,
immediately prior to such adjournment, there are not sufficient votes to approve the Coherent merger proposal, to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Coherent
stockholders or to constitute a quorum (which we refer to as the &#147;Coherent adjournment proposal&#148;). </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors of Coherent has fixed the close of business on May&nbsp;17, 2021
as the record date for the Coherent special meeting. Only holders of record of Coherent common stock as of the close of business on the record date for the Coherent special meeting are entitled to notice of, and to vote at, the Coherent special
meeting or any adjournment or postponement thereof. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is very important regardless of the number of shares of Coherent
common stock that you own. </B>The merger cannot be completed without the approval of the Coherent merger proposal by Coherent stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Coherent&#146;s board of directors recommends that holders of Coherent common stock vote &#147;FOR&#148; each of the proposals to be
considered at the Coherent special meeting. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether or not you plan to attend the Coherent special meeting, we urge you to please
promptly complete, sign, date and return the accompanying proxy card in the enclosed postage-paid envelope or authorize the individuals named on the accompanying proxy card to vote your shares by calling the toll-free telephone number or by using
the Internet as described in the instructions included with the accompanying proxy card. If your shares are held in the name of a bank, broker or other nominee, please follow the instructions on the voting instruction card furnished by such bank,
broker or other nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Andy Mattes </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Director, Chief Executive Officer and
President </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">, 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_1">QUESTIONS AND ANSWERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_2">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_3">The Parties to the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_4">The Merger and the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_5">Merger Consideration</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_6">Treatment of Coherent Equity Awards</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_7">Material U.S. Federal Income Tax Consequences</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_8"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Reasons for the Merger; Recommendation
of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_9">Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent
Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_11">Opinions of Coherent&#146;s Financial Advisors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_10">Opinion of J.P. Morgan </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_10a">Legal Proceedings Regarding the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_12">Appraisal Rights in the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_13">Interests of Coherent&#146;s Directors and Executive Officers in the
Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_14">Board of Directors and Management After the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_15">Regulatory Approvals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_16">Expected Timing of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_17">Conditions to Complete the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_18">Termination of the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_19">Termination Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_20">Debt and Equity Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_21">Anticipated Accounting Treatment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_22">The Rights of Coherent Stockholders Will Change as a Result of the
Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_23">Listing of <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock; Delisting
 and Deregistration of Coherent Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_24">The <FONT STYLE="white-space:nowrap">II-VI</FONT> Special
Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_25">The Coherent Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_26">Certain Beneficial Owners of <FONT STYLE="white-space:nowrap">II-VI</FONT> Common
 Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_27">Certain Beneficial Owners of Coherent Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_28">Ownership of <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock after
 the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_29">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_30">SELECTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_31">COMPARATIVE HISTORICAL AND UNAUDITED PRO FORMA PER SHARE FINANCIAL
DATA</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_32">COMPARATIVE MARKET PRICE AND DIVIDEND INFORMATION (UNAUDITED)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_33">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_34">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_35">THE <FONT STYLE="white-space:nowrap">II-VI</FONT> SPECIAL
MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_36">Date, Time and Place of the Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_37">Matters to Be Considered</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_38">Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_39">Record Date and Quorum</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_40">Vote Required; Treatment of Abstentions and Failure to Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_41">Virtually Attending the <FONT STYLE="white-space:nowrap">II-VI</FONT> Special
 Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_42">Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_43">Shares Held in Street Name</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_44">Revocability of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_45">Adjournments and Postponements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_46">Delivery of Proxy Materials</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_47">Solicitation of Proxies; Payment of Solicitation Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_48">Other Matters to Come Before the <FONT STYLE="white-space:nowrap">II-VI</FONT> Special
 Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_49">Assistance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_50"><FONT STYLE="white-space:nowrap">II-VI</FONT> PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_51">Proposal 1: <FONT STYLE="white-space:nowrap">II-VI</FONT> Share Issuance Proposal
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_52">Proposal 2: <FONT STYLE="white-space:nowrap">II-VI</FONT> Adjournment Proposal
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_53">THE COHERENT SPECIAL MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_54">Date, Time and Place of the Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_55">Matters to Be Considered</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_56">Recommendation of the Coherent Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_57">Record Date and Quorum</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_58">Vote Required; Treatment of Abstentions and Failure to Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_59">Virtually Attending the Coherent Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_60">Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_61">Shares Held in Street Name</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_62">Revocability of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_63">Adjournments and Postponements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_64">Delivery of Proxy Materials</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_65">Solicitation of Proxies; Payment of Solicitation Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_66">Other Matters to Come Before the Coherent Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_67">Assistance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_68">COHERENT PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_69">Proposal 1: Coherent Merger Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_70">Proposal 2: Coherent Compensation Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_71">Proposal 3: Coherent Adjournment Proposal</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_72">INFORMATION ABOUT <FONT STYLE="white-space:nowrap">II-VI</FONT> AND MERGER SUB
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_73">INFORMATION ABOUT COHERENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_74">THE MERGER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_75">Terms of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_76">Background of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_77">Certain Relationships between Coherent and <FONT STYLE="white-space:nowrap">II-VI
</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_78">Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_79">Opinions of Coherent&#146;s Financial Advisors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_80"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Reasons for the Merger; Recommendation
 of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_81">Opinion of J.P. Morgan </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_82">Certain Unaudited Prospective Financial Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_83">Interests of Coherent&#146;s Directors and Executive Officers in the
Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_84">Anticipated Accounting Treatment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_85">Regulatory Approvals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_86">Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_87">Stock Exchange Listings</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_87a">Legal Proceedings Regarding the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_88">Appraisal Rights in the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_89">THE MERGER AGREEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_90">Explanatory Note Regarding the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_91">Structure of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_92">Merger Consideration</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_93">Fractional Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_94">Treatment of Coherent Equity Awards</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_95">Closing of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_96">Effective Time of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_97">Conversion of Shares; Exchange of Coherent Stock Certificates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_98">Representations and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_99">Covenants and Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_100"><FONT STYLE="white-space:nowrap">II-VI</FONT> Governance
Post-Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_101">Shareholder and Stockholder Meetings and Recommendation of <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s Boards of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_102">Agreement Not to Solicit Other Offers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_103">Financing Obligations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_104">Financing Cooperation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_105">Conditions to Complete the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_106">Termination of the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_107">Effect of Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_108">Termination Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_109">Expenses and Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_110">Amendment and Waiver of the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_111">Governing Law</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_112">Jurisdiction and Specific Enforcement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_113">THE INVESTMENT AGREEMENT AND THE STATEMENT WITH RESPECT TO
SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_114">Explanatory Note Regarding the Investment Agreement and Statement with Respect
 to Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_115">The Equity Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_116">The Investment Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_117">The Statement with Respect to Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_118">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_119">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_120">COMPARISON OF STOCKHOLDERS&#146; RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_121">SECURITY OWNERSHIP OF <FONT STYLE="white-space:nowrap">II-VI</FONT> BENEFICIAL
 OWNERS AND MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_122">SECURITY OWNERSHIP OF COHERENT BENEFICIAL OWNERS AND
MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_123">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_124">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_125">DEADLINES FOR SUBMITTING STOCKHOLDER PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_126">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#anxacov">Merger Agreement </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#anxbcov">Investment Agreement </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#anxc">Statement with Respect to Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_127">Section&nbsp;262 of the Delaware General Corporation Law</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">D-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_128">Opinion of BofA Securities, Inc. </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">E-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_129">Opinion of Credit Suisse Securities (USA) LLC </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex G</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx150472_130">Opinion of J.P. Morgan Securities LLC </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">G-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_1"></A>QUESTIONS AND ANSWERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following are some questions that you may have about the merger, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or
the Coherent special meeting, and brief answers to those questions. We urge you to read carefully the remainder of this joint proxy statement/prospectus because the information in this section does not provide all of the information that might be
important to you with respect to the merger and the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting. Additional important information is also contained in the documents incorporated by reference into
this joint proxy statement/prospectus. See &#147;Where You Can Find More Information&#148; beginning on page 245 of this joint proxy statement/prospectus. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>In this joint proxy statement/prospectus, unless the context otherwise requires: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;BCL&#148; refers to the Pennsylvania Business Corporation Law of 1988, as amended, restated,
supplemented or otherwise modified from time to time;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;BCPE&#148; refers to BCPE Watson (DE) SPV, LP, an affiliate of Bain Capital, LP;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;BofA Securities&#148; refers to BofA Securities, Inc.;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;cancelled shares&#148; refers to shares of Coherent common stock owned by Coherent, <FONT
STYLE="white-space:nowrap">II-VI,</FONT> their subsidiaries or Merger Sub and issued and outstanding immediately prior to the effective time which will be cancelled and retired at the effective time;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;cash consideration&#148; refers to $220.00 of cash per share of Coherent common stock;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Code&#148; refers to the Internal Revenue Code of 1986, as amended;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent&#148; refers to Coherent, Inc.;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent adjournment proposal&#148; refers to the proposal to adjourn the Coherent special meeting to a
later date or dates, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the Coherent special meeting to approve the Coherent merger proposal (as defined below), to ensure that any
supplement or amendment to this joint proxy statement/prospectus is timely provided to Coherent stockholders or to constitute a quorum;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent board&#148; refers to the board of directors of Coherent;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent bylaws&#148; refers to the bylaws of Coherent as in effect as of the date of this joint proxy
statement/prospectus;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent common stock&#148; refers to the common stock of Coherent, par value $0.01 per share;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent compensation proposal&#148; refers to the proposal that Coherent stockholders approve, by
advisory <FONT STYLE="white-space:nowrap">(non-binding)</FONT> vote, certain compensation arrangements that may be paid or become payable to Coherent&#146;s named executive officers in connection with the merger contemplated by the merger
agreement;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent financial advisors&#148; refers to BofA Securities and Credit Suisse;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent ESPP&#148; refers to the Coherent, Inc. Employee Stock Purchase Plan, as amended and restated
as of February</I><I></I><I>&nbsp;28, 2012; </I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent merger proposal&#148; refers to the proposal that Coherent stockholders adopt the merger
agreement;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent RSU&#148; refers to a restricted stock unit covering shares of Coherent common stock, including
any restricted stock units subject to performance-vesting goals or metrics;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent special meeting&#148; refers to the special meeting of Coherent stockholders to consider and
vote upon the Coherent merger proposal and related matters;</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Coherent stockholder&#148; refers to one or more holders of Coherent common stock, as applicable;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;combined company&#148; refers to <FONT STYLE="white-space:nowrap">II-VI</FONT> following the merger,
including in its capacity as the parent company of Coherent;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Credit Suisse&#148; refers to Credit Suisse Securities (USA) LLC;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;debt commitment letter&#148; refers to the Commitment Letter, dated March</I><I></I><I>&nbsp;25, 2021,
as amended and restated on April, 21, 2021, by and among <FONT STYLE="white-space:nowrap">II-VI,</FONT> JPMorgan Chase Bank, N.A., Citigroup Global Markets Inc., MUFG Bank, Ltd., MUFG Securities Americas Inc., PNC Capital Markets LLC, PNC Bank,
National Association, HSBC Securities (USA) Inc., HSBC Bank USA, National Association, Citizens Bank, N.A., Mizuho Bank, Ltd., BMO Capital Markets Corp., Bank of Montreal, TD Securities (USA) LLC, The Toronto-Dominion Bank, New York Branch, TD Bank,
N.A. and First National Bank of Pennsylvania (which we refer to collectively as the &#147;commitment parties&#148;);</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;debt financing&#148; refers to the $4.725</I><I></I><I>&nbsp;billion in third-party debt financing,
which may include some combination of a senior secured revolving credit facility, a senior secured term loan credit facility, a senior unsecured bridge loan facility and/or the issuance of senior unsecured notes or other debt securities, raised by <FONT
STYLE="white-space:nowrap">II-VI</FONT> in connection with the debt commitment letter;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;DGCL&#148; refers to the General Corporation Law of the State of Delaware, as amended;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;dissenting shares&#148; refers to shares of Coherent common stock issued and outstanding immediately
prior to the effective time and held by a holder of record who does not vote in favor of the Coherent merger proposal;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;effective time&#148; refers to the effective time of the merger;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;equity financing&#148; refers to the initial investment and subsequent investment;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Exchange Act&#148; refers to the Securities Exchange Act of 1934, as amended;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;exchange ratio&#148; refers to 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock per share of Coherent common stock;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;financing commitments&#148; refer to the debt commitment letter and the investment agreement
together;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;financings&#148; refer to the debt financing and the equity financing together;</I>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI&#148;</FONT> refers to
<FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> adjournment proposal&#148; refers to the proposal to
adjourn the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies in the event there are not sufficient votes at the time of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting to approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> board&#148; refers to the board of directors of <FONT
STYLE="white-space:nowrap">II-VI;</FONT></I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> bylaws&#148;</I> <I>refers to the amended and restated
bylaws of <FONT STYLE="white-space:nowrap">II-VI</FONT> as in effect as of the date of this joint proxy statement/prospectus;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> common stock&#148; refers to the common stock of <FONT
STYLE="white-space:nowrap">II-VI,</FONT> no par value;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> charter&#148; means the articles of incorporation of <FONT
STYLE="white-space:nowrap">II-VI</FONT> as in effect as of the date of this joint proxy statement/prospectus;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> preferred stock&#148; refers to the preferred stock of <FONT
STYLE="white-space:nowrap">II-VI,</FONT> no par value;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series B convertible preferred stock&#148; refers to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock and <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred
stock;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT>
convertible preferred stock&#148; refers to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> that were newly designated pursuant to the statement with respect to
shares;</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT>
convertible preferred stock&#148; refers to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> that were newly designated pursuant to the statement with respect to
shares;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> share issuance proposal&#148; refers to the proposal that <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders approve the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the terms of the merger agreement in the amounts necessary to complete the merger, the
issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the subsequent investment pursuant to the terms of the investment agreement, and the issuance of
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock issued in the equity financing;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> special meeting&#148; refers to the special meeting of <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders to consider and vote upon the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and related matters;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> shareholders&#148; refers to one or more holders of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock, as applicable;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;initial investment&#148; refers to the issuance and sale by
<FONT STYLE="white-space:nowrap">II-VI</FONT> to BCPE of 75,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock for an aggregate purchase price of
$750.0</I><I></I><I>&nbsp;million pursuant to the investment agreement on March</I><I></I><I>&nbsp;31, 2021;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;investment agreement&#148; refers to the Amended and Restated Investment Agreement, dated as of
March</I><I></I><I>&nbsp;30, 2021, by and between <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE, as it may be amended from time to time in accordance with its terms;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;investors&#148; refer collectively, along with its successors and any respective affiliates thereof that
become an investor party to the investment agreement, to BCPE;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;J.P. Morgan&#148; refers to J.P. Morgan Securities LLC;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;merger&#148; refers to the merger of Merger Sub with and into Coherent, with Coherent continuing as the
surviving corporation in the merger and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI;</FONT></I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;merger agreement&#148; refers to the Agreement and Plan of Merger, dated as of
March</I><I></I><I>&nbsp;25, 2021, by and among <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Merger Sub, as it may be amended from time to time in accordance with its terms;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;merger consideration&#148; means the cash and shares of <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock Coherent stockholders are entitled to receive pursuant to the merger agreement;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Merger Sub&#148; refers to Watson Merger Sub Inc.;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Nasdaq&#148; refers to the Nasdaq Global Select Market; </I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;SEC&#148; refers to the Securities and Exchange Commission;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;Securities Act&#148; refers to the Securities Act of 1933, as amended;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;statement with respect to shares&#148; refers to the Statement with Respect to Shares of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, filed with the Pennsylvania Department of State Corporations Bureau and effective on March</I><I></I><I>&nbsp;30, 2021;</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;subsequent investment&#148; refers to (i)</I><I></I><I>&nbsp;the commitment by the investors to purchase
105,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock immediately prior to the closing of the merger for an aggregate purchase price of
$1.05</I><I></I><I>&nbsp;billion and (ii)</I><I></I><I>&nbsp;the option of the investors to purchase up to 35,000 additional shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible
preferred stock immediately prior to the closing of the merger for an aggregate purchase price of up to $350.0</I><I></I><I>&nbsp;million, in each case, pursuant to the investment agreement and subject to the terms and conditions set forth therein;
and</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>&#147;surviving corporation&#148; refers to the surviving corporation of the merger.</I>
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why am I receiving this joint proxy statement/prospectus? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>You are receiving this joint proxy statement/prospectus because on March&nbsp;25, 2021, <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent entered into the merger agreement, pursuant to which <FONT STYLE="white-space:nowrap">II-VI</FONT> will acquire Coherent through the merger. A
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
copy of the merger agreement is attached as <B>Annex A</B><I> </I>to this joint proxy statement/prospectus and is incorporated by reference herein. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In order to complete the merger, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders must vote in favor of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent stockholders must vote in favor of the Coherent merger proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> is holding the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to obtain approval
of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will also be asked to approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. The
approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders is not required to complete the merger. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Coherent is holding the Coherent special meeting to obtain approval of the Coherent merger proposal. Coherent stockholders will also be asked
to approve, on an advisory <FONT STYLE="white-space:nowrap">(non-binding)</FONT> basis, the Coherent compensation proposal and to approve the Coherent adjournment proposal. Neither the approval of the Coherent compensation proposal nor the approval
of the Coherent adjournment proposal by Coherent stockholders is required to complete the merger. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This document is also a prospectus that
is being delivered to Coherent stockholders because, in connection with the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> is offering shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to Coherent stockholders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This joint proxy statement/prospectus contains important information about the merger agreement, the merger and the other proposals being voted
on at the <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent special meetings. You should read it carefully and in its entirety. The enclosed materials allow you to have your shares of II-VI common stock voted by proxy without attending your
meeting. Your vote is important and we encourage you to submit your proxy as soon as possible. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen in the merger? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In the merger, Merger Sub will merge with and into Coherent, on the terms and subject to the conditions
of the merger agreement, with Coherent continuing as the surviving corporation of the merger and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI.</FONT> Each share of Coherent common stock issued and outstanding immediately prior
to the effective time (other than certain shares of Coherent common stock that are cancelled shares or dissenting shares) will be converted into the right to receive $220.00&nbsp;in cash and 0.91 of a share of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. After completion of the merger, Coherent will no longer be a public company, and Coherent common stock will be delisted from Nasdaq, will be deregistered under the Exchange Act and will
cease to be publicly traded. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will continue to own their existing shares of II-VI common stock. See &#147;The Merger&#148; beginning on page 73 of this joint proxy statement/prospectus and
the merger agreement for more information about the merger. </P></TD></TR></TABLE>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When and where will each of the special meetings take place? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting will be held virtually at
www.virtualshareholdermeeting.com/IIVI2021SM on June&nbsp;24, 2021, at 11:30 a.m., Eastern Time. Online access will begin at 11:15&nbsp;a.m., Eastern Time, and <FONT STYLE="white-space:nowrap">II-VI</FONT> encourages its shareholders to access the
meeting prior to the start time. You will be able to vote your shares electronically and submit questions online during the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting by logging in to the website listed above using the <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number included in your proxy card. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Coherent special meeting will
be held virtually at www.virtualshareholdermeeting.com/COHR2021SM, on June&nbsp;24, 2021, at 8:30&nbsp;a.m., Pacific Time. Online access will begin at 8:15&nbsp;a.m., Pacific Time, and Coherent encourages its stockholders to access the meeting prior
to the start time. You will be able to vote your shares electronically and submit questions online during the Coherent special meeting by logging in to the website listed above using the <FONT STYLE="white-space:nowrap">16-digit</FONT> control
number included in your proxy card. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Even if you plan to attend your respective company&#146;s special meeting, <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent recommend that you vote your shares in advance as described below so that your vote will be counted if you later decide not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
to or become unable to attend the applicable special meeting. Shares held in &#147;street name&#148; may be voted by you only if you obtain a signed legal proxy from your bank, broker or other
nominee giving you the right to vote the shares at the applicable special meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What matters will be considered at each of the special meetings? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting,
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will be asked to consider and vote on the following proposals: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Proposal 1: The <FONT STYLE="white-space:nowrap">II-VI</FONT>
share issuance proposal</I>. Approval of the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the terms of the merger agreement in the amounts necessary to complete the merger, the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> convertible preferred stock in the subsequent investment pursuant to the terms of the investment agreement, and the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock issued in the equity financing; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Proposal 2: The <FONT STYLE="white-space:nowrap">II-VI</FONT>
adjournment proposal. </I>Approval of the adjournment of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to a later date or dates, including to solicit additional proxies if there are not sufficient votes at the time of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting to approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are not required to consider and vote on the adoption of the
merger agreement or the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, and <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are being asked to approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance
proposal in order to satisfy Nasdaq requirements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the Coherent special meeting, Coherent stockholders will be asked to consider and
vote on the following proposals: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Coherent Proposal 1: The Coherent merger proposal</I>. Adoption of the merger agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Coherent Proposal 2: The Coherent compensation proposal</I>. Approval of, on an advisory <FONT
STYLE="white-space:nowrap">(non-binding)</FONT> basis, the merger-related named executive officer compensation payments that will or may be paid by Coherent to its named executive officers in connection with the merger; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Coherent Proposal 3: The Coherent adjournment proposal</I>. Approval of the adjournment of the Coherent
special meeting to solicit additional proxies if there are not sufficient votes at the time of the Coherent special meeting to approve the Coherent merger proposal, to ensure that any supplement or amendment to this joint proxy statement/prospectus
is timely provided to Coherent stockholders or to constitute a quorum. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In order to complete the merger, among other
things, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders must approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and Coherent stockholders must approve the Coherent merger proposal. The approvals of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, the Coherent compensation proposal or the Coherent adjournment proposal are not required to complete the merger, and the merger may be completed even if approval of one or more of those
proposals is not obtained. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will Coherent stockholders receive in the merger? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In the merger, Coherent stockholders will be entitled to receive $220.00 in cash and 0.91 of a share of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock for each share of Coherent common stock held immediately prior to the completion of the merger. <FONT STYLE="white-space:nowrap">II-VI</FONT> will not issue any fractional shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock in the merger. Coherent stockholders who would otherwise be entitled to a fractional share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the merger will instead receive an
amount in cash (without interest and rounded down to the nearest cent) determined by multiplying the volume weighted average price of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for the ten trading day period, starting with
the opening of trading on the 11th trading day prior to the closing date and ending on the closing of trading on the second to last trading day prior to the closing date, as reported by Bloomberg, by the fraction of a share of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock that such stockholder would otherwise be entitled to receive. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders receive in the merger?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will not receive any
consideration, and their shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock will remain outstanding. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will the value of the merger consideration change between the date of this joint proxy statement/prospectus
and the time the merger is completed? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Yes. Although the amount of cash and number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock that Coherent stockholders will receive is fixed, the value of the merger consideration will fluctuate between the date of this joint proxy statement/prospectus and the completion of the merger based upon the market value of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. Based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on Nasdaq on March&nbsp;24, 2021, the last trading day before the public announcement of the merger, of
$67.26, the merger consideration represented approximately $281.21 in value for each share of Coherent common stock. Based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on Nasdaq on April&nbsp;30, 2021 of $67.14,
the merger consideration represented approximately $281.10 in value for each share of Coherent common stock. Any fluctuation in the market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock after the date of this joint proxy
statement/prospectus will change the value of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock that Coherent stockholders will receive. We urge you to obtain current market quotations of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (trading symbol &#147;IIVI&#148;) and Coherent common stock (trading symbol &#147;COHR&#148;). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How will the merger affect Coherent equity awards? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>At the effective time, each Coherent RSU held by a <FONT STYLE="white-space:nowrap">non-employee</FONT>
member of Coherent&#146;s board of directors (which we refer to each as a &#147;Coherent director RSU&#148;) that is outstanding immediately prior to the effective time will, automatically and without any required action on the part of the holder
thereof, vest (if unvested) and be cancelled and converted into the right to receive the merger consideration as if such Coherent director RSU had been settled in shares of Coherent common stock immediately prior to the effective time.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each time- or performance-based Coherent RSU (other than any Coherent director RSU) that is
outstanding immediately prior to the effective time will be converted into an award (which we refer to as a &#147;converted RSU&#148;) covering that number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, rounded down to the
nearest whole share, equal to the product of (x)&nbsp;the number of shares of Coherent common stock subject to such award of Coherent RSUs (and, with respect to any Coherent RSUs that are subject to performance-vesting goals or metrics (which we
refer to as &#147;Coherent PSUs&#148;)), the number of shares of Coherent common stock will be determined based on the greater of the target or actual level of achievement of such goals or metrics immediately prior to the effective time, as
determined by the Coherent board (or a committee thereof) and (y)&nbsp;the sum of (A)&nbsp;the exchange ratio, and (B)&nbsp;the quotient obtained by dividing (i)&nbsp;the cash consideration by (ii)&nbsp;the volume weighted average price of a share
of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for a ten trading day period, starting with the opening of trading on the 11th trading day prior to the closing date to the closing of trading on the second to last trading day prior to
the closing date, as reported by Bloomberg. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>For details on the treatment of Coherent equity awards, see &#147;The Merger
Agreement&#151;Treatment of Coherent Equity Awards&#148; beginning on page&nbsp;157 of this joint proxy statement/prospectus. </B></P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are the investment agreement and the equity financing? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>In connection with entering into the merger agreement, on March&nbsp;30, 2021, <FONT
STYLE="white-space:nowrap">II-VI</FONT> entered into the investment agreement. On March&nbsp;31, 2021, pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated the initial investment of
$750.0&nbsp;million. Pursuant to the investment agreement and subject to the terms and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least
$1.05&nbsp;billion, which may be increased by up to an additional $350.0&nbsp;million, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
immediately prior to the closing of the merger. The issuance and sale of the <FONT STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> convertible
preferred stock in the subsequent investment is contingent upon consummation of the merger in accordance with the merger agreement, and is subject to certain other closing conditions customary for transactions of this type. A copy of each of the
investment agreement and statement with respect to shares is attached hereto as <B>Annex&nbsp;B</B> and <B>Annex&nbsp;C</B>, respectively. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The investors have agreed to certain restrictions on transfer and standstill provisions, and will receive certain board governance and
registration rights. The conversion price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock will initially be $85.00 per share, subject to adjustments as set forth in the statement with respect to shares.
</P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For more information on the terms of the investment agreement and the terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series&nbsp;B convertible preferred stock, see &#147;The Investment Agreement and the Statement with Respect to Shares&#148; beginning on page&nbsp;183 of this joint proxy statement/prospectus. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What equity stake will Coherent stockholders as of immediately prior to the merger hold in the combined
company following completion of the merger? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Based on the number of shares of Coherent common stock outstanding and reserved for issuance as of
April&nbsp;30, 2021, it is estimated that Coherent stockholders and holders of Coherent equity awards entitled to receive merger consideration as of immediately prior to the merger will collectively own approximately 15.0%, <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders as of immediately prior to the merger (excluding as a result of the equity financing) will own approximately 70.7%, and the investors will own approximately 14.3% of the outstanding shares of
common stock of the combined company (in each case, on an as-converted and fully diluted basis and without regard to the fact that immediately prior to the merger, certain holders may own both <FONT STYLE="white-space:nowrap">II-VI</FONT> and
Coherent stock). </P></TD></TR></TABLE>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How does the <FONT STYLE="white-space:nowrap">II-VI</FONT> board recommend that I vote at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The <FONT STYLE="white-space:nowrap">II-VI</FONT> board recommends that you vote &#147;FOR&#148; the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How does the Coherent board recommend that I vote at the Coherent special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The Coherent board recommends that you vote &#147;FOR&#148; the Coherent merger proposal,
&#147;FOR&#148; the Coherent compensation proposal and &#147;FOR&#148; the Coherent adjournment proposal. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In
considering the recommendations of the Coherent board, Coherent stockholders should be aware that Coherent directors and executive officers may have interests in the merger that are different from, or in addition to, the interests of Coherent
stockholders generally. For a more complete description of these interests, see &#147;The Merger&#151;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#148; beginning on page&nbsp;139 of this joint proxy
statement/prospectus. </P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who is entitled to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The record date for the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting is May&nbsp;17, 2021
(which we refer to the as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> record date&#148;). All <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders who held shares at the close of business on the
<FONT STYLE="white-space:nowrap">II-VI</FONT> record date are entitled to receive notice of, and to vote at, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder is entitled to cast one&nbsp;vote on each matter properly brought before the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting for each share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock that such holder owned of record as of the II-VI record date. As of the close of business on April&nbsp;30, 2021,
there were 105,007,546 outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Virtual attendance at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting is not required to vote. See below and &#147;The <FONT
STYLE="white-space:nowrap">II-VI</FONT> Special Meeting&#151;Proxies&#148; beginning on page&nbsp;59 of this joint proxy statement/prospectus for instructions on how to have your shares voted without attending the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who is entitled to vote at the Coherent special meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The record date for the Coherent special meeting is May&nbsp;17, 2021 (which we refer to as the &#147;Coherent
record date&#148;). All Coherent stockholders who held shares at the close of business on the Coherent record date are entitled to receive notice of, and to vote at, the Coherent special meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each Coherent stockholder is entitled to cast one vote on each matter properly brought before the Coherent special meeting for each share of
Coherent common stock that such holder owned of record as of the Coherent record date. As of the close of business on April&nbsp;30, 2021, there were 24,531,522 outstanding shares of Coherent common stock. Virtual attendance at the Coherent special
meeting is not required to vote. See below and &#147;The Coherent Special Meeting&#151;Proxies&#148; beginning on page&nbsp;66 of this joint proxy statement/prospectus for instructions on how to have your shares voted without attending the Coherent
special meeting. </P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What constitutes a quorum for the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The presence, in person (virtually) or by proxy, of shareholders entitled to cast at least a majority of
votes that all shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> are entitled to cast on the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date will constitute a quorum at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting. Based solely on the number of shares of II-VI common stock outstanding on April&nbsp;30, 2021, the presence, in person or by proxy, of shareholders entitled to cast at least 52,503,774 votes will be required to establish a quorum at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting. If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder and you fail to submit a proxy or are not present virtually at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting, your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock will not be counted towards a quorum. Abstentions are considered present for purposes of establishing a quorum. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There must be a quorum for the vote on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal to be taken at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting. If there is no quorum, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting may be adjourned or postponed to another date if the <FONT STYLE="white-space:nowrap">II-VI</FONT>
adjournment proposal is approved, which may subject <FONT STYLE="white-space:nowrap">II-VI</FONT> to additional expense and delay or prevent the completion of the merger. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What constitutes a quorum for the Coherent special meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Holders of a majority of the shares of Coherent common stock entitled to vote at the Coherent special
meeting, present in person (virtually) or represented by proxy, will be necessary to constitute a quorum for the transaction of business at the Coherent special meeting. Based solely on the number of shares of Coherent common stock outstanding on
April&nbsp;30, 2021, the presence in person or by proxy of at least 12,265,762 shares of Coherent common stock will be required to establish a quorum at the Coherent special meeting. If you are a Coherent stockholder and you fail to submit a proxy
or to attend the Coherent special meeting, your shares of Coherent common stock will not be counted towards a quorum. Abstentions are considered present for purposes of establishing a quorum. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What vote is required for the approval of each proposal at the <FONT STYLE="white-space:nowrap">II-VI</FONT>
special meeting? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Proposal 1:
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal</I>. Assuming that a quorum is present, approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal requires the affirmative vote of at least a majority
of the votes cast by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy. Abstentions and shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock not present or represented by proxy at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, whether due to a record holder&#146;s failure to vote or a &#147;street name&#148;
holder&#146;s failure to instruct such holder&#146;s bank, broker or other nominee how to vote, will have no effect on the outcome of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Proposal 2: <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal</I>. Approval
of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal requires the affirmative vote of at least a majority of the votes that all <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy, are entitled to cast. Shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock not present or represented by proxy at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, whether due to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure to instruct the stockholder&#146;s bank, broker or other nominee how to vote,
will have no effect on the outcome of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. Abstentions will have the same effect as votes cast &#147;AGAINST&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment
proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What vote is required for the approval of each proposal at the Coherent special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><I>Coherent Proposal 1: Coherent merger proposal</I>. Approval of the Coherent merger proposal requires
the affirmative vote of the holders of a majority of the outstanding shares of Coherent common stock entitled to vote on the Coherent merger proposal. Shares of Coherent common stock not present or represented by proxy at the Coherent special
meeting, whether due to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure to instruct such holder&#146;s bank, broker or other nominee how to vote, and shares present but not voted, whether by abstention or
otherwise, will have the same effect as votes cast &#147;AGAINST&#148; the Coherent merger proposal. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent
Proposal 2: Coherent compensation proposal</I>. Approval of the Coherent compensation proposal requires the affirmative vote of the holders of a majority of the shares present or represented by proxy at the Coherent special meeting and entitled to
vote on the Coherent compensation proposal. Shares of Coherent common stock not present or represented by proxy at the Coherent special meeting, whether due to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure
to instruct such holder&#146;s bank, broker or other nominee how to vote, will have no effect on the outcome of the Coherent compensation proposal. Abstentions will have the same effect as votes cast &#147;AGAINST&#148; the Coherent compensation
proposal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent</I> <I>Proposal 3: Coherent</I> <I>adjournment proposal</I>. Approval of the Coherent adjournment proposal requires
the affirmative vote of the holders of a majority of the shares present or represented by proxy at the Coherent special meeting and entitled to vote on the Coherent adjournment proposal. Shares of Coherent common stock not present or represented by
proxy at the Coherent special meeting, whether due to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure to instruct such holder&#146;s bank, broker or other nominee how to vote, will have no effect on the
outcome of the Coherent adjournment proposal. Abstentions will have the same effect as votes cast &#147;AGAINST&#148; the Coherent adjournment proposal. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why are Coherent stockholders being asked to consider and vote on a proposal to approve, by <FONT
STYLE="white-space:nowrap">non-binding,</FONT> advisory vote, merger-related compensation arrangements for the Coherent named executive officers (i.e., the Coherent compensation proposal)? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Under SEC rules, Coherent is required to seek a <FONT STYLE="white-space:nowrap">non-binding,</FONT>
advisory vote with respect to the compensation that may be paid or become payable to Coherent&#146;s named executive officers that is based on or otherwise relates to the merger, or &#147;golden parachute&#148; compensation. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if Coherent stockholders do not approve, by
<FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote, merger-related compensation arrangements for Coherent&#146;s named executive officers (i.e., the Coherent compensation proposal?) </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The vote on the proposal to approve the merger-related compensation arrangements for each of
Coherent&#146;s named executive officers is separate and apart from the votes to approve the other proposals being presented at the Coherent special meeting. Because the vote on the proposal to approve the merger-related executive compensation is
advisory in nature only, it will not be binding upon <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. Accordingly, the merger-related compensation will be paid to Coherent&#146;s named executive officers to the extent payable in accordance
with the terms of their compensation agreements and arrangements even if the holders of Coherent common stock do not approve the Coherent compensation proposal. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What if I hold shares in both <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you hold shares of both <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and Coherent common
stock, you will receive separate packages of proxy materials. A vote cast as a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder will not count as a vote cast as a Coherent stockholder, and a vote cast as a Coherent stockholder will not
count as a vote cast as a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder. Therefore, please submit separate proxies for your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and your shares of Coherent common stock.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How can I vote my shares at my respective special meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><U><FONT STYLE="white-space:nowrap">II-VI</FONT></U> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Record holders</I>. Shares held directly in your name as the holder of record of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
may be virtually voted at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting via the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website at www.virtualshareholdermeeting.com/IIVI2021SM. You will need the <FONT
STYLE="white-space:nowrap">16-digit</FONT> control number included on your proxy card in order to access and vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Shares in &#147;street name.&#148;</I> Shares of II-VI common stock held in &#147;street name&#148; may be voted at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting by you only if you obtain a specific control number and follow the instructions from your bank, broker or other nominee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Coherent</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Record
holders.</I> Shares held directly in your name as the holder of record of Coherent common stock may be virtually voted at the Coherent special meeting via the Coherent special meeting website at www.virtualshareholdermeeting.com/COHR2021SM. You will
need the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number included on your proxy card in order to access and vote at the Coherent special meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Shares in &#147;street name.&#148;</I> Shares of Coherent common stock held in &#147;street name&#148; may be virtually voted at the
Coherent special meeting via the Coherent special meeting website only if you obtain a specific control number and follow the instructions provided by your bank, broker or other nominee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For more information on attending the special meetings, see &#147;The <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting&#148;
beginning on page&nbsp;57 of this joint proxy statement/prospectus and &#147;The Coherent Special Meeting&#148; beginning on page&nbsp;64 of this joint proxy statement/prospectus. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What if during the <FONT STYLE="white-space:nowrap">check-in</FONT> time or during my respective special
meeting I have technical difficulties or trouble accessing the virtual meeting website?<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will each have technicians ready to assist you with
any technical difficulties you may have accessing the respective virtual meeting websites. If you encounter any difficulties accessing the applicable virtual meeting website during the <FONT STYLE="white-space:nowrap">check-in</FONT> or meeting
time, please call the technical support number that will be posted on the virtual meeting website <FONT STYLE="white-space:nowrap">log-in</FONT> page at www.virtualshareholdermeeting.com/IIVI2021SM for the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting and www.virtualshareholdermeeting.com/COHR2021SM for the Coherent special meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How can I vote my shares without virtually attending my respective special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Whether you hold your shares directly as a shareholder of record of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or a stockholder of record of Coherent common stock or beneficially in &#147;street name,&#148; you may direct your vote by proxy without virtually attending the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting, as applicable. If you are a shareholder or stockholder of record, you can vote by proxy over the Internet, by telephone or by mail by following the instructions
provided in the enclosed proxy card. If you hold shares beneficially in &#147;street name,&#148; you should follow the voting instructions provided by your bank, broker or other nominee. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additional information on voting procedures can be found under &#147;The <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting&#148; on
page&nbsp;57 of this joint proxy statement/prospectus and under &#147;The Coherent Special Meeting&#148; on page&nbsp;64 of this joint proxy statement/prospectus. </P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If I submit a proxy, how are my shares voted? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Regardless of whether you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder or a Coherent
stockholder, and regardless of the method you choose to vote, the individuals named on the enclosed proxy card will vote your shares in the way that </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
you indicate at the applicable special meeting. When completing your proxy card, you may specify whether your shares should be voted &#147;FOR&#148; or &#147;AGAINST&#148; or to
&#147;ABSTAIN&#148; from voting on all, some or none of the specific items of business to come before the applicable special meeting. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder and you properly sign your proxy card but do not mark the boxes showing
how your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock should be voted on a matter, the shares represented by your properly signed proxy will be voted &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> share
issuance proposal and &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If you are a
Coherent stockholder and you properly sign your proxy card but do not mark the boxes showing how your shares of Coherent common stock should be voted on a matter, the shares represented by your properly signed proxy will be voted &#147;FOR&#148; the
Coherent merger proposal, &#147;FOR&#148; the compensation proposal and &#147;FOR&#148; the Coherent adjournment proposal, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If you fail to submit a valid proxy and to virtually attend the applicable special meeting, or if your shares are held through a bank,
brokerage firm or other nominee and you do not instruct your bank, brokerage firm or other nominee to vote your shares, your shares will not be voted on any of the matters being considered at the applicable special meeting and, if you are a Coherent
stockholder, will have the effect of a vote &#147;AGAINST&#148; the Coherent merger proposal. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if I transfer my shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock before
the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The <FONT STYLE="white-space:nowrap">II-VI</FONT> record date is earlier than the date of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting and the date that the merger is expected to be completed. If you transfer your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock after the
<FONT STYLE="white-space:nowrap">II-VI</FONT> record date, but before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, you will retain your right to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if I transfer my shares of Coherent common stock before the Coherent special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Coherent record date is earlier than the date of the Coherent special meeting and the date that the merger
is expected to be completed. If you transfer your shares of Coherent common stock after the Coherent record date, but before the Coherent special meeting, you will retain your right to vote at the Coherent special meeting. However, you will have
transferred the right to receive the merger consideration in the merger. In order to receive the merger consideration, you must hold your shares of Coherent common stock through the effective time. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What do I need to do now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After carefully reading and considering the information contained in this joint proxy statement/prospectus,
please respond by completing, signing and dating the accompanying proxy card and returning it in the enclosed postage-paid envelope, or by submitting your proxy by telephone or through the Internet, as soon as possible so that your shares may be
represented at your meeting. Please note that if you hold shares beneficially in &#147;street name,&#148; you should follow the voting instructions provided by your bank, broker or other nominee. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is the difference between holding shares as a holder of record and as a beneficial owner?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A</B>:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If your shares of common stock are registered directly in your name with the transfer agent of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, you are considered the holder of record with respect to those shares. As the holder of record, you have the right to vote or to grant a proxy for your vote directly to <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent, respectively, or to a third party to vote at the applicable special meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by a bank, brokerage firm or other nominee, you are considered the beneficial owner of shares held in &#147;street
name,&#148; and your bank, brokerage firm or other nominee is considered the holder of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
record with respect to those shares. Your bank, brokerage firm or other nominee will send to you, as the beneficial owner, a package describing the procedure for voting your shares. You should
follow the instructions provided by them to vote your shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If my shares are held in &#147;street name&#148; by a broker, bank or other nominee, will my broker, bank or
other nominee vote my shares for me? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A</B>:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. If your shares are held in the name of a bank, brokerage firm or other nominee, you are considered the
&#147;beneficial holder&#148; of the shares held for you in what is known as &#147;street name.&#148; You are not the &#147;record holder&#148; of such shares. If this is the case, this joint proxy statement/prospectus has been forwarded to you by
your bank, brokerage firm or other nominee, and you must provide instructions to your bank, brokerage firm or other nominee to direct how your shares are to be voted at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or the
Coherent special meeting. Your bank, broker or other nominee cannot vote your shares without instructions from you. Please check the voting instructions provided by your bank, broker or other nominee. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All of the proposals to be voted on by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting and Coherent stockholders at the Coherent special meeting are <FONT STYLE="white-space:nowrap">non-routine</FONT> matters. As a result, if your shares are held in &#147;street name&#148;
through a brokerage firm and you do not provide voting instructions, your broker will not have discretionary authority to vote your shares at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting, as
applicable, and, accordingly, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent do not expect any broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on any of the proposals at the special meetings. A broker <FONT
STYLE="white-space:nowrap">non-vote</FONT> occurs on an item when (i)&nbsp;a broker has discretionary authority to vote on at least one routine proposal at a meeting, but under stock exchange rules is not permitted to vote on other <FONT
STYLE="white-space:nowrap">non-routine</FONT> proposals without instructions from the beneficial owner of the shares and (ii)&nbsp;that broker exercises its discretionary authority on the routine proposal after the beneficial owner fails to provide
such instructions, resulting in broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on each of the <FONT STYLE="white-space:nowrap">non-routine</FONT> proposals. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why is my vote important? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you do not vote, it will be more difficult for <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent to
obtain the necessary quorum to hold its respective special meeting. In addition, if you are a Coherent stockholder, your failure to submit a proxy or vote at the Coherent special meeting, or failure to instruct your bank or broker how to vote at the
Coherent special meeting, will have the same effect as a vote &#147;AGAINST&#148; the Coherent merger proposal. The merger cannot be completed without the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders and the approval of the Coherent merger proposal by Coherent stockholders. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board and the Coherent board recommend that you vote &#147;FOR&#148;
for each of the proposals submitted at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting and the Coherent special meeting, respectively. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Can I change my vote after I have delivered my proxy or voting instruction card? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. You can change your vote at any time before your proxy is voted at your meeting. You can do this by:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subsequently submitting a new proxy (including over the Internet or telephone) for the applicable special meeting
that is received by the deadline specified on the accompanying proxy card; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">giving written notice of your revocation to Coherent&#146;s Corporate Secretary or
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary, as applicable; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">virtually attending and voting at the applicable special meeting via the applicable special meeting website.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by a broker, bank or other nominee, you should contact your broker, bank or other nominee to
change your vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Execution or revocation of a proxy will not in any way affect your right to virtually attend
and vote at the applicable special meeting via the applicable special meeting website. Written notices of revocation and other communications relating to the revocation of proxies should be addressed to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder</I>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>If you are a Coherent stockholder</I>:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Coherent, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Attn: Secretary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Attn: Corporate Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">375 Saxonburg Boulevard</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">investor.relations@coherent.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Saxonburg, PA 16056</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5100 Patrick Henry Drive</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Santa Clara, CA 95054</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will <FONT STYLE="white-space:nowrap">II-VI</FONT> be required to submit the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal to its shareholders even if the <FONT STYLE="white-space:nowrap">II-VI</FONT> board has withdrawn, modified or qualified its recommendation? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Unless the merger agreement is terminated before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting, <FONT STYLE="white-space:nowrap">II-VI</FONT> is required to submit the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal to its shareholders even if the <FONT STYLE="white-space:nowrap">II-VI</FONT> board has withdrawn
or modified its recommendation. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will Coherent be required to submit the Coherent merger proposal to its stockholders even if the Coherent
board has withdrawn, modified or qualified its recommendation? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Unless the merger agreement is terminated before the Coherent special meeting, Coherent is required to
submit the Coherent merger proposal to its stockholders even if the Coherent board has withdrawn or modified its recommendation. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Are <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders entitled to appraisal rights?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are not entitled to appraisal rights under
Pennsylvania law, the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter or the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws. For more information, see &#147;The Merger&#151;Appraisal Rights in the Merger&#148; beginning on page&nbsp;149
of this joint proxy statement/prospectus. </P></TD></TR></TABLE>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Are Coherent stockholders entitled to appraisal rights? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Record holders of Coherent common stock who do not vote in favor of the Coherent merger proposal, who
continuously hold such shares through the effective time, and who otherwise comply with the requirements and procedures of Section&nbsp;262 of the DGCL, may be entitled to exercise appraisal rights, which generally entitle stockholders to receive in
lieu of the merger consideration a cash payment of an amount determined by the Court of Chancery of the State of Delaware (which we refer to as the &#147;Court of Chancery&#148;) to be the &#147;fair value&#148; of their Coherent common stock,
exclusive of any elements of value arising from the accomplishment or expectation of the merger, together with interest to be paid on the amount determined to be fair value, if any, as determined by the Court of Chancery, if certain conditions,
including as related to ownership thresholds, are met. The fair value of Coherent common stock could be less than, more than or the same as the value of the merger consideration. A detailed description of the procedures required to be followed in
order to perfect appraisal rights by Coherent stockholders if desired is included in &#147;The Merger&#151;Appraisal Rights in the Merger&#148; beginning on page&nbsp;149 of this joint proxy statement/prospectus, which detailed description is
qualified by reference to the full text of Section&nbsp;262 of the DGCL as attached as <B>Annex&nbsp;D</B> to this joint proxy statement/prospectus. Due to the complexity of the procedures described above, Coherent stockholders who are considering
exercising such rights are encouraged to carefully review <B>Annex&nbsp;D</B> and seek the advice of legal counsel. For more information, see &#147;The Merger&#151;Appraisal Rights in the Merger&#148; beginning on page&nbsp;149 of this joint proxy
statement/prospectus. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Are there any risks that I should consider in deciding whether to vote? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. You should read and carefully consider the risk factors set forth in &#147;Risk Factors&#148; beginning on
page 42 of this joint proxy statement/prospectus. You also should read and carefully consider the risk factors of II-VI and Coherent contained in the documents that are incorporated by reference into this joint proxy statement/prospectus.&nbsp;
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are the material U.S. federal income tax consequences of the merger to Coherent stockholders?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The exchange of Coherent common stock for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and cash
pursuant to the merger is expected to be treated as a taxable transaction for stockholders of Coherent for U.S. federal income tax purposes. Accordingly, assuming that such exchange is treated as a taxable transaction, a Coherent stockholder who
receives <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and cash in exchange for such stockholder&#146;s shares of Coherent common stock pursuant to the merger generally will recognize capital gain or loss equal to the difference, if
any, between (1)&nbsp;the sum of the cash and the fair market value of any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock received by such stockholder in the merger and (2)&nbsp;the stockholder&#146;s adjusted tax basis in its
Coherent common stock exchanged therefor. In addition, you may be subject to U.S. federal <FONT STYLE="white-space:nowrap">non-income,</FONT> state or local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws that are not discussed in this
joint proxy statement/prospectus. You should therefore consult with your own tax advisor(s) for a full understanding of the tax consequences to you of the merger.<B> </B>For a more complete discussion of material U.S. federal income tax consequences
of the merger, see &#147;Material U.S. Federal Income Tax Consequences of the Merger&#148; beginning on page&nbsp;190 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When is the merger expected to be completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent expect the merger to close by <FONT
STYLE="white-space:nowrap">year-end</FONT> 2021. However, neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent can predict the actual date on which the merger will be completed, or if the merger will be completed at all, because
completion is subject to conditions and factors outside the control of both companies. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent must first obtain the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance
proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and the approval of the Coherent merger proposal by Coherent stockholders, as well as obtain necessary regulatory approvals and satisfy certain other closing conditions.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if the merger is not completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the merger is not completed, Coherent stockholders will not receive any consideration for their shares of
Coherent common stock in connection with the merger. Instead, Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> will remain independent public companies, Coherent common stock will continue to be listed and traded on Nasdaq, and <FONT
STYLE="white-space:nowrap">II-VI</FONT> will not complete the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the merger agreement. Depending on the circumstances in which the merger agreement is
terminated, <FONT STYLE="white-space:nowrap">II-VI</FONT> may be required to pay a termination fee of $337.7&nbsp;million or $500&nbsp;million, as applicable, or Coherent may be required to pay a termination fee of $108.8&nbsp;million. In addition,
if the merger agreement is terminated in certain circumstances, <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent may be required to pay to the other $25&nbsp;million to cover the other party&#146;s costs and expenses in connection with the
merger agreement. See &#147;The Merger Agreement&#151;Termination Fees&#148; beginning on page&nbsp;180 of this joint proxy statement/prospectus for a more detailed discussion of the circumstances under which a termination fee or expense payment
will be required to be paid. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, if the merger agreement is terminated, the investment agreement will
automatically terminate, the equity financing will not be completed in full, and <FONT STYLE="white-space:nowrap">II-VI</FONT> will not issue the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT>
<FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> convertible preferred stock pursuant to the investment agreement. The 75,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT>
convertible preferred stock issued on March&nbsp;31, 2021 pursuant to the investment agreement will remain issued and outstanding even if the merger agreement is terminated and the merger is not completed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Should I send in my stock certificates now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. Please do not send in your stock certificates with your proxy. After the merger is completed, an exchange
agent designated by <FONT STYLE="white-space:nowrap">II-VI</FONT> and reasonably acceptable to Coherent (which we refer to as the &#147;exchange agent&#148;) will send you instructions for exchanging Coherent stock certificates for the merger
consideration. See &#147;The Merger Agreement&#151;Conversion of Shares; Exchange of Coherent Stock Certificates&#148; beginning on page&nbsp;158 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How will Coherent stockholders receive the merger consideration to which they are entitled?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Coherent stockholder will be sent a letter of transmittal within five business days after closing the
merger, together with instructions for surrendering your shares of Coherent common stock for the merger consideration to which you are entitled. The exchange agent will forward to you the applicable merger consideration to which you are entitled
after receiving the proper documentation from you. For more information on the documentation you are required to deliver to the exchange agent, see the section entitled &#147;The Merger Agreement&#151;Conversion of Shares; Exchange of Coherent Stock
Certificates&#148; beginning on page&nbsp;158 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will solicit and pay the cost of soliciting proxies? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">II-VI</FONT> will bear the entire cost of proxy solicitation, including
preparation, assembly, printing and mailing of the notice of <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, proxy card, this joint proxy statement/prospectus and any additional materials furnished to
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders. Copies of these materials will be furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are beneficially owned by others to forward to those
beneficial owners. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> may reimburse banks, brokerage firms, other nominees or their respective agents for their expenses in forwarding proxy materials to beneficial owners of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> directors, officers and employees also may solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be
paid any additional amounts for soliciting proxies. <FONT STYLE="white-space:nowrap">II-VI</FONT> has engaged MacKenzie Partners, Inc. to aid in the solicitation of proxies from brokers, bank nominees and other institutional owners for approximately
$25,000, plus reimbursement of related expenses. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Coherent will bear the entire cost of proxy solicitation, including
preparation, assembly, printing and mailing of the notice of Coherent special meeting, proxy card, this joint proxy statement/prospectus and any additional materials furnished to Coherent stockholders. Copies of these materials will be furnished to
brokerage houses, fiduciaries and custodians holding shares in their names that are beneficially owned by others to forward to those beneficial owners. In addition, Coherent may reimburse the costs of forwarding these materials to those beneficial
owners. Coherent also may reimburse banks, brokerage firms, other nominees or their respective agents for their expenses in forwarding proxy materials to beneficial owners of Coherent common stock. Coherent&#146;s directors, officers and employees
also may solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts for soliciting proxies. Coherent has engaged Georgeson LLC to aid in the solicitation of proxies from brokers,
bank nominees and other institutional owners for approximately $25,000, plus reimbursement of related expenses. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What should I do if I receive more than one set of voting materials for the same special meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you hold shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock in
&#147;street name&#148; and also directly in your name as a holder of record or otherwise or if you hold shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock in more than one brokerage account, you may
receive more than one set of voting materials relating to the same special meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Record holders</I>. For shares
held directly, please complete, sign, date and return each proxy card by mail (or submit your voting instructions by telephone or Internet as provided on each proxy card) or otherwise follow the voting instructions provided in this joint proxy
statement/prospectus in order to ensure that all of your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock are voted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Shares in &#147;street name.&#148;</I> For shares held in &#147;street name&#148; through
a bank, broker or other nominee, you should follow the procedures provided by your bank, broker or other nominee to vote your shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who can help answer my questions? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders</I>: If you have any questions about the merger
or how to submit your proxy or voting instruction card, or if you need additional copies of this joint proxy statement/prospectus or the enclosed proxy card or voting instruction card, you should contact: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mark Lourie, Vice President, Corporate Communications, at the following address or phone number:
375&nbsp;Saxonburg Boulevard, Saxonburg, Pennsylvania 16056 or telephone number at <FONT STYLE="white-space:nowrap">(724)&nbsp;352-4455;</FONT> or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proxy solicitor, MacKenzie Partners, Inc., at the following
address or phone number: 1407&nbsp;Broadway, 27th&nbsp;Floor, New York, New York 10018, or shareholders may call toll-free at <FONT STYLE="white-space:nowrap">(800)&nbsp;322-2885</FONT> or collect at (212)
<FONT STYLE="white-space:nowrap">929-5500.</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent stockholders</I>: If you have any questions about the
merger or how to submit your proxy or voting instruction card, or if you need additional copies of this joint proxy statement/prospectus or the enclosed proxy card or voting instruction card, you should contact: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent&#146;s Investor Relations at (408) <FONT STYLE="white-space:nowrap">764-4110</FONT> or
investor.relations@coherent.com; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent&#146;s proxy solicitor, Georgeson LLC, at the following address or phone number: 1290&nbsp;Avenue of the
Americas, 9th&nbsp;Floor, New York, New York 10104 or toll-free at (888) <FONT STYLE="white-space:nowrap">666-2580.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Where can I find more information about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You can find more information about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent from the various
sources described in the section entitled &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_2"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information in this joint proxy statement/prospectus and may not contain all of the information that is
important to you. You should carefully read this entire joint proxy statement/prospectus and the other documents we refer you to for a more complete understanding of the matters being considered at the special meetings. In addition, we incorporate
by reference important business and financial information about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent into this joint proxy statement/prospectus. You may obtain the information incorporated by reference into this joint proxy
statement/prospectus without charge by following the instructions in the section entitled &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_3"></A>The Parties to the Merger (pages 71 and 72) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation, is a global leader in engineered materials and
optoelectronic components, and is a vertically integrated manufacturing company that develops, manufactures and markets engineered materials and optoelectronic components and devices for precision use in industrial materials processing, optical
communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences and automotive applications. Headquartered in Saxonburg, Pennsylvania, <FONT STYLE="white-space:nowrap">II-VI</FONT> has research and
development, manufacturing, sales, service, and distribution facilities worldwide. <FONT STYLE="white-space:nowrap">II-VI</FONT> produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in
various forms, including integrated with advanced software to enable its customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock is traded on Nasdaq under the symbol &#147;IIVI.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Watson Merger Sub Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375 Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(724) <FONT STYLE="white-space:nowrap">352-4455</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Watson Merger Sub Inc., a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI,</FONT> is a Delaware corporation incorporated on
March&nbsp;4, 2021 for the purpose of effecting the merger. Merger Sub has not conducted any activities other than those incidental to its formation and the matters contemplated by the merger agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent, Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, California 95054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(408) <FONT
STYLE="white-space:nowrap">764-4000</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent, Inc., a Delaware corporation, is one of the world&#146;s leading providers of
lasers, laser-based technologies and laser-based system solutions in a broad range of commercial, industrial and scientific applications. Coherent designs, manufactures, services and markets lasers and related accessories for a diverse
</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
group of customers. Since inception in 1966, Coherent has grown through internal expansion and through strategic acquisitions of complementary businesses, technologies, intellectual property,
manufacturing processes and product offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent common stock is traded on Nasdaq under the symbol &#147;COHR.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_4"></A>The Merger and the Merger Agreement (pages 73 and 156) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms and conditions of the merger are contained in the merger agreement, a copy of which is attached as<B> Annex A</B> to this joint proxy
statement/prospectus. You are encouraged to read the merger agreement carefully and in its entirety, as it is the primary legal document that governs the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions of the merger agreement, at the completion of the merger, Merger Sub will merge with and into Coherent,
with Coherent continuing as the surviving corporation in the merger and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_5"></A>Merger Consideration (page 156) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the merger, Coherent stockholders will receive $220.00&nbsp;in cash and 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock for each share of Coherent common stock they hold immediately prior to the effective time. <FONT STYLE="white-space:nowrap">II-VI</FONT> will not issue any fractional shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
in the merger. Coherent stockholders who would otherwise be entitled to a fraction of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the merger will instead receive, for the fraction of a share, an amount in cash (without
interest and rounded down to the nearest cent) determined by multiplying the volume weighted average price of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for the ten trading day period, starting with the opening of trading
on the 11th trading day prior to the date of the completion of the merger to the closing of trading on the second to last trading day prior to the date of the completion of the merger, as reported by Bloomberg, by the fraction of a share of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock that such stockholder would otherwise be entitled to receive. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock is listed on Nasdaq under the symbol &#147;IIVI,&#148; and Coherent common stock is listed on Nasdaq under the symbol &#147;COHR.&#148; The following table shows the closing sale prices of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock and Coherent common stock as reported on Nasdaq on March&nbsp;24, 2021, the last full trading day before the public announcement of the merger agreement, and on April&nbsp;30, 2021, the last
practicable trading day before the date of this joint proxy statement/prospectus. This table also shows the implied value of the merger consideration to be issued in exchange for each share of Coherent common stock, which was calculated by
multiplying the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on those dates by the exchange ratio of 0.91 and adding the per share cash consideration of $220.00. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI&nbsp;Common&nbsp;Stock</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Common&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Implied&nbsp;Value&nbsp;of<BR>One Share of<BR>Coherent<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;24, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">257.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">259.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information on the merger consideration, see &#147;The Merger&#151;Terms of the Merger&#148;
beginning on page&nbsp;73 and &#147;The Merger Agreement&#151;Merger Consideration&#148; beginning on page 156 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_6"></A>Treatment of Coherent Equity Awards (page 157) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent Director RSUs.</I></B> At the effective time, each Coherent director RSU that is outstanding immediately prior to
the effective time will, automatically and without any required action on the </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
part of the holder thereof, vest (if unvested) and be cancelled and converted into the right to receive the merger consideration as if such Coherent director RSU had been settled in shares of
Coherent common stock immediately prior to the effective time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent RSUs.</I></B> At the effective time, each
Coherent RSU (other than any Coherent director RSU) that is outstanding immediately prior to the effective time will be converted into an award covering that number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, rounded
down to the nearest whole share, equal to the product of (x)&nbsp;the number of shares of Coherent common stock subject to such award of Coherent RSUs (and, with respect to any Coherent RSUs that are subject to performance-vesting goals or metrics,
the number of shares of Coherent common stock will be determined based on the greater of the target or actual level of achievement of such goals or metrics immediately prior to the effective time, as determined by the Coherent board or a committee
thereof) and (y)&nbsp;the sum of (A)&nbsp;the exchange ratio and (B)&nbsp;the quotient obtained by dividing (i)&nbsp;the $220.00 cash consideration by (ii)&nbsp;the volume weighted average price of a share of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for a ten trading day period, starting with the opening of trading on the 11th trading day prior to the closing date to the closing of trading on the second to last trading day prior to the
closing date, as reported by Bloomberg. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Involuntary Termination Protection for Coherent RSUs.</I></B> In the event that the
employment of a continuing employee (other than any continuing employee who is a participant under the Coherent change in control leadership severance plan as of immediately prior to the effective time) (which we refer to as a &#147;covered
continuing employee&#148;) is terminated by Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries without cause within the period beginning immediately following the closing date and ending on the date that is
twelve (12)&nbsp;months following the closing date (or, if earlier, December&nbsp;31, 2022) (which we refer to as a &#147;qualifying termination&#148;), the vesting of each award of converted RSUs resulting solely from a Coherent RSU that was
outstanding and held by such covered continuing employee as of the date of the merger agreement will accelerate as to: (A)&nbsp;if such covered continuing employee&#146;s qualifying termination occurs during calendar year 2021, the sum of:
(x)&nbsp;100% of the total number of converted RSUs that otherwise would have vested during calendar year 2021 under the applicable vesting schedule in effect on the closing had such covered continuing employee remained employed with Coherent, <FONT
STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2021 (and reduced by the total number of converted RSUs that vested in calendar year 2021 prior to such
qualifying termination) plus (y)&nbsp;50% of the total number of converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the closing had such covered continuing employee remained
employed with Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2022, or (B)&nbsp;if such covered continuing employee&#146;s qualifying
termination occurs during calendar year 2022, 50% of the total number of converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the closing had such covered continuing employee
remained employed with Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2022 (and reduced by the total number of converted RSUs that
vested in calendar year 2022 prior to such qualifying termination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Coherent ESPP</I></B>. Offering periods under the Coherent ESPP
underway as of the effective time of the merger will terminate no later than five days prior to the effective time, any shortened offering will be treated as a full and effective offering for purposes of the Coherent ESPP (including any pro rata
adjustments to reflect the shortened offering) and outstanding purchase rights under the Coherent ESPP will be exercised no later than one business day prior to the effective time. Subject to the consummation of the merger, the Coherent ESPP will
terminate effective immediately prior to the effective time. Coherent ESPP participants as of the date of the merger agreement will be precluded from increasing their rate of payroll withholding or making additional cash contribution to the Coherent
ESPP, except as required by applicable law. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information on Coherent&#146;s equity-based awards, see &#147;The Merger
Agreement &#151;Treatment of Coherent Equity Awards&#148; beginning on page&nbsp;157 of this joint proxy statement/prospectus. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_7"></A>Material U.S. Federal Income Tax Consequences of the Merger (page&nbsp;190)
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchange of Coherent common stock for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and cash pursuant to the merger
is expected to be treated as a taxable transaction for U.S. federal income tax purposes. Therefore, assuming that such exchange is treated as a taxable transaction, a U.S. holder (as defined below in the section entitled &#147;Material U.S. Federal
Income Tax Consequences of the Merger&#148; beginning on page 190) of Coherent common stock who receives <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and cash in exchange for such U.S. holder&#146;s shares of Coherent common stock
pursuant to the merger generally will recognize capital gain or loss equal to the difference, if any, between (i)&nbsp;the sum of the cash and the fair market value of any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock received
by such U.S. holder in the merger and (ii)&nbsp;the U.S. holder&#146;s adjusted tax basis in its Coherent common stock exchanged therefor. For a more complete discussion of material U.S. federal income tax consequences of the merger, see
&#147;Material U.S. Federal Income Tax Consequences of the Merger&#148; beginning on page&nbsp;190 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>You should be aware that the tax consequences to you of the merger may depend upon your own situation. In addition, you may be subject
to U.S. federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws that are not discussed in this joint proxy statement/prospectus. You should therefore consult with your own tax advisor(s) for a full understanding of the tax
consequences to you of the merger. </I></B></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_8"></A><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Reasons for the Merger;
Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board (page&nbsp;123) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
<FONT STYLE="white-space:nowrap">II-VI</FONT> board has determined that the merger, the merger agreement, the investment agreement and the transactions contemplated by the merger agreement and the investment agreement are advisable and in the best
interests of <FONT STYLE="white-space:nowrap">II-VI</FONT> and its shareholders and has adopted and approved the merger agreement, the investment agreement, the merger, the equity financing and the other transactions contemplated by the merger
agreement and the investment agreement. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board recommends that <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders vote &#147;FOR&#148; the approval of the share issuance and &#147;FOR&#148;
the other proposal to be presented at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. For a more detailed discussion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board&#146;s recommendation, see &#147;The <FONT
STYLE="white-space:nowrap">Merger&#151;II-VI&#146;s</FONT> Reasons for the Merger; Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board&#148; beginning on page&nbsp;123 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_9"></A>Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board (page&nbsp;98) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent board has determined that the merger, the merger agreement and the transactions contemplated by the merger agreement are advisable
and in the best interests of Coherent and its stockholders and has adopted and unanimously approved the merger agreement, the merger and the other transactions contemplated by the merger agreement. The Coherent board recommends that Coherent
stockholders vote &#147;FOR&#148; the adoption of the merger agreement and &#147;FOR&#148; the other proposals to be presented at the Coherent special meeting. For a more detailed discussion of the Coherent board&#146;s recommendation, see &#147;The
Merger&#151;Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148; beginning on page&nbsp;98 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_11"></A>Opinions of Coherent&#146;s Financial Advisors (page&nbsp;103) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Opinion of BofA Securities</I></B><B> (page&nbsp;103; Annex E) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the merger, BofA Securities, at a meeting of the Coherent board, delivered to the Coherent board a written opinion, dated
March&nbsp;24, 2021, as to the fairness, from a financial point of view and as of the date of the opinion, of the merger consideration to be received in the merger by holders of Coherent common stock, other than the holders of any cancelled shares
or any dissenting shares. The full text of the written opinion, dated March&nbsp;24, 2021, of BofA Securities, which describes, among other things, the assumptions made, procedures followed, factors considered and limitations on the review
undertaken, is attached as <B>Annex&nbsp;E</B> hereto and is incorporated by reference herein in its entirety. <B>BofA Securities provided its opinion to the</B> </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>Coherent board</B> <B>(in its capacity as such) for the benefit and use of the Coherent board in connection with and for purposes of its evaluation of the merger consideration from a financial
point of view. BofA Securities&#146; opinion does not address any other term or aspect of the merger and no opinion or view was expressed as to the relative merits of the merger in comparison to other strategies or transactions that might be
available to Coherent or in which Coherent might engage or as to the underlying business decision of Coherent to proceed with or effect the merger. BofA Securities&#146; opinion does not constitute a recommendation to any stockholder as to how to
vote or act in connection with the merger or any related matter.</B> Coherent has agreed to pay BofA Securities for its services in connection with the merger an aggregate fee currently estimated to be approximately $57,700,000 based on the closing
price of II-VI common stock on April&nbsp;23, 2021, a total of $2&nbsp;million of which was paid upon rendering two opinions in connection with the January&nbsp;18 Lumentum Merger Agreement (as defined below) and the March&nbsp;9 Lumentum Merger
Agreement (as defined below), $1&nbsp;million of which was paid in connection with its opinion dated March&nbsp;24, 2021 and the remainder of which is contingent upon the completion of the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a further discussion of BofA Securities&#146; opinion, Coherent&#146;s relationship with BofA Securities and the terms of BofA
Securities&#146; engagement, see &#147;The Merger&#151;Opinions of Coherent&#146;s Financial Advisors&#151;Opinion of BofA Securities&#148; beginning on page&nbsp;103 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Opinion of Credit Suisse</I></B><B> (page 114; Annex F) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent retained Credit Suisse as its financial advisor in connection with the merger based on Credit Suisse&#146;s qualifications, experience
and reputation as an internationally recognized investment banking and financial advisory firm. On March&nbsp;24, 2021, Credit Suisse rendered its oral opinion to the Coherent board (which was subsequently confirmed in writing by delivery of Credit
Suisse&#146;s written opinion dated as of the same date) to the effect that, as of March&nbsp;24, 2021, and subject to the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters considered by
Credit Suisse in connection with the preparation of its opinion, the merger consideration set forth in the merger agreement was fair, from a financial point of view, to the holders of shares of Coherent common stock, other than the holders of any
cancelled shares or any dissenting shares. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse&#146;s opinion was directed to the Coherent board and only addressed the
fairness, from a financial point of view, to the holders of shares of Coherent common stock, other than the holders of any cancelled shares or any dissenting shares, of the merger consideration set forth in the merger agreement and did not address
any other aspect or implication of the merger. <B>The summary of Credit Suisse&#146;s opinion in this joint proxy statement/prospectus is qualified in its entirety by reference to the full text of its written opinion, a copy of which is attached as
Annex F hereto and sets forth the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters considered by Credit Suisse in connection with the preparation of its opinion. However, neither Credit
Suisse&#146;s written opinion nor the summary of its opinion and the related analyses set forth in this joint proxy statement/prospectus is intended to be, and they do not constitute, advice or a recommendation to any security holder as to how such
security holder should vote or act with respect to any matter relating to the merger. </B>Credit Suisse is entitled to receive from Coherent a transaction fee of $17.0&nbsp;million, $2.0&nbsp;million of which became payable upon the rendering of
Credit Suisse&#146;s opinion on March&nbsp;9, 2021, $2.0&nbsp;million of which became payable upon the rendering of Credit Suisse&#146;s opinion on March&nbsp;24, 2021, $10.0&nbsp;million of which is payable contingent upon the closing of the merger
and, at Coherent&#146;s sole discretion, $3.0&nbsp;million of which may be paid at the closing of the merger. See &#147;The Merger&#151;Opinions of Coherent&#146;s Financial Advisors&#151;Opinion of Credit Suisse&#148; beginning on page&nbsp;114 of
this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_10"></A>Opinion of J.P. Morgan (page&nbsp;126) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to an engagement letter, <FONT STYLE="white-space:nowrap">II-VI</FONT> retained J.P.&nbsp;Morgan as its financial advisor in
connection with the proposed merger. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a meeting of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on March&nbsp;17,
2021, J.P.&nbsp;Morgan rendered an oral opinion, confirmed by delivery of a written opinion dated March&nbsp;17, 2021, to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to the effect that, as of such date and based upon and subject to the
assumptions made, procedures followed, matters considered and limitations on the review undertaken by J.P.&nbsp;Morgan in preparing the opinion, the merger consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the merger was
fair, from a financial point of view, to <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The full text of the written opinion of
J.P.&nbsp;Morgan dated March&nbsp;17, 2021, which sets forth the assumptions made, procedures followed, matters considered and limitations on the review undertaken by J.P.&nbsp;Morgan in preparing the opinion, is attached as Annex G to this joint
proxy statement/prospectus and is incorporated herein by reference. The summary of the opinion of J.P.&nbsp;Morgan set forth in this joint proxy statement/prospectus is qualified in its entirety by reference to the full text of such opinion. <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> shareholders are urged to read the opinion in its entirety. J.P.&nbsp;Morgan&#146;s written opinion was addressed to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board (in its capacity as such) in
connection with and for the purposes of its evaluation of the proposed merger, was directed only to the merger consideration payable in the merger and did not address any other aspect of the merger. J.P.&nbsp;Morgan expressed no opinion as to the
fairness of the merger consideration to the holders of any class of securities, creditors or other constituencies of <FONT STYLE="white-space:nowrap">II-VI</FONT> or as to the underlying decision by <FONT STYLE="white-space:nowrap">II-VI</FONT> to
engage in the proposed merger. The issuance of J.P. Morgan&#146;s opinion was approved by a fairness committee of J.P. Morgan. The opinion does not constitute a recommendation to any shareholder as to how such shareholder should vote with respect to
the proposed merger or any other matter. </B></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_10a"></A>Legal Proceedings Regarding the Merger (page&nbsp;149) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;28, 2021, a purported stockholder of Coherent filed a complaint in the United States District Court for the Southern District of
New York captioned <I>Stein v. Coherent, Inc., et al.</I>, Civil Action No. 1:21-cv-3775. The complaint names as defendants Coherent and members of the Coherent board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_12"></A>Appraisal Rights in the Merger (page 149) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger is completed and certain other statutory requirements described herein are met, record holders of Coherent common stock who do
not vote in favor of the Coherent merger proposal, who continuously hold such shares through the effective time and who properly demand appraisal of their shares may be entitled to appraisal rights in connection with the merger under
Section&nbsp;262 of the DGCL. This means that holders of shares of Coherent common stock are entitled to have their shares appraised by the Court of Chancery and to receive in lieu of the merger consideration a cash payment of an amount determined
by the Court of Chancery equal to the &#147;fair value&#148; of their Coherent common stock, exclusive of any elements of value arising from the accomplishment or expectation of the merger, together with interest to be paid on the amount determined
to be fair value, if any, as determined by the Court of Chancery as described further herein, so long as they comply with the procedures established by Section&nbsp;262 of the DGCL and certain other conditions relating to stock ownership thresholds
are met. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A detailed description of the procedures required to be followed in order to perfect appraisal rights by Coherent
stockholders if desired is included in the section titled &#147;The Merger&#151;Appraisal Rights in the Merger&#148; beginning on page&nbsp;149 of this joint proxy statement/prospectus, which detailed description is qualified by reference to the
full text of Section&nbsp;262 of the DGCL as attached as <B>Annex&nbsp;D</B> to this joint proxy statement/prospectus. Due to the complexity of the procedures described above, Coherent stockholders who are considering exercising such rights are
encouraged to carefully review <B>Annex&nbsp;D</B> and seek the advice of legal counsel. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Coherent stockholders considering
seeking appraisal should be aware that the fair value of their shares of Coherent common stock as determined by the Court of Chancery pursuant to Section&nbsp;262 of the DGCL could be more than, the same as or less than the value of the merger
consideration. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are not entitled to appraisal rights under Pennsylvania
law, the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter or the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_13"></A>Interests of Coherent&#146;s Directors and Executive Officers in the Merger
(page 139) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering the recommendations of the Coherent board with respect to the merger, Coherent&#146;s stockholders should be
aware that certain of Coherent&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and executive officers have economic interests in the merger that are different from, or in addition to, those of Coherent&#146;s stockholders
generally. These interests include, among others: (i)&nbsp;the continued employment of Coherent executive officers with the combined company, including potential increases in compensation, (ii)&nbsp;the continued service of certain <FONT
STYLE="white-space:nowrap">non-employee</FONT> members of the Coherent board as directors of <FONT STYLE="white-space:nowrap">II-VI,</FONT> (iii)&nbsp;the treatment of equity awards, including the potential accelerated vesting of such awards in the
event of a qualifying termination of employment following the merger, (iv)&nbsp;the potential severance benefits for executive officers in the event of a qualifying termination of employment following the merger and (v)&nbsp;continuing
indemnification rights of <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Coherent board and Coherent executive officers following the merger. For more information, see &#147;The Merger&#151;Interests of Coherent&#146;s Directors
and Executive Officers in the Merger&#148; beginning on page&nbsp;139 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_14"></A>Board of
Directors and Management After the Merger (page 170 and page 184) </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the merger agreement, following the
completion of the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> will appoint two directors designated by Coherent, and reasonably acceptable to <FONT STYLE="white-space:nowrap">II-VI,</FONT> to the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board from among the directors serving on the Coherent Board as of prior to the effective time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the investment agreement, following the closing of the initial investment and for so long as the investors
beneficially own shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (or shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued upon the conversion thereof) that represent, in the
aggregate and on an as-converted basis, at least 25% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, on an as-converted basis, that they held immediately following the completion of either the initial
investment (if the subsequent investment has not occurred) or the equity financing, the investors will have the right to nominate one designee and to designate one observer to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board. The
investors&#146; initial designee and observer to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board were Stephen Pagliuca and Joseph Robbins, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It has not yet been determined the extent to which any executive officers of Coherent will become executive officers of <FONT
STYLE="white-space:nowrap">II-VI</FONT> upon completion of the merger, or whether the executive officers of <FONT STYLE="white-space:nowrap">II-VI</FONT> will otherwise remain unchanged. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_15"></A>Regulatory Approvals (page 145) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Completion of the merger is subject to the termination or expiration of any applicable waiting period (or extension thereof) under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (which we refer to as the &#147;HSR Act&#148;), and the receipt of the other applicable regulatory clearances or approvals,
including antitrust authorizations or approvals in the People&#146;s Republic of China, Germany, South Korea and, if necessary or advisable, the United Kingdom. These jurisdictions can impose conditions on case approval under the applicable
competition laws as they deem necessary or desirable, including, but not limited to, seeking divestiture of substantial assets of the parties or requiring the parties to license, or hold separate, assets or to not engage in certain types of conduct.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>United States</I>. Under the HSR Act, certain transactions, including the merger, may not be completed until notifications have been
given and information furnished to the Antitrust Division of the United States Department of Justice (which we refer to as the &#147;Antitrust Division&#148;) and the United States Federal Trade Commission (which we refer to as the &#147;FTC&#148;),
and all statutory waiting period requirements have been satisfied. A transaction notifiable under the HSR Act may not be completed until the expiration of a <FONT STYLE="white-space:nowrap">30-calendar</FONT> day
</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
waiting period following the parties&#146; filings of their respective HSR Act notification forms or the early termination of that waiting period. In certain circumstances, the review period may
be extended by either the parties or the Antitrust Division or the FTC. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent each filed their respective HSR Act notification forms on April&nbsp;8, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>China</I>. Under the Antimonopoly Law of the People&#146;s Republic of China (which we refer to as the &#147;AML&#148;), transactions
involving parties with sales above certain revenue levels cannot be completed until they are reviewed and approved by the State Administration for Market Regulation (which we refer to as &#147;SAMR&#148;).
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues to exceed SAMR&#146;s statutory thresholds for review, and completion of the merger is therefore conditioned upon SAMR approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Germany</I>. Under the German Act against Restraints of Competition of 1958 <I>(Gesetz gegen Wettbewerbsbeschr&auml;nkungen)</I> (as
amended), transactions involving parties with sales above certain revenue levels cannot be completed until they are either reviewed and approved by the Federal Cartel Office of the Federal Republic of Germany (&#147;FCO&#148;) or the relevant
waiting periods have expired without the FCO having prohibited the merger. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues in Germany to exceed the statutory thresholds, and completion of the merger is therefore
conditioned upon either FCO approval or the expiration of the relevant waiting periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>South Korea</I>. Under the Monopoly Regulation
and Fair Trade Act (which we refer to as &#147;MRFTA&#148;), the Republic of Korea requires that transactions involving parties with sales above a certain threshold be reported to the Korea Fair Trade Commission (which we refer to as
&#147;KFTC&#148;) for review and approval. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues to exceed KFTC&#146;s statutory threshold for review, and completion of the merger is therefore conditioned upon KFTC
approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>United Kingdom</I>. Merger control filings under the United Kingdom&#146;s Enterprise Act 2002 (which we refer to as the
&#147;Enterprise Act&#148;) are not mandatory but the United Kingdom&#146;s Competition and Markets Authority (the &#147;CMA&#148;) has the ability to open an investigation into the transaction, or may seek to or request a filing from the parties if
certain jurisdictional thresholds are met. If the parties agree that a filing under the Enterprise Act is necessary or advisable, the merger shall be conditioned upon relevant approvals from the CMA under the Enterprise Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time before or after the expiration of the statutory waiting periods under the HSR Act, the Antitrust Division or the FTC may take
action under the antitrust laws, including seeking to enjoin the completion of the merger, to rescind the merger or to conditionally permit completion of the merger subject to regulatory conditions or other remedies. In addition, <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> regulatory bodies and U.S. state attorneys general could take action under other applicable regulatory laws as they deem necessary or desirable in the public interest, including, without limitation, seeking
to enjoin or otherwise prevent the completion of the merger or permitting completion subject to regulatory conditions. Private parties may also seek to take legal action under regulatory laws under some circumstances. There can be no assurance that
a challenge to the merger on antitrust or other regulatory grounds will not be made or, if such a challenge is made, that it would not be successful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_16">
</A>Expected Timing of the Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent expect to complete the merger by <FONT
STYLE="white-space:nowrap">year-end</FONT> 2021. However, it is possible that factors outside the control of both companies could result in the merger being completed at a different time or not at all. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_17"></A>Conditions to Complete the Merger (page 177) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As more fully described in this joint proxy statement/prospectus and in the merger agreement, the obligations of
<FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub and Coherent, as applicable, to consummate the merger are subject to the satisfaction or waiver of certain conditions, including, among others, the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders and approval of the Coherent merger proposal by Coherent stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declaration of the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> of which this joint
proxy statement/prospectus is a part as effective and no stop order or proceedings have been issued, initiated or threatened by the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval for the listing of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued
in the merger on Nasdaq, subject to official notice of issuance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any injunction by any court or other tribunal of competent jurisdiction prohibiting the
consummation of the merger being in effect, or law that prohibits the consummation of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable waiting periods shall have expired or been terminated, and any approvals required shall have been
obtained under the HSR Act or under certain other antitrust or foreign investment laws (which we refer to as the &#147;antitrust laws&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of the representations and warranties of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub
and Coherent contained in the merger agreement as of the closing, subject to the applicable materiality standards provided in the merger agreement (and the receipt of an officers&#146; certificate to such effect); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance and compliance by <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub and Coherent in all
material respects of all obligations and covenants required to be performed by or complied with by them under the merger agreement at or prior to the effective time (and the receipt of an officers&#146; certificate to such effect); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any event, change, effect, development or occurrence that, since the date of the merger agreement,
has had or would reasonably be expected to have a material adverse effect on <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent (and the receipt of an officers&#146; certificate to such effect). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_18"></A>Termination of the Merger Agreement (page 179) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement may be terminated at any time prior to the completion of the merger, whether before or after the receipt of the required
vote to adopt the merger agreement by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or Coherent stockholders, in the following circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by mutual written consent of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if the merger has not been consummated on or
before 5:00 pm, Eastern time, on December&nbsp;25, 2021 (the &#147;original end date&#148;); provided that, if on the original end date the approval under the HSR Act or under certain other antitrust laws has not been satisfied (but all other
conditions to the closing of the merger have been satisfied or waived by all parties entitled to the benefit of such conditions), the original end date will be extended in accordance with the merger agreement, with the first extended end date
occurring on March&nbsp;25, 2022, the second extended end date occurring on June&nbsp;25, 2022 and the third and final extended end date occurring on September&nbsp;25, 2022 (the end date after taking such adjustments into account, the &#147;end
date&#148;) (which we refer to as the &#147;end date termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if an injunction permanently restraining,
enjoining or otherwise prohibiting the consummation of the merger has been entered and is considered final and nonappealable, provided that the party seeking to terminate the merger agreement has used reasonable best efforts to prevent the
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
entry of and to remove such relevant legal restraint in accordance with the merger agreement, and that the injunction is not primarily due to a material breach of a representation, warranty,
covenant, or other agreement set forth in the merger agreement by such party (which we refer to as the &#147;injunction termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if the approval of the <FONT
STYLE="white-space:nowrap">(i)&nbsp;II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders has not been obtained following the conclusion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting (including any adjournments or postponements thereof) (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> special meeting termination&#148;) or (ii)&nbsp;the Coherent merger proposal by Coherent stockholders has not
been obtained following the conclusion of the Coherent special meeting (including any adjournments or postponements thereof) (which we refer to as the &#147;Coherent special meeting termination&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, if the other party (including Merger Sub if
Coherent is the terminating party) has breached or failed to perform any of its or their representations, warranties, covenants or other agreements contained in the merger agreement, which breach or failure to perform (i)&nbsp;if it occurred or was
continuing to occur on the closing date, would result in the failure of conditions to the terminating party&#146;s obligations to close and (ii)&nbsp;by its nature, cannot be cured prior to the end date, or if such breach or failure is capable of
being cured by the end date, the other party has not cured such breach or failure within 30&nbsp;days after receiving written notice from the terminating party describing such break or failure in reasonable detail, provided that the terminating
party is not then in material breach of any representation, warranty, covenant or other agreement contained in the merger agreement that would result in a failure of a condition to the other party&#146;s obligation to close; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI,</FONT> prior to the approval of the Coherent merger proposal, in the
event of an adverse recommendation change by Coherent (which we refer to as the &#147;Coherent adverse recommendation change termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent, prior to the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal,
in the event of an adverse recommendation change by <FONT STYLE="white-space:nowrap">II-VI</FONT> (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> adverse recommendation change termination&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI,</FONT> at any time prior to the approval of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, in order to enter into an agreement with respect to a superior proposal; provided that (i)&nbsp;in advance of or concurrently with such termination,
<FONT STYLE="white-space:nowrap">II-VI</FONT> pays or causes to be paid the <FONT STYLE="white-space:nowrap">II-VI</FONT> termination fee (as defined below) and <FONT STYLE="white-space:nowrap">(ii)&nbsp;II-VI</FONT> has otherwise complied in all
respects (other than de minimis noncompliance unrelated to such superior proposal) with its <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations and SEC filing obligations under the merger agreement (which we refer to as the <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> superior proposal termination&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent, at any time prior to the approval of the Coherent merger proposal, in order to enter into an
agreement with respect to a superior proposal; provided that (i)&nbsp;in advance of or concurrently with such termination, Coherent pays or causes to be paid the Coherent termination fee (as defined below) and (ii)&nbsp;Coherent has otherwise
complied in all respects (other than de minimis noncompliance unrelated to such superior proposal) with its <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations and SEC filing obligations under the merger agreement (which we refer to
as the &#147;Coherent superior proposal termination&#148;). </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_19"></A>Termination Fees (page 180) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending on the circumstances in which the merger agreement is terminated, <FONT STYLE="white-space:nowrap">II-VI</FONT> may be required to
pay a termination fee of $337.7&nbsp;million to Coherent or Coherent may be required to pay a termination fee of $108.8&nbsp;million to <FONT STYLE="white-space:nowrap">II-VI.</FONT> Upon the termination of the merger agreement for failure to obtain
antitrust approval from SAMR, <FONT STYLE="white-space:nowrap">II-VI</FONT> may be required to pay Coherent a termination fee of $500&nbsp;million. In addition, if the merger agreement is terminated in certain circumstances, <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent may be required to pay to the other $25&nbsp;million to cover the other party&#146;s costs and expenses in connection with the merger agreement. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_20"></A>Debt and Equity Financing (page 146) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> currently anticipates that it will finance the cash payments required to consummate the merger
through a combination of (i)&nbsp;approximately $900&nbsp;million of cash, cash equivalents and short-term investments from the combined balance sheets of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, (ii)&nbsp;approximately
$4,725&nbsp;million of third-party debt financing, which may include some combination of a senior secured revolving credit facility, a senior secured term loan credit facility, a senior unsecured bridge loan facility and/or the issuance of senior
unsecured notes or other debt securities (which we refer to as the &#147;debt financing&#148; and, together with the equity financing, the &#147;financings&#148;) and (iii)&nbsp;approximately $1,800&nbsp;million (assuming the investors do not
exercise their option to invest up to an additional $350.0&nbsp;million) pursuant to the equity financing. These amounts are sufficient to (a)&nbsp;pay Coherent stockholders the amounts due to them under the merger agreement, (b)&nbsp;refinance or
otherwise discharge any outstanding indebtedness of Coherent and II-VI required to be repaid at the completion of the merger, and (c)&nbsp;pay any fees, costs and expenses incurred in connection with the merger. The completion of the merger is not,
however, subject to a financing condition or to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to obtain the financings. See the section titled &#147;The Merger&#151;Financing&#148; beginning on page&nbsp;146 of this joint proxy
statement/prospectus for more information. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement,
<FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the debt commitment letter. Subject to the terms of the debt commitment letter, the commitment parties have committed to provide a senior secured term loan &#147;A&#148; facility in an
aggregate principal amount of $850&nbsp;million, a senior secured term loan &#147;B&#148; facility in an aggregate principal amount of $2,800&nbsp;million, a senior secured revolving credit facility in an aggregate principal amount of
$350&nbsp;million and a senior unsecured bridge loan facility in an aggregate principal amount of $1,125&nbsp;million (which we refer to as the &#147;bridge loan facility&#148; and collectively with the other foregoing facilities, the
&#147;facilities&#148;). The bridge loan facility will only be drawn to the extent <FONT STYLE="white-space:nowrap">II-VI</FONT> is unable to issue senior unsecured notes or other debt securities at or prior to the closing of the merger in an amount
sufficient to close the transaction. The funding of the facilities provided for in the debt commitment letter is contingent on the satisfaction of customary conditions, including the execution and delivery of definitive documentation with respect to
the facilities in accordance with the terms sets forth in the debt commitment letter and the consummation of the merger in accordance with the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement, on March&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> also entered into
the investment agreement. On March&nbsp;31, 2021, pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated the initial investment of $750.0&nbsp;million. Pursuant to the investment agreement and
subject to the terms and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least $1.05&nbsp;billion, which may be increased by up to an additional
$350.0&nbsp;million, immediately prior to the closing of the merger. The issuance and sale of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the
subsequent investment is contingent upon consummation of the merger in accordance with the merger agreement, and is subject to certain other closing conditions customary for transactions of this type. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The investors have agreed to certain restrictions on transfer and standstill provisions, and will receive certain board governance and
registration rights. The conversion price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will initially be $85.00 per share, subject to adjustments as set forth in the statement with respect to shares. For
more information on the terms of the investment agreement and of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, see the section titled &#147;The Investment Agreement and the Statement with Respect to
Shares&#148; beginning on page&nbsp;183 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_21"></A>Anticipated Accounting Treatment
(page&nbsp;145) </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent each prepare their respective financial statements in
accordance with accounting principles generally accepted in the United States (&#147;GAAP&#148;). The merger will be accounted for using the acquisition method of accounting with <FONT STYLE="white-space:nowrap">II-VI</FONT> as the accounting
acquirer and Coherent as the accounting acquiree. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Under the acquisition method of accounting, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> assets and liabilities will be recorded at carrying value and the assets and liabilities
associated with Coherent will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the assets acquired and liabilities assumed, if applicable, will be recognized as
goodwill. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_22"></A>The Rights of Coherent Stockholders Will Change as a Result of the Merger (page&nbsp;218) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights of Coherent stockholders are governed by Delaware law and by the Coherent charter and bylaws of Coherent. As a result of the merger,
Coherent stockholders will become holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, and their rights will be governed by Pennsylvania law and the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter and <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws. Coherent stockholders will have different rights once they become holders of common stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> due to differences in governing law and between the Coherent
governing documents and the <FONT STYLE="white-space:nowrap">II-VI</FONT> governing documents. These differences are described in more detail under &#147;Comparison of Stockholders&#146; Rights&#148; beginning on page&nbsp;218 of this joint proxy
statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_23"></A>Listing of <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock; Delisting and Deregistration of
Coherent Common Stock (page&nbsp;149) </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued in
the merger will be listed for trading on Nasdaq under the symbol &#147;IIVI.&#148; In addition, following the merger, Coherent common stock will be delisted from Nasdaq, deregistered under the Exchange Act and cease to be publicly traded. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_24"></A>The <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting (page&nbsp;57) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting will be held virtually at www.virtualshareholdermeeting.com/IIVI2021SM on
June&nbsp;24, 2021, at 11:30 a.m., Eastern Time. At the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will be asked to vote on the following matters: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting if you owned shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock at the close of business on May&nbsp;17, 2021. Only <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders of record on such date are entitled to receive notice of, and to vote at, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting or any adjournment or postponement thereof. On April&nbsp;30, 2021, there were 105,007,546 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding, approximately 2.2%
of which were owned and entitled to be voted by <FONT STYLE="white-space:nowrap">II-VI</FONT> directors and executive officers and their affiliates (which percentage is inclusive of restricted shares of II-VI common stock, II-VI common stock
underlying granted but unvested II-VI restricted stock units, II-VI common stock underlying II-VI stock options exercisable within 60 days of the II-VI record date, and II-VI common stock indirectly owned). Although none of them has entered into any
agreement obligating them to do so, <FONT STYLE="white-space:nowrap">II-VI</FONT> currently expects that all of its directors and executive officers will vote their shares &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> share
issuance proposal and &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. Each holder of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock is entitled to one vote for each share of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock owned at the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
presence, in person (virtually) or represented by proxy, of shareholders entitled to cast at least a majority of the votes that all shareholders are entitled to cast on the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date will constitute a
quorum at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder and you fail to submit a proxy or to be present virtually at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock will not be counted towards a quorum. Abstentions are considered present for purposes of establishing a quorum.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There must be a quorum for a vote on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal to be taken at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting. If there is no quorum, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting may be adjourned or postponed to another date if the <FONT STYLE="white-space:nowrap">II-VI</FONT>
adjournment proposal is approved at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming that a quorum is present, approval of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal requires the affirmative vote of at least a majority of the votes cast by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy. Approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal requires the affirmative vote of at least a majority of the votes that all <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy, are entitled to cast. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you mark &#147;ABSTAIN&#148; on your proxy, it will have no effect on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance
proposal, and it will have the same effect as a vote &#147;AGAINST&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder and you fail to submit a proxy or
to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or fail to instruct your bank, broker or other nominee how to vote with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal or the <FONT
STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, your shares will not be deemed to be represented at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, and it will have no effect on the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal or the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, see &#147;The
<FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting&#148; beginning on page&nbsp;
57 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_25"></A>The Coherent Special Meeting (page&nbsp;64) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent special meeting will be virtually held at www.virtualshareholdermeeting.com/COHR2021SM on June&nbsp;24, 2021, at 8:30&nbsp;a.m.,
Pacific Time. At the Coherent special meeting, Coherent stockholders will be asked to vote on the following matters: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve the Coherent merger proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve the Coherent compensation proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve the Coherent adjournment proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote at the Coherent special meeting if you owned shares of Coherent common stock at the close of business on May&nbsp;17, 2021. Only
Coherent stockholders of record on such date are entitled to receive notice of, and to vote at, the Coherent special meeting or any adjournment or postponement of the Coherent special meeting. On April&nbsp;30, 2021, there were 24,531,522 shares of
Coherent common stock outstanding, less than 1% of which were owned and entitled to be voted by Coherent directors and executive officers and their affiliates. We currently expect that Coherent&#146;s directors and executive officers will vote their
shares in favor of the adoption of the merger agreement, although none of them has entered into any agreements obligating them to do so. Each holder of shares of Coherent common stock is entitled to one vote for each share of Coherent common stock
owned at the Coherent record date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of a majority of the shares of Coherent common stock entitled to vote at the special
meeting, present in person (virtually) or represented by proxy, will be necessary to constitute a quorum for the transaction of business at the Coherent special meeting. If you are a Coherent stockholder and you fail to submit a proxy or to attend
the Coherent special meeting, your shares of Coherent common stock will not be counted towards a quorum. Abstentions are considered present for purposes of establishing a quorum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent merger proposal will be approved if the holders of a majority of the outstanding shares of Coherent common stock entitled to vote
on the Coherent merger proposal vote &#147;FOR&#148; such proposal. The Coherent compensation proposal will be approved if the holders of a majority of the shares present or represented by proxy at the meeting and entitled to vote on the Coherent
compensation proposal vote &#147;FOR&#148; such proposal. The Coherent adjournment proposal will be approved if the holders of a majority of the shares present or represented by proxy at the meeting and entitled to vote on the Coherent adjournment
proposal vote &#147;FOR&#148; such proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you mark &#147;ABSTAIN&#148; on your proxy, fail to submit a proxy or vote at the
Coherent special meeting or fail to instruct your bank, broker or other nominee how to vote with respect to the Coherent merger proposal, it </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will have the same effect as a vote &#147;AGAINST&#148; the Coherent merger proposal. If you mark &#147;ABSTAIN&#148; on your proxy, it will have the same effect as a vote &#147;AGAINST&#148; the
Coherent compensation proposal and the Coherent adjournment proposal, as applicable. If you are a Coherent stockholder and you fail to submit a proxy or to vote at the Coherent special meeting or fail to instruct your bank, broker or other nominee
how to vote with respect to the Coherent compensation proposal or the Coherent adjournment proposal, your shares will not be deemed to be represented at the Coherent special meeting, and it will have no effect on the Coherent compensation proposal
or the Coherent adjournment proposal, as applicable. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Coherent special meeting, see &#147;The Coherent
Special Meeting&#148; beginning on page&nbsp;64 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_26"></A>Certain Beneficial Owners of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Common Stock (page&nbsp;238) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the close of business on April&nbsp;30, 2021, directors and
executive officers of <FONT STYLE="white-space:nowrap">II-VI</FONT> beneficially owned and were entitled to vote approximately 2,324,073 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, collectively representing approximately
2.2% of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding on April&nbsp;30, 2021 (which percentage is inclusive of restricted shares of II-VI common stock, II-VI common stock underlying granted but unvested II-VI
restricted stock units, II-VI common stock underlying II-VI stock options exercisable within 60 days of the II-VI record date, and II-VI common stock indirectly owned). Although none of them has entered into any agreement obligating them to do so, <FONT
STYLE="white-space:nowrap">II-VI</FONT> currently expects that all of its directors and executive officers will vote their shares &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and &#147;FOR&#148; the <FONT
STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. For more information regarding the security ownership of <FONT STYLE="white-space:nowrap">II-VI</FONT> directors and executive officers, see &#147;Security Ownership of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Beneficial Owners and Management&#148; beginning on page&nbsp;
238 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_27"></A>Certain Beneficial Owners of Coherent Common Stock (page&nbsp;241) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the close of business on April&nbsp;30, 2021, directors and executive officers of Coherent beneficially owned and were entitled to vote
approximately 168,075 shares of Coherent common stock, collectively representing less than 1% of the shares of Coherent common stock outstanding on April&nbsp;30, 2021 (which percentage is inclusive of Coherent RSUs vesting within 60 days of the
Coherent record date and Coherent common stock indirectly owned). Although none of them has entered into any agreement obligating them to do so, Coherent currently expects that all of its directors and executive officers will vote their shares
&#147;FOR&#148; the Coherent merger proposal, &#147;FOR&#148; the Coherent compensation proposal and &#147;FOR&#148; the Coherent adjournment proposal. For more information regarding the security ownership of Coherent directors and executive
officers, see &#147;Security Ownership of Coherent Beneficial Owners and Management&#148; beginning on page&nbsp;241 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_28"></A>Ownership of <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock after the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of Coherent common stock outstanding as of April&nbsp;30, 2021, in connection with the merger, <FONT
STYLE="white-space:nowrap">II-VI</FONT> expects to issue approximately 22.3&nbsp;million shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to holders of Coherent common stock and equity holders entitled to receive merger
consideration upon completion of the merger. The actual number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued upon completion of the merger will be determined at the completion of the merger based on, among
other things, the number of shares of Coherent common stock outstanding at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of Coherent common
stock outstanding as of April&nbsp;30, 2021, upon completion of the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent estimate that Coherent stockholders and equity holders entitled to receive merger consideration as of immediately
prior to the merger will collectively own approximately 15.0%, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders as of immediately prior to the merger (excluding as a result of the equity financing) will own
</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
approximately 70.7%, and the investors will own approximately 14.3% of the outstanding shares of common stock of the combined company (in each case, on an as-converted and fully diluted basis and
without regard to the fact that immediately prior to the merger, certain holders may own both <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent stock). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_29"></A>Risk Factors (page&nbsp;42) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In evaluating the merger agreement, the investment agreement, the statement with respect to shares, the merger, the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock in the merger or the issuance and sale of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock in the equity financing, you should carefully read this
joint proxy statement/prospectus and give special consideration to the factors discussed in &#147;Risk Factors&#148; beginning on page&nbsp;42 of this joint proxy statement/prospectus. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_30"></A>SELECTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following selected unaudited pro forma condensed combined financial information (which we refer to as the
&#147;selected pro forma information&#148;) gives effect to the merger, the equity financing, the debt financing, and other transactions described in the section entitled &#147;Unaudited Pro Forma Condensed Combined Financial Information.&#148; The
merger will be accounted for using the acquisition method of accounting with <FONT STYLE="white-space:nowrap">II-VI,</FONT> as the accounting acquirer, and Coherent, as the accounting acquiree. Under this method of accounting, the aggregate merger
consideration will be allocated to Coherent&#146;s assets acquired and liabilities assumed based upon their estimated fair values at the date of completion of the merger. Any differences between the estimated fair value of the consideration
transferred and the estimated fair value of the assets acquired and liabilities assumed will be recorded as goodwill. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selected
unaudited pro forma balance sheet information as of December&nbsp;31, 2020 gives effect to the merger, the equity financing, and the debt financing as if those transactions had been completed on December&nbsp;31, 2020 and combines the unaudited
consolidated balance sheet of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of December&nbsp;31, 2020 with Coherent&#146;s unaudited consolidated balance sheet as of January&nbsp;2, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selected unaudited pro forma statement of earnings (loss) information for the year ended June&nbsp;30, 2020 and the six months ended
December&nbsp;31, 2020 give effect to the merger, the equity financing, and the debt financing, along with other transactions described in the section entitled &#147;Unaudited Pro Forma Condensed Combined Financial Information,&#148; as if they had
occurred on July&nbsp;1, 2019, the first day of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year 2020, and combines the historical results of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar Corporation, a
subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> that was acquired on September&nbsp;24, 2019 (which we refer to as &#147;Finisar&#148;). The unaudited pro forma condensed combined statement of earnings (loss) for the fiscal year ended
June&nbsp;30, 2020 combines the audited consolidated statement of earnings of <FONT STYLE="white-space:nowrap">II-VI</FONT> for the fiscal year ended June&nbsp;30, 2020, the Coherent unaudited consolidated statement of operations for the twelve
months ended July&nbsp;4, 2020 and Finisar&#146;s unaudited consolidated statement of operations for the three month period ended July&nbsp;28, 2019. The unaudited pro forma condensed combined statement of earnings (loss) for the six months ended
December&nbsp;31, 2020 combines the unaudited consolidated statement of earnings of <FONT STYLE="white-space:nowrap">II-VI</FONT> for the six months ended December&nbsp;31, 2020 with Coherent&#146;s unaudited consolidated statement of operations for
the six months ended January&nbsp;2, 2021. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selected pro forma information has been presented for informational purposes only and is
not necessarily indicative of what the combined company&#146;s financial position or results of operations actually would have been had the merger and other transactions described in the section entitled &#147;Unaudited Pro Forma Condensed Combined
Financial Information&#148; been completed as of the dates indicated. In addition, the selected pro forma information does not purport to project the future financial position or operating results of the combined company. The selected pro forma
information should be read together with unaudited pro forma condensed combined financial information and the accompanying notes in the section entitled &#147;Unaudited Pro Forma Condensed Combined Financial Information.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of and for the</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months<BR>Ended<BR>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">(in&nbsp;thousands,&nbsp;except&nbsp;per&nbsp;share&nbsp;amounts)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Pro Forma Statement of Earnings (Loss) Information:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,157,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,890,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net earnings (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,069,852</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9.74</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9.74</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Pro Forma Balance Sheet Information:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">924,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,862,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,921,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt including the current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,982,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,992,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,784,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_31"></A>COMPARATIVE HISTORICAL AND UNAUDITED PRO FORMA PER SHARE
FINANCIAL DATA </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Historical Per Share Data for <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock and Coherent Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent&#146;s most recent fiscal year ended on October 3, 2020 and II-VI&#146;s most recent fiscal year ended on June 30, 2020. As a
consequence of Coherent&#146;s and II-VI&#146;s different fiscal years, the amounts presented as Coherent&#146;s historical information in the table below for the six months ended December 31, 2020 represent Coherent&#146;s historical information
for the six month period ended January 2, 2021 and was prepared by taking the unaudited consolidated statement of operations for the three months ended January 2, 2021, adding the audited consolidated statement of operations for the fiscal year
ended October 3, 2020 and subtracting the unaudited consolidated statement of operations for the nine months ended July 4, 2020. In addition, the amounts presented as Coherent&#146;s historical information in the table below for the fiscal year
ended June 30, 2020 represent Coherent&#146;s historical information for the twelve month period ended July 4, 2020 and was prepared by taking the unaudited consolidated statement of operations for the nine months ended July 4, 2020, adding the
audited consolidated statement of operations for the fiscal year ended September 28, 2019, and subtracting the unaudited consolidated statement of operations for the nine months ended June 29, 2019. The historical per share data for II-VI common
stock below is derived from the audited consolidated financial statements of II-VI as of and for the fiscal year ended June 30, 2020, and the unaudited condensed consolidated financial statements of II-VI as of and for the six months ended December
31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Combined Per Share Data for <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock set forth below gives effect to
the merger, and the estimated financing used to finance the merger, as if it had been consummated on July&nbsp;1, 2019, the beginning of the earliest period presented, in the case of earnings per share data, and as of December&nbsp;31, 2020 in the
case of book value per share data, and assuming that each outstanding share of Coherent common stock had been converted into the merger consideration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock has been derived from the
audited consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of and for the fiscal year ended June&nbsp;30, 2020 and the unaudited consolidated financial statements of Coherent as of and for the twelve months ended
July&nbsp;4, 2020, which are calculated by adding the unaudited condensed consolidated financial statements of Coherent as of and for the three months ended September&nbsp;28, 2019 included in Coherent&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K,</FONT> as amended, to the unaudited condensed consolidated financial statements of Coherent as of and for the nine months ended July&nbsp;4, 2020. In addition, the unaudited pro forma combined per share data for <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock has been derived from the unaudited condensed consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of and for the six months ended December&nbsp;31, 2020 and the
unaudited condensed consolidated financial statements of Coherent as of and for the three months ended January&nbsp;2, 2021. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited
pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock has been derived using the acquisition method of accounting. See the section entitled &#147;Unaudited Pro Forma Condensed Combined Financial
Information.&#148; Accordingly, the pro forma adjustments reflect the assets and liabilities of Coherent at their preliminary estimated fair values. Differences between these preliminary estimates and the values finalized within 12 months after the
completion of the merger in accordance with applicable accounting guidance could occur and these differences could have a material impact on the unaudited pro forma combined per share information set forth below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock does not purport to represent
the actual results of operations that <FONT STYLE="white-space:nowrap">II-VI</FONT> would have achieved had the merger been completed at the relevant dates used or to project the future results of operations that
<FONT STYLE="white-space:nowrap">II-VI</FONT> may achieve after the merger. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Combined Per Coherent Equivalent Share Data </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma combined Coherent equivalent per share data set forth below shows the effect of the merger from the perspective of an
owner of Coherent common stock. The information was calculated by multiplying the unaudited pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock by the exchange ratio. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Historical and Unaudited Pro Forma Combined Per Share Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read the below information in conjunction with the historical consolidated financial statements of
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent and related notes that have been filed with the SEC, certain of which are incorporated by reference into this joint proxy statement/prospectus. See the section entitled &#147;Where You Can
Find More Information&#148; in this joint proxy statement/prospectus. The unaudited pro forma combined per share data for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and the unaudited pro forma combined per Coherent equivalent share
data is derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial statements and related notes included in this joint proxy statement/prospectus. See the section entitled &#147;Unaudited Pro Forma
Condensed Combined Financial Information.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain historical and unaudited pro forma combined per
share information for <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of/For<BR>the<BR>Six<BR>Months<BR>Ended<BR>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of/For<BR>the<BR>Year<BR>Ended<BR>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> &#151; Historical</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.79)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.79)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book value per share of common stock(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends declared per share of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Coherent &#151; Historical</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17.52)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(17.52)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book value per share of common stock(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends declared per share of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Combined Per <FONT STYLE="white-space:nowrap">II-VI</FONT> Share Data for <FONT
STYLE="white-space:nowrap">II-VI</FONT> Common Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.63)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9.74)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.63)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9.74)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book value per share of common stock(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Combined Per Coherent Equivalent Share Data(4)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings (loss) per share:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.57)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8.86)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings (loss) per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.57)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8.86)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book value per share of common stock(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated by dividing shareholders&#146; equity of $3,236,813,000 and $2,076,803,000 as of December&nbsp;31,
2020 and June&nbsp;30, 2020, respectively, by 104,556,769 and 92,559,621 outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock as of December&nbsp;31, 2020 and June&nbsp;30, 2020, respectively. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated by dividing stockholders&#146; equity of $951,878,000 and $893,506,000 as of January&nbsp;2, 2021
and July&nbsp;4, 2020, respectively, by 24,447,000 and 24,256,000 outstanding shares of Coherent common stock as of January&nbsp;2, 2021 and July&nbsp;4, 2020, respectively. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated by dividing pro forma shareholders&#146; equity of $4,784,358,000 by 128,453,725 pro forma
outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Unaudited pro forma combined book value per share of common stock as of June&nbsp;30, 2020 is not applicable as the estimation of pro forma adjustments have been
calculated as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assumes amounts calculated by multiplying unaudited pro forma combined per share amounts by the exchange ratio.
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_32"></A>COMPARATIVE MARKET PRICE AND DIVIDEND INFORMATION (UNAUDITED)
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock are listed for trading on Nasdaq under the symbol
&#147;IIVI.&#148; Shares of Coherent common stock are listed for trading on Nasdaq under the symbol &#147;COHR.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Closing Prices; Implied
Value Per Share </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the closing sales prices per share of <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock and Coherent common stock on Nasdaq, and the per share value of one share of Coherent common stock implied by the merger consideration, on the following dates: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">March&nbsp;24, 2021, the last trading day before the day on which <FONT STYLE="white-space:nowrap">II-VI</FONT>
and Coherent announced the execution of the merger agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">April&nbsp;30, 2021, the last practicable trading day prior to the date of this joint proxy statement/prospectus
for which this information could be calculated. </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI&nbsp;Common&nbsp;Stock</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Common&nbsp;Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Implied&nbsp;Value&nbsp;Per<BR>Share (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March&nbsp;24, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">257.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April&nbsp;30, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">259.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The implied value per share, as of each date, is equal to (i) $220.00, the cash portion of the merger
consideration, plus (ii) 0.91, the exchange ratio for the merger, multiplied by the closing market price of one share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on such date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above table shows only historical comparisons. The market price of Coherent common stock and <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock will fluctuate prior to the Coherent special meeting and before the consummation of the merger, which will affect the implied value of the stock portion of the merger consideration to be paid to the Coherent stockholders. These
comparisons may not provide meaningful information to Coherent stockholders in determining whether to adopt the merger agreement. Coherent stockholders are urged to obtain current market quotations for <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock and Coherent common stock and to review carefully the other information contained in, or incorporated by reference into, this joint proxy statement/prospectus in considering whether to adopt the merger Agreement. See &#147;Where You Can
Find More Information&#148; beginning on page 245 of this joint proxy statement/prospectus. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Historical Market Price and Dividend Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth, for the periods indicated and based on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year, the
intraday high and low sales prices per share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and per share of Coherent common stock, in both cases as reported on Nasdaq. <FONT STYLE="white-space:nowrap">II-VI</FONT> has not
historically paid dividends on its common stock, and Coherent has not paid a cash dividend on its common stock since its fiscal year 2013. Neither company presently anticipates paying any dividends on its common stock in the foreseeable future. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Dividend<BR>Declared</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2018</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">320.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">230.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">329.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">190.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">145.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2019</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">192.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">179.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">144.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2020</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">173.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">169.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">141.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">159.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2021</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">149.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">270.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">144.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter (through April&nbsp;30, 2021)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">270.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Dividend<BR>Declared</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2018</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2019</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2020</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Fiscal Year 2021</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter (through April&nbsp;30, 2021)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_33"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the statements contained or incorporated by reference into this joint proxy statement/prospectus are &#147;forward-looking
statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Words such as &#147;anticipate,&#148;
&#147;estimate,&#148; &#147;continue,&#148; &#147;expect,&#148; &#147;project,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;believe,&#148; &#147;target,&#148; &#147;objective,&#148; &#147;goal,&#148; &#147;positions,&#148;
&#147;prospects,&#148; &#147;potential,&#148; &#147;will,&#148; &#147;would,&#148; &#147;should,&#148; &#147;could,&#148; &#147;may&#148; and words and terms of similar substance identify forward-looking statements, including any statements or
discussions regarding timing of completion of the merger, expected benefits of the merger and the future operating or financial performance of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or the combined company identify forward-looking
statements. All forward-looking statements are management&#146;s present expectations or forecasts of future events and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in
the forward-looking statements. In addition to the factors relating to the merger discussed under the caption &#147;Risk Factors&#148; beginning on page 42 of this joint proxy statement/prospectus and the factors previously disclosed in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s reports filed with the SEC, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure of any one or more of the assumptions stated herein to prove to be correct; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conditions to the completion of the merger and the equity financing, including the receipt of any required
stockholder and regulatory approvals, and the risks that those conditions will not be satisfied in a timely manner or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the occurrence of any event, change or other circumstances that could give rise to an amendment or termination of
the merger agreement, including the receipt by Coherent of an unsolicited proposal from a third party; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to finance the merger, the substantial indebtedness
that <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to incur in connection with the merger and the need to generate sufficient cash flows to service and repay such debt; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that <FONT STYLE="white-space:nowrap">II-VI</FONT> may be unable to achieve expected synergies,
operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate Coherent&#146;s operations with those of <FONT STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that such integration may be more difficult, time-consuming or costly than expected or that
operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">litigation and any unexpected costs, charges or expenses resulting from the merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that disruption from the merger materially and adversely affects the respective businesses, reputational
brand value and operations of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential adverse reactions or changes to business relationships resulting from the announcement, pendency or
completion of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> to retain and hire key employees;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks relating to forward-looking statements and other &#147;Risk Factors&#148; discussed in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2020 and additional risk factors that may be identified from time to time in future filings of <FONT
STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchasing and inventory management patterns of customers and
<FONT STYLE="white-space:nowrap">end-users;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timely release of new products, and acceptance and adoption of such new products by the market;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the introduction of new products by competitors and other competitive responses; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to integrate recently acquired businesses and
realize synergies, cost savings and opportunities for growth in connection therewith, together with the risks, costs and uncertainties associated with such acquisitions and integration efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to devise and execute strategies to respond to
changing market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks to anticipated growth in industries and sectors in which <FONT STYLE="white-space:nowrap">II-VI</FONT>
and Coherent operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks to realizing the benefits of investments in research and development and commercialization of
innovations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> stock price will not trade in line with
industrial technology leaders; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks of business and economic disruption related to the currently ongoing
<FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak and any other worldwide health epidemics or outbreaks that may arise. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For any forward-looking statements made in this joint proxy statement/prospectus or in any documents incorporated by reference into this joint
proxy statement/prospectus, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You are cautioned not to
place undue reliance on the forward-looking statements, which speak only as of the date of this joint proxy statement/prospectus or the dates of the documents incorporated by reference in this joint proxy statement/prospectus. Except as required by
applicable law, neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent undertakes to update these forward-looking statements to reflect facts, circumstances, assumptions or events that occur after the date the forward-looking statements
are made. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information about factors that could cause actual results to differ materially from those described in the
forward-looking statements, see the reports that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have filed with the SEC as described under &#147;Where You Can Find More Information&#148; beginning on page 245 of this joint proxy
statement/prospectus. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We expressly qualify in their entirety all forward-looking statements attributable to either of us or any
person acting on our behalf by the cautionary statements contained or referred to in this joint proxy statement/prospectus. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_34"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>In addition to the other information contained in or incorporated by reference into this joint proxy statement/prospectus, including the
matters addressed under the caption &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page 40 of this joint proxy statement/prospectus, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders should carefully
consider the following risk factors in deciding how to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, and Coherent stockholders should carefully consider the following risk factors in deciding how to vote at the Coherent
special meeting. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The merger is subject to approval by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and Coherent stockholders. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order for the merger to be completed, among other things, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders must approve the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and Coherent stockholders must approve the Coherent merger proposal. There can be no assurance that either approval will be obtained. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Because the market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock fluctuates, Coherent stockholders cannot be certain of the market
value of the merger consideration they will receive. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the merger, each share of Coherent common stock issued and
outstanding immediately prior to the effective time (other than certain shares of Coherent common stock that are cancelled shares or dissenting shares) will be converted into the right to receive $220.00&nbsp;in cash and 0.91 of a share of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. The exchange ratio will not be adjusted for changes in the market price of either <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock between the date of the
merger agreement and the effective time. Changes in the price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock prior to the merger will affect the value that Coherent stockholders will receive as a result of the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock price changes may result from a variety of factors, including general market and economic conditions, changes in Coherent&#146;s and <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> businesses, operations and prospects and regulatory considerations, many of which factors are beyond Coherent&#146;s and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> control. Therefore, at the
time of the Coherent special meeting, Coherent stockholders will not know the market value of the consideration to be received at the effective time. Coherent stockholders should obtain current market quotations for shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock and for shares of Coherent common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The market price of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock after the merger may be affected by factors different from those affecting the shares of Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> currently. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the merger, Coherent stockholders will become <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders. <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> business differs from that of Coherent. Accordingly, the results of operations of the combined company and the market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock after the
completion of the merger may be affected by factors different from those currently affecting the independent results of operations of each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. For a discussion of the businesses of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent and of certain factors to consider in connection with those businesses, see the documents incorporated by reference in this joint proxy statement/prospectus and referred to under &#147;Where You
Can Find More Information&#148; beginning on page 245 of this joint proxy statement/prospectus. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the issuance of shares
of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the merger could on its own have the effect of depressing the market price for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. In addition, many Coherent stockholders may
decide not to hold the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock they receive as a result of the merger. Other Coherent stockholders, such as funds with limitations on their permitted holdings of stock in individual
issuers, may be required to sell the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock they receive as a result of the merger. Any such sales of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock could have the effect of
depressing the market price for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>There can be no assurance that <FONT STYLE="white-space:nowrap">II-VI</FONT> will be able to secure the
funds necessary to pay the merger consideration, in a timely manner or at all. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> intends
to finance a portion of the merger consideration with the debt financing. To this end, <FONT STYLE="white-space:nowrap">II-VI</FONT> has entered into the debt commitment letter containing commitments as of the date of this joint proxy
statement/prospectus for a senior secured term loan &#147;A&#148; facility in an aggregate principal amount of $850&nbsp;million, a senior secured term loan &#147;B&#148; facility in an aggregate principal amount of $2,800&nbsp;million, a senior
secured revolving credit facility in an aggregate principal amount of $350&nbsp;million and a senior unsecured bridge loan facility in an aggregate principal amount of $1,125&nbsp;million (which we refer to as the &#147;bridge loan facility&#148;
and collectively with the other foregoing facilities, the &#147;facilities&#148;). However, as of the date of this joint proxy statement/prospectus, neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor any of its subsidiaries has entered into
definitive agreements for the debt financing (or other financing arrangements in lieu thereof), and the obligation of the lender to provide the debt financing under the debt commitment letter is subject to a number of customary conditions. There is
a risk that these conditions will not be satisfied and the debt financing may not be available when required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> also intends to finance a portion of the merger consideration with the equity financing. To this end, on March&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the investment
agreement. On March&nbsp;31, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated the initial investment of $750.0&nbsp;million pursuant to the investment agreement. Pursuant to the investment agreement and subject to the terms
and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least $1.05&nbsp;billion, which may be increased by up to an additional $350.0&nbsp;million,
immediately prior to the closing of the merger. However, the purchase and issuance of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the subsequent investment and
the completion of the equity financing is subject to a number of customary conditions, and there can be no assurance that the equity financing will be completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the debt financing contemplated by the debt commitment letter or the subsequent investment contemplated by the investment
agreement is not available, there is a risk that other financing may not be available on acceptable terms, in a timely manner or at all. Although <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> obligation to consummate the merger is not
conditioned upon the financings, if <FONT STYLE="white-space:nowrap">II-VI</FONT> is unable to obtain the financings, the merger may be delayed or not completed, in which case <FONT STYLE="white-space:nowrap">II-VI</FONT> would be in breach of its
obligations under the merger agreement. See the section titled &#147;The Merger&#151;Financing&#148; beginning on page&nbsp;146 of this joint proxy statement/prospectus for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The agreements that will govern the indebtedness to be incurred or assumed in connection with the merger are expected to contain various covenants that
impose restrictions on <FONT STYLE="white-space:nowrap">II-VI</FONT> and certain of its subsidiaries that may affect their ability to operate their businesses. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agreements that will govern the indebtedness to be incurred or assumed in connection with the merger, including pursuant to the debt
financing, are expected to contain various affirmative and negative covenants that will, subject to certain significant exceptions, restrict the ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> and certain of its subsidiaries to, among other
things, have liens on their property, incur additional indebtedness, enter into sale and lease-back transactions, make loans, advances or other investments, make <FONT STYLE="white-space:nowrap">non-ordinary</FONT> course asset sales, declare or pay
dividends or make other distributions with respect to equity interests, and/or merge or consolidate with any other person or sell or convey certain of its assets to any one person, among other things. In addition, the definitive documentation
governing certain of the facilities is expected to contain financial maintenance covenants that will require <FONT STYLE="white-space:nowrap">II-VI</FONT> to maintain a certain leverage ratio and an interest coverage ratio at the end of each fiscal
quarter. The ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> and its subsidiaries to comply with these provisions may be affected by events beyond their control. Failure to comply with these covenants could result in an event of default,
which, if not cured or waived, could accelerate <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> repayment obligations under the applicable definitive documentation so defaulted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>In connection with the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> will incur significant additional indebtedness, which could adversely affect <FONT
STYLE="white-space:nowrap">II-VI,</FONT> including by decreasing <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business flexibility, and will increase its interest expense and the credit rating of the combined company could be downgraded.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated long-term debt of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of December&nbsp;31, 2020 was approximately
$1.4&nbsp;billion. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> pro forma long-term debt as of December&nbsp;31, 2020, after giving effect to the merger and the anticipated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
incurrence and extinguishment of indebtedness in connection therewith, will be approximately $4.9&nbsp;billion. <FONT STYLE="white-space:nowrap">II-VI</FONT> will have substantially increased
indebtedness following completion of the merger in comparison to that of <FONT STYLE="white-space:nowrap">II-VI</FONT> on a recent historical basis, which could have the effect, among other things, of reducing
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> flexibility to respond to changing business and economic conditions and increasing <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> interest expense.
<FONT STYLE="white-space:nowrap">II-VI</FONT> will also incur various costs and expenses associated with the financing. The amount of cash required to pay interest on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> increased indebtedness levels
following completion of the merger and thus the demands on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cash resources will be greater than the amount of cash flows required to service the indebtedness of
<FONT STYLE="white-space:nowrap">II-VI</FONT> prior to the transaction. The increased levels of indebtedness following completion of the merger could also reduce funds available for working capital, capital expenditures, acquisitions, share
repurchases and other general corporate purposes and may create competitive disadvantages for <FONT STYLE="white-space:nowrap">II-VI</FONT> relative to other companies with lower debt levels. If <FONT STYLE="white-space:nowrap">II-VI</FONT> does not
achieve the expected benefits and cost savings from the merger, or if the financial performance of the combined company does not meet current expectations, then <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to service its indebtedness
may be adversely impacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> credit ratings impact the cost and
availability of future borrowings and, accordingly, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cost of capital. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ratings reflect each rating organization&#146;s opinion of <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial strength, operating performance and ability to meet <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> debt obligations. In connection with the debt financing, it is anticipated that <FONT
STYLE="white-space:nowrap">II-VI</FONT> will seek ratings of its indebtedness from S&amp;P and Moody&#146;s. There can be no assurance that <FONT STYLE="white-space:nowrap">II-VI</FONT> will achieve a particular rating or maintain a particular
rating in the future. In addition, there can be no assurance that the credit ratings of existing II-VI debt will not be subject to a downgrade below investment grade. If a ratings downgrade were to occur or if the combined company fails to obtain an
investment grade rating, the combined company could experience higher borrowing costs in the future and more restrictive debt covenants which would reduce profitability and diminish operational flexibility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, <FONT STYLE="white-space:nowrap">II-VI</FONT> may be required to raise substantial additional financing to fund working capital,
capital expenditures, acquisitions or other general corporate requirements. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to arrange additional financing will depend on, among other factors,
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial position and performance, as well as prevailing market conditions and other factors beyond <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> control.
<FONT STYLE="white-space:nowrap">II-VI</FONT> cannot assure you that it will be able to obtain additional financing on terms acceptable to <FONT STYLE="white-space:nowrap">II-VI</FONT> or at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Integrating Coherent may be more difficult, costly or time-consuming than expected and <FONT STYLE="white-space:nowrap">II-VI</FONT> may fail to realize
the anticipated benefits of the merger, including expected financial and operating performance of <FONT STYLE="white-space:nowrap">II-VI</FONT> after the merger. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of the merger will depend, in part, on the ability to realize the anticipated benefits and cost savings from <FONT
STYLE="white-space:nowrap">II-VI</FONT> acquiring Coherent. To realize the anticipated benefits and cost savings from the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> must successfully integrate Coherent in a manner that permits those
benefits and cost savings to be realized. The combined business&#146;s ability to successfully manage this expanded business will depend, in part, upon management&#146;s ability to implement an effective integration of the two companies and its
ability to manage a combined business with significantly larger size and scope with the associated increased costs and complexity. If <FONT STYLE="white-space:nowrap">II-VI</FONT> is not able to successfully achieve these objectives, or is not able
to achieve these objectives on a timely basis, the anticipated benefits of the merger may not be realized fully or at all or may take longer to realize than expected. In addition, the actual cost savings of the merger could be less than anticipated.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have operated and, until the completion of the merger, must continue to
operate independently. It is possible that the integration process could result in the loss of key employees, the disruption of each company&#146;s ongoing businesses or inconsistencies in standards, controls, procedures and policies that adversely
affect the companies&#146; ability to maintain relationships with clients, customers, suppliers and employees or to achieve the anticipated benefits and cost savings of the merger. Integration efforts between the two companies may also divert
management attention and resources. These integration matters could have an adverse effect on each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent during this transition period and for an undetermined period after completion of the
merger on the combined company. All projections regarding the combined company&#146;s business are, by their nature, estimates which are subject to risks and uncertainties. Business and financial measures of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
combined company, including, but not limited to, revenue, free cash flow, synergies and dividend yield, are uncertain and subject to change based on changes in assumptions underlying such
measures or other changes in circumstances, many of which may be outside of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> or Coherent&#146;s control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent may have difficulty attracting, motivating and retaining executives and other employees in light
of the merger. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Uncertainty about the effect of the merger on <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent employees may
have an adverse effect on <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent and consequently the combined company. This uncertainty may impair <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s ability to attract,
retain and motivate personnel both before and after completion of the merger. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent are dependent on the experience and industry knowledge of their officers and other key employees to execute
their business plans. The success of the merger will depend in part on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to retain the talents and dedication of key employees currently employed by Coherent. Employee retention may be
particularly challenging during the pendency of the merger, as employees may feel uncertain about their future roles with the combined company. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent may have to provide additional
compensation in order to retain employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If key employees terminate their employment with <FONT STYLE="white-space:nowrap">II-VI</FONT>
or Coherent, or with the combined company after completion of the merger, the combined company&#146;s business activities may be adversely affected and management&#146;s attention may be diverted from successfully integrating <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent to hiring suitable replacements, all of which may cause the combined company&#146;s business to suffer. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent may not be able to
locate or retain suitable replacements for any key employees who leave either company. Accordingly, no assurance can be given that <FONT STYLE="white-space:nowrap">II-VI</FONT> will be able to attract or retain key employees following the completion
of the merger to the same extent that <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent has been able to attract or retain employees in the past. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulatory approvals may not be received, may take longer than expected or may impose conditions that are not presently anticipated or that could have an
adverse effect on the combined company following the merger. </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before the merger may be completed, certain waiting periods must
expire or terminate and applicable approvals must be obtained under certain antitrust, competition and foreign investment laws and regulations. In deciding whether to grant regulatory clearances and approvals, the relevant governmental entities may
consider, among other things, the effect of the merger on competition within their relevant jurisdiction. The terms and conditions of the approvals that are granted may impose requirements, limitations or costs or place restrictions on the conduct
of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business. There can be no assurance that regulators will not impose conditions, terms, obligations or restrictions and that such conditions, terms, obligations or restrictions will not have the
effect of delaying completion of the merger or imposing additional material costs on or materially limiting the revenues of <FONT STYLE="white-space:nowrap">II-VI</FONT> following the merger. In addition, neither
<FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent can provide assurance that any such conditions, terms, obligations or restrictions will not result in the delay or abandonment of the merger. For a more detailed description of the
regulatory review process, see &#147;The Merger&#151;Regulatory Approvals&#148; beginning on page&nbsp;145 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The unaudited pro forma combined financial information included in this joint proxy statement/prospectus are preliminary and estimated, and the actual
financial condition and results of operations of the combined company after the merger may differ materially. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma
combined financial information in this joint proxy statement/prospectus are presented for illustrative purposes only and are not necessarily indicative of what the combined company&#146;s actual financial condition or results of operations would
have been had the merger been completed on the dates indicated. The unaudited pro forma combined financial information reflect adjustments, which are based upon preliminary estimates, to record the Coherent identifiable assets acquired and
liabilities assumed at fair value and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the resulting goodwill recognized. The purchase price allocation reflected in this joint proxy statement/prospectus is preliminary, and final allocation of the purchase price will be based upon
the actual purchase price and the fair value of the assets and liabilities of Coherent as of the date of the completion of the merger. Accordingly, the final acquisition accounting adjustments may differ materially from the pro forma adjustments
reflected in this joint proxy statement/prospectus. For more information, see &#147;Unaudited Pro Forma Condensed Combined Financial Information&#148; beginning on page&nbsp;193 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial estimates are based on various assumptions that may not prove to be appropriate and such
financial estimates may not be realized. </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial estimates set forth in the forecast included under &#147;The
Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus are based on assumptions of, and information available to, the management of
<FONT STYLE="white-space:nowrap">II-VI</FONT> at the time prepared. The assumptions underlying such financial estimates may not prove to be appropriate and any or all of such estimates may not be realized. The financial estimates can be adversely
affected by known or unknown risks and uncertainties, many of which are beyond <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> control. Many factors mentioned in this joint proxy statement/prospectus and
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> other filings with the SEC incorporated by reference into this joint proxy statement/prospectus, including the risks outlined in this &#147;Risk Factors&#148; section and in <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> public filings and the events and/or circumstances described under &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page&nbsp;40 of this joint proxy
statement/prospectus will be important in determining <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> future results. See &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. As a
result of these contingencies, actual future results may vary materially from <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> estimates. In view of these uncertainties, the inclusion of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT>
financial estimates in this joint proxy statement/prospectus is not and should not be viewed as a representation that the forecasted results will be achieved. These financial estimates are based on
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> internal financial forecasts and were not prepared with a view toward public disclosure or toward compliance with published guidelines of any regulatory or professional body. Further, any
forward-looking statement speaks only as of the date on which it is made, and <FONT STYLE="white-space:nowrap">II-VI</FONT> undertakes no obligation, other than as required by applicable law, to update its financial estimates herein to reflect
events or circumstances after the date those financial estimates were prepared or to reflect the occurrence of anticipated or unanticipated events or circumstances. The <FONT STYLE="white-space:nowrap">II-VI</FONT> financial estimates included in
this joint proxy statement/prospectus have been prepared by, and are the responsibility of, <FONT STYLE="white-space:nowrap">II-VI.</FONT> Moreover, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> independent auditors, Ernst&nbsp;&amp; Young
LLP, have not compiled, examined or performed any procedures with respect to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance
on such information or its achievability, and, accordingly, Ernst&nbsp;&amp; Young LLP assumes no responsibility for, and disclaims any association with, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> prospective financial information. The
reports of Ernst&nbsp;&amp; Young LLP incorporated by reference herein relate exclusively to the historical financial information of the entities named in those reports and do not cover any other information in this joint proxy statement/prospectus
and should not be read to do so. See &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent&#146;s financial estimates are based on various assumptions that may not prove to be appropriate and such financial estimates may not be realized.
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial estimates set forth in the forecast included under &#147;The Merger&#151;Certain Unaudited Prospective Financial
Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus are based on assumptions of, and information available to, the management of Coherent at the time prepared. The assumptions underlying such financial estimates may
not prove to be appropriate and any or all of such estimates may not be realized. The financial estimates can be adversely affected by known or unknown risks and uncertainties, many of which are beyond Coherent&#146;s control. Many factors mentioned
in this joint proxy statement/prospectus and Coherent&#146;s other filings with the SEC incorporated by reference into this joint proxy statement/prospectus, including the risks outlined in this &#147;Risk Factors&#148; section and in
Coherent&#146;s public filings and the events and/or circumstances described under &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page&nbsp;40 of this joint proxy statement/prospectus will be important in
determining Coherent&#146;s future results. See &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. As a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result of these contingencies, actual future results may vary materially from Coherent&#146;s estimates. In view of these uncertainties, the inclusion of Coherent&#146;s financial estimates in
this joint proxy statement/prospectus is not and should not be viewed as a representation that the forecasted results will be achieved. These financial estimates are based on Coherent&#146;s internal financial forecasts and were not prepared with a
view toward public disclosure or toward compliance with published guidelines of any regulatory or professional body. Further, any forward-looking statement speaks only as of the date on which it is made, and Coherent undertakes no obligation, other
than as required by applicable law, to update its financial estimates herein to reflect events or circumstances after the date those financial estimates were prepared or to reflect the occurrence of anticipated or unanticipated events or
circumstances. The Coherent financial estimates included in this joint proxy statement/prospectus have been prepared by, and are the responsibility of, Coherent. Moreover, Coherent&#146;s independent auditors, Deloitte&nbsp;&amp; Touche LLP, have
not compiled, examined or performed any procedures with respect to Coherent&#146;s prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance on such information or its achievability, and,
accordingly, Deloitte&nbsp;&amp; Touche LLP assumes no responsibility for, and disclaims any association with, Coherent&#146;s prospective financial information. The reports of Deloitte&nbsp;&amp; Touche LLP incorporated by reference herein relate
exclusively to the historical financial information of the entities named in those reports and do not cover any other information in this joint proxy statement/prospectus and should not be read to do so. See &#147;The Merger&#151;Certain Unaudited
Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus for more information. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain of
Coherent&#146;s directors and executive officers may have interests in the merger that may differ from the interests of Coherent stockholders. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent stockholders should be aware that some of Coherent&#146;s directors and executive officers may have interests in the merger and have
arrangements that are different from, or in addition to, those of Coherent stockholders generally. These interests and arrangements may create potential conflicts of interest. The Coherent board was aware of these respective interests and considered
these interests, among other matters, when making its decision to adopt the merger agreement, and in recommending that holders of common stock vote to approve the Coherent merger proposal. For a more complete description of these interests, see
&#147;The Merger&#151;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#148; beginning on page&nbsp;139 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The merger is subject to conditions, including certain conditions that may not be satisfied, and may not be completed on a timely basis, or at all. In
addition, the merger agreement may be terminated in certain circumstances. Failure to complete the merger could have material and adverse effects on <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The completion of the merger is subject to a number of conditions, which make the completion and timing of the completion of the merger
uncertain. In addition, the merger agreement may be terminated in certain circumstances. If the merger is not completed on a timely basis, or at all, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s respective ongoing
businesses may be adversely affected and, without realizing any of the benefits of having completed the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will be subject to a number of risks, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will be required to pay certain costs relating to the
merger, whether or not the merger is completed, such as legal, accounting, financial advisor and printing fees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under the merger agreement, each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent is subject to
certain restrictions on the conduct of its business prior to completing the merger, which may adversely affect its ability to execute certain of its business strategies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">time and resources committed by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s
respective management teams to matters relating to the merger could otherwise have been devoted to pursuing other beneficial opportunities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the market price of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> or Coherent&#146;s common stock could
decline to the extent that the current market prices reflect a market assumption that the merger will be completed; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depending on the circumstances in which the merger agreement is terminated,
<FONT STYLE="white-space:nowrap">II-VI</FONT> may be required to pay a termination fee of $337.7&nbsp;million or $500&nbsp;million, as applicable, or Coherent may be required to pay a termination fee of $108.8&nbsp;million, which termination fees
may make it more difficult for <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent to pursue alternatives to the merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the merger agreement is terminated in certain circumstances, <FONT STYLE="white-space:nowrap">II-VI</FONT> or
Coherent may be required to pay to the other $25&nbsp;million to cover the other party&#146;s costs and expenses in connection with the merger agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if the merger is not completed, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent may experience negative reactions from
financial markets and from their respective customers and employees. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent could also be subject to litigation related to any failure to complete the merger or to enforcement proceedings commenced
against <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent to perform their respective obligations under the merger agreement. If the merger is not completed, neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent can assure
their shareholders or stockholders, respectively, that the risks described above will not materialize and will not adversely affect their respective businesses or financial results or the market price of their respective common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Failure to consummate the merger will result in Coherent receiving little or no benefit from the termination fee Coherent paid in connection with
terminating the March&nbsp;9 Lumentum Merger Agreement. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger agreement is terminated or if Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> do not consummate the transactions contemplated by the merger agreement, Coherent will receive little or no benefit from the termination fee it paid to Lumentum in the amount of $217.6&nbsp;million in
connection with the termination of the March&nbsp;9 Lumentum Merger Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have
incurred, and will incur, significant transaction-related costs in connection with the merger. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent has incurred and will incur substantial expenses in connection with the negotiation and completion of the transactions contemplated by the merger agreement, as well as the costs and expenses
of filing, printing and mailing this joint proxy statement/prospectus, and filing and other fees paid or to be paid to the SEC and other regulatory agencies in connection with the merger. These fees and costs will be significant. In addition, <FONT
STYLE="white-space:nowrap">II-VI</FONT> will incur significant costs with respect to the financings for the cash consideration to be paid in connection with the merger. If the merger is not completed, <FONT STYLE="white-space:nowrap">II-VI</FONT>
and Coherent may have to recognize these expenses without realizing the expected benefits of the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent also expect to incur a number of <FONT STYLE="white-space:nowrap">non-recurring</FONT> transaction-related costs associated with combining the operations of the two companies and achieving desired
synergies. Additional unanticipated costs may be incurred in the integration of the businesses of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. There can be no assurance that the elimination of certain duplicative costs, as well as the
realization of other efficiencies related to the integration of the two businesses, will offset the incremental transaction-related costs over time. Thus, any net benefit may not be achieved in the near term, the long term or at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The closing of the merger may trigger change in control provisions in certain agreements to which Coherent is a party. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the merger may trigger change in control provisions in certain agreements to which Coherent is a party. If Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> are unable to negotiate waivers of those provisions, the counterparties may exercise their rights and remedies under the agreements, potentially terminating the agreements or seeking monetary damages. Even if
Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> are able to negotiate waivers, the counterparties may require a fee for such waiver or seek to renegotiate the agreements on terms less favorable to Coherent or the combined company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will be subject to business uncertainties
while the merger is pending. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Uncertainty about the effect of the merger on employees, suppliers and customers may have an adverse
effect on <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. These uncertainties may impair <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> or Coherent&#146;s ability to attract, retain and motivate key personnel until the merger is
completed, and could cause customers and others that deal with <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent to seek to change existing business relationships with <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent is subject to business uncertainties and contractual restrictions while the merger is
pending, which could adversely affect each of Coherent&#146;s and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> businesses and operations. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the merger agreement, Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> are subject to certain restrictions on the
conduct of their respective business prior to completing the merger, which may adversely affect each party&#146;s ability to execute certain of its business strategies. Such limitations could negatively affect each party&#146;s businesses and
operations prior to the completion of the merger. Furthermore, the process of planning to integrate two businesses and organizations for the post-merger period can divert management attention and resources and could ultimately have an adverse effect
on each of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the merger, parties with which Coherent or <FONT
STYLE="white-space:nowrap">II-VI</FONT> does business may experience uncertainty associated with the merger, including with respect to current or future business relationships with Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or the
combined business. It is possible that some customers, suppliers and other persons with whom Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> has a business relationship may delay or defer certain business decisions or might decide to seek
to terminate, change or renegotiate their relationships with Coherent or <FONT STYLE="white-space:nowrap">II-VI,</FONT> as applicable, as a result of the merger, which could negatively affect Coherent&#146;s or
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> revenues, earnings and cash flows, as well as the market price of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, regardless of whether the merger is completed. See &#147;The
Merger Agreement&#151;Covenants and Agreements&#151;Conduct of Businesses Prior to the Completion of the Merger&#148; beginning on page 162 of this joint proxy statement/prospectus for a description of the restrictive covenants applicable to <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent common stock will
have a reduced ownership and voting interest in the combined company after the merger and the completion of the equity financing and will therefore have less voting influence over the combined company. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent common stock currently have the right to vote in the election of the
board of directors and on other matters involving <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, respectively. In the merger, each Coherent stockholder who receives shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
will become a holder of common stock of the combined company, with a percentage ownership of the combined company that is smaller than such holder&#146;s percentage ownership of Coherent. Upon completion of the merger, we estimate that Coherent
stockholders as of immediately prior to the merger will collectively own approximately 15.0%, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders as of immediately prior to the merger (excluding as a result of the equity financing) will own
approximately 70.7%, and the investors will own approximately 14.3% of the outstanding shares of common stock of the combined company (in each case, on an as-converted and fully diluted basis and without regard to the fact that immediately prior to
the merger, certain holders may own both <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent stock). As a result, Coherent stockholders will have less voting influence on the combined company and may have less influence on its management and
policies than they now have on Coherent, and <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will have less voting influence on the combined company and may have less influence on its management and policies than they now have on <FONT
STYLE="white-space:nowrap">II-VI.</FONT> </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent stockholders have appraisal rights subject to the requirements of the DGCL. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger is completed and certain other statutory requirements described herein are met, Coherent stockholders who do not vote in favor of
the Coherent merger proposal and otherwise properly perfect their appraisal rights may be entitled to a judicial determination of the &#147;fair value&#148; of their shares in connection with the merger under Section&nbsp;262 of the DGCL, which
generally entitles stockholders to receive in lieu of the merger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consideration a cash payment of an amount determined by the Court of Chancery to be equal to the &#147;fair value&#148; of their Coherent common stock as of the effective time exclusive of any
elements of value arising from the accomplishment or expectation of the merger, together with interest to be paid on the amount determined to be fair value, if any, as determined by the Court of Chancery. The appraised value would be determined by
the Court of Chancery and could be less than, the same as or more than the value of the merger consideration. Coherent stockholders who have properly demanded appraisal rights must file a petition for appraisal with the Court of Chancery within 120
days after the effective date. Should a material number of Coherent&#146;s stockholders exercise appraisal rights and should the Court of Chancery determine that the fair value of such shares of Coherent common stock is materially greater than the
value of the merger consideration, it could have an adverse effect on the financial condition and results of operation of <FONT STYLE="white-space:nowrap">II-VI</FONT> after the merger. For a more detailed description of the appraisal rights
available to Coherent stockholders, see the section titled &#147;The Merger&#151;Appraisal Rights in the Merger&#148; beginning on page 149 of this joint proxy statement/prospectus, which detailed description is qualified by reference to the full
text of Section&nbsp;262 of the DGCL as attached as <B>Annex D</B> to this joint proxy statement/prospectus. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shareholder or stockholder
litigation could prevent or delay the closing of the merger or otherwise negatively impact the business and operations of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent may incur costs in connection with the defense or settlement of any shareholder or
stockholder lawsuits filed in connection with the merger. Such litigation could have an adverse effect on the financial condition and results of operations of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent and could prevent or delay the
consummation of the merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock have different rights from holders of Coherent
common stock. </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of the merger, Coherent stockholders will no longer be stockholders of Coherent, a Delaware
corporation, but will instead become shareholders of <FONT STYLE="white-space:nowrap">II-VI,</FONT> a Pennsylvania corporation. As such, their rights as <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will be governed by Pennsylvania law
and the terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter and the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws, as they may be amended from time to time. Pennsylvania law and the terms of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> charter and the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws are in some respects materially different than Delaware law and the terms of the Coherent charter and the Coherent bylaws, as they may
be amended from time to time, which currently govern the rights of Coherent stockholders. See &#147;Comparison of Stockholders&#146; Rights&#148; beginning on page 218 of this joint proxy statement/prospectus for a discussion of the different rights
associated with shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and shares of Coherent common stock. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The issuance of shares
of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in connection with completing the equity financing will reduce the relative voting power of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
(including the voting power that current holders of Coherent common stock will have immediately after completion of the merger as holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock), will dilute the ownership of such holders and
may adversely affect the market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;Series&nbsp;B-1&nbsp;convertible</FONT></FONT> preferred stock will initially be nonvoting. Following the expiration of the required waiting period under the HSR Act, the
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B&nbsp;convertible preferred stock will have voting rights, voting as one class with <FONT STYLE="white-space:nowrap">II-VI&nbsp;common</FONT> stock, on
<FONT STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis,</FONT> subject to limited exceptions. As a result, the issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in connection with completing the
equity financing will result in the immediate and substantial dilution to the interests of the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (including the interests of current holders of Coherent common stock after the
completion of the merger as holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, the conversion price of
the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will initially be $85.00 per share, subject to adjustments as set forth in the statement with respect to shares. For more information on the terms of the
investment agreement and of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, see the section titled &#147;The Investment Agreement and the Statement with Respect to Shares&#148; beginning on page 183 of this
joint proxy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statement/prospectus. Any sales in the public market of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issuable upon conversion of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock could adversely affect prevailing market prices of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Sales by such holders of a substantial number of
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred shares have rights, preferences and privileges that
are not held by, and are preferential to, the rights of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of <FONT STYLE="white-space:nowrap">II-VI,</FONT> the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock are
entitled to receive certain payments (i)&nbsp;prior to any amounts paid to holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and each other class or series of <FONT STYLE="white-space:nowrap">II-VI</FONT> capital stock now
existing or hereafter authorized, the terms of which do not expressly provide that such class or series ranks either (x)&nbsp;senior to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock as to dividend rights
or distribution rights upon such a liquidation event or (y)&nbsp;on parity with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock as to dividend rights and distribution rights upon a such a liquidation event
and (ii)&nbsp;on parity with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> 6% Series&nbsp;A Mandatory Convertible Preferred Stock, having no par value per share (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT>
Series&nbsp;A mandatory convertible preferred stock&#148;), and each other class or series of <FONT STYLE="white-space:nowrap">II-VI</FONT> capital stock established after the closing of the initial investment, the terms of which expressly provide
that such class or series ranks on a parity basis with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock as to dividend rights and distribution rights upon such a liquidation event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions may make it more costly for a potential acquirer to engage in a business combination transaction with <FONT
STYLE="white-space:nowrap">II-VI.</FONT> Provisions that have the effect of potentially discouraging, delaying or preventing such a transaction could limit the opportunity for <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders to receive a
premium for their shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and could also affect the price that some investors are willing to pay for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. This could reduce the
remaining amount of its assets, if any, available to distribute to holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock also have certain
redemption, conversion and consent rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> obligations to the holders of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock could limit its ability to obtain additional financing or increase its borrowing costs, which could have an adverse effect on
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial condition. These preferential rights could also result in divergent interests between the holders of shares of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible
preferred stock and holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The redemption right of the holders of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock may result in the use of <FONT STYLE="white-space:nowrap">II-VI</FONT> cash in such a way that could adversely affect
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business, financial condition or results of operations and, therefore, the interests of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (including the interests of current
holders of Coherent common stock after the completion of the merger as holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock). </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time on or after the ten year anniversary of the applicable issuance date of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series&nbsp;B convertible preferred stock and subject to the procedures set forth in the statement with respect to shares, each holder of such shares will have the right to require <FONT STYLE="white-space:nowrap">II-VI</FONT> to redeem all of such
holder&#146;s shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock for cash at a price per share equal to the sum of the applicable stated value for such shares plus accrued or declared and unpaid
dividends on such shares that had not previously been added to such stated value.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>This may have the effect of reducing funds available for working capital, capital expenditures, acquisitions and
other general corporate purposes, thereby negatively affecting the interests of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (including the interests of current holders of Coherent common stock after the completion of the
merger as holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock can
exercise significant control over <FONT STYLE="white-space:nowrap">II-VI,</FONT> which could limit the ability of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to influence the outcome of key transactions, including a change
of control. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;Series&nbsp;B-1&nbsp;Convertible</FONT></FONT> Preferred Stock will initially be nonvoting. Following the expiration of the required waiting period under the HSR
Act, the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B&nbsp;convertible preferred stock will have voting rights, voting as one class with <FONT STYLE="white-space:nowrap">II-VI&nbsp;common</FONT> stock, on <FONT
STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis,</FONT> subject to limited exceptions. As a result, the holders of shares of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock have the ability to
significantly influence the outcome of any matter submitted for the vote of the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. The investors are entitled to act separately in their own respective interests with respect to
their ownership interests in <FONT STYLE="white-space:nowrap">II-VI</FONT> and have the ability to substantially influence all matters that require approval by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders, including the approval of
significant corporate transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, <FONT STYLE="white-space:nowrap">II-VI</FONT> may not undertake certain actions without
the prior written approval of the holders of a majority of the issued and outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, voting separately from <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock. Subject to certain exceptions, <FONT STYLE="white-space:nowrap">II-VI</FONT> must not: (1)&nbsp;alter or change the rights, preferences or privileges of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock
or amend, modify or supplement any provision of the organizational documents of <FONT STYLE="white-space:nowrap">II-VI</FONT> in a manner that adversely affects the rights, powers, preferences or privileges of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock; (2)&nbsp;authorize or issue any senior stock (as defined below) (or securities convertible into senior stock), or amend or alter
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> articles of incorporation to increase the number of authorized or issued shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock; (3)&nbsp;decrease the number
of authorized shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (other than as permitted pursuant to a conversion, redemption or repurchase by <FONT STYLE="white-space:nowrap">II-VI</FONT> thereof); (4)
issue any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (other than pursuant to the investment agreement); and (5)&nbsp;effect any voluntary deregistration or delisting with Nasdaq of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, <FONT STYLE="white-space:nowrap">II-VI</FONT> may not, unless the
investors otherwise consent in writing (or if such action is taken with respect to a Permitted Issuance (as defined in the investment agreement)), so long as the investors own at least 5% of the number of shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock that they held immediately following the completion of either the initial investment (if the subsequent investment has not occurred) or the equity financing,
(i)&nbsp;authorize or issue any parity stock (as defined below) and (ii)&nbsp;pay any cash dividend on <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (other than ordinary dividends (as defined below)).
<FONT STYLE="white-space:nowrap">II-VI</FONT> also may not, unless the investors otherwise consent in writing (or if such action is taken with respect to a Permitted Issuance (as defined in the investment agreement)), so long as the investors own at
least 25% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock that they held immediately following the completion of either the initial investment (if the subsequent investment has not
occurred) or the equity financing, redeem, repurchase or otherwise acquire (or make or declare any dividend or distribution in respect of) any junior stock (as defined below) (subject to certain exceptions, including, among other things, ordinary
dividends, <FONT STYLE="white-space:nowrap">non-cash</FONT> dividends or other distributions paid <I>pro rata</I> to all holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and, if applicable, holders of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, repurchases of junior stock of up to $100&nbsp;million on an aggregate annual basis and dividends on junior stock in kind or in the form of other junior securities or
securities convertible into or exchange for such junior securities). Moreover, under the investment agreement, following the closing of the initial investment and for so long as the investors beneficially own shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (or shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued upon the conversion thereof) that represent, in the aggregate and on an as-converted
basis, at least 25% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, on an as-converted basis, that they held immediately following the completion of either the initial investment (if the subsequent investment
has not occurred) or the equity financing, the investors will have the right to nominate one designee and to designate one observer to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board. Circumstances may occur in which the interests of the
investors could conflict with the interests of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> other shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to the Combined Company Following the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Although <FONT STYLE="white-space:nowrap">II-VI</FONT> expects that its acquisition of Coherent will result in cost savings, synergies and other benefits,
the combined company may not realize those benefits because of integration difficulties and other challenges. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition of Coherent will depend in large part on the success of the management of the combined company in integrating the customers, suppliers, manufacturing operations, quality systems, information
systems, strategies, technologies and personnel of the two companies following the completion of the merger. The combined company may fail to realize some or all of the anticipated benefits of the merger if the integration process takes longer than
expected or is more costly than expected. The failure of the combined company to meet the challenges involved in successfully integrating the operations of the two companies or to otherwise realize any of the anticipated benefits of the merger,
including additional cost savings and synergies, could impair the operations of the combined company. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> anticipates that the overall integration of Coherent will be a time-consuming and
expensive process that, without favorable market conditions proper planning and effective and timely implementation and leadership, could significantly disrupt the combined company&#146;s business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Potential difficulties the combined company may encounter in the integration process include the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the integration of management teams, strategies, technologies and operations, products and services;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the disruption of ongoing businesses and distraction of their respective management teams from ongoing business
concerns; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the retention of and possible decrease in business from the existing customers of both companies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the creation of uniform standards, controls, procedures, policies and information systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the reduction of the costs associated with each company&#146;s operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the integration of corporate cultures and maintenance of employee morale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the retention of key employees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential unknown liabilities associated with the merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The anticipated cost savings, synergies and other benefits of the merger assume a successful integration of the companies and are based on
projections and other assumptions, which are inherently uncertain. Even if integration is successful, anticipated cost savings, synergies and other benefits may not be achieved. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock may decline in the future as a result of the merger. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock may decline in the future as a result of the merger for a number
of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unsuccessful integration of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> (including for the
reasons set forth in the preceding risk factor); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure of the combined company to achieve the perceived benefits of the merger, including financial results,
as rapidly as or to the extent anticipated by financial or industry analysts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of these factors are beyond the
control of <FONT STYLE="white-space:nowrap">II-VI.</FONT> As a consequence, current <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and Coherent stockholders, who will become holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock after completion of the merger, could lose the value of their investment in <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The merger may not be accretive on the projected timeline and may cause dilution to the combined
company&#146;s earnings per share, which may negatively affect the market price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> currently anticipates that the merger will be accretive to earnings per share (on an adjusted
earnings basis) in the second year after the merger. This expectation is based on preliminary estimates which may materially change. The combined company could also encounter additional transaction-related costs or other factors such as the failure
to realize all of the benefits anticipated in the merger. All of these factors could cause dilution to the combined company&#146;s earnings per share or decrease or delay the expected accretive effect of the merger and cause a decrease in the market
price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The combined company&#146;s future results will suffer if it does not effectively
manage its expanded operations following the merger. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the merger, the size of the business of the combined company will
increase significantly beyond the current size of either <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> or Coherent&#146;s current businesses. The combined company&#146;s future success depends, in part, upon its ability to manage this
expanded business, which may pose substantial challenges for management, including challenges related to the management and monitoring of new operations and associated increased costs and complexity. There can be no assurance that the combined
company will be successful or that it will realize the expected operating efficiencies, cost savings, revenue enhancements and other benefits currently anticipated from the merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent face competition, which is expected to intensify after the closing of the merger and which may
reduce the market share and profits of <FONT STYLE="white-space:nowrap">II-VI</FONT> after consummation of the merger. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competition in
the industries in which <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent operate is intense. Increased competition could hurt <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s businesses, hinder their market share
expansion and lead to pricing pressures that may adversely impact their margins and revenues. If the combined company is unable to successfully compete following the merger, its business, prospects, liquidity, financial condition and results of
operations could be materially and adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the consummation of the merger, the combined company&#146;s competitive
position could be weakened by strategic alliances or consolidation within the combined company&#146;s industries or the development of new technologies by competitors. The combined company&#146;s ability to compete successfully will depend on how
well it markets its products and services and on its ability to anticipate and respond to various competitive factors affecting its industries, including changes in customer preferences, and changes in the product offerings or pricing strategies of
the combined company&#146;s competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the consummation of the merger, competition could materially adversely affect the combined
company in several ways, including (i)&nbsp;the loss of customers and market share, (ii)&nbsp;the combined company&#146;s need to lower prices or increase expenses to remain competitive and (iii)&nbsp;the loss of business relationships within <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> existing markets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> is expected to incur substantial
expenses related to the merger and integration. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> is expected to incur substantial
expenses in connection with the merger and the related integration. There are a large number of processes, policies, procedures, operations, technologies and systems that may need to be integrated, including purchasing, accounting and finance,
sales, payroll, pricing and benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While <FONT STYLE="white-space:nowrap">II-VI</FONT> has assumed that a certain level of expenses
will be incurred, there are many factors beyond its control that could affect the total amount or the timing of the integration expenses. Moreover, many of the expenses that will be incurred are, by their nature, difficult to estimate accurately.
These expenses could, particularly in the near term, exceed the savings that <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to achieve from the elimination of duplicative expenses and the realization of economies of scale and cost savings.
These integration expenses likely will result in the combined company taking significant charges against earnings following the completion of the merger, and the amount and timing of such charges are uncertain at present. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Following the consummation of the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> will be bound by
all of the obligations and liabilities of both companies. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the consummation of the merger, the combined company will become
bound by all of the obligations and liabilities of Coherent in addition to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> obligations and liabilities existing prior to the consummation of the merger. Neither
<FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent can predict the financial condition of the combined company at the time of the combination or the ability of the combined company to satisfy its obligations and liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The merger may result in a loss of suppliers and strategic alliances and may result in the termination of existing contracts. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the merger, some of the suppliers of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent may increase prices or may terminate
or scale back their business relationship with, or even become competitors of, the combined company. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have contracts with suppliers, vendors, and other business partners which may require <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent to obtain consents from these other parties in connection with the merger, which may not be obtained at all or on favorable terms. If supplier relationships or strategic alliances are adversely
affected by the merger, or if the combined company, following the merger, loses the benefits of the contracts of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, the combined company&#146;s business and financial performance could suffer.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Following the merger, the combined company will have a substantial amount of debt, which could adversely affect its business, financial condition or
results of operations and prevent it from fulfilling its debt-related obligations. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the merger, the combined company will
have a substantial amount of debt. As of December&nbsp;31, 2020, on a pro forma basis, the combined company would have had approximately $4.9&nbsp;billion of outstanding long-term debt (including under its outstanding debt securities and borrowings
under <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> credit facilities). The combined company&#146;s substantial debt could have important consequences for the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, including:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making it more difficult for the combined company to satisfy its obligations with respect to its debt or to its
trade or other creditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increasing the combined company&#146;s vulnerability to adverse economic or industry conditions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limiting the combined company&#146;s ability to obtain additional financing to fund capital expenditures and
acquisitions, particularly when the availability of financing in the capital markets is limited; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requiring the combined company to pay higher interest rates upon refinancing or on the combined company&#146;s
variable rate indebtedness if interest rates rise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requiring a substantial portion of the combined company&#146;s cash flows from operations and the proceeds of any
capital markets offerings or loan borrowings for the payment of interest on the combined company&#146;s debt and reducing the combined company&#146;s ability to use its cash flows to fund working capital, capital expenditures, acquisitions and
general corporate requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limiting the combined company&#146;s flexibility in planning for, or reacting to, changes in its business and the
industries in which it operates; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">placing the combined company at a competitive disadvantage to less leveraged competitors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combined company may not generate sufficient cash flow from operations, together with any future borrowings, to enable the combined
company to pay its indebtedness, or to fund the combined company&#146;s other liquidity needs. The combined company may need to refinance all or a portion of its indebtedness, on or before its maturity. The combined company may not be able to
refinance any of its indebtedness on commercially reasonable terms or at all. In addition, the combined company may incur additional indebtedness in order to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
finance its operations, to fund acquisitions, or to repay existing indebtedness. If the combined company cannot service its indebtedness, it may have to take actions such as selling assets,
seeking additional debt or equity or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances. Any such actions, if necessary, may not be able to be effected on commercially reasonable terms or at all, or on terms
that would be advantageous to the combined company&#146;s stockholders or on terms that would not require <FONT STYLE="white-space:nowrap">II-VI</FONT> to breach the terms and conditions of its existing or future debt agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read and consider risk factors specific to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business that will also affect the
combined company after the merger. These risks are described in the sections entitled<I> &#147;Risk Factors&#148; in <FONT STYLE="white-space:nowrap">II-V</FONT></I>I&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year ended June&nbsp;30, 2020 and in other documents incorporated by reference into this joint proxy statement/prospectus. See &#147;Where You Can Find More Information&#148; beginning on page 245 of this joint proxy statement/prospectus for
the location of information incorporated by reference into this joint proxy statement/prospectus. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to Coherent&#146;s Business
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read and consider risk factors specific to Coherent&#146;s business that will also affect the combined company after
the merger. These risks are described in the sections entitled &#147;<I>Risk Factors</I>&#148; in Coherent&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended October&nbsp;3, 2020, in Coherent&#146;s
Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal quarter ended January&nbsp;2, 2021 and in other documents incorporated by reference into this joint proxy statement/prospectus. See &#147;Where You Can Find More
Information&#148; beginning on page 245 of this joint proxy statement/prospectus for the location of information incorporated by reference into this joint proxy statement/prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_35"></A>THE <FONT STYLE="white-space:nowrap">II-VI</FONT> SPECIAL
MEETING </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section contains information for <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders about the special meeting
that <FONT STYLE="white-space:nowrap">II-VI</FONT> has called to allow <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders to consider and vote on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and other related
matters. This joint proxy statement/prospectus is accompanied by a notice of the special meeting of <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and a form of proxy card that the <FONT STYLE="white-space:nowrap">II-VI</FONT> board is
soliciting for use at the II-VI special meeting and at any adjournments or postponements of the II-VI special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_36"></A>Date,
Time and Place of the Meeting </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting will be held virtually on
June&nbsp;24, 2021, at 11:30&nbsp;a.m., Eastern Time. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of ongoing developments related to the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, <FONT STYLE="white-space:nowrap">II-VI</FONT> has elected to hold the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting solely by means of remote communication via live webcast. <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders will be able to virtually attend and vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting by visiting www.virtualshareholdermeeting.com/IIVI2021SM. <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders must first register at the special meeting website in order to obtain a unique meeting invitation by electronic mail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> has retained Broadridge Financial Solutions, Inc. to host the live webcast of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting. You may call the technical support number that will be available 30 minutes before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting begins at
www.virtualshareholdermeeting.com/IIVI2021SM if you encounter any technical difficulty <FONT STYLE="white-space:nowrap">logging-in</FONT> or otherwise accessing the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_37"></A>Matters to Be Considered </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders will be asked
to consider and vote upon the following proposals: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will not transact on other business at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting, except for business properly brought before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or any adjournment or postponement thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_38"></A>Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board recommends that you vote &#147;FOR&#148; the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. See &#147;The <FONT STYLE="white-space:nowrap">Merger&#151;II-VI&#146;s</FONT> Reasons
for the Merger; Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board&#148; beginning on page 123 of this joint proxy statement/prospectus for a more detailed discussion of the <FONT STYLE="white-space:nowrap">II-VI</FONT>
board&#146;s recommendation. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_39"></A>Record Date and Quorum </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board has fixed the close of business on May&nbsp;17, 2021 as the <FONT
STYLE="white-space:nowrap">II-VI</FONT> record date for determination of <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders entitled to notice of and to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. As of
April&nbsp;30, 2021, there were 105,007,546&nbsp;shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The presence, in person (virtually) or represented by proxy, of shareholders entitled to cast at least a majority of the votes that all
shareholders are entitled to cast on the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date will constitute a quorum at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. If you are a
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder and you fail to submit a proxy or to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock will
not be counted towards a quorum. Abstentions are considered present for purposes of establishing a quorum. There must be a quorum for votes on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issuance proposal to be taken at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. If there is no quorum, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting may be
adjourned or postponed to another date if the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal is approved at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, each share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
is entitled to one (1)&nbsp;vote on all matters properly submitted to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
of April&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> directors and executive officers and their affiliates owned and were entitled to vote approximately 2.3&nbsp;million shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock (which aggregate number is inclusive of restricted shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock underlying granted but unvested
<FONT STYLE="white-space:nowrap">II-VI</FONT> restricted stock units, <FONT STYLE="white-space:nowrap">II-VI</FONT> stock options exercisable within 60 days of the II-VI record date, <FONT STYLE="white-space:nowrap">II-VI</FONT> restricted stock
units vesting within 60&nbsp;days of the record date, and <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock indirectly owned), representing approximately 2.2% of the outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock. We currently expect that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> directors and executive officers will vote their shares in favor of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, although none of them
has entered into any agreements obligating them to do so. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_40"></A>Vote Required; Treatment of Abstentions and Failure to Vote
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Vote required</U>: Assuming that a quorum is present, approval of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal requires the affirmative vote of at least a majority of the votes cast by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy. This vote will satisfy the vote requirements of Listing Rule 5635(d) of Nasdaq with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance
proposal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Effect of abstentions and failures to vote</U>: If you mark &#147;ABSTAIN&#148; on your proxy, it will have no
effect on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. If you fail to submit a proxy or to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or fail to instruct your bank, broker or other nominee
how to vote with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, your shares will not be deemed to be represented at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, and it will have no effect
on the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal: </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Vote required</U>: Approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal requires
the affirmative vote of at least a majority of the votes that all <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders present at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, in person or by proxy, are entitled to cast.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Effect of abstentions and failures to vote</U>: If you mark &#147;ABSTAIN&#148; on your proxy, it will have
the same effect as a vote &#147;AGAINST&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. If you fail to submit a proxy or to vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or fail to instruct
your bank, broker or other nominee how to vote with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, your shares will not be deemed to be represented at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting, and it will have no effect on the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more
information on attending and voting at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, see &#147;&#151;Virtually Attending the <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting&#148; below in this joint proxy
statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_41"></A>Virtually Attending the <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you wish to virtually attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting via the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website, you must (i)&nbsp;be a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder of record at the close of business on May&nbsp;17, 2021, (ii) hold your shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock beneficially in the name of a broker, bank or other nominee as of the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date or (iii)&nbsp;hold a valid proxy for the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To enter the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website and
virtually attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, you must first register at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website by visiting www.virtualshareholdermeeting.com/IIVI2021SM in
order to obtain a unique meeting invitation by email. If you hold your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in street name beneficially through a broker, bank or other nominee and you wish to virtually attend and vote
at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting via the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website, you must provide a legal proxy from your bank, broker or other nominee during registration to obtain
a virtual control number. If you are unable to obtain a legal proxy from your bank, broker or other nominee, you will be able to register to attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, but may not vote your shares at
the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you plan to virtually attend and vote at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting via the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website, <FONT STYLE="white-space:nowrap">II-VI</FONT> still encourages you to submit your voting instructions in advance
by the Internet, telephone or (if you received a paper copy of the proxy materials) by mail so that your vote will be counted even if you later decide not to virtually attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting via the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting website. Submitting your proxy by the Internet, telephone or mail will not limit your right to virtually attend and vote at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting via
the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting website if you later decide to do so. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_42"></A>Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder may vote by in person (virtually) or by proxy at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. If you hold your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in your name as a holder of record, to submit a proxy, you, as a
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder, may use one of the following methods: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>By telephone</U>: by calling the toll-free number indicated on the accompanying proxy card and following the
recorded instructions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Through the Internet</U>: by visiting the website indicated on the accompanying proxy card and following the
instructions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>By mail</U>: by completing and returning the accompanying proxy card in the enclosed postage-paid envelope.
The envelope requires no additional postage if mailed in the United States. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> requests that <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders submit a proxy by
telephone, over the Internet or by completing and signing the accompanying proxy card and returning it to <FONT STYLE="white-space:nowrap">II-VI</FONT> as soon as possible in the enclosed postage-paid envelope. When the accompanying proxy card is
returned properly executed, the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock represented by it will be voted at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting in accordance with the instructions contained
on the proxy card. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; by a broker, bank or other nominee, you will receive instructions
from your broker, bank or other nominee that you must follow in order to vote your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, which will identify which of the above choices are available to you in order to submit a proxy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you submit your voting instructions by proxy, regardless of the method you choose to submit your proxy, the individuals named on the
enclosed proxy card, and each of them, with full power of substitution and resubstitution, will vote your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the way that you indicate. When completing the telephone or Internet
processes or the proxy card, you may specify whether your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock should be voted &#147;FOR&#148; or &#147;AGAINST&#148; or to &#147;ABSTAIN&#148; from voting on all, some or none of the
specific items of business to come before the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you properly sign your
proxy card but do not mark the boxes showing how your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock should be voted on a matter, the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock represented by your
properly signed proxy will be voted &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every vote is important. Accordingly, you should sign, date and return the enclosed proxy card, or submit a proxy via the Internet or by
telephone, whether or not you plan to attend the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. Sending in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
your proxy card by mail, by telephone or on the Internet will not prevent you from voting your shares personally at the meeting because you may revoke your proxy at any time before it is voted at
the meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_43"></A>Shares Held in Street Name </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; through a broker, bank or other nominee, you must instruct the broker, bank or other nominee
on how to vote your shares. Your broker, bank or other nominee will vote your shares only if you provide specific instructions on how to vote by following the instructions provided to you by your broker, bank or other nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may not vote shares held in &#147;street name&#148; by returning a proxy card directly to <FONT STYLE="white-space:nowrap">II-VI</FONT> or
by voting at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting unless you provide a &#147;legal proxy&#148; giving you the right to vote the shares, which you must obtain from your broker, bank or other nominee. If you choose to vote
your shares at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, please bring proof of identification and the proxy from your bank, broker or other nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, brokers, banks or other nominees who hold shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on behalf of their
customers may not give a proxy to <FONT STYLE="white-space:nowrap">II-VI</FONT> to vote those shares with respect to any of the proposals without specific instructions from their customers, as brokers, banks, and other nominees do not have
discretionary voting power on the proposals that will be voted upon at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_44">
</A>Revocability of Proxies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder of record, you may revoke your
proxy at any time before it is voted by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submitting a written notice of revocation to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary prior
to the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, which notice must bear a date later than the date of the previously submitted proxy and be received by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary prior to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">signing and returning a new proxy card with a later date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submitting your voting instructions by telephone or the Internet at a later time; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attending and voting at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or revoking your proxy
in person. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold your shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock through a broker, bank
or other nominee, you should contact your broker, bank or other nominee to change your vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attendance at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting will not in and of itself constitute revocation of a proxy. A revocation or later-dated proxy received by <FONT STYLE="white-space:nowrap">II-VI</FONT> after the vote will not affect the vote. <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary&#146;s mailing address is: <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056, Attn: Secretary. If the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting is postponed or adjourned, it will not affect the ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders as of the <FONT STYLE="white-space:nowrap">II-VI</FONT> record date to
exercise their voting rights or to revoke any previously-granted proxy using the methods described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_45"></A>Adjournments and
Postponements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although it is not currently expected, the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting may be
adjourned or postponed on one or more occasions for the purpose of soliciting additional proxies if there are insufficient votes at the time of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to approve the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal or if a quorum is not present at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> may also postpone or adjourn the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting
to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders prior to the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An adjournment generally may be made with the affirmative vote of the holders of a majority
of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock present in person or represented by proxy and entitled to vote thereon. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_46">
</A>Delivery of Proxy Materials </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by applicable law, only one copy of this joint proxy statement/prospectus is being
delivered to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders residing at the same address, unless such <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders have notified <FONT STYLE="white-space:nowrap">II-VI</FONT> of their desire
to receive multiple copies of the joint proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will promptly deliver,
upon oral or written request, a separate copy of the joint proxy statement/prospectus to any <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders residing at an address to which only one copy of such document was mailed. A <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholder who wishes to receive a separate copy of this joint proxy statement/prospectus may obtain one, without charge, by sending a request to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated,
375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056, Attention: Mark Lourie or by calling (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_47">
</A>Solicitation of Proxies; Payment of Solicitation Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This joint proxy statement/prospectus is being provided to holders of
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in connection with the solicitation of proxies by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to be voted at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting and at any adjournments or postponements of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. <FONT STYLE="white-space:nowrap">II-VI</FONT> will bear all costs and expenses in connection with the solicitation of proxies,
including the costs of filing, printing and mailing this joint proxy statement/prospectus for the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To assist in the solicitation of proxies, <FONT STYLE="white-space:nowrap">II-VI</FONT> has retained MacKenzie Partners, Inc., for a fee of
$25,000 plus reimbursement of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses for its services. <FONT STYLE="white-space:nowrap">II-VI</FONT> and its proxy solicitor may also request banks,
brokers and other intermediaries holding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock beneficially owned by others to send this joint proxy statement/prospectus to, and obtain proxies from, the beneficial owners and may
reimburse such record holders for their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in so doing. Solicitation of proxies by mail may be supplemented by telephone and other
electronic means, advertisements and personal solicitation by the directors, officers or employees of <FONT STYLE="white-space:nowrap">II-VI.</FONT> No additional compensation will be paid to our directors, officers or employees for solicitation.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_48"></A>Other Matters to Come Before the <FONT STYLE="white-space:nowrap">II-VI</FONT> Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> management knows of no other business to be presented at the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, but if any other matters are properly presented to the meeting or any adjournments thereof, the persons named in the proxies will vote upon them in accordance with the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board&#146;s recommendations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_49"></A>Assistance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you need assistance in completing your proxy card, have questions regarding <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> special
meeting or would like additional copies of this joint proxy statement/prospectus, please contact <FONT STYLE="white-space:nowrap">II-VI</FONT> at <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, 375 Saxonburg, PA 16056, Attention: Mark
Lourie, Telephone (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_50"></A><FONT STYLE="white-space:nowrap">II-VI</FONT> PROPOSALS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_51"></A>Proposal 1: <FONT STYLE="white-space:nowrap">II-VI</FONT> Share Issuance Proposal </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> is asking <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders to approve the issuance of
(i)&nbsp;shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the terms of the merger agreement in the amounts necessary to complete the merger, (ii)&nbsp;shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the subsequent investment pursuant to the terms of the investment agreement and (iii)&nbsp;shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion
of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock issued in the equity financing. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders should read this joint proxy statement/prospectus carefully and in
its entirety, including the annexes, for more detailed information concerning the merger agreement, the investment agreement, the statement with respect to shares, the merger, the equity financing, the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock in connection with the merger, the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in connection with the equity financing and the other
transactions contemplated by the merger agreement and the investment agreement. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the merger agreement is attached to this
joint proxy statement/prospectus as <B>Annex A</B> and a summary of the terms is included under &#147;The Merger Agreement&#148; beginning on page 156 of this joint proxy statement/prospectus. A copy of each of the investment agreement and statement
with respect to shares is attached to this joint proxy statement/prospectus as <B>Annex B</B> and <B>Annex C</B>, respectively, and a summary of each of the investment agreement and statement with respect to shares is included under &#147;The
Investment Agreement and the Statement with Respect to Shares&#148; beginning on page 183 of this joint proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After
careful consideration, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board determined that the merger, the merger agreement, the investment agreement and the transactions contemplated by the merger agreement and the investment agreement are
advisable and in the best interests of <FONT STYLE="white-space:nowrap">II-VI</FONT> and <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and adopted and approved the merger agreement, the investment agreement, the merger and the other
transactions contemplated by the merger agreement and the investment agreement. Accordingly, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board directed that the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal be submitted
to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and recommended that <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. See &#147;The <FONT
STYLE="white-space:nowrap">Merger&#151;II-VI&#146;s</FONT> Reasons for the Merger; Recommendation of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board&#148; beginning on page 123 of this joint proxy statement/prospectus for a more detailed
discussion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board&#146;s recommendation. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The
<FONT STYLE="white-space:nowrap">II-VI</FONT> board recommends a vote &#147;FOR&#148; the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_52"></A>Proposal 2: <FONT STYLE="white-space:nowrap">II-VI</FONT> Adjournment Proposal </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting may be adjourned to a later date or dates, if necessary or appropriate,
including to solicit additional proxies if there are insufficient votes at the time of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting, the number of shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock present or represented and voting in favor of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal is insufficient to approve the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, <FONT STYLE="white-space:nowrap">II-VI</FONT> intends to move to adjourn the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting in order to enable the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board to solicit additional proxies for approval of the share issuance. In that event, <FONT STYLE="white-space:nowrap">II-VI</FONT> will ask <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders to vote
upon the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal, but not the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal. <FONT STYLE="white-space:nowrap">II-VI</FONT> does not intend to call a vote on the <FONT
STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal to solicit additional proxies if the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal is approved at the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting.
Any determination of whether it is necessary or appropriate to adjourn the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to solicit additional proxies will be made on or behalf of <FONT STYLE="white-space:nowrap">II-VI</FONT> by the
presiding officer of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting (as determined in accordance with the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws) and will be consistent with the terms of the merger agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this proposal, <FONT STYLE="white-space:nowrap">II-VI</FONT> is asking <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders to authorize the holder of any proxy solicited by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on a discretionary basis to vote in favor of adjourning the
<FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting to another time and place (if any) for the purpose of soliciting additional proxies, including the solicitation of proxies from <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders
who have previously voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The <FONT STYLE="white-space:nowrap">II-VI</FONT> board recommends a vote &#147;FOR&#148; the <FONT
STYLE="white-space:nowrap">II-VI</FONT> adjournment proposal. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_53"></A>THE COHERENT SPECIAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section contains information for Coherent stockholders about the special meeting that Coherent has called to allow Coherent stockholders
to consider and vote on the merger agreement and other related matters. This joint proxy statement/prospectus is accompanied by a notice of the special meeting of Coherent stockholders and a form of proxy card that the Coherent board is soliciting
for use at the Coherent special meeting and at any adjournments or postponements of the Coherent special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_54"></A>Date, Time
and Place of the Meeting </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent special meeting is scheduled to be held virtually via live webcast on June&nbsp;24, 2021,
beginning at 8:30&nbsp;a.m., Pacific Time, unless postponed to a later date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of ongoing developments related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, Coherent has elected to hold the Coherent special meeting solely by means of remote communication via live webcast. Coherent stockholders will be able to virtually attend and vote at the Coherent
special meeting by visiting www.virtualshareholdermeeting.com/COHR2021SM. Coherent stockholders must first register at the special meeting website in order to obtain a unique meeting invitation by electronic mail. Coherent stockholders may request
access to the list of Coherent stockholders entitled to vote at the Coherent special meeting during the live webcast. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent has
retained Broadridge LLC to host the live webcast of the Coherent special meeting. On the day of the Coherent special meeting, Broadridge LLC may be contacted toll-free at (800) <FONT STYLE="white-space:nowrap">542-1061</FONT> to answer any questions
regarding how to virtually attend the Coherent special meeting or if you encounter any technical difficulty accessing or during the Coherent special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_55"></A>Matters to Be Considered </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Coherent special meeting, holders of Coherent common stock will be asked to consider and vote upon the following proposals: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Coherent merger proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Coherent compensation proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Coherent adjournment proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_56"></A>Recommendation of the Coherent Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent board recommends that you vote &#147;FOR&#148; the Coherent merger proposal, &#147;FOR&#148; the Coherent compensation proposal
and &#147;FOR&#148; the Coherent adjournment proposal. See &#147;The Merger&#151;Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148; beginning on page 98 of this joint proxy statement/prospectus for a more detailed
discussion of the Coherent board&#146;s recommendation. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_57"></A>Record Date and Quorum </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent board has fixed the close of business on May 17, 2021 as the Coherent record date for determination of Coherent stockholders
entitled to notice of and to vote at the Coherent special meeting. As of April&nbsp;30, 2021, there were 24,531,522 shares of Coherent common stock outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of a majority of the shares of Coherent common stock outstanding on the record date must be present, either virtually at the Coherent
special meeting or by proxy, to constitute a quorum at the Coherent special meeting. If you are a Coherent stockholder and you fail to submit a proxy or to attend the Coherent special meeting, your shares of Coherent common stock will not be counted
towards a quorum. Abstentions are considered present for purposes of establishing a quorum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Coherent special meeting, each share of Coherent common stock is entitled to one vote
on all matters properly submitted to holders of Coherent common stock. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2021, Coherent directors and executive
officers and their affiliates owned and were entitled to vote approximately 168,075 shares of Coherent common stock (which aggregate number is inclusive of Coherent RSUs vesting within 60&nbsp;days of the Coherent record date and Coherent common
stock indirectly owned), representing less than 1% of the outstanding shares of Coherent common stock. We currently expect that Coherent&#146;s directors and executive officers will vote their shares in favor of the Coherent merger proposal,
although none of them has entered into any agreements obligating them to do so. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_58"></A>Vote Required; Treatment of Abstentions
and Failure to Vote </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent merger proposal: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Vote required</U>: Approval of the Coherent merger proposal requires the affirmative vote of a majority of the
outstanding shares of Coherent common stock entitled to vote on the Coherent merger proposal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Effect of abstentions and failures to vote</U>: If you mark &#147;ABSTAIN&#148; on your proxy, fail to submit
a proxy or attend the Coherent special meeting or fail to instruct your bank, broker or other nominee how to vote with respect to the Coherent merger proposal, it will have the same effect as a vote &#147;AGAINST&#148; the Coherent merger proposal.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent compensation proposal: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Vote required</U>: Approval of the Coherent compensation proposal requires the affirmative vote of the holders
of a majority of the shares present or represented by proxy at the meeting and entitled to vote on the Coherent compensation proposal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Effect of abstentions and failures to vote</U>: If you mark &#147;ABSTAIN&#148; on your proxy, it will have
the same effect as a vote &#147;AGAINST&#148; the Coherent adjournment proposal. If you fail to submit a proxy or to attend the Coherent special meeting or fail to instruct your bank, broker or other nominee how to vote with respect to the Coherent
compensation proposal, your shares will not be deemed to be represented at the Coherent special meeting, and it will have no effect on the Coherent compensation proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coherent adjournment proposal: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Vote required</U>: Approval of the Coherent adjournment proposal requires the affirmative vote of the holders
of a majority of the shares present or represented by proxy at the meeting and entitled to vote on the Coherent adjournment proposal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Effect of abstentions and failures to vote</U>: If you mark &#147;ABSTAIN&#148; on your proxy, it will have
the same effect as a vote &#147;AGAINST&#148; the Coherent adjournment proposal. If you fail to submit a proxy or to attend the Coherent special meeting or fail to instruct your bank, broker or other nominee how to vote with respect to the Coherent
adjournment proposal, your shares will not be deemed to be represented at the Coherent special meeting, and it will have no effect on the Coherent adjournment proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_59"></A>Virtually Attending the Coherent Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you wish to virtually attend the Coherent special meeting via the Coherent special meeting website, you must (i)&nbsp;be a Coherent
stockholder of record at the close of business on May&nbsp;17, 2021, (ii) hold your shares of Coherent common stock beneficially in the name of a broker, bank or other nominee as of the Coherent record date or (iii)&nbsp;hold a valid proxy for the
Coherent special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To enter the Coherent special meeting website and virtually attend the Coherent special
meeting, you must first register at the Coherent special meeting website by visiting www.virtualshareholdermeeting.com/COHR2021SM in order to obtain a unique meeting invitation by email. If you hold your shares of Coherent common stock in street
name beneficially through a broker, bank or other nominee and you wish to virtually attend and vote at the Coherent special meeting via the Coherent special meeting website, you must provide a legal proxy from your bank, broker or other nominee
during registration to obtain a virtual control number. If you are unable to obtain a legal proxy from your bank, broker or other nominee, you will be able to register to attend the Coherent special meeting, but may not vote your shares at the
Coherent special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you plan to virtually attend and vote at the Coherent special meeting via the Coherent special meeting
website, Coherent still encourages you to submit your voting instructions in advance by the Internet, telephone or (if you received a paper copy of the proxy materials) by mail so that your vote will be counted even if you later decide not to
virtually attend the Coherent special meeting via the Coherent special meeting website. Submitting your proxy by the Internet, telephone or mail will not limit your right to virtually attend and vote at the Coherent special meeting via the Coherent
special meeting website if you later decide to do so. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_60"></A>Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of shares of Coherent common stock may vote in person (virtually) or by proxy at the Coherent special meeting. If you hold your shares
in your name as a holder of record, to submit a proxy, you, as a holder of Coherent shares, may use one of the following methods: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>By telephone</U>: by calling the toll-free number indicated on the accompanying proxy card and following the
recorded instructions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>Through the Internet</U>: by visiting the website indicated on the accompanying proxy card and following the
instructions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><U>By mail</U>: by completing and returning the accompanying proxy card in the enclosed postage-paid envelope.
The envelope requires no additional postage if mailed in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent requests that holders of Coherent
shares submit a proxy by telephone, over the Internet or by completing and signing the accompanying proxy card and returning it to Coherent as soon as possible in the enclosed postage-paid envelope. When the accompanying proxy card is returned
properly executed, the shares represented by it will be voted at the Coherent special meeting in accordance with the instructions contained on the proxy card. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a holder&#146;s shares are held in &#147;street name&#148; by a broker, bank or other nominee, the holder should check the voting form used
by that firm to determine whether the holder may submit a proxy by telephone or the Internet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you submit your voting instructions by
proxy, regardless of the method you choose to submit your proxy, the individuals named on the enclosed proxy card, and each of them, with full power of substitution and resubstitution, will vote your shares of Coherent common stock in the way that
you indicate. When completing the telephone or Internet processes or the proxy card, you may specify whether your shares of Coherent common stock should be voted &#147;FOR&#148; or &#147;AGAINST&#148; or to &#147;ABSTAIN&#148; from voting on all,
some or none of the specific items of business to come before the Coherent special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you properly sign your proxy card but do
not mark the boxes showing how your shares of Coherent common stock should be voted on a matter, the shares of Coherent common stock represented by your properly signed proxy will be voted &#147;FOR&#148; the Coherent merger proposal,
&#147;FOR&#148; the Coherent compensation proposal and &#147;FOR&#148; the Coherent adjournment proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every vote is important.
Accordingly, you should sign, date and return the enclosed proxy card, or submit a proxy via the Internet or by telephone, whether or not you plan to attend the Coherent special meeting. Sending </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in your proxy card by mail, by telephone or on the Internet will not prevent you from voting your shares personally at the meeting because you may revoke your proxy at any time before it is voted
at the meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_61"></A>Shares Held in Street Name </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares of Coherent common stock are held in &#147;street name&#148; through a broker, bank or other nominee, you must instruct the
broker, bank or other nominee on how to vote your shares. Your broker, bank or other nominee will vote your shares only if you provide specific instructions on how to vote by following the instructions provided to you by your broker, bank or other
nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may not vote shares of Coherent common stock held in &#147;street name&#148; by returning a proxy card directly to Coherent
or by voting at the Coherent special meeting unless you provide a &#147;legal proxy&#148; giving you the right to vote the shares, which you must obtain from your broker, bank or other nominee. If you choose to vote your shares at the Coherent
special meeting, please bring proof of identification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, brokers, banks or other nominees who hold shares on behalf of their
customers may not give a proxy to Coherent to vote those shares with respect to any of the proposals without specific instructions from their customers, as brokers, banks, and other nominees do not have discretionary voting power on the proposals
that will be voted upon at the Coherent special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_62"></A>Revocability of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a holder of shares of Coherent common stock of record, you may revoke your proxy at any time before it is voted by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submitting a written notice of revocation to Coherent&#146;s corporate secretary prior to the Coherent special
meeting, which notice must bear a date later than the date of the previously submitted proxy and be received by Coherent&#146;s corporate secretary prior to the Coherent special meeting ; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">signing and returning a new proxy card with a later date; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submitting your voting instructions by telephone or the Internet at a later time; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attending and voting at the Coherent special meeting or revoking your proxy in person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold your shares of Coherent common stock through a broker, bank or other nominee, you should contact your broker, bank or other
nominee to change your vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attendance at the Coherent special meeting will not in and of itself constitute revocation of a proxy. A
revocation or later-dated proxy received by Coherent after the vote will not affect the vote. Coherent&#146;s corporate secretary&#146;s mailing address is: Coherent, Inc., 5100 Patrick Henry Drive, Santa Clara, California 95054, Attention:
Corporate Secretary. If the Coherent special meeting is postponed or adjourned, it will not affect the ability of holders of Coherent common stock as of the Coherent record date to exercise their voting rights or to revoke any previously-granted
proxy using the methods described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_63"></A>Adjournments and Postponements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although it is not currently expected, the Coherent special meeting may be adjourned or postponed on one or more occasions for the purpose of
soliciting additional proxies if there are insufficient votes at the time of the Coherent special meeting to adopt the Coherent merger proposal or if a quorum is not present at the Coherent special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent may also postpone or adjourn the Coherent special meeting to allow reasonable additional time for the filing or mailing of any
supplemental or amended disclosure required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by Coherent stockholders prior to the Coherent special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_64"></A>Delivery of Proxy Materials </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by applicable law, only one copy of this joint proxy statement/prospectus is being delivered to holders of Coherent common stock
residing at the same address, unless such holders of Coherent common stock have notified Coherent of their desire to receive multiple copies of the joint proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent will promptly deliver, upon oral or written request, a separate copy of the joint proxy statement/prospectus to any holder of
Coherent common stock residing at an address to which only one copy of such document was mailed. Requests for additional copies should be directed to Investor Relations at (408) <FONT STYLE="white-space:nowrap">764-4110</FONT> or
investor.relations@coherent.com or Coherent&#146;s proxy solicitor, Georgeson LLC by calling toll-free at (888) <FONT STYLE="white-space:nowrap">666-2580.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_65"></A>Solicitation of Proxies; Payment of Solicitation Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This joint proxy statement/prospectus is being provided to holders of shares of Coherent common stock in connection with the solicitation of
proxies by the Coherent board to be voted at the Coherent special meeting and at any adjournments or postponements of the Coherent special meeting. Coherent will bear all costs and expenses in connection with the solicitation of proxies, including
the costs of filing, printing and mailing this joint proxy statement/prospectus for the Coherent special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To assist in the
solicitation of proxies, Coherent has retained Georgeson LLC and estimates it will pay Georgeson LLC a fee of approximately $25,000 plus reimbursement of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses for Georgeson LLC&#146;s services. Coherent and its proxy solicitor will also request banks, brokers and other intermediaries holding shares of Coherent common stock beneficially owned by others to send this joint proxy statement/prospectus
to, and obtain proxies from, the beneficial owners and may reimburse such record holders for their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in so doing. Solicitation of proxies
by mail may be supplemented by telephone and other electronic means, advertisements and personal solicitation by the directors, officers or employees of Coherent. No additional compensation will be paid to our directors, officers or employees for
solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not send in any Coherent stock certificates with your proxy card (or, if you hold your shares in &#147;street
name&#148; your voting instruction card). If the merger closes, the exchange agent will mail a transmittal letter with instructions for the surrender of stock certificates to holders of Coherent common stock as soon as practicable after completion
of the merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_66"></A>Other Matters to Come Before the Coherent Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent management knows of no other business to be presented at the Coherent special meeting, but if any other matters are properly presented
to the meeting or any adjournments thereof, the persons named in the proxies will vote upon them in accordance with the Coherent board&#146;s recommendations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_67"></A>Assistance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
you need assistance in completing your proxy card, have questions regarding Coherent&#146;s special meeting or would like additional copies of this joint proxy statement/prospectus, please contact Investor Relations at (408) <FONT
STYLE="white-space:nowrap">764-4110</FONT><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>or investor.relations@coherent.com or Coherent&#146;s proxy solicitor, Georgeson LLC, by calling toll-free at (888)
<FONT STYLE="white-space:nowrap">666-2580.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-68- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_68"></A>COHERENT PROPOSALS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_69"></A>Proposal 1: Coherent Merger Proposal </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent is asking holders of Coherent common stock to adopt the merger agreement and the transactions contemplated thereby. Holders of
Coherent common stock should read this joint proxy statement/prospectus carefully and in its entirety, including the annexes, for more detailed information concerning the merger agreement and the merger. A copy of the merger agreement is attached to
this joint proxy statement/prospectus as <B>Annex&nbsp;A</B>. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After careful consideration, the Coherent board unanimously approved
and declared advisable the merger agreement and the transactions contemplated by the merger agreement, including the merger. See &#147;The Merger&#151;Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148; beginning on
page&nbsp;98 of this joint proxy statement/prospectus for a more detailed discussion of the Coherent board&#146;s recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Coherent board recommends a vote &#147;FOR&#148; the Coherent merger proposal. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_70"></A>Proposal 2: Coherent Compensation Proposal </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;14A of the Exchange Act and <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-21</FONT> thereunder, Coherent is seeking
a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory stockholder approval of the compensation of Coherent&#146;s named executive officers that is based on or otherwise relates to the merger as disclosed in the section entitled &#147;The
Merger&#151;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#151;Golden Parachute Compensation&#148; beginning on page&nbsp;143 of this joint proxy statement/prospectus. The proposal gives holders of Coherent common stock
the opportunity to express their views on the merger-related compensation of Coherent&#146;s named executive officers. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly,
Coherent is asking holders of Coherent common stock to vote &#147;FOR&#148; the adoption of the following resolution, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the compensation that will or may be paid or become payable to the Coherent named executive officers, in connection with
the merger, and the agreements or understandings pursuant to which such compensation will or may be paid or become payable, in each case as disclosed pursuant to Item&nbsp;402(t) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> in
&#147;The Merger&#151;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#151;Golden Parachute Compensation&#148; are hereby APPROVED.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vote on the advisory compensation proposal is a vote separate and apart from the votes on the proposals to approve the Coherent merger
proposal and approve the Coherent adjournment proposal. Accordingly, if you are a holder of Coherent common stock, you may vote to approve the Coherent merger proposal and/or the Coherent adjournment proposal and vote not to approve the Coherent
compensation proposal, and vice versa. If the merger is completed, the merger-related compensation will be paid to Coherent&#146;s named executive officers to the extent payable in accordance with the terms of the compensation agreements and
arrangements even if holders of Coherent common stock fail to approve the advisory vote regarding merger-related compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The
Coherent board unanimously recommends a vote &#147;FOR&#148; the advisory Coherent compensation proposal. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_71"></A>Proposal 3: Coherent Adjournment Proposal </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent special meeting may be adjourned to another time or place, if necessary or appropriate, to solicit additional proxies if there
are insufficient votes at the time of the Coherent special meeting to approve the Coherent merger proposal, to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Coherent stockholders
or to constitute a quorum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-69- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, at the Coherent special meeting, the number of shares of Coherent common stock present
or represented and voting in favor of the Coherent merger proposal is insufficient to approve the Coherent merger proposal, Coherent intends to move to adjourn the Coherent special meeting in order to enable the Coherent board to solicit additional
proxies for approval of the merger. In that event, unless the chair of the meeting adjourns the meeting without stockholder action, Coherent will ask holders of Coherent common stock to vote upon the Coherent adjournment proposal, but not the
Coherent merger proposal or the Coherent compensation proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this proposal, Coherent is asking holders of Coherent common stock to
authorize the holder of any proxy solicited by the Coherent board on a discretionary basis to vote in favor of adjourning the Coherent special meeting to another time and place, if any, for the purpose of soliciting additional proxies, including the
solicitation of proxies from holders of Coherent common stock who have previously voted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Coherent board recommends a vote
&#147;FOR&#148; the Coherent adjournment proposal. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-70- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_72"></A>INFORMATION ABOUT <FONT STYLE="white-space:nowrap">II-VI</FONT>
AND MERGER SUB </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation, is a global leader in engineered materials and
optoelectronic components, and is a vertically integrated manufacturing company that develops, manufactures and markets engineered materials and optoelectronic components and devices for precision use in industrial materials processing, optical
communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences and automotive applications. Headquartered in Saxonburg, Pennsylvania, <FONT STYLE="white-space:nowrap">II-VI</FONT> has research and
development, manufacturing, sales, service, and distribution facilities worldwide. <FONT STYLE="white-space:nowrap">II-VI</FONT> produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in
various forms, including integrated with advanced software to enable its customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock is traded on Nasdaq under the symbol &#147;IIVI.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> world headquarters
are located at 375&nbsp;Saxonburg Boulevard, Saxonburg, Pennsylvania 16056. The telephone number at that location is (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> Additional information about <FONT STYLE="white-space:nowrap">II-VI</FONT>
can be found at <I><FONT STYLE="white-space:nowrap">www.II-VI.com</FONT></I> and in documents incorporated by reference in this joint proxy statement/prospectus. See &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this
joint proxy statement/prospectus. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger Sub </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Watson Merger Sub Inc., a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI,</FONT> is a Delaware corporation incorporated on
March&nbsp;4, 2021 for the purpose of effecting the merger. Merger Sub has not conducted any activities other than those incidental to its formation and the matters contemplated by the merger agreement. Merger Sub&#146;s headquarters are located at
375&nbsp;Saxonburg Boulevard, Saxonburg, Pennsylvania 16056. The telephone number at that location is (724) <FONT STYLE="white-space:nowrap">352-4455.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-71- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_73"></A>INFORMATION ABOUT COHERENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent, Inc., a Delaware corporation, is one of the world&#146;s leading providers of lasers, laser-based technologies and laser-based
system solutions in a broad range of commercial, industrial and scientific applications. Coherent designs, manufactures, services and markets lasers and related accessories for a diverse group of customers. Since inception in 1966, Coherent has
grown through internal expansion and through strategic acquisitions of complementary businesses, technologies, intellectual property, manufacturing processes and product offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent common stock is traded on Nasdaq under the symbol &#147;COHR.&#148; Coherent&#146;s headquarters are located at 5100&nbsp;Patrick
Henry Drive, Santa Clara, California 95054. The telephone number at that location is (408) <FONT STYLE="white-space:nowrap">764-4000.</FONT> Additional information about Coherent can be found at <I>www.coherent.com</I> and in documents incorporated
by reference in this joint proxy statement/prospectus. See &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-72- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_74"></A>THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This section of the joint proxy statement/prospectus describes material aspects of the merger. This summary may not contain all of the
information that is important to you. You should carefully read this entire joint proxy statement/prospectus and the other documents we refer you to for a more complete understanding of the merger. In addition, we incorporate important business and
financial information about each of us into this joint proxy statement/prospectus by reference. You may obtain the information incorporated by reference into this joint proxy statement/prospectus without charge by following the instructions in the
section entitled &#147;Where You Can Find More Information&#148; beginning on page&nbsp;
245 of this joint proxy statement/prospectus. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_75"></A>Terms of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Coherent board and the <FONT STYLE="white-space:nowrap">II-VI</FONT> board has approved the merger agreement, the merger and the
other transactions contemplated by the merger agreement. The merger agreement provides that Merger Sub will merge with and into Coherent, with Coherent surviving the merger as a wholly owned subsidiary of
<FONT STYLE="white-space:nowrap">II-VI.</FONT> The <FONT STYLE="white-space:nowrap">II-VI</FONT> board has also approved the investment agreement, the statement with respect to shares, the equity financing and the other transactions contemplated by
the investment agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the merger, each share of Coherent common stock issued and outstanding immediately prior to the effective
time (other than certain shares of Coherent common stock that are cancelled shares or dissenting shares) will be converted into the right to receive $220.00&nbsp;in cash and 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock. Holders of Coherent common stock will receive cash in lieu of fractional shares. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent stockholders are being asked to
adopt the merger agreement. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are being asked to approve the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the terms of the merger agreement in
the amounts necessary to complete the merger, the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">Series&nbsp;B-2</FONT> convertible preferred stock in the subsequent investment pursuant to the
terms of the investment agreement, and the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon any conversion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock issued in
the equity financing. See &#147;The Merger Agreement&#148; beginning on page&nbsp;156 of this joint proxy statement/prospectus for additional and more detailed information regarding the legal documents that govern the merger, including information
about the conditions to the completion of the merger and the provisions for terminating or amending the merger agreement. See &#147;The Investment Agreement and the Statement with Respect to Shares&#151;The Investment Agreement&#148; beginning on
page&nbsp;
184 of this joint proxy statement/prospectus for additional and more detailed information regarding the investment agreement. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_76">
</A>Background of the Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their respective businesses, senior management and the boards of directors of
each of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> regularly review, assess and discuss developments in their markets, their company&#146;s performance, strategy and competitive position in their markets and potential strategic
initiatives and alternatives in light of economic and market conditions. A centerpiece of these discussions is often the customer-supplier nature of the commercial relationship. As part of these ongoing reviews, from time to time each of Coherent
and <FONT STYLE="white-space:nowrap">II-VI</FONT> have discussed with other parties potential business combinations, joint ventures, strategic alliances and other strategic transactions that might advance their mutual strategic objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In fall 2019, Dr. John Ambroseo, then-Chief Executive Officer and President of Coherent, met with Alan S. Lowe, Chief Executive Officer of
Lumentum Holdings Inc. (which we refer to as &#147;Lumentum&#148;), when Mr.&nbsp;Lowe expressed Lumentum&#146;s interest in a potential merger with Coherent. Dr.&nbsp;Ambroseo did not express support or opposition to a merger and indicated he would
discuss the matter with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;4, 2019, Lumentum sent Dr.&nbsp;Ambroseo a written indication of interest in
acquiring Coherent at a price of $166.55 per share payable in Lumentum stock, which was promptly shared with the Coherent board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-73- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;11, 2019, at Coherent&#146;s request, BofA Securities sent Coherent a
relationship disclosure memorandum, which disclosure included fees that BofA Securities and its affiliates had earned in recent years from Lumentum and Coherent, which was shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;14, 2019, the Coherent board met in person. Coherent&#146;s management team and representatives of BofA Securities attended
the meeting, with representatives of BofA Securities attending telephonically. Dr.&nbsp;Ambroseo recounted his meeting with Mr.&nbsp;Lowe and described his assessment of Lumentum&#146;s proposal in light of his view of Coherent&#146;s business
outlook, opportunities, challenges and risks, as well as Coherent&#146;s pending leadership transition following Dr.&nbsp;Ambroseo&#146;s planned retirement. Representatives of BofA Securities presented a preliminary financial analysis of
Lumentum&#146;s proposal, including the relative stock trading histories of Coherent and Lumentum, and a pro forma combination analysis, derived in part from each of Coherent&#146;s and Lumentum&#146;s publicly available financial results and Wall
Street estimates of each of Coherent&#146;s and Lumentum&#146;s future financial results. After discussion, the Coherent board determined that Coherent&#146;s business plans and strategies presented a better opportunity to create long-term value for
Coherent&#146;s stockholders than Lumentum&#146;s proposed merger, and accordingly instructed Dr.&nbsp;Ambroseo to inform Lumentum that the Coherent board was not interested in exploring a merger with Lumentum based on Lumentum&#146;s proposal.
Dr.&nbsp;Ambroseo subsequently informed Mr.&nbsp;Lowe of the Coherent board&#146;s decision and delivered a letter to Lumentum reflecting Coherent&#146;s response to Lumentum&#146;s proposal. The Coherent board also discussed the relationship
disclosure memorandum received from BofA Securities on October&nbsp;11, 2019, a copy of which had been made available to the Coherent board prior to the meeting. After consulting with its legal advisors, the Coherent board determined that the
information in BofA Securities&#146; disclosure memorandum did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent in connection with a potential transaction with Lumentum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;16, 2019, Dr.&nbsp;Ambroseo met with Mr.&nbsp;Lowe at Mr.&nbsp;Lowe&#146;s request to discuss further the Coherent
board&#146;s reasoning behind rejecting Lumentum&#146;s October&nbsp;4, 2019 proposal, where Mr.&nbsp;Lowe expressed that he would discuss the proposed transaction further with the Lumentum board and that he expected Lumentum to submit an enhanced
offer following further internal discussions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;29, 2019, Lumentum sent Dr.&nbsp;Ambroseo a revised indication of interest
in acquiring Coherent for $173.00 to $178.00 per share, 20% of which would be payable in cash and 80% of which would be payable in Lumentum stock, which was promptly shared with the Coherent board. Shortly thereafter, Mr.&nbsp;Lowe called
Dr.&nbsp;Ambroseo to reiterate Lumentum&#146;s strong interest in acquiring Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;7, 2019, the Coherent board met in
person. Coherent&#146;s management team and representatives of BofA Securities attended the meeting, with representatives of BofA Securities attending telephonically. Dr.&nbsp;Ambroseo recounted his most recent discussion with Mr.&nbsp;Lowe and his
assessment of Lumentum&#146;s October&nbsp;29 proposal in light of his view of Coherent&#146;s business outlook, opportunities, challenges and risks. Representatives of BofA Securities presented a preliminary financial analysis of Lumentum&#146;s
October&nbsp;29 proposal, including the relative stock trading histories of Coherent and Lumentum, a preliminary valuation analysis of Coherent based on the financial plans of Coherent&#146;s management which recently had been reviewed and
unanimously approved by the Coherent board on September&nbsp;25, 2019, and a pro forma combination analysis, derived in part from Coherent&#146;s management projections and Lumentum&#146;s publicly available financial results and Wall Street
estimates of Lumentum&#146;s future financial results. After discussion, the Coherent board again determined that Coherent&#146;s business plans and strategies presented a better opportunity to create long-term value for Coherent&#146;s
stockholders, and accordingly instructed Dr.&nbsp;Ambroseo to inform Lumentum again that the Coherent board was not interested in exploring a merger with Lumentum based on Lumentum&#146;s October&nbsp;29 proposal and Dr.&nbsp;Ambroseo informed
Mr.&nbsp;Lowe of the Coherent board&#146;s decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;11, 2019, Dr.&nbsp;Ambroseo met with Mr.&nbsp;Lowe at
Mr.&nbsp;Lowe&#146;s request to discuss further the Coherent board&#146;s reasoning behind rejecting Lumentum&#146;s October&nbsp;29, 2019 proposal. Dr.&nbsp;Ambroseo and Mr.&nbsp;Lowe discussed the timing of a potential transaction and whether the
parties might consider sharing internal projections at this juncture in order for Lumentum to provide a further enhanced proposal to acquire Coherent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-74- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;18, 2019, Lumentum sent Dr.&nbsp;Ambroseo a revised indication of interest
in acquiring Coherent for $195.00 per share but not specifying the precise mix of cash and stock consideration, which was promptly shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;24, 2019, the Coherent board met by telephone conference. Coherent&#146;s management team and representatives of BofA
Securities and Skadden Arps, Slate, Meagher&nbsp;&amp; Flom LLP (which we refer to as &#147;Skadden&#148;), Coherent&#146;s legal advisor, attended the meeting. Dr.&nbsp;Ambroseo described Lumentum&#146;s November&nbsp;18 proposal and his assessment
of Lumentum&#146;s latest proposal in light of his view of Coherent&#146;s business outlook, opportunities, challenges and risks. Representatives of BofA Securities presented a preliminary financial analysis of Lumentum&#146;s November&nbsp;18
proposal, including the relative stock trading histories of Coherent and Lumentum, a preliminary valuation analysis of Coherent based on the financial plans of Coherent&#146;s management which recently had been reviewed and unanimously approved by
the Coherent board and a pro forma combination analysis, derived in part from Lumentum&#146;s publicly available financial results and Wall Street estimates of Lumentum&#146;s future financial results. After discussion, the Coherent board determined
once again that Coherent&#146;s business plans and strategies presented a better opportunity to create long-term value for Coherent&#146;s stockholders, and accordingly instructed Dr.&nbsp;Ambroseo to inform Lumentum once again that the Coherent
board was not interested in exploring a merger with Lumentum based on the terms of Lumentum&#146;s November&nbsp;18 proposal and Dr.&nbsp;Ambroseo informed Mr.&nbsp;Lowe of the Coherent board&#146;s decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During or around November 2019, with the Coherent board&#146;s knowledge, Dr.&nbsp;Ambroseo took telephone calls from Mr.&nbsp;Lowe. During
these calls, Mr.&nbsp;Lowe expressed Lumentum&#146;s continued interest in acquiring Coherent and Dr.&nbsp;Ambroseo observed that the Coherent board believed Lumentum&#146;s latest proposal continued to undervalue Coherent. Dr.&nbsp;Ambroseo did not
give Mr.&nbsp;Lowe any indication of values or prices at which the Coherent board would be willing to entertain merger discussions with Lumentum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;5, 2020, Lumentum sent Dr.&nbsp;Ambroseo a revised indication of interest in acquiring Coherent for $217.50 per share, 50% of
which would be payable in cash and 50% of which would be payable in Lumentum stock, which was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
January&nbsp;11, 2020, the Coherent board met by video conference. Coherent&#146;s management team and representatives of Skadden attended the meeting. Dr.&nbsp;Ambroseo recounted his two most recent discussions with Mr.&nbsp;Lowe and described
Lumentum&#146;s January&nbsp;5 proposal and his assessment of Lumentum&#146;s latest proposal in light of his view of Coherent&#146;s business outlook, opportunities, challenges and risks. Representatives of BofA Securities then presented a
preliminary financial analysis of Lumentum&#146;s January&nbsp;5 proposal, including the relative stock trading histories of Coherent and Lumentum, a preliminary valuation analysis of Coherent based on the financial plans of Coherent&#146;s
management which recently had been reviewed and unanimously approved by the Coherent board and a pro forma combination analysis, derived in part from Coherent&#146;s management projections and Lumentum&#146;s publicly available financial results and
Wall Street estimates of Lumentum&#146;s future financial results. After discussion, the Coherent board concluded that Lumentum&#146;s January&nbsp;5 proposal continued to undervalue Coherent but nevertheless warranted further discussions with
Lumentum so the Coherent board authorized management to meet with Lumentum management to discuss strategic alignment and synergies that might be available through combining their respective businesses. In addition, the Coherent board requested that
Dr.&nbsp;Garry Rogerson, Chairman of the Coherent board, work with management to develop the information that would be presented at the meeting with Lumentum, and Dr.&nbsp;Rogerson spoke the next day with Steve Skaggs and Sandeep Vij, members of the
Coherent board, to discuss the information to be sought from management for such purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;20, 2020, Coherent and
Lumentum entered into a customary <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement to facilitate the exchange of information between the parties, which included customary &#147;standstill&#148; provisions that did not include <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;don&#146;t ask, don&#146;t waive&#148; restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;21, 2020 and
January&nbsp;22, 2020, Coherent management met with Lumentum management to discuss strategic alignment and synergies that might be available through combining their respective businesses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-75- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
During this meeting, Coherent shared confidential information, including management&#146;s long-term financial forecasts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;7, 2020, following the management meeting between Coherent and Lumentum, Lumentum sent the Coherent board a revised
indication of interest in acquiring Coherent for $222.50 per share, 50% of which would be paid in cash and 50% of which would be paid in Lumentum stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the week of February&nbsp;10, 2020, Dr.&nbsp;Ambroseo had a previously scheduled meeting with Dr.&nbsp;John&nbsp;T.C. Lee, President
and Chief Executive Officer of MKS Instruments, Inc. (which we refer to herein as &#147;MKS&#148;), during which Dr.&nbsp;Lee expressed MKS&#146; interest in a potential business combination transaction with Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;15, 2020, the Coherent board met by telephone conference. Coherent&#146;s management team and representatives of Skadden
attended the meeting. The Coherent board discussed, among other things, the management meetings between Coherent&#146;s and Lumentum&#146;s management teams, as well as Lumentum&#146;s February&nbsp;7 proposal. After discussion, the Coherent board
determined that Dr.&nbsp;Rogerson should, together with Coherent&#146;s financial and legal advisors, continue to engage with Lumentum in an effort to obtain Lumentum&#146;s best acquisition price and address the Coherent board&#146;s concerns
regarding transaction and value certainty. Representatives of Skadden provided advice regarding the Coherent board&#146;s fiduciary duties in connection with its consideration of the transaction proposed by Lumentum. At this meeting, the Coherent
board also discussed Dr.&nbsp;Ambroseo&#146;s recent meeting with Dr.&nbsp;Lee and determined that representatives of BofA Securities should contact MKS&#146; financial advisors to assess the level of MKS&#146; interest in Coherent and determine if
MKS would submit a written acquisition proposal on a timeframe that would enable the Coherent board to assess an MKS transaction in parallel with its consideration of a potential merger with Lumentum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;17, 2020, at Coherent&#146;s request, BofA Securities sent Coherent an updated relationship disclosure memorandum, dated as
of February&nbsp;6, 2020, which disclosure included fees that BofA Securities and its affiliates had earned in recent years from Lumentum, MKS and Coherent, which was shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;18, 2020, at the Coherent board&#146;s direction, representatives of BofA Securities contacted Lumentum&#146;s financial
advisors to request and negotiate an increased purchase price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;19, 2020, at the Coherent board&#146;s direction,
representatives of BofA Securities contacted MKS&#146; financial advisors to gauge MKS&#146; interest in submitting a transaction proposal to the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;20, 2020, upon further discussion among representatives of Coherent and Lumentum, Lumentum sent Coherent a revised indication
of interest in acquiring Coherent for $225.00 per share, 49% would be payable in cash and 51% of which would be payable in Lumentum stock, which was promptly shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;24, 2020, MKS sent Coherent an indication of interest in acquiring Coherent for $195.00 per share, consisting of an
unspecified mix of cash and stock consideration, which was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;4, 2020, the Coherent
board met by video conference. Coherent&#146;s management team and representatives of BofA Securities and Skadden attended the meeting. Representatives of BofA Securities outlined Lumentum&#146;s February&nbsp;20 proposal and MKS&#146;
February&nbsp;24 proposal and presented a preliminary financial analysis of both transactions, including the relative stock trading histories of Coherent, Lumentum and MKS, a preliminary valuation analysis of Coherent based on the financial plans of
Coherent&#146;s management which recently had been reviewed and unanimously approved by the Coherent board and a pro forma combination analysis, derived in part from Lumentum&#146;s publicly available financial results and Wall Street
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-76- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
estimates of Lumentum&#146;s future financial results and MKS&#146; publicly available financial results and Wall Street estimates of MKS&#146; future financial results. Dr.&nbsp;Rogerson updated
the Coherent board on recent discussions with representatives of Lumentum and MKS since Coherent&#146;s last board meeting. After discussion, the Coherent board determined to continue discussion with Lumentum based on its February&nbsp;20 proposal
but also continue discussions with MKS to determine if MKS would be willing to improve its acquisition proposal. The Coherent board also discussed the relationship disclosure memorandum received from BofA Securities on February&nbsp;17, 2020 (dated
as of February&nbsp;6, 2020), a copy of which had been made available to the Coherent board prior to the meeting. After consulting with its legal advisors, the Coherent board determined that the information in BofA Securities&#146; disclosure
memorandum did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent in connection with a potential transaction with Lumentum or MKS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At this time, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic was spreading around the world, lockdowns were imposed worldwide,
economic outlooks were becoming uncertain and stock prices in the U.S. and elsewhere began to deteriorate significantly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;9,
2020, Mr.&nbsp;Lowe and Dr.&nbsp;Rogerson spoke on the phone, which was memorialized in a letter of the same date, and Mr.&nbsp;Lowe indicated that Lumentum had decided to halt work on a potential transaction with Coherent given the potential
economic impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and uncertainty in the global stock markets. As a result of this development and the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic gripping the globe,
Coherent determined not to pursue further discussions with MKS at this time as well. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;10, 2020, Mr.&nbsp;Bret DiMarco,
Executive Vice President, Chief Legal Officer and Corporate Secretary of Coherent, sent Ms.&nbsp;Judy Hamel, Senior Vice President, General Counsel and Secretary of Lumentum, a letter requesting that Lumentum return or destroy all Coherent
confidential information provided to Lumentum under the terms of the <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement between Coherent and Lumentum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2020, Dr.&nbsp;Vincent&nbsp;D. Mattera, Jr., Chief Executive Officer of <FONT STYLE="white-space:nowrap">II-VI,</FONT> and
Dr.&nbsp;Ambroseo had a dinner meeting in which they discussed a variety of industry topics. During the course of the meeting, Dr.&nbsp;Mattera raised the question of whether Coherent would be amenable to discussing a combination of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;6, 2020, Coherent announced the appointment of Mr.&nbsp;Andreas W.
Mattes, as Coherent&#146;s new President and Chief Executive Officer, effective immediately, replacing Dr.&nbsp;Ambroseo, who previously had announced his intent to retire and entered into a CEO Transition and Retirement Agreement with Coherent on
April&nbsp;13, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through the spring and summer of 2020, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board undertook an ordinary
course review of strategic alternatives. This review included consideration of, among other alternatives, a potential acquisition of Coherent. On June&nbsp;1, 2020, Dr.&nbsp;Mattera and Mr.&nbsp;Mattes held an introductory meeting in which
Dr.&nbsp;Mattera expressed <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> interest in a potential combination transaction with Coherent. At a meeting of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board held by video conference on
August&nbsp;20, 2020 to review various strategic M&amp;A opportunities, representatives of a financial advisor provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and management team with an overview, based solely on publicly available
information, of a possible transaction with Coherent, and the strategic rationale for such a transaction. The II-VI board and management team discussed Coherent&#146;s status as a global provider of laser and laser-based technologies, its scale and
service infrastructure and the opportunity for <FONT STYLE="white-space:nowrap">II-VI</FONT> to access new markets and to diversify revenues such a transaction would provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;20, 2020, Coherent announced its entry into an Executive Transition Agreement with Kevin Palatnik, Executive Vice President and
Chief Financial Officer of Coherent, pursuant to which Mr.&nbsp;Palatnik would retire from his role at Coherent no later than February&nbsp;28, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;25, 2020, Mr.&nbsp;Mattes was contacted by Dr.&nbsp;Lee who informed Mr.&nbsp;Mattes that MKS was interested in <FONT
STYLE="white-space:nowrap">re-starting</FONT> discussions with Coherent regarding a potential merger transaction. Dr.&nbsp;Lee provided his </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-77- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
perspectives on the earlier limited engagement and noted that his board was fully supportive of his outreach. MKS followed up this call on August&nbsp;25, 2020 by sending Coherent an indication
of interest in acquiring Coherent for $165.00 to $175.00 per share, consisting of an unspecified mix of cash and stock consideration, which was promptly shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;28, 2020, Mr.&nbsp;Mattes and Dr.&nbsp;Lee discussed the August&nbsp;25 MKS proposal and the need to enter into a <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreement to facilitate further discussions between the parties. On the same day, Dr.&nbsp;Mattera and Mr.&nbsp;Mattes had a previously scheduled call to discuss industry trends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Dr.&nbsp;Lee shared with Mr.&nbsp;Mattes information regarding MKS&#146; revenue model for Coherent&#146;s
consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;4, 2020, Coherent and MKS entered into a customary
<FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement, which included customary &#147;standstill&#148; provisions that did not include <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;don&#146;t ask, don&#146;t waive&#148;
restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;8, 2020, Mr.&nbsp;Mattes and Dr.&nbsp;Lee discussed MKS&#146; revenue model previously shared with
Mr.&nbsp;Mattes on September&nbsp;2, 2020, and discussed next steps with respect to a potential transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;14, 2020,
after discussions between Mr.&nbsp;Mattes and Dr.&nbsp;Lee, MKS sent Coherent a revised indication of interest in acquiring Coherent for $180.00 per share, consisting of an unspecified mix of consideration, which was promptly shared with the
Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;20, 2020, Mr.&nbsp;Mattes and Dr.&nbsp;Mattera held a meeting at which Dr.&nbsp;Mattera indicated <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> potential interest in collaborating more closely with Coherent regarding their ongoing commercial relationship as well as to determine whether a potential business combination of their respective
businesses was feasible at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;29 and 30, 2020, the Coherent board met by video conference. Coherent&#146;s
management team attended the meeting. The Coherent board discussed, among other things, BofA Securities&#146; preliminary financial analysis of MKS&#146; September&nbsp;14 proposal, a preliminary valuation analysis of Coherent based on the financial
forecasts of Coherent&#146;s management and a pro forma combination analysis, derived in part from MKS&#146; publicly available financial results and Wall Street estimates of MKS&#146; future financial results. After discussion, the Coherent board
directed Coherent&#146;s management team to meet with MKS to further discuss the strategic merits and financial synergies of a business combination of their respective businesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;2, 2020, at the direction of the Coherent board, Mr.&nbsp;Mattes discussed with Dr.&nbsp;Lee the strategic merits and
financial synergies of a potential business combination between Coherent and MKS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;16, 2020, Coherent&#146;s management
team met with MKS&#146; management team and provided a management presentation outlining Coherent&#146;s business plans and financial projections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also in October 2020, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, in consultation with management, determined to further explore
the possibility of pursuing a transaction with Coherent. <FONT STYLE="white-space:nowrap">II-VI</FONT> management subsequently contacted representatives of Allen&nbsp;&amp; Company LLC (&#147;Allen&nbsp;&amp; Company&#148;) and, after
Allen&nbsp;&amp; Company confirmed that it had not provided material investment banking services to <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent during the prior <FONT STYLE="white-space:nowrap">two-year</FONT> period for which
Allen&nbsp;&amp; Company received compensation, <FONT STYLE="white-space:nowrap">II-VI</FONT> engaged Allen&nbsp;&amp; Company as its financial advisor. On October&nbsp;28, 2020, with the authorization of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board, Dr.&nbsp;Mattera called Mr.&nbsp;Mattes to inform Mr.&nbsp;Mattes of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> interest in pursuing a potential transaction with Coherent and potential
next steps. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;30, 2020, MKS sent Coherent a revised proposal to acquire Coherent for $183.00 per share, consisting of an
unspecified mix of cash and stock consideration, which was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;5, 2020, a committee
of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board held a meeting at which all <FONT STYLE="white-space:nowrap">II-VI</FONT> directors were present. At that meeting, <FONT STYLE="white-space:nowrap">II-VI</FONT> management introduced
Allen&nbsp;&amp; Company to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and Allen&nbsp;&amp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-78- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, based on publicly available information, with an overview of Coherent as a potential acquisition target and facilitated a
discussion of potential next steps with respect to a transaction involving <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
November&nbsp;6, 2020, the Coherent board met by video conference. Coherent&#146;s management team and representatives of BofA Securities and Skadden attended the meeting. Representatives of BofA Securities outlined MKS&#146; October&nbsp;30
proposal and presented a preliminary financial analysis of the MKS proposal, including the relative stock trading histories of Coherent and MKS, a preliminary valuation analysis of Coherent based on the financial plans of Coherent&#146;s management
which recently had been reviewed and unanimously approved by the Coherent board and a pro forma combination analysis, derived in part from MKS&#146; publicly available financial results and Wall Street estimates of MKS&#146; future financial
results. After a discussion of the MKS proposal, the Coherent board discussed the advisability of contacting Lumentum to assess its interest in <FONT STYLE="white-space:nowrap">re-starting</FONT> the merger discussions that had been terminated in
March 2020 and instructed management and BofA Securities to contact Lumentum. The Coherent board then discussed Mr.&nbsp;Mattes&#146; conversation with Dr.&nbsp;Mattera and how to further gauge <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT>
interest in a potential transaction between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. After discussion, the Coherent board instructed management and BofA Securities to contact representatives of
<FONT STYLE="white-space:nowrap">II-VI.</FONT> During the course of this discussion, BofA Securities informed the Coherent board that BofA Securities was a frequent advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> and that a lead member of
the BofA Securities team working with Coherent was part of the BofA Securities team that regularly covered <FONT STYLE="white-space:nowrap">II-VI.</FONT> The Coherent board did not take any action in response to this disclosure pending a
determination of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> level of interest in a transaction with Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
November&nbsp;6, 2020, at the Coherent board&#146;s direction, a representative of BofA Securities contacted a representative of Lumentum to assess its interest in a potential transaction. On November&nbsp;7, 2020, at the Coherent board&#146;s
direction, a representative of BofA Securities contacted a representative of <FONT STYLE="white-space:nowrap">II-VI</FONT> to assess <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> interest in a potential transaction. On November&nbsp;9, 2020,
Mr.&nbsp;Lowe contacted Mr.&nbsp;Mattes to convey Lumentum&#146;s interest in <FONT STYLE="white-space:nowrap">re-starting</FONT> discussions regarding Lumentum&#146;s potential acquisition of Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;10, 2020, Coherent released earnings for the fiscal quarter ended October&nbsp;3, 2020, highlighting net sales during such
quarter of $316.8&nbsp;million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $7.7&nbsp;million, or $0.32 per diluted share and, for the fiscal year ended October&nbsp;3, 2020, net sales of $1,229.0&nbsp;million
and net loss on a GAAP basis of $414.1&nbsp;million, or $17.18 per diluted share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a regular meeting of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board held by video conference on November&nbsp;10, 2020, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board discussed, among other things, the possibility of pursuing an acquisition of Coherent.
Management presented an overview of Coherent as a potential acquisition target and potential next steps with respect to a transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Mattes and Mr.&nbsp;Lowe spoke again on November&nbsp;11, 2021, and Mr.&nbsp;Lowe reiterated Lumentum&#146;s continued interest in
exploring a potential acquisition of Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;12 and November&nbsp;13, 2020, the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board met to further discuss the possibility of pursuing a transaction with Coherent. <B></B>Allen&nbsp;&amp; Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, based on publicly
available information, with, among other things, a business and financial profile of Coherent, certain preliminary market and other industry-related information and an illustrative overview of certain implied transaction metrics at various
theoretical purchase prices and cash/stock consideration mix. Later in the day on November&nbsp;13, 2020, following a discussion between Mr.&nbsp;Mattes and Dr.&nbsp;Mattera, and with the authorization of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board, <FONT STYLE="white-space:nowrap">II-VI</FONT> sent Coherent a preliminary indication of interest in acquiring Coherent for $150.00 per share, 20% of which would be paid in cash and 80% of which
would be paid in <FONT STYLE="white-space:nowrap">II-VI</FONT> stock, which was promptly shared with the Coherent board. Together with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposal, <FONT STYLE="white-space:nowrap">II-VI</FONT> also
sent Coherent a presentation regarding <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business and outlining the potential synergies of a combined company, which was also shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on November&nbsp;13, 2020, Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into a customary <FONT
STYLE="white-space:nowrap">non-disclosure</FONT> agreement, which included customary &#147;standstill&#148; provisions but did not include <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;don&#146;t ask, don&#146;t waive&#148; restrictions.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-79- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;14, 2020, after discussions between Messrs. Mattes and Lowe, Lumentum sent
Coherent an indication of interest in acquiring Coherent for $200.00 per share, 50% would be paid in cash and 50% of which would be paid in Lumentum stock, which was promptly shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;15, 2020, the Coherent board met by video conference. Coherent&#146;s management team, BofA Securities and Skadden attended
the meeting. Mr.&nbsp;Mattes began by outlining the three acquisition proposals that Coherent had received from each of MKS, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Lumentum. Mr.&nbsp;Mattes then discussed the status of the management
team&#146;s ongoing strategic plan review and refresh work on Coherent&#146;s business plans and strategies in preparation for the board&#146;s regularly scheduled meeting in December. After discussion, the Coherent board determined to continue
discussions with each of MKS, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Lumentum so that, during its regularly scheduled December board meeting, the Coherent board could evaluate Coherent&#146;s strategic planning process, stand-alone
business plan and prospects in comparison to a potential sale of Coherent. After consultation with its legal advisors and in light of the terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposal relative to the proposals Coherent had
received from MKS and Lumentum, the Coherent board did not believe it was necessary to retain an additional financial advisor to supplement BofA Securities&#146; advisory work at that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;16, 2020, at Coherent&#146;s request, BofA Securities sent Coherent an updated relationship disclosure memorandum, which
disclosure included fees that BofA Securities and its affiliates had earned in recent years from MKS, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum and Coherent, which was shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on November&nbsp;16, 2020, at the direction of the Coherent board, Mr.&nbsp;Mattes held separate discussions with each of Dr.&nbsp;Lee,
Mr.&nbsp;Lowe and Dr.&nbsp;Mattera, to discuss the Coherent board&#146;s feedback with respect to each party&#146;s respective acquisition proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;17, 2020, Coherent and Lumentum entered into a supplemental <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement,
which included customary &#147;standstill&#148; restrictions on both parties but did not include <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;don&#146;t ask, don&#146;t waive&#148; restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;18, 2020, Coherent&#146;s management team met with Lumentum&#146;s management team by video conference and gave a management
presentation outlining Coherent&#146;s business plans and financial projections. Lumentum also presented a preliminary view of its business plans and financial projections at this meeting. On November&nbsp;23, 2020, Coherent&#146;s management team
met with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management team by video conference and gave the same management presentation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;29, 2020, the Coherent board met by video conference. Coherent&#146;s management team, BofA Securities and Skadden attended
the meeting. During the meeting, Mr.&nbsp;Mattes provided an update on the management team&#146;s most recent meetings with Lumentum and <FONT STYLE="white-space:nowrap">II-VI.</FONT> The Coherent board also discussed the relationship disclosure
memorandum that Coherent had received from BofA Securities on November&nbsp;16, 2020, a copy of which had been made available to the Coherent board prior to the meeting. The Coherent board took notice of the fact that BofA Securities previously had
provided advisory services to <FONT STYLE="white-space:nowrap">II-VI,</FONT> but determined the past provision of such services did not represent a disqualifying conflict of interest in light of the competitive nature of the transaction process
involving Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> BofA Securities&#146; performance in advising Coherent up to that date, and the fact that such compensated services were historical,
<FONT STYLE="white-space:nowrap">non-recurring</FONT> and unrelated to the currently contemplated potential transaction between Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> The Coherent board also observed that <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposed acquisition price was significantly lower than the acquisition prices proposed by each of MKS and Lumentum, suggesting at the time that it was unlikely that the Coherent board would conclude
that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal was preferable to those of MKS or Lumentum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning on
November&nbsp;30, 2020 through early December 2020, Coherent&#146;s management team held multiple <FONT STYLE="white-space:nowrap">follow-up</FONT> meetings with the management teams of each of Lumentum, MKS and
<FONT STYLE="white-space:nowrap">II-VI,</FONT> each by video conference, to address questions and other inquiries from each of these parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;1, 2020, representatives of Coherent asked each of Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> to provide
its best acquisition proposal in advance of a scheduled meeting of the Coherent board on December&nbsp;15, 2020, with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-80- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an updated view on price, consideration mix, governance and financing based on information that Coherent had provided during the previous month so that the Coherent board could evaluate their
proposals at that meeting and make a final determination regarding a potential transaction. All three parties were informed that Coherent was evaluating other acquisition proposals, that the Coherent board expected to make a determination regarding
a potential transaction during the December&nbsp;15 board meeting and that it should not be assumed that there would be further opportunities to submit improved proposals after the December&nbsp;15 meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;8, 2020, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference to discuss the status of its ongoing
discussions with Coherent. Members of management provided an update regarding their recent conversations with representatives of Coherent and Coherent&#146;s request that bidders submit revised proposals. Allen&nbsp;&amp; Company provided the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board, based on certain financial data provided by the management of <FONT STYLE="white-space:nowrap">II-VI,</FONT> with, among other things, certain preliminary financial information relating to Coherent and
the proposed transaction and an updated illustrative overview of certain implied transaction metrics at various theoretical purchase prices and cash/stock consideration mix. Management provided an overview of its due diligence review of Coherent,
and noted that certain key due diligence requests of <FONT STYLE="white-space:nowrap">II-VI</FONT> remained unaddressed since as of such date <FONT STYLE="white-space:nowrap">II-VI</FONT> had only been provided limited access to internal, <FONT
STYLE="white-space:nowrap">non-public</FONT> business and financial data of Coherent as Coherent had informed <FONT STYLE="white-space:nowrap">II-VI</FONT> that it did not intend to provide complete access to confidential information to multiple
bidders. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board considered these and other factors and authorized management to submit a revised indication of interest to Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;11, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> sent Coherent a revised indication of interest to acquire Coherent
for $190.00 per share, 20% of which would be paid in cash and 80% of which would be paid in <FONT STYLE="white-space:nowrap">II-VI</FONT> stock, which was promptly shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on December&nbsp;11, 2020, MKS sent Coherent a revised indication of interest in acquiring Coherent for $200.00 per share, 38% of which
would be paid in cash and 62% of which would be paid in MKS stock, together with a highly confident letter from a financial institution with respect to the potential debt financing for the proposed transaction. The proposal, together with the highly
confident letter, was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;12, 2020, Lumentum sent Coherent a revised indication of
interest in acquiring Coherent for $208.00 per share, 48% would be paid in cash and 52% of which would be paid in Lumentum stock, together with a highly confident letter from Deutsche Bank Securities Inc. with respect to the debt financing for the
proposed transaction. The proposal, together with the highly confident letter, was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
December&nbsp;15, 2020, the Coherent board met by video conference at a regularly scheduled meeting. Coherent&#146;s management team and representatives of Skadden attended the meeting. The Coherent board discussed BofA Securities&#146;
presentation, which previously had been made available to the Coherent board, summarizing the latest acquisition proposals from each of Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> and providing a preliminary valuation analysis of
each of the proposals, including the relative stock trading histories of Coherent, Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> a preliminary valuation analysis of Coherent based on the financial plans of Coherent&#146;s
management which recently had been reviewed and unanimously approved by the Coherent board and a pro forma combination analysis of each of the proposed transactions, derived in part from the publicly available financial results and Wall Street
estimates of each party&#146;s future financial results and the financial projections provided by each of the proposed acquirors during their meetings with Coherent management. The Coherent board discussed the opportunities and risks of a business
combination with each of Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> and, after discussion, instructed management to work with Skadden to provide a draft merger agreement to each of Lumentum, MKS and <FONT
STYLE="white-space:nowrap">II-VI</FONT> and request final acquisition proposals with proposed revisions to the draft merger agreement by December&nbsp;20, 2020 so that the Coherent board could make a final determination with respect to a potential
sale of Coherent to one of the three bidders. The Coherent board again discussed the relationship disclosure memorandum received from BofA Securities on November&nbsp;16, 2020, a copy of which had been made available to the Coherent board prior to
the meeting. The Coherent board took notice of the fact that, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-81- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in addition to the factors considered at the November&nbsp;29, 2020 meeting of the Coherent board, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposed acquisition price was meaningfully
lower than the proposals received from MKS and Lumentum, suggesting at the time that it was unlikely that the Coherent board would conclude that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal was preferable to those
submitted by Lumentum and MKS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;16, 2020, at the request of the Coherent board, representatives of BofA Securities
distributed a draft merger agreement to each of Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> requesting final acquisition proposals by December&nbsp;20, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on December&nbsp;16, 2020, at the direction of the Coherent board, Mr.&nbsp;Mattes held separate discussions with each of Mr.&nbsp;Lowe,
Dr.&nbsp;Mattera, and Dr.&nbsp;Lee to discuss the Coherent board&#146;s feedback with respect to each party&#146;s respective proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference on December&nbsp;16 and December&nbsp;20, 2020 to discuss the
status of the ongoing process with Coherent. Members of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management team and representatives of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal advisor, K&amp;L Gates LLP (&#147;K&amp;L
Gates&#148;), and Allen&nbsp;&amp; Company also attended the meeting. At the December&nbsp;20, 2020 meeting, among other things, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board discussed proposed revisions to the merger agreement previously
distributed by BofA Securities, which merger agreement, as revised by <FONT STYLE="white-space:nowrap">II-VI,</FONT> provided for (i)&nbsp;a termination fee payable by Coherent to <FONT STYLE="white-space:nowrap">II-VI</FONT> of $150&nbsp;million
under specified circumstances (including termination by Coherent to accept a superior proposal), (ii)&nbsp;a termination fee payable by <FONT STYLE="white-space:nowrap">II-VI</FONT> to Coherent of $150&nbsp;million under specified circumstances
(including termination by <FONT STYLE="white-space:nowrap">II-VI</FONT> to accept a superior proposal), and if the merger agreement was terminated for failure to obtain antitrust approvals, a termination fee payable by
<FONT STYLE="white-space:nowrap">II-VI</FONT> to Coherent of $250&nbsp;million, (iii)&nbsp;expense reimbursement by Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> up to $5&nbsp;million in the event the merger agreement was terminated
under certain circumstances and (iv)&nbsp;an obligation on the part of each of the parties to take all actions necessary, proper or advisable to obtain regulatory approvals for the transaction, subject to exceptions for actions relating to material
assets of <FONT STYLE="white-space:nowrap">II-VI</FONT> and actions which would have a material adverse effect on <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or their respective subsidiaries following the closing of the acquisition. <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> management noted that the proposal would be accompanied by a highly confident letter from J.P. Morgan with respect to the debt financing for the proposed transaction. Allen&nbsp;&amp; Company provided
the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain implied transaction metrics at various theoretical purchase prices and cash/stock consideration mix. The <FONT
STYLE="white-space:nowrap">II-VI</FONT> board discussed the potential terms of an acquisition proposal and, after deliberation and consideration of the limited nature of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> due diligence access to
internal business and financial data from Coherent, authorized management to submit an acquisition proposal within the range of $195.26 to $198.26 per share, together with the revised merger agreement reviewed with the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board at the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subsequently, on the same date,
<FONT STYLE="white-space:nowrap">II-VI</FONT> delivered a revised proposal to acquire Coherent for $39.60 in cash and 2.124 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock (implying an
aggregate value of approximately $198.00 per Coherent share based on the prevailing trading price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common shares at the close of trading on December&nbsp;18, 2021), together with the revised merger
agreement and a highly confident letter from J.P. Morgan regarding the debt financing for the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on December&nbsp;20,
2020, each of Lumentum and MKS sent Coherent their proposed revisions to the merger agreement. Together with their proposed revisions to the merger agreement, Lumentum sent a revised proposal to acquire Coherent for $218.00 per share, 46% of which
would be paid in cash and 54% of which would be paid in Lumentum stock, and MKS did not submit a revised proposal at this time. Each of the proposals (including the <FONT STYLE="white-space:nowrap">II-VI</FONT> proposal) was promptly shared with the
Coherent board. The proposed merger agreement from Lumentum provided for (i)&nbsp;a termination fee payable by Coherent to Lumentum in certain situations equal to 4% of transaction value on the signing date, (ii)&nbsp;a reverse termination fee
payable by Lumentum to Coherent in certain situations equal to 4% of Lumentum&#146;s market capitalization on the signing date, (iii)&nbsp;expense reimbursement by Coherent or Lumentum up to $10&nbsp;million in the event the merger agreement was
terminated under certain circumstances and (iv)&nbsp;for the parties to use their respective reasonable best efforts to obtain regulatory approvals for the transaction. The proposed merger agreement from MKS provided for (i)&nbsp;a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-82- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
termination fee payable by Coherent to MKS in certain situations equal to $200&nbsp;million, (ii)&nbsp;a reverse termination fee payable by MKS to Coherent in certain situations equal to
$200&nbsp;million, (iii)&nbsp;expense reimbursement by Coherent or MKS up to $25&nbsp;million in the event the merger agreement was terminated under certain circumstances and (iv)&nbsp;for the parties to use their respective reasonable best efforts
to obtain regulatory approvals for the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;21, 2020, Mr.&nbsp;Lowe called Mr.&nbsp;Mattes to receive a process
update. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2020, MKS sent Coherent a revised acquisition proposal to acquire Coherent for $222.00&nbsp;per share, 34%
of which would be payable in cash and 66% of which would be payable in MKS stock, which was promptly shared with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
December&nbsp;23, 2020, the Coherent board met by video conference. Coherent&#146;s management team attended the meeting. The Coherent board discussed the acquisition proposals received from Lumentum, MKS and
<FONT STYLE="white-space:nowrap">II-VI,</FONT> including summary materials relating to each proposal provided by Skadden and a financial analysis of each of the proposals provided by BofA Securities, each of which had been made available to the
Coherent board prior to the meeting. The Coherent board discussed the opportunities and risks of each proposal, including each party&#146;s proposed changes to the merger agreement that Coherent had provided to each of the bidders and the regulatory
analysis provided by representatives of Skadden. The Board also assessed, among other things, the proposed per share consideration by each of Lumentum, MKS and II-VI, the composition of such consideration, regulatory considerations with respect to
each proposal, and potential synergies contemplated by each of the bidders in connection with each proposal. After discussion, the Coherent board instructed management to approach Lumentum to discuss whether Lumentum would submit an additional
proposal to refine its offer in light of Coherent&#146;s regulatory analysis of the proposed transaction and terms relating to regulatory clearance provided in Lumentum&#146;s proposed revisions to the merger agreement. At Lumentum&#146;s request
and in light of the fact that Coherent had asked each of the bidders to submit its best proposal for consideration by the Coherent board at this meeting, and in light of the various considerations discussed at this Coherent board meeting, the
Coherent board authorized management to enter into a brief period of exclusive negotiations with Lumentum to explore whether an acceptable transaction could be finalized by the parties. Following the meeting, Mr.&nbsp;Mattes called Mr.&nbsp;Lowe and
communicated the Coherent board&#146;s decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;26, 2020, following ongoing discussion between Lumentum and Coherent
and their respective financial and legal advisors, Lumentum sent Coherent a revised proposal to acquire Coherent for $225.00 per share, 44% of which would be paid in cash and 56% of which would be paid in Lumentum stock, which was promptly shared
with the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;27, 2020, at Lumentum&#146;s request, and with the prior approval of the Coherent board,
Coherent and Lumentum entered into an exclusivity agreement to enable Lumentum to complete its confirmatory due diligence review of Coherent and finalize its financing arrangements for the proposed transaction. Coherent thereafter informed each of
MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> that Coherent had entered into an exclusivity agreement with a third party and was ceasing discussions with each of them with respect to a potential transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;28, 2020, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference at which members of <FONT
STYLE="white-space:nowrap">II-VI</FONT> management and representatives of Allen&nbsp;&amp; Company provided an update regarding the events of the prior week. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board discussed a range of possible
responses to Coherent&#146;s decision to enter into an exclusivity agreement with a third party, including the possibility of submitting an updated acquisition proposal to Coherent prior to Coherent&#146;s execution of a merger agreement with such
third party. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board also considered various risks and considerations associated with these potential responses, including that any further proposals made at the time would continue to be parametered
by the limited nature of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> due diligence access to internal, <FONT STYLE="white-space:nowrap">non-public</FONT> business and financial data from Coherent. Following this discussion, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board determined not to take any immediate further action with respect to a transaction with Coherent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-83- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;29, 2020, at Coherent&#146;s direction, Skadden sent Lumentum&#146;s
counsel, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. (which we refer to as &#147;Wilson Sonsini&#148;), a revised draft of Lumentum&#146;s proposed merger agreement for the proposed transaction. The revised draft merger agreement from Coherent
provided for (i)&nbsp;a termination fee payable by Coherent to Lumentum in certain situations equal to 3% of transaction value on the signing date, (ii)&nbsp;a reverse termination fee payable by Lumentum to Coherent in certain situations equal to 3%
of Lumentum&#146;s market capitalization on the signing date and in certain situations related to regulatory approval in China, equal to 8% of Lumentum&#146;s market capitalization on the signing date, (iii)&nbsp;expense payment by Coherent or
Lumentum equal to $25&nbsp;million in the event the merger agreement was terminated under certain circumstances and (iv)&nbsp;for the parties to take all actions necessary, proper or advisable to obtain regulatory approvals for the transaction.
Representatives of Wilson Sonsini and Skadden continued to negotiate these provisions until the merger agreement was agreed to between the parties on January&nbsp;18, 2021, which we refer to as the &#147;January 18 Lumentum Merger Agreement&#148; in
this joint proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From late December 2020 through early January 2021, Coherent and Lumentum and their respective
financial and legal advisors held due diligence meetings by video conference and the parties continued to discuss and negotiate the terms of the proposed transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;3, 2021, Wilson Sonsini sent Skadden a revised draft of the proposed Lumentum merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;5, 2021, Wilson Sonsini sent Skadden initial drafts of the debt commitment documents that Lumentum intended to enter into in
connection with the proposed transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;7, 2021, the Coherent board met by video conference. Coherent&#146;s management
team attended the meeting and discussed the terms of Lumentum&#146;s latest acquisition proposal and certain terms of Lumentum&#146;s proposed merger agreement and financing arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;8, 2021, at Coherent&#146;s direction, Skadden sent Wilson Sonsini a revised draft of the proposed Lumentum merger agreement
reflecting feedback from the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;9, 2021, Coherent&#146;s management team met with Lumentum&#146;s management
team by video conference. Representatives of Skadden and Wilson Sonsini were also present. Each of Coherent&#146;s and Lumentum&#146;s management teams discussed terms of the proposed merger agreement, including with respect to regulatory matters,
employment matters and interim operating restrictions applicable to the parties&#146; business operations during the pendency of the proposed transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;14, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of
Skadden also attended the meeting. At this meeting, the Coherent board discussed the status of negotiations with Lumentum and BofA Securities presented an updated financial analysis of the proposed transaction with Lumentum. Coherent&#146;s
management presented to the Coherent board, and the Coherent board accepted for use in connection with its evaluation of the proposed transaction and BofA Securities&#146; fairness opinion, a revised set of financial forecasts for Coherent&#146;s
long-term financial performance, which had been revised to account for, among other things, the passage of time and further insight into Coherent&#146;s performance (including the fact that Coherent would most likely cease material third-party
M&amp;A activity during the pendency of the proposed Lumentum transaction). The Coherent board then authorized BofA Securities to rely on these revised financial forecasts in its financial analysis of the proposed Lumentum transaction and the
rendering of a fairness opinion if and when BofA Securities was requested to do so. The revised forecasts were subsequently shared with Lumentum and its advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From January&nbsp;16 through 18, 2021, representatives of Wilson Sonsini and Skadden continued to negotiate the terms of the proposed merger
agreement for the transaction and BofA Securities and Deutsche Bank discussed calculation of the exchange ratio for the stock portion of the merger consideration for the proposed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction. As a result of negotiations over the calculation of the exchange ratio, Lumentum and Coherent agreed upon an exchange ratio that implied a headline transaction value of $226.00 per
Coherent share based on the prevailing trading price of Lumentum shares at such time, comprised of $100.00 in cash, without interest, and 1.1851 validly issued, fully paid and nonassessable shares of Lumentum common stock per share of Coherent
common stock payable at the completion of the transaction. The final version of the January&nbsp;18 Lumentum Merger Agreement included the following terms: (i)&nbsp;a termination fee payable by Coherent to Lumentum in certain situations (including
termination of the merger agreement by Coherent to accept a superior proposal) equal to 3.9% of transaction value on the signing date, or $217.6&nbsp;million, (ii)&nbsp;a reverse termination fee payable by Lumentum to Coherent in certain situations
(including termination of the merger agreement by Lumentum to accept a superior proposal) equal to 3.9% of Lumentum&#146;s market capitalization on the signing date, or $337.7&nbsp;million, and if the merger agreement was terminated for failure to
obtain antitrust approval from a Chinese governmental entity, Lumentum would be required to pay Coherent a termination fee equal to 5% of transaction value on the signing date, or $279&nbsp;million, (iii)&nbsp;expense payment by Coherent or Lumentum
equal to $25&nbsp;million in the event the merger agreement was terminated under certain circumstances and (iv)&nbsp;for the parties to take all actions necessary, proper or advisable to obtain regulatory approvals for the transaction, subject to
limitations on actions required to be taken by Lumentum obtain regulatory approval in China. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;17, 2021, Coherent and
Mr.&nbsp;Palatnik agreed to terminate his Executive Transition Agreement, entered into on August&nbsp;20, 2020, which had contemplated that Mr.&nbsp;Palatnik would not continue his employment with Coherent beyond February&nbsp;28, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;18, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of BofA
Securities and Skadden also attended the meeting. A representative of Skadden summarized the fully negotiated terms of the proposed merger agreement for the transaction with Lumentum. Representatives of BofA Securities provided an overview regarding
the overall process undertaken by Coherent and BofA Securities in connection with the proposed transaction, including the bidding process with Lumentum as well as each of MKS and <FONT STYLE="white-space:nowrap">II-VI.</FONT> Representatives of BofA
Securities then reviewed with the Coherent board its financial analysis of the merger consideration to be paid in the proposed transaction based on Coherent&#146;s and Lumentum&#146;s respective financial forecasts and current market data, all of
which previously had been reviewed and unanimously approved by the Coherent board for use by BofA Securities in connection with its financial analysis. Following this presentation and upon the request of the Coherent board, BofA Securities delivered
to the Coherent board its oral opinion, subsequently confirmed by delivery of a written opinion, dated January&nbsp;18, 2021, to the effect that, as of such date and based on and subject to the assumptions, limitations, qualifications and other
matters considered in the preparation of such opinion as set forth in such opinion, the merger consideration to be received in the first merger by the holders of Coherent common stock (other than the holders of any cancelled shares or any dissenting
shares) was fair, from a financial point of view, to such holders. Mr.&nbsp;DiMarco then presented a set of proposed resolutions approving the January&nbsp;18 Lumentum Merger Agreement, the transactions contemplated thereby and certain related
matters and the Coherent board unanimously approved the foregoing resolutions. The Coherent board also discussed the updated relationship disclosure memorandum received from BofA Securities on January&nbsp;18, 2021, a copy of which had been
submitted to the Coherent board prior to the meeting, which disclosure included fees that BofA Securities and its affiliates had earned in recent years from Lumentum and Coherent. After consulting with its legal advisors, the Coherent board
determined that the information in BofA Securities&#146; disclosure memorandum did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent in connection with a potential transaction with Lumentum.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the evening of January&nbsp;18, 2021, Coherent and Lumentum executed the January&nbsp;18 Lumentum Merger Agreement, by and among
Lumentum, Cheetah Acquisition Sub, Inc. (&#147;Lumentum Merger Sub&nbsp;I&#148;) and Cheetah Acquisition Sub LLC, which provided for the merger of Lumentum Merger Sub&nbsp;I with and into Coherent (the &#147;Lumentum merger&#148;). The execution of
the January&nbsp;18 Lumentum Merger Agreement was announced in a joint press release issued by Coherent and Lumentum on the morning of January&nbsp;19, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-85- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the announcement of the January&nbsp;18 Lumentum Merger Agreement, <FONT
STYLE="white-space:nowrap">II-VI</FONT> management reviewed the terms of the transaction and considered the potential impact of the Lumentum merger on the business and financial prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> as a
stand-alone company as well as the potential merits of a transaction between Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> In light of these and other factors, <FONT STYLE="white-space:nowrap">II-VI</FONT> management considered a range
of potential strategic actions and responses, including the possibility of making an unsolicited proposal to acquire Coherent. Throughout the subsequent two weeks, members of <FONT STYLE="white-space:nowrap">II-VI</FONT> management discussed, with
the assistance of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal and financial advisors, the possible terms and conditions of an acquisition proposal as well as the potential timeline and strategy for making a proposal. Members of <FONT
STYLE="white-space:nowrap">II-VI</FONT> management also engaged in preliminary discussions with four potential equity financing sources&#151;Bain Capital, L.P. (&#147;Bain&#148;), two private equity firms and J.P. Morgan&#151;for a potential
transaction involving <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent and/or other strategic uses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subsequently, on
February&nbsp;4, 2021, MKS sent the Coherent board an unsolicited proposal to acquire each share of Coherent common stock for $115.00 in cash and 0.7473 of a share of MKS common stock at the completion of the transaction (implying an aggregate value
of $240.00 per share based on the price per share of MKS common stock at the close of trading on February 4), subject to customary closing conditions including receipt of U.S. and foreign antitrust approvals and stockholder approvals. At the close
of trading on February&nbsp;4, the merger consideration contemplated by the January&nbsp;18 Lumentum Merger Agreement implied a transaction value of $206.13 per Coherent share. Among other changes from the January&nbsp;18 Lumentum Merger Agreement,
the proposed merger agreement from MKS provided that (i)&nbsp;MKS would pay the termination fee of $217.6&nbsp;million to Lumentum on the signing date on behalf of Coherent, (ii)&nbsp;a similar termination fee would be payable by Coherent to MKS in
certain situations (including termination of the merger agreement by Coherent to accept a superior proposal), and (iii)&nbsp;MKS would have a <FONT STYLE="white-space:nowrap">pre-closing</FONT> marketing period to syndicate its financing commitments
following receipt of stockholder approvals and regulatory approvals for the proposed transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;6, 2021, BofA
Securities sent to the Coherent board an updated relationship disclosure memorandum, which disclosure included fees that BofA Securities and its affiliates had earned in recent years from MKS, Lumentum and Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;7, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of BofA
Securities and Skadden also attended the meeting. Representatives of Skadden provided an overview of the Coherent board&#146;s fiduciary duties in light of Coherent&#146;s receipt of MKS&#146; unsolicited acquisition proposal and Coherent&#146;s
pending merger transaction with Lumentum, and the terms of the January&nbsp;18 Lumentum Merger Agreement applicable to the Coherent board&#146;s consideration of MKS&#146; acquisition proposal. Representatives of BofA Securities then presented a
preliminary financial analysis of MKS&#146; acquisition proposal. Following discussion with Coherent&#146;s legal and financial advisors, the Coherent board determined to engage in discussions with MKS in order to further evaluate MKS&#146; proposal
after determining that the MKS proposal would reasonably be expected to lead to a transaction that was superior to Coherent&#146;s pending merger with Lumentum and that failure to evaluate such proposal would be inconsistent with the Coherent
board&#146;s fiduciary duties. The Coherent board also discussed the updated relationship disclosure memorandum received from BofA Securities on February&nbsp;6, 2021, a copy of which had been submitted to the Coherent board prior to the meeting.
After consulting with its legal advisors, the Coherent board determined that the information in BofA Securities&#146; disclosure memorandum did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent
in connection with a potential transaction with MKS or Lumentum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;8, 2021, Coherent issued a press release announcing its
receipt of an unsolicited acquisition proposal from MKS and Coherent&#146;s intent to engage in discussions with MKS to further evaluate MKS&#146; proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following Coherent&#146;s announcement, <FONT STYLE="white-space:nowrap">II-VI</FONT> management continued to review the strategic rationale
and potential risks and benefits of an acquisition of Coherent, with the assistance of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal and financial advisors. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and advisors
also continued discussions with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> potential equity financing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-86- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sources regarding the potential for providing equity financing to <FONT STYLE="white-space:nowrap">II-VI</FONT> for a potential transaction involving <FONT STYLE="white-space:nowrap">II-VI</FONT>
and Coherent and/or other strategic uses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;9, 2021, Coherent and MKS commenced discussions and the Coherent team, with
assistance from its financial and legal advisors, began to facilitate MKS&#146; due diligence review process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;11, 2021,
the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference. Members of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management team and representatives of Wachtell, Lipton, Rosen&nbsp;&amp; Katz (&#147;Wachtell
Lipton&#148;), which <FONT STYLE="white-space:nowrap">II-VI</FONT> engaged as an additional legal advisor, Allen&nbsp;&amp; Company and J.P. Morgan, which <FONT STYLE="white-space:nowrap">II-VI</FONT> engaged as an additional financial advisor, also
attended the meeting. Members of management provided an overview of the key events that had transpired since the announcement of the January&nbsp;18 Lumentum Merger Agreement and presented their recommendation that
<FONT STYLE="white-space:nowrap">II-VI</FONT> submit an unsolicited proposal to acquire Coherent for $130.00 in cash and 1.3055 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock (implying an
aggregate value of approximately $260.00 per share based on the price per share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock at the close of trading on February&nbsp;11, 2021). Members of management also described the key terms of
the proposal, including the proposed merger agreement. Among other changes from the January&nbsp;18 Lumentum Merger Agreement, the proposed merger agreement provided (i)&nbsp;that Coherent would not be required to pay any termination fee to <FONT
STYLE="white-space:nowrap">II-VI,</FONT> but that it would be required to pay expense reimbursement in the amount of $25&nbsp;million in certain situations (including termination of the merger agreement by Coherent to accept a superior proposal) and
(ii)&nbsp;an earlier date at which either party could terminate the merger agreement if the transaction had not been consummated by that date. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> proposed to include a highly confident letter
from J.P. Morgan relating to the debt financing for the transaction as part of the proposal. Management also noted that discussions were ongoing with potential sources of equity financing, including with Bain. Allen&nbsp;&amp; Company provided the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, a comparative overview of the consideration provided for in the January&nbsp;18 Lumentum Merger Agreement and MKS&#146; February&nbsp;4 proposal and, based on certain financial
data provided by the management of <FONT STYLE="white-space:nowrap">II-VI,</FONT> certain updated preliminary financial information relating to Coherent and the proposed transaction and an updated illustrative overview of certain implied transaction
metrics at various theoretical purchase prices and financing scenarios. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board considered this information, as well as the potential risks and opportunities of a transaction with Coherent relative to
the risks and opportunities if it did not undertake a transaction with Coherent and, after deliberation, directed management to submit an unsolicited proposal to acquire Coherent upon the terms discussed and reviewed with the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board, which proposal was sent to the Coherent board on the morning of February&nbsp;12, 2021. Later that day, <FONT STYLE="white-space:nowrap">II-VI</FONT> issued a press release announcing its proposal to
acquire Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;13, 2021, BofA Securities submitted to the Coherent board an updated relationship disclosure
memorandum, which disclosure included fees that BofA Securities and its affiliates had earned in recent years from MKS, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum and Coherent, which was shared with the Coherent board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;14, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of BofA
Securities and Skadden also attended the meeting. Representatives of Skadden provided an overview of the Coherent board&#146;s fiduciary duties in light of Coherent&#146;s receipt of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> unsolicited
acquisition proposal and Coherent&#146;s pending merger transaction with Lumentum, and the terms of the January&nbsp;18 Lumentum Merger Agreement applicable to the Coherent board&#146;s consideration of
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal. Representatives of BofA Securities then presented a preliminary financial analysis of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal. Following
discussion with Coherent&#146;s legal and financial advisors, the Coherent board determined to engage in discussions with <FONT STYLE="white-space:nowrap">II-VI</FONT> in order to further evaluate <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT>
proposal after determining that the <FONT STYLE="white-space:nowrap">II-VI</FONT> proposal would reasonably be expected to lead to a transaction that was superior to Coherent&#146;s pending merger with Lumentum and that failure to evaluate such
proposal would be inconsistent with the Coherent board&#146;s fiduciary duties. At the meeting, the Coherent board also discussed the updated relationship disclosure memorandum provided by BofA Securities on February&nbsp;13, 2021. In light of such
disclosure memorandum, the Coherent board determined that it did not believe that BofA Securities&#146; relationship with <FONT STYLE="white-space:nowrap">II-VI</FONT> rose to the level of a disqualifying conflict of interest or raised a material
concern about BofA Securities&#146; role as a financial advisor to the Coherent board. However, the Coherent board nevertheless determined that it would be in the best interest </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-87- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Coherent and its stockholders to establish an ad hoc committee (which we refer to as the &#147;Financial Advisor Committee&#148;), comprised of Mr.&nbsp;Mattes and Mr.&nbsp;Skaggs, to meet
with and ultimately recommend to the Coherent board an additional financial advisor to advise the Coherent board, which financial advisor would be asked to provide an independent assessment of any proposal from
<FONT STYLE="white-space:nowrap">II-VI</FONT> in order to address any actual or perceived conflict of interest arising from BofA Securities&#146; relationship with <FONT STYLE="white-space:nowrap">II-VI</FONT> as well as to provide an independent
assessment of any other proposals received by Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;15, 2021, Coherent issued a press release announcing its intent
to engage in discussions with <FONT STYLE="white-space:nowrap">II-VI</FONT> to evaluate <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;15 and 16, 2021, the Financial Advisor Committee met with multiple additional financial advisors to discuss the potential
transactions providing for the acquisition of Coherent and, as noted below, subsequently engaged Credit Suisse as an additional financial advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning on February&nbsp;16, 2021 through March&nbsp;9, 2021, representatives of Coherent and, as applicable, BofA Securities and Credit
Suisse, held meetings with representatives of <FONT STYLE="white-space:nowrap">II-VI</FONT> and MKS telephonically and by video conference to discuss certain business and legal due diligence matters, including an
<FONT STYLE="white-space:nowrap">in-person</FONT> meeting between Dr.&nbsp;Mattera and Mr.&nbsp;Mattes on February&nbsp;21, 2021. Coherent provided representatives of <FONT STYLE="white-space:nowrap">II-VI</FONT> and MKS with access to its virtual
data room and provided various business and legal due diligence materials, including financial forecasts prepared by the Coherent management team. In addition, at Coherent&#146;s direction, representatives of Skadden met with representatives of
Wachtell Lipton and MKS&#146; legal advisor, Wilmer Cutler Picker Hale and Dorr LLP (which we refer to as &#147;WilmerHale&#148;), to discuss the <FONT STYLE="white-space:nowrap">II-VI</FONT> proposal and the MKS proposal, respectively.
Representatives of Skadden indicated that the parties were expected to complete their due diligence by the end of the first week of March 2021, with each of the parties to submit final proposals no later than March&nbsp;5, 2021. <FONT
STYLE="white-space:nowrap">II-VI</FONT> management, with the assistance of Wachtell Lipton and Allen&nbsp;&amp; Company, also continued to engage in discussions with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> potential equity financing
sources regarding the potential terms and conditions of equity financing to be provided by one or a combination of such sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
February&nbsp;16, 2021, MKS sent a letter to the Coherent board regarding the proposed transaction between Coherent and MKS, describing its view on the strategic rationale for such a combination and its view on a path to obtaining regulatory
approval for the proposed transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;20, 2021, the Coherent board met by video conference. Members of Coherent&#146;s
management team and representatives of Skadden also attended the meeting. Members of Coherent&#146;s management team and representatives of Skadden provided an overview of Coherent&#146;s interactions with each of the potential acquirors and their
respective advisors during the previous week, describing engagement on due diligence, regulatory, antitrust, financial and other matters. Mr.&nbsp;Mattes also updated the Coherent board on discussions the Financial Advisor Committee had held with
two potential financial advisors earlier in the week, with the Financial Advisor Committee ultimately recommending that Coherent engage Credit Suisse as an additional financial advisor to Coherent, including in connection with the proposal from <FONT
STYLE="white-space:nowrap">II-VI,</FONT> in order to address any actual or perceived conflicts of interest arising from BofA Securities&#146; relationship with <FONT STYLE="white-space:nowrap">II-VI,</FONT> on the basis of Credit Suisse&#146;s
reputation and experience in the sector and in competitive situations of this type. The Coherent board unanimously authorized and approved the engagement of Credit Suisse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;23, 2021, an article entitled &#147;Coherent is Said to Ask for Offers in Bidding War Next Week&#148; was published by
Bloomberg, describing the proposed transaction with Lumentum and the competing offers by each of MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> including that Coherent had asked each of MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT>
to submit final bids by late the following week. Representatives for Coherent, MKS, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum and Bain declined to comment for the article. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;26, 2021, WilmerHale sent Skadden a revised draft of the Coherent confidential disclosure letter and a draft of MKS&#146;
confidential disclosure letter. Also on February&nbsp;26, 2021, Wachtell Lipton sent Skadden draft debt commitment documents relating to the proposed acquisition of Coherent by <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-88- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;26, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board held a
regular meeting by video conference at which it discussed the status of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> discussions with Coherent and the ongoing review by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and
advisors of the due diligence materials and information provided by Coherent and its advisors. Members of management provided an update regarding the strategic rationale for and potential risks and benefits associated with a transaction with
Coherent in light of the due diligence information provided by Coherent and its advisors. Allen&nbsp;&amp; Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain
implied transaction metrics at various theoretical purchase prices, cash/stock consideration mix and financing scenarios. Allen&nbsp;&amp; Company and J.P. Morgan also updated the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on the status of
discussions with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> potential equity financing sources and proposed terms for such equity financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the first week of March 2021, after further discussions and multiple rounds of negotiations with Bain and the other potential equity
financing sources, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and management team determined that the terms of Bain&#146;s proposed equity financing were the most favorable overall and, accordingly,
<FONT STYLE="white-space:nowrap">II-VI</FONT> management negotiated the terms of a potential investment agreement with Bain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
March&nbsp;1, 2021, at Coherent&#146;s direction, representatives of Skadden conferred separately with representatives of Wachtell Lipton and WilmerHale to provide additional detail on Coherent&#146;s proposed process for receiving revised proposals
by 5:00 p.m. Eastern time on March&nbsp;5, 2021 and areas in which their client&#146;s respective proposals could be improved. Also on March&nbsp;1, 2021, at Coherent&#146;s direction, representatives of Skadden sent Wachtell Lipton, WilmerHale and
Wilson Sonsini a revised draft of the Coherent confidential disclosure letter as well as proposed changes to the January&nbsp;18 Lumentum Merger Agreement for consideration by MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with
their final proposals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;1 and March&nbsp;2, 2021, representatives of Coherent, BofA Securities and Credit Suisse held
meetings with representatives of MKS telephonically and by video conference to discuss certain business and due diligence matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
March&nbsp;2, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference. Members of management provided an update on the status of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> discussions with Coherent and Bain.
Allen&nbsp;&amp; Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain implied transaction metrics at various theoretical purchase prices and financing
scenarios. J.P.&nbsp;Morgan separately provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, certain financial information relating to Coherent and the proposed transaction based on certain financial data
provided by the management of <FONT STYLE="white-space:nowrap">II-VI.</FONT> The <FONT STYLE="white-space:nowrap">II-VI</FONT> board also discussed with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and legal and financial advisors
the potential risks and benefits associated with proceeding with a transaction with Coherent, including potential synergies for the combined company in light of the additional due diligence information provided, as well as the possibility of further
modifying the terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal, including increasing the proposed purchase price, varying the mix of cash and stock consideration, altering the financing structure for the
transaction, and/or modifying the regulatory efforts covenants contemplated by the proposed merger agreement. Also on or about March&nbsp;2, 2021, at <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> request, J.P. Morgan provided certain
information regarding J.P. Morgan&#146;s material investment banking relationships with <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent during the prior <FONT STYLE="white-space:nowrap">two-year</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;3, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of BofA
Securities, Credit Suisse and Skadden also attended the meeting. Coherent&#146;s management team described the engagement of representatives of MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> over the preceding weeks in due diligence and
reverse due diligence, noting that each of the parties had been provided, in a manner consistent with the January&nbsp;18 Lumentum Merger Agreement, access to the same information that had been provided to Lumentum during its due diligence of
Coherent and describing the process for negotiations of proposed revised merger agreements with representatives of each MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> and their respective advisors. Mr.&nbsp;Mattes also explained that each of
MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> had been asked to provide a revised proposal by March&nbsp;5, 2021 to enable the Coherent board to meet over the weekend to determine whether either such proposal was superior to Coherent&#146;s
pending transaction with Lumentum, as documented in the January&nbsp;18 Lumentum Merger Agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-89- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and described the opportunity for Lumentum to attempt to match any proposal made by MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> in accordance with the terms of the January&nbsp;18
Lumentum Merger Agreement. Representatives of BofA Securities and Credit Suisse provided their financial analysis of the proposals previously made by each of MKS and <FONT STYLE="white-space:nowrap">II-VI</FONT> in comparison with Coherent&#146;s
pending transaction with Lumentum, as set forth in, and subject to the terms and conditions of, the January&nbsp;18 Lumentum Merger Agreement, highlighting the comparative trading prices of each of the parties, both before and following the
February&nbsp;23 Bloomberg article, which appeared to have had a significant impact on the stock prices of each of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum and MKS. Representatives of BofA Securities and Credit Suisse also provided
overviews of MKS&#146; and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> respective businesses, as well as past and projected future performance, the impact of MKS&#146; and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> expected pro
forma debt on their respective credit ratings and the impact a collar providing for a fixed exchange ratio within a range of bidder stock prices subject to adjustment outside that fixed range could reasonably be expected to have on the value of
MKS&#146; and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> respective proposals in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later on March&nbsp;3, 2021, at
Coherent&#146;s direction, Skadden sent WilmerHale a revised draft of MKS&#146; confidential disclosure letter. Representatives of Skadden, WilmerHale, MKS and Coherent continued to negotiate the terms of the Coherent confidential disclosure letter
until the second meeting of the Coherent board on March&nbsp;7, 2021. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;4, 2021, the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference to discuss next steps in connection with the submission of an updated binding acquisition proposal for Coherent. Allen&nbsp;&amp; Company provided the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain implied transaction metrics at various theoretical purchase prices and financing scenarios. J.P.&nbsp;Morgan separately provided the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, certain updated financial information relating to Coherent and the proposed transaction based on financial forecasts and synergy and other estimates provided by <FONT
STYLE="white-space:nowrap">II-VI</FONT> management (including, at <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> direction, the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">II-VI-prepared</FONT></FONT> Coherent prospective financial information, the potential combined company cost savings and the potential combined company revenue synergies, as described
in &#147;Certain Unaudited Prospective Financial Information&#148; beginning on page 133 of this joint proxy statement/prospectus) and assuming, at the direction of <FONT STYLE="white-space:nowrap">II-VI</FONT> management, (i)&nbsp;a per share
consideration of approximately $260.00 per share based on <FONT STYLE="white-space:nowrap">the&nbsp;10-day&nbsp;volume</FONT> weighted average price (VWAP) <FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;shares</FONT> as of March&nbsp;4, 2021
(consisting of $170.00 in cash and 1.1161 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock) and (ii) $1.5&nbsp;billion of new equity financing from Bain, to be funded at the closing of a merger
transaction with Coherent. A representative of Wachtell Lipton also reviewed the key legal terms of the final form of merger agreement proposed to be included with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> final proposal. Among other
changes from <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> February&nbsp;12 proposal, the proposed merger agreement contemplated (a)&nbsp;a $500&nbsp;million termination fee payable by <FONT STYLE="white-space:nowrap">II-VI</FONT> to Coherent
in the event the merger agreement was terminated for failure to obtain antitrust approval from a Chinese governmental entity, (b)&nbsp;an outside date of up to 18 months and (c)&nbsp;certain changes to the interim operating covenants (and
corresponding exceptions in Coherent&#146;s confidential disclosure letter) to which Coherent would be subject during the pendency of the transaction, which would enhance Coherent&#146;s overall flexibility to operate its businesses prior to
closing. A Wachtell Lipton representative then reviewed the key legal terms of the final form of investment agreement proposed to be included with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> binding proposal. In addition, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board discussed the material relationships disclosure previously provided by J.P. Morgan on March&nbsp;2, 2021, a copy of which had been made available to the <FONT STYLE="white-space:nowrap">II-VI</FONT>
board prior to the meeting. After consulting with its legal advisors, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board determined that the information in J.P. Morgan&#146;s disclosure memorandum did not present any conflicts of interest that
suggested J.P. Morgan was not qualified to act as a financial advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with a potential transaction with Coherent. Following discussion, the <FONT STYLE="white-space:nowrap">II-VI</FONT>
board determined to adjourn the meeting until the following day. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on March&nbsp;4, 2021, at Coherent&#146;s direction, Skadden
sent Wachtell Lipton a revised draft of the Coherent confidential disclosure letter. Representatives of Skadden, Wachtell Lipton, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent continued to negotiate the terms of the Coherent
confidential disclosure letter until the execution of the amended and restated merger agreement with Lumentum on March&nbsp;9, 2021, which we refer to as the &#147;March 9 Lumentum Merger Agreement&#148; in this joint proxy statement/prospectus.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-90- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;5, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board reconvened to
continue its discussions from the previous day. Allen&nbsp;&amp; Company and J.P. Morgan separately provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with certain financial information discussed with the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board on the previous day, updated for market data and, as applicable, to reflect a proposed per share consideration of approximately $260.00 per share based on the VWAP
<FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;shares</FONT> as of March&nbsp;5, 2021 (consisting of $170.00 in cash and 1.0981 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock). The <FONT
STYLE="white-space:nowrap">II-VI</FONT> board discussed with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and legal and financial advisors the terms of the proposals, including the terms of the proposed merger agreement and
investment agreement, and determined to submit an updated binding proposal to acquire Coherent for $170.00 in cash and 1.0981 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock, together with
proposed forms of merger agreement, investment agreement and other transaction documents reflecting the terms discussed and reviewed by the board at the meeting. Later on March&nbsp;5, 2021, representatives of
<FONT STYLE="white-space:nowrap">II-VI</FONT> sent the proposal materials to representatives of Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on March&nbsp;5, 2021, MKS
sent Coherent a proposal to acquire each share of Coherent common stock for $135.00 in cash and 0.7516 of a share of MKS common stock (with the stock component subject to adjustment based on a symmetrical 10% collar) (implying an aggregate value of
$249.99 per share based on the price per share of MKS common stock at the close of trading on March&nbsp;5, 2021), together with revised drafts of the merger agreement, the Coherent confidential disclosure letter, MKS&#146; confidential disclosure
letter and the draft debt commitment documents relating to the proposed acquisition of Coherent by MKS. The March&nbsp;5 MKS proposal did not contemplate changes to any other terms of its proposed merger agreement. As compared to the January&nbsp;18
Lumentum Merger Agreement, the proposed merger agreement from MKS (i)&nbsp;provided that MKS would pay the termination fee of $217.6&nbsp;million to Lumentum on the signing date on behalf of Coherent, (ii)&nbsp;provided that a similar termination
fee would be payable by Coherent to MKS in certain situations (including termination of the January&nbsp;18 Lumentum Merger Agreement by Coherent to accept a superior proposal), and (iii)&nbsp;included a
<FONT STYLE="white-space:nowrap">pre-closing</FONT> marketing period for MKS to syndicate its financing commitments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;6,
2021, at the instruction of Coherent management, representatives of BofA Securities and Credit Suisse spoke with representatives of <FONT STYLE="white-space:nowrap">II-VI</FONT> in order to better understand
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> calculation of synergies and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> thoughts on its prospective credit ratings in light of its latest revised proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the morning of March&nbsp;7, 2021, Lumentum sent Coherent a revised proposal to acquire Coherent for $262.05 per share based on the
prevailing trading price of Lumentum common shares at the close of trading on March&nbsp;5, 2021, comprised of $175.00 in cash and 1.0109 shares of Lumentum common stock payable per share of Coherent common stock, together with revised drafts of the
merger agreement and debt commitment documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later that morning, representatives of each of Lumentum and Coherent discussed the terms
of their merger agreement, including, among others, the proposed termination fee payable by Coherent to Lumentum in certain situations (including termination of the merger agreement by Coherent to accept a superior proposal) equal to approximately
5.5% of the equity value of the transaction, or $360&nbsp;million (increased from $217.6&nbsp;million in the January&nbsp;18 Lumentum Merger Agreement), which Coherent believed to be inappropriate under the circumstances and unwarranted by
Lumentum&#146;s proposed changes to its merger agreement. After such discussions, Lumentum sent Coherent a revised lower proposal to acquire Coherent for $257.05 per share based on the prevailing trading price of Lumentum common shares at the close
of trading on March&nbsp;5, 2021, comprised of $170.00 in cash and 1.0109 shares of Lumentum common stock payable per share of Coherent common stock, together with a revised draft of the merger agreement, reflecting a termination fee of
approximately 4.1% of the equity value of the transaction, or $260&nbsp;million, an increase over the January 18 Lumentum Merger Agreement, but which Coherent continued to believe to be inappropriate under the circumstances and unwarranted by
Lumentum&#146;s proposed changes to its merger agreement. Thereafter, members of Coherent&#146;s management team and representatives of BofA Securities and Credit Suisse met with representatives of Lumentum by video conference to discuss certain
business and due diligence matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-91- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Midday on March&nbsp;7, 2021, the Coherent board met by video conference. Members of
Coherent&#146;s management team and representatives of Skadden also attended the meeting. Representatives of Coherent management provided an update on discussion with each of <FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS and Lumentum and the
revised proposal received from Lumentum the morning of March&nbsp;7, 2021. Representatives of Skadden provided an overview of changes to the January&nbsp;18 Lumentum Merger Agreement proposed by each of <FONT STYLE="white-space:nowrap">II-VI,</FONT>
MKS and Lumentum, noting that the increased termination fee payable by Coherent to Lumentum in certain situations (including termination of the merger agreement by Coherent to accept a superior proposal) that Lumentum had proposed could reasonably
be expected to have a chilling effect on future proposals from <FONT STYLE="white-space:nowrap">II-VI</FONT> or MKS and, thus, lead to a premature ending of the bidding process. In light of the additional proposal received from Lumentum provided
shortly before such meeting, and the additional time necessary for Coherent&#146;s financial advisors to prepare an analysis of such proposal, the Coherent board determined to postpone further discussion of the proposals and adjourned until later on
March&nbsp;7, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the evening on March&nbsp;7, 2021, the Coherent board met again by video conference. Members of Coherent&#146;s
management team and representatives of BofA Securities, Credit Suisse and Skadden also attended the meeting. Representatives of BofA Securities and Credit Suisse provided an overview regarding the overall process undertaken by Coherent, BofA
Securities and Credit Suisse in connection with the revised proposals, including the bidding process with MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> and the additional proposals received from Lumentum. Representatives of BofA Securities
and Credit Suisse provided a financial analysis of each of the proposals, including an overview of stock market activity leading up to March&nbsp;5, 2021, including in light of the February&nbsp;23 Bloomberg article, a discussion of synergies
anticipated by each of Lumentum, MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> and short- and long-term comparisons of each of the proposals. Representatives of Coherent management also discussed their views of each of the proposals,
including an overview of discussions between Messrs. Mattes and Lowe relating to Lumentum&#146;s unsolicited proposals on March&nbsp;7, 2021. After discussion, the Coherent board unanimously determined, in consultation with its financial and legal
advisors, that the revised acquisition proposal Coherent received from <FONT STYLE="white-space:nowrap">II-VI</FONT> constituted a superior proposal under the terms of the January&nbsp;18 Lumentum Merger Agreement with Lumentum and, at the Coherent
board&#146;s direction, representatives of Skadden notified representatives of Wilson Sonsini accordingly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;8, 2021,
Coherent issued a press release announcing the Coherent board&#146;s determination that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> March&nbsp;5, 2021 proposal constituted a superior proposal under the terms of the January&nbsp;18 Lumentum
Merger Agreement with Lumentum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the issuance of Coherent&#146;s press release,
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management provided updates to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on March&nbsp;8, 2021 and March&nbsp;9, 2021. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board
discussed with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and legal and financial advisors the possibility of further updating the terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposal to acquire Coherent
(including the financial impact on <FONT STYLE="white-space:nowrap">II-VI</FONT> and the combined company if <FONT STYLE="white-space:nowrap">II-VI</FONT> were to increase the consideration in its acquisition proposal and/or vary the mix of cash and
stock consideration) and the timing for submitting a revised proposal. Allen&nbsp;&amp; Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain implied
transaction metrics at various theoretical purchase prices and cash/stock consideration mix. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;9, 2021, at Coherent&#146;s
direction, Skadden sent Wilson Sonsini a revised draft of the Coherent confidential disclosure letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later on March&nbsp;9, 2021,
Lumentum sent Coherent a further revised proposal to acquire each share of Coherent common stock for $175.00 in cash and 1.0109 shares of Lumentum common stock (implying an aggregate value of $261.62 per share based on the per share price of
Lumentum common stock at the close of trading on March&nbsp;9, 2021), together with revised drafts of the March&nbsp;9 Lumentum Merger Agreement, the Coherent confidential disclosure letter, and the debt commitment documents relating to the proposed
acquisition of Coherent by Lumentum. Lumentum&#146;s revised proposal did not seek to increase the termination fee provided in the January&nbsp;18 Lumentum Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the evening of March&nbsp;9, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and
representatives of BofA Securities, Credit Suisse and Skadden also attended the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-92- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
A representative of Skadden summarized the fully negotiated terms of the proposed March&nbsp;9 Lumentum Merger Agreement for the transaction with Lumentum. Representatives of BofA Securities and
Credit Suisse provided an overview regarding the overall process undertaken by Coherent, BofA Securities and Credit Suisse, as applicable, in connection with the proposed transaction, including the bidding process with Lumentum as well as each of
MKS and <FONT STYLE="white-space:nowrap">II-VI,</FONT> both before the execution of the January&nbsp;18 Lumentum Merger Agreement and following their respective rebids in early February. Representatives of BofA Securities and Credit Suisse, as
applicable, then presented their respective financial analyses of the merger consideration to be paid in the proposed transaction based on the financial forecasts for Coherent and Lumentum, which forecasts previously had been reviewed and
unanimously approved by the Coherent board for use by BofA Securities and Credit Suisse in connection with their respective financial analyses and current market data. Following these presentations and upon the request of the Coherent board, each of
BofA Securities and Credit Suisse delivered to the Coherent board their respective oral opinions, each subsequently confirmed by delivery of a written opinion, dated March&nbsp;9, 2021, to the effect that, as of such date and based on and subject to
the assumptions, limitations, qualifications and other matters considered in the preparation of such opinion as set forth in such opinion, the merger consideration to be received in the merger by the holders of Coherent common stock (other than the
holders of, in the case of BofA Securities&#146; written opinion, any cancelled shares or any dissenting shares, and in the case of Credit Suisse&#146;s written opinion, any cancelled shares or any dissenting shares (each as described in the merger
agreement)) was fair, from a financial point of view, to such holders. For more information, see &#147;The Merger&#151;Opinions of Coherent&#146;s Financial Advisors&#148; beginning on page&nbsp;103 of this joint proxy statement/prospectus.
Mr.&nbsp;DiMarco then presented a set of proposed resolutions approving the March&nbsp;9 Lumentum Merger Agreement, the transactions contemplated thereby and certain related matters and the Coherent board unanimously approved the foregoing
resolutions. The Coherent board also discussed the relationship disclosure memorandum received from Credit Suisse on March&nbsp;9, 2021, a copy of which had been submitted to the Coherent board prior to the meeting, which disclosure included certain
material relationships, to the extent applicable, among that Credit Suisse, including officers on the Credit Suisse team working with Coherent, and <FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum, Bain and Coherent. After consulting
with its legal advisors, the Coherent board determined that the information in Credit Suisse&#146;s disclosure memorandum did not present any conflicts of interest that suggested Credit Suisse was not qualified to advise Coherent in connection with
a potential transaction with <FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum or Bain. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Promptly following the Coherent
board meeting, on the evening of March&nbsp;9, 2021, Coherent and Lumentum executed the March&nbsp;9 Lumentum Merger Agreement, the execution of which was announced by each of Coherent and Lumentum in press releases on the morning of March&nbsp;10,
2021. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later in the morning of March&nbsp;10, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference to
discuss the March&nbsp;9 Lumentum Merger Agreement and potential revisions to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> prior acquisition proposal to Coherent. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management provided an
overview of the key terms of the March&nbsp;9 Lumentum Merger Agreement, after which Allen&nbsp;&amp; Company provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an updated illustrative overview of certain
implied transaction metrics at various theoretical purchase prices and cash/stock consideration mix. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management also provided for preliminary discussion certain financial information, including
the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjusted prospective financial information that had been prepared by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management to reflect the potential impact on
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business and financial prospects in the event of an acquisition of Coherent by Lumentum, as described in &#147;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133
of this joint proxy statement/prospectus. The <FONT STYLE="white-space:nowrap">II-VI</FONT> board discussed the financial impact of revising the terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition proposal, including increasing
the purchase price and varying the mix of cash and directed management, with the assistance <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal and financial advisors, to prepare an improved acquisition proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through the course of March&nbsp;10, 2021, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and legal and financial advisors
engaged in further discussions regarding <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financing commitments. As an outcome of these discussions, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Bain agreed to revise the terms of the form of
investment agreement, pursuant to which Bain would agree to provide $750&nbsp;million of its equity financing commitment promptly following the execution of a merger agreement with Coherent, with the remaining $750&nbsp;million (as well as a
possible additional $500&nbsp;million investment) to be funded no later than the closing of the merger transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-93- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board held a meeting by video conference
on the morning of March&nbsp;11, 2021. Management presented its recommendation that <FONT STYLE="white-space:nowrap">II-VI</FONT> submit an updated proposal to acquire Coherent for $195.00 in cash and 1.00 share of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock (implying an aggregate value of approximately $272.68 per Coherent share based on the <FONT STYLE="white-space:nowrap">10-day&nbsp;VWAP</FONT> <FONT
STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;shares</FONT> as of March&nbsp;10, 2021). J.P. Morgan reviewed with the <FONT STYLE="white-space:nowrap">II-VI</FONT> board its financial analysis of Coherent and the proposed transaction based on such
proposal utilizing financial forecasts and synergy and other estimates provided by <FONT STYLE="white-space:nowrap">II-VI</FONT> management (including, at <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> direction, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">II-VI-prepared</FONT></FONT> Coherent prospective financial information, the potential combined company
cost savings and the potential combined company revenue synergies, as described in the section of this joint proxy statement/prospectus entitled &#147;Certain Unaudited Prospective Financial Information&#148;). A representative of Wachtell Lipton
also reviewed the legal terms of the form of the Bain investment agreement proposed to be included with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> updated acquisition proposal, as well as an updated form of merger agreement which provided
for, among other things, a termination fee of $108.8&nbsp;million payable by Coherent to <FONT STYLE="white-space:nowrap">II-VI</FONT> in certain situations (including termination of the merger agreement by Coherent to accept a superior proposal),
representing approximately half of the comparable termination fee reflected in the March&nbsp;9 Lumentum Merger Agreement. Following discussion, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board directed management to submit an updated
proposal to acquire Coherent, together with updated forms of the merger agreement, Bain investment agreement and other transaction documents, in each case, reflecting the terms discussed and reviewed with the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board at the meeting. Later on March&nbsp;11, 2021, representatives of <FONT STYLE="white-space:nowrap">II-VI</FONT> sent the proposal materials to Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later on March&nbsp;11, 2021, S&amp;P Global Ratings (which we refer to as &#147;SPGR&#148;) announced that, in light of Lumentum&#146;s
increased offer to acquire Coherent and the execution of the March&nbsp;9 Lumentum Merger Agreement, as announced on March&nbsp;10, 2021, SPGR placed all ratings of Lumentum on CreditWatch with negative implications, which placement would be
resolved upon the closing of its proposed acquisition of Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the evening on March&nbsp;11, 2021, the Coherent board met by video
conference. Members of Coherent&#146;s management team and representatives of BofA Securities, Credit Suisse and Skadden also attended the meeting. Representatives of BofA Securities and Credit Suisse provided a financial analysis of the proposal
received from <FONT STYLE="white-space:nowrap">II-VI</FONT> on March&nbsp;11, 2021, including an overview of stock market activity leading up to March&nbsp;11, 2021 and a comparison with the merger consideration to be paid in the pending amended
merger agreement with Lumentum. After discussion, the Coherent board unanimously determined, in consultation with its financial and legal advisors, that the revised acquisition proposal Coherent received from
<FONT STYLE="white-space:nowrap">II-VI</FONT> constituted a superior proposal under the terms of the March&nbsp;9 Lumentum Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2021, Coherent issued a press release announcing the Coherent board&#146;s determination that
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> March&nbsp;11, 2021 proposal constituted a superior proposal under the terms of the March&nbsp;9 Lumentum Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;16, 2021, SPGR announced that, after <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> increased offer to acquire Coherent,
as announced on March&nbsp;12, 2021, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> credit ratings and outlook remained unchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;17, 2021, Lumentum sent Coherent a further revised proposal to acquire each share of Coherent common stock for $220.00 in cash
and 0.6100 of a share of Lumentum common stock (implying an aggregate value of $275.00 per share based on the price per share of Lumentum common stock at the close of trading on March&nbsp;16, 2021), together with revised drafts of the March&nbsp;9
Lumentum Merger Agreement, the Coherent confidential disclosure letter and the debt commitment documents relating to the proposed acquisition of Coherent by Lumentum. Lumentum also sent the Coherent board a draft investment agreement to be entered
into by and among Lumentum, Silver Lake Alpine, L.P., Silver Lake Alpine (Offshore Master), L.P. and Silver Lake Alpine II, L.P., each affiliates of Silver Lake Partners, which we refer to collectively as &#147;Silver Lake,&#148; relating to the
financing of the proposed acquisition of Coherent by Lumentum. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-94- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shortly thereafter, on the morning of March&nbsp;17, 2021, Coherent issued a press release
announcing the Coherent board&#146;s consideration of Lumentum&#146;s March&nbsp;17, 2021 proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the announcement, members
of Coherent&#146;s management team and representatives of BofA Securities and Credit Suisse held a meeting with representatives of Lumentum by video conference to discuss certain business and due diligence matters. Separately, members of <FONT
STYLE="white-space:nowrap">II-VI</FONT> management contacted representatives of Bain and J.P. Morgan to ascertain the willingness of each party to provide additional financing in support of a further revised proposal to acquire Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on March&nbsp;17, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference to discuss Lumentum&#146;s
revised acquisition proposal and potential next steps. Management again discussed with the <FONT STYLE="white-space:nowrap">II-VI</FONT> board the potential merits of a transaction with Coherent and potential impact of the proposed Lumentum merger
on the business and financial prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> as a stand-alone company and presented its recommendation that <FONT STYLE="white-space:nowrap">II-VI</FONT> submit an updated offer to acquire Coherent for
$220.00 in cash and 0.9100 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock per share of Coherent common stock (implying an aggregate value of approximately $287.18 per Coherent share based on the <FONT
STYLE="white-space:nowrap">10-day</FONT> VWAP of <FONT STYLE="white-space:nowrap">II-VI&nbsp;shares</FONT> as of March&nbsp;17, 2021). Also discussed was the form of definitive merger agreement to be submitted to Coherent with such updated offer.
Allen&nbsp;&amp; Company reviewed with the <FONT STYLE="white-space:nowrap">II-VI</FONT> board the financial terms of Lumentum&#146;s latest proposal and provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an
updated illustrative overview of certain implied transaction metrics at various theoretical purchase prices and cash/stock consideration mix. J.P. Morgan separately reviewed with the <FONT STYLE="white-space:nowrap">II-VI</FONT> board its financial
analysis of the proposed merger consideration provided for in the definitive form of the merger agreement based on financial forecasts and synergy and other estimates provided by <FONT STYLE="white-space:nowrap">II-VI</FONT> management (including,
at <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> direction, the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjusted prospective financial information, the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">II-VI-prepared</FONT></FONT> Coherent prospective financial information, the potential combined company cost savings and the potential combined company revenue synergies, as described
in the section of this joint proxy statement/prospectus entitled &#147;Certain Unaudited Prospective Financial Information&#148;) and, at the request of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, rendered an oral opinion, confirmed by
delivery of a written opinion dated March&nbsp;17, 2021, to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to the effect that, as of such date and based upon and subject to the assumptions made, procedures followed, matters considered and
limitations on the review undertaken by J.P. Morgan in preparing the opinion, the merger consideration proposed to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the merger was fair, from a financial point of view, to <FONT
STYLE="white-space:nowrap">II-VI.</FONT> Members of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management then provided an overview of their discussions regarding additional financing for the transaction. The
<FONT STYLE="white-space:nowrap">II-VI</FONT> board authorized management to submit an updated offer to acquire Coherent upon the terms discussed and reviewed with the <FONT STYLE="white-space:nowrap">II-VI</FONT> board at the meeting. The <FONT
STYLE="white-space:nowrap">II-VI</FONT> board also directed management to seek to increase the size of the debt and equity financing commitments from J.P. Morgan and Bain, respectively, for such updated offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the <FONT STYLE="white-space:nowrap">II-VI</FONT> board meeting, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and
legal and financial advisors engaged in further discussions with J.P. Morgan and Bain regarding <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financing commitments. As an outcome of these discussions, J.P. Morgan agreed to increase the size
of its debt commitment by $625&nbsp;million and Bain agreed that, in addition to the committed amount of $1.5&nbsp;billion, it would potentially provide an additional amount of up to $650&nbsp;million (in lieu of the $500&nbsp;million contemplated
by the previously negotiated form of the Bain investment agreement). During the evening of March&nbsp;17, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> delivered its updated offer to Coherent, together with proposed forms of transaction
agreements (including updated debt commitment documents from J.P. Morgan and the updated form of investment agreement with Bain). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After
receipt of the <FONT STYLE="white-space:nowrap">II-VI</FONT> revised proposal on March&nbsp;17, 2021, the Coherent board met by video conference. Members of Coherent&#146;s management team and representatives of BofA Securities, Credit Suisse and
Skadden also attended the meeting. The Coherent board discussed <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> March&nbsp;17, 2021 proposal and Lumentum&#146;s March&nbsp;17, 2021 proposal. In light of the revised proposal received from <FONT
STYLE="white-space:nowrap">II-VI</FONT> shortly prior to the scheduled time for such meeting, the Coherent board determined, in consultation with BofA Securities and Credit Suisse, that additional time to review the
<FONT STYLE="white-space:nowrap">II-VI</FONT> revised proposal to permit Coherent&#146;s financial advisors to prepare an analysis of such revised proposal would be beneficial, so the Board determined to postpone further discussion of the proposals
and adjourned the meeting until later in the day on March&nbsp;17, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-95- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later that evening, the Coherent board again met by video conference. Members of
Coherent&#146;s management team and representatives of BofA Securities, Credit Suisse and Skadden also attended the meeting. Representatives of each of BofA Securities and Credit Suisse provided their respective financial analyses of the revised
proposals received from each of Lumentum and <FONT STYLE="white-space:nowrap">II-VI</FONT> earlier that day on March&nbsp;17, 2021, including an overview of stock market activity leading up to March&nbsp;17, 2021 and a comparison of the valuations
of each proposal. After discussion, the Coherent board determined, in consultation with its financial and legal advisors, that the revised acquisition proposal Coherent received from <FONT STYLE="white-space:nowrap">II-VI</FONT> continued to
constitute a superior proposal under the terms of the March&nbsp;9 Lumentum Merger Agreement and was superior to the revised Lumentum proposal received on March&nbsp;17, 2021. The Coherent board also discussed the updated relationship disclosure
memoranda received from each of BofA Securities and Credit Suisse on March&nbsp;17, 2021, copies of which had been submitted to the Coherent board prior to the meeting, which disclosure included (a)&nbsp;fees that BofA Securities and its affiliates
had earned in recent years from <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum, Bain, Silver Lake and Coherent, and (b)&nbsp;certain material relationships, to the extent applicable, among Credit Suisse, including officers on the Credit
Suisse team working with Coherent, and <FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum, Bain, Silver Lake and Coherent. After consulting with its legal advisors, the Coherent board determined that the information in (i)&nbsp;BofA
Securities&#146; disclosure memorandum did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent in connection with a potential transaction with <FONT STYLE="white-space:nowrap">II-VI,</FONT>
Lumentum, Bain or Silver Lake and (ii)&nbsp;Credit Suisse&#146;s disclosure memorandum did not present any conflicts of interest that suggested Credit Suisse was not qualified to advise Coherent in connection with a potential transaction with <FONT
STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum, Bain or Silver Lake. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;18, 2021, Coherent issued a press release
announcing the Coherent board&#146;s determination that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> March&nbsp;17, 2021 offer constituted a superior proposal under the terms of the March&nbsp;9 Lumentum Merger Agreement and was also
superior to the March&nbsp;17, 2021 Lumentum proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;20, 2021 and March&nbsp;22, 2021, the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference. Members of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management team and representatives of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal and
financial advisors also attended the meeting. At the meeting, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board discussed potential next steps in connection with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> revised offer to acquire
Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the night of March&nbsp;22, 2021, Lumentum sent Coherent a further revised proposal to acquire each share of Coherent common
stock for $230.00 in cash and 0.6724 of a share of Lumentum common stock (implying an aggregate value of $287.50 per share based on the per share price of Lumentum common stock at the close of trading on March&nbsp;22, 2021), together with revised
drafts of the March&nbsp;9 Lumentum Merger Agreement, the Coherent confidential disclosure letter, the debt commitment documents and the investment agreement with Silver Lake, each relating to the proposed acquisition of Coherent by Lumentum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;23, 2021, Coherent issued a press release announcing the Coherent board&#146;s consideration of Lumentum&#146;s March&nbsp;22,
2021 proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also on March&nbsp;23, 2021, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board met by video conference to consider
Lumentum&#146;s latest proposal. Members of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management team and representatives <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> legal and financial advisors also attended the meeting.
Allen&nbsp;&amp; Company and J.P. Morgan separately provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board with, among other things, an illustrative overview of certain implied transaction metrics at various theoretical purchase prices and
cash/stock consideration mix. Members of management also provided their views on potential further revisions to the terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> updated offer as submitted to Coherent on March&nbsp;17, 2021. The <FONT
STYLE="white-space:nowrap">II-VI</FONT> board and management discussed the potential risks and benefits of further modifying the financial terms of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposal and determined that <FONT
STYLE="white-space:nowrap">II-VI</FONT> should not further revise its offer at the time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;24, 2021, <FONT
STYLE="white-space:nowrap">II-VI</FONT> sent Coherent a letter expressing <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> view that its March&nbsp;17, 2021 offer continued to constitute a superior proposal under the terms of the March&nbsp;9
Lumentum Merger Agreement and was also superior to Lumentum&#146;s March&nbsp;22, 2021 proposal. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-96- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Later on March&nbsp;24, 2021, the Coherent board met by video conference. Members of
Coherent&#146;s management team and representatives of BofA Securities, Credit Suisse and Skadden also attended the meeting. Representatives of each of BofA Securities and Credit Suisse provided their respective financial analyses of the revised
proposals received from Lumentum on March&nbsp;22, 2021 and from <FONT STYLE="white-space:nowrap">II-VI</FONT> on March&nbsp;17, 2021, including an overview of stock market activity leading up to March&nbsp;23, 2021 and a comparison of the
valuations of each proposal. In light of such analysis, the Coherent board determined that the revised proposals received from Lumentum and <FONT STYLE="white-space:nowrap">II-VI</FONT> each appeared to be close in terms of short-term value, but
that the <FONT STYLE="white-space:nowrap">II-VI</FONT> proposal reflected a higher long-term value (including the synergies presented by the <FONT STYLE="white-space:nowrap">II-VI</FONT> revised proposal) (for a more detailed discussion regarding
the Coherent board&#146;s reasons for accepting the <FONT STYLE="white-space:nowrap">II-VI</FONT> proposal, see the section entitled &#147;Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148; beginning on page&nbsp;98
of this joint proxy statement/prospectus). After discussion, the Coherent board unanimously determined, in consultation with its financial and legal advisors, that the proposal received from <FONT STYLE="white-space:nowrap">II-VI</FONT> on
March&nbsp;17, 2021 continued to constitute a superior proposal under the March&nbsp;9 Lumentum Merger Agreement, and unanimously approved termination of the March&nbsp;9 Lumentum Merger Agreement, payment to Lumentum of the $217.6&nbsp;million
termination fee and entry into the merger agreement with <FONT STYLE="white-space:nowrap">II-VI.</FONT> The Coherent board also discussed the updated relationship disclosure memoranda received from each of BofA Securities and Credit Suisse on
March&nbsp;23, 2021, copies of which had been submitted to the Coherent board prior to the meeting, which disclosure included (a)&nbsp;fees that BofA Securities and its affiliates had earned in recent years from
<FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum, Bain, Silver Lake and Coherent and (b)&nbsp;certain material relationships, to the extent applicable, among Credit Suisse, including officers on the Credit Suisse team working with Coherent,
and <FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum, Bain, Silver Lake and Coherent. After consulting with its legal advisors, the Coherent board determined that the information in (i)&nbsp;BofA Securities&#146; disclosure memorandum
did not present any conflicts of interest that suggested BofA Securities was not qualified to advise Coherent in connection with a potential transaction with <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum, Bain or Silver Lake and
(ii)&nbsp;Credit Suisse&#146;s disclosure memorandum did not present any conflicts of interest that suggested Credit Suisse was not qualified to advise Coherent in connection with a potential transaction with
<FONT STYLE="white-space:nowrap">II-VI,</FONT> MKS, Lumentum, Bain or Silver Lake. Upon the request of the Coherent board, BofA Securities delivered to the Coherent board its oral opinion, subsequently confirmed by delivery of a written opinion,
dated March&nbsp;24, 2021, to the effect that, as of such date and based on and subject to the assumptions, limitations, qualifications and other matters considered in the preparation of such opinion as set forth in such opinion, the merger
consideration to be received in the merger by the holders of Coherent common stock (other than the holders of any cancelled shares or any dissenting shares) was fair, from a financial point of view, to such holders. Upon request of the Coherent
board, Credit Suisse delivered to the Coherent board its oral opinion, subsequently confirmed by delivery of a written opinion, dated March&nbsp;24, 2021, to the effect that, as of such date and based on and subject to the assumptions, limitations,
qualifications and other matters considered in the preparation of such opinion as set forth in such opinion, the merger consideration to be received by the holders of Coherent common stock (other than the holders of cancelled shares or dissenting
shares (each as described in the merger agreement)) in the merger was fair, from a financial point of view, to such holders. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the
morning of March&nbsp;25, 2021, Coherent terminated the March&nbsp;9 Lumentum Merger Agreement, paid to Lumentum by wire transfer the $217.6&nbsp;million termination fee, and executed with <FONT STYLE="white-space:nowrap">II-VI</FONT> the merger
agreement, the execution of which was announced in separate press releases issued by each of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> on the morning of March&nbsp;25, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;31, 2021, SPGR announced that, in light of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> increased offer to acquire
Coherent and the execution of the merger agreement, SPGR placed all ratings on <FONT STYLE="white-space:nowrap">II-VI</FONT> on CreditWatch with negative implications, which placement would be resolved upon the closing of its proposed acquisition of
Coherent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_77"></A>Certain Relationships between Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and their respective affiliates engage in transactions and enter into agreements with
each other in the ordinary course of business, including certain agreements pursuant to which the parties provide certain commercially-available products. Except as described in this joint proxy statement/prospectus, there are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-97- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and have been no past, present or proposed material contracts, arrangements, understandings, relationships, negotiations or transactions during the current calendar year or the five immediately
preceding calendar years, between Coherent or its affiliates, on the one hand, and <FONT STYLE="white-space:nowrap">II-VI</FONT> or its affiliates, on the other hand, concerning a merger, consolidation or acquisition, a tender offer for or other
acquisition of securities, the election of directors, or the sale or other transfer of a material amount of assets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_78"></A>Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a meeting held on March&nbsp;24, 2021, the Coherent board unanimously: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommended that Coherent&#146;s stockholders adopt the merger agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determined that the merger agreement and the transactions contemplated by the merger agreement are advisable to,
and in the best interests of, Coherent and its stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approved the execution, delivery and performance of the merger agreement and the transactions contemplated by the
merger agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directed that the adoption of the merger agreement be submitted to a vote at a meeting of Coherent&#146;s
stockholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Accordingly, the Coherent board has unanimously approved the merger agreement and, accordingly, as of
the date hereof, continues to recommend that the holders of Coherent common stock vote &#147;FOR&#148; the Coherent merger proposal. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In reaching its decision to approve and declare advisable the merger agreement, the merger and the other transactions contemplated by the
merger agreement, the Coherent board, as described in &#147;The Merger&#151;Background of the Merger&#148;<B> </B>beginning on page&nbsp;73 of this joint proxy statement/prospectus, held a number of meetings, consulted with Coherent&#146;s senior
management and its outside legal counsel, Skadden, and financial advisors BofA Securities and Credit Suisse, respectively, and considered the business, assets and liabilities, results of operations, financial performance, strategic direction and
prospects of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> (including in comparison with Lumentum) and determined that the merger was in the best interests of Coherent and its stockholders. At its meeting held on March&nbsp;24, 2021,
after due consideration and consultation with Coherent&#146;s senior management and outside legal and financial advisors, the Coherent board unanimously approved and declared advisable the merger agreement, the merger and the other transactions
contemplated by the merger agreement and recommended that Coherent stockholders vote in favor of the adoption of the merger agreement. In making its determination, the Coherent board focused on a number of factors, including the following material
factors: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of Coherent&#146;s and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business, operations, financial
condition, stock performance, product lines, earnings and prospects (in reviewing these factors, the Coherent board considered <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial condition and the fact that
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business, operations and risk profile complement those of Coherent, creating the opportunity for the combined company to leverage complementary and diversified revenue streams and to have superior
future earnings and prospects compared to Coherent&#146;s earnings and prospects on a stand-alone basis or relative to other potential strategic alternatives reasonably available to Coherent); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strategic rationale for the merger, including: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unique opportunity to create a global leader in photonic solutions, compound semiconductors, and laser and
technology systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the opportunity to use complementary scale across the entire value chain and increase competitiveness in all
laser technology product lines, including in materials macro- and micro-processing, display processing and instrumentation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-98- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the opportunity for greater diversification of revenue by <FONT STYLE="white-space:nowrap">end-market</FONT> and
geography, and the deeper market intelligence from Coherent and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> complementary business models; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the broader sales force available to the combined company in light of complementary geographic aspects;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the opportunity to accelerate the growth of the combined company through complementary platforms and the
opportunity for vertical integration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expectation that the merger will enable the combined company to generate approximately $250&nbsp;million in
cost savings following the completion of the merger, due to increased operating efficiencies and leveraging economies of scale; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the belief of the Coherent board that the merger is more favorable to Coherent stockholders than the
opportunities and strategic alternatives reasonably available to Coherent on a stand-alone basis or through an alternative transaction, which the Coherent board evaluated with the assistance of Coherent&#146;s management and its outside financial
and legal advisors, taking into account the potential risks, rewards and uncertainties associated with each alternative; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Coherent, with the assistance of BofA Securities, acting at the direction of the Coherent board,
identified and engaged with three potential bidders, in an effort to obtain the best value reasonably available to Coherent stockholders and conducted a robust sales process through the execution of the January&nbsp;18 Lumentum Merger Agreement with
Lumentum on January&nbsp;18, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Coherent entered into confidentiality agreements with three potential bidders, and that Coherent,
through extensive negotiations, was able to increase Lumentum&#146;s proposed merger consideration from an initial proposal of $166.55 per share to a final offer of $226.00 per share upon the execution of the January&nbsp;18 Lumentum Merger
Agreement on January&nbsp;18, 2021, and that the Coherent board believed that, at the time of the Coherent board&#146;s deliberations regarding consideration, Lumentum was unwilling to increase its proposal further at that time;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Coherent, with the assistance of BofA Securities and Credit Suisse, acting at the direction of the
Coherent board, engaged with Lumentum, MKS (following its revised proposal on February&nbsp;4, 2021) and <FONT STYLE="white-space:nowrap">II-VI</FONT> (following its revised proposal on February&nbsp;12, 2021), in an effort to obtain the best value
reasonably available to Coherent stockholders and conducted a robust negotiation process through the execution of the merger agreement on March&nbsp;25, 2021; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, following the announcement of the merger on January&nbsp;19, 2021, Coherent received multiple
enhanced proposals from each of Lumentum, <FONT STYLE="white-space:nowrap">II-VI</FONT> and MKS, pursuant to which Coherent, through negotiations following receipt of such proposals, was able to increase the proposed merger consideration from an
initial proposal of $226.00 per share upon the execution of the January&nbsp;18 Lumentum Merger Agreement on January&nbsp;18, 2021 to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> final offer of $281.21 per share upon the execution of the
merger agreement on March&nbsp;25, 2021, and that the Coherent board believed that, at the time of the Coherent board&#146;s deliberations regarding consideration, <FONT STYLE="white-space:nowrap">II-VI</FONT> was unwilling to increase its proposal
further at that time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Coherent, through extensive negotiations, was able to increase
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proposed merger consideration from an initial proposal of $150.00 per share to a final offer of $281.21 per share upon the execution of the merger agreement on March&nbsp;25, 2021;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, as of the announcement of the merger agreement on March&nbsp;25, 2021, the per share value of the
merger consideration reflected an 85% premium to Coherent&#146;s closing stock price as of January&nbsp;15, 2021, the last full trading day prior to the date of announcement of the January&nbsp;18 Lumentum Merger Agreement, an 83% premium to the
average Coherent closing stock price during the month prior to and including January&nbsp;15, 2021, and a 117% premium to the average Coherent closing stock price during the year prior to and including January&nbsp;15, 2021; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-99- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expectation that, with increased scale, the combined company will be able to increase research and
development investment in order to accelerate innovation in existing and future markets requiring the unique capabilities of photonics; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the combined company&#146;s increased potential for long-term value creation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expectation that the combined company will be better positioned to serve the needs of a global customer base
increasingly dependent on photonics to enable important <FONT STYLE="white-space:nowrap">end-market</FONT> transitions, including the shift to digital and virtual approaches to work and life, the transition to 5G in wireless networking, advanced
bioinstrumentation, advanced microelectronics, and new materials for next generation consumer electronic devices, flat panel and OLED displays, communications equipment, electric and autonomous vehicles, and energy storage; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to harness Coherent&#146;s and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> collective
expertise in technology, and research and development to drive improvement across the combined company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cultural alignment between Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> including shared
values and commitment to integrity, operational excellence, client and member satisfaction, innovation and stockholder value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information and discussions with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> senior management
regarding <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business, financial condition, results of operations, current business strategy and prospects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the current and prospective business environment in which Coherent and
<FONT STYLE="white-space:nowrap">II-VI</FONT> operate, including international, national and local economic conditions, the competitive and regulatory environment and the likely effects of these factors on Coherent and the combined company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that the merger will enable Coherent stockholders to maintain equity in the combined company thereby giving them
an opportunity to participate in the future success of the combined company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that, upon completion of the merger as contemplated by the merger agreement on March&nbsp;25, 2021, <FONT
STYLE="white-space:nowrap">II-VI</FONT> stockholders and former Coherent stockholders will own approximately 84% and 16%, respectively, of the combined company (based on fully diluted shares outstanding of the combined company as of March&nbsp;24,
2021); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of the merger agreement, including: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the consideration payable to Coherent stockholders in connection with the merger includes a fixed
number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, thereby ensuring that Coherent stockholders will receive a <FONT STYLE="white-space:nowrap">pre-determined</FONT> percentage of the combined company&#146;s equity
irrespective of changes in market prices of either company or the trading markets generally; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the customary and generally reciprocal nature of the representations, warranties and covenants of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> in the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the flexibility permitted under the interim operating covenants which restrict the conduct of Coherent&#146;s
business prior to closing of the merger, and the fact that <FONT STYLE="white-space:nowrap">II-VI</FONT> is subject to certain similar provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the limited closing conditions included in the merger agreement and the likelihood that all such conditions would
be satisfied; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of a financing condition in the merger agreement and the receipt by
<FONT STYLE="white-space:nowrap">II-VI</FONT> of (i)&nbsp;an executed debt financing commitment letter to provide a substantial portion of the financing needed to complete the merger from a reputable, large commercial bank, and (ii)&nbsp;an executed
investment agreement with a reputable private equity firm to provide a substantial amount of equity financing, together with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cash on hand; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the nature of the conditions to the debt financing commitment and the obligation of <FONT
STYLE="white-space:nowrap">II-VI</FONT> to do all things necessary, proper or advisable to arrange, obtain and complete the debt financing prior to the closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-100- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">both parties&#146; obligation to take all actions necessary to obtain regulatory clearance in each of the
jurisdictions in which such clearance is required (subject to certain exceptions in China), and the parties&#146; expectations that such clearances will be obtained given the lack of competitive overlap between their respective businesses;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that two members of the <FONT STYLE="white-space:nowrap">13-member</FONT> board of directors of the
combined company will have been members of the Coherent board as of immediately prior to the effective time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as demonstrated by the extensive negotiation history, Coherent&#146;s right to engage in negotiations with, and
provide information to, any third party from whom Coherent receives an unsolicited proposal relating to a competing transaction if the Coherent board has determined in good faith, after consultation with its outside legal counsel and financial
advisors, that such proposal constitutes or could reasonably be expected to lead to a transaction that is superior to the proposed transactions with <FONT STYLE="white-space:nowrap">II-VI</FONT> and the failure to take such action would be
reasonably expected to be inconsistent with Coherent&#146;s directors&#146; fiduciary duties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the deal protection and termination provisions of the merger agreement, including Coherent&#146;s right to
receive a termination fee of (a)&nbsp;$337.7&nbsp;million if the merger agreement is terminated under certain circumstances, including in the event that (i)&nbsp;the <FONT STYLE="white-space:nowrap">II-VI</FONT> board no longer recommends that <FONT
STYLE="white-space:nowrap">II-VI</FONT> stockholders vote &#147;FOR&#148; the proposal to approve the share issuance or <FONT STYLE="white-space:nowrap">(ii)&nbsp;II-VI</FONT> willfully breaches certain of its
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> or related covenants and (b)&nbsp;$500&nbsp;million if the merger agreement is terminated for failure to obtain antitrust approval from a Chinese governmental entity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the end date under the merger agreement, which is subject to extension such that it allows for time that is
expected to be sufficient to complete the merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the review of the Coherent board, with the assistance of Coherent&#146;s legal and financial advisors, of the
terms and conditions of other recent comparable transactions, including premiums relative to stock prices, consideration mix and announced synergy targets, and its overall belief that the terms of the merger agreement were consistent with market
practice and in the best interest of Coherent and its stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the oral opinion of BofA Securities, subsequently confirmed in a written opinion dated March&nbsp;24, 2021, to
the Coherent board as to the fairness, from a financial point of view and as of the date of the opinion, of the merger consideration to be received in the merger by the holders of Coherent common stock (other than the holders of any cancelled shares
or any dissenting shares), as more fully described in &#147;The Merger&#151;Opinions of Coherent&#146;s Financial Advisors&#148; beginning on page&nbsp;103 of this joint proxy statement/prospectus and the full text of the written opinion of BofA
Securities, which is attached as <B>Annex E</B> to this joint proxy statement/prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the oral opinion of Credit Suisse, subsequently confirmed in writing, to the Coherent board that, as of
March&nbsp;24, 2021, subject to the assumptions, limitations, qualifications and other matters considered in the preparation of such opinion as set forth in such opinion, the merger consideration to be received by the holders of Coherent common
stock (other than the holders of any cancelled shares or any dissenting shares (each as described in the merger agreement)) in the merger was fair, from a financial point of view, to such holders, as described in &#147;The Merger&#151;Opinions of
Coherent&#146;s Financial Advisors&#148; beginning on page&nbsp;103 of this joint proxy statement/prospectus and the full text of the written opinion of Credit Suisse, which is attached as <B>Annex F</B> to this joint proxy statement/prospectus;
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fixed exchange ratio and the relative prices of the parties&#146; stock at the time of announcement of the
merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Coherent board&#146;s review and discussions with Coherent&#146;s senior management concerning the due
diligence examination of the operations, financial condition and regulatory compliance programs and prospects of <FONT STYLE="white-space:nowrap">II-VI;</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-101- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expectation that the required regulatory approvals could be obtained in a timely fashion.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent board also considered the potential risks related to the merger but concluded that the anticipated
benefits of combining with <FONT STYLE="white-space:nowrap">II-VI</FONT> were likely to substantially outweigh these risks. These potential risks included: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial performance may not meet
Coherent&#146;s expectations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Coherent stockholders may receive merger consideration at the completion of the merger with a lower
value than such consideration had at the announcement of the merger given the fact that a significant portion of the merger consideration consists of a fixed number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and the
trading price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock may decline before the completion of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that changes in the regulatory landscape or new industry developments, including changes in consumer or
customer preferences following the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, may adversely affect the business benefits anticipated to result from the merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the multi-jurisdictional regulatory and other approvals required in connection with the merger, and the risk that
such approvals will not be received in a timely manner or at all or may result in costs and expenses or impose unacceptable conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the difficulties and management challenges inherent in completing the merger and integrating the business,
operations and workforce of <FONT STYLE="white-space:nowrap">II-VI</FONT> with those of Coherent and the risk of not capturing (or of a delay in capturing) all of the anticipated cost savings currently expected to be generated by the merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of time it could take to complete the merger, including that completion of the merger depends on
factors outside of Coherent&#146;s or <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> control, and the risk that the pendency of the merger for an extended period of time could have an adverse impact on Coherent and <FONT
STYLE="white-space:nowrap">II-VI,</FONT> including their respective customer, supplier and other business relationships; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> may be subject to lawsuits or other
challenges to the merger, and adverse effects of these challenges, including any adverse rulings in lawsuits, may delay or prevent the merger from being completed or that may require Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> to incur
significant costs to address such challenges, including any costs to defend or settle any lawsuits; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the difficulties and management challenges inherent in completing the merger, integrating the businesses and
managing an expanded business, operations and workforce of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> potential time commitment, distractions and other factors, including the challenge of blending board and management leadership,
harmonizing compensation philosophies, employee compensation and benefit plans, and, despite retention efforts, the potential loss of key personnel, customers and suppliers during the pendency of the merger and thereafter; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible diversion of management and employee attention during the pendency of the merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that certain provisions of the merger agreement, although reciprocal, may have the effect of discouraging
alternative transaction proposals involving Coherent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the restrictions in the merger agreement on the conduct of Coherent&#146;s business during the period between
execution of the merger agreement and the consummation of the merger, which could negatively impact Coherent&#146;s ability to pursue certain business opportunities or strategic transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Coherent stockholders or <FONT STYLE="white-space:nowrap">II-VI</FONT> stockholders, as applicable,
may not approve the merger or the issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> shares in the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that the merger agreement may be terminated by <FONT STYLE="white-space:nowrap">II-VI</FONT> in
connection with its receipt of a superior proposal or a change in the recommendation by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to its stockholders with respect to approval of the share issuance; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-102- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Coherent would be required to pay to <FONT STYLE="white-space:nowrap">II-VI</FONT> a termination
fee of $108.8&nbsp;million in the event the merger agreement were to be terminated in connection with a superior proposal or a change in the recommendation by the Coherent board to its stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that, if the merger agreement would be terminated by either party following the failure of the other
party to obtain the required stockholder vote, the terminating party would be required to pay the other party $25&nbsp;million in expenses as payment for such other party&#146;s costs and expenses in connection with the merger agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the transaction costs to be incurred in connection with the merger; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks of the type and nature described in &#147;Risk Factors&#148; beginning on page&nbsp;42 of this joint
proxy statement/prospectus and the matters described in &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page&nbsp;40 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent board determined that the benefits expected to be achieved for Coherent and Coherent stockholders as a result of the merger
outweighed these potential risks and uncertainties. The Coherent board recognized that there can be no assurance of future results, including results considered or expected as disclosed in this section of the joint proxy statement/prospectus. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion of the information and factors considered by the Coherent board includes material factors considered by the Coherent
board, but it is not intended to be exhaustive and may not include all the factors considered by the Coherent board. In view of the wide variety of factors considered, and the complexity of these matters, the Coherent board did not quantify or
assign any relative or specific weights to the various factors that it considered in reaching its determination to approve the merger agreement, the merger and the other transactions contemplated by the merger agreement. Rather, the Coherent board
viewed its decision and respective recommendations as being based on the totality of the information presented to and factors considered by it, including discussions with, and questioning of, Coherent management and Coherent&#146;s financial and
legal advisors. In addition, individual members of the Coherent board may have given differing weights to different factors. It should be noted that this explanation of the reasoning of the Coherent board and certain information presented in this
section are forward-looking in nature and, therefore, that information should be read in light of the factors discussed in the section entitled &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page&nbsp;40 of this
joint proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering the recommendation of the Coherent board, you should be aware that certain directors and
executive officers of Coherent may have interests in the merger that are different from, or in addition to, interests of stockholders of Coherent generally and may create potential conflicts of interest. The Coherent board was aware of these
interests and considered them when evaluating and negotiating the merger agreement, the merger and the other transactions contemplated by the merger agreement, and in making their respective recommendations, including the Coherent board&#146;s
recommendation that Coherent stockholders approve the Coherent compensation proposal and Coherent charter amendment proposal and the other proposals presented at the Coherent special meeting. See &#147;The Merger&#151;Interests of Coherent&#146;s
Directors and Executive Officers in the Merger&#148; beginning on page&nbsp;139 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_79"></A>Opinions of Coherent&#146;s Financial Advisors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion of BofA Securities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent has retained BofA Securities to act as Coherent&#146;s financial advisor in connection with a potential transaction such as the
merger. BofA Securities is an internationally recognized investment banking firm which is regularly engaged in the valuation of businesses and securities in connection with mergers and acquisitions, negotiated underwritings, secondary distributions
of listed and unlisted securities, private placements and valuations for corporate and other purposes. Coherent selected BofA Securities to act as Coherent&#146;s financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-103- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advisor in connection with a potential transaction such as the merger on the basis of BofA Securities&#146; experience in transactions similar to the merger, its reputation in the investment
community and its familiarity with Coherent and its business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;24, 2021, at a meeting of the Coherent board held to evaluate
the merger, BofA Securities delivered to the Coherent board an oral opinion, which was subsequently confirmed by delivery of a written opinion dated March&nbsp;24, 2021, to the effect that, as of the date of the opinion and based on and subject to
various assumptions and limitations described in its written opinion, the merger consideration to be received in the merger by holders of Coherent common stock, other than the holders of any cancelled shares or any dissenting shares, was fair, from
a financial point of view, to such holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The full text of BofA Securities&#146; written opinion to the Coherent board which
describes, among other things, the assumptions made, procedures followed, factors considered and limitations on the review undertaken, is attached as Annex E to this document and is incorporated by reference herein in its entirety. The following
summary of BofA Securities&#146; opinion is qualified in its entirety by reference to the full text of the opinion. BofA Securities delivered its opinion to the Coherent board for the benefit and use of the Coherent board (in its capacity as such)
in connection with and for purposes of its evaluation of the merger consideration from a financial point of view. BofA Securities&#146; opinion does not address any other term or aspect of the merger and no opinion or view was expressed as to the
relative merits of the merger in comparison to other strategies or transactions that might be available to Coherent or in which Coherent might engage or as to the underlying business decision of Coherent to proceed with or effect the merger. BofA
Securities&#146; opinion does not constitute a recommendation to any stockholder as to how to vote or act in connection with the merger or any related matter. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with rendering its opinion, BofA Securities, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain publicly available business and financial information relating to Coherent and <FONT
STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain internal financial and operating information with respect to the business, operations and
prospects of Coherent furnished to or discussed with BofA Securities by the management of Coherent, including certain financial forecasts relating to Coherent prepared by or at the direction of and approved by the management of Coherent (such
forecasts we refer to as &#147;Coherent forecasts&#148; and are set forth in the section titled &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain internal financial and operating information with respect to the business, operations and
prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> furnished to or discussed with BofA Securities by the management of <FONT STYLE="white-space:nowrap">II-VI,</FONT> including certain financial forecasts relating to <FONT
STYLE="white-space:nowrap">II-VI</FONT> prepared by the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> (such forecasts we refer to as <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> forecasts&#148; and are set forth in the section
titled &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed an alternative version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts incorporating
certain adjustments thereto made by the management of Coherent and certain extrapolations thereto prepared by or at the direction of and approved by the management of Coherent (such forecasts we refer to as &#147;adjusted <FONT
STYLE="white-space:nowrap">II-VI</FONT> forecasts&#148; and are set forth in the section titled &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page&nbsp;133 of this joint proxy statement/prospectus) and
discussed with the management of Coherent its assessments as to the relative likelihood of achieving the future financial results reflected in the <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts and the adjusted <FONT
STYLE="white-space:nowrap">II-VI</FONT> forecasts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain estimates furnished to BofA Securities by the management of Coherent as to the amount and timing
of cost savings and the costs of achieving such results (which we refer to as the &#147;cost savings&#148; and are set forth in the section titled &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on
page&nbsp;133 of this joint proxy statement/prospectus) anticipated by the managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> to result from the merger; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-104- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussed the past and current business, operations, financial condition and prospects of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> with members of senior management of Coherent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the potential pro forma financial impact of the merger on the future financial performance of <FONT
STYLE="white-space:nowrap">II-VI,</FONT> including the potential effect on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> estimated earnings per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the trading histories for Coherent common stock and <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock and a comparison of such trading histories with each other and with the trading histories of other companies BofA Securities deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compared certain financial and stock market information of Coherent and
<FONT STYLE="white-space:nowrap">II-VI</FONT> with similar information of other companies BofA Securities deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compared certain financial terms of the merger to financial terms, to the extent publicly available, of other
transactions BofA Securities deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considered the results of BofA Securities&#146; efforts on behalf of Coherent to solicit, at the direction of
Coherent, indications of interest and definitive proposals from Lumentum, MKS and II-VI with respect to a possible acquisition of Coherent prior to the entry by Coherent into the January&nbsp;18 Lumentum Merger Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considered the definitive proposals received from Lumentum and MKS with respect to a possible acquisition of
Coherent after the entry by Coherent into the January&nbsp;18 Lumentum Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the merger agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performed such other analyses and studies and considered such other information and factors as BofA Securities
deemed appropriate. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In arriving at its opinion, BofA Securities assumed and relied upon, without independent
verification, the accuracy and completeness of the financial and other information and data publicly available or provided to or otherwise reviewed by or discussed with it and relied upon the assurances of the managements of Coherent<B> </B>and <FONT
STYLE="white-space:nowrap">II-VI</FONT> that they were not aware of any facts or circumstances that would make such information or data inaccurate or misleading in any material respect. With respect to the
<FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts, BofA Securities was advised by <FONT STYLE="white-space:nowrap">II-VI,</FONT> and assumed, with the consent of Coherent, that they were reasonably prepared on bases reflecting the best
currently available estimates and good faith judgments of the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> as to the future financial performance of <FONT STYLE="white-space:nowrap">II-VI.</FONT> With respect to the Coherent forecasts
and the adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts, BofA Securities was advised by Coherent, and assumed, that they were reasonably prepared on bases reflecting the best currently available estimates and good faith judgments of
the management of Coherent as to the future financial performance of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> With respect to the cost savings, BofA Securities was advised by Coherent and
<FONT STYLE="white-space:nowrap">II-VI,</FONT> and assumed, with the consent of Coherent, that they were reasonably prepared on bases reflecting the best currently available estimates and good faith judgments of the managements of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> as to the matters covered thereby. BofA Securities relied, at the direction of Coherent, on the assessments of the managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> as to <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to achieve the cost savings and was advised by Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> and assumed, with the consent of Coherent, that the cost savings will be realized in
the amounts and at the times projected. BofA Securities did not make and was not provided with any independent evaluation or appraisal of the assets or liabilities (contingent or otherwise) of Coherent<B> </B>or
<FONT STYLE="white-space:nowrap">II-VI,</FONT> nor did it make any physical inspection of the properties or assets of Coherent<B> </B>or <FONT STYLE="white-space:nowrap">II-VI.</FONT> BofA Securities did not evaluate the solvency or fair value of
Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> under any state, federal or other laws relating to bankruptcy, insolvency or similar matters. BofA Securities assumed, at the direction of Coherent, that the merger would be consummated in
accordance with its terms, without waiver, modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary<B> </B>governmental, regulatory and other approvals, consents, releases and waivers
for the merger, no delay, limitation, restriction or condition, including any divestiture requirements or amendments or modifications, would be imposed that would have an adverse effect on Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or
the contemplated benefits of the merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-105- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities expressed no view or opinion as to any terms or other aspects of the merger
(other than the merger consideration to the extent expressly specified in its opinion), including, without limitation, the form or structure of the merger. BofA Securities&#146; opinion was limited to the fairness, from a financial point of view, of
the merger consideration to be received in the merger by holders of Coherent common stock, other than the holders of any cancelled shares or any dissenting shares, and no opinion or view was expressed with respect to any consideration received in
connection with the merger by holders of any class of securities, creditors or other constituencies of any party. In addition, no opinion or view was expressed with respect to the fairness (financial or otherwise) of the amount, nature or any other
aspect of any compensation to any of the officers, directors or employees of any party to the merger, or class of such persons, relative to the merger consideration. Furthermore, no opinion or view was expressed as to the relative merits of the
merger in comparison to other strategies or transactions that might be available to Coherent or in which Coherent might engage or as to the underlying business decision of Coherent to proceed with or effect the merger. BofA Securities also expressed
no view or opinion with respect to, and relied, with Coherent&#146;s consent, upon the assessments of representatives of Coherent regarding, legal, regulatory, accounting, tax and similar matters relating to Coherent,
<FONT STYLE="white-space:nowrap">II-VI</FONT> and the merger (including the contemplated benefits thereof), as to which BofA Securities understood that Coherent obtained such advice as it deemed necessary from qualified professionals. BofA
Securities did not express any opinion as to what the value of <FONT STYLE="white-space:nowrap">II-VI</FONT><B> </B>common stock actually would be when issued or the prices at which Coherent<B> </B>common stock or
<FONT STYLE="white-space:nowrap">II-VI</FONT><B> </B>common stock would trade at any time, including following announcement or consummation of the merger. In addition, BofA Securities expressed no opinion or recommendation as to how any stockholder
should vote or act in connection with the merger or any related matter. Except as described above, Coherent imposed no other limitations on the investigations made or procedures followed by BofA Securities in rendering its opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities&#146; opinion was necessarily based on financial, economic, monetary, market and other conditions and circumstances as in
effect on, and the information made available to BofA Securities as of, the date of its opinion. It should be understood that subsequent developments may affect its opinion, and BofA Securities does not have any obligation to update, revise or
reaffirm its opinion. The issuance of BofA Securities&#146; opinion was approved by a fairness opinion review committee of BofA Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discussion set forth below under &#147;&#151;Summary of Material Coherent Financial Analyses,&#148; &#147;&#151;Summary of Material <FONT
STYLE="white-space:nowrap">II-VI</FONT> Financial Analyses&#148; and &#147;&#151;Summary of Material Relative Financial Analyses&#148; represents a brief summary of the material financial analyses presented by BofA Securities to the Coherent board
in connection with its opinion. <B>The financial analyses summarized below include information presented in tabular format. In order to fully understand the financial analyses performed by BofA Securities, the tables must be read together with the
text of each summary. The tables alone do not constitute a complete description of the financial analyses performed by BofA Securities. Considering the data set forth in the tables below without considering the full narrative description of the
financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of the financial analyses performed by BofA Securities.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-106- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Summary of Material Coherent Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Publicly Traded Companies Analysis. </I>BofA Securities reviewed publicly available financial and stock market information for
Coherent and the following nine publicly traded companies with material operations engaged in the manufacturing of components for optical communications and/or the laser industry: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of January&nbsp;15, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;23, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2021E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2022E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2021E<BR>Adj.</B><br><B>EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2021E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2022E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Novanta Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">IPG Photonics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Han&#146;s Laser Technology Industry Group Co., Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Lincoln Electric Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Lumentum Holdings Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Jenoptik AG</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">nLIGHT, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><I>NM means not meaningful because earnings were either negative or so low that they resulted in
(a)&nbsp;Enterprise Value/ Adj. EBITDA multiples of over 45x or (b)&nbsp;Stock Price/Adjusted EPS multiples of over 55x. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities reviewed, among other things, enterprise values of the selected publicly traded companies, calculated as equity values, based
on closing stock prices on January&nbsp;15, 2021, plus debt, less cash and cash equivalents, as a multiple of calendar year 2021 and calendar year 2022 estimated earnings before interest, taxes, depreciations and amortization, commonly referred to
as &#147;EBITDA,&#148; excluding the impact of stock-based compensation expense, amortization of acquired intangibles and <FONT STYLE="white-space:nowrap">one-time</FONT> charges, which is referred to as &#147;adjusted EBITDA.&#148; BofA Securities
also reviewed per share equity values of the selected publicly traded companies, based on closing stock prices on January&nbsp;15, 2021, as a multiple of calendar year 2021 and calendar year 2022 estimated earnings per share, commonly referred to as
&#147;EPS,&#148; excluding the after-tax impact of stock-based compensation expense, amortization of acquired intangibles and <FONT STYLE="white-space:nowrap">one-time</FONT> charges, which is referred to as &#147;adjusted EPS.&#148; The median
enterprise value / estimated adjusted EBITDA multiple observed for the selected publicly traded companies was 15.8x for calendar year 2021 and 15.0x for calendar year 2022. The median price / estimated adjusted EPS multiple observed for the selected
publicly traded companies was 24.5x for calendar year 2021 and 22.4x for calendar year 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities then applied calendar year
2021 estimated adjusted EBITDA multiples of 11.0x to 15.0x and calendar year 2022 estimated adjusted EBITDA multiples of 10.0x to 13.5x derived from the selected publicly traded companies to Coherent&#146;s calendar year 2021 and calendar year 2022
estimated adjusted EBITDA and applied calendar year 2021 estimated adjusted EPS multiples of 16.5x to 24.5x and calendar year 2022 estimated adjusted EPS multiples of 15.0x to 22.5x derived from the selected publicly traded companies to
Coherent&#146;s calendar year 2021 and calendar year 2022 estimated adjusted EPS. Estimated financial data of the selected publicly traded companies were based on publicly available research analysts&#146; estimates, and estimated financial data of
Coherent were based on the Coherent forecasts. This analysis indicated the following approximate implied per share equity value reference ranges for Coherent (rounded to the nearest $0.25), as compared to the per share price of Coherent common stock
implied by the merger consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="12" ALIGN="center"><B>Implied Per Share Equity Value Reference Ranges for Coherent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EV/CY2021E<BR>Adj. EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/CY2022E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per Share<BR>Price<BR>Implied by<BR>Merger<BR>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$101.75 - $137.50</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">81.25&nbsp;-&nbsp;$120.75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">151.75&nbsp;-&nbsp;$203.75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">128.25&nbsp;-&nbsp;$192.50</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-107- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities also reviewed, among other things, enterprise values of the selected
publicly traded companies, calculated as equity values, based on closing stock prices on March&nbsp;23, 2021, plus debt, less cash and cash equivalents, as a multiple of calendar year 2021 and calendar year 2022 estimated adjusted EBITDA. BofA
Securities also reviewed per share equity values of the selected publicly traded companies, based on closing stock prices on March&nbsp;23, 2021, as a multiple of calendar year 2021 and calendar year 2022 estimated adjusted EPS. The median
enterprise value / estimated adjusted EBITDA multiple observed for the selected publicly traded companies was 14.6x for calendar year 2021 and 14.4x for calendar year 2022. The median price / estimated adjusted EPS multiple observed for the selected
publicly traded companies was 21.9x for calendar year 2021 and 20.1x for calendar year 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities then applied calendar year
2021 estimated adjusted EBITDA multiples of 9.5x to 13.0x and calendar year 2022 estimated adjusted EBITDA multiples of 8.5x to 12.0x derived from the selected publicly traded companies to Coherent&#146;s calendar year 2021 and calendar year 2022
estimated adjusted EBITDA and applied calendar year 2021 estimated adjusted EPS multiples of 13.0x to 22.5x and calendar year 2022 estimated adjusted EPS multiples of 11.5x to 16.5x derived from the selected publicly traded companies to
Coherent&#146;s calendar year 2021 and calendar year 2022 estimated adjusted EPS. Estimated financial data of the selected publicly traded companies were based on publicly available research analysts&#146; estimates, and estimated financial data of
Coherent were based on the Coherent forecasts. This analysis indicated the following approximate implied per share equity value reference ranges for Coherent (rounded to the nearest $0.25), as compared to the per share price of Coherent common stock
implied by the merger consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="12" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Implied Per Share Equity Value Reference Ranges for Coherent</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EV/CY2021E<BR>Adj. EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/CY2022E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Price<BR>Implied&nbsp;by&nbsp;Merger<BR>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$88.25&nbsp;-&nbsp;$119.75</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">64.00&nbsp;-&nbsp;$111.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">129.50&nbsp;-&nbsp;$181.50</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">98.25&nbsp;-&nbsp;$141.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No company used in this analysis is identical or directly comparable to Coherent. Accordingly, an evaluation
of the results of this analysis is not entirely mathematical. Rather, this analysis involves complex considerations and judgments concerning differences in financial and operating characteristics and other factors that could affect the public
trading or other values of the companies to which Coherent was compared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Precedent Transactions Analysis</I>. BofA Securities
reviewed, to the extent publicly available, financial information relating to the following fourteen selected transactions involving companies with material operations engaged in the manufacturing of components for optical communications, the laser
industry and/or the semiconductor equipment industry: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date&nbsp;Announced</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquiror</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Value/<BR>NTME&nbsp;Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Value/<BR>LTM Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2012</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ASML Holding NV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cymer, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ASML Holding NV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hermes&nbsp;Microvision,&nbsp;Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nanometrics&nbsp;Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rudolph&nbsp;Technologies, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">KLA-Tencor&nbsp;Corporation</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Orbotech Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Veeco Instruments Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ultratech, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AMETEK, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zygo Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lam&nbsp;Research&nbsp;Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">KLA-Tencor&nbsp;Corporation</FONT><SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finisar Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electro&nbsp;Scientific&nbsp;Industries,&nbsp;Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Coherent, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">ROFIN-SINAR&nbsp;Technologies&nbsp;Inc.</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-108- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date&nbsp;Announced</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquiror</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Value/<BR>NTME&nbsp;Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Value/<BR>LTM Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Newport Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Orbotech Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SPTS&nbsp;Technologies&nbsp;Group Limited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Newport Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ophir Optronics Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May 2011</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IDEX Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVI Melles Griot</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>NA means not available. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Transaction was terminated. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities reviewed, among other things, transaction values, calculated as the enterprise value implied for the target company based on
the consideration payable in the selected transaction, as a multiple of the target company&#146;s last twelve months ended December&nbsp;31, 2020, which is referred to as &#147;LTM,&#148; adjusted EBITDA and as a multiple of the target
company&#146;s next twelve months ending December&nbsp;31, 2021, which is referred to as &#147;NTM,&#148; estimated adjusted EBITDA. BofA Securities then applied LTM adjusted EBITDA multiples of 10.5x to 16.5x derived from the selected transactions
to Coherent&#146;s LTM adjusted EBITDA and applied NTM estimated adjusted EBITDA multiples of 8.0x to 14.5x derived from the selected transactions to Coherent&#146;s NTM estimated adjusted EBITDA. Estimated financial data of the selected
transactions were based on publicly available information at the time of announcement of the relevant transaction, and estimated financial data of Coherent were based on the Coherent forecasts. This analysis indicated the following approximate
implied per share equity value reference ranges for Coherent (rounded to the nearest $0.25), as compared to the per share price of Coherent common stock implied by the merger consideration: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="25%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="25%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity
Value Reference Ranges for Coherent</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per Share<BR>Price</B><br><B>Implied by<BR>Merger<BR>Consideration</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TV / LTM E Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TV / NTM E Adj. EBITDA</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="white-space:nowrap">$68.25&nbsp;-&nbsp;$105.50</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">$75.00&nbsp;-&nbsp;$133.00</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No company, business or transaction used in this analysis is identical or directly comparable to Coherent or
the merger. Accordingly, an evaluation of the results of this analysis is not entirely mathematical. Rather, this analysis involves complex considerations and judgments concerning differences in financial and operating characteristics and other
factors that could affect the acquisition or other values of the companies, business segments or transactions to which Coherent and the merger were compared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis. </I>BofA Securities performed a discounted cash flow analysis of Coherent to calculate the estimated present
value of the standalone unlevered, <FONT STYLE="white-space:nowrap">after-tax</FONT> free cash flows that Coherent was forecasted to generate during Coherent&#146;s second, third and fourth quarters of fiscal year 2021 and fiscal years 2022 through
2026 based on the Coherent forecasts. BofA Securities calculated terminal values for Coherent by extrapolating Coherent&#146;s unlevered free cash flow at perpetuity growth rates of 3.0% to 4.0%, which perpetuity growth rates were selected based on
BofA Securities&#146; professional judgment and experience. The cash flows and terminal values were then discounted to present value, assuming a <FONT STYLE="white-space:nowrap">mid-year</FONT> convention, as of December&nbsp;31, 2020 using discount
rates ranging from 8.5% to 11.5%, which were based on an estimate of Coherent&#146;s weighted average cost of capital. From the resulting enterprise values, BofA Securities added net cash of $85&nbsp;million to derive equity values. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-109- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This analysis indicated the following approximate implied per share equity value reference
ranges for Coherent (rounded to the nearest $0.25) as compared to the per share price of Coherent common stock implied by the merger consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="35%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity<BR>Value
Reference Range for Coherent</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Price<BR>Implied&nbsp;by&nbsp;Merger&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$104.75&nbsp;-&nbsp;$196.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Factors</I>. BofA Securities also noted certain additional factors that were not considered part of
BofA Securities&#146; material financial analyses with respect to its opinion but were referenced for informational purposes, including, among other things, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trading range for the Coherent common stock for the <FONT STYLE="white-space:nowrap">12-month</FONT> period
as of January&nbsp;15, 2021 (the last trading day prior to the public announcement of the January&nbsp;18 Lumentum Merger Agreement), which was $82.09 to $175.70 per share; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain publicly available equity research analyst price targets for the Coherent common stock available as of
March&nbsp;23, 2021, and noted that the range of such price targets (discounted one year by 10% cost of equity) was $127.25 to $154.50 per share. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Summary of Material <FONT STYLE="white-space:nowrap">II-VI</FONT> Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Publicly Traded Companies Analysis. </I>BofA Securities reviewed publicly available financial and stock market information for <FONT
STYLE="white-space:nowrap">II-VI</FONT> and the following eight publicly traded companies with material operations engaged in the manufacturing of optical/photonic components and/or compound semiconductor materials and devices for communications,
industrial, semiconductor and other <FONT STYLE="white-space:nowrap">end-markets:</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of January&nbsp;15, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;23, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2021E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2022E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2021E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value/<BR>CY&nbsp;2022E<BR>Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Novanta Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">IPG&nbsp;Photonics&nbsp;Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">NeoPhotonics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Coherent, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Lumentum&nbsp;Holdings&nbsp;Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">nLIGHT, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cree, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left"><I>NM means not meaningful because earnings were either negative or so low that they resulted in
(a)&nbsp;Enterprise Value/ Adj. EBITDA multiples of over 45x or (b)&nbsp;Stock Price/Adjusted EPS multiples of over 55x. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities reviewed, among other things, enterprise values of the selected publicly traded companies, calculated as equity values, based
on closing stock prices on January&nbsp;15, 2021, plus debt, less cash and cash equivalents, as a multiple of calendar year 2021 and calendar year 2022 estimated adjusted EBITDA. BofA Securities also reviewed per share equity values of the selected
publicly traded companies, based on closing stock prices on January&nbsp;15, 2021, as a multiple of calendar year 2021 and calendar year 2022 estimated adjusted EPS. The median enterprise value / estimated adjusted EBITDA multiple observed for the
selected publicly traded companies was 19.8x for calendar year 2021 and 17.6x for calendar year 2022. The median price / estimated adjusted EPS multiple observed for the selected publicly traded companies was 20.3x for calendar year 2021 and 38.4x
for calendar year 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-110- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities then applied calendar year 2021 estimated adjusted EBITDA multiples of 13.5x
to 15.0x and calendar year 2022 estimated adjusted EBITDA multiples of 10.0x to 13.5x derived from the selected publicly traded companies to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year 2021 and calendar year 2022 estimated
adjusted EBITDA and applied calendar year 2021 estimated adjusted EPS multiples of 16.5x to 24.5x and calendar year 2022 estimated adjusted EPS multiples of 15.0x to 22.5x derived from the selected publicly traded companies to <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year 2021 and calendar year 2022 estimated adjusted EPS. Estimated financial data of the selected publicly traded companies were based on publicly available research analysts&#146; estimates,
and estimated financial data of <FONT STYLE="white-space:nowrap">II-VI</FONT> were based on the adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts. This analysis indicated the following approximate implied per share equity value
reference ranges for <FONT STYLE="white-space:nowrap">II-VI</FONT> (rounded to the nearest $0.25), as compared to the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;23, 2021: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="12" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Implied Per Share Equity Value Reference Ranges for
<FONT STYLE="white-space:nowrap">II-VI</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EV/CY2021E<BR>Adj. EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/CY2022E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Closing&nbsp;Trading<BR><FONT STYLE="white-space:nowrap">Price&nbsp;of&nbsp;II-VI&nbsp;on</FONT><BR>March&nbsp;23, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$87.50&nbsp;-&nbsp;$97.50</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">65.50&nbsp;-&nbsp;$97.25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">78.75&nbsp;-&nbsp;$107.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">78.25&nbsp;-&nbsp;$117.25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities also reviewed, among other things, enterprise values of the selected publicly traded
companies, calculated as equity values, based on closing stock prices on March&nbsp;23, 2021, plus debt, less cash and </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cash equivalents, as a multiple of
calendar year 2021 and calendar year 2022 estimated adjusted EBITDA. BofA Securities also reviewed per share equity values of the selected publicly traded companies, based on closing stock prices on March&nbsp;23, 2021, as a multiple of calendar
year 2021 and calendar year 2022 estimated adjusted EPS. The median enterprise value / estimated adjusted EBITDA multiple observed for the selected publicly traded companies was 19.6x for calendar year 2021 and 17.2x for calendar year 2022. The
median price / estimated adjusted EPS multiple observed for the selected publicly traded companies was 25.4x for calendar year 2021 and 33.0x for calendar year 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities then applied calendar year 2021 estimated adjusted EBITDA multiples of 9.5x to 13.0x and calendar year 2022 estimated adjusted
EBITDA multiples of 8.5x to 12.0x derived from the selected publicly traded companies to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year 2021 and calendar year 2022 estimated adjusted EBITDA and applied calendar year 2021
estimated adjusted EPS multiples of 13.0x to 22.5x and calendar year 2022 estimated adjusted EPS multiples of 11.5x to 16.5x derived from the selected publicly traded companies to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year
2021 and calendar year 2022 estimated adjusted EPS. Estimated financial data of the selected publicly traded companies were based on publicly available research analysts&#146; estimates, and estimated financial data of
<FONT STYLE="white-space:nowrap">II-VI</FONT> were based on the adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts. This analysis indicated the following approximate implied per share equity value reference ranges for <FONT
STYLE="white-space:nowrap">II-VI</FONT> (rounded to the nearest $0.25), as compared to the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;23, 2021: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="12" ALIGN="center"><B>Implied Per Share Equity Value Reference Ranges for <FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>EV/CY2021E<BR>Adj. EBITDA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/CY2022E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price/CY2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Closing&nbsp;Trading<BR><FONT STYLE="white-space:nowrap">Price&nbsp;of&nbsp;II-VI&nbsp;on</FONT><BR>March&nbsp;23, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$61.00&nbsp;-&nbsp;$84.25</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">51.50&nbsp;-&nbsp;$89.25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">66.75&nbsp;-&nbsp;$95.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">60.00&nbsp;-&nbsp;$86.00</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No company used in this analysis is identical or directly comparable to
<FONT STYLE="white-space:nowrap">II-VI.</FONT> Accordingly, an evaluation of the results of this analysis is not entirely mathematical. Rather, this analysis involves complex considerations and judgments concerning differences in financial and
operating characteristics and other factors that could affect the public trading or other values of the companies to which <FONT STYLE="white-space:nowrap">II-VI</FONT> was compared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis. </I>BofA Securities performed a discounted cash flow analysis of
<FONT STYLE="white-space:nowrap">II-VI</FONT> to calculate the estimated present value of the standalone unlevered, <FONT STYLE="white-space:nowrap">after-tax</FONT> free cash flows that <FONT STYLE="white-space:nowrap">II-VI</FONT> was forecasted
to generate during <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> third and fourth quarters of fiscal year 2021 and fiscal years 2022 through 2026 based on the adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> forecasts. BofA Securities
calculated terminal values for <FONT STYLE="white-space:nowrap">II-VI</FONT> by extrapolating <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> unlevered free cash flow at perpetuity growth rates of 2.5% to 3.5%, which perpetuity growth rates
were </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-111- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
selected based on BofA Securities&#146; professional judgment and experience. The cash flows and terminal values were then discounted to present value, assuming
<FONT STYLE="white-space:nowrap">mid-year</FONT> convention, as of December&nbsp;31, 2020 using discount rates ranging from 7.0% to 9.0%, which were based on an estimate of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> weighted average cost
of capital. From the resulting enterprise values, BofA Securities subtracted net debt of $689&nbsp;million to derive equity values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
analysis indicated the following approximate implied per share equity value reference ranges for <FONT STYLE="white-space:nowrap">II-VI</FONT> (rounded to the nearest $0.25), as compared to the closing price of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;23, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="43%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity
Value<BR>Reference Range for <FONT STYLE="white-space:nowrap">II-VI</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Closing&nbsp;Trading&nbsp;Price&nbsp;of<BR><FONT STYLE="white-space:nowrap">II-VI&nbsp;on&nbsp;March&nbsp;23,&nbsp;2021</FONT></B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$99.00&nbsp;-&nbsp;$182.50</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">$65.85</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Factors.</I> BofA Securities also noted certain additional factors that were not considered part of
BofA Securities&#146; material financial analyses with respect to its opinion but were referenced for informational purposes, including, among other things, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the trading range for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for the <FONT
STYLE="white-space:nowrap">12-month</FONT> period as of March&nbsp;23, 2021, which was $24.25 to $99.58 per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain publicly available equity research analyst price targets for the
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock available as of March&nbsp;23, 2021, and noted that the range of such price targets (discounted one year by 8.0% cost of equity) was $66.75 to $140.75 per share. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Summary of Material Relative Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Pro Forma Analysis. </I>BofA Securities performed a pro forma analysis to calculate the theoretical change in value for Coherent
stockholders resulting from the merger based on a comparison of (i)&nbsp;the pro forma ownership by Coherent stockholders of the combined company following the merger and (ii)&nbsp;the 100% ownership by Coherent stockholders of the Coherent common
stock on a stand-alone basis. For Coherent on a stand-alone basis, BofA Securities used the reference range obtained in its discounted cash flow analysis described above under &#147;&#151;Summary of Material Coherent Financial
Analyses&#151;Discounted Cash Flow Analysis.&#148; BofA Securities then calculated the implied pro forma equity value per share of Coherent common stock resulting from the merger as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the implied equity value of Coherent on a standalone basis plus the implied equity value of <FONT
STYLE="white-space:nowrap">II-VI</FONT> on a standalone basis (each as calculated using the discounted cash flow analysis described above); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the implied equity value of net estimated cost savings to the combined company applying a perpetuity
growth rate of 3.0% to 4.0% and a discount rate range of 8.5% to 11.5%; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">less the decrease in cash from the merger to the combined company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus $220.00 cash per share included in the merger consideration. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This analysis yielded the following implied per share equity value reference ranges for Coherent common stock on a standalone basis and,
assuming 13.9% pro forma ownership by Coherent stockholders, for the combined company, excluding payment in kind interest payable on the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (rounded to the nearest
$0.25): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per Share Equity<BR>Value Reference<BR>Ranges for<BR>Coherent<BR>Common Stock</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stand-Alone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">$104.75&nbsp;-&nbsp;$196.25</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro Forma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">$286.75&nbsp;-&nbsp;$367.75</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-112- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Miscellaneous </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, the discussion under &#147;&#151;Summary of Material Coherent Financial Analyses,&#148; &#147;&#151;Summary of Material <FONT
STYLE="white-space:nowrap">II-VI</FONT> Financial Analyses&#148; and &#147;&#151;Summary of Material Relative Financial Analyses&#148; represents a brief summary of the material financial analyses presented by BofA Securities to the Coherent board
in connection with its opinion and is not a comprehensive description of all analyses undertaken by BofA Securities in connection with its opinion. The preparation of a financial opinion is a complex analytical process involving various
determinations as to the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, a financial opinion is not readily susceptible to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">partial analysis or summary description. BofA Securities believes that its analyses summarized above must be considered as a whole. BofA Securities further
believes that selecting portions of its analyses and the factors considered or focusing on information presented in tabular format, without considering all analyses and factors or the narrative description of the analyses, could create a misleading
or incomplete view of the processes underlying BofA Securities&#146; analyses and opinion. The fact that any specific analysis has been referred to in the summary above is not meant to indicate that such analysis was given greater weight than any
other analysis referred to in the summary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In performing its analyses, BofA Securities considered industry performance, general business
and economic conditions and other matters, many of which are beyond the control of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> The estimates of the future performance of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> in
or underlying BofA Securities&#146; analyses are not necessarily indicative of actual values or actual future results, which may be significantly more or less favorable than those estimates or those suggested by BofA Securities&#146; analyses. These
analyses were prepared solely as part of BofA Securities&#146; analysis of the fairness, from a financial point of view, of the merger consideration and were provided to the Coherent board in connection with the delivery of BofA Securities&#146;
opinion. The analyses do not purport to be appraisals or to reflect the prices at which a company might actually be sold or the prices at which any securities have traded or may trade at any time in the future. Accordingly, the estimates used in,
and the ranges of valuations resulting from, any particular analysis described above are inherently subject to substantial uncertainty and should not be taken to be BofA Securities&#146; view of the actual values of Coherent or <FONT
STYLE="white-space:nowrap">II-VI.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The type and amount of consideration payable in the merger was determined through negotiations
between Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> rather than by any financial advisor, and was unanimously approved by the Coherent board. The decision to enter into the merger agreement was solely that of the Coherent board. As
described above, BofA Securities&#146; opinion and analyses were only one of many factors considered by the Coherent board in its evaluation of the merger and should not be viewed as determinative of the views of the Coherent board or management
with respect to the merger or the merger consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent has agreed to pay BofA Securities for its services in connection with
the merger an aggregate fee currently estimated to be approximately $57,700,000 based on the closing price of II-VI common stock on April&nbsp;23, 2021, a total of $2 million of which was paid upon rendering two opinions in connection with the
January&nbsp;18 Lumentum Merger Agreement and the March&nbsp;9 Lumentum Merger Agreement, $1&nbsp;million of which was paid in connection with its opinion dated March&nbsp;24, 2021 and the remainder of which is contingent upon the completion of the
merger. Coherent also has agreed to reimburse BofA Securities for its reasonable expenses incurred in connection with BofA Securities&#146; engagement and to indemnify BofA Securities, its affiliates, and each of their respective directors,
officers, employees and agents and each other controlling person of BofA Securities or any of its affiliates against specified liabilities, including liabilities under the federal securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities and its affiliates comprise a full service securities firm and commercial bank engaged in securities, commodities and
derivatives trading, foreign exchange and other brokerage activities, and principal investing as well as providing investment, corporate and private banking, asset and investment management, financing and financial advisory services and other
commercial services and products to a wide range of companies, governments and individuals. In the ordinary course of their businesses, BofA Securities and its affiliates may invest on a principal basis or on behalf of customers or manage funds that
invest, make or hold long or short positions, finance positions or trade or otherwise effect transactions in equity, debt or other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-113- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities or financial instruments (including derivatives, bank loans or other obligations) of Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and certain of their respective affiliates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities and its affiliates in the past have provided, currently are providing, and in the future may provide, investment banking,
commercial banking and other financial services to Coherent and/or certain of its affiliates and have received or in the future may receive compensation for the rendering of these services, including (i)&nbsp;acting as financial advisor to Coherent
in connection with the merger, (ii)&nbsp;having acted or acting as joint lead arranger, joint bookrunner for, and a lender under, certain term loans, letters of credit and other credit facilities of Coherent and/or certain of its affiliates,
(iii)&nbsp;having provided or providing certain treasury management services and products to Coherent and/or certain of its affiliates, and (iv)&nbsp;having provided or providing certain derivatives and foreign exchange trading services to Coherent
and/or certain of its affiliates. From March&nbsp;1, 2019 through February&nbsp;28, 2021, BofA Securities and its affiliates derived aggregate revenues from Coherent and its affiliates of approximately $10&nbsp;million for investment and corporate
banking services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, BofA Securities and its affiliates in the past have provided, currently are providing, and in the future
may provide, investment banking, commercial banking and other financial services to <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates and have received or in the future may receive compensation for the rendering of these
services, including (i)&nbsp;having acted as financial advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with its acquisition of Finisar Corporation, (ii)&nbsp;having acted or acting as administrative agent, collateral agent, <FONT
STYLE="white-space:nowrap">co-lead</FONT> arranger, joint bookrunner for, and/or a lender under, certain term loans, letters of credit and credit facilities of <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates,
(iii)&nbsp;having acted as manager or underwriter for various debt and/or equity offerings of <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates, (iv)&nbsp;having provided or providing certain treasury management services
and products to <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates, and (v)&nbsp;having provided or providing certain derivatives and foreign exchange trading services to <FONT STYLE="white-space:nowrap">II-VI</FONT>
and/or certain of its affiliates.<B> </B>From March&nbsp;1, 2019 through February&nbsp;28, 2021, BofA Securities and its affiliates derived aggregate revenues from <FONT STYLE="white-space:nowrap">II-VI</FONT> and its affiliates of approximately
$80&nbsp;million for investment and corporate banking services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, BofA Securities and its affiliates in the past have
provided, currently are providing, and in the future may provide, investment banking, commercial banking and other financial services to Bain Capital, LP (&#147;Bain&#148;), an affiliate of BCPE, and/or certain affiliates and/or portfolio companies
of Bain, and have received or in the future may receive compensation for the rendering of these services, including (i)&nbsp;having acted or acting as administrative agent, collateral agent, arranger, bookrunner and/or lender for Bain and/or certain
of its affiliates and/or portfolio companies under various credit, leasing and other facilities of Bain and/or certain of its affiliates and/or portfolio companies (including, without limitation, in connection with the financing for certain
acquisition transactions), (ii) having acted or acting as manager or underwriter for various equity and debt offerings undertaken by Bain and/or certain of its affiliates and/or portfolio companies, (iii)&nbsp;having provided or providing certain
treasury management services and products to Bain and/or certain of its affiliates and/or portfolio companies, and (iv)&nbsp;having provided or providing certain derivatives and foreign exchange trading services to Bain and/or certain of its
affiliates and/or portfolio companies. In addition, certain of our affiliates maintain certain commercial (including vendor and/or customer) relationships with Bain and/or certain of its affiliates and/or portfolio companies. From March&nbsp;1, 2019
through February&nbsp;28, 2021, BofA Securities and its affiliates derived aggregate revenues from Bain and its affiliates of approximately $100&nbsp;million for investment and corporate banking services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion of Credit Suisse </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
March&nbsp;24, 2021, Credit Suisse rendered its oral opinion to the Coherent board (which was subsequently confirmed in writing by delivery of Credit Suisse&#146;s written opinion dated as of the same date) to the effect that, as of March&nbsp;24,
2021, and subject to the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters considered by Credit Suisse in connection with the preparation of its opinion, the merger consideration set
forth in the merger agreement was fair, from a financial point of view, to the holders of shares of Coherent common stock, other than the holders any cancelled shares or any dissenting shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-114- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Credit Suisse&#146;s opinion was directed to the Coherent board and only addressed the
fairness, from a financial point of view, to the holders of shares of Coherent common stock, other than the holders of any cancelled shares or any dissenting shares, of the merger consideration set forth in the merger agreement and did not address
any other aspect or implication of the merger. The summary of Credit Suisse&#146;s opinion in this joint proxy statement/prospectus is qualified in its entirety by reference to the full text of its written opinion, a copy of which is attached as
Annex F hereto and sets forth the procedures followed, assumptions made, qualifications and limitations on the review undertaken and other matters considered by Credit Suisse in connection with the preparation of its opinion. However, neither Credit
Suisse&#146;s written opinion nor the summary of its opinion and the related analyses set forth in this joint proxy statement/prospectus is intended to be, and they do not constitute, advice or a recommendation to any security holder as to how such
security holder should vote or act with respect to any matter relating to the merger. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In arriving at its opinion, Credit Suisse: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed an execution copy of the merger agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain publicly available business and financial information relating to Coherent and <FONT
STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain other information relating to Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT>
including: (i)&nbsp;the Coherent management case prospective financial information, (ii)&nbsp;the Coherent adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information and (iii)&nbsp;the
<FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information (see &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#148; beginning on page 133 of this joint proxy statement/prospectus);
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussed the business and prospects of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> with the
management of each of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> and certain of their respective representatives and affiliates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed estimates prepared and provided to Credit Suisse by Coherent&#146;s management with respect to the
potential combined company synergies, including the costs necessary to achieve such synergies, anticipated by Coherent&#146;s management to result from the merger, which estimates, for the avoidance of doubt, did not include the potential combined
company revenue synergies prepared by II-VI&#146;s management (see &#147;The Merger&#151;Certain Unaudited Prospective Financial Information&#151;Certain Potential Combined Company Cost Savings and Revenue Synergies&#148; beginning on page 139 of
this joint proxy statement/prospectus); </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considered certain financial and stock market data of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT>
and compared that data with similar data for other companies with publicly traded equity securities in businesses Credit Suisse deemed similar to those of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> respectively;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considered, to the extent publicly available, the financial terms of certain other business combinations and
other transactions which had been effected; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considered such other information, financial studies, analyses and investigations and financial, economic and
market criteria which Credit Suisse deemed relevant. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with its review, Credit Suisse did not independently
verify any of the foregoing information and, with the consent of the Coherent board, Credit Suisse assumed and relied upon such information being complete and accurate in all respects material to its analyses and opinion. With respect to the
Coherent management case prospective financial information and the Coherent adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, Credit Suisse was advised by Coherent&#146;s management, and Credit Suisse assumed
with the consent of the Coherent board, that such forecasts had been reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of Coherent&#146;s management as to the future financial performance of
Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> respectively. With respect to the potential combined company synergies, Credit Suisse was advised by Coherent&#146;s management, and Credit Suisse assumed with the consent of the Coherent
board, that they had been reasonably prepared in good faith on bases reflecting the best currently available estimates and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-115- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
judgments of Coherent&#146;s management as to the potential synergies, including the costs necessary to achieve such synergies, anticipated to result from the merger and Credit Suisse assumed
that the potential combined company synergies will be realized in the amounts and at the times indicated thereby. In addition, Credit Suisse relied upon, without independent verification, the assessment of Coherent&#146;s management as to
(i)&nbsp;its ability to retain key employees, (ii)&nbsp;the strategic benefits anticipated to result from the merger, (iii)&nbsp;the existing technology, products and services of Coherent and the validity or marketability of, and risks associated
with, the future technology, products and services of Coherent and (iv)&nbsp;the ability of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> to integrate their respective businesses. At the direction of the Coherent board, Credit Suisse
assumed that the Coherent management case prospective financial information, the Coherent adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information and the potential combined company synergies are a reasonable basis
upon which to evaluate Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the merger and, at the direction of the Coherent board, Credit Suisse relied upon the Coherent management case prospective financial information, the Coherent
adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information and the potential combined company synergies for purposes of its analyses and opinion. Credit Suisse expressed no view or opinion with respect to the Coherent
management case prospective financial information, the Coherent adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information, the
potential combined company synergies, or the assumptions and methodologies upon which they are based. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of its analyses and
opinion, Credit Suisse assumed, with the consent of the Coherent board, that, in the course of obtaining any regulatory or third party consents, approvals or agreements in connection with the merger, no modification, delay, limitation, restriction
or condition would be imposed that would have an adverse effect on Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or the contemplated benefits of the merger. In addition, for purposes of its analyses and opinion, with the consent of the
Coherent board, Credit Suisse assumed that the merger and any related transactions will be consummated in compliance with all applicable laws and regulations and in accordance with the terms of the merger agreement without waiver, modification or
amendment of any term, condition or agreement thereof that was material to Credit Suisse&#146;s analyses or opinion. In addition, Credit Suisse was not requested to make, and has not made, an independent evaluation or appraisal of the assets or
liabilities (contingent or otherwise) of Coherent or <FONT STYLE="white-space:nowrap">II-VI,</FONT> nor was Credit Suisse furnished with any such evaluations or appraisals. With the consent of the Coherent board, Credit Suisse further assumed that
the final form of the merger agreement, when executed by the parties thereto, would conform to the execution copy reviewed by Credit Suisse in all respects material to Credit Suisse&#146;s analyses and opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse&#146;s opinion addressed only the fairness, from a financial point of view, of the merger consideration set forth in the merger
agreement to the holders of shares of Coherent common stock, other than the holders of any cancelled shares or any dissenting shares, and did not address any other aspect or implication of the merger or any aspect or implication of any other
agreement, arrangement or understanding entered into in connection therewith or otherwise, including, without limitation, the form or structure of the merger and the fairness of the amount or nature of, or any other aspect relating to, any
compensation or consideration to be received or otherwise payable to any officers, directors, employees, security holders or affiliates of any party to the merger, or class of such persons, relative to the merger consideration or otherwise.
Furthermore, Credit Suisse did not express any advice or opinion regarding matters that require legal, regulatory, accounting, insurance, intellectual property, tax, environmental, executive compensation or other similar professional advice. Credit
Suisse assumed that Coherent had or would obtain such advice or opinions from the appropriate professional sources. The issuance of Credit Suisse&#146;s opinion was approved by Credit Suisse&#146;s authorized internal committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse&#146;s opinion was necessarily based on information made available to Credit Suisse as of the date of its opinion and upon
financial, economic, market and other conditions as they existed and could be evaluated on the date of its opinion. Credit Suisse did not undertake, and is under no obligation, to update, revise, reaffirm or withdraw its opinion, or otherwise
comment on or consider events occurring or coming to Credit Suisse&#146;s attention after the date of its opinion. Credit Suisse&#146;s opinion did not address the relative merits of the merger as compared to alternative transactions or strategies
that might have been available to Coherent, nor did it address </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-116- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the underlying business decision of the Coherent board or Coherent to proceed with or effect the merger. Credit Suisse did not express any opinion as to what the value of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock actually would be when issued pursuant to the merger or the price or range of prices at which Coherent common stock or <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock may be purchased,
sold or otherwise transferred at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse&#146;s opinion and analyses were for the information of the Coherent board (in
its capacity as such) in connection with its consideration of the merger and were among many factors considered by the Coherent board in evaluating the merger. Credit Suisse&#146;s opinion did not constitute advice or a recommendation to the
Coherent board with respect to the merger or advice or any recommendation to any security holder as to how such holder should vote or act on any matter relating to the merger. Neither Credit Suisse&#146;s opinion nor its analyses were determinative
of the merger consideration or of the views of the Coherent board with respect to the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In preparing its opinion to the Coherent
board, Credit Suisse performed a variety of analyses, including those described below. The summary of Credit Suisse&#146;s financial analyses is not a complete description of the analyses underlying Credit Suisse&#146;s opinion. The preparation of
such an opinion is a complex process involving various quantitative and qualitative judgments and determinations with respect to the financial, comparative and other analytic methods employed and the adaptation and application of those methods to
the unique facts and circumstances presented. As a consequence, neither Credit Suisse&#146;s opinion nor the analyses underlying its opinion are readily susceptible to partial analysis or summary description. Credit Suisse arrived at its opinion
based on the results of all analyses undertaken by it and assessed as a whole and did not draw, in isolation, conclusions from or with regard to any individual analysis, analytic method or factor. Accordingly, Credit Suisse believes that its
analyses must be considered as a whole and that selecting portions of its analyses, analytic methods and factors, without considering all analyses and factors or the narrative description of the analyses, could create a misleading or incomplete view
of the processes underlying its analyses and opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In performing its analyses, Credit Suisse considered business, economic, industry
and market conditions, financial and otherwise, and other matters as they existed on, and could be evaluated as of, the date of its opinion. No company, business or transaction used in Credit Suisse&#146;s analyses for comparative purposes is
identical to Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or the merger. While the results of each analysis were taken into account in reaching its overall conclusion with respect to fairness, Credit Suisse did not make separate or
quantifiable judgments regarding individual analyses. The implied valuation reference ranges indicated by Credit Suisse&#146;s analyses are illustrative and not necessarily indicative of actual values nor predictive of future results or values,
which may be significantly more or less favorable than those suggested by the analyses. In addition, any analyses relating to the value of assets, businesses or securities do not purport to be appraisals or to reflect the prices at which businesses
or securities actually may be sold, which may depend on a variety of factors, many of which are beyond the control of Coherent and Credit Suisse. Much of the information used in, and accordingly the results of, Credit Suisse&#146;s analyses are
inherently subject to substantial uncertainty. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material financial analyses performed in connection with the preparation of Credit Suisse&#146;s opinion
rendered to the Coherent board on March&nbsp;24, 2021. The analyses summarized below include information presented in tabular format. The tables alone do not constitute a complete description of the analyses. Considering the data in the tables below
without considering the full narrative description of the analyses, as well as the methodologies underlying, and the assumptions, qualifications and limitations affecting, each analysis, could create a misleading or incomplete view of Credit
Suisse&#146;s analyses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of its analyses, Credit Suisse reviewed a number of financial metrics including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value&#151;generally the value, as of a specified date, of the relevant company&#146;s outstanding
equity securities (taking into account its options and other outstanding dilutive securities) plus the value as of such date of its net debt (the value of its outstanding indebtedness, preferred stock and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-117- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
capital lease obligations less the amount of cash and cash equivalents on its balance sheet) and <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests, less the value as of such date
of its equity method investments (as applicable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adjusted EBITDA&#151;generally the amount, for a specified time period, of the relevant company&#146;s earnings
before interest, taxes, depreciation and amortization, adjusted to exclude, as applicable, the impact of stock-based compensation expense and <FONT STYLE="white-space:nowrap">one-time</FONT> charges; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adjusted EPS&#151;generally the amount, for a specified time period, of the relevant company&#146;s earnings per
share, adjusted to exclude, as applicable, the <FONT STYLE="white-space:nowrap">after-tax</FONT> impact of amortization of intangibles, stock-based compensation expense and <FONT STYLE="white-space:nowrap">one-time</FONT> charges.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Financial Analyses Regarding Coherent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Companies Analysis Regarding Coherent</I>. Credit Suisse considered certain financial data for Coherent and selected companies with
publicly traded equity securities Credit Suisse deemed relevant. The selected companies were selected because they were deemed to be similar to Coherent in one or more respects (based on Credit Suisse&#146;s experience and professional judgment).
None of the selected companies identified as meeting Credit Suisse&#146;s selection criteria were excluded from the analysis. Stock prices for the selected companies used in the selected companies analysis described below were as of March&nbsp;24,
2021. The estimates of Coherent&#146;s future financial performance for calendar years 2021 and 2022 used in the selected companies analysis described below were based on the Coherent management case prospective financial information. Estimates of
the future financial performance of the selected companies listed below for calendar years 2021 and 2022 were based on publicly available research analyst estimates for the fiscal years of those companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial data reviewed consisted of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value as a multiple of estimated Adjusted EBITDA for calendar year 2021 (&#147;Enterprise Value / CY
2021E Adj. EBITDA&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value as a multiple of estimated Adjusted EBITDA for calendar year 2022 (&#147;Enterprise Value / CY
2022E Adj. EBITDA&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Per share stock price as a multiple of estimated Adjusted EPS for calendar year 2021 (&#147;Stock Price / CY
2021E Adj. EPS&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Per share stock price as a multiple of estimated Adjusted EPS for calendar year 2022 (&#147;Stock Price / CY
2022E Adj. EPS&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The companies selected by Credit Suisse and the multiples considered by Credit Suisse in its
analysis were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value /<BR>CY&nbsp;2021E<BR>Adj.&nbsp;EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value /<BR>CY&nbsp;2022E<BR>Adj.&nbsp;EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Price /<BR>CY&nbsp;2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Price&nbsp;/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lumentum Holdings Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPG Photonics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Novanta Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">nLIGHT, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JENOPTIK AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>NM means not meaningful because earnings were either negative or so low that they resulted in Stock
Price&nbsp;/ Adjusted EPS multiples of over 75x. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-118- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Taking into account the results of the selected companies analysis, Credit Suisse applied
calendar year 2021 estimated Adjusted EBITDA multiples of 12.0x to 14.0x and calendar year 2022 estimated Adjusted EBITDA multiples of 11.0x to 13.0x derived from the selected publicly traded companies to Coherent&#146;s calendar year 2021 and
calendar year 2022 estimated Adjusted EBITDA and applied calendar year 2021 estimated Adjusted EPS multiples of 19.0x to 22.0x and calendar year 2022 estimated Adjusted EPS multiples of 16.0x to 19.0x derived from the selected publicly traded
companies to Coherent&#146;s calendar year 2021 and calendar year 2022 estimated Adjusted EPS. This analysis indicated the following approximate implied per share equity value reference ranges for Coherent, as compared to the per share price of
Coherent common stock implied by the merger consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="4" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied&nbsp;Per&nbsp;Share&nbsp;Equity&nbsp;Value&nbsp;Reference&nbsp;
Range</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Price</B><br><B>Implied&nbsp;by&nbsp;Merger<BR>Consideration</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2021</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="white-space:nowrap">$93.58&nbsp;-&nbsp;$128.57</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">136.83&nbsp;-&nbsp;$196.29</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Transactions Analysis Regarding Coherent</I>. Credit Suisse also considered the financial terms of
certain business combinations and other transactions Credit Suisse deemed relevant since 2014. The selected transactions were selected because the target companies were deemed to be similar to Coherent in one or more respects (based on Credit
Suisse&#146;s experience and professional judgment). Financial data for the selected transactions were based on public filings, publicly available research analysts&#146; estimates and other publicly available information. Financial data for
Coherent was based on the Coherent management case prospective financial information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial data for the selected transactions
reviewed by Credit Suisse consisted of Enterprise Value implied by the consideration proposed or paid in the selected transactions, as a multiple of the target companies&#146; estimated next twelve&nbsp;months Adjusted EBITDA as of the date of
announcement of the transaction (&#147;NTM Adj. EBITDA&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transactions selected by Credit Suisse and the multiples considered by
Credit Suisse in its analysis were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date Announced</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquirer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise<BR>Value /<BR>NTM&nbsp;Adj.<BR>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cisco Systems, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acacia Communications, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Marvell Technology Group Ltd.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Inphi Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rudolph Technologies, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nanometrics Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Finisar Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">October 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>MKS Instruments, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Electro Scientific Industries, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">KLA-Tencor</FONT> Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Orbotech Ltd.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Lumentum Holdings Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Oclaro, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>Corning Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>3M Company (Communication Markets Division)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Veeco Instruments Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ultratech, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corning Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Alliance Fiber Optic Products, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Coherent, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rofin-Sinar Technologies Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>MKS Instruments, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Newport Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">April 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Infinera Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transmode AB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Koch Industries, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Oplink Communications, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Taking into account the results of the selected transactions analysis, Credit Suisse applied estimated NTM
Adj. EBITDA multiples of 12.0x to 15.0x derived from the selected transactions to Coherent&#146;s calendar year 2021 estimated Adjusted EBITDA and to Coherent&#146;s calendar year 2022 estimated Adjusted EBITDA. This
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-119- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
analysis indicated the following approximate implied per share equity value reference ranges for Coherent, as compared to the per share price of Coherent common stock implied by the merger
consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="4" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity Value
Reference Range</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Price</B><br><B>Implied&nbsp;by&nbsp;Merger<BR>Consideration</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2021</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="white-space:nowrap">$110.69&nbsp;-&nbsp;$137.51</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">181.45&nbsp;-&nbsp;$225.97</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis Regarding Coherent</I>. Credit Suisse also performed a discounted cash flow
analysis with respect to Coherent by calculating the estimated net present value of the projected <FONT STYLE="white-space:nowrap">after-tax,</FONT> unlevered free cash flows of Coherent, treating stock-based compensation as a cash expense, based on
the Coherent management case prospective financial information. Credit Suisse applied, based on its experience and professional judgment, a range of terminal value multiples of 10.0x to 12.0x to the Coherent Adjusted EBITDA estimate for the fiscal
year ending September&nbsp;2026 and discount rates ranging from 8.5% to 10.5% derived from a weighted average cost of capital calculation. The discounted cash flow analysis indicated the following approximate implied equity value per share reference
range for Coherent common stock, as compared to the implied value of the merger consideration: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="26%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity Value
Reference Range</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share&nbsp;Price&nbsp;Implied&nbsp;by<BR>Merger Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$163.89&nbsp;-&nbsp;$209.68</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">281.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Financial Analyses Regarding <FONT STYLE="white-space:nowrap">II-VI</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Companies Analysis Regarding <FONT STYLE="white-space:nowrap">II-VI</FONT></I>. Credit Suisse considered certain financial data for
<FONT STYLE="white-space:nowrap">II-VI</FONT> and selected companies with publicly traded equity securities Credit Suisse deemed relevant. The selected companies were selected because they were deemed to be similar to
<FONT STYLE="white-space:nowrap">II-VI</FONT> in one or more respects (based on Credit Suisse&#146;s experience and professional judgment). None of the selected companies identified as meeting Credit Suisse&#146;s selection criteria were excluded
from the analysis. Stock prices for the selected companies used in the selected companies analysis described below were as of March&nbsp;24, 2021, except for Coherent&#146;s stock price, which was as of January&nbsp;15, 2021, the last trading day
before Coherent and Lumentum jointly announced their entry into the January&nbsp;18 Lumentum Merger Agreement. The estimates of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> future financial performance for calendar years 2021 and 2022 used
in the selected companies analysis described below were based on the Coherent Adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information. Estimates of the future financial performance of the selected companies listed
below for calendar years 2021 and 2022 were based on publicly available research analyst estimates for the fiscal years of those companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial data reviewed consisted of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value as a multiple of estimated Adjusted EBITDA for calendar year 2021 (&#147;Enterprise Value / CY
2021E Adj. EBITDA&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enterprise Value as a multiple of estimated Adjusted EBITDA for calendar year 2022 (&#147;Enterprise Value / CY
2022E Adj. EBITDA&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Per share stock price as a multiple of estimated Adjusted EPS for calendar year 2021 (&#147;Stock Price / CY
2021E Adj. EPS&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Per share stock price as a multiple of estimated Adjusted EPS for calendar year 2022 (&#147;Stock Price / CY
2022E Adj. EPS&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-120- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The companies selected by Credit Suisse and the multiples considered by Credit Suisse in its
analysis were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise&nbsp;Value&nbsp;/<BR>CY&nbsp;2021E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Enterprise&nbsp;Value&nbsp;/<BR>CY&nbsp;2022E<BR>Adj. EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Price&nbsp;/<BR>CY&nbsp;2021E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Price&nbsp;/<BR>CY&nbsp;2022E<BR>Adj. EPS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Coherent, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lumentum Holdings Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MKS Instruments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPG Photonics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Novanta Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">nLIGHT, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JENOPTIK AG</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marvell Technology Group Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cree, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ciena Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.6x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MACOM Technology Solutions Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MaxLinear, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.5x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.1x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ADVA Optical Networking SE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.7x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NeoPhotonics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.2x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41.3x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Applied Optoelectronics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>NM means not meaningful because earnings were either negative or so low that they resulted in Stock Price /
Adjusted EPS multiples of over 75x. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>NA means not available. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Taking into account the results of the selected companies analysis, Credit Suisse applied calendar year 2021 estimated Adjusted EBITDA
multiples of 12.0x to 16.0x and calendar year 2022 estimated Adjusted EBITDA multiples of 10.0x to 14.0x derived from the selected publicly traded companies to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year 2021 and calendar year
2022 estimated Adjusted EBITDA and applied calendar year 2021 estimated Adjusted EPS multiples of 18.0x to 24.0x and calendar year 2022 estimated Adjusted EPS multiples of 16.0x to 20.0x derived from the selected publicly traded companies to <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> calendar year 2021 and calendar year 2022 estimated Adjusted EPS. This analysis indicated the following approximate implied per share equity value reference ranges for
<FONT STYLE="white-space:nowrap">II-VI,</FONT> as compared to the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;24, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="4" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Implied Per Share Equity Value Reference Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Closing&nbsp;per&nbsp;Share&nbsp;Price</B><br><B>of <FONT STYLE="white-space:nowrap">II-VI</FONT> on</B><br><B>March&nbsp;24, 2021</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2021</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CY2022</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="white-space:nowrap">$71.38&nbsp;-&nbsp;$104.05</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">78.77&nbsp;-&nbsp;$111.11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis Regarding <FONT STYLE="white-space:nowrap">II-VI</FONT></I>. Credit Suisse
also performed a discounted cash flow analysis with respect to <FONT STYLE="white-space:nowrap">II-VI</FONT> by calculating the estimated net present value of the projected <FONT STYLE="white-space:nowrap">after-tax,</FONT> unlevered free cash flows
of <FONT STYLE="white-space:nowrap">II-VI,</FONT> treating stock-based compensation as a cash expense, based on the Coherent Adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information. Credit Suisse applied, based on
its experience and professional judgment, a range of terminal value multiples of 9.5x to 11.5x to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Adjusted EBITDA estimate for the fiscal year ending June&nbsp;2026 and discount rates ranging from
8.0% to 10.0% derived from a weighted average cost of capital calculation. The discounted cash flow analysis indicated the following approximate implied equity value per share reference range for <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock, as compared to the closing stock price for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;24, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="30%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Implied Per Share Equity Value
Reference Range</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Closing&nbsp;per&nbsp;Share&nbsp;Price&nbsp;of&nbsp;II-VI</FONT><BR>on March&nbsp;24, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">$89.83&nbsp;-&nbsp;$114.61</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-121- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Financial Analyses&#151;the Merger </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Pro Forma Discounted Cash Flow Analysis</I>. Credit Suisse also reviewed a comparison of the standalone per share equity value reference
range indicated by its discounted cash flow analysis for the Coherent common stock described above, which we refer to in this section of the joint proxy statement/prospectus as the &#147;standalone Coherent DCF value,&#148; with the equity value
reference range, attributable to a share of Coherent common stock after giving effect to the consummation of the merger (including the present value of the synergies estimates provided by Coherent&#146;s management and the cash consideration), which
we refer to in this section of the joint proxy statement/prospectus as the &#147;pro forma Coherent DCF value.&#148; For purposes of analyzing the pro forma Coherent DCF value, Credit Suisse used the discounted cash flow analyses described above for
each of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> on a standalone basis, and accounted for (i)&nbsp;the estimated present value of the synergies estimates anticipated by the management of Coherent to result from the merger (applying
(x)&nbsp;a range of discount rates of 8.5% to 10.5% (selected based on Credit Suisse&#146;s professional judgment) and (y)&nbsp;a range of terminal value multiples of 10.0x to 12.0x (selected based on Credit Suisse&#146;s professional judgment) to
the <FONT STYLE="white-space:nowrap">estimated&nbsp;pre-tax&nbsp;synergies</FONT> for calendar year 2024 reflected in the synergies estimates), (ii) the cash consideration and (iii)&nbsp;the incremental debt expected to result from the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This pro forma discounted cash flow analysis indicated the following approximate implied per share equity value reference range for the pro
forma Coherent DCF value, as compared to the range indicated by the discounted cash flow analysis described above for the standalone Coherent DCF value. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="27%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Implied&nbsp;Per&nbsp;Share&nbsp;Equity&nbsp;Value&nbsp;Reference&nbsp;Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma&nbsp;Coherent<BR>DCF Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Standalone&nbsp;Coherent<BR>DCF Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">289.20&nbsp;-&nbsp;$316.08</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">163.89&nbsp;-&nbsp;$209.68</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Supplemental Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse also noted for the Coherent board certain additional information that was not considered material to Credit Suisse&#146;s
financial analyses with respect to its opinion but was referenced for informational purposes, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Historical Trading High and Low Stock Prices</I>.&nbsp;Credit Suisse reviewed the intraday stock prices for
each trading day during the <FONT STYLE="white-space:nowrap">52-week</FONT> period ended January&nbsp;15, 2021 for Coherent common stock and the <FONT STYLE="white-space:nowrap">52-week</FONT> period ended March&nbsp;24, 2021 for <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. Credit Suisse noted that the high and low intraday prices during such periods were $179.05 and $78.21 for Coherent common stock and $100.44 and $23.90 for
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Credit Suisse observed that the closing trading price for Coherent common stock on January&nbsp;15, 2021 was $151.95, and the closing trading price for
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;24, 2021 was $67.26; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Equity Research Price Targets</I>.&nbsp;Credit Suisse reviewed the publicly available price targets for
Coherent prior to or on January&nbsp;15, 2021, and publicly available price targets for <FONT STYLE="white-space:nowrap">II-VI</FONT> prior to or on March&nbsp;24, 2021. Credit Suisse noted that the available research analysts&#146; share price
targets reviewed with the Coherent board (i)&nbsp;for Coherent ranged from $170 to $108 per share (with a mean of $152 and a median of $160 per share) and (ii)&nbsp;for <FONT STYLE="white-space:nowrap">II-VI</FONT> ranged from $152 to $72 per share
(with a mean of $107 and a median of $105 per share). The ranges of price targets for <FONT STYLE="white-space:nowrap">II-VI</FONT> implied a range of offer values per Coherent common share of $286 to $358 per share. Credit Suisse observed that the
closing trading price for Coherent common stock on January&nbsp;15, 2021 was $151.95 and that the closing trading price for <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;24, 2021 was $67.26. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Other Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent retained Credit Suisse as its financial advisor in connection with the merger based on Credit Suisse&#146;s qualifications, experience
and reputation as an internationally recognized investment banking and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-122- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial advisory firm. Credit Suisse is entitled to receive a transaction fee of $17.0&nbsp;million, $2.0&nbsp;million of which became payable upon the rendering of Credit Suisse&#146;s opinion
on March&nbsp;9, 2021, $2.0&nbsp;million of which became payable upon the rendering of Credit Suisse&#146;s opinion on March&nbsp;24, 2021, $10.0&nbsp;million of which is payable contingent upon the closing of the merger and, at Coherent&#146;s sole
discretion, $3.0&nbsp;million of which may be paid at the closing of the merger. In addition, Coherent has agreed to reimburse Credit Suisse for certain of its expenses and to indemnify it and certain related parties for certain liabilities and
other items arising out of or related to Credit Suisse&#146;s engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Credit Suisse and its affiliates may in the future provide
investment banking and other financial advice and services to Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and their respective affiliates for which advice and services Credit Suisse and its affiliates would expect to receive
compensation. Credit Suisse is a full service securities firm engaged in securities trading and brokerage activities as well as providing investment banking and other financial advice and services. In the ordinary course of business, Credit Suisse
and its affiliates may acquire, hold or sell, for its and its affiliates&#146; own accounts and the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of Coherent, <FONT
STYLE="white-space:nowrap">II-VI</FONT> and their respective affiliates, and any other company that may be involved in the merger, as well as provide investment banking and other financial advice and services to such companies and their affiliates.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_80"></A><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Reasons for the Merger; Recommendation of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board has unanimously
(i)&nbsp;determined that the merger agreement, the investment agreement, and the transactions contemplated by the merger agreement and the investment agreement (including the merger and the issuance of shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> capital stock pursuant to the merger agreement and the investment agreement (which we refer to as the &#147;share issuance&#148;)) are in the best interests of
<FONT STYLE="white-space:nowrap">II-VI</FONT> and <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders, (ii)&nbsp;approved the execution, delivery and performance by <FONT STYLE="white-space:nowrap">II-VI</FONT> of the merger agreement, the
investment agreement, and the consummation of the transactions contemplated by the merger agreement and the investment agreement (including the merger and the share issuance), and (iii)&nbsp;resolved to recommend the approval by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders of the share issuance and submit the share issuance to <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the course of reaching its recommendation, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board considered the following material
factors relating to the share issuance proposal, each of which the <FONT STYLE="white-space:nowrap">II-VI</FONT> board believes supported its decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Strategic Considerations</I>.<B> </B>The <FONT STYLE="white-space:nowrap">II-VI</FONT> board believes that the merger and the share
issuance will provide a number of significant strategic benefits to the combined company, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the creation of a global leader in photonic solutions, compound semiconductors, and laser technology and systems
with approximately $4.1&nbsp;billion in annual revenue, leveraging disruptive technology platforms operating at scale to address a combined market of approximately $25&nbsp;billion; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s complementary lasers, optics and
electronics technologies at the subsystems and systems level will enable compelling solutions to accelerate growth in aerospace and defense, life sciences and laser-additive manufacturing, while driving margin expansion and profitability;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial opportunities to utilize complementary scale at all levels of the value chain and increased
competitiveness in all laser technology product lines, including in materials macro- and micro-processing, display processing and instrumentation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent&#146;s service network, located in the largest manufacturing hubs in the world, will act as a
distribution channel for a broad combined portfolio of components, including <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> high-margin aftermarket consumables, as well as a channel for recurring subsystems and systems service contracts;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deeper insights into laser end markets that will inform the combined company&#146;s strategic investments ahead
of demand and influence industry direction, which are expected to lead to stronger customer partnerships and higher returns on investments; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-123- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">greater diversification of revenue by end market and geography, cushioning short-term cycles and enabling
sustained strategic investments in new technology platforms to fuel long-term growth; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the combined company will achieve $250&nbsp;million in annual cost synergies (EBITDA impact) within 36 months of
closing; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the belief that the transaction will be accretive to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> earnings per share in the second year following closing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Factors
Considered by the <FONT STYLE="white-space:nowrap">II-VI</FONT> Board</I>. In addition to considering the strategic factors described above, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board considered the following additional factors relating
to the merger and the share issuance, all of which it viewed as supporting its decision to approve the merger and the share issuance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">its knowledge of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> business, operations, financial condition,
earnings and prospects on a stand-alone basis and its understanding of Coherent&#146;s business, operations, financial condition, earnings and prospects, taking into account the results of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> due
diligence review of Coherent and based upon <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> long-term supplier relationship with Coherent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the current and prospective competitive climate in the industry in which
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent operate, including the anticipated post-COVID recovery in the industrial markets around the world potential for further consolidation and competition, and the alternatives reasonably
available to <FONT STYLE="white-space:nowrap">II-VI</FONT> if it did not pursue the proposed combination and the opportunities that may be available following the proposed combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s respective businesses have
limited competitive concerns, which increases the likelihood that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will be able to obtain the required regulatory clearances to consummate the merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the oral opinion of J.P. Morgan delivered to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, which was
confirmed by delivery of a written opinion, dated March&nbsp;17, 2021, to the effect that, as of such date and based upon and subject to the assumptions made, procedures followed, matters considered and limitations on the review undertaken by J.P.
Morgan in preparing its opinion, the merger consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the merger was fair, from a financial point of view, to <FONT STYLE="white-space:nowrap">II-VI,</FONT> as more fully described
below in the section titled &#147;Opinion of J.P. Morgan&#148; beginning on page 126 of this joint proxy statement/prospectus; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms and conditions of the merger agreement, the investment agreement and the likelihood of completing the
merger and the share issuance on the anticipated schedule; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions of the merger agreement permitting <FONT STYLE="white-space:nowrap">II-VI</FONT> to terminate the
merger agreement to accept a superior proposal, subject to compliance with certain procedures and payment of a termination fee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the limitations imposed in the merger agreement on the solicitation or consideration by Coherent of alternative
acquisition proposals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, in the event of a termination of the merger agreement arising from a change in the Coherent board
recommendation or Coherent accepting a superior proposal, Coherent is required to pay <FONT STYLE="white-space:nowrap">II-VI</FONT> a termination fee of $108.8&nbsp;million, as described under &#147;The Merger Agreement&#151;Termination Fees&#148;
beginning on page 180 of this joint proxy statement/prospectus; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Coherent is required to pay <FONT STYLE="white-space:nowrap">II-VI</FONT> $25&nbsp;million as
payment for <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> costs and expenses in connection with the merger agreement if the merger agreement is terminated by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in the event the
approval of the Coherent merger proposal by Coherent stockholders has not been obtained following the conclusion of the Coherent special meeting; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the exchange ratio is fixed and will not fluctuate based upon changes in the market price of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock between the date of the merger agreement and the date of the consummation of the proposed merger, providing greater certainty to <FONT STYLE="white-space:nowrap">II-VI</FONT> regarding the
anticipated financial benefits of the transaction. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-124- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Factors Relating to the Equity Financing</I>. In addition to the fact that the equity
financing is expected to facilitate <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to finance and consummate the merger (and thereby increase the likelihood that <FONT STYLE="white-space:nowrap">II-VI</FONT> will be able to realize the
above-described benefits anticipated in connection with the merger), the <FONT STYLE="white-space:nowrap">II-VI</FONT> board considered the following additional factors relating to the equity financing, all of which it viewed as supporting its
decision to approve the equity financing: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the equity financing will enable <FONT STYLE="white-space:nowrap">II-VI</FONT> to significantly
reduce the leverage that <FONT STYLE="white-space:nowrap">II-VI</FONT> would otherwise be required to incur in order to consummate the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the conversion price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock was at a significant premium from the then current trading price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that execution of the investment agreement would substantially lessen
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> reliance on future capital market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that BCPE has already funded $750&nbsp;million of the equity financing, irrespective of whether or not
the merger is consummated, immediately increasing <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cash balance and its capacity to deploy capital with respect to the merger as well as other strategic initiatives; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the addition of Steve Pagliuca, the <FONT STYLE="white-space:nowrap">Co-Chairman</FONT> of Bain, to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board, thereby contributing to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board his experience of more than 30 years as a private equity leader and his expertise as a corporate director.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> board weighed these advantages and opportunities against a number of
other factors identified in its deliberations weighing negatively against the merger and the equity financing, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the challenges inherent in the combination of two businesses of the size and scope of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent and the cultures of each company, including the risks that integration costs may be greater than anticipated, that it may be difficult to retain key employees and that management&#146;s attention
might be diverted toward integration matters for an extended period of time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk of not achieving all of the anticipated cost savings or revenue synergies and the risk that strategic
benefits and other anticipated benefits might not be realized or may take longer than expected to achieve; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of the merger consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the
proposed transaction, which, based on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on the Nasdaq Stock Market on March 17, 2021 represented aggregate value of approximately $256.82 per share of Coherent common
stock, or a premium of 69% to the closing price of Coherent common stock January&nbsp;15, 2021, the last trading day before the announcement of the January&nbsp;18 Lumentum Merger Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential that, if the <FONT STYLE="white-space:nowrap">II-VI</FONT> stock price increases between signing
and closing, the nominal value of the merger consideration will increase given the fixed exchange ratio; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that regulatory agencies may not approve the proposed combination or may impose terms and conditions on
their approvals that adversely affect the financial results of the combined company (as described in &#147;Risk Factors&#151;Risk Factors Relating to the Merger&#148; beginning on page 42 of this joint proxy statement/prospectus);
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the restrictions in the merger agreement on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to take
certain actions outside the ordinary course of business prior to the consummation of the merger, which may delay or prevent <FONT STYLE="white-space:nowrap">II-VI</FONT> from undertaking certain actions or business opportunities that may arise prior
to the consummation of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions of the merger agreement permitting Coherent to terminate the merger agreement to accept a superior
proposal, subject to compliance with certain procedures and payment of a termination fee; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-125- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the limitations imposed in the merger agreement on the solicitation or consideration by <FONT
STYLE="white-space:nowrap">II-VI</FONT> of alternative acquisition proposals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, in the event of a termination of the merger agreement arising from a change in the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board recommendation or <FONT STYLE="white-space:nowrap">II-VI</FONT> accepting a superior proposal, <FONT STYLE="white-space:nowrap">II-VI</FONT> will be required to pay Coherent a termination fee of
$337.7&nbsp;million, as described under &#147;The Merger Agreement&#151;Termination Fees&#148; beginning on page 180 of this joint proxy statement/prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that <FONT STYLE="white-space:nowrap">II-VI</FONT> will be required to pay Coherent $25&nbsp;million as
payment for Coherent&#146;s costs and expenses in connection with the merger agreement if the merger agreement is terminated by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in the event the approval of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders has not been obtained following the conclusion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, in the event of a termination of the merger agreement arising from a failure to obtain antitrust
approval from a Chinese governmental entity, <FONT STYLE="white-space:nowrap">II-VI</FONT> will be required to pay Coherent a termination fee of $500&nbsp;million, as described under &#147;The Merger Agreement&#151;Termination Fees&#148; beginning
on page 180 of this joint proxy statement/prospectus; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the increased leverage and commitments of the combined company relating to the financing for the transaction,
which, while believed to be appropriate for a company with the expected earnings profile of the combined company, could reduce <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> credit ratings, limit its access to credit markets or make such
access more expensive, and reduce its operational and strategic flexibility; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">various other risks of the type and nature described in the section entitled &#147;Risk Factors&#148; beginning
on page 42 of this joint proxy statement/prospectus and the matters described under &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page 40 of this joint proxy statement/prospectus. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing discussion of the factors considered by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board is not intended to be
exhaustive, but rather includes the principal factors considered by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board. In view of the wide variety of factors considered in connection with its evaluation of the merger and the share issuance and
the complexity of these matters, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board did not find it useful and did not attempt to quantify or assign any relative or specific weights to the various factors that it considered in reaching its
determination to approve the merger agreement, the investment agreement, and the transactions contemplated by the merger agreement and the investment agreement (including the merger and the share issuance) and to make its recommendations to <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders. In addition, individual members of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board may have given differing weights to different factors. The <FONT STYLE="white-space:nowrap">II-VI</FONT>
board conducted an overall review of the factors described above, including discussions with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> management and outside legal and financial advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The explanation of the reasoning of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and certain information presented in this section
are forward-looking in nature and, therefore, the information should be read in light of the factors discussed in the section entitled &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; beginning on page 40 of this joint proxy
statement/prospectus. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_81"></A>Opinion of J.P. Morgan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to an engagement letter, <FONT STYLE="white-space:nowrap">II-VI</FONT> retained J.P.&nbsp;Morgan as its financial advisor in
connection with the proposed merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At a meeting of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on March&nbsp;17, 2021,
J.P.&nbsp;Morgan rendered an oral opinion, confirmed by delivery of a written opinion dated March&nbsp;17, 2021, to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to the effect that, as of such date and based upon and subject to the
assumptions made, procedures followed, matters considered and limitations on the review undertaken by J.P.&nbsp;Morgan in preparing the opinion, the merger consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the merger was
fair, from a financial point of view, to <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-126- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The full text of the written opinion of J.P.&nbsp;Morgan dated March&nbsp;17, 2021, which
sets forth the assumptions made, procedures followed, matters considered and limitations on the review undertaken by J.P.&nbsp;Morgan in preparing the opinion, is attached as Annex G to this joint proxy statement/prospectus and is incorporated
herein by reference. The summary of the opinion of J.P.&nbsp;Morgan set forth in this joint proxy statement/prospectus is qualified in its entirety by reference to the full text of such opinion. <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT>
shareholders are urged to read the opinion in its entirety. J.P.&nbsp;Morgan&#146;s written opinion was addressed to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board (in its capacity as such) in connection with and for the purposes of its
evaluation of the proposed merger, was directed only to the merger consideration payable in the merger and did not address any other aspect of the merger. J.P.&nbsp;Morgan expressed no opinion as to the fairness of the merger consideration to the
holders of any class of securities, creditors or other constituencies of <FONT STYLE="white-space:nowrap">II-VI</FONT> or as to the underlying decision by <FONT STYLE="white-space:nowrap">II-VI</FONT> to engage in the proposed merger. The issuance
of J.P. Morgan&#146;s opinion was approved by a fairness committee of J.P. Morgan. The opinion does not constitute a recommendation to any shareholder as to how such shareholder should vote with respect to the proposed merger or any other matter.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with preparing its opinion, J.P.&nbsp;Morgan, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed an execution version, provided to J.P.&nbsp;Morgan on March&nbsp;17, 2021, of the merger agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain publicly available business and financial information concerning Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> and the industries in which they operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compared the proposed financial terms of the merger with the publicly available financial terms of certain
transactions involving companies J.P.&nbsp;Morgan deemed relevant and the consideration received for such companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compared the financial and operating performance of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT>
with publicly available information concerning certain other companies J.P.&nbsp;Morgan deemed relevant and reviewed the current and historical market prices of Coherent common stock and <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and
certain publicly traded securities of such other companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain internal financial analyses and forecasts prepared by the management of <FONT
STYLE="white-space:nowrap">II-VI</FONT> relating to the businesses of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> including the potential financial benefit to <FONT STYLE="white-space:nowrap">II-VI</FONT> of preserving <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> growth plan as a result of the merger as well as the estimated amount and timing of the cost savings and related expenses and revenue enhancements expected to result from the merger (such financial
benefit, cost savings and revenue enhancements, collectively, the &#147;Synergies&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performed such other financial studies and analyses and considered such other information as J.P.&nbsp;Morgan
deemed appropriate for the purposes of its opinion. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, J.P.&nbsp;Morgan held discussions with certain members
of the managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect to certain aspects of the merger, and the past and current business operations of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> the financial
condition and future prospects and operations of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> the effects of the merger on the financial condition and future prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> and certain other
matters J.P.&nbsp;Morgan believed necessary or appropriate to its inquiry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In giving its opinion, J.P.&nbsp;Morgan relied upon and
assumed the accuracy and completeness of all information that was publicly available or was furnished to or discussed with J.P.&nbsp;Morgan by Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> or otherwise reviewed by or for
J.P.&nbsp;Morgan, and J.P.&nbsp;Morgan did not independently verify (and did not assume responsibility or liability for independently verifying) any such information or its accuracy or completeness. J.P.&nbsp;Morgan did not conduct and was not
provided with any valuation or appraisal of any assets or liabilities, nor did J.P.&nbsp;Morgan evaluate the solvency of Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> under any state or federal laws relating to bankruptcy, insolvency or
similar matters. In relying on financial analyses and forecasts provided to J.P.&nbsp;Morgan or derived therefrom, including the Synergies, J.P.&nbsp;Morgan assumed that they were reasonably prepared based on assumptions reflecting the best
currently available estimates and judgments by the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> as to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-127- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expected future results of operations and financial condition of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> to which such analyses or forecasts relate. J.P.&nbsp;Morgan expressed
no view as to such analyses or forecasts (including the Synergies) or the assumptions on which they were based. J.P.&nbsp;Morgan also assumed that the merger and the other transactions contemplated by the merger agreement will be consummated as
described in the merger agreement and that the definitive merger agreement would be executed by Coherent and would not differ in any material respects from the execution version thereof furnished to J.P.&nbsp;Morgan. J.P.&nbsp;Morgan also assumed
that the representations and warranties made by <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent in the merger agreement and the related agreements were and will be true and correct in all respects material to its analysis and that the
merger and the other transactions contemplated by the merger agreement would not have any tax consequences in any respect material to its analysis. J.P.&nbsp;Morgan is not a legal, regulatory or tax expert and relied on the assessments made by
advisors to <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect to such issues. J.P.&nbsp;Morgan further assumed that all material governmental, regulatory or other consents and approvals necessary for the consummation of the merger will be
obtained without any adverse effect on Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> or on the contemplated benefits of the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.P.&nbsp;Morgan&#146;s opinion was necessarily based on economic, market and other conditions as in effect on, and the information made
available to J.P.&nbsp;Morgan as of, the date of such opinion. J.P.&nbsp;Morgan&#146;s opinion noted that subsequent developments may affect J.P.&nbsp;Morgan&#146;s opinion and that J.P.&nbsp;Morgan does not have any obligation to update, revise, or
reaffirm such opinion. J.P.&nbsp;Morgan&#146;s opinion is limited to the fairness to <FONT STYLE="white-space:nowrap">II-VI,</FONT> from a financial point of view, of the merger consideration to be paid by
<FONT STYLE="white-space:nowrap">II-VI</FONT> in the proposed merger and J.P.&nbsp;Morgan has expressed no opinion as to the fairness of the merger consideration to the holders of any class of securities, creditors or other constituencies of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or as to the underlying decision by <FONT STYLE="white-space:nowrap">II-VI</FONT> to engage in the merger. Furthermore, J.P.&nbsp;Morgan expressed no opinion with respect to the amount or nature of any
compensation to any officers, directors or employees of any party to the merger, or any class of such persons relative to the merger consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the merger or with respect to the
fairness of any such compensation. J.P.&nbsp;Morgan expressed no opinion as to the prices at which <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock or Coherent common stock will trade at any future time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the merger agreement, including the merger consideration, were determined through
<FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, and the decision to enter into the merger agreement was solely that of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board and the Coherent board. J.P.&nbsp;Morgan&#146;s opinion and financial analyses were only one of the many factors considered by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board in its
evaluation of the proposed merger and should not be viewed as determinative of the views of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or <FONT STYLE="white-space:nowrap">II-VI</FONT> management with respect to the proposed merger or
the merger consideration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financial Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with customary investment banking practice, J.P.&nbsp;Morgan employed generally accepted valuation methodologies in rendering its
opinion to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on March&nbsp;17, 2021 and contained in the presentation to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board on such date in connection with the rendering of such opinion. The
following summary of the material financial analyses utilized by J.P. Morgan does not purport to be a complete description of the analyses or data presented by J.P.&nbsp;Morgan. Some of the summaries of the financial analyses include information
presented in tabular format. The tables are not intended to stand alone, and in order to more fully understand the financial analyses used by J.P.&nbsp;Morgan, the tables must be read together with the full text of each summary. Considering the data
set forth below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of J.P.&nbsp;Morgan&#146;s analyses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the financial analyses described below, (i)&nbsp;the term &#147;implied per share merger consideration&#148; means an implied
value of $285.34 per share, calculated based on the cash consideration of $220 per share and, for the stock consideration, the exchange ratio of 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for each outstanding share
of Coherent common stock and the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on March&nbsp;16, 2021 of $71.80 per share and (ii)&nbsp;implied equity value per share reference ranges have been rounded to the nearest
$0.25. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-128- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Public Trading Multiples Analysis</I>. Using publicly available information,
J.P.&nbsp;Morgan compared selected financial data of Coherent with similar data for selected publicly traded companies engaged in businesses that J.P.&nbsp;Morgan deemed sufficiently analogous to those engaged in by Coherent. The companies selected
by J.P.&nbsp;Morgan were as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ciena Corporation </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IDEX Corporation </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Infinera Corporation </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">IPG Photonics Corporation </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lumentum Holdings Inc. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MKS Instruments, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">NeoPhotonics Corporation </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Viavi Solutions Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the selected companies reviewed is identical to Coherent and certain of these companies may have characteristics that are materially
different from those of Coherent. However, these companies were selected because they are publicly traded companies that J.P.&nbsp;Morgan considered relevant for purposes of analysis. The analyses necessarily involve complex considerations and
judgments concerning differences in financial and operational characteristics of the companies involved and other factors that could affect the companies differently than they would affect Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Using publicly available information, J.P.&nbsp;Morgan observed for each selected company, among other information, the ratio of the
company&#146;s firm value (&#147;FV&#148;) to the company&#146;s estimated EBITDA (calculated as earnings before interest, taxes, depreciation and amortization prior to giving effect to stock-based compensation expense and on a calendarized basis to
align with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal <FONT STYLE="white-space:nowrap">year-end)</FONT> for the fiscal year ending June&nbsp;30, 2022 (the &#147;FV/2022E EBITDA&#148;). The multiples implied by such ratios were based
on the selected companies&#146; closing stock prices on March&nbsp;16, 2021 (or, in the case of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Lumentum and MKS, the last trading day prior to public announcement by such company regarding a potential
transaction with Coherent) and publicly available Wall Street research analysts&#146; EBITDA estimates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.P.&nbsp;Morgan observed that
the FV/2022E EBITDA multiples for the selected companies ranged from a low of 11.4x to a high of 21.1x (with a mean of 15.5x and a median of 13.7x). J.P.&nbsp;Morgan then applied a FV/2022E EBITDA multiple range of 11.5x to 21.0x to Coherent&#146;s
estimated EBITDA (calendarized to align with <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> June 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> fiscal <FONT STYLE="white-space:nowrap">year-end)</FONT> as provided by <FONT
STYLE="white-space:nowrap">II-VI</FONT> management. This yielded an implied equity value per share reference range for Coherent of $161.50 to $291.75, as compared to the implied per share merger consideration of $285.34. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-129- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Selected Transactions Analysis</I>. Using publicly available information,
J.P.&nbsp;Morgan examined selected transactions involving businesses that J.P.&nbsp;Morgan deemed sufficiently analogous to the business of Coherent. Specifically, J.P.&nbsp;Morgan reviewed the following selected transactions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Announcement Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Acquiror</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Target</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">March 2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Lumentum Holdings Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Coherent, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">January 2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Cisco Systems, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Acacia Communications, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">September 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">ams AG</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">OSRAM Licht AG</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">November 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Finisar Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">October 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">MKS Instruments, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Electro Scientific Industries, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">March 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Lumentum Holdings Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Oclaro, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">March 2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Coherent, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">ROFIN-SINAR Technologies, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">February 2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">MKS Instruments, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Newport Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">October 2012</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">ASML Holding NV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Cymer, Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the selected transactions reviewed was identical to the merger. However, the selected transactions
were chosen because they are transactions involving target companies that J.P.&nbsp;Morgan considered relevant for purposes of analysis. The analyses necessarily involve complex considerations and judgments concerning differences in financial and
operational characteristics of the companies involved and other factors that could affect the selected transactions differently than they would affect the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Using publicly available information, J.P.&nbsp;Morgan observed for each of the selected transactions, among other information, the multiple
of the target company&#146;s FV implied by the consideration paid or payable in such transaction to the target company&#146;s estimated EBITDA (based on publicly available Wall Street research analysts&#146; estimates as of the date of the relevant
transaction announcement) for the next 12 months (&#147;NTM&#148;) following announcement of the applicable transaction (the &#147;FV/NTM EBITDA&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.P.&nbsp;Morgan observed that the FV/NTM EBITDA multiples for the selected transactions ranged from a low of 8.9x to a high of 28.4x (with a
mean of 16.0x and a median of 12.0x). J.P.&nbsp;Morgan then applied a FV/NTM EBITDA multiple range of 9.0x to 28.5x to Coherent&#146;s estimated EBITDA for the calendar year ending December&nbsp;31, 2021 based on estimates provided by <FONT
STYLE="white-space:nowrap">II-VI</FONT> management. This yielded an implied equity value per share reference range for Coherent of $99.00 to $304.75, as compared to the implied per share merger consideration of $285.34. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis</I>. J.P.&nbsp;Morgan conducted a discounted cash flow analysis of Coherent by calculating the estimated
present value of the unlevered free cash flows expected to be generated by Coherent during the second half of the fiscal year ending June&nbsp;30, 2021 through the full fiscal year ending June&nbsp;30, 2031 based on financial projections provided by
<FONT STYLE="white-space:nowrap">II-VI</FONT> management. J.P.&nbsp;Morgan calculated a range of terminal values for Coherent at the end of this period by applying a perpetuity growth rate ranging from 3.0% to 4.0% to the unlevered free cash flows
of Coherent during the terminal period of the projections. The unlevered free cash flows and the range of terminal values were discounted to present values as of December&nbsp;31, 2020 using a discount rate ranging from 9.5% to 10.5%. For purposes
of this analysis, stock-based compensation was treated as a cash expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This analysis yielded implied equity value per share reference
ranges for Coherent of (i) $140.25 to $181.50 on a stand-alone basis (before giving effect to potential Synergies), (ii) $169.50 to $220.00 taking into account estimates of <FONT STYLE="white-space:nowrap">II-VI</FONT> management as to the potential
financial benefit to <FONT STYLE="white-space:nowrap">II-VI</FONT> of preserving <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> growth plan assuming Coherent was not acquired by Lumentum, (iii) $257.75 to $337.00 additionally taking into
account potential cost synergies anticipated by <FONT STYLE="white-space:nowrap">II-VI</FONT> management to result from the merger, and (iv) $325.25 to $436.50 additionally taking into account potential revenue synergies anticipated by <FONT
STYLE="white-space:nowrap">II-VI</FONT> management to result from the merger, in each case as compared to the implied per share merger consideration of $285.34. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-130- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Intrinsic Theoretical Value Creation Analysis</I><I>. </I>J.P.&nbsp;Morgan conducted an
analysis of the implied theoretical per share value creation of the merger to existing holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock based on the pro forma equity ownership of such holders in the combined company upon
consummation of the merger relative to the implied equity value per share of <FONT STYLE="white-space:nowrap">II-VI</FONT> on a stand-alone basis, in each case based on projections and other data provided by
<FONT STYLE="white-space:nowrap">II-VI</FONT> management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.P.&nbsp;Morgan calculated the implied pro forma equity value per share to
holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock by taking into account (i)&nbsp;(a) the implied midpoint equity value of <FONT STYLE="white-space:nowrap">II-VI</FONT> on a stand-alone basis derived from a discounted cash flow
analysis of <FONT STYLE="white-space:nowrap">II-VI</FONT> based on financial projections for <FONT STYLE="white-space:nowrap">II-VI</FONT> provided by <FONT STYLE="white-space:nowrap">II-VI</FONT> management utilizing the methodology, including the
same selected perpetuity growth rate and discount rate ranges, described above for Coherent under &#147;<I>Discounted Cash Flow Analysis,</I>&#148; (b)&nbsp;the implied midpoint equity value of Coherent on a stand-alone basis derived from the
discounted cash flow analysis of Coherent described above under &#147;<I>Discounted Cash Flow Analysis</I>&#148; and (c)&nbsp;the aggregate estimated present value of the potential Synergies based on estimates provided by <FONT
STYLE="white-space:nowrap">II-VI</FONT> management, offset by (ii)&nbsp;the aggregate amount of the cash portion of the merger consideration, estimated transaction-related expenses as provided by <FONT STYLE="white-space:nowrap">II-VI</FONT>
management and the termination fee payable to Lumentum as provided in the merger agreement between Coherent and Lumentum. Based on the implied pro forma equity ownership of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the
combined company upon consummation of the merger, this indicated that the merger could create a hypothetical incremental implied equity value per share for holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock of approximately 3.4%
relative to the implied equity value per share of <FONT STYLE="white-space:nowrap">II-VI</FONT> on a stand-alone basis. There can be no assurance that the projected financial information and impacts from the merger will not be substantially greater
or less than those estimated by <FONT STYLE="white-space:nowrap">II-VI</FONT> management or as described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Additional Information
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">J.P.&nbsp;Morgan observed the following additional information that was not considered part of J.P.&nbsp;Morgan&#146;s financial
analyses with respect to its opinion but was noted for informational purposes (per share amounts are rounded to the nearest $0.25): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">historical prices of Coherent common stock during the <FONT STYLE="white-space:nowrap">52-week</FONT> period
prior to January&nbsp;15, 2021, which indicated low to high intraday prices during such period ranging from $78.25 per share to $179.00 per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain publicly available equity research analysts&#146; stock price targets for Coherent common stock, which
indicated stock price targets ranging from $125.00 per share to $170.00 per share. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Miscellaneous </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing summary does not purport to be a complete description of the analyses or data presented by J.P.&nbsp;Morgan. The preparation of a
fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. J.P.&nbsp;Morgan believes that the foregoing summary and its analyses must be considered as a whole and that selecting portions of
the foregoing summary and these analyses, without considering all of its analyses as a whole, could create an incomplete view of the processes underlying the analyses and its opinion. As a result, implied reference ranges from any particular
analysis, combination of analyses or as otherwise described above were merely utilized to create points of reference for analytical purposes and should not be taken to be the view of J.P.&nbsp;Morgan with respect to the actual value of Coherent or <FONT
STYLE="white-space:nowrap">II-VI.</FONT> The order of analyses described does not represent the relative importance or weight given to those analyses by J.P.&nbsp;Morgan. In arriving at its opinion, J.P.&nbsp;Morgan did not attribute any particular
weight to any analyses or factors considered by it and did not form an opinion as to whether any individual analysis or factor (positive or negative), considered in isolation, supported or failed to support its opinion. Rather, J.P.&nbsp;Morgan
considered the totality of the factors and analyses performed in determining its opinion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-131- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Analyses based upon forecasts of future results are inherently uncertain, as they are
subject to numerous factors or events beyond the control of the parties and their advisors. Accordingly, forecasts and analyses utilized by J.P.&nbsp;Morgan are not necessarily indicative of actual future results, which may be significantly more or
less favorable than suggested by those analyses. Moreover, J.P.&nbsp;Morgan&#146;s analyses are not and do not purport to be appraisals or otherwise reflective of the prices at which businesses actually could be acquired or sold. None of the
selected companies reviewed as described in the above summary is identical to Coherent or <FONT STYLE="white-space:nowrap">II-VI,</FONT> and none of the selected transactions reviewed was identical to the merger and certain of the selected companies
may have characteristics that are materially different from those of Coherent or <FONT STYLE="white-space:nowrap">II-VI.</FONT> However, the companies selected were chosen because they are publicly traded companies with operations and businesses
that, for purposes of J.P.&nbsp;Morgan&#146;s analysis, may be considered similar to those of Coherent and/or <FONT STYLE="white-space:nowrap">II-VI.</FONT> The transactions selected were similarly chosen because their participants, size and other
factors, for purposes of J.P.&nbsp;Morgan&#146;s analysis, may be considered similar to the merger. The analyses necessarily involve complex considerations and judgments concerning differences in financial and operational characteristics of the
companies involved and other factors that could affect the companies compared to Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> and the transactions compared to the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a part of its investment banking business, J.P.&nbsp;Morgan and its affiliates are continually engaged in the valuation of businesses and
their securities in connection with mergers and acquisitions, investments for passive and control purposes, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements, and valuations for corporate and
other purposes. J.P.&nbsp;Morgan was selected as a financial advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect to the merger on the basis of, among other things, such experience and its qualifications and reputation in connection
with such matters and its familiarity with <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and the industries in which they operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For services rendered in connection with the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to pay J.P.&nbsp;Morgan an
aggregate fee of $12&nbsp;million, of which a portion was payable in connection with delivery of J.P.&nbsp;Morgan&#146;s opinion and $8.5&nbsp;million of which is contingent and payable upon the closing of the merger. In addition, <FONT
STYLE="white-space:nowrap">II-VI</FONT> has agreed to reimburse J.P.&nbsp;Morgan for expenses incurred in connection with its services, including fees and disbursements of counsel, and will indemnify J.P.&nbsp;Morgan against certain liabilities
arising out of J.P.&nbsp;Morgan&#146;s engagement. During the two years preceding the date of J.P.&nbsp;Morgan&#146;s opinion, neither J.P.&nbsp;Morgan nor its affiliates had any material financial advisory or other material commercial or investment
banking relationships with Coherent. During the two years preceding the date of J.P.&nbsp;Morgan&#146;s opinion, J.P.&nbsp;Morgan and its affiliates had commercial or investment banking relationships with
<FONT STYLE="white-space:nowrap">II-VI</FONT> for which J.P.&nbsp;Morgan and such affiliates received customary compensation. Such services during such period have included acting as joint lead bookrunner on an offering of equity securities and
convertible equity securities in July 2020. Further, on March&nbsp;25, 2021, an affiliate of J.P.&nbsp;Morgan separately entered into an agreement with <FONT STYLE="white-space:nowrap">II-VI</FONT> pursuant to which such affiliate is expected to
arrange for and provide debt financing to <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with the merger. In addition, on March&nbsp;27, 2021, J.P.&nbsp;Morgan entered into an agreement to act as placement agent for a private placement
of equity securities of II-VI, including to an affiliate of Bain in connection with the equity financing. J.P.&nbsp;Morgan estimates that it and its affiliate will receive aggregate fees of approximately $77&nbsp;million pursuant to these financing
arrangements. During the two years preceding the date of J.P.&nbsp;Morgan&#146;s opinion, J.P.&nbsp;Morgan and its affiliates have had, and continue to have, commercial or investment banking relationships with Bain, certain affiliates of Bain and
certain portfolio companies of affiliates of Bain, for which J.P. Morgan and its affiliates have received, or will receive, customary compensation. In addition, J.P. Morgan&#146;s commercial banking affiliate is an agent bank and a lender under
outstanding credit facilities of certain portfolio companies of affiliates of Bain, for which it receives customary compensation or other financial benefits. In addition, J.P.&nbsp;Morgan and its affiliates hold, on a proprietary basis, less than 1%
of the outstanding common stock of each of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Bain. During the <FONT STYLE="white-space:nowrap">two-year</FONT> period preceding delivery of its opinion ending on February&nbsp;28, 2021, the
aggregate fees recognized by J.P.&nbsp;Morgan from <FONT STYLE="white-space:nowrap">II-VI</FONT> were approximately $8&nbsp;million and the aggregate fees recognized by J.P.&nbsp;Morgan from Bain, certain of Bain&#146;s affiliates and certain
portfolio companies of affiliates of Bain were approximately $112&nbsp;million. In the ordinary course of their businesses, J.P.&nbsp;Morgan and its affiliates may actively trade the debt and equity securities or financial instruments (including
derivatives, bank loans or other obligations) of <FONT STYLE="white-space:nowrap">II-VI,</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-132- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Coherent, Bain, certain of Bain&#146;s affiliates and certain portfolio companies of affiliates of Bain for their own accounts or for the accounts of customers and, accordingly, they may at any
time hold long or short positions in such securities or other financial instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_82"></A>Certain Unaudited Prospective Financial
Information </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent do not, as a matter of course, publicly disclose forecasts
or internal projections as to their respective future performance, earnings or other results given, among other reasons, the inherent uncertainty and subjectivity of the underlying assumptions and estimates, other than, from time to time, estimated
ranges of certain expected financial results and operational metrics for the current year and certain future years in their respective regular earnings press releases and other investor materials. However,
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent are including certain unaudited prospective financial information in this section of this joint proxy statement/prospectus because it was among the financial information shared between <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent in connection with the discussions regarding, or provided to the Coherent board and the <FONT STYLE="white-space:nowrap">II-VI</FONT> board for purposes of considering and evaluating, the merger
and the merger agreement. Certain of such prospective financial information also was provided to Coherent&#146;s financial advisors, BofA Securities and Credit Suisse, and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisor,
J.P.&nbsp;Morgan, as more fully described below for their use and reliance in connection with their respective opinions and related financial analyses as described under &#147;The Merger&#151;Opinions of Coherent&#146;s Financial Advisors&#148; and
&#147;The Merger&#151;Opinion of J.P.&nbsp;Morgan&#148; beginning on pages 103 and 126, respectively, of this joint proxy statement/prospectus. Set forth below is a summary of the material unaudited prospective financial information provided by the
respective managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with the merger. We refer in this joint proxy statement/prospectus to such unaudited prospective financial information, collectively, as the
&#147;prospective financial information.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospective financial information was not prepared for the purpose of, or with a
view toward, public disclosure or with a view toward complying with the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information, published guidelines of
the SEC regarding forward-looking statements or generally accepted accounting principles. The prospective financial information is not being included in this joint proxy statement/prospectus in order to influence any
<FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder or Coherent stockholder as to whether or how such shareholder or stockholder, as applicable, should vote or act with respect to the approval of any the proposals presented at the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting or any other matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the prospective
financial information was prepared on a reasonable basis, reflects the best currently available estimates and judgments of the respective managements of II-VI and Coherent, as applicable, and presents, to the best of the knowledge and belief of the
respective managements of II-VI and Coherent, as applicable, the expected course of action and the expected future financial performance of II-VI and Coherent, and is presented with numeric specificity, it reflects numerous estimates and assumptions
made by the respective managements of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, as applicable, taking into account information available at the time such prospective financial information was prepared. The estimates and assumptions
underlying the prospective financial information involve judgments with respect to, among other things, economic, competitive, financial, market and industry conditions and future business decisions and contingencies that may not be realized and
that are inherently subject to significant business, economic, competitive, financial, market and industry uncertainties and risks, including, among other things, the inherent uncertainty of the business and economic conditions affecting the
industry in which <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent operate and the risks and uncertainties described under &#147;Risk Factors&#148; and &#147;Cautionary Statement Regarding Forward-Looking Statements&#148; in this joint
proxy statement/prospectus and in the reports that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent file with the SEC from time to time, all of which are difficult to predict and many of which are outside the control of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent and will be beyond the control of the combined company. There can be no assurance that the underlying assumptions, expected contingencies or estimated results will be realized, and actual results
could differ materially from those reflected in the prospective financial information, whether or not the merger is completed. Further, these assumptions do not include all potential actions that the managements of
<FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent could or might have taken during these time periods. The inclusion in this joint proxy statement/prospectus of the unaudited prospective financial information below
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-133- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
should not be regarded as an indication that <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent considered, or now consider, this prospective financial information to be material
information to any <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or Coherent stockholders, as the case may be, particularly in light of the inherent risks and uncertainties associated with such prospective financial information. The
prospective financial information is not fact and should not be relied upon as being necessarily indicative of actual future results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
prospective financial information also reflects numerous variables, expectations and assumptions based on information available to the respective managements of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, as applicable, at the time
it was prepared, that are subject to change and do not take into account changes in such variables, expectations, assumptions or information or in any underlying circumstances or events occurring after the date they were prepared. No assurances can
be given that if the prospective financial information and the underlying assumptions had been prepared as of the date of this joint proxy statement/prospectus, similar variables, expectations or assumptions would be used and similar prospective
financial information would be prepared. In addition, the prospective financial information may not reflect the manner in which the combined company would operate after the merger. <B>Neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor
Coherent has updated the prospective financial</B> <B>information included in this joint proxy statement/prospectus, and neither <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent nor, after completion of the merger, the combined company,
undertakes any obligation to update or otherwise revise the prospective financial information to reflect circumstances existing since their preparation or to reflect the occurrence of subsequent or unanticipated circumstances or events, even in the
event that any or all of the underlying variables, expectations, assumptions or information are shown to be inappropriate, or to reflect changes in economic, competitive, financial, market or industry conditions.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of the foregoing, and considering that the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting and the Coherent special
meeting will be held several months after the prospective financial information was prepared, as well as the uncertainties inherent in any forecasted information, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders and Coherent stockholders
are cautioned not to place unwarranted reliance on such information, and are urged to review <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s most recent SEC filings for a description of their reported financial results and
the financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent incorporated by reference in this joint proxy statement/prospectus. See &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint
proxy statement/prospectus for further information. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospective financial information was prepared by the managements of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent, as applicable. Neither Ernst&nbsp;&amp; Young LLP <FONT STYLE="white-space:nowrap">(II-VI&#146;s</FONT> independent registered public accounting firm) nor Deloitte&nbsp;&amp; Touche LLP
(Coherent&#146;s independent registered public accounting firm) has audited, reviewed, examined, compiled or applied agreed upon procedures with respect to the prospective financial information and, accordingly, neither Ernst&nbsp;&amp;
Young&nbsp;LLP nor Deloitte&nbsp;&amp; Touche LLP has expressed any opinion or any other form of assurance on such information or its achievability, and assume no responsibility for, and disclaim any association with, the prospective financial
information. The reports of the independent registered public accounting firms incorporated by reference in this joint proxy statement/prospectus relate to the historical financial information of <FONT STYLE="white-space:nowrap">II-VI</FONT> and
Coherent, respectively. Such reports do not extend to the prospective financial information and should not be read to do so. No independent registered public accounting firm has examined, compiled or otherwise performed any procedures with respect
to the prospective financial information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The various prospective financial information described below was each prepared separately
using, in some cases, different assumptions, and the different estimates are not intended to be added together. Adding the prospective financial information together for <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent is not intended to
represent the results that the combined company will achieve if the merger is completed and is not intended to represent forecasted financial information for the combined company if the merger is completed. By including in this joint proxy
statement/prospectus a summary of the prospective financial information, neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent nor any of their respective representatives has made or makes any representation to any person regarding the
ultimate performance of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or the combined company compared to the information contained in the prospective financial information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-134- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The various prospective financial information described below contain certain <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> financial measures that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, as applicable, believe are helpful in understanding past financial performance and future results. The managements of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent regularly use a variety of financial measures that are not in accordance with GAAP for forecasting, budgeting and measuring financial performance. The
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures. While <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent believe that these <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> financial measures may provide meaningful information to help investors understand the operating results and to analyze their respective financial and business trends on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">period-to-period</FONT></FONT> basis, there are limitations associated with the use of these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures. These <FONT STYLE="white-space:nowrap">non-GAAP</FONT>
financial measures are not prepared in accordance with GAAP, are not reported by all of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent&#146;s competitors and may not be directly comparable to similarly titled measures of Coherent&#146;s
competitors given potential differences in the exact method of calculation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Coherent Prospective Financial Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following three tables set forth selected unaudited prospective financial information representing Coherent management&#146;s evaluation of
Coherent&#146;s estimated future financial performance on a stand-alone basis, without reference to the merger, consisting of (A)&nbsp;floor case prospective financial information, which we refer to in this joint proxy statement/prospectus as the
&#147;Coherent floor case prospective financial information,&#148; (B) target case prospective financial information, which we refer to in this joint proxy statement/prospectus as the &#147;Coherent target case prospective financial
information&#148; and (C)&nbsp;management case prospective financial information, which we refer to in this joint proxy statement/prospectus as the &#147;Coherent management case prospective financial information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Coherent floor case prospective financial information reflected a conservative view of the Coherent prospective financial information
based on near term and strategic projects that were in process and therefore not yet included in Coherent&#146;s publicly available financial results, and the Coherent target case prospective financial information reflected a more optimistic view of
the Coherent prospective financial information based on accelerated revenue growth and a higher level of capital expenditures in fiscal years 2022 and 2023 and also included prospective financial information for fiscal year 2024. The Coherent
management case prospective financial information reflected certain adjustments that Coherent management made to the Coherent target case prospective financial information to (i)&nbsp;exclude third-party M&amp;A activity and (ii)&nbsp;reflect
certain revised assumptions, including that Coherent would reduce its interest expense by paying off its term loan debt and reduce its research and development expenses. On January&nbsp;14, 2021, the Coherent board reached a consensus that the
Coherent management case prospective financial information set forth a more realistic set of information than either the Coherent floor case prospective financial information or the Coherent target case prospective financial information based on the
passage of time and further insight into Coherent&#146;s performance, and determined that the Coherent management case prospective financial information represented the appropriate framework for the preparation of BofA Securities&#146; and,
subsequently, Credit Suisse&#146;s financial analyses and rendering their respective opinions, and subsequently authorized Coherent management to deliver the Coherent management case prospective financial information to <FONT
STYLE="white-space:nowrap">II-VI</FONT> and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisors. In addition, extrapolations to the Coherent management case prospective financial information were prepared at the direction of, and
approved by, Coherent management for Coherent&#146;s fiscal years 2025 through 2026. Such extrapolations were not provided to <FONT STYLE="white-space:nowrap">II-VI</FONT> or <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisors.
At the direction of Coherent, BofA Securities and Credit Suisse used the Coherent management case prospective financial information and such extrapolations in connection with their respective financial analyses and opinions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-135- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>A. Coherent floor case prospective financial
information</U><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>&nbsp;&nbsp;Fiscal&nbsp;year&nbsp;ended&nbsp;September&nbsp;30,&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP><I>(in&nbsp;millions, except per share amounts)</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share<SUP
STYLE="font-size:85%; vertical-align:top">(3)(4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Coherent floor case prospective financial information was not prepared or extrapolated for Coherent&#146;s
fiscal years 2024 through 2026. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share excludes the after tax impact of
amortization of intangibles, stock-based compensation and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A version of the Coherent floor case prospective financial information shared with <FONT
STYLE="white-space:nowrap">II-VI</FONT> and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s respective financial advisors included certain immaterial variations in <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings
per share for fiscal years 2021 through 2023 based on a lower assumed tax rate. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>B. Coherent target case prospective financial
information</U><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>(in&nbsp;millions, except per share amounts)</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share<SUP
STYLE="font-size:85%; vertical-align:top">(3)(4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Coherent target case prospective financial information was not prepared or extrapolated for Coherent&#146;s
fiscal years 2025 through 2026. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share excludes the
<FONT STYLE="white-space:nowrap">after-tax</FONT> impact of amortization of intangibles, stock-based compensation and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A version of the Coherent target case prospective financial information shared with Coherent&#146;s financial
advisors included certain immaterial variations in <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share for fiscal year 2021 based on a lower assumed tax rate. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>C. Coherent management case prospective financial information </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>(in&nbsp;millions, except per share amounts)</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;1,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;2,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;2,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 13.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered free cash
flow<SUP STYLE="font-size:85%; vertical-align:top">(3)(4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share excludes the
<FONT STYLE="white-space:nowrap">after-tax</FONT> impact of amortization of intangibles, stock-based compensation and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered free cash flow, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to
Adjusted EBITDA, less stock-based compensation, which is treated as a cash expense, less cash taxes and capital expenditures and adjusted for changes in net working capital. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The version of the Coherent management case prospective financial information shared with <FONT
STYLE="white-space:nowrap">II-VI</FONT> and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisors did not include projections for the fiscal years ended 2025 and 2026 or any calculations of unlevered free cash flow.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-136- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Coherent-Adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> Prospective Financial
Information </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> provided Coherent with certain unaudited prospective financial
information relating to <FONT STYLE="white-space:nowrap">II-VI</FONT> more fully described and referred to below as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> prospective financial information.&#148; Coherent management adjusted the <FONT
STYLE="white-space:nowrap">II-VI</FONT> prospective financial information to moderate the 2023 fiscal year revenue growth rate and other assumptions to reflect the competitive environment. This adjusted unaudited prospective financial information
was provided by Coherent to BofA Securities and Credit Suisse. In addition, extrapolations to such adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information were prepared at the direction of, and approved by,
Coherent&#146;s management for <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year 2026. At the direction of Coherent, BofA Securities and Credit Suisse used such adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective
financial information and extrapolations as presented in the following table, which we refer to in this joint proxy statement/prospectus as the &#147;Coherent-adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial
information,&#148; in connection with their respective financial analyses and opinions. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;June 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>(in&nbsp;millions, except per share amounts)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;3,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;3,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;3,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;4,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;4,496</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;4,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">916</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered free cash
flow<SUP STYLE="font-size:85%; vertical-align:top">(3)(4)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> earnings per share excludes the
<FONT STYLE="white-space:nowrap">after-tax</FONT> impact of amortization of intangibles, stock-based compensation and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered free cash flow, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to
Adjusted EBITDA, less stock-based compensation, which is treated as a cash expense, less cash taxes and capital expenditures, and adjusted for changes in net working capital. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information shared with
Coherent and Coherent&#146;s financial advisors did not include projections for the fiscal year ended 2026 or any calculations of unlevered free cash flow. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Prospective Financial Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth selected unaudited prospective financial information representing <FONT STYLE="white-space:nowrap">II-VI</FONT>
management&#146;s evaluation of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> estimated stand-alone future financial performance based on an internal financial model that <FONT STYLE="white-space:nowrap">II-VI</FONT> historically used in
connection with its strategic planning and budgeting process. Among other things, this model assumes continued collaboration, consistent with recent experience, of <FONT STYLE="white-space:nowrap">II-VI</FONT> with its key suppliers, including
Coherent, with respect to the development, manufacturing and marketing of a range of materials, components and other products. This unaudited prospective financial information was provided to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent and to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s respective financial advisors and is presented in the following table
and referred to in this joint proxy statement/prospectus as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> prospective financial information.&#148;<B> </B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="42" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;June 30,<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>(in&nbsp;millions)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2027E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2028E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2029E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2030E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2031E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">916</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net operating profit (after
tax)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered free cash flow<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for other expenses and income and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-137- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Net Operating Profit (After Tax), a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers
to Adjusted EBITDA less stock-based compensation, depreciation and cash taxes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered free cash flow, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to
Adjusted EBITDA, burdened by stock-based compensation, adjusted for cash taxes, capital expenditures, changes in net working capital and earnings from equity investments. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information shared with
Coherent and Coherent&#146;s financial advisors separately presented certain amounts that were not otherwise separately presented in the version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information shared with the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisors. In addition, the version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information shared with
Coherent and Coherent&#146;s financial advisors did not include projections for the fiscal years ended 2026 to 2031 or any calculations of net operating profit (after tax) and unlevered free cash flow. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">II-VI</FONT> Adjusted Prospective Financial Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the initial announcement of Coherent&#146;s proposed Lumentum merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> management began
considering the potential impact of the Lumentum merger on the business and financial prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> as a stand-alone company. In the course of this review, <FONT STYLE="white-space:nowrap">II-VI</FONT>
management considered that, given that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Lumentum compete with respect to certain products, <FONT STYLE="white-space:nowrap">II-VI</FONT> would likely no longer be able to rely on Coherent as a key
supplier to its businesses if the Lumentum merger were consummated, which would impact certain growth assumptions. Accordingly, <FONT STYLE="white-space:nowrap">II-VI</FONT> management provided the <FONT STYLE="white-space:nowrap">II-VI</FONT> board
and <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial advisors with certain unaudited prospective financial information adjusting the <FONT STYLE="white-space:nowrap">II-VI</FONT> prospective financial information to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">reflect the potential impact on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> estimated stand-alone future financial performance if the Lumentum merger
were consummated and Coherent was no longer a key supplier to the businesses of <FONT STYLE="white-space:nowrap">II-VI.</FONT> This unaudited prospective financial information is presented in the following table and referred to in this joint proxy
statement/prospectus as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> adjusted prospective financial information.&#148; <FONT STYLE="white-space:nowrap">II-VI</FONT> directed J.P. Morgan, in connection with its opinion and related
financial analyses, to use and rely upon the <FONT STYLE="white-space:nowrap">II-VI</FONT> adjusted prospective financial information for purposes of evaluating <FONT STYLE="white-space:nowrap">II-VI</FONT> on a stand-alone basis and the <FONT
STYLE="white-space:nowrap">II-VI</FONT> prospective financial information for purposes of evaluating the potential financial benefit to <FONT STYLE="white-space:nowrap">II-VI</FONT> of preserving <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT>
growth plan as a result of the merger. <B></B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="42" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;June 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>($ in millions)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2027E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2028E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2029E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2030E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2031E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,896</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">884</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net operating profit (after
tax)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered free cash flow<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for other expenses and income and <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Net Operating Profit (After Tax), a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers
to Adjusted EBITDA less stock-based compensation, depreciation and cash taxes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered free cash flow, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to
Adjusted EBITDA, burdened by stock-based compensation, adjusted for cash taxes, capital expenditures, changes in net working capital and earnings from equity investments. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">II-VI-Prepared</FONT></FONT> Coherent Prospective Financial
Information </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> management prepared certain prospective financial information on
Coherent based on the Coherent management case prospective financial information, reflecting <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year presentation and including extrapolations for
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal years 2025 through 2031. <FONT STYLE="white-space:nowrap">II-VI</FONT> directed J.P. Morgan to use and rely upon such prospective financial information for purposes of J.P. Morgan&#146;s
opinion and related financial analyses. This </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-138- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unaudited prospective financial information is presented in the following table and referred to in this joint proxy statement/prospectus as the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;II-VI-prepared</FONT></FONT> Coherent prospective financial information.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="42" ALIGN="center"><B>Fiscal&nbsp;year&nbsp;ended&nbsp;June 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><I>($ in millions)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2022E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2027E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2028E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2029E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2030E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2031E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Revenue</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,393</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net operating profit (after
tax)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unlevered free cash flow<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to earnings
before interest, tax, depreciation and amortization and stock-based compensation, adjusted for <FONT STYLE="white-space:nowrap">one-time</FONT> charges. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Net Operating Profit (After Tax), a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers
to Adjusted EBITDA less stock-based compensation, depreciation and amortization and cash taxes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered free cash flow, a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, refers to
Adjusted EBITDA, burdened by stock-based compensation, adjusted for cash taxes, capital expenditures, and changes in net working capital. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Potential Combined Company Cost Savings and Revenue Synergies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> management and Coherent management both independently prepared and discussed with one another
estimates of the amount and timing of the impact of certain potential combined company cost savings, which we refer to in this joint proxy statement/prospectus as the &#147;potential combined company cost savings.&#148; The potential combined
company cost savings reflect estimated cost savings of approximately $250&nbsp;million per year from increased operating efficiencies and leveraging economies of scale, which are expected to be fully realized within three years after the completion
of the merger. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> management independently prepared estimates of the amount and timing of the impact of certain potential combined company revenue synergies (primarily driven by increased
growth in the aerospace and defense, life sciences and laser-additive manufacturing markets), which we refer to in this joint proxy statement/prospectus as the &#147;potential combined company revenue synergies.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_83"></A>Interests of Coherent&#146;s Directors and Executive Officers in the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering the recommendation of the Coherent board to vote &#147;FOR&#148; the merger proposal, &#147;FOR&#148; the compensation proposal
and &#147;FOR&#148; the adjournment proposal, Coherent stockholders should be aware that certain of Coherent&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and executive officers have economic interests in the merger that are
different from, or in addition to, those of Coherent stockholders generally. These interests include, among others: (i)&nbsp;the continued employment of Coherent executive officers with the combined company, including potential increases in
compensation, (ii)&nbsp;the continued service of certain <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Coherent board as directors of <FONT STYLE="white-space:nowrap">II-VI,</FONT> (iii)&nbsp;the treatment of equity awards,
including the potential accelerated vesting of such awards in the event of a qualifying termination of employment following the merger, (iv)&nbsp;the potential severance benefits for executive officers in the event of a qualifying termination of
employment following the merger and (v)&nbsp;continuing indemnification rights of <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Coherent board and Coherent executive officers following the merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Assumptions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise specifically noted, for purposes of quantifying the potential payments and benefits described in this section, the
following assumptions were used: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The relevant price per share of Coherent common stock is $255.65, which is the average closing price per share of
Coherent common stock as reported on Nasdaq over the first five business days following the first public announcement of the merger on March&nbsp;25, 2021; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-139- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effective time is April&nbsp;23, 2021, which is the assumed date of the closing of the merger solely for
purposes of the disclosure in this section; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The employment of each executive officer of Coherent will have been terminated by Coherent without
&#147;cause&#148; or without &#147;just cause&#148; or due to the executive officer&#146;s resignation for &#147;good reason&#148; (as such terms are defined in the relevant plans and agreements), in either case immediately following the assumed
effective time of April&nbsp;23, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To the extent determined based on the actual level of performance as of the effective time, the performance
metrics applicable to Coherent PSUs and under Coherent&#146;s variable incentive compensation plan will have been achieved at the target level of performance; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The potential payments and benefits described in this section are not at a level subject to a &#147;cutback&#148;
to avoid the &#147;golden parachute&#148; excise tax that may be imposed under Section&nbsp;4999 of the Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
purposes of this disclosure, Coherent&#146;s named executive officers are: (i)&nbsp;Andreas Mattes, President and Chief Executive Officer; (ii)&nbsp;Kevin Palatnik, Executive Vice President and Chief Financial Officer; (iii)&nbsp;Dr. Mark Sobey,
Executive Vice President and Chief Operating Officer; (iv)&nbsp;Bret DiMarco, Executive Vice President, Chief Legal Officer and Corporate Secretary; (v)&nbsp;Dr. John Ambroseo, former President and Chief Executive Officer; and (vi)&nbsp;Thomas Merk,
former Executive Vice President and General Manager, Industrial Lasers&nbsp;&amp; Systems. Each of Coherent&#146;s executive officers are its named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the amounts provided below are estimates based on multiple assumptions that may or may not actually occur or be accurate as of the date
referenced, the actual amounts, if any, that may be paid or become payable may materially differ from the amounts set forth below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent Director RSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each Coherent RSU owned by a Coherent director (which we refer to as &#147;Coherent director RSU&#148;) that is
outstanding immediately prior to the effective time will, automatically and without any required action on the part of the holder thereof, vest (if unvested) and be cancelled and converted into the right to receive the merger consideration as if
such Coherent director RSU had been settled in shares of Coherent common stock immediately prior to the effective time, which consideration will be paid to each holder within two business days following the effective time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent RSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each Coherent RSU (other than any Coherent director RSU) that is outstanding immediately prior to the effective time
will be converted into an award covering that number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, rounded down to the nearest whole share (which we refer to as &#147;converted RSUs&#148;), equal to the product of
(x)&nbsp;the number of shares of Coherent common stock subject to such award of Coherent RSUs (and, with respect to any Coherent RSUs that are subject to performance-vesting goals or metrics, the number of shares of Coherent common stock will be
determined based on the greater of the target or actual level of achievement of such goals or metrics immediately prior to the effective time, as determined by the Coherent board or a committee thereof) and (y)&nbsp;the sum of (A)&nbsp;the exchange
ratio, and (B)&nbsp;the quotient obtained by dividing (i)&nbsp;the $220.00 cash consideration by (ii)&nbsp;the volume weighted average price of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for a ten trading day period,
starting with the opening of trading on the 11th trading day prior to the closing date to the closing of trading on the second to last trading day prior to the closing date, as reported by Bloomberg. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Accelerated Vesting of Equity Awards Held by Directors and Executive Officers Upon Certain Terminations of Employment or Service
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each outstanding Coherent director RSU will convert into merger consideration in the manner described
above. At the effective time, each unvested Coherent RSU held by the named executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-140- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officers of Coherent will convert into equity awards with respect to shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the manner described above, with those Coherent RSUs
that are subject to performance-vesting goals or metrics converting at the greater of the target (100%) or actual level of performance (the maximum level of which is 200% vesting), and will remain subject to the same service-based vesting conditions
as were applicable immediately prior to the effective time. In the event that a named executive officer experiences a termination of employment by Coherent without &#147;just cause&#148; or by the executive officer for &#147;good reason,&#148; in
either case, within twenty-four (24)&nbsp;months following the effective time, then each Coherent RSU that was outstanding as of the date of the merger agreement (and certain Coherent RSUs that may be granted following the date of the merger
agreement) will become fully vested upon such termination of employment. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the assumptions described above under
&#147;&#151;Certain Assumptions&#148; beginning on page 139 of this joint proxy statement/prospectus, the following table summarizes, as of April&nbsp;23, 2021, the outstanding unvested Coherent director RSUs held by each <FONT
STYLE="white-space:nowrap">non-employee</FONT> member of the Coherent board, excluding any grants that may be made after April&nbsp;23, 2021. Depending on when the merger is completed, certain outstanding equity awards shown in the table below may
become vested in accordance with their terms without regard to the merger. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Coherent&nbsp;Director&nbsp;RSUs&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Rogerson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Flatley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Fletcher</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Matthews</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">191,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;McMullen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Skaggs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Vij</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the section entitled &#147;&#151;Golden Parachute Compensation&#148;<B> </B>beginning on page 143 of
this joint proxy statement/prospectus for an estimate of the amounts that would become payable to each of Coherent&#146;s named executive officers in respect of their unvested Coherent RSUs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Change in Control and Leadership Severance Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each current named executive officer of Coherent is a participant in Coherent&#146;s change in control and leadership severance plan (which we
refer to as the &#147;severance plan&#148;). The severance plan provides for the following severance benefits in the event that a current named executive officer&#146;s employment is terminated without &#147;just cause&#148; or by the participant
for &#147;good reason,&#148; in either case, within two (2)&nbsp;months prior to or within two (2)&nbsp;years following the occurrence of the merger: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum equal to 200% (299% for Mr.&nbsp;Mattes) times the sum of the executive officer&#146;s (x)&nbsp;annual
base salary as in effect immediately prior to the occurrence of the merger or immediately prior to the executive officer&#146;s termination of employment, whichever is higher, and (y)&nbsp;target annual bonus as in effect immediately prior to the
occurrence of the merger or immediately prior to the executive officer&#146;s termination of employment, whichever is higher; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a monthly cash amount of $2,750 to be paid in lieu of subsidized COBRA benefits, which amount will be paid for 36
(for Mr.&nbsp;Mattes) or 24 (for each other executive officer) months following termination of employment; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting of each then-outstanding Coherent RSU. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-141- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provision of benefits described above is conditioned upon the named executive
officer&#146;s execution of a release of claims in favor of Coherent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The severance plan provides that if a participant receives any
amount, whether under the severance plan or otherwise, that is subject to the &#147;golden parachute&#148; excise tax imposed pursuant to Section&nbsp;4999 of the Code, the amount of the payments to be made to the participant will be reduced to the
extent necessary to avoid imposition of the excise tax, but only if the net amount of the reduced payments exceeds the net amount that the executive officer would receive following imposition of the excise tax and all income and related taxes. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the section entitled &#147;&#151;Golden Parachute Compensation&#148;<B> </B>beginning on page 143 of this joint proxy
statement/prospectus for an estimate of the amounts that would become payable to each of Coherent&#146;s named executive officers in respect of their participation in the severance plan upon a qualifying termination of employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ambroseo Transition Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transition and retirement agreement between Coherent and Dr. John Ambroseo, the former President and Chief Executive Officer of Coherent,
provides that in the event his employment is terminated without &#147;just cause&#148; or he terminates employment for &#147;good reason,&#148; in either case, within two months prior to or within two (2)&nbsp;years following the occurrence of the
merger but prior to December&nbsp;1, 2021, then he would be eligible to receive the following severance benefits as if he were the chief executive officer of Coherent as of the date the merger is consummated: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum equal to 299% times the sum of the executive officer&#146;s (x)&nbsp;annual base salary as in effect
immediately prior to the occurrence of the merger or immediately prior to the executive officer&#146;s termination of employment, whichever is higher, and (y)&nbsp;target annual bonus as in effect immediately prior to the occurrence of the merger or
immediately prior to the executive officer&#146;s termination of employment, whichever is higher; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a monthly cash amount of $2,750 to be paid in lieu of subsidized COBRA benefits, which amount will be paid for 36
months following termination of employment; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerated vesting of each then-outstanding Coherent RSU. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ambroseo will also receive the foregoing severance benefits in the event that the closing of the merger occurs prior to
December&nbsp;1, 2021 and he continues to provide services through that date. The provision of benefits described above is conditioned upon the executive officer&#146;s execution of a release of claims in favor of Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the section entitled &#147;&#151;Golden Parachute Compensation&#148;<B> </B>beginning on page 143 of this joint proxy statement/prospectus
for an estimate of the amounts that would become payable to Dr.&nbsp;Ambroseo under his transition and retirement agreement upon a qualifying termination of employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Variable Compensation Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each named executive officer of Coherent participates in Coherent&#146;s variable compensation plan, an annual cash incentive compensation plan
(which we refer to as the &#147;variable compensation plan&#148;). Each participant in the variable compensation plan will receive an annual bonus for the year in which the merger is consummated based on the higher of the target level or actual
level of achievement of the applicable performance metrics, which bonus will be prorated based on the number of days in the performance period elapsed prior to the closing date of the merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-142- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the section entitled &#147;&#151;Golden Parachute Compensation&#148;<B>
</B>beginning on page 143 of this joint proxy statement/prospectus for an estimate of the amounts that would become payable to each of Coherent&#146;s named executive officers in respect of their participation in the variable compensation plan. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Agreements with <FONT STYLE="white-space:nowrap">II-VI</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this joint proxy statement/prospectus, none of the Coherent executive officers has entered into any agreement with <FONT
STYLE="white-space:nowrap">II-VI</FONT> or any of its affiliates regarding employment with, or the right to purchase or participate in the equity of, <FONT STYLE="white-space:nowrap">II-VI</FONT> or one or more of its affiliates. Prior to or
following the closing of the merger, however, some or all of the Coherent executive officers may discuss or enter into agreements with <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of its affiliates regarding employment with, or the right to
purchase or participate in the equity of, <FONT STYLE="white-space:nowrap">II-VI</FONT> or one or more of its affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification and Insurance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the merger agreement, Coherent&#146;s directors and executive officers will be entitled to certain ongoing
indemnification and coverage for a period of six years following the effective time under directors&#146; and officers&#146; liability insurance policies from the surviving corporation. This indemnification and insurance coverage is further
described in the section entitled &#147;The Merger Agreement&#151;Covenants and Agreements&#151;Director and Officer Indemnification and Insurance&#148; beginning on page 169 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Golden Parachute Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Item 402(t) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, the table below sets forth
the compensation that is based on, or otherwise relates to, the merger that will or may become payable to each named executive officer of Coherent in connection with the merger. For additional details regarding the terms of the payments and benefits
described below, see the discussion under the heading &#147;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#148; above, which is incorporated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amounts shown in the table below are estimates based on multiple assumptions that may or may not actually occur or be accurate on the
relevant date, including the assumptions described below and in the footnotes to the table, and do not reflect certain compensation actions that may occur prior to completion of the merger, including any equity award grants that may be made after
April&nbsp;23, 2021. The following table does not include any amounts that are payable to the named executive officer irrespective of the closing of the merger. For purposes of calculating such amounts, the following assumptions were used: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The relevant price per share of Coherent common stock is $255.65, which is the average closing price per share of
Coherent common stock as reported on Nasdaq over the first five business days following the first public announcement of the merger on March&nbsp;25, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The effective time is April&nbsp;23, 2021, which is the assumed date of the closing of the merger solely for
purposes of the disclosure in this section; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The employment of each named executive officer of Coherent will have been terminated by Coherent without
&#147;cause&#148; or without &#147;just cause&#148; or due to the executive officer&#146;s resignation for &#147;good reason&#148; (as such terms are defined in the relevant plans and agreements), in either case immediately following the assumed
effective time of April&nbsp;23, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To the extent determined based on the actual level of performance as of the effective time, the performance
metrics applicable to Coherent PSUs and under the variable incentive compensation plan will have been achieved at the target level of performance; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The potential payments and benefits described in this section are not at a level subject to a &#147;cutback&#148;
to avoid the &#147;golden parachute&#148; excise tax that may be imposed under Section&nbsp;4999 of the Code. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-143- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this disclosure, Coherent&#146;s named executive officers are:
(i)&nbsp;Andreas Mattes, President and Chief Executive Officer; (ii)&nbsp;Kevin Palatnik, Executive Vice President and Chief Financial Officer; (iii)&nbsp;Dr. Mark Sobey, Executive Vice President and Chief Operating Officer; (iv)&nbsp;Bret DiMarco,
Executive Vice President, Chief Legal Officer and Corporate Secretary; (v)&nbsp;Dr. John Ambroseo, former President and Chief Executive Officer; and (vi)&nbsp;Thomas Merk, former Executive Vice President and General Manager, Industrial
Lasers&nbsp;&amp; Systems. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Named Executive Officer</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andreas Mattes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,382,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,365,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,748,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Palatnik</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,275,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,511,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 8,786,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. Mark Sobey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,310,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,300,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,610,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bret DiMarco</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,903,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 8,728,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,632,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. John Ambroseo<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,758,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,729,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 8,488,436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Merk</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,186,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,186,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As noted above, Dr.&nbsp;Ambroseo is the former President and Chief Executive Officer of Coherent and is party
to a transition and retirement agreement with Coherent. For more information, see the section titled &#147;The Merger&#150;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#150;Ambroseo Transition Agreement&#148; beginning
on page 142 of this joint proxy statement/prospectus </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Cash</I>. Represents the portion of the (i)&nbsp;severance payable to each named executive officer upon a
qualifying termination of employment that is based on or otherwise relates to the merger and (ii)&nbsp;the annual bonus for the year in which the merger is consummated based on the higher of the target level or actual level of achievement of the
applicable performance metrics (which is calculated and shown here at the target level of performance), which bonus will be prorated based on the number of days in the performance period elapsed prior to the effective time. The cash severance
payable to each named executive officer other than Dr.&nbsp;Ambroseo is only a &#147;double-trigger&#148; payment, which means the amounts will become payable only upon a qualifying termination of employment within two (2)&nbsp;months prior to, or
within two (2)&nbsp;years following, the effective time of merger. The cash severance payable to Dr.&nbsp;Ambroseo would also be payable upon his retirement if he continues employment following the closing until his scheduled retirement on
December&nbsp;1, 2021. The prorated annual incentive bonus is a &#147;single-trigger&#148; payment, which means that the amounts will become payable upon continued employment through the effective time of the merger. For further details regarding
the cash severance that may become payable to Coherent&#146;s named executive officers, see &#147;The Merger&#150;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#150;Change in Control and Leadership Severance Plan&#148;
beginning on page 141 of this joint proxy statement/prospectus and &#147;The Merger&#150;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#150;Ambroseo Transition Agreement&#148; beginning on page 142 of this joint proxy
statement/prospectus. For further details regarding the prorated annual incentive bonus under the variable compensation plan, see &#147;The Merger&#150;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#150;Variable
Compensation Plan&#148; beginning on page 142 of this joint proxy statement/prospectus. The estimated amount of each such payment is shown in the following table: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Named Executive Officer</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash<BR>Severance</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prorated<BR>Annual&nbsp;Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payment<BR>in Lieu of<BR>Subsidized<BR>COBRA</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andreas Mattes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,591,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,692,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,382,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Palatnik</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,785,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 424,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,275,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. Mark Sobey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,800,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 443,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,310,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bret DiMarco</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,496,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 341,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,903,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. John Ambroseo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,659,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,758,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Merk</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-144- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Equity</I>. Represents the value of the Coherent RSUs (including Coherent PSUs, which, as noted under
&#147;Certain Assumptions,&#148; are quantified here assuming attainment of the applicable performance metrics at the target level of performance (100%)) held by each named executive officer. The amounts payable in respect of the Coherent RSUs for
named executive officers other than Mr.&nbsp;Merk are &#147;double-trigger&#148; payments, which means the accelerated payment amounts will become payable only upon a qualifying termination of employment within two (2)&nbsp;months prior to, or
within (2)&nbsp;years following, the effective time of the merger. Mr.&nbsp;Merk&#146;s termination agreement provided him with the continued ability to earn PSUs that had been granted to him in November 2018 and November 2019 as though he had
continued employment and such PSUs are set forth in this table although the timing of the payments has not been changed. For further details regarding the treatment of Coherent equity awards in connection with the merger, see &#147;The Merger
Agreement&#151;Treatment of Coherent Equity Awards&#148; beginning on page 157 of this joint proxy statement/prospectus. The estimated amount of each such payment is shown in the following table: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">&nbsp;&nbsp;&nbsp;&nbsp;Coherent&nbsp;RSUs&nbsp;(Time-Based)&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent PSUs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Named Executive Officer</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andreas Mattes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;6,998,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;14,367,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;21,365,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Palatnik</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,608,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 2,902,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,511,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. Mark Sobey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,270,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,030,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 13,300,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bret DiMarco</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,261,022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 3,467,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 8,728,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. John Ambroseo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 977,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 5,751,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,729,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Merk</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,186,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,186,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Membership on the Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the merger agreement, following the completion of the merger, <FONT STYLE="white-space:nowrap">II-VI</FONT> will
appoint two (2)&nbsp;directors designated by Coherent, and reasonably acceptable to <FONT STYLE="white-space:nowrap">II-VI,</FONT> to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board from among the directors serving on the Coherent board as
of prior to the effective time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;18, 2021, the Coherent board approved the amendment and restatement of the bylaws of Coherent, which became effective
immediately, to include a forum selection clause that establishes the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain legal claims and actions, unless Coherent consents in writing to the selection of an
alternate forum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_84"></A>Anticipated Accounting Treatment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent each prepare their respective financial statements in accordance with GAAP. The
merger will be accounted for using the acquisition method of accounting with <FONT STYLE="white-space:nowrap">II-VI,</FONT> as the accounting acquirer, and Coherent, as the accounting acquiree. Under the acquisition method of accounting, <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> assets and liabilities will be recorded at carrying value and the assets and liabilities associated with Coherent will be recorded at estimated fair value as of the acquisition date. The excess of the
purchase price over the estimated fair values of the assets acquired and liabilities assumed, if applicable, will be recognized as goodwill. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_85">
</A>Regulatory Approvals </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The completion of the merger is subject to the termination or expiration of any applicable waiting period (or
extension thereof) under the HSR Act, and the receipt of the other applicable regulatory clearances or approvals, including antitrust authorizations or approvals in the People&#146;s Republic of China, Germany, South Korea and, if necessary or
advisable, the United Kingdom. These jurisdictions can impose conditions on case approval under the applicable competition laws as they deem necessary or desirable, including, but not limited to, seeking divestiture of substantial assets of the
parties or requiring the parties to license, or hold separate, assets or to not engage in certain types of conduct. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-145- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>United States</I>. Under the HSR Act and related rules, certain transactions, including
the merger, may not be completed until notifications have been given and information furnished to the Antitrust Division or the FTC and all statutory waiting period requirements have been satisfied. A transaction notifiable under the HSR Act may not
be completed until the expiration of a <FONT STYLE="white-space:nowrap">30-calendar</FONT> day waiting period following the parties&#146; filings of their respective HSR Act notification forms or the early termination of that waiting period. In
certain circumstances the review period may be extended by either of the parties or the Antitrust Division or the FTC. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent each filed their respective HSR Act notification forms on April&nbsp;8,
2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>China</I>. Under the AML, transactions involving parties with sales above certain revenue levels cannot be completed until they
are reviewed and approved by SAMR. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues to exceed SAMR&#146;s statutory thresholds for review, and completion of the merger is therefore subject to SAMR approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Germany</I>. Under the German Act against Restraints of Competition of 1958 <I>(Gesetz gegen Wettbewerbsbeschr&auml;nkungen)</I> (as
amended), transactions involving parties with sales above certain revenue levels cannot be completed until they are either reviewed and approved by the FCO or the relevant waiting periods have expired without the FCO having prohibited the merger. <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues in Germany to exceed the statutory thresholds, and completion of the merger is therefore conditioned upon either FCO approval or the expiration of the relevant waiting
periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>South Korea</I>. Under MRFTA the Republic of Korea requires that transactions involving parties with sales above a certain
threshold be reported to the KFTC for review and approval. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have sufficient revenues to exceed the KFTC&#146;s statutory threshold for review, and completion of the merger is therefore
subject to KFTC approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>United Kingdom</I>. Merger control filings under the Enterprise Act are not mandatory, but the CMA has the
ability to open an investigation into the transaction, or may seek or request a filing from the parties if certain jurisdictional thresholds are met. If the parties agree that a filing under the Enterprise Act is necessary or advisable, the merger
shall be conditioned upon relevant approvals from the CMA under the Enterprise Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time before or after the expiration of the
statutory waiting periods under the HSR Act, the Antitrust Division or the FTC may take action under the antitrust laws, including seeking to enjoin the completion of the merger, to rescind the merger or to conditionally permit completion of the
merger subject to regulatory conditions or other remedies. In addition, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulatory bodies and U.S. state attorneys general could take action under other applicable regulatory laws as they deem
necessary or desirable in the public interest, including, without limitation, seeking to enjoin or otherwise prevent the completion of the merger or permitting completion subject to regulatory conditions. Private parties may also seek to take legal
action under regulatory laws under some circumstances. There can be no assurance that a challenge to the merger on antitrust or other regulatory grounds will not be made or, if such a challenge is made, that it would not be successful. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_86"></A>Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> currently anticipates that it will finance the cash payments required to consummate the merger through a combination of approximately $900&nbsp;million of cash from the combined balance sheets of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent, the debt financing of approximately $4,725&nbsp;million of third-party debt financing, which may include some combination of a senior secured revolving credit facility, a senior secured term loan
credit facility, a senior unsecured bridge loan facility and/or the issuance of senior unsecured notes or other debt securities, and the equity financing of approximately $<B></B>1,800&nbsp;million in exchange for 180,000&nbsp;shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock (assuming the investors do not exercise their option to invest up to an additional $350.0&nbsp;million in exchange for up to 35,000 shares of II-VI Series&nbsp;B-2
convertible preferred stock). These amounts are sufficient to (i)&nbsp;pay Coherent&#146;s stockholders the amounts due to them under the merger agreement, (ii)&nbsp;refinance or otherwise discharge any outstanding indebtedness of Coherent and II-VI
required to be repaid at the completion of the merger, and (iii)&nbsp;pay any fees, costs and expenses incurred in connection with the merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-146- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Debt Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with execution of the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the debt commitment letter
pursuant to which the commitment parties have committed to provide to <FONT STYLE="white-space:nowrap">II-VI</FONT> a senior secured term loan &#147;A&#148; facility in an aggregate principal amount of $850&nbsp;million, a senior secured term loan
&#147;B&#148; facility in an aggregate principal amount of $2,800&nbsp;million, a senior secured revolving credit facility in an aggregate principal amount of $350&nbsp;million (which we refer to, together with the term loan &#147;A&#148; facility
and the term loan &#147;B&#148; facility mentioned in this sentence, the &#147;senior secured facilities&#148;), and a senior unsecured bridge loan facility in an aggregate principal amount of $1,125&nbsp;million (which we refer to as the
&#147;bridge loan facility&#148; and collectively with the other foregoing facilities, the &#147;facilities&#148;), in each case, subject to the execution of definitive documentation and the satisfaction of customary closing conditions. The bridge
loan facility will only be drawn to the extent <FONT STYLE="white-space:nowrap">II-VI</FONT> is unable to issue senior unsecured notes or other debt securities at or prior to the closing of the merger in an amount sufficient to close the
transaction. <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to enter into definitive documentation for the facilities prior to or concurrently with the consummation of the transactions contemplated by the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each commitment party&#146;s commitment to provide the facilities under the debt commitment letter expires on the first to occur of (i) 5:00
p.m., New York City time, on the date that is five business days after December&nbsp;25, 2021, subject to the extension of such date to be five business days after March&nbsp;25, 2022, June&nbsp;25, 2022 and September&nbsp;25, 2022, in each case
pursuant to the terms of the merger agreement, (ii)&nbsp;the date of the termination of the merger agreement in accordance with its terms or (iii)&nbsp;as to any facility, the consummation of the merger without the use of such facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of the facilities is conditioned on the consummation of the merger in accordance with the merger agreement and on other
customary conditions, including, without limitation, the following (subject, in each case, to customary &#147;certain funds&#148; provisions): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">execution of final definitive documentation with respect to the facilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of any &#147;company material adverse effect&#148; (as defined in the merger agreement) since the date of
the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the repayment of certain indebtedness of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> and the
termination of liens in connection therewith; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to certain limitations, the taking of certain actions necessary to establish and perfect a security
interest in specified items of collateral; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivery of customary legal opinions, a solvency certificate in a
<FONT STYLE="white-space:nowrap">pre-agreed</FONT> form, and certain other customary resolutions, certificates and other documents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivery of certain historical financial statements (including pro forma financial statements) of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent (which shall not include any obligation to provide &#147;excluded information&#148; (as defined in the merger agreement)); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accuracy of specified representations and warranties in the merger agreement and the accuracy in all material
respects of specified representations and warranties to be contained in the definitive documentation for the facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivery of documentation and other information about the borrowers and guarantors required under applicable
&#147;know your customer&#148; and anti-money laundering rules and regulations (including the PATRIOT Act and beneficial owner regulations); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">payment of certain fees and expenses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lead arrangers shall have received information required to prepare a customary confidential information
memorandum for the facilities; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-147- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to the bridge facility, engagement of one or more banks to sell or place the senior unsecured notes
and delivery of a customary offering documentation in connection therewith. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations under each facility will be
guaranteed by certain material domestic subsidiaries of <FONT STYLE="white-space:nowrap">II-VI,</FONT> including, without limitation, Coherent. The obligations under the senior secured facilities will be
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and the guarantors&#146; senior secured obligations, secured by a lien on substantially all of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and each guarantor&#146;s assets (which we refer
to collectively as the &#147;collateral&#148;) subject to customary exclusions, and will rank senior to any of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and each guarantor&#146;s unsecured indebtedness, including the bridge facility
and/or any senior unsecured notes or other debt securities, to the extent of the value of the collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The definitive documentation
governing the facilities is expected to contain customary affirmative and negative covenants, including covenants that limit or restrict <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and its subsidiaries&#146; ability to, among other things,
incur indebtedness, grant liens, undergo certain fundamental changes, dispose of assets, make investments, enter into transactions with affiliates, and make certain restricted payments, in each case subject to limitations and exceptions to be set
forth in the definitive documentation governing the facilities. The definitive documentation governing the facilities is also expected to contain customary events of default that include, among other things, certain payment defaults, covenant
defaults, cross-defaults to other indebtedness, change of control defaults, judgment defaults, and bankruptcy and insolvency defaults. In addition, the definitive documentation governing certain of the facilities is expected to contain financial
maintenance covenants that will require <FONT STYLE="white-space:nowrap">II-VI</FONT> to maintain a certain leverage ratio and an interest coverage ratio at the end of each fiscal quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to take, or cause to be taken, all actions and do,
or cause to be done, all things necessary, proper or advisable to arrange, obtain and complete the debt financing at or prior to the closing of the merger on the terms and subject to the conditions described in the debt commitment letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of the facilities is subject to certain conditions but is not subject to due diligence or other similar conditions. Further,
the debt commitment letter contains customary &#147;certain funds&#148; provisions which materially limit the number and scope of conditions precedent to the funding of the facilities on the closing date. However, such financing may not be
considered certain. In the event that the facilities are not available to <FONT STYLE="white-space:nowrap">II-VI</FONT> on the terms set forth in the debt commitment letter or <FONT STYLE="white-space:nowrap">II-VI</FONT> anticipates that the
facilities will not be available on the terms set forth in the debt commitment letter due to the failure of a condition thereto or for any other reason, <FONT STYLE="white-space:nowrap">II-VI</FONT> may seek alternative financing. As of the date of
this joint proxy statement/prospectus, no alternative financing arrangements or alternative financing plans have been made in the event that the facilities are not available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The definitive documentation governing the facilities has not been finalized and, accordingly, the actual terms of the facilities may differ
from those described in this joint proxy statement/prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Equity Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement, on March&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the
investment agreement. On March&nbsp;31, 2021, pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated the initial investment of $750.0&nbsp;million. Pursuant to the investment agreement and subject to
the terms and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least $1.05&nbsp;billion, which may be increased by up to an additional
$350.0&nbsp;million, immediately prior to the closing of the merger. The issuance and sale of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the
subsequent investment is contingent upon the consummation of the merger in accordance with the merger agreement, and is subject to certain other closing conditions customary for transactions of this type. The investment agreement will terminate
following the occurrence of certain events, including: (i)&nbsp;automatically upon the valid termination of the merger agreement in accordance with its terms, (ii)&nbsp;the mutual written consent of <FONT STYLE="white-space:nowrap">II-VI</FONT> and
the investors and (iii)&nbsp;written notice from either <FONT STYLE="white-space:nowrap">II-VI</FONT> or the investors if the closing of the equity financing has not occurred on or prior to December&nbsp;25, 2021 (subject to certain extensions).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-148- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible
preferred stock are set forth in the statement with respect to shares. The conversion price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock will initially be $85.00 per share, subject to adjustments as
set forth in the statement with respect to shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of each of the investment agreement and statement with respect to shares is
attached hereto as <B>Annex B</B> and <B>Annex&nbsp;C</B>, respectively. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information on the terms of the investment
agreement and the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series&nbsp;B convertible preferred stock, see the section titled &#147;The Investment Agreement and the Statement with Respect to Shares&#148; beginning on page&nbsp;183 of this joint
proxy statement/prospectus. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_87"></A>Stock Exchange Listings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> common stock is listed for trading on Nasdaq under the symbol &#147;IIVI&#148; and Coherent
common stock is listed on Nasdaq under the symbol &#147;COHR.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the merger agreement, <FONT
STYLE="white-space:nowrap">II-VI</FONT> is required to use its reasonable best efforts to cause the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued in the merger to be approved for listing on Nasdaq, subject to
official notice of issuance, prior to the closing date. Neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent will be required to complete the merger if such shares are not authorized for listing on Nasdaq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement further provides that, as promptly as practicable after the effective time, <FONT STYLE="white-space:nowrap">II-VI</FONT>
is required to cause shares of Coherent common stock to be delisted from Nasdaq and deregistered under the Exchange Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_87a"></A>Legal Proceedings Regarding the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the filing of the Registration Statement on Form&nbsp;S-4 in connection with the merger between II-VI and Coherent, on April&nbsp;28,
2021, a purported stockholder of Coherent filed a complaint in the United States District Court for the Southern District of New York captioned <I>Stein v. Coherent, Inc., et al.</I>, Civil Action No.&nbsp;1:21-cv-3775. The complaint names as
defendants Coherent and members of the Coherent board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The complaint alleges that the defendants violated Sections&nbsp;14(a) and 20(a)
of the Exchange Act, by filing a materially incomplete and misleading Registration Statement on Form&nbsp;S-4 in connection with the merger. The complaint seeks a preliminary injunction against the closing of the merger until such time as additional
information is disclosed in the Registration Statement on Form&nbsp;
S-4, as well as damages. Coherent believes the complaint is without merit. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_88"></A>Appraisal Rights in the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are not entitled to appraisal or dissenters&#146; rights in connection with the
merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger is completed, holders of shares of Coherent common stock who do not vote in favor of the adoption of the merger
agreement, who continuously hold such shares as of immediately prior to and through the effective time of the merger and who properly demand appraisal of their shares may be entitled to appraisal rights in connection with the merger under
Section&nbsp;262 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion is not a complete statement of the law pertaining to appraisal rights under the
DGCL and is qualified in its entirety by the full text of Section&nbsp;262 of the DGCL, which is attached to this joint proxy statement/prospectus as <B>Annex&nbsp;D</B> and incorporated herein by reference. The following summary does not constitute
any legal or other advice nor does it constitute a recommendation that Coherent stockholders exercise their appraisal rights under Section&nbsp;262 of the DGCL. All references in Section&nbsp;262 of the DGCL and in this summary to a &#147;Coherent
stockholder&#148; are to the record holder of Coherent common stock unless otherwise noted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-149- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
herein. Only a holder of record of Coherent common stock is entitled to demand appraisal rights for the shares registered in that holder&#146;s name. A person having a beneficial interest in
shares of Coherent common stock held of record in the name of another person, such as a broker, bank or other nominee, must act promptly to cause the record holder to follow the steps summarized below properly and in a timely manner to perfect
appraisal rights. If you hold your shares of Coherent common stock through a broker, bank or other nominee and you wish to exercise appraisal rights, you should consult with your broker, bank or the other nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Coherent stockholder contemplating the exercise of such appraisal rights should review carefully the provisions of Section&nbsp;262 of the
DGCL, particularly the procedural steps required to properly demand and perfect such rights. Failure to follow the steps required by Section&nbsp;262 of the DGCL for demanding and perfecting appraisal rights may result in the loss of such rights.
Under Section&nbsp;262 of the DGCL, holders of shares of Coherent common stock who (i)&nbsp;do not vote in favor of the Coherent merger proposal; (ii)&nbsp;continuously are the record holders of such shares through the effective time; and
(iii)&nbsp;otherwise follow the procedures set forth in Section&nbsp;262 of the DGCL may be entitled to have their shares appraised by the Court of Chancery and to receive payment in cash of the &#147;fair value&#148; of the shares, exclusive of any
element of value arising from the accomplishment or expectation of the merger, as determined by the Court of Chancery, together with interest to be paid upon the amount determined to be fair value, if any, as determined by the Court of Chancery.
However, immediately before the merger, Coherent common stock will be listed on a national exchange. Therefore, pursuant to Section&nbsp;262(g) of the DGCL, after an appraisal petition has been filed, the Court of Chancery will dismiss appraisal
proceedings as to all holders of shares of common stock who asserted appraisal rights unless (a)&nbsp;the total number of shares for which appraisal rights have been pursued and perfected exceeds 1% of the outstanding shares of Coherent common stock
as measured in accordance with subsection (g)&nbsp;of Section&nbsp;262 of the DGCL or (b)&nbsp;the value of the merger consideration in respect of such shares exceeds $1&nbsp;million. We refer to these conditions as the &#147;ownership
thresholds.&#148; Unless the Court of Chancery, in its discretion, determines otherwise for good cause shown, interest on an appraisal award will accrue and compound quarterly from the effective time through the date the judgment is paid at 5% over
the Federal Reserve discount rate (including any surcharge) as established from time to time during such period; provided, however, that at any time before the Court of Chancery enters judgment in the appraisal proceeding, the surviving corporation
in the merger may pay to each stockholder entitled to appraisal an amount in cash, in which case any such interest will accrue after the time of such payment only on the amount that equals the sum of (1)&nbsp;the difference, if any, between the
amount so paid and the &#147;fair value&#148; of the shares as determined by the Court of Chancery and (2)&nbsp;interest theretofore accrued, unless paid at such time. The surviving corporation is under no obligation to make such voluntary cash
payment prior to such entry of judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;262 of the DGCL, where a merger agreement is to be submitted for adoption at
a meeting of stockholders, the corporation, not less than 20&nbsp;days prior to the meeting, must notify each of its stockholders who was such on the record date for notice of such meeting with respect to shares for which appraisal rights are
available that appraisal rights are available and include in the notice a copy of Section&nbsp;262 of the DGCL. This joint proxy statement/prospectus constitutes Coherent&#146;s notice to stockholders that appraisal rights are available in
connection with the merger, and the full text of Section&nbsp;262 of the DGCL is attached to this joint proxy statement/prospectus as <B>Annex D</B>. Any holder of Coherent common stock who wishes to exercise appraisal rights, or who wishes to
preserve such holder&#146;s right to do so, should review the following discussion and <B>Annex D</B> carefully because failure to timely and properly comply with the procedures specified will result in the loss of appraisal rights. A Coherent
stockholder who loses his, her or its appraisal rights will be entitled to receive the merger consideration described in the merger agreement (without interest). Moreover, because of the complexity of the procedures for exercising the right to seek
appraisal of shares of Coherent common stock, Coherent believes that if a Coherent stockholder considers exercising such rights, such stockholder should seek the advice of legal counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent stockholders wishing to exercise the right to seek an appraisal of their shares of Coherent common stock must do <B>ALL</B> of the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder must not vote in favor of the Coherent merger proposal; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-150- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder must deliver to Coherent a written demand for appraisal before the vote on the Coherent merger
proposal at the Coherent special meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder must continuously hold the shares from the date of making the demand through the effective time
(a stockholder will lose appraisal rights if the stockholder transfers the shares before the effective time); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder or the surviving corporation in the merger must file a petition in the Court of Chancery
requesting a determination of the fair value of the shares within 120 days after the effective time. The surviving corporation is under no obligation to file any such petition and has no intention of doing so. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, for any Coherent stockholders to exercise appraisal rights, at least one of the ownership thresholds must be met. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Filing Written Demand</I>. Any holder of Coherent common stock wishing to exercise appraisal rights must deliver to Coherent, before the
vote on the adoption of the merger agreement at the Coherent special meeting, a written demand for the appraisal of the Coherent stockholder&#146;s shares, and that stockholder must not vote, virtually or by proxy, such shares in favor of the
Coherent merger proposal. A holder of shares of Coherent common stock wishing to exercise appraisal rights must hold of record the shares on the date the written demand for appraisal is made and must continue to hold the shares of record through the
effective time, since such person will lose his, her or its appraisal rights if the shares are transferred prior to the effective date of the merger. A proxy that is submitted and does not contain voting instructions will, unless timely revoked, be
voted in favor of the Coherent merger proposal, and it will constitute a waiver of the Coherent stockholder&#146;s right of appraisal and will nullify any previously delivered written demand for appraisal. Therefore, a Coherent stockholder who
submits a proxy and who wishes to exercise appraisal rights must submit a proxy containing instructions to vote against the Coherent merger proposal or abstain from voting on the Coherent merger proposal. Neither voting against the Coherent merger
proposal, nor submitting a proxy against the Coherent merger proposal, nor abstaining from voting or failing to vote on the Coherent merger proposal, will in and of itself constitute a written demand for appraisal satisfying the requirements of
Section&nbsp;262 of the DGCL. The written demand for appraisal must be in addition to and separate from any proxy or vote on the Coherent merger proposal. The written demand must reasonably inform Coherent of the identity of the holder as well as
the intention of the holder to demand an appraisal of the &#147;fair value&#148; of the shares held by the holder. A Coherent stockholder&#146;s failure to make the written demand prior to the taking of the vote on the Coherent merger proposal at
the Coherent special meeting will constitute a waiver of appraisal rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only a holder of record of shares of Coherent common stock is
entitled to demand an appraisal of the shares registered in that holder&#146;s name. A demand for appraisal in respect of shares of Coherent common stock should be executed by or on behalf of the holder of record, fully and correctly, as the
holder&#146;s name appears on the holder&#146;s stock certificates, should specify the holder&#146;s name and mailing address and the number of shares registered in the holder&#146;s name, and must state that the person intends thereby to demand
appraisal of the holder&#146;s shares in connection with the merger. If the shares are owned of record in a fiduciary or representative capacity, such as by a trustee, guardian or custodian, execution of the demand should be made in that capacity,
and if the shares are owned of record by more than one person, as in a joint tenancy and tenancy in common, the demand should be executed by or on behalf of all joint owners. An authorized agent, including an agent for two or more joint owners, may
execute a demand for appraisal on behalf of a holder of record; however, the agent must identify the record owner or owners and expressly disclose that, in executing the demand, the agent is acting as agent for the record owner or owners. If the
shares are held in &#147;street name&#148; by a broker, bank or nominee, the broker, bank or nominee may exercise appraisal rights with respect to the shares held for one or more beneficial owners while not exercising the rights with respect to the
shares held for other beneficial owners; in such case, however, the written demand should set forth the number of shares as to which appraisal is sought and where no number of shares is expressly mentioned the demand will be presumed to cover all
shares of Coherent common stock held in the name of the record owner. <B>COHERENT STOCKHOLDERS WHO HOLD THEIR SHARES IN BROKERAGE ACCOUNTS OR OTHER NOMINEE FORMS AND WHO</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-151- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>WISH TO EXERCISE APPRAISAL RIGHTS ARE URGED TO CONSULT WITH THEIR BANKS,</B> <B>BROKERS OR OTHER NOMINEES, AS APPLICABLE, TO DETERMINE THE APPROPRIATE PROCEDURES FOR THE MAKING OF A DEMAND FOR
APPRAISAL BY SUCH A NOMINEE.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All written demands for appraisal pursuant to Section&nbsp;262 of the DGCL should be sent or delivered
to Coherent, Inc., 5100 Patrick Henry Drive, Santa Clara, California 95054, Attn: Corporate Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time within 60&nbsp;days
after the effective time, any Coherent stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party may withdraw his, her or its demand for appraisal and accept the merger consideration by delivering to
Coherent, as the surviving corporation in the merger, a written withdrawal of the demand for appraisal and an acceptance of the merger consideration. Any such attempt to withdraw the demand made more than 60&nbsp;days after the effective time will
require written approval of the surviving corporation in the merger. No appraisal proceeding in the Court of Chancery will be dismissed as to any Coherent stockholder without the approval of the Court of Chancery, and such approval may be
conditioned upon such terms as the Court of Chancery deems just; provided, however, that any Coherent stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party may withdraw his, her or its demand for
appraisal and accept the merger consideration within 60&nbsp;days after the effective time. If the surviving corporation in the merger does not approve a request to withdraw a demand for appraisal and to accept the merger consideration when that
approval is required, or if the Court of Chancery does not approve the dismissal of an appraisal proceeding, the Coherent stockholder will be entitled to receive only the appraised value determined in any such appraisal proceeding, which value could
be less than, equal to or more than the consideration being offered pursuant to the merger agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Notice by the Surviving
Corporation</I>. Within ten days after the effective time, the surviving corporation in the merger, or its successors or assigns, will notify each holder of Coherent common stock, who has complied with Section&nbsp;262 of the DGCL, and who has not
voted in favor of the Coherent merger proposal, of the date on which the merger became effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Filing a Petition for Appraisal</I>.
Within 120 days after the effective time, but not thereafter, the surviving corporation in the merger or any holder of Coherent common stock who has complied with Section&nbsp;262 of the DGCL and is entitled to appraisal rights under
Section&nbsp;262 of the DGCL may commence an appraisal proceeding by filing a petition in the Court of Chancery, with a copy served on the surviving corporation in the merger, or its successors or assigns, in the case of a petition filed by a
Coherent stockholder, demanding a determination of the fair value of the shares held by all Coherent stockholders entitled to appraisal. The surviving corporation in the merger is under no obligation to and has no present intention to file a
petition and holders should not assume that the surviving corporation will file a petition or initiate any negotiations with respect to the fair value of the shares of Coherent common stock. Accordingly, any holders of shares of Coherent common
stock who desire to have their shares appraised should initiate all necessary action to perfect their appraisal rights in respect of shares of Coherent common stock within the time and in the manner prescribed in Section&nbsp;262 of the DGCL. The
failure of a holder of Coherent common stock to file such a petition in the period and manner specified in Section&nbsp;262 of the DGCL could nullify the Coherent stockholder&#146;s previous written demand for appraisal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within 120 days after the effective time, any holder of Coherent common stock who has complied with the requirements for exercise of appraisal
rights will be entitled, upon written request, to receive from the surviving corporation in the merger a statement setting forth the aggregate number of shares not voted in favor of the Coherent merger proposal and with respect to which demands for
appraisal have been received and the aggregate number of holders of such shares. The statement must be mailed to the requesting stockholder within ten days after a written request therefor has been received by the surviving corporation in the merger
or within ten days after the expiration of the period for delivery of demands for appraisal, whichever is later. Notwithstanding the foregoing, a person who is the beneficial owner of shares of Coherent common stock held either in a voting trust or
by a nominee on behalf of such person may, in such person&#146;s own name, file a petition seeking appraisal or request from the surviving corporation in the merger, or its successors or assigns, the statement described in this paragraph. As noted
above, however, the demand for appraisal can only be made by a Coherent stockholder of record. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-152- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a petition for an appraisal is timely filed by a holder of shares of Coherent common
stock and a copy thereof is served upon the surviving corporation in the merger, the surviving corporation will then be obligated within 20&nbsp;days after such service to file with the Delaware Register in Chancery a duly verified list (which we
refer to as the &#147;verified list&#148;) containing the names and addresses of all Coherent stockholders who have demanded an appraisal of their shares and with whom agreements as to the value of their shares have not been reached. Upon the filing
of any such petition, the Court of Chancery may order that notice of the time and place fixed for the hearing on the petition be mailed to the surviving corporation in the merger and all of Coherent stockholders shown on the verified list at the
addresses stated therein. Such notice will also be published at least one week before the day of the hearing in a newspaper of general circulation published in the City of Wilmington, Delaware, or in another publication determined by the Court of
Chancery. The costs of these notices are borne by the surviving corporation in the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After notice to the stockholders as required
by the Court of Chancery, the Court of Chancery is empowered to conduct a hearing on the petition to determine those Coherent stockholders who have complied with Section&nbsp;262 of the DGCL and who have become entitled to appraisal rights
thereunder. The Court of Chancery may require Coherent stockholders who demanded payment for their shares to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceeding; and if any
Coherent stockholder fails to comply with the direction, the Court of Chancery may dismiss the proceedings as to such stockholder. The Court of Chancery will dismiss appraisal proceedings as to all Coherent stockholders who assert appraisal rights
unless (a)&nbsp;the total number of shares for which appraisal rights have been pursued and perfected exceeds 1% of the outstanding shares of Coherent common stock as measured in accordance with subsection (g)&nbsp;of Section&nbsp;262 of the DGCL or
(b)&nbsp;the value of the merger consideration in respect of the shares for which appraisal rights have been pursued and perfected exceeds $1&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Determination of Fair Value</I>. After the Court of Chancery determines the holders of Coherent common stock entitled to appraisal and that
at least one of the ownership thresholds above has been satisfied in respect of Coherent stockholders seeking appraisal rights, the appraisal proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules
specifically governing appraisal proceedings. Through such proceeding, the Court of Chancery shall determine the &#147;fair value&#148; of the shares, exclusive of any element of value arising from the accomplishment or expectation of the merger,
together with interest, if any, to be paid upon the amount determined to be the fair value. Unless the Court of Chancery in its discretion determines otherwise for good cause shown, interest from the effective time through the date of payment of the
judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date and the date of payment of the judgment.
However, the surviving corporation in the merger has the right, at any point prior to the Court of Chancery&#146;s entry of judgment in the proceedings, to make a voluntary cash payment to each Coherent stockholder seeking appraisal. If the
surviving corporation in the merger makes a voluntary cash payment pursuant to subsection (h)&nbsp;of Section&nbsp;262 of the DGCL, interest will accrue thereafter only on the sum of (i)&nbsp;the difference, if any, between the amount paid by the
surviving corporation in such voluntary cash payment and the fair value of the shares as determined by the Court of Chancery and (ii)&nbsp;interest theretofore accrued, unless paid at that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining fair value, the Court of Chancery will take into account all relevant factors. In Weinberger v. UOP, Inc., the Supreme Court of
Delaware discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that &#147;proof of value by any techniques or methods that are generally considered acceptable in the financial community and
otherwise admissible in court&#148; should be considered, and that &#147;[f]air price obviously requires consideration of all relevant factors involving the value of a company.&#148; The Supreme Court of Delaware stated that, in making this
determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other facts that could be ascertained as of the date of the merger that throw any light on future
prospects of the merged corporation. Section&nbsp;262 of the DGCL provides that fair value is to be &#147;exclusive of any element of value arising from the accomplishment or expectation of the merger.&#148; In Cede&nbsp;&amp; Co. v. Technicolor,
Inc., the Delaware </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-153- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Supreme Court stated that such exclusion is a &#147;narrow exclusion [that] does not encompass known elements of value,&#148; but which rather applies only to the speculative elements of value
arising from such accomplishment or expectation. In Weinberger, the Supreme Court of Delaware also stated that &#147;elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the
merger and not the product of speculation, may be considered.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent stockholders considering seeking appraisal should be aware
that the fair value of their shares as so determined by the Court of Chancery could be less than, the same as or more than the value of the merger consideration and that an investment banking opinion as to the fairness from a financial point of view
of the merger consideration is not an opinion as to, and may not in any manner address, &#147;fair value&#148; under Section&nbsp;262 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although Coherent believes that the merger consideration is fair, no representation is made as to the outcome of the appraisal of fair value
as determined by the Court of Chancery, and Coherent stockholders should recognize that such an appraisal could result in a determination of a value lower or higher than, or the same as, the merger consideration. None of the parties to the merger
anticipates offering more than the merger consideration to any Coherent stockholder exercising appraisal rights, and each of the parties to the merger agreement reserves the right to make a voluntary cash payment pursuant to subsection (h)&nbsp;of
Section&nbsp;262 of the DGCL and to assert, in any appraisal proceeding, that for purposes of Section&nbsp;262 of the DGCL, the &#147;fair value&#148; of a share of Coherent common stock is less than the merger consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon application by the surviving corporation in the merger or by any Coherent stockholder entitled to participate in the appraisal
proceeding, the Court of Chancery may, in its discretion, proceed to trial upon the appraisal prior to the final determination of Coherent stockholders entitled to an appraisal. Any holder of shares of Coherent common stock whose name appears on the
verified list and, if such shares are represented by certificates and if so required, who has submitted such Coherent stockholder&#146;s certificates of stock to the Delaware Register in Chancery, may participate fully in all proceedings until it is
finally determined that such Coherent stockholder is not entitled to appraisal rights or that neither of the ownership thresholds is met. The Court of Chancery will direct the payment of the fair value of the Coherent shares, together with interest,
if any, by the surviving corporation in the merger to Coherent stockholders entitled thereto. Payment will be made to each such Coherent stockholder, in the case of holders of uncertificated stock, forthwith, and in the case of holders of shares
represented by certificates, upon the surrender to the surviving corporation in the merger of the certificate(s) representing such stock. The Court of Chancery&#146;s decree may be enforced as other decrees in such court may be enforced. If a
petition for appraisal is not timely filed or if neither of the ownership thresholds is met, then the right to an appraisal will cease. The costs of the appraisal proceedings (which do not include attorneys&#146; fees or the fees and expenses of
experts) may be determined by the Court of Chancery and taxed upon the parties as the Court of Chancery deems equitable under the circumstances. Upon application of a Coherent stockholder, the Court of Chancery may also order all or a portion of the
expenses incurred by a Coherent stockholder in connection with an appraisal proceeding, including, without limitation, reasonable attorneys&#146; fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares
entitled to an appraisal. In the absence of such an order, each party bears its own expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the effective time, no
Coherent stockholder who has demanded appraisal rights will be entitled to vote such shares of Coherent common stock for any purpose or to receive payment of dividends or other distributions on the stock, except dividends or other distributions on
the holder&#146;s shares of Coherent common stock, if any, payable to Coherent stockholders as of a time prior to the effective time. If any stockholder who demands appraisal of shares of Coherent common stock under Section&nbsp;262 of the DGCL
fails to perfect or effectively loses or withdraws such holder&#146;s right to appraisal, the stockholder&#146;s shares of Coherent common stock will be deemed to have been converted at the effective time into the right to receive the merger
consideration, without interest. A Coherent stockholder will fail to perfect, or effectively lose or withdraw, the holder&#146;s right to appraisal if no petition for appraisal is filed within 120 days after the effective time, if neither of the
ownership thresholds is met or if the Coherent stockholder delivers to the surviving corporation in the merger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-154- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a written withdrawal of such stockholder&#146;s demand for an appraisal and an acceptance of the merger consideration, either within 60&nbsp;days after the effective time or thereafter with the
written approval of the surviving corporation. Once a petition for appraisal is filed with the Court of Chancery, however, the appraisal proceeding may not be dismissed as to any Coherent stockholder who commenced the proceeding or joined that
proceeding as a named party without the approval of the Court of Chancery. Failure to comply strictly with all of the procedures set forth in Section&nbsp;262 of the DGCL may result in the loss of a stockholder&#146;s statutory appraisal rights.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>In view of the complexity of Section&nbsp;262 of the DGCL, Coherent stockholders wishing to exercise appraisal rights are encouraged
to consult legal counsel before attempting to exercise those rights. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-155- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_89"></A>THE MERGER AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This section of the joint proxy statement/prospectus describes the material terms of the merger agreement. The</I><B><I>
</I></B><I>description in this section and elsewhere in this joint proxy statement/prospectus is subject to,</I><B><I> </I></B><I>and qualified in its entirety by reference to, the complete text of the merger agreement, which is attached as
</I><B><I>Annex&nbsp;A </I></B><I>to this joint proxy statement/prospectus and incorporated by reference herein. This summary does not</I><B><I> </I></B><I>purport to be complete and may not contain all of the information about the merger agreement
that is important to</I><B><I> </I></B><I>you. We urge you to read the full text of the merger agreement, as it is the legal document governing the merger.</I><B><I> </I></B><I>This section is not intended to provide you with any factual information
about <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. Such information</I><B><I> </I></B><I>can be found elsewhere in this joint proxy statement/prospectus and in the public filings <FONT STYLE="white-space:nowrap">II-VI</FONT> and
Coherent make with</I><B><I> </I></B><I>the SEC, as described in the section entitled &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this</I><B><I> </I></B><I>joint proxy statement/prospectus. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_90"></A>Explanatory Note Regarding the Merger Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement and this summary of terms are included to provide you with information regarding the terms of the merger agreement.
Factual disclosures about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent contained in this joint proxy statement/prospectus or in the public reports of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent filed with the SEC may
supplement, update or modify the factual disclosures about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent contained in the merger agreement. The merger agreement contains representations and warranties by
<FONT STYLE="white-space:nowrap">II-VI,</FONT> on the one hand, and by Coherent, on the other hand, made solely for the benefit of the parties to the merger agreement. The representations, warranties and covenants made in the merger agreement by <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent were qualified and subject to important limitations and qualifications agreed to by <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent in connection with negotiating the terms of the
merger agreement. In particular, in your review of the representations and warranties contained in the merger agreement and described in this summary, it is important to bear in mind that the representations and warranties were negotiated with the
principal purpose of establishing circumstances in which a party to the merger agreement may have the right not to consummate the merger if the representations and warranties of the other party prove to be untrue due to a change in circumstance or
otherwise, and allocating risk between the parties to the merger agreement, rather than establishing matters as facts. The representations and warranties also may be subject to a contractual standard of materiality different from that generally
applicable to shareholders and stockholders and reports and documents filed with the SEC, and some were qualified by the matters contained in the confidential disclosure schedules that <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent each
delivered in connection with the merger agreement and certain documents filed with the SEC. Moreover, information concerning the subject matter of the representations and warranties, which do not purport to be accurate as of the date of this joint
proxy statement/prospectus, may have changed since the date of the merger agreement. Accordingly, the representations and warranties in the merger agreement should not be relied on by any persons as characterizations of the actual state of facts
about <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent at the time they were made or otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_91"></A>Structure of the
Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and the Coherent board has adopted and approved the merger
agreement. The merger agreement provides that Merger Sub will merge with and into Coherent, with Coherent surviving the merger as a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_92"></A>Merger Consideration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of Coherent common stock issued and outstanding immediately prior to the effective time, except for shares of Coherent common stock
that are cancelled shares or dissenting shares, will be converted into the right to receive $220.00&nbsp;in cash and 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, prior to the effective time, the outstanding shares of Coherent common stock or <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock
have been changed into a different number or class of shares as a result of a stock dividend, subdivision, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-156- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reorganization, reclassification, recapitalization, stock split, reverse stock split, combination or exchange of shares, or any similar event, the merger consideration will be equitably adjusted
to proportionally reflect the change. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_93"></A>Fractional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will not issue any fractional shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock in the merger. In lieu of the issuance of any such fractional share, the combined company will pay to each former holder of shares of Coherent common stock who otherwise would be entitled to receive such fractional share an amount in cash
(rounded down to the nearest cent) determined by multiplying (i)&nbsp;the volume weighted average price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on Nasdaq as reported by Bloomberg for the consecutive period of ten full trading
days ending on the second to last trading day prior to the closing date by (ii)&nbsp;the fraction of a share (after taking into account all shares of Coherent common stock held by such holder immediately prior to the effective time) of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock which such holder would otherwise be entitled to receive pursuant to the merger agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_94">
</A>Treatment of Coherent Equity Awards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent Director RSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each Coherent director RSU that is outstanding immediately prior to the effective time will, automatically and without
any required action on the part of the holder thereof, vest (if unvested) and be cancelled and converted into the right to receive the merger consideration as if such Coherent director RSU had been settled in shares of Coherent common stock
immediately prior to the effective time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Coherent RSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time, each Coherent RSU (other than any Coherent director RSU) that is outstanding immediately prior to the effective time
will be converted into an award covering that number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, rounded down to the nearest whole share, equal to the product of (x)&nbsp;the number of shares of Coherent common stock
subject to such award of Coherent RSUs (and, with respect to any Coherent RSUs that are subject to performance-vesting goals or metrics, the number of shares of Coherent common stock will be determined based on the greater of the target or actual
level of achievement of such goals or metrics immediately prior to the effective time, as determined by the Coherent board or a committee thereof) and (y)&nbsp;the sum of (A)&nbsp;the exchange ratio, and (B)&nbsp;the quotient obtained by dividing
(i)&nbsp;the $220.00 cash consideration by (ii)&nbsp;the volume weighted average price of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for a ten trading day period, starting with the opening of trading on the 11th trading
day prior to the closing date to the closing of trading on the second to last trading day prior to the closing date, as reported by Bloomberg. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Involuntary Termination Protection for Coherent RSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the employment of a continuing employee (other than any continuing employee who is a participant under the Coherent change in
control leadership severance plan as of immediately prior to the effective time) is terminated by Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries without cause within the period beginning immediately
following the closing date and ending on the date that is 12&nbsp;months following the closing date (or, if earlier, December&nbsp;31, 2022), the vesting of each award of converted RSUs resulting solely from a Coherent RSU that was outstanding and
held by such covered continuing employee as of the date of the merger agreement will accelerate as to: (A)&nbsp;if such covered continuing employee&#146;s qualifying termination occurs during calendar year 2021, the sum of: (x) 100% of the total
number of converted RSUs that otherwise would have vested during calendar year 2021 under the applicable vesting schedule in effect on the closing had such covered continuing employee remained employed with Coherent,
<FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2021 (and reduced by the total number of converted RSUs that vested in calendar year 2021 prior
to such qualifying termination plus (y) 50% of the total number of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-157- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the closing had such covered continuing employee remained employed
with Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2022, or (B)&nbsp;if such covered continuing employee&#146;s qualifying
termination occurs during calendar year 2022, 50% of the total number of converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the closing had such covered continuing employee
remained employed with Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or their respective subsidiaries through the last applicable vesting date for such award in calendar year 2022 (and reduced by the total number of converted RSUs that
vested in calendar year 2022 prior to such qualifying termination). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Coherent Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Coherent employees who are participants in the Coherent ESPP as of the date of the merger agreement may not (i)&nbsp;increase their payroll
contribution rate under the Coherent ESPP from the rate then in effect, or (ii)&nbsp;make any future <FONT STYLE="white-space:nowrap">non-payroll</FONT> cash contribution to the Coherent ESPP, except as required by applicable law. Any offering
period that would otherwise be outstanding as of the effective time will terminate no later than five days prior to the effective time, any shortened offering will be treated as a full and effective offering for purposes of the Coherent ESPP
(including any pro rata adjustments to reflect the shortened offering) and outstanding purchase rights under the Coherent ESPP will be exercised no later than one business day prior to the effective date. Subject to the consummation of the merger,
the Coherent ESPP will terminate effective immediately prior to the effective time. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information on Coherent&#146;s
equity-based awards, see &#147;The Merger&#151;Interests of Coherent&#146;s Directors and Executive Officers in the Merger&#148; beginning on page&nbsp;139 of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_95"></A>Closing of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the merger agreement is terminated, as described in the section entitled &#147;The Merger Agreement&#151;Termination of the Merger
Agreement&#148; beginning on page&nbsp;179 of this joint proxy statement/prospectus, the closing of the transactions contemplated by the merger agreement will take place as soon as practicable, on a date no later than the fifth business day after
the satisfaction or waiver (to the extent permitted under applicable law) of the last of the conditions described in the section entitled &#147;The Merger Agreement&#151;Conditions to Complete the Merger&#148; beginning on page&nbsp;177 of this
joint proxy statement/prospectus (other than those conditions that by their nature can only be satisfied at the closing, but subject to the satisfaction or permitted waiver of all such conditions), unless another date, time or place is agreed to in
writing by Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_96"></A>Effective Time of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger will become effective at the time that the certificate of merger has been duly filed with the Secretary of State of the State of
Delaware or at such other, later date and time as Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> agree and specify in the certificate of merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_97"></A>Conversion of Shares; Exchange of Coherent Stock Certificates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Letter of Transmittal </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as reasonably practicable after the effective time and in any event within five business days of the closing date, <FONT
STYLE="white-space:nowrap">II-VI</FONT> is required to cause the exchange agent to mail to each holder of record of Coherent common stock immediately prior to the effective time that have been converted at the effective time into the right to
receive the merger consideration, a letter of transmittal and instructions for use in effecting the surrender of shares of Coherent common stock in exchange for the merger consideration and any dividends or distributions to be paid pursuant the
merger agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-158- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a certificate for Coherent common stock has been lost, stolen, mutilated or destroyed,
(i)&nbsp;upon the making of an affidavit of that fact by the person claiming such certificate to be lost, stolen, mutilated or destroyed, and (ii), if required by <FONT STYLE="white-space:nowrap">II-VI</FONT> or the exchange agent, the posting by
such person of a bond in such amount as <FONT STYLE="white-space:nowrap">II-VI</FONT> or the exchange agent may determine is reasonably necessary as indemnity against any claim that may be made against it, the surviving corporation with respect to
such certificate, the exchange agent will issue in exchange for such lost, stolen, mutilated or destroyed certificate, the merger consideration and any dividends and distributions deliverable pursuant to the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the effective time, the stock transfer books of Coherent will be closed, and there will be no transfers on the stock transfer books of
the surviving corporation of the shares of Coherent common stock that were outstanding immediately prior to the effective time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Withholding </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
of the surviving corporation, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the exchange agent will be entitled to deduct and withhold, or cause the exchange agent to deduct and withhold, from any payment made pursuant to the merger agreement
such amounts as may be required to be deducted and withheld with respect to the making of such payment under applicable tax law. To the extent that amounts are so withheld and paid over to the appropriate governmental tax authority, such amounts
will be treated for all purposes of the merger agreement as having been paid to the person in respect of which such deduction and withholding was made. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends and Distributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No dividends or other distributions with a record date after the effective time and declared with respect to
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock will be paid to the holder of any unsurrendered certificate until the holder thereof surrenders such certificate in accordance with the merger agreement. After the surrender of a certificate
in accordance with the merger agreement, the record holder thereof will be entitled to receive any such dividends or other distributions, without any interest thereon, which theretofore had become payable with respect to the whole shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock represented by such shares of Coherent common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_98"></A>Representations
and Warranties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement contains representations and warranties made by <FONT STYLE="white-space:nowrap">II-VI</FONT>
regarding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate matters, including due organization and qualification and subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capitalization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate authority relative to the merger agreement and the absence of conflicts with, or violations of,
organizational documents or other obligations as a result of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Merger Sub; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reports and financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of certain changes or events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">internal controls and procedures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of undisclosed liabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with laws and permits; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">environmental matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee benefit plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">labor and employment matters; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-159- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investigations and litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of information supplied for inclusion in this joint proxy statement/prospectus and other similar
documents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anti-bribery matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exports and sanctions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tax matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">real property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ownership of Coherent common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the vote required; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">customers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">finders or brokers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the II-VI board of an opinion from J.P. Morgan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inapplicability of takeover laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">affiliate transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">available funds; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of other representations or warranties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement contains representations and warranties made by Coherent regarding: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate matters, including due organization and qualification and subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capitalization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate authority relative to the merger agreement and the absence of conflicts with, or violations of,
organizational documents or other obligations as a result of the merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reports and financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of certain changes or events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">internal controls and procedures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of undisclosed liabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with laws and permits; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">environmental matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee benefit plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">labor and employment matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investigations and litigations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of information supplied for inclusion in this joint proxy statement/prospectus and other similar
documents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anti-bribery matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exports and sanctions; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-160- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tax matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">real property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material contracts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">customers and vendors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">government contracts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">finders or brokers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the Coherent board of a fairness opinion from each of BofA Securities and Credit Suisse;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inapplicability of takeover laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">affiliate transactions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of other representations or warranties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain representations and warranties of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent are qualified as to &#147;material
adverse effect.&#148; For purposes of the merger agreement, a &#147;material adverse effect,&#148; when used in reference to either <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent, Merger Sub or the surviving corporation, means an event,
state of facts, circumstance, change, effect, development, occurrence or combination of the foregoing that individually or in the aggregate has had or would reasonably be expected to have a material adverse effect on the business, financial
condition or results of operations of such party and its subsidiaries taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, a material adverse effect will not be
deemed to include the impact of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes after the date of the merger agreement in general business, economic or market conditions in the United
States or elsewhere in the world (including changes generally in prevailing interest rates, credit availability and liquidity, currency exchange rates and price levels or trading volumes in the United States or foreign securities or credit markets),
changes in political or social conditions (including civil unrest, protests and public demonstrations) or any other law, directive, pronouncement or guideline issued by a government entity, or any outbreak or escalation of hostilities, declared or
undeclared acts of war or terrorism, in each case generally affecting the industries in which such party and its subsidiaries operate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any changes or developments generally in the industries in which such party or its subsidiaries are expected to
conduct their business after the closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the announcement or the existence of, compliance with or performance under, the merger agreement or the
transactions contemplated thereby (provided that this bullet will not apply to any representation or warranty under specified sections of the merger agreement to the extent the purpose of such representation or warranty is to address the
consequences resulting from the execution and delivery of the merger agreement or the performance of obligations or satisfaction of conditions under the merger agreement); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any taking of any action or failure to take an action at the request of
<FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent or their respective affiliates or that is required by the terms of the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in applicable law, GAAP or accounting standards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">floods, hurricanes, tornados, earthquakes, fires or other natural disasters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">national or international disasters, acts of God, sabotage, calamities, emergencies, or any escalation or
worsening thereof, whether or not occurring or commenced before the date of the merger agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-161- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> and any
political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a governmental entity, the Centers for Disease Control and Prevention or the World Health
Organization, &#147;sheltering in place,&#148; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or any change in such law (including
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures), directive, pronouncement or guideline or interpretation thereof, or the action of any third party arising out of or relating to any of the foregoing, in each case, following the date of the
merger agreement or any material worsening of such conditions threatened or existing as of the date of the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any actions arising from allegations of breach of fiduciary duty or otherwise relating to the merger agreement or
the transactions contemplated thereby; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent to meet any financial projections or
forecasts or estimates of revenues, earnings or other financial metrics for any period (provided that this bullet shall not prevent or otherwise affect a determination that any event, change, effect, development or occurrence underlying such failure
has resulted in, or contributed to a material adverse effect); </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except, with respect to the first, second, fifth, sixth, seventh and
eighth bullet, to the extent disproportionately affecting <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or their respective subsidiaries, taken as a whole, as compared to other companies in the industry in which such party and its
subsidiaries operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representations and warranties in the merger agreement do not survive the effective time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_99"></A>Covenants and Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Conduct of Businesses Prior to the Completion of the Merger </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent has covenanted and agreed that, from and after the date of the merger
agreement until the effective time (or earlier termination of the merger agreement), subject to exceptions specified in the merger agreement, it will use commercially reasonable efforts to conduct its business in all material respects in the
ordinary course of business, and will use commercially reasonable efforts to preserve intact their present lines of business, and to maintain their rights, franchises and permits. Notwithstanding the foregoing, each of
<FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will be permitted to take, and nothing in the merger agreement will prohibit a party from taking, any action reasonably taken or omitted to be taken in connection with or in response to <FONT
STYLE="white-space:nowrap">COVID-19.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the date of the merger agreement until the effective time (or earlier
termination of the merger agreement), subject to exceptions specified in the merger agreement, each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will not and will not permit its subsidiaries to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amend or restate any organizational document, except, in each case, for any immaterial or ministerial amendments
thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">split, combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities
in respect of, in lieu of or in substitution for any shares of its capital stock, except for any such transaction by a wholly owned (direct or indirect) subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent that remains a wholly
owned (direct or indirect) subsidiary following the consummation of such transaction; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorize or pay any dividends on or make any distribution with respect to its outstanding shares of capital
stock (whether in cash, assets, stock or other securities of the party or its subsidiaries), except dividends or distributions by any subsidiaries only to <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent or to any other wholly owned (direct
or indirect) subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-162- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the date of the merger agreement until the effective time (or earlier
termination of the merger agreement), subject to exceptions specified in the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> will not and will not permit any of its subsidiaries to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization, or take any action with respect to any securities owned by such person, in each case, that would reasonably be expected to prevent, materially impede or materially delay the consummation of the merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire (by purchase, merger, joint venture, partnership, consolidation, dissolution, liquidation, tender offer,
exchange offer, recapitalization, reorganization, share exchange, business combination or similar transaction) any business or material amount of assets from any other person except for such acquisitions for an amount not to exceed $100&nbsp;million
in value in the aggregate (for all such transactions), in each case that would not reasonably be expected to (A)&nbsp;impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any authorization, consent, order,
declaration or approval of any governmental entity necessary to consummate the transactions contemplated by the merger agreement or the expiration or termination of any applicable waiting period, (B)&nbsp;materially increase the risk of any
governmental entity entering an order prohibiting the consummation of the transactions contemplated by the merger agreement, (C)&nbsp;materially increase the risk of not being able to remove any such order on appeal or otherwise, or
(D)&nbsp;prevent, materially delay or materially impair the ability of <FONT STYLE="white-space:nowrap">II-VI</FONT> or the Merger Sub to consummate the transactions contemplated by the merger agreement, including the merger and the financings;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, sell, pledge, dispose of or encumber, or authorize the issuance, sale, pledge, disposition or encumbrance
of, any shares of its capital stock or other ownership interest in <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of its subsidiaries or any securities convertible into or exchangeable for any such shares or ownership interest, or any rights,
warrants or options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to cause to be exercisable any otherwise unexercisable option under any existing <FONT
STYLE="white-space:nowrap">II-VI</FONT> benefit plans (except as otherwise provided by the terms of the merger agreement or the express terms of any unexercisable or unexercised options or warrants outstanding on the date of the merger agreement),
other than (A)&nbsp;issuances of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in respect of the exercise or settlement of any <FONT STYLE="white-space:nowrap">II-VI</FONT> stock awards outstanding on the date of the merger
agreement, (B)&nbsp;the sale of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock pursuant to the exercise of <FONT STYLE="white-space:nowrap">II-VI</FONT> options or the settlement of any
<FONT STYLE="white-space:nowrap">II-VI</FONT> stock awards, if necessary to effectuate an option direction upon exercise or for withholding of taxes in accordance with their terms on the date of the merger agreement, (C)&nbsp;grants of equity awards
in the ordinary course of business, in amounts consistent with past practice, pursuant to any <FONT STYLE="white-space:nowrap">II-VI</FONT> benefit plan, and (D)&nbsp;the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock or the grant of equity awards in connection with the acquisition of any business or material amount of assets from any other person that is permitted by the terms of the merger agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur, assume, guarantee or otherwise become liable for any indebtedness for borrowed money or any guarantee of
such indebtedness (other than the debt financing) except any such incurrence, assumption, guarantee or other liability which would not be reasonably expected to prevent, materially delay or materially impair the ability of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or the Merger Sub to consummate the transactions contemplated by the merger agreement, including the merger and the debt financings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly or indirectly, purchase, redeem or otherwise acquire any shares of the capital stock of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or any of its subsidiaries or any rights, warrants or options to acquire any such shares, except for transactions among <FONT STYLE="white-space:nowrap">II-VI</FONT> and its wholly owned (direct or indirect)
subsidiaries or among <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> wholly owned (direct or indirect) subsidiaries or in connection with the exercise of any options, or the vesting or settlement of any
<FONT STYLE="white-space:nowrap">II-VI</FONT> equity awards issued in the ordinary course of business; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">agree, in writing or otherwise, to take any of the foregoing actions that are prohibited pursuant to the merger
agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-163- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the date of the merger agreement until the effective time (or earlier
termination of the merger agreement), subject to exceptions specified in the merger agreement, Coherent will not and will not permit its subsidiaries to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization, or take any action with respect to any securities owned by such person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any acquisition of any other person or business or make any loans, advances or capital contributions to, or
investments in, any other person, except as made in connection with any transaction among Coherent and its wholly owned (direct or indirect) subsidiaries or among Coherent&#146;s wholly owned (direct or indirect) subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell, lease, license, transfer, exchange or swap or otherwise dispose of or encumber (other than permitted liens)
(or enter into, amend, modify, or terminate any contract to do any of the foregoing with respect to) any intellectual property, any real property, or any tangible properties or assets, except in connection with (A)&nbsp;sales, transfers and
dispositions of inventory and products, <FONT STYLE="white-space:nowrap">(B)&nbsp;non-exclusive</FONT> licenses of intellectual property to customers and suppliers, or (C)&nbsp;leases of real property under which Coherent or any of its subsidiaries
is a tenant, in the case of each of clauses (A)&nbsp;through (C), in the ordinary course of business or encumbrances under the Coherent credit agreement contemplated in the merger agreement (provided that prior to entering into any lease of real
property in the ordinary course of business with an annual rent amount exceeding $1,000,000, Coherent will provide advance notice to, and reasonably consult with, <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect thereto);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorize any capital expenditures except for capital expenditures (A)&nbsp;to maintain, replace or repair
damaged assets or (B)&nbsp;otherwise provided for in Coherent&#146;s capital expenditure budget set forth in its disclosure letter; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as permitted in the merger agreement or in connection with any repayment, redemption or discharge of any
Coherent indebtedness, enter into, modify, amend or terminate, or waive any material rights under any material contract or under any permit, or enter into any new contract which would be a material contract if it were in effect on the date of the
merger agreement, in each case, other than in the ordinary course of business (provided that (a)&nbsp;this ordinary course of business exception will not apply with respect to any contract of the nature described in designated sections of the merger
agreement and (b)&nbsp;promptly following entering into, modifying, amending or terminating any material contract of the nature described in the merger agreement, Coherent will provide notice to <FONT STYLE="white-space:nowrap">II-VI</FONT> of such
action to the extent permitted under the terms of the relevant material contract; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">materially change any material accounting policies or procedures or any of its methods of reporting income,
deductions or other material items, except as required by GAAP, SEC rule or policy or applicable law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, sell, pledge, dispose of or encumber (other than permitted liens), or authorize the issuance, sale,
pledge, disposition or encumbrance of (other than permitted liens), any shares of its capital stock or other ownership interest in Coherent or any of its subsidiaries or any securities convertible into or exchangeable for any such shares or
ownership interest, or any rights, warrants or options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to cause to be exercisable any otherwise unexercisable option under
any existing Coherent benefit plans (except as otherwise provided by the terms of the merger agreement or the express terms of any unexercisable or unexercised warrants outstanding on the date of the merger agreement), other than (A)&nbsp;issuances
of shares of Coherent common stock in respect of the settlement of any Coherent RSUs or the exercise of rights under the Coherent ESPP, (B)&nbsp;the sale of shares of Coherent common stock pursuant to the vesting and settlement of Coherent RSUs for
withholding of taxes, (C)&nbsp;grants of service-based vesting Coherent RSUs (without performance-vesting goals or metrics) in the ordinary course of business on terms consistent with past practices (including vesting), which grants will, in the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-164- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
aggregate with respect to all grants made to each group of employees having the same employment level, not exceed the aggregate grant date value of Coherent RSUs granted during calendar year 2020
to each such group of employees as set forth in Coherent&#146;s disclosure letter; provided that grants to Coherent&#146;s change in control plan participants following the date of the merger agreement will not provide for accelerated vesting upon a
qualifying termination or upon consummation of the merger or any other transaction contemplate thereby, in each case, under the Coherent&#146;s change in control plan, certain sections of the merger agreement, or any other contract, and
(D)&nbsp;pledges under the Coherent credit agreement contemplated in the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur, assume, guarantee or otherwise become liable for any additional indebtedness for borrowed money or any
guarantee of such indebtedness, except for (A)&nbsp;additional indebtedness not to exceed $5&nbsp;million (provided that prompt written notice of any such indebtedness in excess of $1&nbsp;million is provided to
<FONT STYLE="white-space:nowrap">II-VI),</FONT> (B) any indebtedness among Coherent and its wholly owned (direct or indirect) subsidiaries or among Coherent&#146;s wholly owned (direct or indirect) subsidiaries and (C)&nbsp;any guarantees by
Coherent of indebtedness of subsidiaries of Coherent or guarantees by Coherent&#146;s subsidiaries of indebtedness of Coherent or any subsidiary of Coherent, which indebtedness is under the Coherent credit agreement contemplated in the merger
agreement or incurred in compliance with this paragraph; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commence or threaten (other than to protect a material right), or waive, release, assign, settle or compromise
any pending or threatened action or proceeding, other than waivers, releases, assignments, settlements or compromises that do not (A)&nbsp;exceed $2&nbsp;million individually and $6&nbsp;million in the aggregate and (B)&nbsp;involve any admission of
wrongdoing or equitable relief; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change or revoke any material tax election, change any material tax accounting method, file any material amended
tax return, enter into any closing agreement, request any material tax ruling, settle or compromise any material tax proceeding or surrender any claim for a material refund of taxes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">except as permitted in the merger agreement: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">grant or provide any severance or termination payments or benefits to any current or former employee, officer, <FONT
STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor or consultant of Coherent or any of its subsidiaries (including any obligation to <FONT STYLE="white-space:nowrap">gross-up,</FONT> indemnify or otherwise
reimburse any such individual for any tax incurred by any such individual, including under Section&nbsp;409A or 4999 of the Code), except for severance or termination payments or benefits granted or provided in the ordinary course of business in
connection with retention, new hires, or promotions of employees of Coherent or any of its subsidiaries with a title of Vice President or below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerate the time of payment or vesting of, or the lapsing of restrictions with respect to, or fund or
otherwise secure the payment of, any compensation or benefits (including any equity or equity-based awards) to any current or former employee, officer, <FONT STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor
or consultant of Coherent or any of its subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the compensation payable to any current or former employee, officer,
<FONT STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor or consultant of Coherent or any of its subsidiaries, other than in the ordinary course of business (including in connection with promotions in the
ordinary course of business) for employees with a title of Vice President or below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish, adopt, terminate or amend any material Coherent benefit plan or any plan, program, arrangement, policy
or agreement that would be a Coherent benefit plan if it were in existence on the date of the merger agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire or retain any person to be an officer, employee, or individual independent contractor or consultant of
Coherent or any of its subsidiaries, other than the hiring or retention of: (i)&nbsp;employees with a title of Vice President or below, <FONT STYLE="white-space:nowrap">(ii)&nbsp;non-employee</FONT> directors or (iii)&nbsp;independent contractors
and consultants having annual compensation of less than $200,000 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-165- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
(excluding, for the avoidance of doubt, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors), in each case, in the ordinary course of business; provided that, for purposes of clause
(iii), any such contractor or consultant will enter into a service agreement on substantially a form made available to <FONT STYLE="white-space:nowrap">II-VI</FONT> prior to the date of the merger agreement and any variation which has the net effect
of a material negative or detrimental impact on Coherent will be subject to review and approval by <FONT STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terminate the employment of any current employee with a title of Vice President or above other than for cause; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into, adopt, materially amend, terminate or extend any local collective bargaining agreement or other
similar labor-related agreement, except, in each case, as required by law and expressly required pursuant to the terms of such agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">agree, in writing or otherwise, to take any of the foregoing actions that are prohibited pursuant to the merger
agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Regulatory Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing of the merger, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub and Coherent shall take, or cause to be taken,
all actions, and do, or cause to be done, all things necessary, proper or advisable under the merger agreement and any applicable antitrust laws, including the HSR Act, to consummate and make effective, as promptly as practicable after the date of
the merger agreement, the merger, including (A)&nbsp;preparing and filing all documentation to effect all necessary and advisable filings, notifications, notices, petitions, statements, registrations, submissions of information, applications and
other documents (including any required or recommended filings under applicable antitrust laws) that are or may become necessary, proper or advisable in connection with the consummation of the transactions contemplated by the merger agreement,
(B)&nbsp;satisfying the conditions to consummating the merger, (C)&nbsp;defending any lawsuits or other legal proceedings, whether judicial or administrative, challenging the merger agreement or the consummation of the transactions contemplated by
the merger agreement, including seeking to have any stay or temporary restraining order entered by any court or other governmental entity vacated or reversed, (D)&nbsp;taking all actions necessary to obtain (and cooperating with each other in
obtaining) as promptly as practicable any consent, authorization, order or approval of, or any exemption by, or to avoid an investigation, action, proceeding or other challenge of the legality of the transactions contemplated by the merger agreement
by, any governmental entity required to be obtained or made by <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub, Coherent or any of their respective subsidiaries in connection with the merger or the taking of any action contemplated by the
merger agreement (collectively, which we refer to as &#147;regulatory approvals&#148;), and (E)&nbsp;executing and delivering any additional instruments necessary to consummate the merger and to fully carry out the purposes of the merger agreement.
Additionally, each of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub, Coherent and any of their respective affiliates shall not take any action after the date of the<B><I> </I></B>merger agreement that would reasonably be expected to (i)
impose any material delay in the obtaining of, or materially increase the risk of not obtaining, the expiration, termination or waiver of any applicable waiting period pursuant to the HSR Act, or any other regulatory approval necessary to consummate
the transactions contemplated by the merger agreement, (ii)&nbsp;materially increase the risk of any governmental entity entering an injunction or order prohibiting the consummation of the transactions contemplated by the merger agreement or
(iii)&nbsp;materially increase the risk of not being able to remove any such injunction or order on appeal or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent shall file, as soon as practicable and advisable after the date of the merger agreement, all notices, reports and other documents required to be filed by such party with any governmental entity
with respect to the merger and the other transactions contemplated by the merger agreement, and shall submit as promptly as reasonably practicable any additional information requested by any such governmental entity. Without limiting the generality
of the foregoing, each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent shall, in consultation and cooperation with the other: (i)&nbsp;within ten business days after the date of the merger agreement (or such other date as may be
mutually agreed to by <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent), prepare and file the notifications required under the HSR Act; and (ii)&nbsp;as promptly as practicable and advisable after the date of the merger agreement, but in
no event later </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-166- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
than as required by applicable antitrust laws, prepare and file, or <FONT STYLE="white-space:nowrap">pre-file</FONT> with regard to any governmental entity that requires such <FONT
STYLE="white-space:nowrap">pre-filing</FONT> prior to any formal filing of, all other notifications required under any other antitrust laws. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent shall respond as promptly as reasonably
practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other governmental entity in connection with antitrust or related matters. Neither <FONT
STYLE="white-space:nowrap">II-VI</FONT> nor Coherent shall extend any waiting period under the HSR Act or other antitrust laws without, or enter into any agreement with the FTC or the United States Department of Justice or any other governmental
entity that would restrain, delay or prevent the consummation of the transactions contemplated by the merger agreement except with, the prior written consent of the other parties to the merger agreement (which shall not be unreasonably withheld,
conditioned or delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s
undertakings described above, <FONT STYLE="white-space:nowrap">II-VI</FONT> and its affiliates shall take any and all steps and agree to any and all regulatory remedies or commitments necessary to avoid or eliminate each and every impediment under
any applicable antitrust laws that may be asserted by any governmental entity so as to enable the parties to close the merger as promptly as practicable, and in any event prior to the date upon which either party may terminate the merger agreement
in accordance with its terms. Notwithstanding the foregoing or anything else in the merger agreement to the contrary, none of <FONT STYLE="white-space:nowrap">II-VI</FONT> and its affiliates shall be required to take any steps or agree to (and
Coherent and its affiliates shall not without <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> prior written consent take any steps or agree to) any regulatory remedies or commitments that may be necessary to avoid or eliminate any impediment
under any applicable antitrust law that may be asserted by the People&#146;s Republic of China or any of its related governmental entities to sell, divest, license, hold separate, or otherwise dispose of any assets, material intellectual property,
licenses, product lines, operations or businesses relating to any business or operations of a party or any of its subsidiaries (including any that are used in or are a component), but excluding any business or operations of a party or any of its
subsidiaries to the extent it competes in China with any business or operations of the other party or any of its subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Employee Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a <FONT STYLE="white-space:nowrap">one-year</FONT> period commencing on the closing date (which we refer to as the &#147;continuation
period&#148;), each employee of Coherent or its subsidiaries who remains employed by <FONT STYLE="white-space:nowrap">II-VI</FONT> or its affiliates (which we refer to each as a &#147;continuing employee&#148;) will receive from <FONT
STYLE="white-space:nowrap">II-VI</FONT> (or its applicable affiliate)&nbsp;(i) at least the same base salary that was provided to such continuing employee immediately prior to the closing date; (ii)&nbsp;target total direct compensation (i.e., base
salary, target annual bonus opportunity, and long-term equity incentive opportunity) that is at least as favorable in the aggregate as the target total direct compensation in effect for such continuing employee immediately prior to the closing date;
and (iii)&nbsp;other compensation and employee benefits (excluding those contemplated by clauses (i)&nbsp;and (ii), defined benefit pension, nonqualified deferred compensation, post-termination or retiree health or welfare, and severance) that are
substantially as favorable in the aggregate as the compensation and benefits provided to similarly situated employees of <FONT STYLE="white-space:nowrap">II-VI</FONT> or its affiliates or, if more favorable, provided to such continuing employee by
Coherent under Coherent&#146;s benefit plans or otherwise under any applicable collective bargaining agreement or other labor-related agreement or arrangement applicable to such continuing employee immediately prior to the closing date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any continuing employee whose employment is terminated other than for cause during the continuation period will be entitled to receive the
severance payments and benefits that <FONT STYLE="white-space:nowrap">II-VI</FONT> provides to similarly situated employees of <FONT STYLE="white-space:nowrap">II-VI</FONT> or its affiliates or, if more favorable, such continuing employee would have
been entitled to receive from Coherent and its affiliates under its applicable written severance plans and policies as in effect immediately prior to the closing and that are scheduled on the relevant section of the Coherent disclosure letter.
However, to the extent such continuing employee holds converted RSUs, such converted RSUs will vest in accordance with the terms of the merger agreement or, if more favorable, the terms of any vesting acceleration provided for in any plan or
arrangement maintained by Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of their respective subsidiaries or any agreement between Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of their respective subsidiaries, on
the one hand, and any continuing employee, on the other hand. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-167- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each individual who is employed by Coherent or any of its affiliates as of immediately prior
to the closing and is a participant in a cash bonus or short-term incentive program maintained by Coherent or any of its affiliates for the year in which the closing occurs will be eligible to receive a cash bonus based on the higher of the target
level achievement and actual level of achievement of the applicable performance criteria in effect immediately prior to the closing, determined immediately prior to the closing by the compensation committee of the Coherent board in its reasonable
discretion based on its assessment of such performance criteria. The bonus will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the number of days in the applicable performance period that have elapsed as of the closing. Any such bonus
will be paid to the applicable employee no later than the next payroll of Coherent or the applicable affiliate employing such employee that occurs following the closing date and, in any event, no later than 20&nbsp;days following the closing date.
Following the closing, continuing employees will be eligible to participate in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cash bonus or short-term incentive programs on a <FONT STYLE="white-space:nowrap">pro-rated</FONT> basis for the
remainder of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year in which the closing occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will, and will cause any of its applicable affiliates to (i)&nbsp;waive all limitations as to
any preexisting condition or waiting periods in its applicable welfare plans with respect to participation and coverage requirements applicable to each continuing employee under any welfare plans that such continuing employee may be eligible to
participate in after the closing and (ii)&nbsp;credit each continuing employee for any copayments, deductibles, offsets or similar payments made under a Coherent benefit plan during the plan year that includes the closing for purposes of satisfying
any applicable copayment, deductible, offset or similar requirements under the comparable plans of <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of its affiliates. As of the closing, <FONT STYLE="white-space:nowrap">II-VI</FONT> will, or will
cause its applicable affiliates to, credit to continuing employees the amount of vacation time that such employees had accrued under any applicable Coherent benefit plan as of the closing. In addition, as of the closing, <FONT
STYLE="white-space:nowrap">II-VI</FONT> will, and will cause its applicable affiliates to give continuing employees full credit for purposes of eligibility, vesting and determination of level of benefits under any employee benefit and compensation
plans or arrangements (including for purposes of vacation and severance but excluding for any purpose benefits under defined benefit plans, nonqualified deferred compensation, post-termination or retiree medical plans or frozen or grandfathered
benefit plans) maintained by <FONT STYLE="white-space:nowrap">II-VI</FONT> or its applicable affiliates that such continuing employees may be eligible to participate in after the closing for such continuing employees&#146; service with Coherent or
any of its subsidiaries to the same extent that such service was credited for purposes of any comparable Coherent benefit plan immediately prior to the closing, except to the extent such treatment would result in duplicative benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in the merger agreement, from and after the closing date,
<FONT STYLE="white-space:nowrap">II-VI</FONT> will cause Coherent to honor, in accordance with their terms without giving effect to any amendments thereto after the closing date, all payments, benefits and obligations under any employment, change in
control and severance plans, agreements and arrangements of Coherent and its affiliates that are set forth in the relevant section of the Coherent disclosure letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The occurrence of the closing will be deemed to be a change in control (or a similar term) under all Coherent benefit plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent will terminate, effective as of the day before Coherent becomes a member of the same controlled group of corporations as <FONT
STYLE="white-space:nowrap">II-VI,</FONT> any and all 401(k) plans maintained by Coherent or any of its subsidiaries (which we refer to as the &#147;Coherent qualified plans&#148;) and any Coherent benefit plan listed on the relevant section of the
Coherent disclosure letter, unless <FONT STYLE="white-space:nowrap">II-VI</FONT> provides written notice to Coherent that such benefit plan will not be terminated at least ten business days before the closing date. In such event, prior to the
closing date and thereafter, Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> will take any and all action as may be required, including amendments to a U.S. <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution plan
maintained by <FONT STYLE="white-space:nowrap">II-VI</FONT> or one of its subsidiaries (which we refer to each as a <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> qualified plan&#148;), to vest all account balances in the terminated Coherent
qualified plans and permit each continuing employee to make rollover contributions of eligible rollover distributions in cash or notes in an amount equal to the eligible rollover distribution portion of the account balance distributable to such
continuing employee from such Coherent qualified plan to the corresponding <FONT STYLE="white-space:nowrap">II-VI</FONT> qualified plan. If the Coherent qualified plan is terminated as described herein, (i)&nbsp;the continuing employees will be
eligible to participate in a <FONT STYLE="white-space:nowrap">II-VI</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-168- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualified plan as soon as practicable following the closing date and (ii)&nbsp;Coherent will provide <FONT STYLE="white-space:nowrap">II-VI</FONT> evidence that the Coherent qualified plans have
been terminated pursuant to resolutions of the Coherent board or the board of directors of its subsidiaries, as applicable. The form and substance of such resolutions will be subject to the reasonable review and approval of <FONT
STYLE="white-space:nowrap">II-VI,</FONT> which will not be unreasonably withheld or delayed. Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> will use their respective reasonable best efforts to take whatever actions are needed to cause
each continuing employee to be immediately eligible, as of the closing date, to receive matching contributions consistent with the plan terms under the <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution plan in which such
continuing employee is eligible to participate from and after the closing. However, the total matching contributions payable to a continuing employee for the calendar year in which the closing date occurs will not exceed the maximum amount of
matching contributions that such continuing employee otherwise could have received from Coherent had such continuing employee been participating in such <FONT STYLE="white-space:nowrap">tax-qualified</FONT> deferred contribution plan for the full
calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of the closing, Coherent will pay to each &#147;exempt&#148; employee located in North America an amount
equal to such employee&#146;s accrued or credited but unused vacation time. To the extent not paid at the closing, <FONT STYLE="white-space:nowrap">II-VI</FONT> will cause such amounts to be paid to the applicable employee no later than the next
payroll of Coherent or the applicable affiliate employing such employee that occurs following the closing date and, in any event, no later than 20&nbsp;days following the closing date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing, Coherent will, and will cause its subsidiaries to, comply with any notice or consultation requirement under any
collective bargaining agreement, works council agreement or similar labor-related agreement with respect to the merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Director
and Officer Indemnification and Insurance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement provides that all rights to exculpation, indemnification and
advancement of expenses for acts or omissions occurring at or prior to the effective time, as provided in Coherent&#146;s or its subsidiaries&#146; respective certificate of incorporation or bylaws or other organizational documents or in any
agreement, will survive the merger and will continue in full force and effect. For a period of six years from the effective time, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the surviving corporation will maintain in effect any and all
exculpation, indemnification and advancement of expenses provisions of Coherent&#146;s and any of its subsidiaries&#146; certificate of incorporation and bylaws or similar organizational documents in effect immediately prior to the effective time or
in any indemnification agreements of Coherent or its subsidiaries with any of their respective current or former directors, officers or employees in effect immediately prior to the effective time, and will not amend, repeal or otherwise modify any
such provisions or the exculpation, indemnification or advancement of expenses provisions of the surviving corporation&#146;s organizational documents in any manner that would adversely affect the rights thereunder of any individuals who,
immediately before the effective time, were current or former directors, officers or employees of Coherent or any of its subsidiaries. However, all rights to indemnification and exculpation in respect of any action pending or asserted or any claim
made within such period will continue until the disposition of such action or resolution of such claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement requires the
surviving corporation and <FONT STYLE="white-space:nowrap">II-VI</FONT> to cause the surviving corporation, to indemnify and hold harmless each current and former director, officer or employee of Coherent or any of its subsidiaries and each person
who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise if such service was at the request or for the benefit of Coherent or any
of its subsidiaries (which we refer to each, together with such person&#146;s heirs, executors or administrators, as an &#147;indemnified party&#148;), in each case against any costs or expenses, judgments, fines, losses, claims, damages,
liabilities and amounts paid in settlement in connection with any actual or threatened written claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative (an &#147;action&#148;), arising out of,
relating to or in connection with any action or omission by them in their capacities as such. In the event of any such action, the surviving corporation will reasonably cooperate with the indemnified party in the defense of any such action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-169- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement requires the surviving corporation and
<FONT STYLE="white-space:nowrap">II-VI</FONT> to cause the surviving corporation, to maintain in effect, for a period of six (6)&nbsp;years from the effective time, the coverage provided by the directors&#146; and officers&#146; liability insurance
and fiduciary liability insurance maintained by or for the benefit of Coherent and its subsidiaries as of the effective time (which we refer to as the &#147;D&amp;O insurance&#148;) or provide substitute policies for Coherent, its subsidiaries and
the persons who are covered by the D&amp;O insurance, with terms, conditions, retentions and limits of liability that are not less favorable than the D&amp;O insurance with respect to acts or omissions occurring or alleged to have occurred at or
prior to the effective time. However, <FONT STYLE="white-space:nowrap">II-VI</FONT> will not be required to pay annual premiums in excess of 350% of the last aggregate annual premium paid by Coherent for the D&amp;O insurance (which we refer to as
the &#147;maximum amount&#148;). Furthermore, if such insurance is not available or the aggregate annual premium for such insurance exceeds the maximum amount, <FONT STYLE="white-space:nowrap">II-VI</FONT> will cause the surviving corporation to
obtain, and the surviving corporation will obtain, the best coverage available for a cost not exceeding the maximum amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In lieu of
the foregoing, (i)&nbsp;Coherent may, in its sole discretion, or <FONT STYLE="white-space:nowrap">(ii)&nbsp;II-VI</FONT> may, in each case, at <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> cost, purchase directors&#146; and officers&#146;
liability and fiduciary liability &#147;tail&#148; insurance with terms, conditions, retentions and limits of liability that are not less favorable than the D&amp;O insurance, and that is otherwise reasonably satisfactory to Coherent, with respect
to acts or omissions occurring or alleged to have occurred at or prior to the effective time. In no event will the cost of such &#147;tail&#148; insurance, if purchased by Coherent, exceed the maximum amount and, if such &#147;tail&#148; insurance
is purchased, <FONT STYLE="white-space:nowrap">II-VI</FONT> will have satisfied their obligation to provide and maintain D&amp;O insurance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Additional Covenants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement also contains additional covenants, including, among others, covenants relating to the access to information of the other
company, the filing of this joint proxy statement/prospectus, third-party consents and approvals, exemption from takeover laws, public announcements with respect to the transactions contemplated by the merger agreement, control of the other
party&#146;s operations prior to the effective time, exemption under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act, shareholder or stockholder litigation relating to the transactions contemplated by the merger agreement, the
listing of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued in the merger, cooperation on financing and indebtedness matters, the activities and voting of the Merger Sub, the resignation of the directors and
officers of each Coherent subsidiary and certain tax matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_100"></A><FONT STYLE="white-space:nowrap">II-VI</FONT> Governance
Post-Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have agreed to certain provisions
relating to the governance of <FONT STYLE="white-space:nowrap">II-VI</FONT> after the merger, including the composition of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board of directors. At the effective time, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board will be comprised of 13 directors, including two directors designated by Coherent, and reasonably acceptable to <FONT STYLE="white-space:nowrap">II-VI.</FONT> These two directors must have been directors
on the Coherent board immediately prior to the effective time and must each qualify as an &#147;independent director&#148; under applicable Nasdaq rules and regulations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_101"></A>Shareholder and Stockholder Meetings and Recommendation of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and
Coherent&#146;s Boards of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have each agreed to hold the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting and the Coherent special meeting as soon as practicable after the effectiveness of the registration statement of which this joint proxy statement/prospectus is a part. <FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent may each choose to postpone or adjourn its own special meeting (the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting, as the case may be) up to two
times and for up to 45&nbsp;days in the aggregate, (i)&nbsp;for the absence of a quorum, (ii)&nbsp;in the event of a board recommendation change by its respective board of directors or (iii)&nbsp;in the event of a change to the method or structure
of effecting the combination of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent must each adjourn or postpone its own special meeting (the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting, as the case may be) at the request of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-170- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the other party up to two times and for up to 45&nbsp;days in the aggregate in the event of a (x)&nbsp;board recommendation change by its respective board of directors or (y)&nbsp;change to the
method or structure of effecting the combination of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> and Coherent have agreed under the merger agreement to, through their respective boards of directors, recommend that <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders approve the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> recommendation&#148;) and that Coherent stockholders approve the Coherent merger proposal (which we refer
to as the &#147;Coherent recommendation&#148;), and to include such recommendations in this joint proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger
agreement provides that, subject to the exceptions described below, neither the <FONT STYLE="white-space:nowrap">II-VI</FONT> board nor the Coherent board will (i)&nbsp;withhold, withdraw, modify or qualify, in each case in a manner adverse to the
other party, its approval or recommendation of the merger or the merger agreement, (ii)&nbsp;fail to include in this joint proxy statement/prospectus its recommendation in favor of the merger agreement and the
<FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal or the Coherent merger proposal, as applicable, (iii)&nbsp;adopt, approve, recommend or endorse an alternative transaction proposal or publicly announce an intention to adopt,
approve, recommend or endorse an alternative transaction proposal, (iv)&nbsp;fail to publicly and without qualification (x)&nbsp;recommend against any alternative transaction proposal or (y)&nbsp;reaffirm its recommendation of the merger agreement
and the merger within ten business days of the other party&#146;s written request to do so (or, if earlier, at least two business days prior to the <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting or the Coherent special meeting, as
applicable), following the public announcement of any alternative transaction proposal, or (v)&nbsp;publicly propose to do any of the foregoing actions in clauses (i)&nbsp;through (iv) (any action in clauses (i)&nbsp;through (iv) is referred to in
the joint proxy statement/prospectus as a &#147;board recommendation change&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing restrictions, in the
event that, prior to obtaining the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or the approval of the Coherent merger proposal by Coherent
stockholders, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or the Coherent board, respectively, may effect a board recommendation change if (i)&nbsp;after receiving advice of its outside counsel and, with respect to financial matters, its
financial advisors, it determines in good faith that taking such action would be required to comply with its fiduciary duties under applicable law, (ii)&nbsp;it has provided the other party five business days&#146; written notice that it intends to
effect a board recommendation change and a reasonable description of the event or circumstances giving rise to its determination to take such action and (iii)&nbsp;at the end of such notice period, taking into account any amendment or modification
to the merger agreement proposed by the other party and, after receiving the advice of its outside counsel and, with respect to financial matters, its financial advisors, it determines in good faith that taking such action would nevertheless be
required to comply with its fiduciary duties under applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_102"></A>Agreement Not to Solicit Other Offers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent has agreed that it will, and will cause each of its subsidiaries to, and
instruct its and their respective officers, directors, employees, agents, financial advisors, investment bankers, attorneys, accountants and other representatives (collectively, &#147;representatives&#148;) to: (i)&nbsp;immediately cease any
solicitation, knowing encouragement, discussions or negotiations with any persons that may be ongoing with respect to any takeover proposal (including any solicitation, knowing encouragement, discussions, or negotiations that may be ongoing as of
the date of the merger agreement, including with Lumentum Holdings Inc. and MKS Instruments, Inc. and their respective affiliates and any representatives of the foregoing), and (ii)&nbsp;from and after the date of the merger agreement until the
effective time or, if earlier, the termination of the merger agreement, not, directly or indirectly, (A)&nbsp;solicit, initiate or knowingly facilitate or knowingly encourage any inquiries regarding, or the making of any proposal or offer that
constitutes, or would reasonably be expected to lead to, a takeover proposal, (B)&nbsp;engage in, continue or otherwise participate in any substantive discussions or negotiations regarding, or furnish to any other person any <FONT
STYLE="white-space:nowrap">non-public</FONT> information in connection with or for the purpose of encouraging or facilitating, a takeover proposal or (C)&nbsp;approve, recommend or enter into, or propose to approve, recommend or enter into, any
letter of intent or similar document, agreement, commitment, or agreement in principle providing for a takeover proposal (including, in each case of clauses (A), (B), and (C), from, with, or otherwise with respect
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-171- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to with Lumentum Holdings Inc. and MKS Instruments, Inc. and their respective affiliates and any representatives of the foregoing). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent has agreed that it will not take any action to exempt any person from the
restrictions on &#147;business combinations&#148; contained in DGCL 203 or their respective organizational documents or otherwise cause such restrictions not to apply. Except (i)&nbsp;as necessary to take any actions that <FONT
STYLE="white-space:nowrap">II-VI,</FONT> Coherent or any third party would otherwise be permitted to take pursuant to the merger agreement or (ii)&nbsp;if the <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent board determines in good faith,
after consultation with its outside financial advisors and outside legal counsel, that any such action or forbearance would reasonably be expected to be inconsistent with its fiduciary duties under applicable law,
<FONT STYLE="white-space:nowrap">(A)&nbsp;II-VI</FONT> or Coherent, as applicable, and its subsidiaries will not release any third party from, or waive, amend or modify any provision of, or grant permission under any standstill or confidentiality
provision in any agreement to which <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent or any of its subsidiaries is a party and <FONT STYLE="white-space:nowrap">(B)&nbsp;II-VI</FONT> or Coherent, as applicable, will, and will cause its
subsidiaries to, enforce the confidentiality and standstill provisions of any such agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, if at any time from and after the
date of the merger agreement and prior to obtaining the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or the approval of the Coherent merger
proposal by Coherent stockholders, <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, respectively, directly or indirectly receives a bona fide, unsolicited written takeover proposal from any person that did not result from a material breach
(including, for the avoidance of doubt, a deemed material breach) of Coherent&#146;s nonsolicitation obligations under the merger agreement and if the <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent board determines in good faith, after
consultation with its outside financial advisors and outside legal counsel, that such takeover proposal constitutes or would reasonably be expected to lead to a superior proposal, and failure to take such action would reasonably be expected to be
inconsistent with its fiduciary duties under applicable law, then <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent and its representatives may, directly or indirectly, (i)&nbsp;furnish, pursuant to an acceptable confidentiality agreement,
information (including <FONT STYLE="white-space:nowrap">non-public</FONT> information) with respect to the party and its subsidiaries, and afford access to the business, properties, assets, employees, officers, contracts, books and records of the
party and its subsidiaries, to the person that has made such takeover proposal and its representatives and potential sources of funding. <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, will substantially concurrently with
the delivery to such person provide to the other party any <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning the party or any of its subsidiaries that is provided or made available to such person or its representatives unless
such <FONT STYLE="white-space:nowrap">non-public</FONT> information has been previously provided or made available to the other party and (ii)&nbsp;engage in or otherwise participate in discussions or negotiations with the person making such
takeover proposal (including as a part thereof, making counterproposals) and its representatives and potential sources of financing regarding such takeover proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will promptly (within 24&nbsp;hours after receipt) notify, orally and in
writing, the other party of any takeover proposal received by the party or any of its representatives. Notice will include the identity of the person making the takeover proposal and the material terms and conditions thereof and indicate whether the
party has furnished <FONT STYLE="white-space:nowrap">non-public</FONT> information to, or entered into discussions or negotiations with, such third party. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent will keep the other party
reasonably informed on a reasonably current basis as to the status of such takeover proposal. Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent agrees that it and its subsidiaries will not enter into any agreement with any person
subsequent to the date of the merger agreement which prohibits <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent from providing any information to the other party in accordance with the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and the Coherent board will not (A)&nbsp;fail to include the <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent recommendation in the joint proxy statement/prospectus, (B)&nbsp;change, qualify, withhold, withdraw or modify, or authorize or publicly propose to change, qualify, withhold, withdraw or modify, in
a manner adverse to the other party, the <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent recommendation, (C)&nbsp;make or publicly propose to make any recommendation in connection with a tender offer or exchange offer other than a
recommendation against such offer, or (D)&nbsp;within five business days after a request by the other party, fail to recommend against a takeover proposal or fail to reaffirm the <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent
recommendation. However, (1)&nbsp;such five business day period will be extended for an additional five business days following any material modification to any takeover proposal occurring after the </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-172- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
receipt of the other party&#146;s written request and (2)&nbsp;the other party will be entitled to make such a written request for reaffirmation only once for each takeover proposal and once for
each material amendment to such takeover proposal; (any action described above in this paragraph being referred to as an &#147;adverse recommendation change&#148;). Each of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board and the Coherent
board also will not authorize, cause or permit <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or any of its subsidiaries to enter into any letter of intent, agreement, commitment or agreement in principle providing for any takeover proposal
(other than an acceptable confidentiality agreement entered into in accordance with the merger agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders approve the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal and before Coherent stockholders approve the Coherent merger proposal, after receiving a bona fide unsolicited
written takeover proposal after the date of the merger agreement that did not result from a material breach (including, for the avoidance of doubt, a deemed material breach) of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> nonsolicitation
obligations under the merger agreement, (x)&nbsp;the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or the Coherent board, as applicable, may make an adverse recommendation change if it has determined in good faith, after consultation with its
outside financial advisors and outside legal counsel, that (i)&nbsp;such takeover proposal constitutes a superior proposal and (ii)&nbsp;in light of such takeover proposal, the failure to take such action would reasonably be expected to be
inconsistent with the board&#146;s fiduciary duties under applicable law and/or <FONT STYLE="white-space:nowrap">(y)&nbsp;II-VI</FONT> or Coherent, as applicable, may terminate the merger agreement in order to enter into a binding written agreement
with respect to a superior proposal. Prior to making any adverse recommendation change or terminating the merger agreement as described above, (A)&nbsp;the party has to give the other party at least four business days&#146; prior written notice of
its intention to take such action (which notice will specify the material terms and conditions of any such superior proposal) and contemporaneously provide to the other party a copy of the superior proposal and a copy of any written proposed
transaction documents with the person making such superior proposal, (B)&nbsp;the party has to negotiate in good faith with the other party during such notice period, to the extent the other party wishes to negotiate in good faith, to enable the
other party to propose revisions to the terms of the merger agreement such that it would cause such superior proposal to no longer constitute a superior proposal, (C)&nbsp;following the end of such notice period, the board will have considered in
good faith any revisions to the terms of the merger agreement proposed in writing by the other party, and will have determined, after consultation with its outside financial advisors and outside legal counsel, that the superior proposal continues to
constitute a superior proposal if the revisions proposed by the other party were to be given effect, and (D)&nbsp;in the event of any change to any material terms of such superior proposal, the party will, in each case, deliver to the other party an
additional notice consistent with that described in the merger agreement and a new notice period will commence during which time the party will be required to comply with the requirements of the merger agreement anew with respect to such additional
notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than in connection with a superior proposal, nothing in the merger agreement will prohibit or restrict the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board or the Coherent board from making an adverse recommendation change in response to an intervening event (as defined below) if the board has determined in good faith, after consultation with its outside
financial advisors and outside legal counsel, that the failure of the party board to make an adverse recommendation change would be inconsistent with the board&#146;s fiduciary duties under applicable law. Prior to making such adverse recommendation
change, (i)&nbsp;the party will give the other party at least four business days&#146; prior written notice of its intention to take such action, which notice will specify the reasons therefor, (ii)&nbsp;the party will negotiate, and direct its
representatives to negotiate, in good faith with the other party during such notice period after giving any such notice, to the extent the other party wishes to negotiate, to enable the other party to propose revisions to the terms of the merger
agreement such that it would not permit the party board to make an adverse recommendation change and (iii)&nbsp;following the end of such notice period, the party&#146;s board will have considered in good faith any revisions to the terms of the
merger agreement proposed in writing by the other party, and will have determined, after consultation with its outside financial advisors and outside legal counsel, that failure to make an adverse recommendation change in response to such
intervening event would be inconsistent with the board&#146;s fiduciary duties under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and their respective boards will not be prohibited from taking and disclosing to their
respective shareholders or stockholders a position contemplated by Rule <FONT STYLE="white-space:nowrap">14e-2(a)</FONT> or Rule <FONT STYLE="white-space:nowrap">14d-9</FONT> promulgated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-173- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the Exchange Act or from making any &#147;stop, look and listen&#148; communication or any other similar disclosure to their stockholders pursuant to Rule
<FONT STYLE="white-space:nowrap">14d-9(f)</FONT> under the Exchange Act if, in the determination in good faith of their board, after consultation with outside counsel, the failure so to disclose would reasonably be expected to be inconsistent with
the fiduciary duties under applicable law or obligations under applicable federal securities law of their board so long as such communication <FONT STYLE="white-space:nowrap">re-affirms</FONT> the Coherent recommendation or the <FONT
STYLE="white-space:nowrap">II-VI</FONT> recommendation, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any action taken or omission made by any representative of a party
or any of its affiliates that, if taken or made by such party would be a breach of the party&#146;s <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the merger agreement, will be deemed to be a breach of such obligations
under the merger agreement by that party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of the merger agreement, a &#147;takeover proposal&#148; means, with respect
to <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, as applicable, other than the merger, (A)&nbsp;any inquiry, proposal or offer for or with respect to a merger, consolidation, business combination, recapitalization, binding share
exchange, liquidation, dissolution, joint venture or other similar transaction involving <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, or any of its subsidiaries whose assets constitute 15% or more of the consolidated
assets of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, (B)&nbsp;any inquiry, proposal or offer to acquire in any manner, directly or indirectly, in one or more transactions, more than 15% of the outstanding common stock
of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, or securities of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, representing more than 15% of the voting power of such party or (C)&nbsp;any
inquiry, proposal or offer to acquire in any manner, directly or indirectly, in one or more transactions, assets or businesses of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable, or its subsidiaries, including pursuant to a
joint venture, representing more than 15% of the consolidated assets, revenues or net income of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of the merger agreement, a &#147;superior proposal&#148; means a bona fide, unsolicited written takeover proposal received
after the date of the merger agreement (A)&nbsp;that did not result from a material breach (or a deemed material breach) of a party&#146;s <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations under the merger agreement, (B)&nbsp;that
if consummated would result in a third party (or in the case of a direct merger between such third party and <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, the stockholders of such third party) acquiring, directly or indirectly, more
than 50.1% of the outstanding common stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent or more than 50.1% of the assets or revenues of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent and their respective subsidiaries,
taken as a whole, (C)&nbsp;that the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or the Coherent board determines in good faith, after consultation with its outside financial advisor and outside legal counsel, is reasonably capable of being
completed, taking into account all financial, legal, regulatory, timing and other aspects of such proposal, including all conditions contained therein and the person making such takeover proposal, and (D)&nbsp;that the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board or Coherent board determines in good faith after consultation with its outside financial advisor and outside legal counsel (taking into account any changes to the merger agreement proposed by the
other party in response to such takeover proposal, and all financial, legal, regulatory, timing and other aspects of such takeover proposal, including all conditions contained therein and the person making such proposal, and the merger agreement),
is more favorable to the shareholder or stockholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent from a financial point of view than the transaction contemplated by the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of the merger agreement, an &#147;acceptable confidentiality agreement&#148; means any customary confidentiality agreement
that contains provisions that are no less favorable in the aggregate to <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent than the confidentiality agreement between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. Such
confidentiality agreement will not prohibit compliance by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent with any of its obligations in the merger agreement. <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent may grant a waiver,
amendment or release under any confidentiality agreement, standstill agreement or similar agreement to the extent necessary to allow a takeover proposal to be made to such party or the board of such party (or any committee thereof), and <FONT
STYLE="white-space:nowrap">(B)&nbsp;II-VI</FONT> and Coherent agree that, by execution of the merger agreement, both parties will be deemed to have waived, as of immediately prior to the execution and delivery of the merger agreement, any provision
in any such agreement to the extent necessary to allow the applicable counterparty to convey a takeover proposal to <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent or their respective boards (or any committee thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of the merger agreement, an &#147;intervening event&#148; means any material event or development or material change in
circumstances first occurring or arising after the date of the merger agreement and prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-174- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or the approval of the Coherent merger
proposal by Coherent stockholders if and only if such event, development or change in circumstances was not known by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, the Coherent board or those individuals in the parties respective
disclosure letters nor reasonably foreseeable by such persons as of or prior to the date of the merger agreement. However, none of the following events, developments or changes in circumstances constitutes an intervening event: (A)&nbsp;events,
developments or changes that involve or relate to a takeover proposal; or (B)&nbsp;the fact in and of itself that <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent meets or exceeds or fails to meet or exceed internal or published
projections, forecasts or revenue or earnings predictions for any period; provided that the exceptions in clause (B)&nbsp;do not exclude any event, development or change in circumstance underlying any such change in market price or trading volume,
or meeting or exceeding, or failure to meet or exceed such projections, forecasts or predictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_103"></A>Financing Obligations
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> will take or cause to be taken all actions and to do,
or cause to be done, all things reasonably necessary, proper or advisable to arrange, obtain and complete the financings at or prior to the closing of the merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will not agree to or permit any amendment, supplement or other modification or replacement of,
or any termination or reduction of, or grant any waiver of, any condition, remedy or other provision under the financing commitments without the prior written consent of Coherent if such amendment, supplement, modification, replacement, termination,
reduction or waiver would or would reasonably be expected to (i)&nbsp;reduce the aggregate amount of the financings below the amount required to consummate the merger (taking into account other sources of funding (other than cash of Coherent and its
subsidiaries)), (ii) impose new or additional conditions or otherwise expand, amend or modify any of the conditions to the receipt of the financings, in each case, in a manner that would reasonably be expected to materially delay or prevent the
closing of the merger or make the timely funding of the financings or the satisfaction of the conditions to obtaining the financings materially less likely to occur or (iii)&nbsp;adversely impact in any material respect the ability of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Merger Sub to enforce its rights against the other parties to the financing commitments. Notwithstanding the foregoing, <FONT STYLE="white-space:nowrap">II-VI</FONT> and its subsidiaries may amend, amend
and restate or replace the existing debt commitment letter and related fee letters to add lenders, lead arrangers, bookrunners, syndication agents or similar entities, make or permit assignments and replacements of an individual lender thereunder in
connection with the syndication of the debt financing and/or terminate or reduce the aggregate amount of the financing commitments if <FONT STYLE="white-space:nowrap">II-VI</FONT> and its subsidiaries have a sufficient amount of available cash on
hand from other sources (other than cash of Coherent and its subsidiaries) to (a)&nbsp;pay Coherent stockholders the amounts due to them under the merger agreement, (b)&nbsp;refinance or otherwise discharge any outstanding indebtedness of Coherent
required to be repaid at the completion of the merger, and (c)&nbsp;pay any fees, costs and expenses incurred in connection with the merger. <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to provide Coherent with information regarding any
such changes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> has an obligation to keep Coherent reasonably informed of the status the
financings and to promptly provide written notice of any default or material breach by any party to the financing commitments (or in the case of the debt commitment letter, financing agreements related thereto) or of any termination or threatened
termination thereof of which <FONT STYLE="white-space:nowrap">II-VI</FONT> or Merger Sub has knowledge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The receipt of the financings is
not a condition to the closing of the merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_104"></A>Financing Cooperation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing date, Coherent has agreed to, and to cause its subsidiaries to, use reasonable best efforts, and to use its reasonable
best efforts to cause its and their respective representatives to use reasonable best efforts, to provide <FONT STYLE="white-space:nowrap">II-VI</FONT> and its subsidiaries with all cooperation reasonably requested in writing by <FONT
STYLE="white-space:nowrap">II-VI</FONT> to assist it in causing the conditions in the financing commitments to be satisfied or as is otherwise reasonably requested </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-175- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in writing by <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with the financings and/or any permitted replacement, or amended, modified or alternative financing, including, but not
limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">causing Coherent&#146;s management team, with appropriate seniority and expertise, to participate in a reasonable
number of meetings, presentations, road shows, due diligence sessions, drafting sessions and sessions with lenders, investors and rating agencies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reasonably cooperating with the syndication and marketing efforts of
<FONT STYLE="white-space:nowrap">II-VI</FONT> and its financing sources, including assisting with the preparation of customary rating agency presentations, bank information memoranda, road show materials, offering memoranda, prospectuses,
registration statements and other customary marketing materials required in connection with the financings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assisting <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with the preparation and registration of
any pledge and security documents or other documents relating to the pledge of collateral, indentures, supplemental indentures, currency or interest hedging arrangements, credit agreements and other definitive financing documents as may be requested
by <FONT STYLE="white-space:nowrap">II-VI</FONT> or its financing sources (including using reasonable best efforts to obtain consents of accountants for use of their reports in any materials relating to the debt financing and accountants&#146;
comfort letters, in each case as reasonably requested by <FONT STYLE="white-space:nowrap">II-VI</FONT> or its financing sources), and otherwise reasonably facilitating the pledging of collateral and the granting of security interests in respect of
the debt financing, provided that such documents will not take effect until the effective time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent required in connection with the debt financing, furnishing
<FONT STYLE="white-space:nowrap">II-VI</FONT> and its financing sources, as promptly as practicable, with (i)&nbsp;audited consolidated balance sheets and related statements of income (or operations, as applicable) and cash flows of Coherent and its
subsidiaries for the three most recently completed fiscal years ended at least 90&nbsp;days before the closing date, (ii)&nbsp;unaudited consolidated balance sheets and related unaudited statements of income and cash flows of Coherent and its
subsidiaries, for each subsequent fiscal quarter (other than the fourth fiscal quarter) ended at least 45&nbsp;days before the closing date, (iii)&nbsp;to the extent reasonably available to Coherent, financial information regarding Coherent and its
subsidiaries necessary for <FONT STYLE="white-space:nowrap">II-VI</FONT> to prepare any pro forma financial statements for historical periods required by the debt commitment letter, (iv)&nbsp;other information, including historical financial
information and related audit reports of Coherent&#146;s auditors for Coherent and its subsidiaries, of the type that would be required by Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC or by Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> promulgated by the SEC, in each case for a registered public offering of securities or for a private placement of debt securities, (v)&nbsp;such other pertinent and customary and reasonably available information
regarding Coherent and its subsidiaries as is necessary or customary and as may be reasonably requested in writing by <FONT STYLE="white-space:nowrap">II-VI</FONT> for use in connection with any prospectus, registration statement or offering
memorandum for an issuance of securities or that is otherwise necessary to receive from Coherent&#146;s independent accountants customary &#147;comfort&#148; and (vi)&nbsp;such other pertinent and customary and reasonably available information
regarding Coherent and its subsidiaries as is necessary or customary and as may be reasonably requested in writing by <FONT STYLE="white-space:nowrap">II-VI</FONT> for use in connection with any confidential information memorandum and any bank
presentation used for the syndication of the debt financing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">so long as requested at least ten business days prior to the closing date, furnishing <FONT
STYLE="white-space:nowrap">II-VI</FONT> or any of its financing sources with all documentation and other information required by regulatory authorities pursuant to applicable &#147;know your customer&#148; and anti-money laundering rules and
regulations at least three business days prior to the closing date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering customary authorization letters that authorize the distribution of the confidential information
memorandum to prospective lenders, which letters shall contain a customary <FONT STYLE="white-space:nowrap">&#147;10b-5&#148;</FONT> representation with respect to Coherent and its subsidiaries and contain a representation that the public-side
version does not include material <FONT STYLE="white-space:nowrap">non-public</FONT> information about Coherent and its subsidiaries or their securities; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-176- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">taking all corporate and other actions, subject to the occurrence of the closing date, reasonably requested by <FONT
STYLE="white-space:nowrap">II-VI</FONT> or any of its subsidiaries and necessary and customary to permit the consummation of the financings. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions described in this section or any other provision of the merger agreement, the cooperation described above is
subject to customary limitations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All <FONT STYLE="white-space:nowrap">non-public</FONT> or other confidential information provided by
Coherent or any of its representatives pursuant to the merger agreement will be kept confidential in accordance with the confidentiality agreement between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent, except that <FONT
STYLE="white-space:nowrap">II-VI</FONT> or any of its subsidiaries will be permitted to disclose such information to any of its financing sources or prospective financing sources, ratings agencies and other financial institutions and investors that
are or may become parties to the debt financing and to any underwriters, initial purchasers or placement agents in connection with the debt financing (and, in each case, to their respective counsel and auditors) so long as such persons are subject
to other confidentiality undertakings no less favorable in the aggregate to Coherent than those contained in the confidentiality agreement between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to (i)&nbsp;indemnify and hold harmless Coherent, its subsidiaries and their
respective representatives from and against any loss, damage, claim, interest, cost, or expense (including legal fees and expenses), award, judgement, penalty and amounts paid in settlement suffered or incurred in connection with providing the
cooperation and support described in this section and any information utilized in connection therewith (other than information provided by Coherent or any of its subsidiaries) and (ii)&nbsp;promptly, upon request of Coherent, reimburse Coherent and
its subsidiaries for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by Coherent or its subsidiaries in connection with providing the cooperation
and support described in this section. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_105"></A>Conditions to Complete the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s respective obligations to complete the merger are subject to the
satisfaction or waiver, at or prior to the effective time, of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT
STYLE="white-space:nowrap">II-VI</FONT> shareholders and approval of the Coherent merger proposal by Coherent stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declaration of the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> of which this joint
proxy statement/prospectus is a part as effective and no stop order or proceedings have been issued, initiated or threatened by the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval for the listing of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued
in the merger on Nasdaq, subject to official notice of issuance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no injunction by any court or other tribunal of competent jurisdiction prohibiting the consummation of the merger
being in effect, and no law having been adopted or effected that prohibits the consummation of the merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable waiting periods shall have expired or been terminated, and any approvals required shall have been
obtained under the HSR Act or under certain other antitrust laws, as defined above. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Coherent&#146;s
obligation to complete the merger is subject to the satisfaction or waiver, at or prior to the effective time, of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain representations and warranties of <FONT STYLE="white-space:nowrap">II-VI</FONT> and the Merger Sub
relating to organization, corporate power and authority, capital stock, approval of the merger agreement, no brokers, and no applicable takeover laws, contained in the merger agreement, being true and correct in all material respects, as of
March&nbsp;25, 2021 and as of the date on which the merger is completed (except to the extent expressly made as of a different date, in which case as of such date), and the receipt by Coherent of an officer&#146;s certificate from <FONT
STYLE="white-space:nowrap">II-VI</FONT> to such effect; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-177- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each other representation and warranty of <FONT STYLE="white-space:nowrap">II-VI</FONT> and the Merger Sub
contained in the merger agreement, being true and correct as of March&nbsp;25, 2021 and as of the date on which the merger is completed (except to the extent expressly made as of a different date, in which case as of such date), except where the
failure to be so true and correct (without giving effect to any qualifications or limitations as to materiality, material adverse effect or similar qualifiers), has not had and would not have a material adverse effect on <FONT
STYLE="white-space:nowrap">II-VI</FONT> or the Merger Sub, and the receipt by Coherent of an officer&#146;s certificate from <FONT STYLE="white-space:nowrap">II-VI</FONT> to such effect; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance and compliance by <FONT STYLE="white-space:nowrap">II-VI</FONT> in all material respects of all
obligations and covenants required to be performed by it or complied with by it under the merger agreement at or prior to the effective time, and the receipt by Coherent of an officer&#146;s certificate from
<FONT STYLE="white-space:nowrap">II-VI</FONT> to such effect; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any event, change, effect, development or occurrence that, since the date of the merger agreement,
has had or would reasonably be expected to have a material adverse effect, and the receipt by Coherent of an officer&#146;s certificate from <FONT STYLE="white-space:nowrap">II-VI</FONT> to such effect. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> obligation to complete the merger is subject to the satisfaction or waiver,
at or prior to the effective time, of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain representations and warranties of Coherent relating to capital structure contained in the merger
agreement being true and correct in all respects (other than immaterial inaccuracies), as of March&nbsp;25, 2021 and as of the date on which the merger is completed (except to the extent expressly made as of a different date, in which case as of
such date), and the receipt by <FONT STYLE="white-space:nowrap">II-VI</FONT> of an officer&#146;s certificate from Coherent to such effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain representations and warranties of Coherent relating to organization, corporate power and authority,
capital stock, approval of the merger agreement, no brokers, and no applicable takeover laws, contained in the merger agreement, being true and correct in all material respects, as of March&nbsp;25, 2021 and as of the date on which the merger is
completed (except to the extent expressly made as of a different date, in which case as of such date), and the receipt by <FONT STYLE="white-space:nowrap">II-VI</FONT> of an officer&#146;s certificate from Coherent to such effect;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each other representation and warranty of Coherent contained in the merger agreement, being true and correct as
of March&nbsp;25, 2021 and as of the date on which the merger is completed (except to the extent expressly made as of a different date, in which case as of such date), except where the failure to be so true and correct (without giving effect to any
qualifications or limitations as to materiality, material adverse effect or similar qualifiers), has not had and would not have a material adverse effect on Coherent, and the receipt by <FONT STYLE="white-space:nowrap">II-VI</FONT> of an
officer&#146;s certificate from Coherent to such effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance and compliance by Coherent in all material respects of all obligations and covenants required to
be performed by it or complied with by it under the merger agreement at or prior to the effective time and the receipt by <FONT STYLE="white-space:nowrap">II-VI</FONT> of an officers&#146; certificate from Coherent to such effect), except for a
breach by Coherent of (A)&nbsp;its financing obligations under the merger agreement of which <FONT STYLE="white-space:nowrap">II-VI</FONT> had knowledge but failed to deliver a <FONT STYLE="white-space:nowrap">non-cooperation</FONT> notice (as
defined in the merger agreement) or (B)&nbsp;its obligation to deliver notice to <FONT STYLE="white-space:nowrap">II-VI</FONT> following the entrance into, modification, amendment, or termination of a material government contract; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any event, change, effect, development or occurrence that, since the date of the merger agreement,
has had or would reasonably be expected to have a material adverse effect (and the receipt by <FONT STYLE="white-space:nowrap">II-VI</FONT> of an officers&#146; certificate from Coherent to such effect). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent can provide assurance as to when or if all of the conditions to the merger
can or will be satisfied or waived by the appropriate party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-178- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_106"></A>Termination of the Merger Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement can be terminated at any time prior to completion of the merger, whether before or after the receipt of approval of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders or approval of the Coherent merger proposal by Coherent stockholders, in the following circumstances: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by mutual written consent of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if the merger has not been consummated on or
before 5:00 pm, Eastern time, on December&nbsp;25, 2021 (which we refer to as the &#147;original end date&#148;), provided that if on the original end date the approval under the HSR Act or under certain other antitrust laws has not been satisfied
(but all other conditions to the closing of the merger have been satisfied or waived by all parties entitled to the benefit of such conditions), the original end date will be extended in accordance with the merger agreement, with the first extended
end date occurring on March&nbsp;25, 2022, the second extended end date occurring on June&nbsp;25, 2022 and the third and final extended end date occurring on September&nbsp;25, 2022 (the end date after taking such adjustments into account, the
&#147;end date&#148;) (which we refer to as the &#147;end date termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if an injunction permanently restraining,
enjoining or otherwise prohibiting the consummation of the merger has been entered and is considered final and nonappealable, provided that the party seeking to terminate the merger agreement has used reasonable best efforts to prevent the entry of
and to remove such relevant legal restraint in accordance with the merger agreement, and that the injunction is not primarily due to a material breach of a representation, warranty, covenant, or other agreement set forth in the merger agreement by
such party (which we refer to as the &#147;injunction termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent if the approval of the <FONT
STYLE="white-space:nowrap">(i)&nbsp;II-VI</FONT> share issuance proposal by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders has not been obtained following the conclusion of the <FONT STYLE="white-space:nowrap">II-VI</FONT> special
meeting (including any adjournments or postponements thereof) (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> special meeting termination&#148;) or (ii)&nbsp;the Coherent merger proposal by Coherent stockholders has not
been obtained following the conclusion of the Coherent special meeting (including any adjournments or postponements thereof) (which we refer to as the &#147;Coherent special meeting termination&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent, if the other party (including the Merger Sub
if Coherent is the terminating party) has breached or failed to perform any of its or their representations, warranties, covenants or other agreements contained in the merger agreement, which breach or failure to perform (i)&nbsp;if it occurred or
was continuing to occur on the closing date, would result in the failure of conditions to the terminating party&#146;s obligations to close and (ii)&nbsp;by its nature, cannot be cured prior to the end date, or if such breach or failure is capable
of being cured by the end date, the other party has not cured such breach or failure within 30&nbsp;days after receiving written notice from the terminating party describing such break or failure in reasonable detail, provided that the terminating
party is not then in material breach of any representation, warranty, covenant or other agreement contained in the merger agreement that would result in a failure of a condition to the other party&#146;s obligation to close; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI,</FONT> prior to the approval of the Coherent merger proposal, in the
event of an adverse recommendation change by Coherent (which we refer to as the &#147;Coherent adverse recommendation change termination&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent, prior to the approval of the <FONT STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal,
in the event of an adverse recommendation change by <FONT STYLE="white-space:nowrap">II-VI</FONT> (which we refer to as the <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> adverse recommendation change termination&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI,</FONT> at any time prior to the approval of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share issuance proposal, in order to enter into an agreement with respect to a superior proposal, provided that (i)&nbsp;in advance of or concurrently with such termination,
<FONT STYLE="white-space:nowrap">II-VI</FONT> pays or causes to be paid the <FONT STYLE="white-space:nowrap">II-VI</FONT> termination fee (as defined below) and <FONT STYLE="white-space:nowrap">(ii)&nbsp;II-VI</FONT> has otherwise complied in all
respects (other than de minimis noncompliance unrelated to such superior </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-179- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
proposal) with its <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations and SEC filing obligations under the merger agreement (which we refer to as the <FONT
STYLE="white-space:nowrap">&#147;II-VI</FONT> superior proposal termination&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent, at any time prior to the approval of the Coherent merger proposal, in order to enter into an
agreement with respect to a superior proposal, provided that (i)&nbsp;in advance of or concurrently with such termination, Coherent pays or causes to be paid the Coherent termination fee (as defined below) and (ii)&nbsp;Coherent has otherwise
complied in all respects (other than de minimis noncompliance unrelated to such superior proposal) with its <FONT STYLE="white-space:nowrap">non-solicitation</FONT> obligations and SEC filing obligations under the merger agreement (which we refer to
as the &#147;Coherent superior proposal termination&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_107"></A>Effect of Termination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger agreement is terminated pursuant to the above, notice thereof will be given to the other party, specifying the merger agreement
provisions pursuant to which such termination is made and the basis therefor described in reasonable detail. The merger agreement, with certain exceptions, will terminate, and there will be no other liability on the part of <FONT
STYLE="white-space:nowrap">II-VI</FONT> or Coherent to the other except (i)&nbsp;as provided in the confidentiality agreement between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent and certain provisions of the merger agreement and
(ii)&nbsp;liability arising out of or as the result of, fraud or any willful and material breach of any covenant, agreement, or representation or warranty in the merger agreement occurring prior to its termination, in which case the aggrieved party
will not be limited to expense payments or the termination fees described below and will be entitled to all rights and remedies available at law or in equity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_108"></A>Termination Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent will pay <FONT STYLE="white-space:nowrap">II-VI</FONT> a termination fee of $108.8&nbsp;million in cash if the merger agreement is
terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI</FONT> in a Coherent adverse recommendation change termination;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent in a Coherent superior proposal termination; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in a Coherent special meeting termination, if
(i)&nbsp;a takeover proposal for Coherent has been publicly announced or known and has not been publicly withdrawn for at least 15&nbsp;business days prior to the Coherent special meeting and (ii)&nbsp;within 12 months of the termination of the
merger agreement, Coherent or any of its subsidiaries enters into a definitive agreement with respect to or consummates a transaction that is a takeover proposal with a third party (it being understood that for the purposes of this provision, each
reference to &#147;15%&#148; in the definition of &#147;takeover proposal&#148; will be deemed to be a reference to &#147;50.1%&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will pay Coherent a termination fee of $337.7&nbsp;million in cash if the merger agreement is
terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Coherent in a <FONT STYLE="white-space:nowrap">II-VI</FONT> adverse recommendation change termination;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI</FONT> in a <FONT STYLE="white-space:nowrap">II-VI</FONT> superior
proposal termination; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in a <FONT STYLE="white-space:nowrap">II-VI</FONT>
special meeting termination, if (i)&nbsp;a takeover proposal for <FONT STYLE="white-space:nowrap">II-VI</FONT> has been publicly announced or known and has not been publicly withdrawn for at least 15&nbsp;business days prior to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> special meeting and (ii)&nbsp;within 12 months of the termination of the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> or any of its subsidiaries enters into a definitive agreement with
respect to or consummates a transaction that is a takeover proposal with a third party (it being understood that for the purposes of this provision, each reference to &#147;15%&#148; in the definition of &#147;takeover proposal&#148; will be deemed
to be a reference to &#147;50.1%&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will pay Coherent a termination
fee of $500&nbsp;million in cash if the merger agreement is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent (i)&nbsp;in an end date termination, if at the time
of such termination, all closing conditions have been satisfied except for the approval under an antitrust law of a Chinese governmental </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-180- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
entity and (ii)&nbsp;in an injunction termination solely to the extent an injunction has been entered by a Chinese governmental entity pursuant to an antitrust law permanently restraining,
enjoining or otherwise prohibiting the consummation of the merger and such injunction has become final and nonappealable, in each case provided that Coherent has complied in all material respects with its covenants and agreements with respect to
regulatory approvals set forth in the merger agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_109"></A>Expenses and Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the merger agreement is terminated by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in a Coherent special meeting
termination, Coherent will pay <FONT STYLE="white-space:nowrap">II-VI</FONT> $25&nbsp;million as payment for <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> costs and expenses in connection with the merger agreement. If the agreement is
terminated by either <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent in a <FONT STYLE="white-space:nowrap">II-VI</FONT> special meeting termination, <FONT STYLE="white-space:nowrap">II-VI</FONT> will pay Coherent $25&nbsp;million as
payment for Coherent&#146;s costs and expenses in connection with the merger agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth above, whether or not the
merger is consummated, all costs and expenses incurred in connection with the merger, the merger agreement, the merger agreement and the transactions contemplated thereby shall be paid by the party incurring or required to incur such expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_110"></A>Amendment and Waiver of the Merger Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time prior to the effective time, any provision of the merger agreement may be amended or waived if, and only if, such amendment or
waiver is in writing and signed, in the case of an amendment, by a duly authorized representative of each of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent, and the Merger Sub. After receipt of the approval of the Coherent merger proposal,
if any amendment or waiver of a provision of the merger agreement will by applicable law or in accordance with the rules and regulations of Nasdaq require further approval from Coherent stockholders, the effectiveness of such amendment or waiver
will be subject to the approval of Coherent stockholders. Notwithstanding the foregoing, no failure or delay by any party to the merger agreement in exercising any right thereunder will operate as a waiver thereof nor will any single or partial
exercise thereof preclude any other or further exercise of any other right thereunder. Notwithstanding anything to the contrary in the merger agreement, certain sections of the merger agreement may not be amended, supplemented, waived or otherwise
modified in a manner materially adverse to any debt financing source without the prior written consent of such debt financing source. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_111">
</A>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger agreement, and all claims or causes of action that may be based upon, arise out of or relate to the
agreement or the negotiation, execution or performance thereof, will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule that would cause the
application of the laws of any jurisdiction other than the State of Delaware. Notwithstanding anything to the contrary, each of the parties agrees that any right or obligation with respect to any debt financing source in connection with the merger
agreement, the debt financing, the debt commitment letter and the transactions contemplated thereby, and any claim, controversy, dispute, suit, action or proceeding relating thereto or arising thereunder, will be governed by, and construed and
enforced in accordance with, the laws of the State of New York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_112"></A>Jurisdiction and Specific Enforcement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent both agree that irreparable damage would occur (for which monetary damages, even if
available, would not be an adequate remedy) in the event that any of the provisions of the merger agreement were not performed, or were threatened to be not performed, in accordance with their specific terms or were otherwise breached. Accordingly,
the parties agreed that, in addition to any other remedy that may be available to it, including monetary damages, each of the parties shall be entitled to an injunction or injunctions to prevent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-181- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
breaches of the merger agreement and to enforce specifically the terms and provisions of the merger agreement exclusively in the Delaware Court of Chancery and any state appellate court therefrom
within the State of Delaware and all such rights and remedies at law or in equity shall be cumulative, except as may be limited in the merger agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent agrees that it will not bring or support any legal action or proceeding
against the debt financing sources and their respective current, former or future directors, officers, general or limited partners, stockholders, members, managers, controlling persons, affiliates, employees or advisors in any way relating to the
merger agreement or any of the transactions contemplated thereby, including any dispute arising out of or relating in any way to the debt financing or the performance thereof, in any forum other than the Supreme Court of the State of New York,
County of New York or, if under applicable law jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-182- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_113"></A>THE INVESTMENT AGREEMENT AND THE STATEMENT WITH RESPECT TO
SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This section of the joint proxy statement/prospectus describes the material terms of the investment agreement and statement
with respect to shares. The</I><B><I> </I></B><I>description in this section and elsewhere in this joint proxy statement/prospectus is subject to,</I><B><I> </I></B><I>and qualified in its entirety by reference to, the complete text of each of the
investment agreement and statement with respect to shares, which is attached as </I><B><I>Annex B </I></B><I>and </I><B><I>Annex C</I></B><I>, respectively,</I><B><I> </I></B><I>to this joint proxy statement/prospectus and incorporated by reference
herein. This summary does not</I><B><I> </I></B><I>purport to be complete and may not contain all of the information about the investment agreement and statement with respect to shares that is important to</I><B><I> </I></B><I>you. We urge you to
read the full text of the investment agreement and the statement with respect to shares, as they are the legal documents governing the equity financing and the issuance and sale of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B
convertible preferred stock to the investors.</I><B><I> </I></B><I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_114"></A>Explanatory Note Regarding the Investment Agreement
and Statement with Respect to Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The investment agreement, statement with respect to shares and this summary of terms are included
to provide you with information regarding the terms of the investment agreement and the statement with respect to shares. Factual disclosures about <FONT STYLE="white-space:nowrap">II-VI</FONT> contained in this joint proxy statement/prospectus or
in the public reports of <FONT STYLE="white-space:nowrap">II-VI</FONT> filed with the SEC may supplement, update or modify the factual disclosures about <FONT STYLE="white-space:nowrap">II-VI</FONT> contained in the investment agreement and/or the
statement with respect to shares. The investment agreement contains representations and warranties by <FONT STYLE="white-space:nowrap">II-VI</FONT> made solely for the benefit of the parties to the investment agreement. The representations,
warranties and covenants made in the investment agreement by <FONT STYLE="white-space:nowrap">II-VI</FONT> were qualified and subject to important limitations and qualifications agreed to by <FONT STYLE="white-space:nowrap">II-VI</FONT> and the
investors in connection with negotiating the terms of the investment agreement. In particular, in your review of the representations and warranties contained in the investment agreement, it is important to bear in mind that the representations and
warranties were negotiated with the principal purpose of establishing circumstances in which a party to the investment agreement may have the right not to consummate the subsequent investment if the representations and warranties of the other party
prove to be untrue due to a change in circumstance or otherwise, and allocating risk between the parties to the investment agreement, rather than establishing matters as facts. The representations and warranties also may be subject to a contractual
standard of materiality different from that generally applicable to shareholders and reports and documents filed with the SEC, and some were qualified by the matters contained in the confidential disclosure schedules that <FONT
STYLE="white-space:nowrap">II-VI</FONT> delivered to the investors in connection with the investment agreement and certain documents filed with the SEC. Moreover, information concerning the subject matter of the representations and warranties, which
do not purport to be accurate as of the date of this joint proxy statement/prospectus, may have changed since the date of the investment agreement. Accordingly, the representations and warranties in the investment agreement should not be relied on
by any persons as characterizations of the actual state of facts about <FONT STYLE="white-space:nowrap">II-VI</FONT> at the time they were made or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_115"></A>The Equity Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement, on March&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the
investment agreement. On March&nbsp;31, 2021, pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated the initial investment of $750.0&nbsp;million. Pursuant to the investment agreement and subject to
the terms and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least $1.05&nbsp;billion, which may be increased by up to an additional
$350.0&nbsp;million, immediately prior to the closing of the merger. The issuance and sale of the remaining shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the
subsequent investment is contingent upon the consummation of the merger in accordance with the merger agreement, and is subject to certain other closing conditions customary for transactions of this type. The investment agreement will terminate
following the occurrence of certain events, including: (i)&nbsp;automatically upon the valid termination of the merger agreement in accordance with its terms, (ii)&nbsp;the mutual written consent of <FONT STYLE="white-space:nowrap">II-VI</FONT> and
the investors and (iii)&nbsp;written notice from either <FONT STYLE="white-space:nowrap">II-VI</FONT> or the investors if the closing of the equity financing has not occurred on or prior to December&nbsp;25, 2021 (subject to certain extensions). For
more information on the terms of the investment agreement, see the section titled &#147;&#151;The Investment Agreement&#148; below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-183- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible
preferred stock are set forth in the statement with respect to shares, which was filed with the Pennsylvania Department of State Corporations Bureau in connection with the completion of the initial investment. The conversion price of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will initially be $85.00 per share, subject to adjustments as set forth in the statement with respect to shares. For more information on the terms of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, see the section titled &#147;&#151;The Statement with Respect to Shares&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_116"></A>The Investment Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material terms of the investment agreement and is subject to, and qualified in its entirety by reference to,
the complete text of the investment agreement. We encourage you to read the investment agreement, which is attached hereto as <B>Annex B</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Governance Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the investment agreement, following the closing of the initial investment and for so long as the investors beneficially own shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (or shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued upon the conversion thereof) that represent, in the aggregate and on an as-converted basis,
at least 25% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, on an as-converted basis, that they held immediately following the completion of either the initial investment (if the subsequent investment has not
occurred) or the equity financing, the investors will have the right to nominate one designee and to designate one observer to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board. The investors&#146; initial designee and observer to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board were Stephen Pagliuca and Joseph Robbins, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, under the investment
agreement, for so long as the investors beneficially own equity securities of <FONT STYLE="white-space:nowrap">II-VI</FONT> entitled to vote, the investors have agreed to vote all such securities in favor of each director nominated or recommended by
the <FONT STYLE="white-space:nowrap">II-VI</FONT> board for election at each meeting of the shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> involving the election of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Standstill </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under
the investment agreement and subject to exceptions for certain tender offers or exchange offers, the investors have agreed that from the closing of the initial investment until the earlier of (a)&nbsp;the six (6)&nbsp;month anniversary of the
earlier of the date on which (i)&nbsp;no designee of the investors is serving on the <FONT STYLE="white-space:nowrap">II-VI</FONT> board (ii)&nbsp;the investors no longer have a right to nominate a designee or designate an observer to the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board pursuant to the investment agreement or (iii)&nbsp;the investors have irrevocably waived their rights to nominate a designee or designate an observer to the <FONT STYLE="white-space:nowrap">II-VI</FONT>
board pursuant to the investment agreement; <FONT STYLE="white-space:nowrap">(b)&nbsp;II-VI</FONT> entering into a written agreement to consummate a Fundamental Change (as defined in the statement with respect to shares); and (c)&nbsp;the failure of
the shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> to elect the investors&#146; designee to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board nominated pursuant to the investment agreement, the investors will be subject to
certain standstill restrictions. During the period in which the standstill restrictions are in effect, the investors will not, among other things and subject to certain exceptions, (a)&nbsp;acquire or offer or make a public proposal to acquire, by
purchase or otherwise, any securities of <FONT STYLE="white-space:nowrap">II-VI,</FONT> contracts or instruments related to the price of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, or assets or property of <FONT
STYLE="white-space:nowrap">II-VI</FONT> that result in the investors having beneficial ownership over a certain percentage of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding at such time; (b)&nbsp;make, encourage
or participate in any &#147;solicitation&#148; of &#147;proxies&#148; to vote any voting securities of <FONT STYLE="white-space:nowrap">II-VI,</FONT> call or seek a meeting of <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders, initiate a
proposal for action by the <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder, or seek (other than with respect to the investors&#146; designee to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board) election of a director to, or removal
of a director from, the board; (c)&nbsp;make a public announcement concerning (or seek or propose) any merger, tender or exchange offer, recapitalization, reorganization, purchase or other extraordinary transaction of a material portion of the
assets, properties or securities of <FONT STYLE="white-space:nowrap">II-VI;</FONT> (d)&nbsp;act (in concert or alone) to control, advise or influence the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or management of <FONT
STYLE="white-space:nowrap">II-VI;</FONT> or (e)&nbsp;acquire any debt securities of <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-184- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Restrictions on Transfer </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the investment agreement, (a)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock until the later of (i)&nbsp;the twelve (12)-month anniversary of the closing of the initial investment and (ii)&nbsp;the first to occur of (A)&nbsp;the closing of the subsequent
investment and (B)&nbsp;the termination of the merger agreement, and (b)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock, until the twelve
(12)-month anniversary of the closing of the subsequent investment, the investors will not transfer any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock or any <FONT STYLE="white-space:nowrap">II-VI</FONT>
common stock issued upon the conversion thereof. We refer to the period of time in foregoing sentence as the &#147;restricted period.&#148; Following the restricted period, the investors will not knowingly transfer any shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> person (subject to certain exceptions) and will not knowingly transfer any shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to certain competitors of <FONT STYLE="white-space:nowrap">II-VI</FONT> (including any activist investor) or to any person who would own more than 5% of the outstanding shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock following such transfer (subject to certain exceptions). At any time, the investors will be permitted to transfer any portion of their <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B
convertible preferred stock or <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued upon the conversion thereof under the following circumstances: (a)&nbsp;transfers of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock following the restricted period or transfers of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock, in each
case, to certain permitted transferees of the investors (subject to certain exceptions); (b) transfers to <FONT STYLE="white-space:nowrap">II-VI</FONT> or its subsidiaries; (c)&nbsp;subject to any standstill restrictions, transfers pursuant to a
merger, tender offer, recapitalization, consolidation or exchange offer or other similar transaction, in each case, following an announcement of any Fundamental Change involving <FONT STYLE="white-space:nowrap">II-VI</FONT> or its subsidiaries;
(d)&nbsp;transfers in connection with bankruptcy, insolvency or a similar reorganization proceedings; (e)&nbsp;transfers for cash to a <FONT STYLE="white-space:nowrap">non-affiliate</FONT> of the investors to the extent necessary to satisfy a bona
fide payment requirement under any Back Leverage (as defined in the investment agreement); (f) transfers in connection with a mortgage, hypothecation and/or pledge to a financial institution or lender to secure any Back Leverage and the exercise of
any rights thereunder by any such financial institution or lender; (g)&nbsp;transfers approved in writing by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board; and (h)&nbsp;transfers by the investors of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock prior to the end of the restricted period to an affiliate of the investors that is under common control with the investors
and is a special purpose vehicle formed for the purpose of holding a portion of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (subject to certain exceptions). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the initial investment and pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the
investors entered into the Registration Rights Agreement, dated as of March&nbsp;31, 2021, pursuant to which the investors have certain customary registration rights with respect to the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series
B convertible preferred stock and <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issuable upon conversion thereof. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Other Covenants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Affirmative obligations of <FONT STYLE="white-space:nowrap">II-VI</FONT></I>. At any time the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series B convertible preferred stock is outstanding, <FONT STYLE="white-space:nowrap">II-VI</FONT> must: (i)&nbsp;take all lawful action within its control to ensure its authorized capital stock includes a sufficient number of authorized but
unissued shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to convert all outstanding shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock and (ii)&nbsp;as reasonably requested by the
investors, take actions to render inapplicable any control share acquisition, interested stockholder, business combination or similar anti-takeover provision in any organizational document of <FONT STYLE="white-space:nowrap">II-VI</FONT> or under
the BCL or other similar law that is or could become applicable to the investors and its affiliates as a result of the equity financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Negative obligations of <FONT STYLE="white-space:nowrap">II-VI</FONT></I>. At any time the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series B convertible preferred stock is outstanding, <FONT STYLE="white-space:nowrap">II-VI</FONT> must not (unless the prior written approval of the holders of a majority of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible
preferred stock issued and outstanding has been obtained) effect any voluntary deregistration or delisting with Nasdaq of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (subject to certain exceptions). In addition, unless the
investors otherwise consent in writing (or if such action is taken with respect to a Permitted Issuance), so long as the investors own at least 5% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible
preferred stock that they held immediately </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-185- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
following the completion of either the initial investment (if the subsequent investment has not occurred) or the equity financing, <FONT STYLE="white-space:nowrap">II-VI</FONT> must not authorize
or issue any parity stock (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Pipeline Financing</I>. After any termination of the merger agreement, <FONT
STYLE="white-space:nowrap">II-VI</FONT> must offer the investors the opportunity to purchase any senior preferred securities that <FONT STYLE="white-space:nowrap">II-VI</FONT> proposes to issue for cash to finance any material acquisitions. If the
investors decline, <FONT STYLE="white-space:nowrap">II-VI</FONT> may issue such securities on terms no less favorable in any material respect than were offered to the investors. The investors&#146; rights with respect to pipeline financings
terminate when the investors hold less than 50% of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock acquired from <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="tx150472_117"></A>The Statement with Respect to Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material terms of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock
contained in the statement with respect to shares and is subject to, and qualified in its entirety by reference to, the complete text of the statement with respect to shares. We encourage you to read the statement with respect to shares, which is
attached hereto as <B>Annex C</B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Authorized Shares and Liquidation Preference </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the statement with respect to shares, <FONT STYLE="white-space:nowrap">II-VI</FONT> designated and established a series of <FONT
STYLE="white-space:nowrap">II-VI</FONT> preferred stock as the &#147;Series B Convertible Preferred Stock,&#148; with no par value per share, and designated (i)&nbsp;a series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible
preferred stock as &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock,&#148; with no par value per share, and a liquidation preference equal to the greater of (a)&nbsp;the applicable stated value for such shares
plus accrued or declared and unpaid dividends that had not previously been added to such stated value and (b)&nbsp;the amount per share as would be payable in respect of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon the conversion
of such shares, assuming all such outstanding shares were converted into <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock immediately prior to any voluntary or involuntary liquidation, dissolution or winding up of the affairs of <FONT
STYLE="white-space:nowrap">II-VI</FONT> (which we refer to as a <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> liquidation event&#148;), and (ii)&nbsp;a series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock as &#147;Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock,&#148; with no par value per share, and a liquidation preference equal to the greater of (a)&nbsp;the stated value for such shares plus accrued or declared
and unpaid dividends that had not previously been added to such stated value and (b)&nbsp;the amount per share as would be payable in respect of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock upon the conversion of such shares, assuming
all such outstanding shares were converted into <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock immediately prior to the <FONT STYLE="white-space:nowrap">II-VI</FONT> liquidation event. The statement with respect to shares provides that
the number of shares initially constituting the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock is 215,000, consisting of 75,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT
STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock and 140,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ranking </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will rank, with respect to dividend rights and rights on the distribution of assets upon any <FONT STYLE="white-space:nowrap">II-VI</FONT> liquidation event,
(i)&nbsp;senior to <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and each other class or series of <FONT STYLE="white-space:nowrap">II-VI</FONT> capital stock now existing or hereafter authorized, the terms of which do not expressly
provide that such class or series ranks either (x)&nbsp;senior to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock as to dividend rights or distribution rights upon a
<FONT STYLE="white-space:nowrap">II-VI</FONT> liquidation event or (y)&nbsp;on parity with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock as to dividend rights and distribution rights upon a <FONT
STYLE="white-space:nowrap">II-VI</FONT> liquidation event (which we refer to as &#147;junior stock&#148;), (ii) on parity with the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series A mandatory convertible preferred stock and each other class or
series of <FONT STYLE="white-space:nowrap">II-VI</FONT> capital stock established after the closing of the initial investment, the terms of which expressly provide that such class or series ranks on parity with the
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock as to dividend rights and distribution rights upon a <FONT STYLE="white-space:nowrap">II-VI</FONT> liquidation event (which we refer to as &#147;parity stock&#148;),
and (iii)&nbsp;junior to each class or series of capital stock of <FONT STYLE="white-space:nowrap">II-VI</FONT> established after the closing of the initial investment, the terms of which expressly provide that such class or series ranks senior to
the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock as to dividend rights or distribution rights upon a <FONT STYLE="white-space:nowrap">II-VI</FONT> liquidation event (which we refer to as &#147;senior
stock&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-186- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends on each share of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will accrue on the applicable
stated value of such share at 5.00% per annum, subject to adjustments as set forth in the statement with respect to shares. Dividends on each share of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will accrue
daily from and after the issuance date of such share, but shall compound on a quarterly basis on each Dividend Payment Date (as defined in the statement with respect to shares), whether or not earned or declared and whether or not <FONT
STYLE="white-space:nowrap">II-VI</FONT> has assets legally available to make payment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the first Dividend Payment Date after
the fourth anniversary of the applicable issuance date of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, all dividend payments will compound and be added to the applicable stated value of such share on
each Dividend Payment Date (which we refer to as a &#147;PIK dividend&#148;). Following such fourth anniversary, dividends will be payable in the form of, in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> sole discretion, (i)&nbsp;solely cash
(if, as and when authorized by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or any duly authorized committee thereof, to the extent permitted by applicable law), (ii) solely a PIK dividend or (iii)&nbsp;any combination of both. If,
following such fourth anniversary, <FONT STYLE="white-space:nowrap">II-VI</FONT> does not elect to pay a dividend solely in cash or in any combination of cash and PIK dividend, <FONT STYLE="white-space:nowrap">II-VI</FONT> will be deemed to have
elected to pay such dividend solely as a PIK dividend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the <FONT STYLE="white-space:nowrap">II-VI</FONT> board declares a dividend on
the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in the form of any shares of capital stock of a subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> that are, or, when issued, will be, listed or admitted for trading on a U.S.
national security exchange, the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock will be entitled to receive such shares of capital stock payable on the shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issuable upon the conversation of such holders&#146; shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After
the applicable issuance date and following the earliest to occur of (i)&nbsp;the closing of the subsequent investment, (ii)&nbsp;the termination of the merger agreement and (iii)&nbsp;the delivery by <FONT STYLE="white-space:nowrap">II-VI</FONT> of
an offer to repurchase the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock in connection with a Fundamental Change, each holder of shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock has the right, subject to conversion procedures set forth in the statement with respect to shares, to convert such shares
into the number of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock equal to (a)&nbsp;the applicable stated value of such shares divided by such shares&#146; conversion price plus (b)&nbsp;cash in lieu of fractional shares. After the
applicable issuance date, each holder of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock has the right, subject to the conversion procedures set forth in the
statement with respect to shares, to convert such shares into the number of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock equal to (a)&nbsp;the applicable stated value of such shares divided by such shares&#146; conversion price plus
(b)&nbsp;cash in lieu of fractional shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The conversion price of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B
convertible preferred stock will initially be $85.00 per share, subject to adjustment as set forth in the statement with respect to shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to each series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, at any time after the
three&nbsp;year anniversary of the applicable issuance date of such series, if the closing sale price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock exceeds 150% of the then-applicable conversion price of such series for 20 trading
days in any 30 consecutive trading day period, <FONT STYLE="white-space:nowrap">II-VI</FONT> may elect to convert all (but not less than all) of the applicable series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock at the then-applicable conversion price in accordance with the terms of the statement with respect to shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fundamental
Change </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon a Fundamental Change, <FONT STYLE="white-space:nowrap">II-VI</FONT> shall make an offer, subject to the procedures set
forth in the statement with respect to shares, to repurchase, at the option and election of the holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, each share of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock then-outstanding at a purchase price per </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-187- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
share in cash equal to (i)&nbsp;the applicable stated value for such shares plus accrued or declared and unpaid dividends on such shares that had not previously been added to such stated value
plus (ii)&nbsp;if prior to the fifth anniversary of the applicable issuance date for such shares, the aggregate amount of all dividends that would have been paid (subject to certain exceptions) on such shares from the date of repurchase through the
fifth anniversary of the applicable issuance date of such share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption Option </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time on or after the ten&nbsp;year anniversary of the applicable issuance date of the shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock and subject to the procedures set forth in the statement with respect to shares, (i)&nbsp;each holder of such shares will have the right to require <FONT
STYLE="white-space:nowrap">II-VI</FONT> to redeem all of such holder&#146;s shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock for cash at a price per share equal to the sum of the applicable stated value
for such shares plus accrued or declared and unpaid dividends on such shares that had not previously been added to such stated value (which we refer to as the &#147;redemption price&#148;) and <FONT STYLE="white-space:nowrap">(ii)&nbsp;II-VI</FONT>
will have the right, with respect to one or more series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, to redeem, in whole or in part, on a pro rata basis from all holders of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, the outstanding shares of such series of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, for cash, equal to the redemption price.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
shares <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">of&nbsp;II-VI&nbsp;Series&nbsp;B-1&nbsp;convertible</FONT></FONT> preferred stock will initially be nonvoting. Following the expiration of the required waiting period under the
HSR Act, the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B&nbsp;convertible preferred stock will have voting rights, voting as one class with <FONT STYLE="white-space:nowrap">the&nbsp;II-VI&nbsp;common</FONT> stock, on <FONT
STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis,</FONT> subject to limited exceptions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Protective Covenants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock is outstanding, <FONT
STYLE="white-space:nowrap">II-VI</FONT> must not (unless the holders of a majority of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock issued and outstanding otherwise consent in writing or such action is taken
with respect to a Permitted Issuance): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">alter or change the rights, preferences or privileges of the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series B convertible preferred stock or amend, modify or supplement any provision of the organizational documents of <FONT STYLE="white-space:nowrap">II-VI</FONT> in a manner that adversely affects the rights, powers, preferences or privileges of
the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">authorize or issue any senior stock (or securities convertible into senior stock), or amend or alter <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> articles of incorporation to increase the number of authorized or issued shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">decrease the number of authorized shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible
preferred stock (other than as permitted pursuant to a conversion, redemption or repurchase by <FONT STYLE="white-space:nowrap">II-VI</FONT> thereof); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issue any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock (other
than pursuant to the investment agreement). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, unless the investors otherwise consent in writing (or if such
action is taken with respect to a Permitted Issuance), <FONT STYLE="white-space:nowrap">II-VI</FONT> must not: (i)&nbsp;so long as the investors continue to own at least 5% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series B convertible preferred stock that they held immediately following the completion of either the initial investment (if the subsequent investment has not occurred) or the equity financing, pay any cash dividend on <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock (other than cash dividends in amount of up to $3.00 per share in calendar year 2021, increased by 5% each subsequent year (which we refer to as &#147;ordinary dividends&#148;)) and (ii)&nbsp;so
long as the investors continue to own at least 25% of the number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock that they held immediately following the completion of either the initial investment (if
the subsequent investment has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-188- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not occurred) or the equity financing, redeem, repurchase or otherwise acquire (or make or declare any dividend or distribution in respect of) any junior stock (subject to certain exceptions,
including, among other things: ordinary dividends; <FONT STYLE="white-space:nowrap">non-cash</FONT> dividends or other distributions paid <I>pro rata</I> to all holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and, if
applicable, holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock; repurchases of junior stock of up to $100&nbsp;million on an aggregate annual basis; and dividends on junior stock in kind or in the form of
other junior securities or securities convertible into or exchange for such junior securities). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-189- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_118"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a discussion of material U.S. federal income tax consequences of the merger to U.S. holders (as defined below) that
exchange their shares of Coherent common stock for a mix of cash and <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. This discussion is limited to U.S. holders and does not address any tax consequences arising under the Medicare
contribution tax on net investment income or the alternative minimum tax, U.S. federal <FONT STYLE="white-space:nowrap">non-income</FONT> tax laws or the laws of any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction. This
discussion is based upon the Code, the regulations of the U.S. Department of the Treasury and judicial authorities and published positions of the Internal Revenue Service (&#147;IRS&#148;), all as currently in effect on the date of this joint proxy
statement/prospectus. These laws and authorities are subject to change or differing interpretations, possibly retroactively, and any change or differing interpretation could affect the continuing validity of this discussion. We have not sought and
do not intend to seek a ruling from the IRS regarding the matters discussed below. This discussion assumes that the merger will be consummated in accordance with the merger agreement and as described in this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (or other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds shares of Coherent
common stock, the tax treatment of a partner in such partnership for U.S. federal income tax purposes generally will depend upon the status of the partner and the activities of the partnership. Partnerships and partners in such partnerships should
consult their own tax advisors about the tax consequences of the merger to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Holders are urged to consult with their tax advisors
as to the specific tax consequences of the merger to them in light of their particular situations, including the applicability and effect of any U.S. federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#147;U.S. holder&#148; is a beneficial owner of shares of Coherent common stock that is, for U.S. federal
income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, created or
organized in or under the laws of the United States or any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if it (i)&nbsp;is subject to the primary supervision of a U.S. court and one or more United States
persons (as defined in Section&nbsp;7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust, or (ii)&nbsp;has a valid election in effect under applicable Treasury Regulations to be treated as a United States
person; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate that is subject to U.S. federal income tax on its income regardless of its source.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion assumes that U.S. holders of Coherent common stock hold their shares as a capital asset within the
meaning of Section&nbsp;1221 of the Code (generally, property held for investment). Further, this discussion does not address all aspects of U.S. federal income taxation that may be relevant to U.S. holders in light of their particular circumstances
or that may be applicable to U.S. holders if such holders are subject to special treatment under U.S. federal income tax laws, including any holder that is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a bank or other financial institution; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">tax-exempt</FONT> or governmental organization; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a partnership, subchapter S corporation or other pass-through entity or an investor in the foregoing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an insurance company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a regulated investment company or real estate investment trust; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a mutual fund; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-190- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a broker or dealer in securities, stocks, commodities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trader in securities who elects the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of accounting for securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. expatriate, former citizen or long-term resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person who actually or constructively owns more than five percent (5%) (by vote or value) of the outstanding
shares of Coherent common stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a Coherent stockholder who received Coherent common stock through the exercise of employee stock options or
through a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan or otherwise as compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person that has a functional currency other than the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person subject to special tax accounting rules as a result of any item of gross income with respect to Coherent
common stock being taken into account in an &#147;applicable financial statement&#148; as defined in Section&nbsp;451(b) of the Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a holder of options granted under any Coherent benefit plan; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a Coherent stockholder who holds Coherent common stock as part of a hedge, straddle or a constructive sale or
conversion transaction. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent stockholders that are not U.S. holders may have different U.S. federal income tax
consequences than those described below and are urged to consult with their own tax advisors regarding the tax treatment of the merger to them under U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion does not address the tax consequences of any transactions effectuated before, after or at the same time as the
merger, whether or not in connection with the merger, including, without limitation, the tax consequences to holders of options, warrants or similar rights to purchase shares of Coherent common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax Consequences of the Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
receipt of merger consideration by U.S. holders in exchange for shares of Coherent common stock pursuant to the merger is expected to be treated as a taxable transaction for U.S. federal income tax purposes. Therefore, assuming that such exchange is
treated as a taxable transaction, a U.S. holder who receives <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and cash in exchange for shares of Coherent common stock pursuant to the merger generally will recognize capital gain or loss
equal to the difference, if any, between (1)&nbsp;the sum of any cash and the fair market value of any <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock (determined as of the effective time of the merger) received by such U.S. holder in the
merger and (2)&nbsp;the U.S. holder&#146;s adjusted tax basis in its Coherent common stock exchanged therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capital gains of a <FONT
STYLE="white-space:nowrap">non-corporate</FONT> U.S. holder will generally be eligible for preferential U.S. federal income tax rates that are applicable to long-term capital gains if the U.S. holder has held its Coherent common stock for more than
one year as of the effective date of the merger. Capital gains of a <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. holder will generally be subject to short-term capital gains (and taxed at ordinary income tax rates) if the U.S. holder
has held its Coherent common stock for one year or less as of the date of the merger. The deductibility of capital losses is subject to limitations. If a U.S. holder acquired different blocks of Coherent common stock at different times or different
prices, the U.S. holder must determine its tax basis and holding period separately for each block of Coherent common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A U.S.
holder&#146;s aggregate tax basis in <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock received in the merger will equal the fair market value of such stock as of the effective time of the merger. A U.S. holder&#146;s holding period in any
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock received in the merger will begin the day after the effective time of the merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-191- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>U.S. holders are urged to consult with their own tax advisors as to the particular tax
consequences of the merger, including the effect of U.S. federal, state and local tax laws or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The receipt of merger consideration in the merger by a U.S. holder may, under certain circumstances, be subject to information reporting and
backup withholding, currently at a rate of 24%. A U.S. holder will not be subject to backup withholding, however, if such holder: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">furnishes a correct taxpayer identification number and certifies that he, she, or it is not subject to backup
withholding on IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> (included in the letter of transmittal to be delivered to such holder following the completion of the merger) and otherwise complies with all applicable backup withholding rules and
requirements; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">is otherwise exempt from backup withholding and properly certifies such exemption. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any amounts withheld under the backup withholding rules are allowed as a refund or credit against a U.S. holder&#146;s U.S. federal income tax
liability, provided that such holder timely furnishes the required information to the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The foregoing summary of material U.S.
federal income tax consequences is for general informational purposes only and does not constitute tax advice. All holders are urged to consult their own tax advisors with respect to the application of U.S. federal income tax laws to their
particular situations as well as any tax consequences arising under U.S. federal <FONT STYLE="white-space:nowrap">non-income</FONT> tax laws, or under the laws of any state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other taxing
jurisdiction. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-192- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_119"></A>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Introduction </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, <FONT
STYLE="white-space:nowrap">2021,&nbsp;II-VI,</FONT> Coherent and Merger Sub entered into the merger agreement. Pursuant to the terms of the merger agreement, the acquisition of Coherent will be accomplished through a merger of&nbsp;Merger Sub with
and into Coherent, with Coherent surviving the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Previously on June&nbsp;30, 2020, <FONT STYLE="white-space:nowrap">II-VI</FONT>
announced its intention to offer, in concurrent underwritten public offerings, newly issued shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and newly issued shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series A
mandatory convertible preferred stock. On July&nbsp;7, 2020, the public offerings were consummated, and <FONT STYLE="white-space:nowrap">II-VI</FONT> used the proceeds from the public offerings to pay off the remaining balance of $715&nbsp;million
on its senior secured term B loan facility with Bank of America, N.A. (referred to herein as &#147;Bank of America&#148;). We refer to the transactions described in this paragraph as the &#147;public offerings.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Previously on September&nbsp;24, 2019, <FONT STYLE="white-space:nowrap">II-VI</FONT> completed its acquisition of Finisar Corporation
(&#147;Finisar&#148;), a global technology leader for subsystems and components for fiber optic communications (the &#147;Finisar acquisition&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> is providing the following unaudited pro forma condensed combined financial information to aid
you in your analysis of the financial aspects of the merger. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> as
amended by the final rule, Release <FONT STYLE="white-space:nowrap">No.&nbsp;33-10786</FONT> &#147;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined balance sheet as of December&nbsp;31, 2020 gives effect to the merger, the equity financing, and
the debt financing, as if those transactions had been completed on December&nbsp;31, 2020 and combines the unaudited consolidated balance sheet of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of December&nbsp;31, 2020 with Coherent&#146;s
unaudited consolidated balance sheet as of January&nbsp;2, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined statements of earnings (loss)
for the year ended June&nbsp;30, 2020 and the six months ended December&nbsp;31, 2020 give effect to the merger, the equity financing, the debt financing, the public offerings and the Finisar acquisition as if they had occurred on July&nbsp;1, 2019,
the first day of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> fiscal year 2020, and combines the historical results of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar. The unaudited pro forma condensed combined statement
of earnings (loss) for the fiscal year ended June&nbsp;30, 2020 combines the audited consolidated statement of earnings (loss) of <FONT STYLE="white-space:nowrap">II-VI</FONT> for the fiscal year ended June&nbsp;30, 2020, Coherent&#146;s unaudited
consolidated statement of operations for the twelve months ended July&nbsp;4, 2020 and Finisar&#146;s unaudited consolidated statement of operations for the three month period ended July&nbsp;28, 2019. The unaudited pro forma condensed combined
statement of earnings (loss) for the six months ended December&nbsp;31, 2020 combines the unaudited consolidated statement of earnings of <FONT STYLE="white-space:nowrap">II-VI</FONT> for the six months ended December&nbsp;31, 2020 with
Coherent&#146;s unaudited consolidated statement of operations for the six months ended January&nbsp;2, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The historical financial
statements of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar have been adjusted in the accompanying unaudited pro forma condensed combined financial information to give effect to pro forma events that are transaction accounting
adjustments which are necessary to account for the merger, the equity financing, the debt financing, the public offerings and the Finisar acquisition, in accordance with U.S. GAAP. The unaudited pro forma adjustments are based upon available
information and certain assumptions that our management believe are reasonable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial
information should be read in conjunction with: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The accompanying notes to the unaudited pro forma condensed combined financial information;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate audited consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of and
for the fiscal year ended June&nbsp;30, 2020 and the related notes, included in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2020,
incorporated by reference into this joint proxy statement/prospectus; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-193- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate unaudited condensed consolidated financial statements of
<FONT STYLE="white-space:nowrap">II-VI</FONT> as of and for the six months ended December&nbsp;31, 2020 and the related notes, included in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Quarterly Report on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended December&nbsp;31, 2020, incorporated by reference into this joint proxy statement/prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate audited consolidated financial statements of Coherent as of and for the fiscal year ended
October&nbsp;3, 2020 and the related notes, included in Coherent&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as amended, for the fiscal year ended October&nbsp;3, 2020, incorporated by reference into this joint proxy
statement/prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate unaudited condensed consolidated financial statements of Coherent as of and for the three months
ended January&nbsp;2, 2021 and the related notes, included in Coherent&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended January&nbsp;2, 2021, incorporated by reference into this joint proxy
statement/prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate unaudited condensed consolidated financial statements of Coherent as of and for the nine months
ended July&nbsp;4, 2020 and the related notes, included in Coherent&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended July&nbsp;4, 2020, incorporated by reference into this joint proxy
statement/prospectus; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The separate unaudited condensed consolidated financial statements of Finisar as of and for the three months
ended July&nbsp;28, 2019 and the related notes, included in Finisar&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the period ended July&nbsp;28, 2019, incorporated by reference into
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Current Report on Form <FONT STYLE="white-space:nowrap">8-K/A</FONT> filed December&nbsp;9, 2019 and incorporated by reference into this joint proxy statement/prospectus. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
March&nbsp;25, 2021, <FONT STYLE="white-space:nowrap">II-VI,</FONT> Merger Sub and Coherent entered into the merger agreement, pursuant to which <FONT STYLE="white-space:nowrap">II-VI</FONT> agreed to acquire Coherent. Upon completion of the merger,
each share of Coherent common stock issued and outstanding immediately prior to the effective time will be converted into the right to receive (A) $220.00 in cash, without interest, plus (B) 0.91 of a validly issued, fully paid and nonassessable
share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Further, under the terms of the merger agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each time- or performance-based Coherent RSU (other than any Coherent director RSU) that is outstanding
immediately prior to the effective time will be converted into an award covering that number of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, rounded down to the nearest whole share, equal to the product of (x)&nbsp;the
number of shares of Coherent common stock subject to such award of Coherent RSUs (and, with respect to any Coherent PSUs, the number of shares of Coherent common stock will be determined based on the greater of the target or actual level of
achievement of such goals or metrics immediately prior to the effective time, as determined by the Coherent board or a committee thereof) and (y)&nbsp;the sum of (A) 0.91 and (B)&nbsp;the quotient obtained by dividing (i)&nbsp;the $220.00 cash
consideration by (ii)&nbsp;the volume weighted average price of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock for a ten&nbsp;trading day period, starting with the opening of trading on the 11th trading day prior to the
closing date to the closing of trading on the second to last trading day prior to the closing date, as reported by Bloomberg. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each Coherent director RSU that is outstanding immediately prior to the effective time will, automatically and
without any required action on the part of the holder thereof, vest (if unvested) and be cancelled and converted into the right to receive the merger consideration as if such Coherent director RSU had been settled in shares of Coherent common stock
immediately prior to the effective time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A holder&#146;s Coherent RSUs will immediately vest in certain circumstances involving a termination of
employment in connection with a change in control. At this time, II-VI has not made any decisions with respect to labor matters of the combined company. Accordingly, no adjustments have been made to the unaudited pro forma condensed combined
financial statements to reflect any such accelerated vesting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-194- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of the Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the debt commitment letter.
Subject to the terms of the debt commitment letter, the commitment parties have committed to provide a senior secured term loan &#147;A&#148; facility in an aggregate principal amount of $850&nbsp;million, a senior secured term loan &#147;B&#148;
facility in an aggregate principal amount of $2,800&nbsp;million, a senior secured revolving credit facility in an aggregate principal amount of $350&nbsp;million and a senior unsecured bridge loan facility in an aggregate principal amount of
$1,125&nbsp;million (which we refer to as the &#147;bridge loan facility&#148; and collectively with the other foregoing facilities, the &#147;facilities&#148;). The bridge loan facility will only be drawn to the extent <FONT
STYLE="white-space:nowrap">II-VI</FONT> is unable to issue senior unsecured notes or other debt securities at or prior to the closing of the merger in an amount sufficient to close the transaction. The funding of the facilities provided for in the
debt commitment letter is contingent on the satisfaction of customary conditions, including the execution and delivery of definitive documentation with respect to the facilities in accordance with the terms sets forth in the debt commitment letter
and the consummation of the merger in accordance with the merger agreement. For the purposes of this unaudited pro forma condensed combined financial information, <FONT STYLE="white-space:nowrap">II-VI</FONT> intends to draw $100&nbsp;million on the
senior secured revolving credit facility and $1,000&nbsp;million on the bridge loan facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with entering into the merger
agreement, on March&nbsp;30, 2021, <FONT STYLE="white-space:nowrap">II-VI</FONT> entered into the investment agreement. On March&nbsp;31, 2021, pursuant to the investment agreement, <FONT STYLE="white-space:nowrap">II-VI</FONT> and BCPE consummated
the initial investment of $750&nbsp;million through the issuance and sale of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock. Pursuant to the investment
agreement and subject to the terms and conditions set forth therein, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the investors expect to consummate the subsequent investment of at least $1.05&nbsp;billion, which may be increased by up to an
additional $350&nbsp;million, immediately prior to the closing of the merger. The issuance and sale of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in the
subsequent investment is contingent upon the consummation of the merger in accordance with the merger agreement and is subject to certain other closing conditions customary for transactions of this type. For the purposes of this unaudited pro forma
condensed combined financial information, <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to issue the additional 35,000 shares of II-VI Series <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock in connection with the
equity financing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting for the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The merger is being accounted for as a business combination using the acquisition method with <FONT STYLE="white-space:nowrap">II-VI</FONT> as
the accounting acquirer in accordance with Accounting Standards Codification (&#147;ASC&#148;) Topic 805, Business Combinations. Under this method of accounting, the aggregate merger consideration will be allocated to Coherent&#146;s assets acquired
and liabilities assumed based upon their estimated fair values at the date of completion of the merger. The process of valuing the net assets of Coherent immediately prior to the merger, as well as evaluating accounting policies for conformity, is
preliminary. Any differences between the estimated fair value of the consideration transferred and the estimated fair value of the assets acquired and liabilities assumed will be recorded as goodwill. Accordingly, the aggregate merger consideration
allocation and related adjustments reflected in this unaudited pro forma condensed combined financial information are preliminary and subject to revision based on a final determination of fair value. Refer to Note 1&#151;Basis of Presentation for
more information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> plans to finance the merger with cash from the combined company balance
sheets, proceeds from the issuance of new <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in the equity financing, and new debt incurred in the debt financing, as well as the issuance of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Common Stock as merger consideration. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> expects to use proceeds from the debt and equity financing to pay off the remaining balance on the <FONT
STYLE="white-space:nowrap">II-VI</FONT> senior secured first-lien term A loan facility with Bank of America. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma
condensed combined financial information presented is for informational purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the merger, the equity financing, the debt
financing, the public offerings and the Finisar acquisition had been completed on the dates set forth above, nor is it indicative of the future results or financial position of the combined company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-195- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of December&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>($000&#146;s) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI&nbsp;Historical</FONT><BR>As&nbsp;of&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent&nbsp;Reclassed<BR>As of January&nbsp;2,<BR>2021 (Note 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Note&nbsp;4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Accounting<BR>Adjustments&nbsp;-<BR>Financing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Note&nbsp;4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>Combined</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>ASSETS</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Current Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 834,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 508,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,974,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,556,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 924,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">570,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">226,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">797,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">656,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">416,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,170,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Prepaid and refundable income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Prepaid and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">153,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,137,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,278,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,877,285</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,556,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 3,095,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Property, plant&nbsp;&amp; equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">260,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(l)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,540,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,292,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,097,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,494,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">761,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,505,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,286,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">170,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">307,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,646,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,889,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 764,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,561,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,862,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top" COLSPAN="8"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>LIABILITIES AND STOCKHOLDERS&#146; EQUITY</B></P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:7pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 62,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 17,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,218</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,603</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 61,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">313,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Operating lease current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrued income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">263,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 664,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 296,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,218</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 943,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,408,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">428,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(424,053</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,507,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,921,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">579,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">660,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">108,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">285,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,409,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 937,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 139,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,505,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6,992,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Mezzanine Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(g)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total Mezzanine Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Shareholders&#146; Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Series A Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">445,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">445,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,985,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,719,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(h)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,705,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(89,064</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(i)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; &nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accumulated other comprehensive income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(9,948</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(k)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">997,283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">872,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,015,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(j)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(j)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">825,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Treasury stock, at cost</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(206,129</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(206,129</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total shareholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,236,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 951,878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 624,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 4,784,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total liabilities, mezzanine equity and shareholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,646,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,889,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 764,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,561,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,862,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-196- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF EARNINGS (LOSS) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Six Months Ended December&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>($000&#146;s, except per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI</FONT><BR>Historical<BR>Six Months<BR>Ended<BR>December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Public<BR>Offerings<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5C)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR><FONT STYLE="white-space:nowrap">II-VI</FONT> Six<BR>Months<BR>Ended<BR>December<BR>31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Reclassed<BR>Six<BR>Months<BR>Ended<BR>January&nbsp;2,<BR>2021<BR>(Note 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Accounting<BR>Adjustments<BR>&#151;Financing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro<BR>Forma<BR>Combined</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Revenues</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,514,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,514,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">642,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,157,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Costs, Expenses, and Other Expense (Income)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">905,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">905,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">406,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,312,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Internal research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">222,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">226,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">226,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">152,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">522,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(573</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,819</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other expense (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,039</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7,098</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(14,137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total Costs, Expense, &amp; Other Expense (Income)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,348,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,798</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,319,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">617,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">137,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,156,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Earnings (Loss) Before Income Taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">165,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">194,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(137,031</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(81,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Income tax expense (benefit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(30,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(18,036</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Net Earnings (Loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 134,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 22,462</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 156,628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 7,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(106,884</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(63,944</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (6,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Dividends and accretion on redeemable preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Net Earnings (Loss) available to the Common Shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 120,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 22,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 142,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 7,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(106,884</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(124,010</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (80,233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Basic Earnings (Loss) Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (0.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(g)</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Diluted Earnings (Loss) Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (0.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(g)</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-197- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF EARNINGS (LOSS) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Year Ended June&nbsp;30, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>($000&#146;s, except per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">II-VI</FONT><BR>Historical<BR>Year<BR>Ended<BR>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finisar<BR>Reclassed<BR>Three<BR>Months<BR>Ended<BR>July&nbsp;28,<BR>2019<BR>(Note 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finisar<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5B)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Public<BR>Offerings<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5C)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR><FONT STYLE="white-space:nowrap">II-VI</FONT><BR>Year<BR>Ended<BR>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Reclassed<BR>Twelve<BR>Months<BR>Ended<BR>July&nbsp;4,<BR>2020<BR>(Note 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Transaction<BR>Accounting<BR>Adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Transaction<BR>Accounting<BR>Adjustments<BR>- Financing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro<BR>Forma<BR>Combined</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(Note<BR>5A)</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Revenues</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,380,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">285,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(22,051</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,643,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,247,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,890,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Costs, Expenses, and Other Expense (Income)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,560,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">194,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(18,772</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,736,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">805,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,647,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Internal research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">339,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">402,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">527,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">440,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">308,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,224,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Goodwill and other impairment charges</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">451,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">452,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,562</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86,847</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">195,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">282,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other expense (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Total Costs, Expense, &amp; Other Expense (Income)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,443,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">298,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,382</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,562</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,724,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,697,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">535,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">195,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,152,399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Earnings (Loss) Before Income Taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(63,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(13,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(6,669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(81,699</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(449,558</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(535,128</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(195,254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,261,639</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Income tax expense (benefit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(g)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(117,728</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(42,956</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(191,787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Net Earnings (Loss)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (67,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (8,717</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,202</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (78,950</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(421,204</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(417,400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(152,298</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,069,852</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Dividends and accretion on redeemable preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Net Earnings (Loss) available to the Common Shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (67,029)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (8,717</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,202</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(25,602</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(106,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(421,204</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(417,400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(268,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,213,434</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman"><B>Basic and Diluted Earnings (Loss) Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (0.79</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (9.74</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">(g)</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-198- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 1&#151;Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
unaudited pro forma condensed combined financial information and related notes are prepared in accordance with Article 11 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> as amended by the final rule, Release
<FONT STYLE="white-space:nowrap">No.&nbsp;33-10786</FONT> &#147;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar&#146;s historical financial statements were prepared in accordance with
U.S. GAAP and presented in U.S. dollars. As discussed in Note 2, certain reclassifications were made to align <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar&#146;s financial statement presentation.
<FONT STYLE="white-space:nowrap">II-VI</FONT> is currently in the process of evaluating Coherent&#146;s accounting policies, which will be finalized upon completion of the merger, or as more information becomes available. As a result of that review,
additional differences could be identified between the accounting policies of the two companies. With the information currently available, <FONT STYLE="white-space:nowrap">II-VI</FONT> has determined that no significant adjustments are necessary to
conform Coherent&#146;s financial statements to the accounting policies used by <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting in accordance with ASC 805, with <FONT STYLE="white-space:nowrap">II-VI</FONT> as the accounting acquirer, using the fair value
concepts defined in ASC Topic 820, Fair Value Measurement, and based on the historical consolidated financial statements of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar. Under ASC 805, all assets acquired and liabilities
assumed in a business combination are recognized and measured at their assumed acquisition date fair value, while transaction costs associated with the business combination are expensed as incurred. The excess of merger consideration over the
estimated fair value of assets acquired and liabilities assumed, if any, is allocated to goodwill. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The allocation of the aggregate merger
consideration depends upon certain estimates and assumptions, all of which are preliminary. The allocation of the aggregate merger consideration has been made for the purpose of developing the unaudited pro forma condensed combined financial
information. The final determination of fair values of assets acquired and liabilities assumed relating to the merger could differ materially from the preliminary allocation of aggregate merger consideration. The final valuation will be based on the
actual net tangible and intangible assets of Coherent existing at the acquisition date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined
balance sheet, as of December&nbsp;31, 2020, the unaudited pro forma condensed combined statements of earnings (loss) for the year ended June&nbsp;30, 2020 and the unaudited pro forma condensed combined statements of earnings (loss) for the six
months ended December&nbsp;31, 2020 presented herein, are based on the historical financial statements of <FONT STYLE="white-space:nowrap">II-VI,</FONT> Coherent and Finisar. Because of different fiscal period ends, and pursuant to Rule <FONT
STYLE="white-space:nowrap">11-</FONT> 02(c)(3) of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> requiring fiscal period-ends to be within one quarter between the acquirer and acquiree, the following was applied: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The unaudited pro forma condensed combined balance sheet as of December&nbsp;31, 2020 is presented as if <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> acquisition of Coherent had occurred on December&nbsp;31, 2020 and combines the historical balance sheet of <FONT STYLE="white-space:nowrap">II-VI</FONT> as of December&nbsp;31, 2020 with the historical
balance sheet of Coherent as of January&nbsp;2, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The unaudited pro forma condensed combined statement of earnings (loss) for the year ended June&nbsp;30, 2020 has
been prepared as if the merger, the public offerings and the Finisar acquisition had occurred on July&nbsp;1, 2019 and combines <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> historical statement of earnings (loss) for the fiscal year ended
June&nbsp;30, 2020 with Coherent&#146;s historical statement of operations for the twelve month period ended July&nbsp;4, 2020, along with Finisar&#146;s historical statement of operations for the three month period ended July&nbsp;28, 2019.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent&#146;s historical statement of operations for the twelve month period ended July&nbsp;4, 2020 was
prepared by taking the unaudited consolidated statement of operations for the nine months ended July&nbsp;4, 2020, adding the audited consolidated statement of operations for the fiscal year ended
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-199- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
September&nbsp;28, 2019, and subtracting the unaudited consolidated statement of operations for the nine months ended June&nbsp;29, 2019. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Since the Finisar acquisition closed on September&nbsp;24, 2019, Finisar&#146;s results of operations are
presented in the <FONT STYLE="white-space:nowrap">II-VI</FONT> results for the period of September&nbsp;24, 2019 to June&nbsp;30, 2020. The results of Finisar for the three month period ended July&nbsp;28, 2019 is included to derive a twelve month
unaudited pro forma condensed combined statement of operations ended June&nbsp;30, 2020. In addition, the period between September&nbsp;24, 2019 and September&nbsp;30, 2019 has been removed for purposes of the unaudited condensed combined pro forma
statement of earnings (loss) for the year ended June&nbsp;30, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The unaudited pro forma condensed combined statement of earnings (loss) for the six months ended
December&nbsp;31, 2020 has been prepared as if the merger had occurred on July&nbsp;1, 2019 and combines <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> historical statement of earnings (loss) for the six months ended December&nbsp;31, 2020
with Coherent&#146;s historical statement of operations for the six months ended January&nbsp;2, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Coherent&#146;s historical statement of operations for the six months ended January&nbsp;2, 2021 was prepared by
taking the unaudited consolidated statement of operations for the three months ended January&nbsp;2, 2021, adding the audited consolidated statement of operations for the fiscal year ended October&nbsp;3, 2020 and subtracting the unaudited
consolidated statement of operations for the nine months ended July&nbsp;4, 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed
combined financial information does not reflect any anticipated synergies or dissynergies, operating efficiencies or cost savings that may result from the merger or any acquisition and integration costs that may be incurred. The pro forma
adjustments represent <FONT STYLE="white-space:nowrap">II-VI</FONT> management&#146;s best estimates and are based upon currently available information and certain assumptions that <FONT STYLE="white-space:nowrap">II-VI</FONT> believes are
reasonable under the circumstances. <FONT STYLE="white-space:nowrap">II-VI</FONT> is not aware of any material transactions between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent during the periods presented. Accordingly, adjustments to
eliminate transactions between <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent have not been reflected in the unaudited pro forma condensed combined financial information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note <FONT STYLE="white-space:nowrap">2&#151;II-VI,</FONT> Coherent, and Finisar reclassification adjustments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the preparation of this unaudited pro forma condensed combined financial information, management performed a preliminary analysis of
Coherent&#146;s financial information to identify differences in accounting policies as compared to those of <FONT STYLE="white-space:nowrap">II-VI</FONT> and differences in financial statement presentation as compared to the presentation of <FONT
STYLE="white-space:nowrap">II-VI.</FONT> With the information currently available, <FONT STYLE="white-space:nowrap">II-VI</FONT> has determined that no significant adjustments are necessary to conform Coherent&#146;s financial statements to the
accounting policies used by <FONT STYLE="white-space:nowrap">II-VI.</FONT> However, certain reclassification adjustments have been made to conform Coherent&#146;s historical financial statement presentation to
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> financial statement presentation. Following the merger, the combined company will finalize the review of accounting policies and reclassifications, which could be materially different from the
amounts set forth in the unaudited pro forma condensed combined financial information presented herein. This section also includes reclassification adjustments related to the historical Finisar information included for the unaudited pro forma
condensed combined statement of earnings (loss) for the fiscal year ended June&nbsp;30, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Refer to the table below for a summary of reclassification adjustments made to present Coherent&#146;s balance
sheet as of December&nbsp;31, 2020 to conform with that of <FONT STYLE="white-space:nowrap">II-VI&#146;s:</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(in<BR>000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Coherent Historical<BR>Consolidated Balance Sheet<BR>Line
Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Historical
Consolidated<BR>Balance Sheet Line Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent&nbsp;Historical<BR>Consolidated<BR>Balances<BR>As of<BR>January&nbsp;2,&nbsp;2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reclassification</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Reclassed<BR>As of<BR>January&nbsp;2,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cash and cash equivalents</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cash and cash equivalents</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">508,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">508,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Restricted cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Short-term investments</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-200- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(in<BR>000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Coherent Historical<BR>Consolidated Balance Sheet<BR>Line
Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Historical
Consolidated<BR>Balance Sheet Line Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent&nbsp;Historical<BR>Consolidated<BR>Balances<BR>As of<BR>January&nbsp;2,&nbsp;2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reclassification</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Reclassed<BR>As of<BR>January&nbsp;2,<BR>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accounts receivable, net of allowances</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accounts receivable, net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Inventories</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Inventories</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Prepaid expenses and other assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Prepaid and other current assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,414</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)(g)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Prepaid and refundable income taxes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,775 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(g)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Property and equipment, net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Property, plant&nbsp;&amp; equipment, net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Goodwill</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Goodwill</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Intangible assets, net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other intangible assets, net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Non-current</FONT> restricted cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Deferred income taxes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Short-term borrowings and current-portion of long-term obligations</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Current portion of long-term debt</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accounts payable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accounts payable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accrued compensation and benefits</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Operating lease current liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Income taxes payable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accrued income taxes payable</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other current liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other accrued liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,575</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Long-term obligations</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Long-term debt</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">428,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">428,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Deferred income taxes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(e)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Operating lease liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(f)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other long-term liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90,454</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(e)(f)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Common stock</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Common stock</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accumulated other comprehensive loss</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accumulated other comprehensive income (loss)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,948</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,948</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Retained earnings</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Retained earnings</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">872,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">872,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $35.4&nbsp;million of short-term investments to prepaid and other current assets.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $0.6&nbsp;million of finance lease <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets within other assets to property, plant&nbsp;&amp; equipment, net. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $89.9&nbsp;million of other assets to deferred income taxes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $87.6&nbsp;million of other accrued liabilities to accrued compensation and benefits and
operating lease current liabilities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $16.8&nbsp;million of other long-term liabilities to deferred income taxes.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $73.6&nbsp;million of other long-term liabilities to operating lease liabilities.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $36.8&nbsp;million of prepaid expenses and other assets to prepaid and refundable income
taxes. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-201- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Refer to the table below for a summary of adjustments made to present Coherent&#146;s statement of operations
for the six months ended December&nbsp;31, 2020 to conform with that of <FONT STYLE="white-space:nowrap">II-VI&#146;s:</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(in<BR>000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Coherent Historical<BR>Consolidated Statements of<BR>Operations
Line Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT>
Historical<BR>Consolidated Statements<BR>of Earnings (Loss) Line<BR>Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Six&nbsp;Months&nbsp;Ended<BR>January&nbsp;2, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reclassification</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent&nbsp;Reclassed<BR>Six&nbsp;Months&nbsp;Ended<BR>January&nbsp;2, 2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Net sales</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Revenues</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">642,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">642,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of sales</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of goods sold</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">410,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,363</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">406,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Internal research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Selling, general and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Selling, general and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">152,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amortization of intangible assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest income</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Other-net</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other expense (income), net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,789</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,098</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Provision for (benefit from) income taxes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Income tax expense (benefit)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $1.2&nbsp;million of amortization of intangible assets to selling, general and
administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $0.3&nbsp;million of interest income to other expense (income), net. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $4.4&nbsp;million of amortization of intangible assets within cost of goods sold to selling,
general and administrative. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Refer to the table below for a summary of adjustments made to present Coherent&#146;s statement of operations
for the year ended June&nbsp;30, 2020 to conform with that of <FONT STYLE="white-space:nowrap">II-VI&#146;s:</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(in<BR>000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Coherent Historical<BR>Consolidated Statements of<BR>Operations
Line Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT>
Historical<BR>Consolidated Statements<BR>of Earnings (Loss) Line<BR>Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent<BR>Twelve<BR>Months&nbsp;Ended<BR>July&nbsp;4, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reclassification</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Coherent&nbsp;Reclassed<BR>Twelve&nbsp;Months<BR>Ended&nbsp;July&nbsp;4, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Net sales</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Revenues</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,247,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,247,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of sales</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of goods sold</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">840,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,518</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">805,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Internal research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Selling, general and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Selling, general and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">267,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Goodwill and other impairment charges</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">451,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">451,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amortization of intangible assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest income</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,122</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Other-net</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other expense (income), net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,122</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Provision for (benefit from) income taxes</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Income tax expense (benefit)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $5.4&nbsp;million of amortization of intangible assets to selling, general and
administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $1.1&nbsp;million of interest income to other expense (income), net. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $35.5&nbsp;million of amortization of intangible assets within cost of goods sold to
selling, general and administrative. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-202- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Refer to the table below for a summary of adjustments made to present Finisar&#146;s statement of operations
for the three months ended July&nbsp;28, 2019 to conform with that of <FONT STYLE="white-space:nowrap">II-VI&#146;s:</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(in<BR>000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Finisar Historical<BR>Consolidated Statements of<BR>Operations
Line Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT>
Historical<BR>Consolidated Statements<BR>of Earnings (Loss) Line<BR>Items</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finisar&nbsp;Historical<BR>Three Months<BR>Ended July&nbsp;28,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Reclassification</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finisar<BR>Reclassed<BR>Three&nbsp;Months<BR>Ended<BR>July&nbsp;28, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Revenues</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Revenues</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">285,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">285,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of goods sold</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Cost of goods sold</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">194,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amortization of acquired developed technology</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(471</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(b)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Impairment of long lived assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Goodwill and other impairment charges</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Internal research and development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(c)(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sales and marketing</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,107</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(d)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Selling, general and administrative</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(a)(b)(d)(e)(f)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Start-up</FONT> costs</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,076</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(c)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amortization of purchased intangibles</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(230</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(e)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other expense (income), net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Other expense (income), net</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,424</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(g)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Interest income</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,424</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(g)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Income tax expense (benefit)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Income tax expense</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,947</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $2.7&nbsp;million of IT service and communication costs from cost of goods sold to selling,
general and administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $0.5&nbsp;million of amortization of acquired developed technology to selling, general and
administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $17.1&nbsp;million of <FONT STYLE="white-space:nowrap">start-up</FONT> costs to internal
research and development. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $12.1&nbsp;million of sales and marketing expense to selling, general and administrative.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $0.2&nbsp;million of amortization of purchased intangibles to selling, general and
administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $1.2&nbsp;million of IT service and communication costs from research and development to
selling, general and administrative. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Reclassification of $4.4&nbsp;million of interest income to other expense (income), net. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 3&#151;Preliminary purchase price allocation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Estimated Aggregate Merger Consideration </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the estimated aggregate merger consideration for Coherent with reference to
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> share price of $75.77 on April&nbsp;20, 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated cash paid for outstanding Coherent common stock (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,382,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value of estimated shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued to
Coherent stockholders (ii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,687,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated converted Coherent RSUs attributable to
<FONT STYLE="white-space:nowrap">pre-combination</FONT> service (iii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated payment of Coherent debt (iv)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">447,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated consideration for Coherent director RSUs (v)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preliminary estimated aggregate merger consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>7,550,551</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-203- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The cash component of the estimated aggregate merger consideration is based on 24,467,772 shares of outstanding
Coherent common stock being exchanged and the $220 per share cash portion of the merger consideration. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Value of estimated shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued is based on
24,467,772 shares of outstanding Coherent common stock being exchanged and 0.91 of a share of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock at a closing share price of $75.77 on April&nbsp;20, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As discussed in &#147;Description of the Transaction&#146;&#146;, certain equity awards of Coherent will be
replaced by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> equity awards with similar terms. The portion of the estimated fair value of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> equity awards attributable to the <FONT
STYLE="white-space:nowrap">pre-combination</FONT> service period represents aggregate merger consideration. The remainder of the fair value will be recognized as compensation expense subsequent to the merger. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The estimated cash paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> to settle Coherent&#146;s Euro Term
Loan and outstanding line of credit borrowings of $437.7&nbsp;million and $10.0&nbsp;million, respectively. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Estimated consideration for Coherent director RSUs represents the settlement of Coherent RSUs granted to
members of the Coherent board. The estimated consideration consists of $0.3&nbsp;million in cash consideration and $0.1&nbsp;million in consideration in shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preliminary estimated aggregate merger consideration could significantly differ from the amounts presented due to movements in the <FONT
STYLE="white-space:nowrap">II-VI</FONT> share price up to the closing date. A sensitivity analysis related to the fluctuation in the <FONT STYLE="white-space:nowrap">II-VI</FONT> share price was performed to assess the impact a hypothetical change
of 10% on the closing price of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock on April&nbsp;20, 2021 would have on the estimated aggregate merger consideration as of the closing date: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Estimated<BR>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10% increase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,719,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10% decrease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,381,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preliminary Aggregate Merger Consideration Allocation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The assumed accounting for the merger, including the aggregate merger consideration, is based on provisional amounts, and the associated
purchase accounting is not final. The preliminary allocation of the purchase price to the acquired assets and assumed liabilities was based upon the preliminary estimate of fair values. For the preliminary estimate of fair values of assets acquired
and liabilities assumed of Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> used publicly available benchmarking information as well as a variety of other assumptions, including market participant assumptions.
<FONT STYLE="white-space:nowrap">II-VI</FONT> is expected to use widely accepted income-based, market-based, and cost-based valuation approaches upon finalization of purchase accounting for the merger. Actual results may differ materially from the
assumptions within the accompanying unaudited pro forma condensed combined financial information.&nbsp;The unaudited pro forma adjustments are based upon available information and certain assumptions that
<FONT STYLE="white-space:nowrap">II-VI</FONT> believes are reasonable under the circumstances. The purchase price adjustments relating to the Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> combined financial information are preliminary
and subject to change, as additional information becomes available and as additional analyses are performed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-204- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the preliminary aggregate merger consideration allocation, as
if the merger had been completed on December&nbsp;31, 2020: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preliminary Purchase Price Allocation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 508,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">226,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">513,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other intangible assets, net (ii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,525,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant&nbsp;&amp; equipment, net (iii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,201,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued income taxes payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">595,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Estimated aggregate merger consideration</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>7,550,551</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The unaudited pro forma condensed combined balance sheet has been adjusted to record Coherent&#146;s
inventories at a preliminary fair value of approximately $513.5&nbsp;million, an increase of $97.1&nbsp;million from the carrying value. The unaudited pro forma condensed combined statement of earnings (loss) for the year ended June&nbsp;30, 2020
has been adjusted to recognize additional cost of goods sold related to the increased basis. The additional costs are not anticipated to affect the condensed combined statements of earnings (loss) beyond twelve months after the acquisition date.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary identifiable intangible assets in the unaudited pro forma condensed combined financial information
consists of the following: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preliminary<BR>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated<BR>Useful Life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trade names and trademarks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 105,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.8&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Customer relationships</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">796,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.5&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Developed technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,623,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.5&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets acquired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<B></B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2,525,659</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A 10% change in the valuation of intangible assets would cause a corresponding increase or decrease in the
amortization expense of approximately $14.3&nbsp;million for the six months ended December&nbsp;31, 2020 and $28.5&nbsp;million for the year ended June&nbsp;30, 2020. Pro forma amortization is preliminary and based on the use of straight-line
amortization. The amount of amortization following the merger may differ significantly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-205- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
between periods based upon the final value assigned and amortization methodology used for each identifiable intangible asset. </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The unaudited pro forma condensed combined balance sheet has been adjusted to record Coherent&#146;s property,
plant and equipment (consisting of land, buildings and improvements, equipment, furniture and fixtures, and leasehold improvements) at a preliminary fair value of approximately $290.4&nbsp;million, an increase of $29.6&nbsp;million from the carrying
value. The unaudited pro forma condensed combined statements of earnings (loss) have been adjusted to recognize additional depreciation expense related to the increased basis under cost of goods sold. The additional depreciation expense is computed
with the assumption that the various categories of assets will be depreciated over a useful life of <FONT STYLE="white-space:nowrap">10-15</FONT> years on a straight-line basis. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 4&#151;Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects adjustment to cash and cash equivalents: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><I>(000&#146;s)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><I>Pro forma transaction accounting adjustments:</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> transaction costs related to the merger (i)</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69,300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Coherent transaction costs related to the merger (i)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(74,173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid to settle Coherent director RSUs (ii)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of Coherent debt (iii)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(447,671</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for outstanding Coherent common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,382,910</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,974,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash from new debt financing, net of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,634,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash from issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock, net of equity issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of <FONT STYLE="white-space:nowrap">II-VI</FONT> debt (iv)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,163,507</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment&#151;financing to cash and cash
equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,556,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These costs consist of legal advisory, financial advisory, accounting and consulting costs.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">One-time</FONT> payment to settle equity awards for directors, as described in
Note 3 above. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The estimated cash paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> to settle Coherent&#146;s Euro Term
Loan and outstanding line of credit borrowings of $437.7&nbsp;million and $10.0&nbsp;million, respectively. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The estimated cash paid to settle <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> senior secured
first-lien term A loan facility with Bank of America including accrued interest. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the preliminary purchase accounting adjustment for inventories based on the acquisition method of
accounting. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s inventories&#151;carrying value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(416,381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preliminary fair value of acquired inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">513,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 97,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Represents the adjustment of acquired inventories to its preliminary estimated fair value. After the closing,
the step up in inventories to fair value will increase cost of goods sold as the inventories are sold, which for purposes of these pro forma financial statements is assumed to occur within the first year after the merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-206- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the preliminary purchase accounting adjustment for estimated intangibles based on the acquisition
method of accounting. Refer to Note 3 of the &#147;Notes to Unaudited Pro Forma Condensed Combined Financial Information&#148; for additional information on the acquired intangible assets expected to be recognized. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s historical net book value of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(19,934</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preliminary fair value of acquired intangibles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,525,659</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,505,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary goodwill adjustment of $4,097&nbsp;million which represents the elimination of historical goodwill
and excess of the estimated aggregate merger consideration over the preliminary fair value of the underlying assets acquired and liabilities assumed. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s historical goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(104,742</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill per purchase price allocation (Note 3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,201,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,097,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the originating deferred taxes resulting from pro forma fair value adjustments of the acquired assets
and assumed liabilities based on the applicable statutory tax rate with the respective estimated purchase price allocation. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on
post-merger activities, including cash needs, the geographical mix of income and changes in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate
in periods subsequent to completion of the merger. This determination is preliminary and subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-207- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the debt financing, net of unamortized debt issuance costs and original issue discount, to fund a
portion of the merger. <FONT STYLE="white-space:nowrap">II-VI</FONT> anticipates drawing down on debt from the commitment parties for $4,750&nbsp;million. The adjustment to current and long-term debt is comprised of the following items:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><I>Pro forma transaction accounting adjustments:</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of Coherent&#146;s Euro term loan and outstanding line of credit borrowings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(439,271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments to debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(439,271</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma transaction accounting adjustments to debt:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,218</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(424,053</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross proceeds from new debt financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revolving Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term Loan A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">850,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term Loan B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Bridge Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt issuance costs related to new debt financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(115,813</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net proceeds from new debt financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 4,634,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlement of <FONT STYLE="white-space:nowrap">II-VI</FONT> debt (and accrued interest)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,134,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments&#151;financing to debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 3,499,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma transaction accounting adjustments&#151;<BR>financing to prepaid and other
current assets&nbsp;&amp; other assets:</P></TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 5,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma transaction accounting adjustments&#151;financing to debt:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued liabilities (ii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion of long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,603</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 3,507,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other assets represents $5.7&nbsp;million of fees related to the establishment of the $350&nbsp;million senior
secured revolving credit facility pursuant to the debt commitment letter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other accrued liabilities represent accrued interest on the senior secured first-lien term A loan facility with
Bank of America. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-208- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock in the equity financing. Holders of shares of II-VI Series B convertible preferred stock will have the right to require II-VI to redeem all of such holder&#146;s shares of II-VI Series B convertible preferred stock, subject to the provisions
and procedures set forth in the statement with respect to shares, and therefore the Series B convertible preferred stock is reflected in mezzanine equity. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT>
preferred stock issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-2</FONT>
preferred stock issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,050,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">II-VI</FONT> Series
<FONT STYLE="white-space:nowrap">B-2</FONT> preferred stock issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Equity issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(64,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments &#150; financing to preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the elimination of Coherent&#146;s historical common stock and the II-VI common stock consideration
component of the merger. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s historical common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value of estimated shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issued to
Coherent stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,687,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated converted Coherent RSUs attributable to
<FONT STYLE="white-space:nowrap">pre-combination</FONT> services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Estimated consideration for Coherent director RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,719,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the elimination of Coherent&#146;s historical additional
<FONT STYLE="white-space:nowrap">paid-in</FONT> capital. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the elimination of Coherent&#146;s retained earnings,
<FONT STYLE="white-space:nowrap">write-off</FONT> of <FONT STYLE="white-space:nowrap">II-VI</FONT> debt issuance costs associated with the senior secured first-lien term A loan facility with Bank of America, and the payment of transaction costs.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><I>Pro forma transaction accounting adjustments:</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(872,519</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> transaction accounting costs (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(69,300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Coherent&#146;s transaction accounting costs (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(74,174</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments to retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,015,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Write-off</FONT> of <FONT STYLE="white-space:nowrap">II-VI</FONT>
debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments&#151;financing to retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(28,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These costs consist of legal advisory, financial advisory, accounting and consulting costs.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-209- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the elimination of Coherent&#146;s historical accumulated other comprehensive income.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the preliminary purchase accounting adjustment for property, plant and equipment based on the
acquisition method of accounting. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of Coherent&#146;s historical net book value of property, plant&nbsp;&amp;
equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(260,795</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preliminary fair value of acquired property, plant&nbsp;&amp; equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments to property, plant&nbsp;&amp; equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 29,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 5 &#150; Pro Forma Adjustments to the Unaudited Condensed Combined Statements of Earnings (Loss) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjustments included in the Coherent Transaction Accounting Adjustments column and Transaction Accounting
Adjustments &#150; Financing column in the accompanying unaudited pro forma condensed combined statements of earnings (loss) for the fiscal year ended June&nbsp;30, 2020 and the six months ended December&nbsp;31, 2020 are as follows:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustments to cost of goods sold, including the preliminary incremental stock-based compensation
expense for <FONT STYLE="white-space:nowrap">II-VI</FONT> replacement equity awards and the estimated fair value of inventories recognized through cost of goods sold during the first year after the merger. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Six&nbsp;Months</B><br><B>Ended&nbsp;December&nbsp;31,</B><br><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Year</B><br><B>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical Coherent stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,156</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,670</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Record stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory <FONT STYLE="white-space:nowrap">step-up</FONT> flowing through cost of goods sold
(i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment depreciation
<FONT STYLE="white-space:nowrap">step-up</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These costs are nonrecurring in nature and not anticipated to affect the condensed combined statements of
earnings (loss) beyond twelve months after the acquisition date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-210- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustments to internal research and development expense associated with the preliminary
incremental stock-based compensation expense for <FONT STYLE="white-space:nowrap">II-VI</FONT> replacement equity awards. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical Coherent stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,687</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Record stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to internal research and development
expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 2,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustments to selling, general and administrative expenses (&#147;SG&amp;A&#148;) including the
amortization of the estimated fair value of intangibles, the preliminary incremental stock-based compensation expense for <FONT STYLE="white-space:nowrap">II-VI</FONT> replacement equity awards and the estimated transaction costs expensed.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical Coherent amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,383</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">142,617</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">285,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical Coherent stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(18,987</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(32,650</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Record stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected transaction expenses (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to SG&amp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Transaction costs are nonrecurring in nature and will not affect the condensed combined statements of earnings
(loss) beyond twelve months after the acquisition date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-211- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the expense related to the financing and amortization of issuance costs related to the merger:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remove historical Coherent interest<BR>expense (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,819</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments to interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,819</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extinguishment of <FONT STYLE="white-space:nowrap">II-VI</FONT> unamortized issuance costs
(ii)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 37,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remove historical <FONT STYLE="white-space:nowrap">II-VI</FONT> interest<BR>expense (i)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(16,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(38,881</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New interest expense on transaction financing (iii):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revolving Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term Loan A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term Loan B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Bridge Facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustments&#151;financing to interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 81,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">195,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This pro forma transaction accounting adjustment reflects the removal of historical interest expense associated
with Coherent&#146;s existing indebtedness which will be extinguished upon consummation of the merger. The pro forma transaction accounting adjustment &#150; financing reflects the removal of historical interest expense associated with the paydown
of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> existing indebtedness related to the legacy senior secured first-lien term A loan facility and senior secured first-lien revolving credit facility with Bank of America. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The extinguishment of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> unamortized costs will not affect
the condensed combined statements of earnings (loss) beyond twelve months after the acquisition date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The new interest expense on transaction financing adjustments included in the unaudited pro forma condensed
combined statements of earnings (loss) reflect the interest expense and amortization of debt issuance costs associated with new debt from the commitment parties. Interest was recognized for the senior secured term loan &#147;A&#148; facility, senior
secured term loan &#147;B&#148; facility, and the bridge loan facility using the effective interest method with the rate equal to the Adjusted LIBO Rate plus 2.25% per annum for the senior secured term loan &#147;A&#148; facility, Adjusted LIBO Rate
plus 2.875% per annum for the senior secured term loan &#147;B&#148; facility, and Adjusted LIBO Rate plus 5% for the bridge loan facility (with the spread increasing by 0.50% for each period of three months). The senior secured revolving credit
facility assumes an interest rate equal to that of the senior secured term loan &#147;A&#148; facility. The bridge facility is assumed to be short-term borrowing and is a backstop in the event the II-VI cannot secure new financing with the
commitment parties. Per the terms of the debt commitment letter, the bridge facility is automatically converted to a senior extended term loan with a maturity of seven years after the conversion date if after one year II-VI has failed to raise
permanent financing. For the purposes of the unaudited pro forma condensed combined financial information, the conversion and extension of the term loan is assumed, along with the applicable interest rate, which is a maximum of 7.25% per the terms
of the debt commitment letter. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-212- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A sensitivity analysis on interest expense for the year ended June&nbsp;30, 2020 and the six
months ended December&nbsp;31, 2020 has been performed to assess the effect of a 12.5 basis point change of the hypothetical interest on the debt financing. The following table shows the change in the interest expense for the debt financing
transaction described above: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interest expense assuming:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase of 0.125%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 2,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 4,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease of 0.125%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,357</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,789</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To record the income tax impact of the pro forma adjustments utilizing a statutory income tax rate in effect of
22% for the year ended June&nbsp;30, 2020 and for the six months ended December&nbsp;31, 2020. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on post-merger activities, including
cash needs, the geographical mix of income and changes in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate in periods subsequent to completion
of the merger. This determination is preliminary and subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustment to record the dividends to holders of shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock, which accrue dividends at a 5% annual rate, compounding on a quarterly basis regardless of whether or not there are earnings or profits and accretion related to the
equity issuance costs of the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock in the equity financing. The dividends and accretion related to the <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B
convertible preferred stock are as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments&#151;financing:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends on <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion on <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma accounting adjustment &#150; financing to dividends and accretion on redeemable
preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-213- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma basic and diluted weighted average shares outstanding are a combination of historic weighted
average shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, the incremental Finisar weighted average shares outstanding, and issuances of shares in connection with the public offerings and the merger. In connection with the merger,
<FONT STYLE="white-space:nowrap">II-VI</FONT> agreed to convert certain equity awards held by Coherent employees into <FONT STYLE="white-space:nowrap">II-VI</FONT> equity awards. At this time, <FONT STYLE="white-space:nowrap">II-VI</FONT> has
completed a preliminary analysis related to eligible employees and vesting schedules in order to determine the impact to the diluted weighted average shares from the converted RSUs. The pro forma basic and diluted weighted average shares outstanding
are as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Pro forma weighted average shares&#151;basic and diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical <FONT STYLE="white-space:nowrap">II-VI</FONT> weighted average shares
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Incremental Finisar weighted average shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of shares in the July&nbsp;7, 2020 Public Offerings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of shares to Coherent common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance for equity awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Replacement awards vesting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average shares&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjustments included in the Finisar Transaction Accounting Adjustments column in the accompanying unaudited pro
forma condensed combined statement of earnings (loss) for the fiscal year ended June&nbsp;30, 2020 are as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the removal of results of Finisar operations for the period between the Finisar acquisition date of
September&nbsp;24, 2019 and September&nbsp;30, 2019, which are presented in the historical <FONT STYLE="white-space:nowrap">II-VI</FONT> results for the year ended June&nbsp;30, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the adjustments to cost of goods sold to record (i)&nbsp;the elimination of historical depreciation
and recognition of new depreciation expense based on the fair value of property, plant and equipment and (ii)&nbsp;the results of Finisar operations for the period between the Finisar acquisition date of September&nbsp;24, 2019 and
September&nbsp;30, 2019, which are presented in the historical <FONT STYLE="white-space:nowrap">II-VI</FONT> results for the year ended June&nbsp;30, 2020. The depreciation of property, plant and equipment is calculated on a straight line basis over
the estimated remaining useful lives as of the Finisar acquisition date for building and leasehold improvements of approximately 5 to 35 years and approximately 3 to 13 years for machinery and equipment. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Year</B><br><B>Ended</B><br><B>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical depreciation and recognition of new depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of results of operations for the <FONT STYLE="white-space:nowrap">six-day</FONT> period
September <FONT STYLE="white-space:nowrap">24-30,</FONT> 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(15,506</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(18,772</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-214- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the adjustments to internal research and development expense to record (i)&nbsp;the difference
between Finisar&#146;s historical stock-based compensation expense related to replacement awards issued to continuing employees as part of the Finisar acquisition agreement and (ii)&nbsp;the results of Finisar operations for the period between the
Finisar acquisition date of September&nbsp;24, 2019 and September&nbsp;30, 2019, which are presented in the historical <FONT STYLE="white-space:nowrap">II-VI</FONT> results for the year ended June&nbsp;30, 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Year<BR>Ended</B><br><B>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of results of operations for the <FONT STYLE="white-space:nowrap">six-day</FONT> period
September <FONT STYLE="white-space:nowrap">24-30,</FONT> 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,944</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to internal research and development
expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the adjustments to SG&amp;A to record (i)&nbsp;elimination of historical amortization expense and
recognition of new amortization expense related to identifiable intangible assets calculated on a straight-line basis, (ii)&nbsp;the difference between Finisar&#146;s historical stock-based compensation expense related to replacement awards issued
to continuing employees as part of the acquisition agreement, and (iii)&nbsp;the results of Finisar operations for the period between the Finisar acquisition date of September&nbsp;24, 2019 and September&nbsp;30, 2019, which are presented in the
historical <FONT STYLE="white-space:nowrap">II-VI</FONT> results for the year ended June&nbsp;30, 2020. Transaction costs that were nonrecurring in nature of approximately $44.2&nbsp;million are included in the unaudited pro forma condensed combined
statement of earnings (loss). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Year<BR>Ended</B><br><B>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical amortization and recognition of new amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,105</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of results of operations for the <FONT STYLE="white-space:nowrap">six-day</FONT> period
September <FONT STYLE="white-space:nowrap">24-30,</FONT> 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,728</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to SG&amp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The amortization of intangible assets is based on the periods over which the economic benefits of the
intangible assets are expected to be realized. Identifiable intangible assets used in the calculation of amortization expense in the unaudited pro forma financial information consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B><br><B>(in&nbsp;millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated<BR>Useful&nbsp;Life</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Developed technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">334.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12.5&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Customer relationships</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">323.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.2 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trademarks and trade names</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 6.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustment to reverse interest expense related to prior Finisar debt extinguished as a part of the
Finisar acquisition. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-215- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustment to eliminate interest income associated with the expected settlement of short-term
investments. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;the&nbsp;Year<BR>Ended</B><br><B>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of results of operations for the <FONT STYLE="white-space:nowrap">six-day</FONT> period
September <FONT STYLE="white-space:nowrap">24-30,</FONT> 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elimination of interest income on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to other expense (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the income tax impact of the pro forma adjustments utilizing a statutory income tax rate in effect of
22% for the year ended June&nbsp;30, 2020. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on post-merger activities, including cash needs, the geographical mix of income and changes
in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate in periods subsequent to completion of the merger. This determination is preliminary and
subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjustments included in the Public Offerings Transaction Accounting Adjustments column in the accompanying
unaudited pro forma condensed combined statements of earnings (loss) for the six months ended December&nbsp;31, 2020 and for the fiscal year ended June&nbsp;30, 2020 are as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the removal of historical interest expense associated with the paydown of the senior secured term B
loan facility with Bank of America which was extinguished through the public offerings. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B></B><I>(000&#146;s)</I><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six Months<BR>Ended&nbsp;December&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended&nbsp;June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Pro forma transaction accounting adjustments:</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of historical <FONT STYLE="white-space:nowrap">II-VI</FONT> interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(573</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(30,787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Write-off</FONT> of debt issuance cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net pro forma transaction accounting adjustment to interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(573</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,562</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the extinguishment of unamortized debt issuance costs related to the senior secured term B loan
facility with Bank of America classified within other expense (income), net for the six months ended December&nbsp;31, 2020. The extinguishment is included within interest expense for the year ended June&nbsp;30, 2020 assuming the public offerings
occurred at the beginning of the fiscal year. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the income tax impact of the pro forma adjustments utilizing a statutory income tax rate in effect of
22% for the year ended June&nbsp;30, 2020 and for the six months ended December&nbsp;31, 2020. The effective tax rate of the combined company could be significantly different (either higher or lower) depending on post-merger activities, including
cash needs, the geographical mix of income and changes in tax law. Because the tax rates used for the pro forma financial information are estimated, the blended rate will likely vary from the actual effective rate in periods subsequent to completion
of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-216- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
the merger. This determination is preliminary and subject to change based upon the final determination of the fair value of the acquired assets and assumed liabilities. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the adjustments to record the dividends to shares of the <FONT STYLE="white-space:nowrap">II-VI</FONT>
Series A mandatory convertible preferred stock which accrue dividends at a 6% annual rate. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-217- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_120"></A>COMPARISON OF STOCKHOLDERS&#146; RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the merger, holders of Coherent common stock will receive shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock in exchange
for their shares of Coherent common stock. <FONT STYLE="white-space:nowrap">II-VI</FONT> is organized under the law of the Commonwealth of Pennsylvania, and Coherent is organized under the law of the State of Delaware. The following is a summary of
the material differences between (i)&nbsp;the current rights of holders of Coherent common stock under the DGCL and the Coherent governing documents and (ii)&nbsp;the current rights of holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common
stock under the BCL and the <FONT STYLE="white-space:nowrap">II-VI</FONT> governing documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent believe that this summary describes the material differences between the rights of
holders of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock as of the date of this joint proxy statement/prospectus and the rights of holders of Coherent common stock as of the date of this joint proxy statement/prospectus; however, it
does not purport to be a complete description of those differences. Copies of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> and Coherent&#146;s governing documents have been filed with the SEC. To find out where copies of these documents can
be obtained, see &#147;Where You Can Find More Information&#148; beginning on page&nbsp;245 of this joint proxy statement/prospectus. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Authorized Capital Stock:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> authorized capital stock consists of (i) 300,000,000 shares of common stock, no par
value; and (ii) 5,000,000 shares of preferred stock, no par value, of which 300,000 shares have been designated as &#147;Series One Preferred Stock,&#148; 2,300,000 shares have been designated as &#147;6.00% Series A Mandatory Convertible Preferred
Stock,&#148; 75,000 shares have been designated as &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock&#148; and 140,000 shares have been designated as &#147;Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock.&#148;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">As of April 30, 2021, there were 105,007,546
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent is authorized to issue 500,000,000 shares of common stock, par value $0.01 per share.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2021, there were 24,531,522 shares of Coherent common stock
outstanding.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Preferred Stock:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The <FONT STYLE="white-space:nowrap">II-VI</FONT> charter authorizes the <FONT STYLE="white-space:nowrap">II-VI</FONT> board to issue all or any part of the authorized and unissued shares of
<FONT STYLE="white-space:nowrap">II-VI</FONT> preferred stock, to divide any or all of such shares into one or more series, to fix and determine the number of such shares and the designation of such series, and to fix and determine the designations,
voting rights, preferences, qualifications, limitations, restrictions and special or relative rights of such series to the fullest extent permitted by the laws of Pennsylvania. The rights of preferred shareholders may supersede the rights of common
shareholders.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">N/A</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-218- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2021, there were 2,300,000 shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Series A mandatory convertible preferred stock and 75,000 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series B convertible preferred stock outstanding. No other shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> preferred stock were outstanding as of such date.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Voting Rights:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter, each holder of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock is
entitled to one vote for each share of common stock held by such shareholder.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">II-VI</FONT> charter does not allow cumulative voting in the election of directors.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Coherent common stock are entitled to one&nbsp;vote for each share of common stock held by such stockholder.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">At a stockholders&#146; meeting at which directors are to be elected, each stockholder
shall be entitled to cumulate votes.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Dividends:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subject to any rights of any outstanding series of <FONT STYLE="white-space:nowrap">II-VI</FONT> shares senior to the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock with respect to dividends, the holders of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock are entitled to such dividends as may be declared from time to time by the <FONT STYLE="white-space:nowrap">II-VI</FONT> board from funds available therefor.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Holders of Coherent common stock are entitled to receive dividends when, as and if declared by the Coherent board out of funds legally available for that purpose.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Size of Board of Directors:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide that the number of directors must be at least five and not more than 11. The
<FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws also provide that the <FONT STYLE="white-space:nowrap">II-VI</FONT> board sets the exact number of directors by resolution adopted by a majority of the entire
<FONT STYLE="white-space:nowrap">II-VI</FONT> board.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">II-VI</FONT> board currently consists of 11 directors. <FONT STYLE="white-space:nowrap">II-VI</FONT> plans to amend the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws prior to the closing of the merger to increase
the maximum number of directors to 13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws require that there be not less than five&nbsp;nor more than nine&nbsp;directors on the Coherent board, the exact number
to be fixed by the board of directors from time to time.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Coherent board
currently consists of eight directors.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Nomination of Directors for Election:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws permit shareholders of record to nominate persons for election as directors at
annual meetings of shareholders if the shareholder gives timely written notice in proper form.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">To be timely, see &#147;Advance Notice Requirements for Stockholder Nominations and Other Proposals&#148; below.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Coherent bylaws provide that nominations for directors may be made at an annual meeting of stockholders only (a)&nbsp;by or at the direction of the board of directors or (b)&nbsp;by a stockholder of Coherent who was (i)&nbsp;a
stockholder of record at the time of the giving of the notice provided and on the record date for the determination of stockholders entitled to vote at the annual meeting</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-219- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">To be in proper form, a shareholder&#146;s written notice must include
(i)&nbsp;the name and address of the proposing person, (ii)&nbsp;the class or series and number of shares owned of record or beneficially by the proposing person, (iii)&nbsp;a description of certain other specified interests or arrangements
involving the proposing person, (iv)&nbsp;a representation that the proposing person is entitled to vote at the meeting, and intends to appear in person or by proxy to propose the nomination, (v)&nbsp;a statement as to whether the proposing person
intends, or is part of a group that intends, to deliver a proxy statement or form of proxy to holders of at least the percentage of the capital stock required to elect the nominee, or solicit proxies or votes from shareholders in support of the
nomination, (vi)&nbsp;any other information relating to the proposing person, the nomination or the nominee that would be required to be disclosed in filings made in connection with solicitations of proxies for election of directors in a contested
election pursuant to Section&nbsp;14 of the Exchange Act, (vii)&nbsp;a description of all direct and indirect compensation, material monetary arrangements, and any other material relationships during the past three years between the proposing
person, on the one hand, and each proposed nominee, nominee&#146;s affiliates and associates, or others acting in concert with the nominee, including information required to be disclosed pursuant to Rule 404 under Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> (viii)&nbsp;with respect to each proposed nominee, a completed and signed questionnaire, representation and agreement as required by the <FONT STYLE="white-space:nowrap">II-VI</FONT> Bylaws, and (ix)&nbsp;such
other information required by <FONT STYLE="white-space:nowrap">II-VI</FONT> to determine the eligibility of the proposed nominee.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and (ii)&nbsp;has complied with the notice procedures. See &#147;Advance Notice Requirements for Stockholder Nominations and Other
Proposals&#148; below for information on when such notice must be received in order to be timely.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The written notice to the Secretary must include, among other things, (i)&nbsp;the name, age, business address and residence address of such nominee,
(ii)&nbsp;the principal occupation or employment of the nominee, (iii)&nbsp;the class and number of shares of Coherent that are beneficially owned by the nominee, (iv)&nbsp;whether and the extent to which any hedging or other transactions has been
entered into by or on behalf of the nominee with respect to any securities of Coherent, or whether any other agreement, arrangement or understanding has been made, the effect or intent of which is to mitigate loss to or manage risk or benefit of
share price changes for, or to increase or decrease the voting power of the nominee, (v)&nbsp;a description of all arrangements or understandings between the nominating stockholder and each nominee and any other person or persons pursuant to which
the nominations are to be made by the nominating stockholder, (vi)&nbsp;a written statement executed by the nominee acknowledging that as a director of Coherent, the nominee will owe a fiduciary duty under Delaware law with respect to Coherent and
its stockholders, (vii)&nbsp;a written statement of the nominee that such nominee, if elected, intends to tender, promptly following such nominee&#146;s election or <FONT STYLE="white-space:nowrap">re-election,</FONT> an irrevocable resignation
effective upon such nominee&#146;s failure to receive the required vote for <FONT STYLE="white-space:nowrap">re-election</FONT> and (viii)&nbsp;any other information relating to the nominee that would be required to be disclosed about such nominee
if proxies were</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-220- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">being solicited for the election of the nominee as a director.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Additionally, with respect to the stockholder providing notice the written notice must contain, among other things, (1)&nbsp;the name and address of the
stockholder, (2)&nbsp;the class and number of shares of Coherent that are held of record or are beneficially owned by the stockholder and any of its affiliates or associates, (3)&nbsp;whether and the extent to which any hedging or other transactions
have been entered into by or on behalf of such stockholder or any of its affiliates or associates with respect to any securities of Coherent, or whether any other agreement, arrangement or understanding has been made, the effect or intent of which
is to mitigate loss to or manage risk or benefit from share price changes, or to increase or decrease the voting power of such stockholder or any of its affiliates or associates, (4)&nbsp;any material interest of the stockholder or any of its
affiliates or associates and (5)&nbsp;a statement whether such stockholder or any of its affiliates or associates will deliver a proxy statement and form of proxy to holders of a number of Coherent&#146;s voting shares reasonably believed by such
stockholder or any of its affiliates or associates to be necessary to elect such nominees.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Election of Directors; Board Classification:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide that director nominees, in an uncontested election, will be elected to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board if the votes cast &#147;for&#148; that
nominee exceed the votes cast &#147;against&#148; that nominee. In addition, if an incumbent director nominee does not receive a majority of the votes cast in an uncontested election, the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide
that the incumbent director will continue to serve on the <FONT STYLE="white-space:nowrap">II-VI</FONT> board until the <FONT STYLE="white-space:nowrap">II-VI</FONT> environmental, social responsibility and governance committee (which we refer to as
the &#147;ESG committee&#148;) makes a</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Coherent bylaws provide that director nominees shall be elected to the board if the votes cast for such nominee&#146;s election exceed the votes cast against such nominee&#146;s election; provided, however, in the event of a
contested election of directors, directors shall be elected by the vote of a plurality of the votes cast. A contested election shall mean any election of directors in which the number of candidates for election of directors exceeds the number of
directors to be elected.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-221- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">recommendation to the <FONT STYLE="white-space:nowrap">II-VI</FONT> board whether to accept or reject the conditional resignation previously
delivered by the incumbent director nominee pursuant to the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws. Within 90 days after certification of the election results, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board must act on the
incumbent director nominee&#146;s tendered resignation, taking into account the ESG committee&#146;s recommendation, and publicly disclose its decision and rationale.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide for a plurality of votes standard for contested elections of directors. Under a plurality of
votes standard, the nominees receiving the highest number of votes are the ones who are elected, up to the total number of directors to be elected.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide that the <FONT STYLE="white-space:nowrap">II-VI</FONT> board is divided into three classes,
each as nearly equal as possible in number of directors. As of the date of this joint proxy statement/prospectus, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board consists of four directors in Classes One and Class&nbsp;Three and three
directors in Class&nbsp;Two.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Elections of directors need not be by written ballot unless a
stockholder demands election by ballot at the meeting and before the voting begins.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The directors of Coherent are elected annually.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Coherent does not have a classified board.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Vacancies on the Board of Directors:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws, vacancies on the <FONT STYLE="white-space:nowrap">II-VI</FONT> board, including as a result of an increase in the total number of directors, may be filled by a majority
of the remaining directors, even if less than a quorum.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Coherent bylaws provide that any vacancies for any reason and any newly created directorships may be filled by the board, acting by the majority of the directors then in office, even if less than a quorum, or by a sole remaining
director. The Coherent stockholders also may fill any vacancies or newly created directorships.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Removal of Directors:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter, any director, any class of directors, or the entire <FONT STYLE="white-space:nowrap">II-VI</FONT> board may be removed from office by a vote of the shareholders at any
time, with or without cause, but only if shareholders entitled to cast at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes which all shareholders would be entitled to cast at an annual election of directors or of</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A director may be removed from office at any time, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors; provided, however, that, so long as stockholders of Coherent are
entitled to cumulative voting, if less than the entire board is to be removed, no director may be removed without cause if the votes</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-222- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">such class vote in favor of such removal.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">cast against his removal would be sufficient to elect him if then cumulatively voted at an election of the entire board of directors.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Amendments to Organizational Documents:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law applicable to a registered corporation, such as <FONT STYLE="white-space:nowrap">II-VI,</FONT> an amendment to the
articles of incorporation can be proposed by a resolution of the corporation&#146;s board of directors or by shareholders if provided for in the corporation&#146;s articles of incorporation or bylaws.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> charter provides that the affirmative
vote of shareholders entitled to cast at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes that all shareholders would be entitled to cast at an annual election of directors, voting together as a single class, is required to
amend, alter, or repeal, or to adopt any provision inconsistent with, any provision in the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter relating to the removal of directors or amendments to the <FONT STYLE="white-space:nowrap">II-VI</FONT>
charter, unless such amendment, repeal, or adoption is unanimously approved by the entire <FONT STYLE="white-space:nowrap">II-VI</FONT> board.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pennsylvania law allows an amendment to the articles to provide different treatment to shareholders within the same class or series, if (i)&nbsp;each group of
separately treated shareholders has a special class vote to approve the treatment or (ii)&nbsp;dissenters&#146; rights are provided to the shareholders of each group that is not given a class vote.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law, certain types of provisions in the bylaws can be adopted or
changed only by the shareholders. Regarding other matters, the bylaws may authorize directors to adopt, amend or repeal the bylaws, subject to the power of the shareholders to change such action. The <FONT STYLE="white-space:nowrap">II-VI</FONT>
bylaws contain such an authorization for action by the directors.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DGCL, an amendment to the certificate of incorporation generally requires the approval of (i)&nbsp;the board of directors,
(ii)&nbsp;a majority of the voting power of the outstanding stock entitled to vote upon the proposed amendment and (iii)&nbsp;a majority of the outstanding stock of each class entitled to vote thereon as a class, if any.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amendment of the Coherent charter and bylaws are not subject to any supermajority
board or stockholder votes. The Coherent charter provides that Coherent reserves the right to amend, alter, change or repeal any provision contained in the charter.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent may confer the powers to adopt, amend or repeal bylaws upon the directors.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Delaware law allows holders of shares within the same class or series to be treated differently in an amendment to the certificate of incorporation so long as
the disparate treatment is equitable, not prohibited by the certificate of incorporation and based on some characteristic of the holders being treated differently.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-223- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Stockholder Action by Written Consent:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Pennsylvania law, any action required or permitted to be taken at a meeting of shareholders may be taken without a meeting if a written consent is signed by all of the shareholders who would be entitled to vote at a
shareholder meeting for that purpose. In addition, under Pennsylvania law applicable to a registered corporation (such as <FONT STYLE="white-space:nowrap">II-VI),</FONT> shareholders may not act by less than unanimous written consent unless
otherwise provided in the articles of incorporation. The <FONT STYLE="white-space:nowrap">II-VI</FONT> charter does not provide for shareholder action by less-than unanimous consent.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Any action that is required to be taken or may be taken at any annual or special meeting of stockholders of Coherent may be taken by written consent if signed by Coherent stockholders having not less than the minimum number of votes
that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Prompt notice of the taking of the corporate action without a meeting by less than unanimous written consent
must be given to those stockholders who have not consented in writing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Special Meetings of Stockholders:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law applicable to a registered corporation (such as <FONT STYLE="white-space:nowrap">II-VI),</FONT> shareholders have a
statutory right to call a special meeting to approve certain business combinations. <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders are not otherwise permitted to call a special meeting or to require the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board to call a special meeting of shareholders, and Pennsylvania law forbids <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> charter from being amended to allow a meeting to be called by holders of
less than 25% of the votes that would be entitled to be cast at the meeting.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws provide that a special meeting of shareholders may be called at any time by a majority of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or by the chairman of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> board by making a written request to the <FONT STYLE="white-space:nowrap">II-VI</FONT> secretary that includes the purpose of the meeting. Only business that is included in the notice of special meeting,
or in a supplement to that notice, may be conducted at a special meeting of shareholders. Special meetings must be held within 60 days after the corporate secretary receives the request.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Notice of such special meeting shall be given in the same manner as for an annual
meeting of shareholders. No business may be transacted at such</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws provide that special meetings of the stockholders may be called at any time only by the board of directors, or by the
chairman of the board, by the president, or by the chief executive officer.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notice
of such special meeting shall be given in the same manner as for an annual meeting of stockholders and also specify the purpose or purposes for which the meeting is called. No business may be transacted at such special meeting other than the
business specified in such notice to stockholders.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Nominations of persons for
election to the Coherent board may be made at a special meeting of stockholders at which directors are to be elected pursuant to Coherent&#146;s notice of meeting (a)&nbsp;by or at the direction of the Coherent board or (b)&nbsp;by any stockholder
who (i)&nbsp;is a stockholder of record at the time of giving the notice and on the record date for the determination of stockholders entitled to vote at the special meeting, and (ii)&nbsp;who delivers a timely written notice of the nomination to
the corporate secretary, in the same form and substance as the notice of nomination required to be delivered in connection with an annual meeting of stockholders. To be timely, such</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-224- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">special meeting other than the business specified in such notice to stockholders.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director nominations may be made at a special meeting of shareholders at which directors
are to be elected (a)&nbsp;by or at the direction of the <FONT STYLE="white-space:nowrap">II-VI</FONT> board or any <FONT STYLE="white-space:nowrap">II-VI</FONT> board committee, or by a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder of
record who complies with the notice procedures set forth in the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws. To be timely, the shareholder must deliver notice to the corporate secretary no earlier than the close of business on the 120th day
before the special meeting and no later than the tenth day following the day on which public announcement of the special meeting is first made.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">notice must be received by the corporate secretary, no later than the close of business on the later of the 90th day prior to the special meeting or the tenth day following the day on which public announcement is first made of the
date of the special meeting and of the nominees proposed by the Coherent board to be elected at such meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Quorum; Required Vote:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provide that the presence, in person or by proxy, of shareholders entitled to cast
at least a majority of the votes that all shareholders are entitled to cast on a particular matter constitutes a quorum at all meetings of the shareholders.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">If a quorum is present at a meeting, except as otherwise provided under Pennsylvania law, the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter, and the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws, shareholder resolutions are passed, and actions are taken, at a meeting with the affirmative vote of shareholders entitled to cast at least a majority of the votes that all shareholders present at the
meeting are entitled to cast.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws provide that the holders of a majority of the stock issued and outstanding and entitled to vote thereat shall constitute
a quorum at all meetings of the stockholders for the transaction of business.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">If a
quorum is present at a meeting, then, other than for the election of directors, the affirmative vote of a majority of the shares present or represented by proxy at the meeting and entitled to vote on any matter shall be the act of the stockholders
unless the vote of a larger number is required by law, the Coherent charter or the Coherent bylaws.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Notice of Stockholder Meetings:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws require all notices of meetings of shareholders to be in writing and given at least five days prior to the meeting to each shareholder entitled to notice of such meeting. The
notice shall specify the date, time, and place of the meeting, how shareholders can attend the meeting, the general nature of the business to be transacted, and the record date for determining shareholders entitled to vote (if</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws require all notices of meetings of stockholders to be in writing and given not less than ten&nbsp;nor more than
60&nbsp;days before the date of the meeting to each stockholder entitled to vote at such meeting. The notice shall specify the place, date, and hour of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting
is called.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Delaware law requires notice to be given at least 20 days before the
date</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-225- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">different from the record date for shareholders entitled to notice).</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Pennsylvania law and the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws require
notice to be given at least ten days before the date of a meeting to vote on any of the following: amendments to the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter; the sale, lease, exchange, or other disposition of all, or substantially all,
of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> assets; the dissolution or winding up of <FONT STYLE="white-space:nowrap">II-VI;</FONT> or a plan of merger, plan of interest exchange, plan of conversion, plan of division, or plan of
domestication.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">of a meeting to vote on a merger agreement, a sale, lease or exchange of all or substantially all assets, a conversion to another form of entity or a transfer, domestication or continuance to a foreign jurisdiction.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Advance Notice Requirements for Stockholder Nominations and Other Proposals:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws permit shareholders of record to bring business before an annual meeting of the
shareholders if the shareholder gives timely written notice in proper form.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be
timely, a shareholder must give written notice to the corporate secretary no later than the close of business on the 120th day, and no earlier than the close of business on the 150th day, before the anniversary date of the preceding year&#146;s
annual meeting, with certain exceptions as specified in the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">To be in proper form, a shareholder&#146;s written notice must include (i)&nbsp;the name and address of the proposing person, (ii)&nbsp;the class or series and
number of shares owned of record or beneficially by the proposing person, (iii)&nbsp;a description of certain other specified interests or arrangements involving the proposing person, (iv)&nbsp;a representation that the proposing person is entitled
to vote at the meeting, and intends to appear in person or by proxy to propose the other business, (v)&nbsp;a statement as to whether the proposing person intends, or is part of a group that intends, to deliver a proxy statement or form of proxy to
holders of at least the percentage of the capital stock required to approve or adopt the proposal, or solicit proxies or votes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws provide that to be properly brought before an annual meeting, business must be brought by either (a)&nbsp;by or at the
direction of the board of directors, (b)&nbsp;pursuant to Coherent&#146;s proxy materials with respect to such meeting, or (c)&nbsp;by a stockholder of Coherent who (i)&nbsp;is a stockholder of record at the time of giving the notice and on the
record date for the determination of stockholders entitled to vote at the annual meeting and (ii)&nbsp;has timely complied in proper written form with the notice procedures.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">To be timely, the stockholder&#146;s notice must be received by the secretary at the principal executive offices of Coherent not later than the 45th day and
not earlier than the 75th day before the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date on which Coherent first mailed its proxy materials or a notice of availability of proxy materials (whichever is earlier) for the
preceding year&#146;s annual meeting; provided, however, that in the event that no annual meeting was held in the previous year or if the date of the annual meeting is advanced more than 30&nbsp;days prior to or delayed by more than 60&nbsp;days
after the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of the previous year&#146;s annual meeting, then notice to be timely must be so received by the secretary not earlier than the close
of</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-226- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">from shareholders in support of the proposal, (vi)&nbsp;any other information relating to the proposing person or the proposal that would be required to be disclosed in filings made in connection with solicitations of proxies in a
contested election pursuant to Section&nbsp;14 of the Exchange Act, (vii)&nbsp;a brief description of the business desired to be brought before the meeting, (viii)&nbsp;the reasons for conducting that business at the meeting, (ix)&nbsp;any material
interest of the shareholder in that business, (x)&nbsp;the text of the proposal, and (xi)&nbsp;the reasons for the proposal and any material interest of the proposing person in the proposal.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">business on the 120th day prior to such annual meeting and not later than the close of business on the later of (i)&nbsp;the 90th day prior
to such annual meeting or (ii)&nbsp;the tenth day following the day on which the public announcement of the date of such annual meeting is first made.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event shall any adjournment or postponement of an annual meeting of stockholders or the announcement thereof commence a new time period for the giving of
a stockholder&#146;s notice.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">A stockholder&#146;s notice to the secretary must set
forth with respect to each matter the stockholder proposes to bring before the annual meeting (i)&nbsp;a brief description of the business intended to be brought before the annual meeting and the reasons for conducting such business at the annual
meeting; (ii)&nbsp;the name and record address of the stockholder proposing such business; (iii)&nbsp;the class and number of shares of Coherent that are held of record or are beneficially owned by the stockholder and any of its affiliates or
associates; (iv)&nbsp;whether and the extent to which any hedging or other transactions have been entered into by or on behalf of such stockholder or any of its affiliates or associates with respect to any securities of Coherent, or whether any
other agreement, arrangement or understanding has been made, the effect or intent of which is to mitigate loss to or manage risk or benefit from share price changes for, or to increase or decrease the voting power of, such stockholder or any of its
affiliates or associates; (v)&nbsp;any material interest of the stockholder or any of its affiliates or associates; and (vi)&nbsp;a statement whether such stockholder or any of its affiliates or associates will deliver a proxy statement and form of
proxy to holders of a number of Coherent&#146;s</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-227- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">voting shares required under applicable law to carry the proposal.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Proxy Access:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws do not provide for proxy access.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent bylaws provide that Coherent shall include the name of a person nominated for election to the board of directors by a
stockholder and certain information with respect to such stockholder nomination in Coherent&#146;s proxy statement and form of proxy card for an annual stockholder&#146;s meeting, if an eligible stockholder, or group of no more than twenty
stockholders: (a)&nbsp;owns continuously for at least three years that number of shares of common stock as shall constitute three percent or more of Coherent&#146;s outstanding common stock as of both (i)&nbsp;a date within seven calendar days prior
to the date of the notice and (ii)&nbsp;the record date for determining stockholders entitled to vote at the annual meeting of stockholders, and (b)&nbsp;provides notice to the board of directors in accordance with the requirements set forth in the
Coherent bylaws.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">To be timely, the notice must be received by the secretary at the
principal executive offices of Coherent not later than the 120th day and not earlier than the 150th day prior to the anniversary of the date of mailing the definitive proxy statement with respect to the preceding year&#146;s annual meeting;
provided, however, that in the event that no annual meeting was held in the previous year or if the date of the annual meeting is advanced more than 30 days prior to or delayed by more than 60 days after the
<FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of the previous year&#146;s annual meeting, then notice to be timely must be so received by the secretary not earlier than the close of business on the 90th day prior to such
annual meeting and not later than the close of business on the later of (i)&nbsp;the 60th day prior to such annual meeting or (ii)&nbsp;the tenth</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-228- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">day following the day on which the public announcement of the date of such annual meeting is first made.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Duties of Directors:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law, the standard of conduct for directors is governed by statute and case law. Pennsylvania law requires that a director
of a Pennsylvania corporation perform his or her duties: (i)&nbsp;in good faith, (ii)&nbsp;in a manner he or she reasonably believes to be in the best interests of the corporation, and (iii)&nbsp;with such care, including reasonable inquiry, skill
and diligence, as a person of ordinary prudence would use under similar circumstances.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In discharging their duties, directors may, in considering the best interests of a corporation, consider, among other things, to the extent they deem
appropriate: (a)&nbsp;the effects of any action upon any or all groups affected by the action, including shareholders, employees, suppliers, customers and creditors of the corporation, and upon communities in which offices or other establishments of
the corporation are located; (b)&nbsp;the short-term and long-term interests of the corporation; (c)&nbsp;the resources, intent and conduct (past, stated and potential) of any person seeking to acquire control of the corporation; and (d)&nbsp;all
other pertinent factors. In considering the best interests of the corporation or the effects of any action, directors are not required to regard any corporate interest or the interests of the shareholders, or any other group affected by the action,
as a dominant or controlling factor.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law, the fiduciary duty of
directors does not require them to take action (including modifying any shareholders rights plan or redeeming any rights thereunder, or taking action under any of the anti-takeover laws) solely because of the effect that such action might have on a
potential or proposed acquisition of</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, the standard of conduct for directors of a corporation is not statutory but is based on fiduciary duty principles developed by Delaware courts. Directors of a Delaware corporation owe a duty of loyalty and a duty
of care to the corporation and its stockholders. Fiduciary duties are not owed to <FONT STYLE="white-space:nowrap">non-stockholder</FONT> constituencies such as customers and employees. The duty of loyalty requires directors to act with the sole
purpose of advancing the best interests of the corporation and its stockholders. The duty of loyalty also encompasses cases where the directors fail to act in good faith, including with respect to the duty of oversight. The duty of care requires
directors to inform themselves of all material information before making a business decision. Directors must also exercise due care in the other aspects of their responsibilities, including their delegation functions. The standard for due care is
gross negligence.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-229- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">control of the corporation, or on the consideration that might be offered or paid to shareholders in such an acquisition.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Limitation of Liability of Directors and Officers</I>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws, no director will be personally liable for monetary damages for any action taken, or any failure to take any action, unless (i)&nbsp;the director has breached or failed
to perform the duties of his or her office and (ii)&nbsp;the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness, other than under criminal statutes and under federal, state and local laws imposing liability on
directors for the payment of taxes.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coherent charter provides that the personal liability of the directors for monetary damages for breach of fiduciary duty as a director is
eliminated to the fullest extent permitted under the DGCL.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Delaware law provides
that a corporation may limit or eliminate a director&#146;s personal liability for monetary damages to the corporation or its stockholders for breach of fiduciary duty as a director, except for liability for: (i)&nbsp;any breach of the
director&#146;s duty of loyalty to such corporation or its stockholders; (ii)&nbsp;acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii)&nbsp;willful or negligent violation of provisions of
Delaware law governing payment of dividends and stock purchases or redemptions; or (iv)&nbsp;any transaction from which the director derived an improper personal benefit.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Indemnification of Directors and Officers:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Pennsylvania law authorizes a corporation to indemnify any director, officer, employee or agent who is or was a representative of, or serving at the request of, the corporation, so long as such person acted in good faith and with a
reasonable belief that his or her actions were in the best interests, or not opposed to the best interests, of the corporation, and with respect to any criminal proceeding, such person had no reasonable cause to believe his or her conduct was
unlawful. In general, the power to indemnify under these provisions of Pennsylvania law does not exist in the case of actions against a director or officer by or in the right of the corporation if the person otherwise entitled to indemnification
shall have been</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Coherent bylaws provide that Coherent shall, to the fullest extent permitted under the DGCL, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit, or
proceeding, whether civil, criminal, administrative or investigative by reason of the fact that such person was a director or officer of Coherent (or any predecessor of the Coherent), or that such director or officer is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture trust or other enterprise (collectively such directors and officers, an &#147;Agent&#148;). Except for proceedings to enforce the rights
to indemnification,</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-230- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">adjudged to be liable to the corporation unless it is judicially determined that, despite the adjudication of liability but in view of all
the circumstances of the case, the person is fairly and reasonably entitled to indemnification for specified expenses.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pennsylvania law states that the statutory rights of indemnification and advancement of expenses are not exclusive of any other rights to which a person might
be entitled under any bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as to the action in his or her official capacity and as to the action or proceeding in another capacity while holding that office.
Pennsylvania law specifies that indemnification pursuant to those alternative sources may be made even if the corporation would not have the power to make such indemnification under other provisions of law, and may be made even in the case of an
action by or in the right of the corporation. However, Pennsylvania law forbids indemnification to be made in any case where the act or failure to act giving rise to the claim is determined by a court to be willful misconduct or recklessness. A
corporation&#146;s articles of incorporation may not provide for indemnification in the case of willful misconduct or recklessness.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws, <FONT STYLE="white-space:nowrap">II-VI</FONT> must indemnify its directors and officers to the
fullest extent not prohibited by law in connection with any actual or threatened action, suit or proceeding that might give rise to an indemnification action or for indemnification. Except for successful indemnification actions to enforce rights to
indemnification, <FONT STYLE="white-space:nowrap">II-VI</FONT> may not indemnify a director or officer in connection with an action initiated by</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent shall not be obligated to indemnify any Agent in connection with a proceeding initiated by such person unless such proceeding was
authorized by the board.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Delaware law, Coherent may indemnify Agents for
attorneys&#146; fees and other expenses, as well as judgments or amounts paid in settlement in civil cases in connection with third-party actions. The Agent must have acted in good faith and in a manner he or she reasonably believed to be in, or not
opposed to, the best interests of the corporation. In criminal cases, Agents may be indemnified for fines and costs if, in addition to the foregoing standard of conduct, they did not have reasonable cause to believe their conduct was unlawful.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, in the case of actions brought by or in the right of Coherent such as
derivative actions, Coherent may only indemnify Agents against expenses and attorneys&#146; fees, and not in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to Coherent.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent may, in its sole discretion, indemnify an employee, trustee or other agent as
permitted by the DGCL. Coherent shall indemnify an employee, trustee or other agent where required by law.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Coherent also has agreed to advance expenses to any Agent incurred in defending a civil or criminal action, suit or proceeding in advance of the final
disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer, to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by
Coherent.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-231- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">that director or officer, unless the board authorizes such proceeding.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws also provide that <FONT
STYLE="white-space:nowrap">II-VI</FONT> may indemnify employees and agents of <FONT STYLE="white-space:nowrap">II-VI</FONT> that are not directors or officers to the extent determined by <FONT STYLE="white-space:nowrap">II-VI.</FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> has entered into agreements with its
directors and officers pursuant to which <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to provide for the indemnification of and the advancing of expenses to each such indemnitee to the fullest extent permitted by law and as set forth in
the applicable agreement, and, to the extent insurance is maintained, for the continued coverage of each such indemnitee under <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> directors&#146; and officers&#146; liability insurance policies.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Pennsylvania law provides mandatory indemnification for any director, officer, employee
or agent who is or was a representative of, or serving at the request of, the corporation if he or she succeeds on the merits or otherwise in the defense of any claim or action or proceeding, or in defense of any claim, issue or matter therein. The
corporation must indemnify him or her to the extent of his or her actual and reasonable expenses (including attorney&#146;s fees) incurred in connection with the claim or action.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Acquisition Proposals:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Pennsylvania law, except in certain limited circumstances where a vote of shareholders is not required, or unless a higher vote is required in the corporation&#146;s articles of incorporation, a plan of merger, a plan of asset
transfer providing for the sale of all or substantially all of the assets of a corporation, or a plan of interest exchange, conversion, division or voluntary dissolution will be adopted upon receiving at a properly convened meeting the affirmative
vote of a majority of the votes cast by all shareholders entitled to vote thereon</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Delaware law, a sale, lease or exchange of all or substantially all of a Delaware corporation&#146;s assets, a merger or consolidation
of a corporation with another corporation or a dissolution of a corporation generally requires the affirmative vote of the corporation&#146;s board of directors and, with limited exceptions, the affirmative vote of a majority of the aggregate voting
power of the outstanding stock entitled to vote on the transaction.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Neither the
Coherent charter nor the Coherent bylaws provide any</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-232- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and the affirmative vote of a majority of the votes cast in any required class vote.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">II-VI</FONT> charter does not require a
supermajority vote of shareholders for any action of shareholders related to business combinations.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Pennsylvania law allows such transactions to provide different treatment to shareholders within the same class or series, if (i)&nbsp;each group of separately
treated shareholders has a special class vote to approve the treatment or (ii)&nbsp;dissenters&#146; rights are provided to the shareholders of each group that is not given a class vote.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">supermajority board or stockholder vote requirements with regard to acquisition proposals.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Delaware law allows holders of shares within the same class or series to be treated
differently in such a transaction so long as the disparate treatment is equitable, not prohibited by the certificate of incorporation and based on some characteristic of the holders being treated differently.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Anti-Takeover Provisions:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Subchapter E of Chapter 25 of the BCL, certain persons that acquire 20% or more of the voting power of a Pennsylvania registered
corporation must pay in cash the &#147;fair value&#148; for the shares held by the other shareholders of the corporation who object to the acquisition transaction. <FONT STYLE="white-space:nowrap">II-VI</FONT> has not opted out of the applicability
of Subchapter E of Chapter 25 of the BCL.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Subchapter F of Chapter 25 of the
BCL, a Pennsylvania registered corporation is prohibited from engaging in a &#147;business combination&#148; with an &#147;interested shareholder&#148; (defined generally to be any beneficial owner of 20% or more of the corporation&#146;s voting
shares), unless (i)&nbsp;the board of directors of such corporation had approved the proposed transaction or had approved the interested shareholder&#146;s acquisition of shares that gave such person beneficial ownership of 20% of the shares
entitled to vote in an election of directors of such corporation, in either case prior to the date on which the shareholder first becomes an interested shareholder (referred to as the &#147;share acquisition date&#148;), (ii) the interested
shareholder owns at least 80% of the shares of the</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 of the DGCL prohibits a Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested
stockholder&#148; for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;before such date, the board of directors of the corporation approved either the business
combination or the transaction that resulted in the stockholder becoming an interested stockholder;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;upon completion of the transaction that resulted in the stockholder becoming an interested
stockholder, the interested stockholder owned at least 85&nbsp;percent of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding
voting stock owned by the interested stockholder) those shares owned (i)&nbsp;by persons who are directors and also officers and (ii)&nbsp;employee stock plans in which employee participants
do</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-233- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">corporation entitled to vote in an election of directors and, no earlier than three months after such interested shareholder reaches such 80%
level, the holders of a majority of the remaining shares approve the proposed transaction and shareholders receive a minimum &#147;fair price&#148; for their shares in the transaction and the other conditions of Subchapter F are met,
(iii)&nbsp;holders of all outstanding common shares approve the transaction, (iv)&nbsp;no earlier than five years after the share acquisition date, a majority of the shares held by shareholders other than the interested shareholder and entitled to
vote in an election of directors approve the transaction, or (v)&nbsp;no earlier than five years after the share acquisition date, a majority of all the shares approve the transaction, all shareholders receive a minimum &#147;fair price&#148; for
their shares and the other conditions of Subchapter F are met. <FONT STYLE="white-space:nowrap">II-VI</FONT> has not opted out of the applicability of Subchapter F of Chapter 25 of the BCL.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Subchapter G of Chapter 25 of the BCL, certain persons who acquire 20% or more, 33
1/3% or more, or 50% or more of the voting power of a Pennsylvania registered corporation for the first time lose the right to vote those &#147;control&#148; shares unless and until their voting rights are reinstated by the affirmative vote of at
least (i)&nbsp;a majority of the disinterested voting shares and (ii)&nbsp;a majority of all voting shares of the corporation. If the acquiring person does not seek such a vote, or if it does and it does not receive the necessary shareholder
approval, the corporation may, within a <FONT STYLE="white-space:nowrap">24-month</FONT> period, redeem the acquired shares at a market-based price. <FONT STYLE="white-space:nowrap">II-VI</FONT> has not opted out of the applicability of Subchapter G
of Chapter 25 of the BCL.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Subchapter H of Chapter 25 of the BCL, certain
persons that own</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.00em; font-size:10pt; font-family:Times New Roman">not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or
exchange offer; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;on or
after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least 66 and 2/3&nbsp;percent of the outstanding voting stock that is
not owned by the interested stockholder.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines a
&#147;business combination&#148; to include the following:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;any merger or consolidation involving the corporation and the interested stockholder;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;any sale, transfer, pledge or
other disposition of 10&nbsp;percent or more of the assets of the corporation involving the interested stockholder;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;subject to certain exceptions, any transaction that results in the issuance or transfer by the
corporation of any stock of the corporation to the interested stockholder;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;any transaction involving the corporation that has the effect of increasing the proportionate
share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;the receipt by the interested stockholder of the benefit of any loans, advances, guarantees,
pledges or other financial benefits by or through the corporation.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In general,
Section&nbsp;203 defines an &#147;interested stockholder&#148; as an entity or person who, together with the person&#146;s affiliates and associates, beneficially owns, or within three</P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-234- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">20% or more of a Pennsylvania registered corporation&#146;s shares, or that has publicly announced an intention to acquire control of the corporation, must disgorge any profits it realizes on the sale of its shares to the
corporation within 18 months of acquiring control status, including any forced sale pursuant to Subchapter G. <FONT STYLE="white-space:nowrap">II-VI</FONT> has not opted out of the applicability of Subchapter H of Chapter 25 of the BCL.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">years prior to the time of determination of interested stockholder status did own, 15&nbsp;percent or more of the outstanding voting stock of
the corporation.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The DGCL allows a corporation&#146;s certificate of incorporation
to contain a provision expressly electing not to be governed by Section&nbsp;203 of the DGCL.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Coherent charter does not contain a provision electing to <FONT STYLE="white-space:nowrap">&#147;opt-out&#148;</FONT> of Section&nbsp;203 of the DGCL.
Because Coherent has not opted out of Section&nbsp;203 of the DGCL, it remains subject to such provision.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Stockholder Rights Plan:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">II-VI</FONT> does not have a shareholder rights plan currently in effect, but under Pennsylvania law, the <FONT STYLE="white-space:nowrap">II-VI</FONT> board could adopt such a plan without
shareholder approval.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Coherent does not currently have a stockholder rights plan in effect, but under Delaware law, the Coherent board could adopt such a plan without stockholder approval.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Dissenters&#146; Rights or Appraisal Rights:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Pennsylvania law, unless the articles of incorporation or bylaws provide otherwise, shareholders generally are not entitled to
dissenters&#146; rights if the shares that would otherwise give rise to such rights are (i)&nbsp;listed on a national securities exchange or (ii)&nbsp;held beneficially or of record by more than 2,000 persons, such as the shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dissenters&#146; rights are
also available if a corporation provides special treatment to different groups of shareholders within the same class or series without giving members of a group receiving different treatment a special class vote on the transaction.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Neither the <FONT STYLE="white-space:nowrap">II-VI</FONT> charter nor the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws contain provisions relating to dissenters&#146; rights.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, stockholders of a Delaware corporation have the right, in certain mergers or consolidations to which the corporation is a party, to demand an appraisal by the Court of Chancery for the fair value of their shares
and to receive payment for the fair value of their shares, plus interest, if any, pursuant to, and in compliance with procedures set forth in, Section&nbsp;262 of the DGCL. Stockholders of a Delaware constituent corporation to a merger are not
entitled to appraisal rights in connection with a merger or consolidation with respect to shares (i)&nbsp;listed on a national securities exchange or held of record by more than 2,000 holders and (ii)&nbsp;for which, pursuant to the plan of merger
or consolidation, stockholders will receive only (a)&nbsp;shares of stock of the corporation surviving or resulting from such merger or consolidation or depository receipts in respect thereof, (b)&nbsp;shares of stock of another corporation or
depository receipts in respect thereof which at the date the</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-235- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">merger or consolidation is completed will be either listed on a national securities exchange or held of record by more than 2,000 holders,
(c)&nbsp;cash in lieu of fractional shares or fractional depository receipts or (d)&nbsp;any combination of the foregoing. Delaware law also provides that, subject to certain exceptions, stockholders of a surviving corporation do not have appraisal
rights in connection with a plan of merger if the merger did not require for its approval the vote of the surviving corporation&#146;s stockholders. Stockholders also do not have appraisal rights in connection with certain &#147;short-form&#148;
mergers between a parent corporation and wholly owned subsidiary corporation. Delaware law permits the certificate of incorporation of a Delaware corporation to provide for appraisal rights in mergers or consolidations in which appraisal rights are
not otherwise available and in connection with amendments to the certificate of incorporation and sales of all or substantially all assets. The Coherent charter contains no provisions giving rise to appraisal rights in such transactions.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Additionally, pursuant to Section&nbsp;262 of the DGCL, if immediately before a merger
or consolidation the shares of a class or series of stock of a corporation as to which appraisal rights are available were listed on a national securities exchange, the Delaware Court of Chancery must dismiss an appraisal proceeding as to all
stockholders who assert appraisal rights unless (i)&nbsp;the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (ii)&nbsp;the value of the consideration provided in the
merger or consolidation for such total number of shares seeking appraisal exceeds</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-236- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><FONT STYLE="white-space:nowrap">II-VI</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Coherent</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1&nbsp;million, or (iii)&nbsp;the merger was approved pursuant to Section&nbsp;253 or Section&nbsp;267 of the DGCL.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">At any time before the entry of judgment in the proceedings, the surviving corporation
may pay to each stockholder entitled to appraisal an amount in cash, in which case interest will accrue thereafter as provided under Section&nbsp;262 of the DGCL only upon the sum of (1)&nbsp;the difference, if any, between the amount so paid and
the fair value of the shares as determined by the Delaware Court of Chancery and (2)&nbsp;interest theretofore accrued, unless paid at that time.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-237- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_121"></A>SECURITY OWNERSHIP OF
<FONT STYLE="white-space:nowrap">II-VI</FONT> BENEFICIAL OWNERS AND MANAGEMENT </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the beneficial ownership
of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock by all directors of <FONT STYLE="white-space:nowrap">II-VI,</FONT> <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> named executive officers, all directors and executive officers of <FONT
STYLE="white-space:nowrap">II-VI</FONT> as a group and each person who is known to be the beneficial owner of more than five percent of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock as of April&nbsp;30, 2021. Unless otherwise indicated,
all persons listed below have sole voting and investment powers over all shares beneficially owned. Applicable percentage ownership is based on 105,007,546 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding as of
April&nbsp;30, 2021. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Beneficial Owner</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Shares of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT><BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Percentage&nbsp;of<BR>Common<BR>Stock<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><BR>55 East 52nd Street
<BR>New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">12,610,275</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">12.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wellington Management Group LLP<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP><BR>c/o
Wellington Management Company LLP <BR>280 Congress Street <BR>Boston, MA 02210</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">12,181,530</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">11.6</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FMR LLC<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP><BR>245 Summer Street <BR>Boston,
MA 02210</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">12,032,399</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">11.5</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP><BR>100 Vanguard Blvd.
<BR>Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">9,892,527</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">9.4</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Hartford Mutual Funds, Inc.<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP><BR>690 Lee
Road<BR>Wayne, PA 19087</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">5,269,952</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph J. Corasanti<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Enrico Digirolamo<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael L. Dreyer<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patricia Hatter<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis J. Kramer<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)(9)(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">888,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vincent D. Mattera, Jr.<SUP STYLE="font-size:85%; vertical-align:top"> (7)(8)(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">586,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David L. Motley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen Pagliuca<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marc Y. E. Pelaez<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">94,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shaker Sadasivam<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard H. Xia<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Giovanni Barbarossa<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136,805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Walter R. Bashaw II<SUP STYLE="font-size:85%; vertical-align:top">(7)(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">96,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Jane Raymond<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jo Anne Schwendinger<SUP STYLE="font-size:85%; vertical-align:top">(7)(8)(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All directors and executive officers as a group (15 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(14)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,324,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There were 105,007,546 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock outstanding as of
April&nbsp;30, 2021. In accordance with the rules and regulations of the SEC, in computing the number of shares beneficially owned by a person and the percentage ownership for each person listed, any shares which the listed person had the right to
acquire within 60 days and shares underlying <FONT STYLE="white-space:nowrap">II-VI</FONT> restricted stock units (which we refer to as <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> RSUs&#148;) are deemed outstanding; however, shares which any
other person had the right to acquire within 60 days and <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by other persons are disregarded in the calculation. Therefore, the denominator used in calculating beneficial ownership among the
persons listed may differ for each person. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-238- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G/A filed with the SEC on February&nbsp;5, 2021. BlackRock, Inc. reported sole
voting power over 12,470,317 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and sole dispositive power over 12,610,275 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. As reported in the Schedule 13G/A,
certain shares reported by BlackRock, Inc., are owned by various subsidiaries of BlackRock, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G/A filed with the SEC on February&nbsp;4, 2021. Wellington Management Group LLP,
Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP reported shared voting power over 9,471,783 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and shared dispositive power over 12,181,530 shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> common stock. In addition, Wellington Management Company LLP reported shared voting power over 9,330,392 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and shared dispositive power over
10,413,236 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. As reported in the Schedule 13G/A, the shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock are owned of record by clients of one or more investment
advisers directly or indirectly owned by Wellington Management Group LLP. The Schedule 13G/A reports that no such client is known to have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of,
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G/A filed with the SEC on February&nbsp;8, 2021. FMR LLC reported sole voting
power over 1,985,045 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock and sole dispositive power over 12,032,399 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. In addition, Abigail P. Johnson reported sole
dispositive power over 12,032,399 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. Through their ownership of voting common shares and the execution of a shareholders&#146; voting agreement, members of the Johnson family,
including Abigail P. Johnson, may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G/A filed with the SEC on February&nbsp;10, 2021. The Vanguard Group reported
shared voting power over 222,372 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock, sole dispositive power over 9,590,129 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> commons stock, and shared dispositive power over
302,398 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. As reported in the Schedule 13G/A, certain shares reported by The Vanguard Group are owned by various subsidiaries of the Vanguard Group. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based solely on a Schedule 13G filed with the SEC on February&nbsp;9, 2021. The Hartford Mutual Funds, Inc., on
behalf of Hartford Midcap Fund and Hartford Small Company Fund, reported shared voting and shared dispositive power over 5,269,952 shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the following stock options that are exercisable within 60 days of March&nbsp;31, 2021: 54,278 options
exercisable by Mr.&nbsp;Corasanti, 3,463 options exercisable by Mr.&nbsp;Digirolamo, 1,500 options exercisable by Mr.&nbsp;Dreyer, 1,453 options exercisable by Ms.&nbsp;Hatter, 297,978 options exercisable by Mr.&nbsp;Kramer, 200,800 options
exercisable by Dr.&nbsp;Mattera, 25,948 options exercisable by Rear Admiral Pelaez, 16,978 options exercisable by Dr.&nbsp;Sadasivam, 45,658 options exercisable by Dr.&nbsp;Xia, 26,630 options exercisable by Dr.&nbsp;Barbarossa, 55,110 options
exercisable by Mr.&nbsp;Bashaw, 53,887 options exercisable by Ms.&nbsp;Raymond, and 10,889 options exercisable by Ms.&nbsp;Schwendinger. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 5,924 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by each of Mr.&nbsp;Corasanti,
Mr.&nbsp;Digirolamo, Mr.&nbsp;Kramer, Rear Admiral Pelaez, Dr.&nbsp;Sadasivam, and Dr.&nbsp;Xia, 6,238 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by Mr.&nbsp;Dreyer, 5,388 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by
Ms.&nbsp;Hatter, 105,186 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by Dr.&nbsp;Mattera, 32,216 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by Dr.&nbsp;Barbarossa, 31,198 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs
held by Mr.&nbsp;Bashaw, 33,857 <FONT STYLE="white-space:nowrap">II-VI</FONT> RSUs held by Ms.&nbsp;Raymond, and 21,835 <FONT STYLE="white-space:nowrap">II-VI</FONT> held by Ms.&nbsp;Schwendinger. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 285,401 shares held in a Spousal Limited Access Trust, as to which Mr.&nbsp;Kramer disclaims
beneficial ownership. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 21,134 shares held on behalf of Dr.&nbsp;Mattera and 5,337 shares held on behalf of Mr.&nbsp;Kramer in
the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated Nonqualified Deferred Compensation Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Excludes any shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock issuable upon conversion of
shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock held by BCPE, an affiliate of Bain Capital, LP, of which Mr.&nbsp;Pagliuca is
<FONT STYLE="white-space:nowrap">Co-Chairman.</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 1,480 shares held by Mr.&nbsp;Bashaw&#146;s spouse and children, as to which Mr.&nbsp;Bashaw disclaims
beneficial ownership. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 2,000 shares held by Ms.&nbsp;Schwendinger&#146;s spouse, as to which Ms.&nbsp;Schwendinger disclaims
beneficial ownership. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-239- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes a total of 805,754 shares subject to stock options exercisable within 60 days of March&nbsp;31, 2021, <FONT
STYLE="white-space:nowrap">285,565&nbsp;II-VI</FONT> RSUs and 232 shares of restricted stock held by all executive officers and directors as a group. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-240- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_122"></A>SECURITY OWNERSHIP OF COHERENT BENEFICIAL OWNERS AND MANAGEMENT
</B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the beneficial ownership of Coherent common stock by all directors of Coherent, Coherent&#146;s named
executive officers named in this joint proxy statement/prospectus, all current directors and executive officers of Coherent as a group, and each person who is known to be the beneficial owner of more than five percent of Coherent common stock as of
April&nbsp;30, 2021. Unless otherwise indicated, all persons listed below have sole voting and investment powers over all shares beneficially owned. Applicable percentage ownership is based on 24,531,522 shares of Coherent common stock outstanding
as of April&nbsp;30, 2021. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Name of Beneficial Owner</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Shares of<BR>Coherent<BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Percentage&nbsp;of<BR>Common<BR>Stock<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><BR>100 Vanguard Blvd.
<BR>Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2,242,232</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">9.14</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP><BR>55 East 52nd Street
<BR>New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2,214,576</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">9.03</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wellington Management Group LLP<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP><BR>c/o
Wellington Management Company LLP <BR>280 Congress Street <BR>Boston, MA 02210</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,879,479</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">7.66</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Victory Capital Management Inc.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP><BR>4900
Tiedeman Rd. 4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor <BR>Brooklyn, OH 44144</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,745,792</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">7.12</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Hartford Mutual Funds, Inc. <SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP><BR>690
Lee Road<BR>Wayne, PA 19087</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,589,206</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">6.48</TD>
<TD NOWRAP VALIGN="top">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andreas W. Mattes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. John R. Ambroseo<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">187,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Palatnik</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr. Mark Sobey</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bret DiMarco<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Merk<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay T. Flatley<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pamela Fletcher</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Beverly Kay Matthews<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael R. McMullen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Garry W. Rogerson<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steve Skaggs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sandeep Vij<SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All directors and executive officers as a group (11 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(11)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">168,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based upon 24,531,522 shares of Coherent common stock outstanding as of April&nbsp;30, 2021. Beneficial
ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to the securities. In computing the number of shares beneficially owned by a person and the percentage ownership of that
person, each share of Coherent common stock subject to options held by that person that are currently exercisable or will be exercisable within 60 days of April&nbsp;30, 2021 and all Coherent RSUs held by that person that will vest within 60 days of
April&nbsp;30, 2021, are deemed outstanding. Such shares are not deemed outstanding for the purpose of computing the percentage ownership of any other person. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-241- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to the information reported by The Vanguard Group (&#147;Vanguard&#148;) on a Schedule 13G/A filed
with the SEC on February&nbsp;10, 2021, Vanguard beneficially owns an aggregate of 2,242,232 shares, which consists of (i) 18,263 shares as to which it has shared voting power, (ii) 2,205,184 shares as to which it has sole dispositive power, and
(iii) 37,048 shares as to which it has shared dispositive power. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to the information reported by BlackRock, Inc. (&#147;BlackRock&#148;) on a Schedule 13G/A filed with
the SEC on January&nbsp;29, 2021, BlackRock beneficially owns an aggregate of 2,214,576 shares, which consists of (i) 2,131,397 shares as to which it has sole voting power and (ii) 2,214,576 shares as to which it has sole dispositive power.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to the information reported by Wellington Management Group LLP (&#147;WMG&#148;), Wellington Group
Holdings LLP (&#147;WGH&#148;), Wellington Investment Advisors Holdings LLP (&#147;WIAH&#148;) and Wellington Management Company LLP (&#147;WMC&#148;) on a Schedule 13G/A jointly filed with the SEC on April&nbsp;12, 2021, (a) each of WMG, WGH and
WIAH beneficially owns an aggregate of 1,879,479 shares, which consists of (i) 1,657,419 shares as to which it has shared voting power and (ii) 1,879,479 shares as to which it has shared dispositive power, and (b)&nbsp;WMC beneficially owns an
aggregate of 1,846,138 shares, which consists of (i) 1,648,884 shares as to which it has shared voting power and (ii) 1,846,138 shares as to which it has shared dispositive power. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to the information reported by Victory Capital Management Inc. (&#147;Victory Capital&#148;) on a
Schedule 13G filed with the SEC on February&nbsp;5, 2021, Victory Capital beneficially owns an aggregate of 1,745,792 shares, which consists of (i) 1,673,292 shares as to which it has sole voting power and (ii) 1,745,792 shares as to which it has
sole dispositive power. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to the information reported by the Hartford Mutual Funds, Inc. on behalf of Hartford Midcap Fund and
Hartford Midcap Value Fund ( &#147;Hartford&#148;) on a Schedule 13G filed with the SEC on February&nbsp;9, 2021, Hartford beneficially owns an aggregate of 1,589,206 shares, as to which it has shared voting and dispositive power.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares are held by the Ambroseo-Lacorte Family Trust, of which Dr.&nbsp;Ambroseo is a trustee.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares are held by the DiMarco Family Trust, of which Mr.&nbsp;DiMarco is a trustee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Merk&#146;s employment with Coherent terminated on December&nbsp;31, 2020. This ownership information
is based on the last information known to Coherent. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares are held by the Flatley Family Trust, of which Mr.&nbsp;Flatley is a trustee. </P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 750 shares issuable upon vesting of Coherent RSUs within 60 days of April&nbsp;30, 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares are held by the 2000 Rogerson Family Revocable Living Trust, of which Dr.&nbsp;Rogerson is a trustee.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares are held by the Vij Family 2001 Trust, of which Mr.&nbsp;Vij is a trustee. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-242- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_123"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock to be issued in connection with the merger will be passed upon
for <FONT STYLE="white-space:nowrap">II-VI</FONT> by K&amp;L Gates LLP, Pittsburgh, Pennsylvania. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_124"></A>EXPERTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI.</FONT> </B>The consolidated financial statements of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries appearing in <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended
June&nbsp;30, 2020, and the effectiveness of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries&#146; internal control over financial reporting as of June&nbsp;30, 2020 (excluding the internal control over financial
reporting of Finisar Corporation), have been audited by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, which as to the report on the effectiveness of
<FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s internal control over financial reporting contains an explanatory paragraph describing the above referenced exclusion of Finisar Corporation from the scope of such firm&#146;s audit
of internal control over financial reporting, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as
experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Finisar</B>. The consolidated financial statements and schedule of Finisar Corporation as of
April&nbsp;28, 2019 and April&nbsp;29, 2018 and for each of the three years in the period ended April&nbsp;28, 2019, incorporated by reference in this joint proxy statement/prospectus have been so incorporated in reliance on the report of BDO USA,
LLP, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Coherent</B>. The financial statements incorporated in this prospectus by reference from Coherent&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended October&nbsp;3, 2020, and the effectiveness of Coherent Inc.&#146;s internal control over financial reporting, have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent
registered public accounting firm, as stated in their reports, which are incorporated herein by reference (which reports (1)&nbsp;express an unqualified opinion on the financial statements and includes an explanatory paragraph referring to a change
in method of accounting for leases in the year ended October&nbsp;3, 2020, and (2)&nbsp;express an unqualified opinion on the effectiveness of internal control over financial reporting. Such financial statements have been so incorporated herein in
reliance upon the reports of such firm given upon their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_125"></A>DEADLINES FOR SUBMITTING STOCKHOLDER PROPOSALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> will hold its 2021 annual meeting of shareholders (the
<FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> 2021 annual meeting&#148;), regardless of whether the merger has been completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposals by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders intended for inclusion in
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proxy statement and form of proxy for the <FONT STYLE="white-space:nowrap">II-VI</FONT> 2021 annual meeting expected to be held in November 2021 must be delivered to the Secretary of <FONT
STYLE="white-space:nowrap">II-VI</FONT> at 375 Saxonburg Boulevard, Saxonburg, PA 16056, by June&nbsp;1, 2021. Rules under the Exchange Act describe the standards as to the submission of shareholder proposals. Additionally, the <FONT
STYLE="white-space:nowrap">II-VI</FONT> board-appointed proxies will have discretionary authority to vote on any director nominations and any other proposals by <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders that are not intended to be
included in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> proxy materials for the <FONT STYLE="white-space:nowrap">II-VI</FONT> 2021 annual meeting but are intended to be presented by the shareholder from the floor, if notice of the intent to
make such proposal is received by <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary at the above address no later than the close of business on July&nbsp;12, 2021, and no earlier than the close of business on June&nbsp;12, 2021.
Otherwise, such proposals will be considered untimely. Any such notice of intent by a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder must also comply with the requirements contained in the <FONT STYLE="white-space:nowrap">II-VI</FONT>
bylaws. To request a copy of the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws, <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholders should contact <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Secretary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-243- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coherent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Proxy Statement Proposals. </I>If the merger is completed on the expected timetable, Coherent does not intend to hold a 2022 annual meeting
for its stockholders. If, however, the merger is not completed on the expected timetable or at all and the Coherent 2022 annual meeting is held, Coherent stockholder proposals may be included in Coherent&#146;s proxy materials for its 2022 annual
meeting so long as they are provided to Coherent on a timely basis and satisfy the other conditions set forth in applicable SEC rules. Under SEC rules, stockholders wishing to submit proposals for inclusion in the proxy statement for the Coherent
2022 annual meeting must submit such written proposals to the following address: Bret DiMarco, Corporate Secretary, Coherent, Inc., 5100 Patrick Henry Dr., Santa Clara, California 95054. Proposals must have been received no later than
November&nbsp;19, 2021, unless the Coherent 2022 annual meeting is called for a date that is not between April&nbsp;6, 2022 and July&nbsp;5, 2022, in which case proposals must be received a reasonable time before Coherent begins to print and send
its proxy materials. In addition, proposals must comply with SEC Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> in order for the proposal to be considered for inclusion in Coherent&#146;s proxy statement. Submission of a proposal does not
guarantee it will be included in Coherent&#146;s proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Proposals and Nominations. </I>The Coherent bylaws also
establish an advance notice procedure with respect to director nominations and stockholder proposals that are not submitted for inclusion in the proxy statement, but that a stockholder instead wishes to present directly from the floor at any annual
meeting. These advance notice provisions are in addition to, and separate from, the requirements that a stockholder must meet in order to have a proposal included in the proxy statement under SEC rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the advance notice provisions of the Coherent bylaws, nominations for director or other business proposals to be addressed at the
Coherent 2022 annual meeting must have been made by a stockholder entitled to vote who has delivered a notice to the Corporate Secretary (at the address above) no later than the close of business on February&nbsp;2, 2022, nor earlier than
January&nbsp;3, 2022. However, if the Coherent 2022 annual meeting is held prior to April&nbsp;6, 2022 or after July&nbsp;5, 2022, the notice must be received no earlier than the close of business on the 120th day prior to the Coherent 2022 annual
meeting and not later than the close of business on the later of (i)&nbsp;the 90th day prior to the Coherent 2022 annual meeting and (ii)&nbsp;the tenth day following the day on which public announcement of the date of such meeting is first made,
and must otherwise be in compliance with applicable laws and regulations in order to be considered for inclusion in the proxy statement and form of proxy relating to that meeting. To be in proper form, a stockholder&#146;s notice must include the
specified information concerning the proposal or nominee. Coherent reserves the right to reject, rule out of order, or take other appropriate action with respect to any nomination or proposal that does not comply with these and other applicable
requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-244- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_126"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent file annual, quarterly and current reports, proxy statements and other information
with the SEC. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including both <FONT STYLE="white-space:nowrap">II-VI</FONT> and
Coherent, which can be accessed at <I>https://www.sec.gov</I>. In addition, documents filed with the SEC by <FONT STYLE="white-space:nowrap">II-VI,</FONT> including the registration statement on Form <FONT STYLE="white-space:nowrap">S-4,</FONT> of
which this joint proxy statement/prospectus forms a part, will be available free of charge by accessing <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> website at <I><FONT STYLE="white-space:nowrap">www.II-VI.com</FONT></I> under the heading
Investors, or, alternatively, by directing a request by telephone or mail to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated at 375 Saxonburg Boulevard, Saxonburg, Pennsylvania 16056, (724)
<FONT STYLE="white-space:nowrap">352-4455,</FONT> and documents filed with the SEC by Coherent will be available free of charge by accessing Coherent&#146;s website at <I>www.coherent.com</I> under the heading Investor Relations, or, alternatively,
by directing a request by telephone, mail or <FONT STYLE="white-space:nowrap">e-mail</FONT> to Coherent, Inc. at 5100 Patrick Henry Drive, Santa Clara, California 95054, (408) <FONT STYLE="white-space:nowrap">764-4110,</FONT> or
investor.relations@coherent.com. The web addresses of the SEC, <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent are included as inactive textual references only. Except as specifically incorporated by reference into this joint proxy
statement/prospectus, information on those web sites is not part of this joint proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> has filed a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> under the
Securities Act with the SEC with respect to <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> securities to be issued in the merger. This joint proxy statement/prospectus constitutes the prospectus of <FONT STYLE="white-space:nowrap">II-VI</FONT>
filed as part of the registration statement. This joint proxy statement/prospectus does not contain all of the information set forth in the registration statement because certain parts of the registration statement are omitted in accordance with the
rules and regulations of the SEC. The registration statement and its exhibits are available for inspection and copying as set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Statements contained in this joint proxy statement/prospectus, or in any document incorporated by reference into this joint proxy
statement/prospectus regarding the contents of any contract or other document, are not necessarily complete, and each such statement is qualified in its entirety by reference to that contract or other document filed as an exhibit with the SEC. The
SEC allows <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent to incorporate by reference into this document documents filed with the SEC by <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. This means that the companies can
disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be a part of this joint proxy statement/prospectus, and later information that we file with the SEC will update and
supersede that information. <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent incorporate by reference the documents listed below and any documents filed by <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent under Section&nbsp;13(a),
13(c), 14 or 15(d) of the Exchange Act after the date of this joint proxy statement/prospectus and before the date of our meetings: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">II-VI</FONT> filings (SEC File <FONT
STYLE="white-space:nowrap">No.&nbsp;001-39375)</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Periods Covered or Date of Filing with the
SEC</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000082031820000023/iivi-20200630.htm">Fiscal year ended June&nbsp;30, 2020, filed on August&nbsp;26, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031820000029/iivi-20200930.htm">Quarterly period ended September&nbsp;
30, 2020, filed on November&nbsp;9, 2020 </A></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031821000004/iivi-20201231.htm">Quarterly period ended December&nbsp;
31, 2020, filed on February&nbsp;9, 2021 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filed December&nbsp;9, 2019 (<A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312519309221/d843447d8ka.htm">Form <FONT STYLE="white-space:nowrap">8-K/A</FONT></A>), July&nbsp;
2, 2020 (<A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031820000016/iivi-20200629.htm">Form <FONT STYLE="white-space:nowrap">8-K/A</FONT></A>), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/820318/000119312520188771/d936973d8k.htm">July&nbsp;7,
 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000117184320006858/f8k_100520.htm">October&nbsp;5, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520290353/d46182d8k.htm">November&nbsp;
12, 2020</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521040190/d83109d8k.htm">February&nbsp;12, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521062382/d22272d8k.htm">March&nbsp;
1, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521073334/d133047d8k.htm">March&nbsp;8, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521079572/d144802d8k.htm">March&nbsp;
12, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521082234/d120694d8k.htm">March&nbsp;16, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521085483/d153030d8k.htm">March&nbsp;
18, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521095186/d130942d8k.htm">March&nbsp;26, 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521102324/d135490d8k.htm">March&nbsp;31, 2021
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Definitive Proxy Statement on Schedule 14A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312520257324/d21265ddef14a.htm">Filed September&nbsp;29, 2020 </A></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-245- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The description of <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> capital stock contained in <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> registration statements filed under Section&nbsp;12 of the Securities Exchange
Act and any amendment or report filed for the purpose of updating those descriptions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filed September&nbsp;14, 1987</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Finisar filings (SEC File
<FONT STYLE="white-space:nowrap">No.&nbsp;000-27999)</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Periods Covered or Date of Filing with the
SEC</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1094739/000109473919000078/fnsr10qq1fy20.htm">Quarterly period ended July&nbsp;28, 2019, filed on September&nbsp;4, 2019 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Coherent filings (SEC File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-33962)</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Periods Covered or Date of Filing with the
SEC</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fiscal year ended October&nbsp;
3, 2020, filed on <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000002151020000049/cohr-20201003.htm">December&nbsp;
1, 2020</A> and amended on <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921010194/tm2030872d3_10ka.htm">February&nbsp;1, 2021</A></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Fiscal year ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000002151019000034/a928201910k.htm">September&nbsp;
28, 2019, filed on November&nbsp;26, 2019</A> and amended on <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465920006791/tm1919396-5_10ka.htm">January&nbsp;24, 2020</A> (solely with respect to Item 7 of Part II therein)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="http://www.sec.gov/Archives/edgar/data/21510/000002151021000022/cohr-20210102.htm">Quarterly period ended January&nbsp;
2, 2021, filed on February&nbsp;
10, 2021 </A></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/21510/000002151020000033/cohr-20200704.htm">Quarterly period
 ended July&nbsp;4, 2020, filed on August&nbsp;12, 2020 </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filed <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921004976/tm213408d4_8k.htm">January&nbsp;
19, 2021</A> (<A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921004984/tm213408d5_8k.htm">two filings), January&nbsp;
20, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921013383/tm213408d19_8k.htm">February&nbsp;8, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921021869/tm213408d22_8k.htm">February&nbsp;12,
2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921022525/tm213408d25_8k.htm">February&nbsp;16, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921032902/tm213408d27_8k.htm">March&nbsp;
8, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921034071/tm213408d32_8k.htm">March&nbsp;
10, 2021</A> (<A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921034088/tm213408d31_8k.htm">two filings</A>), <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921035185/tm219543d1_8k.htm">March&nbsp;
12, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921037368/tm213408d37_8k.htm">March&nbsp;17, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921037976/tm213408d39_8k.htm">March&nbsp;
18, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921039960/tm213408d43_8k.htm">March&nbsp;23, 2021</A>, and <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921041126/tm213408d47_8k.htm">March&nbsp;25,
2021</A> (<A HREF="http://www.sec.gov/Archives/edgar/data/21510/000110465921041590/tm213408d45_8k.htm">two filings</A>) (other than the portions of those documents not deemed to be filed)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Definitive Proxy Statement on Schedule 14A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filed <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000104746921000654/a2243039zdef14a.htm">March&nbsp;19, 2021 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The description of Coherent&#146;s capital stock contained in Coherent&#146;s registration statements filed under Section&nbsp;12 of the Securities Exchange Act and any amendment or report filed for the purpose of updating those
descriptions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filed <A HREF="http://www.sec.gov/Archives/edgar/data/21510/000104746920002119/a2240352zdef14a.htm">April&nbsp;6, 2020 </A></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may request a copy of the documents incorporated by reference into this joint proxy statement/prospectus,
without charge. Requests for documents should be directed to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>if you are a <FONT STYLE="white-space:nowrap">II-VI</FONT> shareholder:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375
Saxonburg Boulevard</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(724) <FONT
STYLE="white-space:nowrap">352-4455</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attn: Mark Lourie</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>if you are a Coherent stockholder:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, California 95054</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(408) <FONT
STYLE="white-space:nowrap">764-4110</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Investor Relations</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Email: investor.relations@coherent.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This joint proxy statement/prospectus does not constitute an offer to sell, or a solicitation of an offer to
purchase, the securities offered by this joint proxy statement/prospectus, or the solicitation of a proxy, in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer, solicitation of an offer or proxy
solicitation in such jurisdiction. Neither <FONT STYLE="white-space:nowrap">II-VI</FONT> nor Coherent have authorized anyone to provide you with information other than the information that is contained in, or incorporated by reference into, this
joint </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-246- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proxy statement/prospectus. Neither the delivery of this joint proxy statement/prospectus nor any distribution of securities pursuant to this joint proxy statement/prospectus shall, under any
circumstances, create any implication that there has been no change in the information set forth or incorporated into this joint proxy statement/prospectus by reference or in our affairs since the date of this joint proxy statement/prospectus. The
information contained in this joint proxy statement/prospectus with respect to <FONT STYLE="white-space:nowrap">II-VI</FONT> was provided by <FONT STYLE="white-space:nowrap">II-VI</FONT> and the information contained in this joint proxy
statement/prospectus with respect to Coherent was provided by Coherent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-247- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_126a"></A><A NAME="anxacov"></A>Annex A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXECUTION VERSION</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT AND PLAN OF MERGER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by
and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COHERENT, INC., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WATSON MERGER SUB INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as
of March&nbsp;25, 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TABLE OF CONTENTS </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;I THE MERGER </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effects of the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organizational Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;II CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect on Capital Stock in the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Appointment of Exchange Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Surrender and Exchange of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Treatment of Company Equity Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;III REPRESENTATIONS AND WARRANTIES OF THE COMPANY </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Qualification, Organization, Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capital Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Authority Relative to this Agreement; No Violation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reports and Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes or Events</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Internal Controls and Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Law; Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Labor and Employment Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Investigations; Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Supplied</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Bribery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exports&nbsp;&amp; Sanctions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-19</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Customers; Vendors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Government Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Finders or Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinion of Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Affiliate Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Additional Representations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Qualification, Organization, Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Capital Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Corporate Authority Relative to this Agreement; No Violation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reports and Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes or Events</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Internal Controls and Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Laws; Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Labor and Employment Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Investigations; Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Information Supplied</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Bribery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exports&nbsp;&amp; Sanctions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership of Company Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Vote Required</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Customers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Finders or Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Opinion of Financial Advisor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Affiliate Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.28</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Available Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.29</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Additional Representations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;V COVENANTS AND AGREEMENTS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conduct of Parent and Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-42</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Access</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Parent No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Filings; Other Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Regulatory Approvals; Efforts; Third-Party Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Takeover Statutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification and Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Control of Operations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Section&nbsp;16 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nasdaq Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Company Indebtedness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Employee Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Merger Sub; Parent Vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subsidiary Director and Officer Resignations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VI CONDITIONS TO THE MERGER </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Each Party&#146;s Obligation to Effect the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Obligation of the Company to Effect the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions to Obligation of Parent to Effect the First Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Frustration of Closing Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VII TERMINATION </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination or Abandonment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination Fee; Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE&nbsp;VIII MISCELLANEOUS </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-73</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Effectiveness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Jurisdiction; Specific Enforcement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assignment; Binding Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments; Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Third-Party Beneficiaries; Liability of Financing Sources</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">A-78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EXHIBITS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;A-1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Surviving Corporation Amended and Restated Certificate of Incorporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;A-2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Surviving Corporation Amended and Restated Bylaws</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER (this &#147;<U>Agreement</U>&#148;), dated as of March&nbsp;25, 2021, is by and among Coherent, Inc., a
Delaware corporation (the &#147;<U>Company</U>&#148;), <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (&#147;<U>Parent</U>&#148;), and Watson Merger Sub Inc., a Delaware corporation and a direct wholly owned
Subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;). Parent, Merger Sub and the Company are each sometimes referred to herein as a &#147;<U>Party</U>&#148; and, collectively, as the &#147;<U>Parties</U>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>WITNESSETH</U>: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties intend that Merger Sub shall be merged with and into the Company (the &#147;<U>Merger</U>&#148;), with the Company
surviving the Merger as a wholly owned Subsidiary of Parent; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of the Company (the &#147;<U>Company
Board</U>&#148;) has unanimously (i)&nbsp;determined that it is in the best interests of its stockholders, and declared it advisable, to enter into this Agreement, (ii)&nbsp;approved the execution, delivery and performance by the Company of this
Agreement and the consummation of the transactions contemplated hereby, including the Merger, and (iii)&nbsp;on the terms and subject to the conditions set forth in this Agreement, resolved to recommend the adoption of this Agreement by the
stockholders of the Company and to submit this Agreement to the stockholders of the Company for adoption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors
of Parent (the &#147;<U>Parent Board</U>&#148;) has unanimously (i)&nbsp;determined that it is in the best interests of Parent and its stockholders, and declared it advisable, to enter into this Agreement, (ii)&nbsp;approved the execution, delivery
and performance by Parent of this Agreement and the consummation of the transactions contemplated hereby, including the Merger and the issuance of shares of Parent Common Stock and Parent Preferred Stock (the &#147;<U>Share Issuance</U>&#148;) in
connection with the transactions contemplated by this Agreement (including, for the avoidance of doubt, the issuance of shares pursuant to the Investment Agreement), and (iii)&nbsp;resolved to recommend the approval by its stockholders of the Share
Issuance and to submit the Share Issuance to the stockholders of Parent for approval; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of Merger Sub has
unanimously (i)&nbsp;determined that it is in the best interests of Merger Sub and its sole stockholder&#146;s, and declared it advisable, to enter into this Agreement, (ii)&nbsp;approved the execution, delivery and performance by Merger Sub of this
Agreement and the consummation of the transactions contemplated hereby, including the Merger, and (iii)&nbsp;resolved to recommend the adoption of this Agreement by Merger Sub&#146;s sole stockholder, and to submit this Agreement to Merger
Sub&#146;s sole stockholder for adoption, and Parent, as Merger Sub&#146;s sole stockholder, has approved the execution, delivery and performance by Merger Sub of this Agreement and the consummation of the transactions contemplated hereby, including
the Merger, and has adopted this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent, Merger Sub and the Company desire to make certain representations,
warranties, covenants and agreements set forth herein in connection with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the
foregoing and the representations, warranties, covenants and agreements contained herein, and intending to be legally bound hereby, Parent, Merger Sub and the Company agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE
MERGER</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>The Merger</U>. At the Effective Time, upon the terms and subject to the satisfaction or valid waiver
of the conditions set forth in this Agreement, and in accordance with the applicable provisions of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;), at the Closing, Merger Sub shall be merged with and into the Company, whereupon the separate corporate existence of Merger Sub
shall cease, and the Company shall continue its existence under Delaware law as the surviving corporation in the Merger (the &#147;<U>Surviving Corporation</U>&#148;) and a wholly owned Subsidiary of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Closing</U>. Upon the terms and subject to the conditions set forth in this Agreement, the closing of the Merger (the
&#147;<U>Closing</U>&#148;) shall take place as soon as practicable (but in any event no later than the fifth Business Day) after the satisfaction or waiver (to the extent permitted by applicable Law) of the last of the conditions set forth in
<U>Article</U><U></U><U>&nbsp;VI</U> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of all such conditions), unless this Agreement has been terminated pursuant to its
terms or unless another time or date is agreed to in writing by the Company and Parent. The date on which the Closing actually occurs is referred to as the &#147;<U>Closing Date</U>.&#148; The Closing shall be held at the offices of Skadden, Arps,
Slate, Meagher&nbsp;&amp; Flom LLP, or remotely by exchange of documents and signatures (or their electronic counterparts), unless another place is agreed upon in writing by the Company and Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Effective Time</U>. Concurrently with the Closing, the Company and Merger Sub shall cause to be filed with the Secretary
of State of the State of Delaware a certificate of merger (the &#147;<U>Certificate of </U><U>Merger</U>&#148;), executed and filed in accordance with, and containing such information as is required by, the relevant provisions of the DGCL in order
to effect the Merger. The Merger shall become effective at such time as the Certificate of Merger has been filed with the Secretary of State of the State of Delaware or at such other, later date and time as is agreed between the Parties and
specified in the Certificate of Merger in accordance with the relevant provisions of the DGCL (such date and time is hereinafter referred to as the &#147;<U>Effective Time</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4 <U>Effects of the Merger</U>. The effects of the Merger shall be as provided in this Agreement and in the applicable
provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving
Corporation, and all debts, claims, obligations, liabilities and duties of the Company and Merger Sub shall become the debts, claims, obligations, liabilities and duties of the First Step Surviving Corporation, all as provided under the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5 <U>Organizational Documents</U>. At the Effective Time, the Company&#146;s Restated and Amended Certificate of Incorporation
(as amended, the &#147;<U>Company Certificate</U>&#148;) and Amended and Restated Bylaws (the &#147;<U>Company Bylaws</U>&#148;) shall be amended and restated, respectively, to be in substantially the forms attached hereto as
<U>Exhibit</U><U></U><U>&nbsp;A-</U><U>1</U> and <U>Exhibit</U><U></U><U>&nbsp;A-</U><U>2</U>, and as so amended and restated shall be the certificate of incorporation and bylaws, respectively, of the Surviving Corporation until thereafter amended
in accordance with the provisions thereof and applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6 <U>Directors and Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From and after the Effective Time, the directors of Merger Sub immediately prior to the Effective Time shall be the initial directors of
the Surviving Corporation and shall hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) From and after the Effective Time, the officers of Merger Sub immediately prior to the Effective Time shall be the initial officers of the
Surviving Corporation and shall hold office until their respective successors are duly elected or appointed and qualified, or their earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7 <U>Parent Board</U>. The parties hereto shall take all necessary actions such that, at the Effective Time, two directors
designated by the Company (each, a &#147;<U>Company Designee</U>&#148;) shall be appointed to the Parent Board, each reasonably acceptable to Parent, from among the directors serving on the Company Board as of immediately prior to the Effective
Time, and each of whom must qualify as an &#147;independent director&#148; under applicable Nasdaq rules and regulations. Each Company Designee shall hold office until the earliest to occur of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
appointment or election and qualification of his or her respective successor or his or her death, resignation, disqualification or proper removal as a member of the Parent Board. In the event
that prior to the Effective Time any Company Designee is unwilling or unable to serve on the Parent Board, the Company shall select a replacement for such individual (who shall be reasonably acceptable to Parent) to serve in such person&#146;s
place. Parent agrees to nominate the Company Designees appointed to the Parent Board pursuant to this <U>Section</U><U></U><U>&nbsp;1.7</U> for reelection at Parent&#146;s first annual stockholders&#146; meeting that occurs after the Closing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>Effect on Capital Stock in the Merger</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, by virtue of the Merger and without any action on the part of Parent, the Company, Merger Sub or the holder of any
shares or securities of Parent, the Company or Merger Sub: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Conversion of Merger Sub Common Stock</U>. Each share of
common stock, par value $0.001 per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be automatically converted into and become one fully paid and nonassessable share of common stock of the Surviving
Corporation and shall constitute the only outstanding shares of capital stock of the Surviving Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
<U>Cancellation of Certain Stock</U>. Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time that is owned or held in treasury by the Company or any of its Subsidiaries and each share of Company Common
Stock issued and outstanding immediately prior to the Effective Time that is owned by Parent, its Subsidiaries or Merger Sub shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist (the
&#147;<U>Cancelled Shares</U>&#148;), and no consideration shall be delivered in exchange therefor or in respect thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Conversion of Company Common Stock</U>. Subject to the other provisions of this <U>Article</U><U></U><U>&nbsp;II</U>,
each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than any Cancelled Shares and any Dissenting Shares) shall, at the Effective Time, be converted automatically into and shall thereafter
represent the right to receive (A)&nbsp;$220.00 in cash (the &#147;<U>Cash Consideration</U>&#148;) and (B)&nbsp;a number of validly issued, fully paid and nonassessable shares of Parent Common Stock equal to the Exchange Ratio (together with the
cash in lieu of fractional shares of Parent Common Stock as specified in <U>Section</U><U></U><U>&nbsp;2.1(d)</U> and the Cash Consideration, the &#147;<U>Merger Consideration</U>&#148;). From and after the Effective Time, all of the shares of
Company Common Stock converted into the right to receive the Merger Consideration pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> shall no longer be outstanding and shall automatically be cancelled and shall cease to exist as of the Effective
Time, and uncertificated shares of Company Common Stock represented by book-entry form (&#147;<U>Book-Entry Shares</U>&#148;) and each certificate that, immediately prior to the Effective Time, represented any such shares of Company Common Stock
(each, a &#147;<U>Certificate</U>&#148;) shall thereafter represent only the right to receive the Merger Consideration into which the shares of Company Common Stock represented by such Book-Entry Share or Certificate have been converted pursuant to
this <U>Section</U><U></U><U>&nbsp;2.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Shares of Dissenting Stockholders</U>. Anything in this Agreement to the contrary
notwithstanding, shares of Company Common Stock issued and outstanding immediately prior to the Effective Time and held by a holder of record who did not vote in favor of the adoption of this Agreement (or consent thereto in writing) and is entitled
to demand and properly demands appraisal of such shares of Company Common Stock pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL (&#147;<U>DGCL 262</U>&#148; and any such shares meeting the requirement of this
sentence, &#147;<U>Dissenting Shares</U>&#148;) shall not be converted into the right to receive the Merger Consideration, but instead at the Effective Time shall be converted into the right to receive payment of such amounts as are payable in
accordance with DGCL 262 (it being understood and acknowledged that at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Effective Time, such Dissenting Shares shall no longer be outstanding, shall automatically be cancelled and shall cease to exist, and such holder shall cease to have any rights with respect
thereto other than the right to receive the fair value of such Dissenting Shares to the extent afforded by DGCL 262); <U>provided</U> that if any such holder shall fail to perfect or otherwise shall waive, withdraw or lose the right to payment of
the fair value of such Dissenting Shares under DGCL 262, then the right of such holder to be paid the fair value of such holder&#146;s Dissenting Shares shall cease and such Dissenting Shares shall be deemed to have been converted as of the
Effective Time into, and to have become exchangeable solely for the right to receive, without interest or duplication, the Merger Consideration. The Company shall give prompt written notice to Parent of any demands received by the Company for fair
value of any shares of Company Common Stock pursuant to DGCL 262 and of any withdrawals of such demands, and Parent shall have the opportunity to participate in all negotiations and proceedings with respect to such demands. Prior to the Effective
Time, the Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or compromise or offer to settle or compromise, any such demand, or agree to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Certain Adjustments</U>. If, between the date of this Agreement and the Effective Time (and as permitted by
<U>Article</U><U></U><U>&nbsp;V</U>), the outstanding shares of Company Common Stock or Parent Common Stock shall have been changed into a different number of shares or a different class of shares by reason of any stock dividend, subdivision,
reorganization, reclassification, recapitalization, stock split, reverse stock split, combination or exchange of shares, or any similar event shall have occurred, then the Merger Consideration shall be equitably adjusted, without duplication, to
proportionally reflect such change; <U>provided</U> that nothing in this <U>Section</U><U></U><U>&nbsp;2.1(c)</U> shall be construed to permit the Company or Parent to take any action with respect to its securities that is prohibited by the terms of
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Fractional Shares</U>. No fractional shares of Parent Common Stock shall be issued in the Merger upon the
surrender for exchange of Certificates or with respect to Book-Entry Shares or otherwise, and such fractional share interests shall not entitle the owner thereof to vote or to any other rights of a stockholder of Parent. Each holder of Company
Common Stock converted pursuant to the Merger that would otherwise have been entitled to receive a fraction of a share of Parent Common Stock (after aggregating all shares evidenced by the Certificates and Book-Entry Shares delivered by such holder)
shall receive from Parent, in lieu thereof and upon surrender thereof, a cash payment (without interest) in an amount equal to such fractional part of a share of Parent Common Stock <I>multiplied by</I> the Parent Common Stock VWAP (rounded down to
the nearest penny). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>[Reserved]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Appointment of Exchange Agent</U>. Prior to the Effective Time, Parent shall appoint a bank or trust company to act as
exchange agent (the &#147;<U>Exchange Agent</U>&#148;), the identity and the terms of appointment of which shall be reasonably acceptable to the Company, for the payment of the Merger Consideration and shall enter into an agreement relating to the
Exchange Agent&#146;s responsibilities with respect thereto, in form and substance reasonably acceptable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4
<U>Surrender and Exchange of Shares</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Deposit of Merger Consideration</U>. Prior to the Effective Time, Parent shall deposit,
or cause to be deposited, with the Exchange Agent (i)&nbsp;evidence of Parent Common Stock in book-entry form (and/or certificates representing such Parent Common Stock, at Parent&#146;s election) representing the full number of whole shares of
Parent Common Stock sufficient to deliver the stock portion of the aggregate Merger Consideration and (ii)&nbsp;cash in an amount sufficient to pay the cash portion of the aggregate Merger Consideration, in each case payable in the Merger to all
holders of Company Common Stock (such shares of Parent Common Stock and cash provided to the Exchange Agent, together with any dividends or other distributions with respect thereto and including any amounts to be paid in cash in lieu of fractional
shares in accordance with <U>Section</U><U></U><U>&nbsp;2.1(d)</U>, the &#147;<U>Exchange Fund</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Exchange
Procedures</U>. As soon as reasonably practicable after the Effective Time and in any event within five Business Days of the Closing Date, Parent shall cause the Exchange Agent to mail to each holder of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
record of shares of Company Common Stock whose shares of Company Common Stock were converted pursuant to <U>Section</U><U></U><U>&nbsp;2.1(a)(iii)</U> into the right to receive the Merger
Consideration (i)&nbsp;a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Certificates or Book-Entry Shares shall pass, only upon, (A)&nbsp;with respect to shares evidenced by
Certificates, delivery of the Certificates (or affidavits of loss in lieu thereof) and (B)&nbsp;with respect to Book-Entry Shares, upon proper delivery of an &#147;agent&#146;s message&#148; regarding the book-entry transfer of Book-Entry Shares (or
such other evidence, if any, of the transfer as the Exchange Agent may reasonably request), as applicable, to the Exchange Agent and shall be in such form and have such other provisions as Parent and the Company may reasonably agree upon prior to
the Effective Time) (the &#147;<U>Letter of Transmittal</U>&#148;) and (ii)&nbsp;instructions for use in effecting the surrender of Certificates or Book-Entry Shares in exchange for the Merger Consideration and any dividends or other distributions
to which such Certificates or Book-Entry Shares become entitled in accordance with <U>Section</U><U></U><U>&nbsp;2.1(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
<U>Surrender of Certificates or Book-Entry Shares</U>. Upon surrender of Certificates or Book-Entry Shares to the Exchange Agent, together with a Letter of Transmittal, duly completed and validly executed in accordance with the instructions thereto,
and such other documents as may reasonably and customarily be required by the Exchange Agent, the holder of such Certificates or Book-Entry Shares shall be entitled to receive, within two Business Days following the later to occur of (i)&nbsp;the
Effective Time or (ii)&nbsp;the Exchange Agent&#146;s receipt of such Certificate (or affidavit of loss in lieu thereof) or Book-Entry Share, in exchange therefor the Merger Consideration into which the shares represented by such Certificates or
Book-Entry Shares have been converted pursuant to this Agreement together with any dividends or other distributions to which such Certificates or Book-Entry Shares become entitled in accordance with <U>Section</U><U></U><U>&nbsp;2.4(d)</U>. In the
event of a transfer of ownership of shares of Company Common Stock that is not registered in the transfer or stock records of the Company, any cash to be paid upon, or shares of Parent Common Stock to be issued upon, due surrender of the Certificate
or Book-Entry Share formerly representing such shares of Company Common Stock may be paid or issued, as the case may be, to such a transferee if such Certificate or Book-Entry Share is presented to the Exchange Agent, accompanied by all documents
required to evidence and effect such transfer and to evidence that any applicable stock transfer or other similar Taxes have been paid or are not applicable. No interest shall be paid or shall accrue on the cash payable upon surrender of any
Certificate or Book-Entry Share. Until surrendered as contemplated by this <U>Section</U><U></U><U>&nbsp;2.4(c)</U>, each Certificate and Book-Entry Share (other than Dissenting Shares) shall be deemed at any time after the Effective Time to
represent only the right to receive, upon such surrender, the Merger Consideration into which the shares represented by such Certificates or Book-Entry Shares have been converted pursuant to this Agreement, together with any dividends or other
distributions to which such Certificates or Book-Entry Shares become entitled in accordance with <U>Section</U><U></U><U>&nbsp;2.4(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Treatment of Unexchanged Shares</U>. No dividends or other distributions, if any, with a record date after the Effective Time with
respect to Parent Common Stock, shall be paid to the holder of any unsurrendered share of Company Common Stock to be converted into cash and shares of Parent Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;2.1(a)(iii)</U> until such holder
shall surrender such share in accordance with this <U>Section</U><U></U><U>&nbsp;2.4</U>. After the surrender in accordance with this <U>Section</U><U></U><U>&nbsp;2.4</U> of a share of Company Common Stock to be converted into cash and shares of
Parent Common Stock pursuant to <U>Section</U><U></U><U>&nbsp;2.1(a)(iii)</U>, the holder thereof shall be entitled to receive (in addition to the Merger Consideration payable to such holder pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>) any
such dividends or other distributions, without any interest thereon, which theretofore had become payable with respect to the share of Parent Common Stock represented by such share of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>No Further Ownership Rights in Company Common Stock</U>. The shares of Parent Common Stock delivered and cash paid in accordance with
the terms of this <U>Article</U><U></U><U>&nbsp;II</U> upon conversion of any shares of Company Common Stock shall be deemed to have been delivered and paid in full satisfaction of all rights pertaining to such shares of Company Common Stock. From
and after the Effective Time, (i)&nbsp;all holders of Certificates and Book-Entry Shares shall cease to have any rights as stockholders of the Company other than the right to receive the Merger Consideration into which the shares represented by such
Certificates or Book-Entry Shares have been converted pursuant to this Agreement upon the surrender of such Certificate or Book-Entry Share in accordance with this <U>Section</U><U></U><U>&nbsp;2.4</U> (together with any dividends or other
distributions to which such Certificates or Book-Entry </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Shares become entitled in accordance with <U>Section</U><U></U><U>&nbsp;2.4(d)</U>), without interest and (ii)&nbsp;the stock transfer books of the Company shall be closed with respect to all
shares of Company Common Stock outstanding immediately prior to the Effective Time. From and after the Effective Time, the stock transfer books of the Company shall be closed, and there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation of shares of Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, any Certificates or Book-Entry Shares formerly representing shares of Company
Common Stock are presented to the Surviving Corporation, Parent or the Exchange Agent for any reason, such Certificates or Book-Entry Shares shall be cancelled and exchanged as provided in this <U>Article</U><U></U><U>&nbsp;II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Investment of Exchange Fund</U>. The Exchange Agent shall invest any cash included in the Exchange Fund as directed by Parent;
<U>provided</U>, <U>however</U>, that no such investment or loss thereon shall affect the amounts payable to holders of Company Common Stock pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>, and following any losses from any such investment,
Parent shall promptly provide additional funds to the Exchange Agent for the benefit of the holders of shares of Company Common Stock at the Effective Time in the amount of such losses, which additional funds will be deemed to be part of the
Exchange Fund, and such investments shall only be in short-term obligations of the United States of America with maturities of no more than 30 days or guaranteed by the United States of America and backed by the full faith and credit of the United
States of America or in commercial paper obligations of issuers organized under the Laws of a state of the United States of America, rated A-1 or P-1 or better by Standard&nbsp;&amp; Poor&#146;s Corporation or Moody&#146;s Investors Service, Inc.,
respectively. Parent shall cause the Exchange Fund to be (i)&nbsp;held for the benefit of the holders of the Company Common Stock and (ii)&nbsp;applied promptly to making the payments pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U>. The Exchange
Fund shall not be used for any purpose other than to fund payments pursuant to <U>Section</U><U></U><U>&nbsp;2.1</U>, except as expressly provided for in this Agreement. Any interest or other income resulting from such investments shall be paid to
Parent, upon demand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Exchange Fund</U>. Any portion of the Exchange Fund (including any interest or other amounts
received with respect thereto) that remains unclaimed by, or otherwise undistributed to, the holders of Certificates and Book-Entry Shares for 12 months after the Effective Time shall be delivered to Parent, upon demand, and any holder of
Certificates or Book-Entry Shares who has not theretofore complied with this <U>Article</U><U></U><U>&nbsp;II</U> shall thereafter look only to Parent or the Surviving Corporation (subject to applicable abandoned property, escheat or other similar
Laws), as general creditors thereof, for satisfaction of its claim for Merger Consideration and any dividends and distributions which such holder has the right to receive pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> without any interest
thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>No Liability</U>. None of Parent, the Company, Merger Sub or the Exchange Agent shall be liable to any person in respect
of any portion of the Exchange Fund or the Merger Consideration delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. Notwithstanding any other provision of this Agreement, any portion of the Merger
Consideration or the cash to be paid in accordance with this <U>Article</U><U></U><U>&nbsp;II</U> that remains undistributed to the holders of Certificates and Book-Entry Shares as of the second anniversary of the Effective Time (or immediately
prior to such earlier date on which the Merger Consideration or such cash would otherwise escheat to or become the property of any Governmental Entity), shall, to the extent permitted by applicable Law, become the property of the Surviving
Corporation, free and clear of all claims or interest of any person previously entitled thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Withholding Rights</U>. Each of
the Surviving Corporation, Parent and the Exchange Agent (without duplication) shall be entitled to deduct and withhold (or cause to be deducted or withheld) from the consideration otherwise payable to any holder of a Certificate or a Book-Entry
Share pursuant to this Agreement such amounts as may be required to be deducted and withheld with respect to the making of such payment under applicable Tax Law. Any amounts so deducted and withheld shall be paid over to the appropriate Taxing
Authority and, to the extent such amounts are paid over to the appropriate Taxing Authority, shall be treated for all purposes of this Agreement as having been paid to the holder of the Certificate or Book-Entry Share in respect of which such
deduction or withholding was made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Lost Certificates</U>. If any Certificate shall have been lost, stolen, mutilated or
destroyed, upon the making of an affidavit of that fact, in form and substance reasonably satisfactory to Parent and the Exchange Agent, by the person claiming such Certificate to be lost, stolen, mutilated or destroyed and, if required by Parent or
the Exchange Agent, the posting by such person of a bond in such amount as Parent or the Exchange Agent may determine is reasonably necessary as indemnity against any claim that may be made against it, the Surviving Corporation with respect to such
Certificate, the Exchange Agent (or, if subsequent to the termination of the Exchange Fund and subject to <U>Section</U><U></U><U>&nbsp;2.4(g)</U>, Parent) shall deliver, in exchange for such lost, stolen, mutilated or destroyed Certificate, the
Merger Consideration and any dividends and distributions deliverable in respect thereof pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5
<U>Treatment of Company Equity Awards</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Company RSUs</U>. At the Effective Time, each award of Company RSUs that is outstanding
immediately prior to the Effective Time other than awards of Director RSUs, shall be converted into an award covering that number of Parent restricted stock units of Parent Common Stock, rounded down to the nearest whole share, (&#147;<U>Converted
RSUs</U>&#148;) equal to the product of (x)&nbsp;the number of shares of Company Common Stock subject to such award of Company RSUs (and, with respect to any Company RSUs that are subject to performance-vesting goals or metrics, the number of shares
of Company Common Stock shall be determined based on the greater of the target or actual level of achievement of such goals or metrics immediately prior to the Effective Time, as determined by the Company Board or a committee thereof) and
(y)&nbsp;the sum of (A)&nbsp;the Exchange Ratio, and (B)&nbsp;the quotient obtained by dividing (i)&nbsp;the Cash Consideration by (ii)&nbsp;the Parent Common Stock VWAP. Any Converted RSUs issued pursuant to this
<U>Section</U><U></U><U>&nbsp;2.5(a)</U> shall be subject to the same terms and conditions as were applicable to such Company RSUs immediately prior to the Effective Time (including any applicable change of control or other accelerated vesting
provisions, whether pursuant to an award agreement or any other agreement between the Company and any holder of any award of Company RSUs or pursuant to any other arrangement or plan applicable to any holder of an award of Company RSUs);
<U>provided</U> that any Company RSUs, the vesting of which had been subject to performance goals or metrics prior to the Effective Time, shall cease to be subject to any such performance-vesting goals or metrics and shall, following the Effective
Time, be subject solely to time- and service-based vesting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Director RSUs</U>. At the Effective Time, each Director RSU (whether
or not vested) that is outstanding immediately prior to the Effective Time shall, automatically and without any required action on the part of the holder thereof, vest (if unvested) and be cancelled and converted into the right to receive the Merger
Consideration in accordance with <U>Section</U><U></U><U>&nbsp;2.1</U> as if such Director RSU had been settled in shares of Company Common Stock immediately prior to the Effective Time (the &#147;<U>Director RSU Consideration</U>&#148;). Parent
shall cause the Surviving Corporation to pay to each holder of a Director RSU the Director RSU Consideration, less any applicable Taxes and without interest, within two Business Days following the Effective Time, subject to any delay required by the
next sentence; <U>provided</U> that any such withholding Taxes required to be paid by or collected on behalf of such holder shall be satisfied by retaining a number of shares of Parent Common Stock having a fair market value (determined by reference
to the closing price of a share of Parent Common Stock on the Closing Date) equal to the minimum statutory amount required to be withheld. Notwithstanding anything herein to the contrary, with respect to any Director RSU that constitutes
nonqualified deferred compensation subject to Section&nbsp;409A of the Code and that the Company determines prior to the Effective Time is not eligible to be terminated in accordance with Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(j)(4)(ix)(B),</FONT> such payment will be made at the earliest time permitted under the applicable Company Benefit Plan that will not trigger a Tax or penalty under Section&nbsp;409A of the
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Involuntary Termination</U>. Notwithstanding the vesting schedule and any other vesting conditions applicable to any Company
RSUs or Converted RSUs, in the event that the employment of a Continuing Employee (other than any Continuing Employee that is a participant under the Company&#146;s Change in Control Severance Plan (as amended, the &#147;<U>CIC Plan</U>&#148;) as of
immediately prior to the Effective Time) (each such Continuing Employee, a &#147;<U>Covered Continuing Employee</U>&#148;) is terminated by the Company, Parent or their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective Subsidiaries without Cause (as defined in <U>Section</U><U></U><U>&nbsp;2.5(c)</U> of the Company Disclosure Letter) within the period beginning immediately following the Closing Date
and ending on the date that is 12 months following the Closing Date (or, if earlier, December&nbsp;31, 2022) (such termination, a &#147;<U>Qualifying Termination</U>&#148;), the vesting of each award of Converted RSUs resulting solely from a Company
RSU that was outstanding and held by such Covered Continuing Employee as of the date of this Agreement (and not any other Converted RSUs) will accelerate as to: (A)&nbsp;if such Covered Continuing Employee&#146;s Qualifying Termination occurs during
calendar year 2021, the sum of: (x)&nbsp;100% of the total number of Converted RSUs that otherwise would have vested during calendar year 2021 under the applicable vesting schedule in effect on the Closing had such Covered Continuing Employee
remained employed with the Company, Parent or their respective Subsidiaries through the last applicable vesting date for such award in calendar year 2021 (and reduced by the total number of Converted RSUs that vested in calendar year 2021 prior to
such Qualifying Termination <I>plus</I> (y)&nbsp;50% of the total number of Converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the Closing had such Covered Continuing Employee
remained employed with the Company, Parent or their respective Subsidiaries through the last applicable vesting date for such award in calendar year 2022, or (B)&nbsp;if such Covered Continuing Employee&#146;s Qualifying Termination occurs during
calendar year 2022, 50% of the total number of Converted RSUs that otherwise would have vested during calendar year 2022 under the applicable vesting schedule in effect on the Closing had such Covered Continuing Employee remained employed with the
Company, Parent or their respective Subsidiaries through the last applicable vesting date for such award in calendar year 2022 (and reduced by the total number of Converted RSUs that vested in calendar year 2022 prior to such Qualifying
Termination). For the avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;2.5(c)</U> shall not amend, modify, change or in any way limit any vesting acceleration provided for in any plan or arrangement maintained by the Company, Parent or any of
their respective Subsidiaries or any agreement between the Company, Parent or any of their respective Subsidiaries, on the one hand, and any Continuing Employee, on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Company and Parent Actions</U>. The Company shall take all actions reasonably necessary or advisable to effect the transactions
contemplated by this <U>Section</U><U></U><U>&nbsp;2.5</U> under all Company equity plans or any other plan or arrangement of the Company, including delivering all required notices, obtaining all necessary consents, and making any determinations
and/or resolutions of the Company Board or a committee thereof. At or prior to the Effective Time, Parent shall take all actions necessary to reserve for issuance a number of shares of Parent Common Stock in respect of each Converted RSU. As soon as
practicable on or following the Effective Time, but no later than three Business Days following the Effective Time, Parent shall file a registration statement on Form S-8, Form S-3 or Form S-1 (or any successor or other appropriate form), as
applicable, with respect to the shares of Parent Common Stock subject to each such award of Converted RSUs and shall maintain the effectiveness of such registration statement or registration statements (and maintain the current status of the
prospectus or prospectuses contained therein) for so long as such awards remain outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>ESPP</U>. As soon as practicable
following the date hereof, the Company Board or a committee thereof shall adopt resolutions to provide that each individual participating in an Offering (as defined in the ESPP) in progress on the date hereof shall not be permitted to
(i)&nbsp;increase his or her payroll contribution rate pursuant to the ESPP from the rate in effect as of the date hereof or (ii)&nbsp;make separate <FONT STYLE="white-space:nowrap">non-payroll</FONT> contributions to the ESPP on or following the
date hereof, except as may be required by applicable Law. Prior to the Effective Time, the Company shall take all actions that may be necessary to, effective upon the consummation of the Merger, (A)&nbsp;cause any Offering that would otherwise be
outstanding at the Effective Time to terminate no later than five days prior to the date on which the Effective Time occurs; (B)&nbsp;make any pro rata adjustments that may be necessary to reflect the shortened Offering, but otherwise treat any
shortened Offering as a fully effective and completed Offering for all purposes pursuant to the ESPP; and (C)&nbsp;cause the exercise (as of no later than one Business Day prior to the date on which the Effective Time occurs) of each outstanding
purchase right pursuant to the ESPP. On such exercise date, the Company shall apply the funds credited as of such date pursuant to the ESPP within each participant&#146;s payroll withholding account to the purchase of whole shares of Company Common
Stock in accordance with the terms of the ESPP. Immediately prior to and effective as of the Effective Time (but subject to the consummation of the Merger), the Company shall terminate the ESPP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Further Assurances</U>. If at any time before or after the Effective
Time, Parent or the Company reasonably believes or is advised that any further instruments, deeds, assignments or assurances are reasonably necessary or desirable to consummate the Mergers and consistent with the terms and conditions of this
Agreement, or to carry out the purposes and intent of this Agreement at or after the Effective Time, then Parent, Merger Sub, the Company and the Surviving Corporation and their respective officers and directors shall execute and deliver all such
proper instruments, deeds, assignments or assurances and do all other things reasonably necessary or desirable to consummate the Merger and to carry out the purposes and intent of this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (x)&nbsp;as disclosed in the Company SEC Documents filed with or furnished to the SEC prior to the date hereof and after
January&nbsp;1, 2019 (excluding any risk factor or forward-looking disclosures contained in such documents under the heading &#147;Risk Factors,&#148; and any disclosure of risks included in any &#147;forward-looking statements&#148; disclaimer, or
other statements that are similarly nonspecific or predictive, cautionary, or forward-looking) or (y)&nbsp;as set forth in the disclosure letter delivered by the Company to Parent immediately prior to the execution of this Agreement (the
&#147;<U>Company Disclosure Letter</U>&#148;) (each section of which qualifies the correspondingly numbered representation, warranty or covenant if specified therein and such other representations, warranties or covenants where its relevance as an
exception to (or disclosure for purposes of) such other representation, warranty or covenant is reasonably apparent on the face of such disclosure), the Company represents and warrants to Parent and Merger Sub as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Qualification, Organization, Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and has all
requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company&#146;s Subsidiaries is a legal entity duly organized, validly existing and in good standing under the Laws of its
respective jurisdiction of organization (to the extent the &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States) and has all requisite corporate or similar power and authority to own, lease and
operate its properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority or be in good standing would not reasonably be expected to have a Company Material Adverse Effect. Each
of the Company and its Subsidiaries is duly qualified or licensed, and has all necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property owned, leased or operated by it or the nature of the
business conducted by it makes such approvals, qualification or licensing necessary (to the extent the &#147;qualification to do business&#148; or &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United
States), except where the failure to be so duly approved, qualified or licensed and in good standing would not reasonably be expected to have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company has made available to Parent prior to the date of this Agreement a true and complete copy of the Company Certificate and the
Company Bylaws (collectively, the &#147;<U>Company Organizational Documents</U>&#148;), in each case, as amended through the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Capital Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of 500,000,000 shares of common stock, par value $0.01 per share (the
&#147;<U>Company Common Stock</U>&#148;), and no shares of preferred stock. As of March&nbsp;2, 2021 (the &#147;<U>Company Capitalization Date</U>&#148;), (i)&nbsp;24,463,754 shares of Company Common Stock were issued and outstanding
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and (ii)&nbsp;no shares of Company Common Stock were held in treasury. As of the Company Capitalization Date, 2,409,742 shares of Company Common Stock were reserved for issuance under Company
equity plans (other than the ESPP), of which amount (A)&nbsp;483,149 shares of Company Common Stock are issuable upon the settlement of outstanding Company RSUs (other than performance-based awards and Director RSUs), (B)&nbsp;157,647 shares of
Company Common Stock are issuable upon the settlement of outstanding Company RSUs that are performance-based awards (assuming performance is achieved at &#147;target&#148;), (C)&nbsp;315,294 shares of Company Common Stock are issuable upon the
settlement of outstanding Company RSUs that are performance-based awards (assuming performance is achieved at &#147;maximum&#148;), and (D)&nbsp;750 shares of Company Common Stock are issuable upon the settlement of outstanding Director RSUs. As of
the Company Capitalization Date, 87,192 shares of Company Common Stock were reserved for issuance under the ESPP, and an aggregate of $4,370,400 was contributed by participants in the ESPP during the Offering that is currently outstanding under the
ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All outstanding shares of Company Common Stock are, and all shares of Company Common Stock reserved for issuance with respect
to Company RSUs, when issued in accordance with the respective terms thereof, will be, duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights. All outstanding equity securities of the Company and its
Subsidiaries, where applicable, are duly authorized, validly issued, fully paid and, in the case of any such Subsidiary which is a corporation, nonassessable and free of preemptive rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth in <U>Section</U><U></U><U>&nbsp;3.2(a)</U> (and other than the shares of Company Common Stock issued since the
Company Capitalization Date pursuant to the terms of outstanding Company RSUs or pursuant to purchases under the ESPP), there are no outstanding shares of capital stock or other equity interests in the Company or subscriptions, options, warrants,
calls, convertible securities, exchangeable securities or other similar rights, agreements or commitments to which the Company or any of its Subsidiaries is a party (i)&nbsp;obligating the Company or any of its Subsidiaries to (A)&nbsp;issue,
transfer, exchange, sell or register for sale any shares of capital stock or other equity interests of the Company or any Subsidiary of the Company or securities convertible into or exchangeable for such shares or equity interests, (B)&nbsp;grant,
extend or enter into any such subscription, option, warrant, call, convertible securities or other similar right, agreement or arrangement, (C)&nbsp;redeem or otherwise acquire any such shares of capital stock or other equity interests,
(D)&nbsp;provide a material amount of funds to, or make any material investment (in the form of a loan, capital contribution or otherwise) in, any Subsidiary, or (E)&nbsp;make any payment to any person the value of which is derived from or
calculated based on the value of Company Common Stock, or (ii)&nbsp;granting any preemptive or antidilutive or similar rights with respect to any security issued by the Company or its Subsidiaries. No Subsidiary of the Company owns any shares of
capital stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company or one of its direct or indirect wholly owned Subsidiaries owns all of the outstanding
shares of capital stock or other equity interests of all Subsidiaries of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Corporate Authority Relative to
this Agreement; No Violation</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company has the requisite corporate power and authority to enter into this Agreement, and,
subject to receipt of approval of this Agreement by holders of at least a majority of the outstanding shares of Company Common Stock (the &#147;<U>Company Stockholder Approval</U>&#148;), and the occurrence of the shareholder advisory vote
contemplated by <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-21(c)</FONT> under the Exchange Act, regardless of the outcome of such vote (the &#147;<U>Company Stockholder Advisory Vote</U>&#148;), to consummate the transactions contemplated
hereby. The execution and delivery by the Company of this Agreement and the consummation of the transactions contemplated hereby have been or shall be duly and validly authorized by the Company Board and, except for the Company Stockholder Approval
(and the occurrence of the Company Stockholder Advisory Vote) and the filing of the Certificate of Merger with the Secretary of State of Delaware, no other corporate proceedings on the part of the Company or vote of the Company&#146;s
securityholders are necessary to authorize the consummation of the transactions contemplated hereby. The Company Board has unanimously (i)&nbsp;resolved to recommend that the Company&#146;s stockholders adopt
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Agreement (the &#147;<U>Company Recommendation</U>&#148;), (ii)&nbsp;determined that this Agreement and the Merger are advisable to, and in the best interests of, the Company and its
stockholders, (iii)&nbsp;approved the execution, delivery and performance of this Agreement and the Merger, and (iv)&nbsp;resolved that the adoption of this Agreement be submitted to a vote at a meeting of the Company&#146;s stockholders. This
Agreement has been duly and validly executed and delivered by the Company and, assuming this Agreement constitutes the legal, valid and binding agreement of the counterparties thereto, constitutes a legal, valid and binding agreement of the Company,
enforceable against the Company in accordance with its terms, except as such enforcement may be subject to the limitation of such enforcement by (A)&nbsp;the effect of bankruptcy, insolvency, reorganization, receivership, conservatorship,
arrangement, moratorium or other Laws affecting or relating to creditors&#146; rights generally or (B)&nbsp;the rules governing the availability of specific performance, injunctive relief or other equitable remedies and general principles of equity,
regardless of whether considered in a proceeding in equity or at law (the &#147;<U>Remedies Exceptions</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Other than in
connection with or in compliance with (i)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware, (ii)&nbsp;the Exchange Act, (iii)&nbsp;the U.S. Securities Act of 1933, as amended, and the rules
promulgated thereunder (the &#147;<U>Securities Act</U>&#148;), (iv)&nbsp;applicable state securities, takeover and &#147;blue sky&#148; Laws, (v)&nbsp;the rules and regulations of Nasdaq, (vi)&nbsp;the HSR Act and each of the other Antitrust Laws
set forth in <U>Section</U><U></U><U>&nbsp;3.3(b)(vi)</U> of the Company Disclosure Letter, and (vii)&nbsp;the Company Stockholder Approval (collectively, the &#147;<U>Company Approvals</U>&#148;), and, subject to the accuracy of the representations
and warranties of Parent and Merger Sub in <U>Section</U><U></U><U>&nbsp;4.3(c)</U>, no other authorization, consent, order, license, Permit or approval (&#147;<U>Consent</U>&#148;) of, or registration, declaration, notice or filing
(&#147;<U>Filing</U>&#148;) with, any United States, state of the United States or local, foreign or multi-national governmental or regulatory agency, commission, court or authority (each, a &#147;<U>Governmental Entity</U>&#148;) is necessary,
under applicable Law, for the consummation by the Company of the transactions contemplated by this Agreement, except for such Consents or Filings as are not required to be obtained or made prior to consummation of such transactions or that, if not
obtained or made, would not materially impede or delay the consummation of the Merger and the other transactions contemplated by this Agreement and which would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The execution and delivery by the Company of this Agreement does not, and (assuming the Company Approvals are
obtained and the Company Credit Agreement is terminated and repaid in full prior to the Effective Time) the consummation of the transactions contemplated hereby and compliance with the provisions hereof will not (i)&nbsp;result in any loss, or
suspension, limitation or impairment of any right of the Company or any of its Subsidiaries to own or use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or
both) under, or give rise to a right of termination, cancellation, first offer, first refusal, modification or acceleration of any material obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note,
bond, mortgage, indenture, Company Real Property Lease, agreement, contract, instrument, permit, concession, franchise, right or license binding upon the Company or any of its Subsidiaries or by which or to which any of their respective properties,
rights or assets are bound or subject, or result in the creation of any liens, claims, mortgages, encumbrances, pledges, security interests, equities or charges of any kind (excluding, in each case, transfer restrictions of general applicability
pursuant to any securities Laws) (each, a &#147;<U>Lien</U>&#148;) other than Permitted Liens (<U>provided</U> that no Lien shall be deemed created by this Agreement), in each case, upon any of the properties or assets of the Company or any of its
Subsidiaries, except for such losses, suspensions, limitations, impairments, conflicts, violations, defaults, terminations, cancellations, accelerations or Liens which have not had and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, (ii)&nbsp;conflict with or result in any violation of any provision of the certificate of incorporation or bylaws or other equivalent organizational document, in each case, as amended or restated, of the
Company or any of its Subsidiaries, (iii)&nbsp;subject to obtaining the Consents set forth in <U>Section</U><U></U><U>&nbsp;3.3(c)(iii)</U> of the Company Disclosure Letter, violate, conflict with, or result in the breach of or constitute a default
(or an event which with notice or lapse of time or both would become a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration under, or result in the loss of
any material benefit or the imposition of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material liability under, any Company Material Contract, or (iv)&nbsp;conflict with or violate any applicable Laws, except for such conflict or violation as has not had and would not reasonably
be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Reports and Financial
Statements</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries has filed or furnished all forms, documents and reports required to be filed
or furnished prior to the date hereof by it with the U.S. Securities and Exchange Commission (the &#147;<U>SEC</U>&#148; and all such forms, documents and reports, the &#147;<U>Company SEC Documents</U>&#148;) since January&nbsp;1, 2018. As of their
respective dates or, if amended, as of the date of the last such amendment, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act of 2002 (the
&#147;<U>Sarbanes-Oxley Act</U>&#148;), as the case may be, and the applicable rules and regulations promulgated thereunder, and none of the Company SEC Documents at the time they were filed or furnished contained any untrue statement of a material
fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not materially misleading. None of the Company&#146;s Subsidiaries are,
or at any time since January&nbsp;1, 2018 have been, required to file any forms, reports or other documents with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The
consolidated financial statements (including all related notes and schedules) of the Company included in the Company SEC Documents (the &#147;<U>Company Financial Statements</U>&#148;) at the time they were filed or furnished (i)&nbsp;fairly present
in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries, as at the respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for the respective
periods then ended (except, in the case of unaudited statements, subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments, the absence of notes and to any other adjustments described therein, including in any notes
thereto, or with respect to pro forma financial information, subject to the qualifications stated therein), (ii)&nbsp;were prepared in conformity with U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;) applied on a consistent
basis during the periods involved (except as may be indicated therein or in the notes thereto) and (iii)&nbsp;comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act
and the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As of the date hereof, there are no outstanding or unresolved comments in any comment letters of the staff of
the SEC received by the Company relating to the Company SEC Documents. As of the date hereof, none of the Company SEC Documents is, to the knowledge of the Company, the subject of ongoing SEC review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Neither the Company nor any of its Subsidiaries is a party to, or has a commitment to effect, enter into or create, any joint venture, or <FONT
STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangement&#148; (as defined in Item 303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act), where the result, purpose or effect of such Contract is to
avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the Company Financial Statements or other Company SEC Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5 <U>Absence of Certain Changes or Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From January&nbsp;1, 2020, through the date of this Agreement, the businesses of each of the Company and its Subsidiaries, as applicable,
have been conducted in all material respects in the Ordinary Course of Business, and none of the Company or any Subsidiary of the Company has undertaken any action that, if taken, during the period from the date of this Agreement to the Effective
Time, would constitute a breach of clauses&nbsp;(i) through (vi), (ix), (x) or (xv) (solely as it relates to clauses&nbsp;(i) through (vi), (ix), or (x)) of <U>Section</U><U></U><U>&nbsp;5.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2020, through the date of this Agreement, there has not been any event, change, effect, development or occurrence
that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.6 <U>Internal Controls and Procedures</U>. The Company has established and
maintains disclosure controls and procedures and internal control over financial reporting (as such terms are defined in paragraphs&nbsp;(e) and (f), respectively, of Rule&nbsp;13a-15 under the Exchange Act) as required by Rule&nbsp;13a-15 under the
Exchange Act. The Company&#146;s disclosure controls and procedures are reasonably designed to ensure that all material information required to be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is accumulated and communicated to the Company&#146;s management as appropriate to allow timely decisions
regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. The Company&#146;s management has completed an assessment of the effectiveness of the Company&#146;s internal
controls over financial reporting in compliance with the requirements of Section&nbsp;404 of the Sarbanes-Oxley Act for the fiscal year ended October&nbsp;3, 2020, and such assessment concluded that such controls were effective. Based on its most
recent evaluation of internal controls over financial reporting prior to the date hereof, management of the Company has disclosed to the Company&#146;s auditors and the audit committee of the Company Board (i)&nbsp;any significant deficiencies and
material weaknesses in the design or operation of internal controls over financial reporting that are reasonably likely to adversely affect in any material respect the Company&#146;s ability to report financial information and (ii)&nbsp;any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal controls over financial reporting, in each case, that was disclosed to the Company&#146;s auditors or the audit committee
of the Company Board in connection with its most recent evaluation of internal controls over financial reporting prior to the date hereof. The Company maintains a system of internal accounting controls designed to provide reasonable assurances
regarding transactions being executed in accordance with management&#146;s general or specific authorization, the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and the
prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#146;s assets that could have a material effect on its financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.7 <U>No Undisclosed Liabilities</U>. There are no liabilities or obligations of the Company or any of its Subsidiaries, whether
accrued, absolute, determined or contingent, except for (i)&nbsp;liabilities or obligations disclosed, reflected or reserved against in the balance sheets included in the Company Financial Statements (or in the notes thereto) filed and publicly
available prior to the date of this Agreement, (ii)&nbsp;liabilities or obligations arising under or in accordance with this Agreement, (iii)&nbsp;liabilities or obligations incurred in the Ordinary Course of Business since October&nbsp;4, 2020, and
(iv)&nbsp;liabilities or obligations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.8 <U>Compliance with Law; Permits</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries are in compliance with, and are not in default under or in violation of, any applicable federal, state,
local or foreign law, statute, ordinance, rule, regulation, judgment, order, injunction, decree or agency requirement of any Governmental Entity (collectively, &#147;<U>Laws</U>&#148; and each, a &#147;<U>Law</U>&#148;), except where such <FONT
STYLE="white-space:nowrap">non-compliance,</FONT> default or violation have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Since January&nbsp;1, 2018, neither the Company
nor any of its Subsidiaries has received any written notice or, to the knowledge of the Company, other communication from any Governmental Entity regarding any violation of, or failure to comply with, any Law, except where such violation or failure
has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The
Company and its Subsidiaries are in possession of all material franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and
orders of all applicable Governmental Entities, and all rights under any Company Material Contract with all Governmental Entities, and have filed all tariffs, reports, notices and other documents with all Governmental Entities necessary for the
Company and its Subsidiaries to own, lease and operate their properties and assets and to carry on their businesses as they are now being conducted (the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;<U>Company Permits</U>&#148;), except where the failure to possess or file the Company Permits has not had and would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all Company Permits are in all respects valid and in full force and effect and
are not subject to any administrative or judicial proceeding that would reasonably be expected to result in modification, termination or revocation thereof. The Company and each of its Subsidiaries is in material compliance with the terms and
requirements of all Company Permits, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:
(i)&nbsp;the Company and each of its Subsidiaries are in compliance, and have since January&nbsp;1, 2018 complied, with all applicable Laws relating to privacy, data protection or information security regarding Personal Data (collectively,
&#147;<U>Data Privacy Laws</U>&#148;); (ii)&nbsp;neither the Company nor any of its Subsidiaries has, since January&nbsp;1, 2018, received any written notice from any applicable Governmental Entity alleging any violation of applicable Data Privacy
Laws by the Company, any of its Subsidiaries or, to the knowledge of the Company, any third-party service providers, outsourcers, processors or other third parties who process, store or otherwise handle Personal Data for or on behalf of the Company
or any of its Subsidiaries (&#147;<U>Company Data Processors</U>&#148;), nor has the Company or any of its Subsidiaries been threatened in writing to be charged with any such violation by any Governmental Entity; (iii)&nbsp;the Company and each of
its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps (including, as appropriate, implementing reasonable technical, physical or administrative safeguards) designed to protect Personal Data in their possession or
under their control against loss and unauthorized access, use, modification or disclosure, and, to the knowledge of the Company, since January&nbsp;1, 2018, there has been no incident of the same, or of the same with respect to any Personal Data
maintained or otherwise processed for or on behalf of the Company or its Subsidiaries; (iv)&nbsp;the Company and each of its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps with respect to all Company Data
Processors to obligate such persons to comply in material respects with applicable Data Privacy Laws and to take reasonable steps to protect and secure Personal Data from loss or unauthorized use, access, modification or disclosure; and (v)&nbsp;the
execution, delivery and performance of this Agreement complies with all Laws relating to privacy, data protection or information security regarding Personal Data (including the General Data Protection Regulation (EU)&nbsp;2016/679, the Data
Protection Act 2018 (UK), and the California Consumer Protection Act) and the Company&#146;s and each of its Subsidiaries&#146; applicable published policies, statements, and notices relating to privacy, data protection or information security
regarding Personal Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.9 <U>Environmental Matters</U>. The Company and its Subsidiaries are, and since January&nbsp;1,
2018 have been, in compliance with all applicable Environmental Laws (which compliance includes the possession, and the compliance with the terms and conditions, by the Company and each of its Subsidiaries of all Company Permits required under
applicable Environmental Laws to conduct their respective business and operations), and there are no investigations, actions, suits or proceedings pending or, to the knowledge of the Company, threatened against the Company or any of its
Subsidiaries, in each case, except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received any written notice from
a Governmental Entity that alleges that the Company or any of its Subsidiaries is violating, or has or may have, violated any Environmental Law, or may have any liability or obligation arising under, retained or assumed by contract or by operation
of law, except for such violations, liabilities and obligations that would not have, individually or in the aggregate, a Company Material Adverse Effect. To the knowledge of the Company, there has been no release of any Hazardous Materials by the
Company or any of its Subsidiaries at, to or from any facilities currently or formerly owned or leased by the Company or any of its Subsidiaries or at any other locations where any Hazardous Materials were generated, manufactured, refined,
transferred, stored, produced, imported, used, processed or disposed of by the Company or any of its Subsidiaries and, in each case, for which the Company or any of its Subsidiaries would reasonably be expected to be subject to any material
liability. Neither the Company nor any of its Subsidiaries has, either through Contract or by operation of law, assumed or agreed to guarantee, reimburse, pledge, defend, hold </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
harmless or indemnify any other person with respect to any liabilities arising under Environmental Laws except as, individually or in the aggregate, has not had and would not reasonably be
expected to have a Company Material Adverse Effect. The Company has delivered or made available to Parent all material environmental assessment reports, investigations and audits in its possession or control, which relate to environmental matters
for which the Company may reasonably be expected to have any material liability with respect to the Company and its Subsidiaries&#146; business and operations, including any such documents relating to the Company Owned Real Property and the Company
Leased Real Property. The representations and warranties set forth in this <U>Section</U><U></U><U>&nbsp;3.9</U>, <U>Section</U><U></U><U>&nbsp;3.3(b)</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5</U>,
<U>Section</U><U></U><U>&nbsp;3.7</U> and <U>Section</U><U></U><U>&nbsp;3.19</U> are the Company&#146;s sole and exclusive representations and warranties relating to Environmental Laws or liabilities relating to the release or disposal of Hazardous
Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 <U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.10(a)</U> of the Company Disclosure Letter lists each material Company Benefit Plan. With respect to each
material Company Benefit Plan, to the extent applicable, correct and complete copies of the following have been delivered or made available to Parent by the Company: (i)&nbsp;the Company Benefit Plan, if written (including all material amendments
thereto), (ii)&nbsp;a written summary, if the Company Benefit Plan is not in writing, (iii)&nbsp;all related trust documents, (iv)&nbsp;all insurance contracts or other funding arrangements, (v)&nbsp;the most recent annual reports (Form 5500) filed
with the IRS, (vi)&nbsp;the most recent determination, opinion or advisory letter from the IRS, (vii)&nbsp;the most recent summary plan description and any summary of material modifications thereto, and (viii)&nbsp;the most recent audited financial
statement and/or actuarial valuation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to result in, individually or in the aggregate, a
material liability to the Company and its Subsidiaries, (i)&nbsp;each Company Benefit Plan has been established, operated and administered in all respects in accordance with its terms and the requirements of all applicable Laws, including ERISA and
the Code, and (ii)&nbsp;all contributions required to be made to any Company Benefit Plan by applicable Law or by any plan document or other contractual undertaking, and all premiums due or payable with respect to insurance policies funding any
Company Benefit Plan, have been timely made or paid or, to the extent not required to be made or paid on or before the date hereof, have been reflected on the books and records of the Company in accordance with GAAP. As of the date hereof, there are
no pending claims or claims threatened in writing (other than routine claims for benefits) by, on behalf of or against any of the Company Benefit Plans except as would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Company Benefit Plan and related trust that is intended to be qualified under Section&nbsp;401(a) of
the Code has received a favorable determination letter or opinion letter, or has pending or has time remaining in which to file, an application for such determination from the IRS, and, to the knowledge of the Company, there is no reason why any
such determination letter should be revoked or not be issued or reissued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) With respect to any Company Benefit Plan subject to Title
IV of ERISA to which the Company, its Subsidiaries or any of their respective ERISA Affiliates has any liability or contributes: (i)&nbsp;since January&nbsp;1, 2016, no such Company Benefit Plan has been terminated so as to result or reasonably be
likely to result, directly or indirectly, in a material liability to the Company or any of its ERISA Affiliates under Title IV of ERISA; (ii)&nbsp;no proceeding has been initiated by the Pension Benefit Guaranty Corporation to terminate any such
Company Benefit Plan or to appoint a trustee for any such Company Benefit Plan; (iii)&nbsp;if any such Company Benefit Plan were to be terminated as of the Closing Date or if any person were to withdraw from such Company Benefit Plan, none of the
Company or any of its ERISA Affiliates would incur, directly or indirectly, any material liabilities under Title IV of ERISA; (iv)&nbsp;no &#147;reportable event&#148; (as defined in Section&nbsp;4043 of ERISA) for which notice has not been waived
has occurred with respect to any such Company Benefit Plan within the past 12&nbsp;months that, individually or in the aggregate, would result in material liabilities to the Company and any of its Subsidiaries, taken as a whole; and
(v)&nbsp;satisfies the minimum funding standards of Section&nbsp;302 of ERISA and Section&nbsp;412 of the Code, whether or not waived, and none of the Company or any of its ERISA Affiliates has provided, or is required to provide, security to any
Company Benefit Plan pursuant to Section&nbsp;401(a)(29) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company, nor its Subsidiaries nor any of their respective ERISA Affiliates
has, at any time since January&nbsp;1, 2016, contributed to, been obligated to contribute to or had any liability (including any contingent liability) with respect to any Multiemployer Plan or Multiple Employer Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The execution of this Agreement and the consummation of the Merger will not, either alone or in combination with another event,
(i)&nbsp;entitle any current or former employee, director, consultant or officer of the Company or any of its Subsidiaries to severance pay or any other similar payment, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of
compensation due any such employee, director, consultant or officer, (iii)&nbsp;trigger any funding obligation under any Company Benefit Plan, or (iv)&nbsp;result in any payment to any &#147;disqualified individual&#148; (as such term is defined in
Treasury Regulations Section&nbsp;1.280G-1) that would, individually or in combination with any other such payment, constitute an &#147;excess parachute payment&#148; (as defined in Section&nbsp;280G(b)(1) of the Code). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) No Company Benefit Plan provides for, and neither the Company nor any of its Subsidiaries otherwise has any obligation to provide, a <FONT
STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes imposed under Section&nbsp;4999 of the Code, Section&nbsp;409A(a)(1)(B) of the Code, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Except as would not, either individually or in the aggregate, reasonably be expected to result in material liability to the Company or its
Subsidiaries, each Company Benefit Plan that is mandated by applicable Law or by a Governmental Entity outside of the United States or that is subject to the laws of a jurisdiction outside of the United States (i)&nbsp;has been maintained in
accordance with all applicable requirements, (ii)&nbsp;if intended to qualify for special Tax treatment, meets all the requirements for such treatment, and (iii)&nbsp;if required, to any extent, to be funded, book-reserved or secured by an insurance
policy, is fully funded, book-reserved or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>Labor and Employment Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.11(a)</U> of the Company Disclosure Letter sets forth a list of all local collective bargaining
agreements, excluding any national, industry or sector-level collective bargaining agreements, to which the Company or any of its Subsidiaries is a party. No strike, material work slowdown, work stoppage, or unfair labor practice against the Company
or any of its Subsidiaries is pending, or to knowledge of the Company, threatened. To the knowledge of the Company, no activities or proceedings of any labor union to organize any employees of the Company or any of its Subsidiaries are pending or
threatened. No labor union or works council currently represents any employees of the Company or any of its Subsidiaries in connection with their employment with the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, the Company and each of its
Subsidiaries is in compliance with all applicable Laws respecting hiring, employment and employment practices, terms and conditions of employment, harassment, retaliation, reasonable accommodations, leaves of absence, occupational safety and health,
workers&#146; compensation, employee classification, wages and hours, engagement of independent contractors (including the appropriate classification of the same), payroll taxes, redundancy, &#147;mass layoffs,&#148; &#147;plant closings&#148; and
immigration with respect to all employees, independent contractors, and other service providers of the Company and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
As of the date of this Agreement, except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, (i)&nbsp;there are no charges, complaints, audits or investigations pending or scheduled by any Governmental
Entity pertaining to the employment practices or actions of the Company or any of its Subsidiaries or, to the Company&#146;s knowledge, threatened against the Company or any of its Subsidiaries and (ii)&nbsp;to the Company&#146;s knowledge, no
complaints or charges relating to employment practices or actions of the Company or any of its Subsidiaries have been made since January&nbsp;1, 2018 to any Governmental Entity or submitted to the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company, neither the Company nor any of its Subsidiaries is
party to a settlement agreement with any employee of the Company or any of its Subsidiaries that involves material allegations of sexual harassment by any employee of the Company or any of its Subsidiaries at the level of Senior Vice President or
above. To the knowledge of the Company, no material allegations of sexual harassment are pending against any employee of the Company or any of its Subsidiaries at the level of Senior Vice President or above in his or her capacity as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 <U>Investigations; Litigation</U>. Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect, (a)&nbsp;there are no actions, suits, inquiries, investigations, proceedings, subpoenas, civil investigative demands or other requests for information relating to potential violations of Law pending
(or, to the knowledge of the Company, threatened) against or affecting the Company or any of its Subsidiaries, or any of their respective properties and (b)&nbsp;there are no Orders of, or before, any Governmental Entity against the Company or any
of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 <U>Information Supplied</U>. The information supplied or to be supplied by the Company for
inclusion in the registration statement on Form S-4 to be filed by Parent in connection with the Share Issuance (the &#147;<U>Form <FONT STYLE="white-space:nowrap">S-4</FONT></U>&#148;) shall not, at the time the Form S-4 is declared effective by
the SEC, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading,
except that no representation or warranty is made by the Company with respect to statements made therein based on information supplied by Parent or its Representatives in writing expressly for inclusion therein. The information supplied or to be
supplied by the Company for inclusion in the joint proxy statement/prospectus included in the Form S-4 (the &#147;<U>Joint Proxy Statement/Prospectus</U>&#148;) will not, at the time the Joint Proxy Statement/Prospectus is first mailed to the
stockholders of the Company and at the time of any meeting of Company stockholders to be held in connection with the Merger, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by the Company with respect to statements made therein based on information
supplied by Parent or its Representatives in writing expressly for inclusion therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 <U>Anti-Bribery</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Other than as would not be material to the Company and its Subsidiaries, taken as a whole, since January&nbsp;1, 2016, neither the Company
nor its Subsidiaries or controlled Affiliates (including their respective officers, directors, employees and, to the knowledge of the Company, agents or other persons acting on behalf of the Company or any of its Subsidiaries or controlled
Affiliates), has taken any action in violation of the Foreign Corrupt Practices Act of 1977, as amended, and any rules or regulations promulgated thereunder, the U.K. Bribery Act 2010, or any other applicable Laws regarding anti-corruption or
anti-bribery (collectively, &#147;<U>Anti-Corruption Laws</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Other than as would not be material to the Company and its
Subsidiaries, taken as a whole, since January&nbsp;1, 2016, neither the Company nor its Subsidiaries or its controlled Affiliates has been subject to any actual, pending or, to the knowledge of the Company, threatened, civil, criminal, or
administrative actions, suits, demands, claims, hearings, notices of violation, investigations, proceedings, demand letters, settlements or enforcement actions, or made any voluntary disclosures to any Governmental Entity, involving the Company, its
Subsidiaries or controlled Affiliates, in each case in any way relating to Anti-Corruption Laws, nor is there any basis therefor. The Company and each of its Subsidiaries and controlled Affiliates have established and maintain compliance programs
and reasonable internal controls and procedures reasonably designed to ensure the Company, its Subsidiaries and its controlled Affiliates (including any of their officers, directors, employees, agents or other persons acting on their behalf) do not
violate the Anti-Corruption Laws. For purposes of this <U>Section</U><U></U><U>&nbsp;3.14</U>, the term &#147;Governmental Entity&#148; shall also include any supra-national or public international organization (<I>e.g.</I>, the World Bank, the Red
Cross, etc.), or any legislative body or committee, division, political party, royal family, or government-owned or controlled enterprise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 <U>Exports</U><U></U><U>&nbsp;&amp; Sanctions</U>. Other than as would not
be material to the Company and its Subsidiaries, taken as a whole, since January&nbsp;1, 2016, the Company and its Subsidiaries have conducted all transactions in compliance with all applicable U.S. import, export, and trade sanctions Laws and
regulations, including the Export Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Treasury Department, and all comparable applicable import
and export laws and regulations outside the United States in each country where the Company and its Subsidiaries conduct business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
(i)&nbsp;the Company and each of its Subsidiaries have prepared and timely filed (taking into account any valid extension of time within which to file) all Tax Returns required to be filed by any of them and all such Tax Returns are complete and
accurate, (ii)&nbsp;the Company and each of its Subsidiaries have timely paid all Taxes that are required to be paid by any of them or that the Company or any of its Subsidiaries are obligated to withhold from amounts owing to any employee,
creditor, stockholders or third party (in each case, whether or not shown on any Tax Return), (iii)&nbsp;there are no currently effective waivers of any statute of limitations with respect to Taxes or extensions of time with respect to a Tax
assessment or deficiency, (iv)&nbsp;all assessments for Taxes due with respect to completed and settled examinations or any concluded litigation have been fully paid, (v)&nbsp;there are no audits, examinations, investigations or other proceedings
pending or threatened in writing in respect of Taxes or Tax matters of the Company or any of its Subsidiaries, (vi)&nbsp;no claim has been made in writing or, to the Company&#146;s knowledge, otherwise, by a Taxing Authority in a jurisdiction where
the Company or any of its Subsidiaries does not file Tax Returns of a certain type that the Company or any of its Subsidiaries is or may be subject to taxation of such type or required to file Tax Returns of such type in that jurisdiction,
(vii)&nbsp;there are no Liens for Taxes on any of the assets of the Company or any of its Subsidiaries other than statutory Liens for Taxes not yet due and payable, (viii)&nbsp;neither the Company nor any of its Subsidiaries is a party to any
agreement or arrangement relating to the apportionment, sharing, assignment or allocation of any Tax or Tax asset (other than an agreement or arrangement solely among members of a group the common parent of which is the Company or commercial
agreements or arrangements not primarily related to Taxes and entered into in the ordinary course of business) or has any liability for Taxes of any person (other than the Company or any of its Subsidiaries) under Treasury Regulation
Section&nbsp;1.1502-6 (or any analogous or similar provision of state, local or foreign Tax Law), as transferee, successor, by Contract (other than commercial Contracts not primarily related to Taxes and entered into in the ordinary course of
business) or otherwise, and (ix)&nbsp;neither the Company nor any of its Subsidiaries is bound with respect to any current or any future taxable period by any closing agreement (within the meaning of Section&nbsp;7121 of the Code), private letter
ruling, technical advice or other ruling or written agreement with a Governmental Entity, in each case, that could reasonably be expected to affect the liability for Taxes of the Company or any of its Subsidiaries following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) None of the Company or any of its Subsidiaries has been a party to any &#147;listed transaction&#148; within the meaning of Treasury
Regulation <FONT STYLE="white-space:nowrap">1.6011-4(b)(2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) None of the Company or any of its Subsidiaries has been a
&#147;controlled corporation&#148; or a &#147;distributing corporation&#148; in any distribution that was purported or intended to be governed by Section&nbsp;355 of the Code (or any similar provision of state, local or foreign Law) occurring during
the <FONT STYLE="white-space:nowrap">two-year</FONT> period ending on the date hereof or that otherwise constitutes part of a &#147;plan&#148; or &#147;series of related transactions&#148; within the meaning of Section&nbsp;355(e) of the Code in
conjunction with the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding any other provisions of this Agreement to the contrary, the representations and
warranties made in this <U>Section</U><U></U><U>&nbsp;3.16</U>, <U>Section</U><U></U><U>&nbsp;3.4</U>, <U>Section</U><U></U><U>&nbsp;3.5</U> (to the extent relating to Taxes), and <U>Section</U><U></U><U>&nbsp;3.10</U> (to the extent relating to
Taxes) are the sole and exclusive representations and warranties of the Company with respect to Taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 <U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have a Company Material Adverse Effect: (i)&nbsp;either the Company or a Subsidiary of the
Company has good and valid title, subject to Permitted Liens, to each material Real Property owned by the Company or any Subsidiary of the Company (such owned property collectively, the &#147;<U>Company Owned Real Property</U>&#148;); and
(ii)&nbsp;either the Company or a Subsidiary of the Company has a good and valid leasehold interest in each material lease, material sublease and other material agreement under which the Company or any of its Subsidiaries uses or occupies or has the
right to use or occupy any Real Property (such property, the &#147;<U>Company Leased Real Property</U>&#148; and such leases, subleases and other agreements, collectively, the &#147;<U>Company Real Property Leases</U>&#148;), in each case, free and
clear of all Liens other than any Permitted Liens and any Lien encumbering the interest of the landlord thereunder. Except as would not reasonably be expected to have a Company Material Adverse Effect, each Company Real Property Lease and each
Company Sublease (defined below) is valid, binding and in full force and effect, subject to the limitation of such enforcement by the Remedies Exceptions. Except as would not reasonably be expected to have a Company Material Adverse Effect, no
uncured default on the part of the Company or, if applicable, its Subsidiary or, to the knowledge of the Company, the landlord, sublandlord or subtenant thereunder (as applicable), exists under any Company Real Property Lease or Company Sublease,
and no event has occurred or circumstance exists which, with the giving of notice, the passage of time, or both, would constitute a material breach or default under a Company Real Property Lease or Company Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have a Company Material Adverse Effect, (i)&nbsp;there are no leases, subleases, licenses,
rights or other agreements affecting any portion of the Company Owned Real Property or the Company Leased Real Property (collectively, the &#147;<U>Company Subleases</U>,&#148; and the Real Property subject to a Company Sublease, the
&#147;<U>Company Subleased Real Property</U>&#148;) that would reasonably be expected to adversely affect the existing use of such Company Owned Real Property or Company Leased Real Property by the Company or its Subsidiaries in the operation of its
business thereon; and (ii)&nbsp;there are no outstanding (A)&nbsp;options or (B)&nbsp;rights of first refusal in favor of any other party to purchase any Company Owned Real Property or any portion thereof or interest therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Section</U><U></U><U>&nbsp;3.17(c)</U> of the Company Disclosure Letter sets forth a true, correct and complete list of (i)&nbsp;each
Company Owned Real Property, including the address thereof and the identity of the Company or its Subsidiary that owns such property, and (ii)&nbsp;each Company Leased Real Property and Company Subleased Real Property, including the address thereof
and the identity of the Company or its Subsidiary that is a party to the applicable Company Real Property Lease or Company Sublease with respect to such property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 <U>Insurance</U>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, as of the date hereof, to the Company&#146;s knowledge (a)&nbsp;all insurance policies held by the Company or any of its Subsidiaries for the benefit of the Company or any of its Subsidiaries as of the date hereof
(each, a &#147;<U>Company Insurance Policy</U>&#148;) are in full force and effect and provide insurance in such amounts and against such risks as the Company has determined to be prudent, taking into account the industries in which the Company and
its Subsidiaries operate, (b)&nbsp;all premiums due and payable in respect of such insurance policies have been timely paid, (c)&nbsp;neither the Company nor any of its Subsidiaries has reached or exceeded its policy limits for any such insurance
policies, (d)&nbsp;neither the Company nor any of its Subsidiaries has received any written notice of cancellation of any Company Insurance Policy, (e)&nbsp;neither the Company nor any of its Subsidiaries is in breach or default under any Company
Insurance Policy, and (f)&nbsp;there is no claim by the Company or any of its Subsidiaries pending under any Company Insurance Policy as to which coverage has been denied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 <U>Material Contracts</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except for this Agreement, the Company Benefit Plans, the Company Real Property Leases, the Company Subleases and agreements filed as
exhibits to the Company SEC Documents (including those that are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filed with the SEC at any time prior to the date hereof and incorporated by reference thereto), as of the date of this Agreement, neither the Company nor any of its Subsidiaries is a party to or
bound by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any &#147;material contract&#148; (as such term is defined in Item&nbsp;601(b)(10) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> of the SEC); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any Contract with any Top Company Customer or Top Company Vendor
pursuant to which material payments are to be made or received by the Company or any of its Subsidiaries or material obligations of the Company or any of its Subsidiaries will remain outstanding after the date of this Agreement, other than with
respect to commercial product Warranties on customary terms; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any Contract under which the Company or any of its
Subsidiaries has continuing indemnification, earnout or similar obligations to or by any third person which are material to the Company and its Subsidiaries, taken as a whole, other than those entered into on customary terms in connection with the
distribution, sale or license of the Company&#146;s products in the Ordinary Course of Business and other than any such Contracts that may be cancelled without liability to the Company or its Subsidiaries upon notice of 90 days or less; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any Contract concerning the acquisition or divestiture of any entity or any business (or all or substantially all of the
assets of any entity or any business), or any investment in, or acquisition or divestiture of any security of, any entity, by the Company or any of its Subsidiaries under which the Company or any of its Subsidiaries has any material continuing
obligations; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any Contract for capital expenditures involving payments of more than $4,000,000 individually or
$8,000,000 in the aggregate, by or on behalf of the Company or any of its Subsidiaries, for which reserves have not already been established in the financial statements of the Company and its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) any Contract which is material to the operations of the Company and its Subsidiaries, taken as a whole, involving a joint
venture or strategic alliance or partnership agreement or other sharing of profits or losses with any person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) any
Contract relating to indebtedness for borrowed money in an amount in excess of $5,000,000 individually; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) any
Contract with any Top Company Customer or Top Company Vendor containing any, or, to the knowledge of the Company, any other material Contract containing any material, covenants, commitments, or other obligations by the Company or any of its
Subsidiaries (A)&nbsp;not to compete with any person in a line of business or activity, (B)&nbsp;not to engage in any line of business or activity in any geographic location in a line of business, activity or geographic location, (C)&nbsp;granting
any exclusive rights to any third party, (D)&nbsp;including &#147;take or pay,&#148; &#147;sole source&#148; or &#147;requirements&#148; obligations, (E)&nbsp;granting any &#147;most favored pricing&#148; or similar terms to any third party, or
(F)&nbsp;otherwise prohibiting or limiting the right of the Company or its Subsidiaries to sell, distribute or manufacture any products or services or to purchase or otherwise obtain any software, components, parts or subassemblies, in each case,
other than any such Contracts (x)&nbsp;that may be cancelled without material liability to the Company or any of its Subsidiaries upon notice of 180 days or less, or (y)&nbsp;which are not material to the Company and its Subsidiaries, taken as a
whole; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) any Contract disclosed or required to be disclosed on <U>Section</U><U></U><U>&nbsp;3.20(g)</U> of the Company
Disclosure Letter; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) any Order or settlement or conciliation agreement entered into since January&nbsp;1, 2018, other
than (A)&nbsp;releases immaterial in nature and amount entered into with former employees or independent contractors of the Company in the Ordinary Course of Business or (B)&nbsp;settlement agreements which would not require the Company to pay
consideration in excess of $2,000,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) any Contract evidencing an outstanding loan, advance or investment by the
Company or any of its Subsidiaries to or in, any person (other than the Company or any other Subsidiary of the Company) of more than $5,000,000 in the aggregate (excluding trade receivables and advances to employees for normally incurred business
expenses, each arising in the Ordinary Course of Business); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) each Material Government Contract (excluding any Government Contracts
with universities or similar institutions on customary and reasonable terms); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) any Contract not described above
and pursuant to which the Company or any of its Subsidiaries has paid or received payments in excess of $5,000,000 in the most recent fiscal year, or is obligated to pay or entitled to receive payments in excess of $5,000,000 in the 12-month period
following the date hereof, in each case, other than (A)&nbsp;Contracts solely between the Company and a wholly owned (direct or indirect) Subsidiary of the Company or solely between wholly owned (direct or indirect) Subsidiaries of the Company,
(B)&nbsp;Contracts with customers, suppliers, vendors, or third-party service providers entered into in the Ordinary Course of Business on reasonable terms or (C)&nbsp;Government Contracts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each contract of any of the types referred to in clauses&nbsp;(i) through (xiii)&nbsp;above in existence as of the date of this Agreement is referred to
herein as a &#147;<U>Company Material Contract</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;neither the Company nor any Subsidiary of the Company is in breach of or default under the terms of any Company Material Contract and, to the knowledge of the Company, no
other party to any Company Material Contract is in breach of or default under the terms of any Company Material Contract, and (ii)&nbsp;each Company Material Contract is a valid and binding obligation of the Company or the Subsidiary of the Company
that is party thereto and, to the knowledge of the Company, of each other party thereto, and is in full force and effect, subject to the Remedies Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
the Company and its Subsidiaries solely and exclusively own the Intellectual Property owned (or purported to be owned) by the Company and its Subsidiaries (&#147;<U>Company Owned IP</U>&#148;), free and clear of all Liens other than Permitted Liens.
All material issued patents, all registered copyrights and all registered trademarks that are registered or filed in the name of the Company or any of its Subsidiaries are subsisting and, to the knowledge of the Company, valid and enforceable.
Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company Owned IP is not subject to any outstanding consent, settlement, Lien (other than Permitted Liens),
decree, order, injunction, judgment or ruling restricting the use thereof in a manner that would reasonably be expected to impair the continued operation of the businesses of the Company and its Subsidiaries as currently conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, as
of the date of this Agreement (i)&nbsp;the conduct of the business of the Company and its Subsidiaries as conducted since January&nbsp;1, 2018 and as presently conducted does not infringe, misappropriate or otherwise violate any Intellectual
Property rights of any third party and (ii)&nbsp;since January&nbsp;1, 2018 through the date of this Agreement, the Company has not received any written claim alleging any such infringement, misappropriation or other violation. Since January&nbsp;1,
2018 through the date of this Agreement, there is no and has not been any legal proceeding brought by a third party against the Company or any of its Subsidiaries (or against another person who has sought indemnification from the Company or any of
its Subsidiaries in connection with such legal proceeding) with respect to any material alleged infringement or other material violation by the Company, its Subsidiaries, any of its or their current products or services, or other operation of the
Company&#146;s or any of its Subsidiaries&#146; businesses, of the Intellectual Property of such third party, that is outstanding and unresolved as of the date of this Agreement, or which, if resolved, has resulted in any material liability or
obligation (including ongoing payment), or the resolution of which required granting any license under any Company Owned IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, as of the date of this Agreement, to the knowledge of the Company, no
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
person or entity is infringing, misappropriating or otherwise violating any Intellectual Property owned by the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries
have, since January&nbsp;1, 2018 through the date of this Agreement, brought (or asserted or threatened in writing) any claim against any person alleging that such person is infringing or misappropriating any material Company Owned IP, that is
outstanding and unresolved as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company and its Subsidiaries have taken commercially reasonable
steps to protect all material trade secrets of the Company or its Subsidiaries. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;to the knowledge of the
Company, there have been no unauthorized uses or disclosures of any such trade secrets, and (ii)&nbsp;none of the Company or its Subsidiaries have published, provided or disclosed, nor are the Company or its Subsidiaries under any present or
contingent obligation to so publish, provide or disclose, any software source code for Company Owned IP, including through or in connection with any agreement requiring the Company or any of its Subsidiaries to place any software source code in
escrow. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, none of the Company or its Subsidiaries have received any support, funding, resources or assistance from any Governmental Entity, or from any university, college, other academic institutions, or
<FONT STYLE="white-space:nowrap">non-profit</FONT> research centers in the development of any Intellectual Property owned by the Company or its Subsidiaries, that resulted in, or is reasonably expected to result in, such third-parties being granted
any rights or licenses to, or ownership interest in, any such Intellectual Property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no rights have been granted
to any Governmental Entity with respect to any Company Owned IP other than substantially the same standard commercial rights as are granted by the Company to commercial end users in the Ordinary Course of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
none of the Company or its Subsidiaries is a member or promoter of, or a contributor to, or made any commitments or agreements regarding, any patent pool, industry standards body, standard-setting organization or other similar organization, in each
case that requires or obligates the Company or any of its Subsidiaries to grant or offer to any other person any license or other right to any Company Owned IP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Section</U><U></U><U>&nbsp;3.20(g)(i)</U> of the Company Disclosure Letter sets forth a complete list of all Contracts pursuant to which
a third person has licensed to the Company or its Subsidiary any material Intellectual Property, excluding any Immaterial License or licenses for open source software, licenses to commercially available <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> software or commercially available technology (including IP blocks) used in the general operation of the business and granted for an annual aggregate fee of less than $5,000,000.
<U>Section</U><U></U><U>&nbsp;3.20(g)(ii)</U> of the Company Disclosure Letter sets forth a complete list of all Contracts pursuant to which the Company or its Subsidiaries have licensed to any third party any material Company Owned IP, excluding
Immaterial Licenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, or as set forth in <U>Section</U><U></U><U>&nbsp;3.20(h)</U> of the Company Disclosure Letter, neither the execution, delivery and performance of this Agreement and such other agreements, documents and instruments to be
executed and delivered after the date hereof, nor the consummation of the transactions contemplated hereby or thereby will: (i)&nbsp;violate or result in the breach, cancellation, termination or suspension of, or acceleration of any payments under
any Contract set forth in <U>Section</U><U></U><U>&nbsp;3.20(g)</U> of the Company Disclosure Letter; (ii)&nbsp;result in the Company or its Subsidiaries transferring any material Company Owned IP to any third party or granting to any third party
any rights or licenses to any material Company Owned IP; or (iii)&nbsp;the imposition of any Lien (other than Permitted Liens) on any Company Owned IP. None of the Company or its Subsidiaries is a party to any Contract pursuant to which, as a result
of the execution, delivery and performance of this Agreement and such other agreements, documents and instruments as are to be executed and delivered after the date hereof in connection with this Agreement, or the consummation of the transactions
contemplated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereby or thereby, will result in Parent or any of its Subsidiaries being (A)&nbsp;required to grant any Top Company Customer or any Top Company Vendor any rights to, licenses to or under, or
immunities to (including any covenant not to sue relating to) any of Parent&#146;s or any of its Subsidiaries&#146; material Intellectual Property, (B)&nbsp;bound by, or subject to, any material noncompetition,
<FONT STYLE="white-space:nowrap">non-solicitation,</FONT> exclusivity or other material restriction on the operation or scope of their respective business, or (C)&nbsp;obligated to pay any material incremental royalties or other material amounts,
offer any material incremental discounts or being bound by any &#147;most favored pricing&#148; terms to any third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Except as
has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries have not taken any action with respect to open source software that has required the
Company or any of its Subsidiaries under any applicable open source license, to (i)&nbsp;grant to any other person any license under any patent included in the Company Owned IP, or (ii)&nbsp;license, disclose, or distribute any material software
included in the Company Owned IP in source code form, for the purpose of preparing derivative works, or for little or no fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the information technology systems (&#147;<U>IT Systems</U>&#148;) used by the Company and its Subsidiaries are
designed, implemented, operated and maintained in accordance with reasonable and customary industry standards and practices for entities operating businesses similar to the business of the Company and its Subsidiaries, including with the respect to
redundancy, reliability, scalability and security, and constitute all the information and communications technology and other systems infrastructure reasonably necessary to carry on the business of the Company and its Subsidiaries as conducted in
the 12 months prior to the date of this Agreement. Without limiting the foregoing, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;the Company and its
Subsidiaries have taken reasonable steps and implemented reasonable procedures to ensure that their IT Systems are free from viruses, contaminants and other harmful code, (ii)&nbsp;the Company and its Subsidiaries have in effect industry standard
disaster recovery plans, procedures and facilities for their businesses and have taken all reasonable steps to safeguard the security and the integrity of their IT Systems, and (iii)&nbsp;there has been no failure, breakdown, loss or impairment of,
or any unauthorized intrusions or breaches of the security with respect to the IT Systems used by the Company or any of its Subsidiaries that (A)&nbsp;has resulted in a disruption or interruption in the operation of the business of the Company or
its Subsidiaries or (B)&nbsp;to the knowledge of the Company, has resulted in loss, unauthorized access to, or unauthorized modification or disclosure of any confidential information of or maintained by, for or on behalf of the Company or its
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, there exist no facts, and no events have occurred, that would reasonably be expected to form the basis of any present or future claim against the Company or its Subsidiaries, whether or not fully covered by insurance, for
liability on account of negligence or product liability or on account of any breach of Warranties of the Company. &#147;<U>Warranties</U>&#148; shall mean all obligations to service, repair (including to provide fixes to program errors), replace,
credit, refund and other obligations based upon or arising out of express or implied warranties made or deemed made in connection with the provision, license or sale of products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 <U>Customers; Vendors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.21(a)</U> of the Company Disclosure Letter sets forth a list of the Top Company Customers. As of the date
hereof, neither the Company nor any of its Subsidiaries has received any written notice from any Top Company Customer that such Top Company Customer shall not continue as a customer of the Company and its Subsidiaries or that such Top Company
Customer intends to terminate, not renew or materially amend existing Contracts with the Company or any of its Subsidiaries or otherwise materially modify its business relationship with the Company and its Subsidiaries, except as would not be
material and adverse to the Company and its Subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;3.21(b)</U> of the Company Disclosure Letter sets forth a
list of the Top Company Vendors. As of the date hereof, neither the Company nor any of its Subsidiaries has received any written notice from any Top Company Vendor that such Top Company Vendor shall not continue as a supplier, vendor, or third-party
service provider to the Company and its Subsidiaries or that such Top Company Vendor intends to terminate, not renew, or materially amend existing Contracts with the Company or any of its Subsidiaries or otherwise materially modify its business
relationship with the Company and its Subsidiaries, except as would not be material and adverse to the Company and its Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 <U>Government Contracts</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company has delivered or made available to Parent prior to the date of this Agreement complete and correct copies of each Material
Government Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) None of the Company or any of its Subsidiaries is in breach of or default under the terms of
any Material Government Contract; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To the knowledge of the Company, each Material Government Contract was legally
awarded and is binding on the parties thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To the knowledge of the Company, no Material Government Contract is
subject to termination solely based on the consummation of the transactions contemplated by this Agreement due to any change in status or prohibition on any change of control provision set forth in such Material Government Contract; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) The representations, certifications and warranties made by the Company and its Subsidiaries with respect to Material
Government Contracts were accurate as of their effective dates; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) None of the Company or any of its Subsidiaries has
received any written show cause, cure, deficiency, default, termination for convenience, bid protest, offset, disallowed, disputes or similar notice relating to any current Material Government Contract; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) To the knowledge of the Company, no event, condition or omission has occurred or currently exists including any
prohibitions on contracting with debarred, suspended or ineligible persons that would constitute grounds for termination of any Material Government Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries possess all facility security clearances and personnel security clearances necessary to conduct the
business as it is currently being conducted as of the date hereof in all material respects and the Company and its Subsidiaries are in compliance in all material respects with the requirements applicable to the facility security clearances,
including those set forth in the National Industrial Security Program Operating Manual and the provisions of all applicable DD254 forms. The Company has no knowledge of any pending revocation of any facility clearance of the Company or any
Subsidiary of the Company or any pending revocation of any personnel security clearance of any employee of the Company or any Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;(i) None of the Company or its Subsidiaries, nor, to the knowledge of the Company, any of their current respective directors,
officers or employees in connection with the performance of the duties for, or on behalf of, the Company or any of its Subsidiaries, is currently debarred, suspended or otherwise excluded from bidding on or participating in the award of any U.S.
Government Contract. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To the knowledge of the Company, none of the Company or its Subsidiaries, nor any of their
current respective directors, officers or employees in connection with the performance of the duties for, or on behalf of, the Company or any of its Subsidiaries, is currently debarred, suspended or otherwise excluded from bidding on or
participating in the award of any non-U.S. Government Contract (except where such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
exclusion is related to the application of local bidding rules applicable to all bidders similarly situated to the Company or its Subsidiaries). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Since January&nbsp;1, 2018, none of the Company or its Subsidiaries has undergone or is currently undergoing any internal or external
regulatory audit, review, inspection, investigation, survey, or examination of records relating to any Government Contracts, other than in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 <U>Finders or Brokers</U>. Except for BofA Securities, Inc. ( &#147;<U>BofA</U>&#148;) and Credit Suisse Securities (USA)
LLC (&#147;<U>Credit Suisse</U>&#148; and, together with BofA, the &#147;<U>Company Financial Advisors</U>&#148;), neither the Company nor any of its Subsidiaries has employed any investment banker, broker or finder in connection with the
transactions contemplated by this Agreement who would be entitled to any fee or any commission in connection with or upon consummation of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 <U>Opinion of Financial Advisor</U><U>s</U>. The Company Board has received the opinion of each of the Company Financial
Advisors to the effect that, as of the date thereof and on the basis of and subject to the assumptions, limitations, qualifications and other matters considered in the preparation thereof as set forth in such opinion, the Merger Consideration to be
received by the holders of Company Common Stock (other than the holders of any Cancelled Shares or Dissenting Shares) in the Merger pursuant to this Agreement is fair, from a financial point of view, to such holders. The Company shall, promptly
following the execution of this Agreement by all parties, furnish an accurate and complete copy of each said written opinion to Parent solely for informational purposes. The Company and Parent have been authorized by each of the Company Financial
Advisors to permit the inclusion of such written opinion of the applicable Company Financial Advisor in its entirety and references thereto in the Form <FONT STYLE="white-space:nowrap">S-4</FONT> and the Joint Proxy Statement/Prospectus, subject to
prior review and consent by the applicable Company Financial Advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 <U>Takeover Laws</U>. Assuming the accuracy of
the representation contained in <U>Section</U><U></U><U>&nbsp;4.19</U>, the Company Board has taken all action necessary to render inapplicable to this Agreement and the transactions contemplated hereby all applicable Takeover Laws (including
Section&nbsp;203 of the DGCL (&#147;<U>DGCL 203</U>&#148;)) and any similar provisions in the Company Certificate or the Company Bylaws. Assuming the accuracy of the representations and warranties contained in <U>Section</U><U></U><U>&nbsp;4.19</U>,
as of the date of this Agreement, no &#147;fair price,&#148; &#147;business combination,&#148; &#147;moratorium,&#148; &#147;control share acquisition&#148; or other anti-takeover statute or similar statute or regulation enacted by any state will
prohibit or impair the consummation of the Merger or the other transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26
<U>Affiliate Transactions</U>. To the knowledge of the Company, no officer, director or Affiliate of the Company or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate family (a)&nbsp;owns any property or right,
tangible or intangible, that is material to the conduct of the business of the Company or its Subsidiaries, (b)&nbsp;with the exception of liabilities incurred in the Ordinary Course of Business, owes money to, or is owed money by, the Company or
its Subsidiaries, or (c)&nbsp;is a party to or the beneficiary of any Contract with the Company or its Subsidiaries, except in each case for compensation and benefits payable under any Company Benefit Plans to officers and employees in their
capacity as officers and employees. Except as disclosed in the Company SEC Documents, there are no Contracts between the Company or any of its Subsidiaries, on the one hand, and any officer, director or Affiliate of the Company or its Subsidiaries
or any individual in such officer&#146;s or director&#146;s immediate family, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.27 <U>No Additional
Representations</U>. Except for the representations and warranties contained in <U>Article</U><U></U><U>&nbsp;IV</U> or in any certificates delivered by Parent in connection with the Merger, the Company acknowledges that neither Parent nor Merger
Sub nor any person on behalf of Parent or Merger Sub makes, and none of the Company or any person acting on behalf of the Company, has relied or is relying upon, any other express or implied representation or warranty with respect to Parent or
Merger Sub or any of their respective Subsidiaries or with respect to any other information provided or made available to the Company in connection with the transactions contemplated hereby, including the accuracy, completeness or currency thereof.
Except as otherwise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expressly provided in this Agreement and to the extent any such information is expressly included in a representation or warranty contained in <U>Article</U><U></U><U>&nbsp;IV</U>, neither
Parent, Merger Sub nor any other person will have or be subject to any liability or obligation to the Company or any other person resulting from the distribution or failure to distribute to the Company, or the Company&#146;s use of, any such
information, including any information, documents, projections, estimates, forecasts or other material, made available to the Company or any other person for purposes of, or in expectation of, the Merger and the other transactions contemplated by
this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except (x)&nbsp;as disclosed in the Parent SEC Documents filed with or furnished to the SEC prior to the date hereof and after January&nbsp;1,
2019 (excluding any risk factor or forward-looking disclosures contained in such documents under the heading &#147;Risk Factors,&#148; and any disclosure of risks included in any &#147;forward-looking statements&#148; disclaimer, or other statements
that are similarly nonspecific or predictive, cautionary, or forward-looking) or (y)&nbsp;as set forth in the disclosure letter delivered by Parent to the Company immediately prior to the execution of this Agreement (the &#147;<U>Parent Disclosure
Letter</U>&#148;) (each section of which qualifies the correspondingly numbered representation, warranty or covenant if specified therein and such other representations, warranties or covenants where its relevance as an exception to (or disclosure
for purposes of) such other representation, warranty or covenant is reasonably apparent on the face of such disclosure), Parent and Merger Sub represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Qualification, Organization, Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Parent is a corporation duly incorporated and presently subsisting under the Laws of the Commonwealth of Pennsylvania. Merger Sub is a
corporation duly incorporated duly formed, validly existing and in good standing under the Laws of the State of Delaware. Each of Parent and Merger Sub&nbsp;has all requisite corporate power and authority to own, lease and operate its properties and
assets and to carry on its business as presently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of Parent&#146;s Subsidiaries is a legal entity duly organized,
validly existing and in good standing under the Laws of its respective jurisdiction of organization (to the extent the &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States) and has all requisite
corporate or similar power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority or be in good standing would not reasonably be
expected to have a Parent Material Adverse Effect. Each of Parent and its Subsidiaries is duly qualified or licensed and has all necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property
owned, leased or operated by it or the nature of the business conducted by it makes such approvals, qualification or licensing necessary (to the extent the &#147;qualification to do business&#148; or &#147;good standing&#148; concept is applicable
in the case of any jurisdiction outside the United States), except where the failure to be so duly approved, qualified or licensed and in good standing would not reasonably be expected to have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Parent has made available to the Company, prior to the date of this Agreement, a true and complete copy of its certificate of
incorporation and bylaws (collectively, the &#147;<U>Parent Organizational Documents</U>&#148;), in each case, as amended through the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Capital Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of Parent consists of 300,000,000 shares of common stock, no par value per share (the &#147;<U>Parent Common
Stock</U>&#148;), and 5,000,000 shares of preferred stock, no par value per share (&#147;<U>Parent</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Preferred Stock</U>&#148;), of which 2,300,000&nbsp;shares are designated Series&nbsp;A Mandatory Convertible Preferred Stock (&#147;<U>Parent Mandatory Convertible Preferred Stock</U>&#148;)
and of which 300,000 shares are designated Series One Preferred Stock (&#147;<U>Parent Series One Preferred Stock</U>&#148;). As of February&nbsp;26, 2021 (the &#147;<U>Parent Capitalization Date</U>&#148;), (i)&nbsp;104,828,047 shares of Parent
Common Stock were issued and outstanding, (ii)&nbsp;13,484,634 shares of Parent Common Stock were held in treasury, (iii)&nbsp;2,300,000 shares of Parent Mandatory Convertible Preferred Stock were issued or outstanding and (iv)&nbsp;no shares of
Parent Series One Preferred Stock were issued and outstanding. As of the Parent Capitalization Date, 13,867,704 shares of Parent Common Stock were reserved for issuance under Parent equity plans, of which amount (A)&nbsp;2,714,466 shares of Parent
Common Stock are issuable upon the exercise of options to purchase or acquire shares of Parent Common Stock (each a &#147;<U>Parent Option</U>&#148;), (B)&nbsp;3,095,514 shares of Parent Common Stock are issuable upon the settlement of outstanding
Parent RSUs (with respect to performance-based awards, assuming performance is achieved at &#147;target&#148;), and (C)&nbsp;518,309 shares of Parent Common Stock are subject to performance share awards (with respect to performance-based awards,
assuming performance is achieved at &#147;target&#148;). As of the Parent Capitalization Date, (A)&nbsp;up to 8,914,798 shares of Parent Common Stock may be issuable upon conversion of the then outstanding shares of Parent Mandatory Convertible
Preferred Stock, (B)&nbsp;up to 7,330,940 shares of Parent Common Stock may be issuable upon conversion of the then outstanding Parent Convertible Notes and (C)&nbsp;up to 74,814 shares of Parent Common Stock may be issuable upon conversion of the
then outstanding Finisar Convertible Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All outstanding shares of Parent Common Stock are, and all shares of Parent Common Stock
to be issued or reserved for issuance in connection with the Merger, when issued in accordance with the terms of this Agreement, will be, duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U> (and other than shares of Parent Common Stock issued since the Parent
Capitalization Date pursuant to the terms of outstanding Parent stock awards or in respect of any outstanding shares of Parent Mandatory Convertible Preferred Stock or any Parent Convertible Notes or Finisar Convertible Notes), as of the date
hereof, there are no outstanding shares of capital stock or other equity interests in Parent or subscriptions, options, warrants, calls, convertible securities, exchangeable securities or other similar rights, agreements or commitments to which
Parent or any of its Subsidiaries is a party (i)&nbsp;obligating Parent or any of its Subsidiaries to (A)&nbsp;issue, transfer, exchange, sell or register for sale any shares of capital stock or other equity interests of Parent or any Subsidiary of
Parent or securities convertible into or exchangeable for such shares or equity interests, (B)&nbsp;grant, extend or enter into any such subscription, option, warrant, call, convertible securities or other similar right, agreement or arrangement,
(C)&nbsp;redeem or otherwise acquire any such shares of capital stock or other equity interests, (D)&nbsp;provide a material amount of funds to, or make any material investment (in the form of a loan, capital contribution or otherwise) in, any
Subsidiary, or (E)&nbsp;make any payment to any person the value of which is derived from or calculated based on the value of Parent Common Stock or Parent Preferred Stock, or (ii)&nbsp;granting any preemptive or antidilutive or similar rights with
respect to any security issued by Parent or its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Corporate Authority Relative to this Agreement; No
Violation</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent and Merger Sub has the requisite corporate power and authority to enter into this Agreement and,
subject to receipt of approval of the Share Issuance by the affirmative vote of a majority of votes cast by holders of Parent Common Stock (the &#147;<U>Parent Stockholder Approval</U>&#148;) present at a meeting of Parent&#146;s stockholders (the
&#147;<U>Parent Stockholders</U><U>&#146;</U><U> Meeting</U>&#148;), to consummate the transactions contemplated hereby and thereby, including the Mergers. The execution and delivery by Parent and Merger Sub of this Agreement and the consummation of
the transactions contemplated hereby have been duly and validly authorized by the boards of directors (or equivalent) of each of Parent and Merger Sub, and except for the Parent Stockholder Approval and the filing of the Certificate of Merger with
the Secretary of State of Delaware, no other corporate proceedings on the part of either Parent or Merger Sub or vote of Parent&#146;s securityholders are necessary to authorize the consummation of the Merger and the transactions contemplated
hereby. The Parent Board has unanimously (i)&nbsp;determined that this Agreement and the Merger are in the best interests of Parent and its stockholders, (ii)&nbsp;approved the execution, delivery and performance by Parent of this Agreement, and the
consummation of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transactions contemplated hereby (including the Merger and the Share Issuance), and (iii)&nbsp;resolved to recommend the approval by its stockholders of the Share Issuance and submit the Share
Issuance to the stockholders of Parent for approval (the &#147;<U>Parent Recommendation</U>&#148;). This Agreement has been duly and validly executed and delivered by each of Parent and Merger Sub, and assuming this Agreement constitutes the legal,
valid and binding agreement of the Company, constitutes the legal, valid and binding agreement of Parent or Merger Sub, as the case may be, enforceable against each of them, in accordance with their terms, except as such enforcement may be subject
to the Remedies Exceptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The board of directors of Merger Sub has unanimously (i)&nbsp;determined that this Agreement and the
Merger are in its and its sole stockholder&#146;s, best interests, (ii)&nbsp;approved the execution, delivery and performance by it of this Agreement and (iii)&nbsp;recommended the adoption of this Agreement by its sole stockholder. Parent, as the
sole stockholder of Merger Sub, has approved the execution, delivery and performance by Merger Sub of this Agreement and the consummation of the transactions contemplated hereby, including the Merger, upon the terms and subject to the conditions
contained herein, and has adopted this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Other than in connection with or in compliance with (i)&nbsp;the filing of the
First Certificate of Merger with the Secretary of State of the State of Delaware, (ii)&nbsp;the Exchange Act, and the rules promulgated thereunder, (iii)&nbsp;the Securities Act, and the rules promulgated thereunder, (iv)&nbsp;applicable state
securities, takeover and &#147;blue sky&#148; Laws, (v)&nbsp;the rules and regulations of Nasdaq, (vi)&nbsp;the HSR Act and each of the other Antitrust Laws set forth in <U>Section</U><U></U><U>&nbsp;3.3(b)(vi)</U> of the Company Disclosure Letter
and (vii)&nbsp;the Parent Stockholder Approval (collectively, the &#147;<U>Parent Approvals</U>&#148;), and subject to the accuracy of the representations and warranties of the Company in <U>Section</U><U></U><U>&nbsp;3.3(b)</U>, no other Consent
of, or Filing with, any Governmental Entity is necessary, under applicable Law, for the consummation by Parent or Merger Sub of the transactions contemplated by this Agreement, except for such Consents or Filings as are not required to be obtained
or made prior to consummation of such transactions or that, if not obtained or made, would not materially impede or delay the consummation of the Mergers and the other transactions contemplated by this Agreement and which would not reasonably be
expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The execution and delivery by Parent and Merger
Sub of this Agreement does not, and (assuming the Parent Approvals are obtained) the consummation of the transactions contemplated hereby and compliance with the provisions hereof will not (i)&nbsp;result in any loss, or suspension, limitation or
impairment of any right of Parent or any of its Subsidiaries to own or use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a
right of termination, cancellation, first offer, first refusal, modification or acceleration of any material obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note, bond, mortgage, indenture,
Parent Real Property Lease, agreement, contract, instrument, permit, concession, franchise, right or license binding upon Parent or any of its Subsidiaries or by which or to which any of their respective properties, rights or assets are bound or
subject, or result in the creation of any Liens other than Permitted Liens (<U>provided</U> that no Lien shall be deemed created by this Agreement), in each case, upon any of the properties or assets of Parent or any of its Subsidiaries, except for
such losses, impairments, suspensions, limitations, conflicts, violations, defaults, terminations, cancellation, accelerations, or Liens which have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect, (ii)&nbsp;conflict with or result in any violation of any provision of the certificate of incorporation or bylaws or other equivalent organizational document, in each case, as amended or restated, of Parent or any of its
Subsidiaries or (iii)&nbsp;conflict with or violate any applicable Laws, except for such conflict or violation as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>Merger Sub</U>. Merger Sub is a wholly owned direct or indirect subsidiary of Parent. Since its date of incorporation,
Merger Sub has not carried on any business nor conducted any operations other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Reports and Financial Statements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Parent and each of its Subsidiaries have filed or furnished all forms, documents and reports required to be filed or furnished prior to
the date hereof by it with the SEC since January&nbsp;1, 2018 (all such forms, documents and reports, the &#147;<U>Parent SEC Documents</U>&#148;). As of their respective dates or, if amended, as of the date of the last such amendment, the Parent
SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes- Oxley Act, as the case may be, and the applicable rules and regulations promulgated thereunder, and none of the Parent
SEC Documents at the time they were filed or furnished contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not materially misleading. None of Parent&#146;s Subsidiaries is, or at any time since January&nbsp;1, 2018 has been, required to file any forms, reports or other documents with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The consolidated financial statements (including all related notes and schedules) of Parent included in the Parent SEC Documents (the
&#147;<U>Parent Financial Statements</U>&#148;) at the time they were filed or furnished (i)&nbsp;fairly present in all material respects the consolidated financial position of Parent and its consolidated Subsidiaries, as at the respective dates
thereof, and the consolidated results of their operations and their consolidated cash flows for the respective periods then ended (except, in the case of unaudited statements, subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit
adjustments, the absence of notes and to any other adjustments described therein, including in any notes thereto or with respect to pro forma financial information, subject to the qualifications stated therein), (ii)&nbsp;were prepared in conformity
with GAAP applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto) and (iii)&nbsp;comply in all material respects with the applicable accounting requirements and with the rules and
regulations of the SEC, the Exchange Act and the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As of the date hereof, there are no outstanding or unresolved
comments in any comment letters of the staff of the SEC received by Parent relating to the Parent SEC Documents. As of the date hereof, none of the Parent SEC Documents is, to the knowledge of Parent, the subject of ongoing SEC review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Neither Parent nor any of its Subsidiaries is a party to, or has a commitment to effect, enter into or create, any joint venture, or <FONT
STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangement&#148; (as defined in Item 303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act), where the result, purpose or effect of such Contract is to
avoid disclosure of any material transaction involving, or material liabilities of, Parent or any of its Subsidiaries in the Parent Financial Statements or other Parent SEC Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Absence of Certain Changes or Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From January&nbsp;1, 2020, through the date of this Agreement, the businesses of each of Parent and its Subsidiaries, as applicable, have
been conducted in all material respects in the Ordinary Course of Business, and none of Parent or any Subsidiary of Parent has undertaken any action that, if taken during the period from the date of this Agreement to the Effective Time, would
constitute a breach of clauses&nbsp;(i) through (v)&nbsp;or (ix) (solely as it relates to clauses&nbsp;(i) through (v)) of <U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2020, through the date of this Agreement, there has not been any event, change, effect, development or occurrence
that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Internal Controls and Procedures</U>. Parent has established and maintains disclosure controls and procedures and internal
control over financial reporting (as such terms are defined in paragraphs&nbsp;(e) and (f), respectively, of Rule&nbsp;13a-15 under the Exchange Act) as required by Rule&nbsp;13a-15 under the Exchange Act. Parent&#146;s disclosure controls and
procedures are reasonably designed to ensure that all material information required to be disclosed by Parent in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods
specified in the rules and forms of the SEC, and that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
all such material information is accumulated and communicated to Parent&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications
required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. Parent&#146;s management has completed an assessment of the effectiveness of Parent&#146;s internal controls over financial reporting in compliance with the requirements of
Section&nbsp;404 of the Sarbanes-Oxley Act for the year ended December&nbsp;31, 2019, and such assessment concluded that such controls were effective. Based on its most recent evaluation of internal controls over financial reporting prior to the
date hereof, management of Parent has disclosed to Parent&#146;s auditors and the audit committee of the Parent Board (i)&nbsp;any significant deficiencies and material weaknesses in the design or operation of internal controls over financial
reporting that are reasonably likely to adversely affect in any material respect Parent&#146;s ability to report financial information and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a
significant role in Parent&#146;s internal controls over financial reporting, in each case, that was disclosed to Parent&#146;s auditors or the audit committee of the Parent Board in connection with its most recent evaluation of internal controls
over financial reporting prior to the date hereof. Parent maintains a system of internal accounting controls designed to provide reasonable assurances regarding transactions being executed in accordance with management&#146;s general or specific
authorization, the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and the prevention or timely detection of unauthorized acquisition, use or disposition of Parent&#146;s
assets that could have a material effect on its financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>No Undisclosed Liabilities</U>. There are no
liabilities or obligations of Parent or any of its Subsidiaries, whether accrued, absolute, determined or contingent, except for (i)&nbsp;liabilities or obligations disclosed, reflected or reserved against in the balance sheets included in the
Parent Financial Statements (or in the notes thereto) filed and publicly available prior to the date of this Agreement, (ii)&nbsp;liabilities or obligations arising under or in accordance with this Agreement, (iii)&nbsp;liabilities or obligations
incurred in the Ordinary Course of Business since December&nbsp;31, 2019, and (iv)&nbsp;liabilities or obligations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.9 <U>Compliance with Laws; Permits</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Parent and its Subsidiaries are in compliance with, and are not in default under or in violation of any Laws, except where such <FONT
STYLE="white-space:nowrap">non-compliance,</FONT> default or violation has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Since January&nbsp;1, 2018, neither Parent nor any
of its Subsidiaries has received any written notice or, to the knowledge of Parent, other communication from any Governmental Entity regarding any actual or possible violation of, or failure to comply with, any Law, except where such violation or
failure has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
Parent and its Subsidiaries are in possession of all material franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and
orders of all applicable Governmental Entities, and all rights under any Parent material Contract with all Governmental Entities, and have filed all tariffs, reports, notices and other documents with all Governmental Entities necessary for the
Company and its Subsidiaries to own, lease and operate their properties and assets and to carry on their businesses as they are now being conducted (the &#147;<U>Parent Permits</U>&#148;), except where the failure to possess or file the Parent
Permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect, all Parent Permits are in all respects valid and in full force and effect and are not subject to any administrative or judicial proceeding that would reasonably be expected to result in modification, termination or
revocation thereof. Parent and each of its Subsidiaries are in material compliance with the terms and requirements of all Parent Permits, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect: (i)&nbsp;Parent and each of its Subsidiaries are in compliance, and have since January&nbsp;1, 2018 complied, with all applicable Data Privacy Laws; (ii)&nbsp;neither Parent nor any of its
Subsidiaries has, since January&nbsp;1, 2018, received any written notice from any applicable Governmental Entity alleging any violation of applicable Data Privacy Laws by Parent, any of its Subsidiaries or, to the knowledge of Parent, any
third-party service providers, outsourcers, processors or other third parties who process, store or otherwise handle Personal Data for or on behalf of Parent or any of its Subsidiaries (&#147;<U>Parent Data Processors</U>&#148;), nor has Parent or
any of its Subsidiaries been threatened in writing to be charged with any such violation by any Governmental Entity; (iii)&nbsp;Parent and each of its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps (including, as
appropriate, implementing reasonable technical, physical or administrative safeguards) designed to protect Personal Data in their possession or under their control against loss and unauthorized access, use, modification or disclosure, and, to the
knowledge of Parent, since January&nbsp;1, 2018, there has been no incident of the same, or of the same with respect to any Personal Data maintained or otherwise processed for or on behalf of Parent or its Subsidiaries; (iv)&nbsp;Parent and each of
its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps with respect to Parent Data Processors to obligate such persons to comply in all material respects with applicable Data Privacy Laws and to take reasonable steps
to protect and secure Personal Data from loss or unauthorized use, access, modification or disclosure; and (v)&nbsp;the execution, delivery and performance of this Agreement complies with all applicable Data Privacy Laws (including the General Data
Protection Regulation (EU)&nbsp;2016/679, the Data Protection Act 2018 (UK), and the California Consumer Protection Act) and Parent&#146;s and each of its Subsidiaries&#146; applicable published policies, statements, and notices relating to privacy,
data protection or information security regarding Personal Data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.10 <U>Environmental Matters</U>. Parent and its
Subsidiaries are, and since January&nbsp;1, 2018 have been, in compliance with all applicable Environmental Laws (which compliance includes the possession, and the compliance with the terms and conditions, by Parent and each of its Subsidiaries of
all Parent Permits required under applicable Environmental Laws to conduct their respective business and operations), and there are no investigations, actions, suits or proceedings pending or, to the knowledge of Parent, threatened against Parent or
any of its Subsidiaries, in each case, except as, individually or in the aggregate, has not had a would not reasonably be expected to have a Parent Material Adverse Effect. Neither Parent nor any of its Subsidiaries has received any written notice
from a Governmental Entity that alleges that Parent or any of its Subsidiaries is violating, or has or may have, violated any Environmental Law, or may have any liability or obligation arising under, retained or assumed by contract or by operation
of law, except for such violations, liabilities and obligations that would not have, individually or in the aggregate, a Parent Material Adverse Effect. To the knowledge of Parent, there has been no release of any Hazardous Materials by Parent or
any of its Subsidiaries at, to or from any facilities currently or formerly owned or leased by Parent or any of its Subsidiaries or at any other locations where any Hazardous Materials were generated, manufactured, refined, transferred, stored,
produced, imported, used, processed or disposed of by Parent or any of its Subsidiaries and, in each case, for which Parent or any of its Subsidiaries would reasonably be expected to be subject to any material liability. Neither Parent nor any of
its Subsidiaries has, either through Contract or by operation of law, assumed or agreed to guarantee, reimburse, pledge, defend, hold harmless or indemnify any other person with respect to any liabilities arising under Environmental Laws except as,
individually or in the aggregate, has not had and would not reasonably be expected to have a Parent Material Adverse Effect. Parent has delivered or made available to the Company all material environmental assessment reports, investigations and
audits in its possession or control, which relate to environmental matters for which Parent may reasonably be expected to have any material liability with respect to Parent and its Subsidiaries&#146; business and operations. The representations and
warranties set forth in this <U>Section</U><U></U><U>&nbsp;4.10</U>, <U>Section</U><U></U><U>&nbsp;4.3(b)</U>, <U>Section</U><U></U><U>&nbsp;4.5</U>, <U>Section</U><U></U><U>&nbsp;4.6</U> and <U>Section</U><U></U><U>&nbsp;4.8</U> are Parent&#146;s
and Merger Sub&#146;s sole and exclusive representations and warranties relating to Environmental Laws or liabilities relating to the release or disposal of Hazardous Materials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.11 <U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to result in, individually or in the aggregate, a material liability to Parent and its
Subsidiaries, (i)&nbsp;each Parent Benefit Plan has been established, operated and administered in all respects in accordance with its terms and the requirements of all applicable Laws, including ERISA and the Code, and (ii)&nbsp;all contributions
required to be made to any Parent Benefit Plan by applicable Law or by any plan document or other contractual undertaking, and all premiums due or payable with respect to insurance policies funding any Parent Benefit Plan, have been timely made or
paid or, to the extent not required to be made or paid on or before the date hereof, have been reflected on the books and records of Parent in accordance with GAAP. As of the date hereof, there are no pending or threatened material claims (other
than routine claims for benefits) by, on behalf of or against any of the Parent Benefit Plans, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2016, no Parent Benefit Plan has been an employee benefit plan subject to Section&nbsp;302 or Title IV of ERISA or
Section&nbsp;412, 430 or 4971 of the Code. None of Parent or any of its ERISA Affiliates has incurred or is reasonably expected to incur any Controlled Group Liability that has not been satisfied in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Neither Parent, nor its Subsidiaries nor any of their respective ERISA Affiliates has, at any time since January&nbsp;1, 2016, contributed
to, been obligated to contribute to or had any liability (including any contingent liability) with respect to any Multiemployer Plan or Multiple Employer Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The execution of this Agreement and the consummation of the Merger will not, either alone or in combination with another event,
(i)&nbsp;entitle any current or former employee, director, consultant or officer of Parent or any of its Subsidiaries to any severance pay or any other similar payment, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of
compensation due any such employee, director, consultant or officer or (iii)&nbsp;trigger any funding obligation under any Parent Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) No Parent Benefit Plan provides for, and neither Parent nor any of its Subsidiaries otherwise has any obligation to provide, a <FONT
STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes imposed under Section&nbsp;4999 of the Code, Section&nbsp;409A(a)(1)(B) of the Code, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Except as would not, either individually or in the aggregate, reasonably be expected to result in material liability to Parent or its
Subsidiaries, each Parent Benefit Plan that is mandated by applicable Law or by a Governmental Entity outside of the United States or that is subject to the laws of a jurisdiction outside of the United States (i)&nbsp;has been maintained in
accordance with all applicable requirements, (ii)&nbsp;if intended to qualify for special Tax treatment, meets all the requirements for such treatment, and (iii)&nbsp;if required, to any extent, to be funded, book-reserved or secured by an insurance
policy, is fully funded, book-reserved or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.12 <U>Labor and Employment Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Neither Parent nor any of its Subsidiaries is party to or bound by any collective bargaining agreement, works council agreement or similar
labor-related agreement or arrangement. No strike, material work slowdown, work stoppage, or unfair labor practice against Parent or any of its Subsidiaries is pending, or to knowledge of Parent, threatened. To the knowledge of Parent, no activities
or proceedings of any labor union to organize any employees of Parent or any of its Subsidiaries are pending or threatened. No labor union or works council currently represents any employees of Parent or any of its Subsidiaries in connection with
their employment with Parent or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a
Parent Material Adverse Effect, Parent and each of its Subsidiaries is in compliance with all applicable Laws respecting hiring, employment and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employment practices, terms and conditions of employment, harassment, retaliation, reasonable accommodations, leaves of absence, occupational safety and health, workers&#146; compensation,
employee classification, wages and hours, engagement of independent contractors (including the appropriate classification of the same), payroll taxes, redundancy, &#147;mass layoffs,&#148; &#147;plant closings&#148; and immigration with respect to
all employees, independent contractors, and other service providers of Parent and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As of the date of this Agreement,
except as has not had, and would not reasonably be expected to have, a Parent Material Adverse Effect, (i)&nbsp;there are no charges, complaints, audits or investigations pending or scheduled by any Governmental Entity pertaining to the employment
practices or actions of Parent or any of its Subsidiaries or, to Parent&#146;s knowledge, threatened against Parent or any of its Subsidiaries and (ii)&nbsp;to Parent&#146;s knowledge, no complaints or charges relating to employment practices or
actions of Parent or any of its Subsidiaries have been made since January&nbsp;1, 2018 to any Governmental Entity or submitted to Parent or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of Parent, neither Parent nor any of its Subsidiaries is party to a settlement agreement with any employee of Parent or
any of its Subsidiaries that involves material allegations of sexual harassment by any employee of Parent or any of its Subsidiaries at the level of Senior Vice President or above. To the knowledge of Parent, no material allegations of sexual
harassment are pending against any employee of Parent or any of its Subsidiaries at the level of Senior Vice President or above in his or her capacity as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.13 <U>Investigations; Litigation</U>. Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect, (a)&nbsp;there are no actions, suits, inquiries, investigations, proceedings, subpoenas, civil investigative demands or other requests for information relating to potential violations of Law pending
(or, to the knowledge of Parent, threatened) against or affecting Parent or any of its Subsidiaries, or any of their respective properties and (b)&nbsp;there are no Orders of, or before, any Governmental Entity against Parent or any of its
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.14 <U>Information Supplied</U>. The information supplied or to be supplied by Parent for inclusion in the
Form S-4 shall not, at the time the Form S-4 is declared effective by the SEC, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by Parent with respect to statements made therein based on information supplied by the Company or its Representatives in writing
expressly for inclusion therein. The information supplied or to be supplied by Parent or its Representatives for inclusion in the Joint Proxy Statement/Prospectus shall not, at the time the Joint Proxy Statement/Prospectus is first mailed to the
stockholders of the Company and at the time of any meeting of Company stockholders to be held in connection with the Merger, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by Parent with respect to statements made therein based on information
supplied by the Company in writing expressly for inclusion therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.15 <U>Anti-Bribery</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Other than as would not be material to Parent and its Subsidiaries, taken as a whole, since January&nbsp;1, 2016, neither Parent nor its
Subsidiaries or controlled Affiliates (including their respective officers, directors, employees and, to the knowledge of Parent, agents or other persons acting on behalf of Parent or any of its Subsidiaries or controlled Affiliates) has taken any
action in violation of the Anti-Corruption Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Other than as would not be material to Parent and its Subsidiaries, taken as a
whole, since January&nbsp;1, 2016, neither Parent nor its Subsidiaries or its controlled Affiliates has been subject to any actual, pending or, to the knowledge of Parent, threatened, civil, criminal, or administrative actions, suits, demands,
claims, hearings, notices of violation, investigations, proceedings, demand letters, settlements or enforcement actions, or made any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
voluntary disclosures to any Governmental Entity, involving Parent, its Subsidiaries or controlled Affiliates, in each case in any way relating to Anti-Corruption Laws nor is there any basis
therefor. Parent and each of its Subsidiaries and controlled Affiliates have established and maintain compliance programs and reasonable internal controls and procedures reasonably designed to ensure Parent, its Subsidiaries and its controlled
Affiliates (including any of their officers, directors, employees, agents or other persons acting on their behalf) do not violate the Anti-Corruption Laws. For purposes of this <U>Section</U><U></U><U>&nbsp;4.15</U>, the term &#147;Governmental
Entity&#148; shall also include any supra-national or public international organization (<I>e.g.</I>, the World Bank, the Red Cross, etc.), or any legislative body or committee, division, political party, royal family, or government-owned or
controlled enterprise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.16 <U>Exports</U><U></U><U>&nbsp;&amp; Sanctions</U>. Other than as would not be material to Parent
and its Subsidiaries, taken as a whole, since January&nbsp;1, 2016, Parent and its Subsidiaries have conducted all transactions in compliance with all applicable U.S. import, export, and trade sanctions Laws and regulations, including the Export
Administration Regulations, the International Traffic in Arms Regulations, the regulations administered by the Office of Foreign Assets Control of the U.S. Treasury Department, and all comparable applicable import and export laws and regulations
outside the United States in each country where Parent and its Subsidiaries conduct business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.17 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,
(i)&nbsp;Parent and each of its Subsidiaries have prepared and timely filed (taking into account any valid extension of time within which to file) all Tax Returns required to be filed by any of them and all such Tax Returns are complete and
accurate, (ii)&nbsp;Parent and each of its Subsidiaries have timely paid all Taxes that are required to be paid by any of them or that Parent or any of its Subsidiaries are obligated to withhold from amounts owing to any employee, creditor,
stockholders or third party (in each case, whether or not shown on any Tax Return), (iii)&nbsp;there are no currently effective waivers of any statute of limitations with respect to Taxes or extensions of time with respect to a Tax assessment or
deficiency, (iv)&nbsp;all assessments for Taxes due with respect to completed and settled examinations or any concluded litigation have been fully paid, (v)&nbsp;there are no audits, examinations, investigations or other proceedings pending or
threatened in writing in respect of Taxes or Tax matters of Parent or any of its Subsidiaries, (vi)&nbsp;no claim has been made in writing or, to Parent&#146;s knowledge, otherwise, by a Taxing Authority in a jurisdiction where Parent or any of its
Subsidiaries does not file Tax Returns of a certain type that Parent or any of its Subsidiaries is or may be subject to taxation of such type or required to file Tax Returns of such type in that jurisdiction, (vii)&nbsp;there are no Liens for Taxes
on any of the assets of Parent or any of its Subsidiaries other than statutory Liens for Taxes not yet due and payable, (viii)&nbsp;neither Parent nor any of its Subsidiaries is a party to any agreement or arrangement relating to the apportionment,
sharing, assignment or allocation of any Tax or Tax asset (other than an agreement or arrangement solely among members of a group the common parent of which is Parent or commercial agreements or arrangements not primarily related to Taxes and
entered into in the ordinary course of business) or has any liability for Taxes of any person (other than Parent or any of its Subsidiaries) under Treasury Regulation Section&nbsp;1.1502-6 (or any analogous or similar provision of state, local or
foreign Tax Law), as transferee, successor, by Contract (other than commercial Contracts not primarily related to Taxes and entered into in the ordinary course of business) or otherwise, and (ix)&nbsp;neither Parent nor any of its Subsidiaries is
bound with respect to any current or any future taxable period by any closing agreement (within the meaning of Section&nbsp;7121 of the Code), private letter ruling, technical advice or other ruling or written agreement with a Governmental Entity,
in each case, that could reasonably be expected to affect the liability for Taxes of Parent or any of its Subsidiaries following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) None of Parent or any of its Subsidiaries has been a party to any &#147;listed transaction&#148; within the meaning of Treasury Regulation
<FONT STYLE="white-space:nowrap">1.6011-4(b)(2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding any other provisions of this Agreement to the contrary, the
representations and warranties made in this <U>Section</U><U></U><U>&nbsp;4.17</U>, <U>Section</U><U></U><U>&nbsp;4.5</U>, <U>Section</U><U></U><U>&nbsp;4.6</U> (to the extent relating to Taxes) and <U>Section</U><U></U><U>&nbsp;4.11</U>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(to the extent relating to Taxes) are the sole and exclusive representations and warranties of Parent and Merger Sub with respect to Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.18 <U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have a Parent Material Adverse Effect: (i)&nbsp;either Parent or a Subsidiary of Parent has
good and valid title, subject to Permitted Liens, to each material Real Property owned by Parent or any Subsidiary of Parent (such owned property collectively, the &#147;<U>Parent Owned Real Property</U>&#148;) and (ii)&nbsp;either Parent or a
Subsidiary of Parent has a good and valid leasehold interest in each material lease, material sublease and other material agreement under which Parent or any of its Subsidiaries uses or occupies or has the right to use or occupy any Real Property
(such property, the &#147;<U>Parent Leased Real Property</U>&#148; and such leases, subleases and other agreements, collectively, the &#147;<U>Parent Real Property Leases</U>&#148;), in each case, free and clear of all Liens other than any Permitted
Liens and any Lien encumbering the interest of the landlord thereunder. Except as would not reasonably be expected to have a Parent Material Adverse Effect, each Parent Real Property Lease and each Parent Sublease (defined below) is valid, binding
and in full force and effect, subject to the limitation of such enforcement by the Remedies Exceptions. Except as would not reasonably be expected to have a Parent Material Adverse Effect, no uncured default of a material nature on the part of
Parent or, if applicable, its Subsidiary or, to the knowledge of Parent, the landlord, sublandlord or subtenant thereunder (as applicable), exists under any Parent Real Property Lease or Parent Sublease, and no event has occurred or circumstance
exists which, with the giving of notice, the passage of time, or both, would constitute a material breach or default under a Parent Real Property Lease or Parent Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have a Parent Material Adverse Effect, (i)&nbsp;there are no leases, subleases, licenses,
rights or other agreements affecting any portion of the Parent Owned Real Property or the Parent Leased Real Property (each, a &#147;<U>Parent Sublease</U>&#148;) that would reasonably be expected to adversely affect the existing use of such Parent
Owned Real Property or Parent Leased Real Property by Parent or its Subsidiaries in the operation of its business thereon; and (ii)&nbsp;there are no outstanding (A)&nbsp;options or (B)&nbsp;rights of first refusal in favor of any other party to
purchase any Parent Owned Real Property or any portion thereof or interest therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.19 <U>Ownership of Company Common
Stock</U>. None of Parent nor Merger Sub (i)&nbsp;beneficially owns, as of the date hereof, any shares of Company Common Stock, or (ii)&nbsp;has beneficially owned during the immediately preceding three years a number of shares of Company Common
Stock that would make it an &#147;interested stockholder&#148; (as such term is defined DGCL 203) of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.20
<U>Vote Required</U>. Except for the Parent Stockholder Approval, no vote is required by the holders of any class or series of Parent&#146;s capital stock to approve and adopt this Agreement or the transactions contemplated hereby under applicable
Law or pursuant to the rules of Nasdaq as a result of this Agreement or the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.21
<U>Intellectual Property</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a
Parent Material Adverse Effect, Parent and its Subsidiaries solely and exclusively own the Intellectual Property owned (or purported to be owned) by Parent and its Subsidiaries (&#147;<U>Parent Owned IP</U>&#148;), free and clear of all Liens other
than Permitted Liens. All material issued patents, all registered copyrights and all registered trademarks that are registered or filed in the name of Parent or any of its Subsidiaries are subsisting and, to the knowledge of Parent, valid and
enforceable. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, the Parent Owned IP is not subject to any outstanding consent, settlement, Lien (other than
Permitted Liens), decree, order, injunction, judgment or ruling restricting the use thereof in a manner that would reasonably be expected to impair the continued operation of the businesses of Parent and its Subsidiaries as currently conducted. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect, as of the date of this Agreement, (i)&nbsp;the conduct of the business of Parent and its Subsidiaries as conducted since January&nbsp;1, 2018 and as presently conducted does not infringe,
misappropriate or otherwise violate any Intellectual Property rights of any third party and (ii)&nbsp;since January&nbsp;1, 2018 through the date of this Agreement, Parent has not received any written claim alleging any such infringement,
misappropriation or other violation. Since January&nbsp;1, 2018 through the date of this Agreement, there is no and has not been any legal proceeding brought by a third party against Parent or any of its Subsidiaries (or against another person who
has sought indemnification from Parent or any of its Subsidiaries in connection with such legal proceeding) with respect to any material alleged infringement or other material violation by Parent, its Subsidiaries, its or their current products or
services, or other operation of Parent&#146;s or any of its Subsidiaries&#146; businesses, of the Intellectual Property of such third party, that is outstanding and unresolved as of the date of this Agreement, or which, if resolved, has resulted in
any material liability or obligation (including ongoing payment), or the resolution of which required granting any license under any Parent Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, as
of the date of this Agreement, to the knowledge of Parent, no person or entity is infringing, misappropriating or otherwise violating any Intellectual Property owned by Parent or any of its Subsidiaries. Neither Parent nor any of its Subsidiaries
have, since January&nbsp;1, 2018 through the date of this Agreement, brought (or asserted or threatened in writing) any claim against any person alleging that such person is infringing or misappropriating any material Parent Owned IP, that is
outstanding and unresolved as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Parent and its Subsidiaries have taken commercially reasonable steps to
protect all material trade secrets of Parent or its Subsidiaries. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (i)&nbsp;to the knowledge of Parent, there have
been no unauthorized uses or disclosures of any such trade secrets, and (ii)&nbsp;none of Parent or its Subsidiaries has published, provided or disclosed, nor are Parent or its Subsidiaries under any present or contingent obligation to so publish,
provide or disclose, any software source code for Parent Owned IP, including through or in connection with any agreement requiring Parent or any of its Subsidiaries to place any software source code in escrow. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,
none of Parent or its Subsidiaries has received any support, funding, resources or assistance from any Governmental Entity, or from any university, college, other academic institutions, or <FONT STYLE="white-space:nowrap">non-profit</FONT> research
centers in the development of any Intellectual Property owned by Parent or its Subsidiaries, that resulted in, or is reasonably expected to result in, such third-parties being granted any rights or licenses to, or ownership interest in, any such
Intellectual Property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, no rights have been granted to any Governmental Entity with respect to any Parent Owned IP
other than substantially the same standard commercial rights as are granted by Parent to commercial end users in the Ordinary Course of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,
none of Parent or its Subsidiaries is a member or promoter of, or a contributor to, or made any commitments or agreements regarding, any patent pool, industry standards body, standard-setting organization or other similar organization, in each case
that requires or obligates Parent or any of its Subsidiaries to grant or offer to any other person any license or other right to any Parent Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,
the IT Systems used by Parent and its Subsidiaries are designed, implemented, operated and maintained in accordance with reasonable and customary industry standards and practices for entities operating businesses similar to the business of Parent
and its Subsidiaries, including with the respect to redundancy, reliability, scalability and security, and constitute all the information and communications </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
technology and other systems infrastructure reasonably necessary to carry on the business of Parent and its Subsidiaries as conducted in the 12 months prior to the date of this Agreement. Without
limiting the foregoing, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, (i)&nbsp;Parent and its Subsidiaries have taken reasonable steps and implemented
reasonable procedures to ensure that their IT Systems are free from viruses, contaminants and other harmful code, (ii)&nbsp;Parent and its Subsidiaries have in effect industry standard disaster recovery plans, procedures and facilities for their
businesses and have taken all reasonable steps to safeguard the security and the integrity of their IT Systems, and (iii)&nbsp;there has been no failure, breakdown, loss or impairment of, or any unauthorized intrusions or breaches of the security
with respect to the IT Systems used by Parent or any of its Subsidiaries that (A)&nbsp;has resulted in a disruption or interruption in the operation of the business of Parent or its Subsidiaries or (B)&nbsp;to the knowledge of Parent, has resulted
in loss, unauthorized access to, or unauthorized modification or disclosure of any confidential information of or maintained by, for or on behalf of Parent or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,
there exist no facts, and no events have occurred, that would reasonably be expected to form the basis of any present or future claim against Parent or its Subsidiaries, whether or not fully covered by insurance, for liability on account of
negligence or product liability or on account of any breach of Warranties of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.22 <U>Customers</U>.
<U>Section</U><U></U><U>&nbsp;4.22</U> of the Parent Disclosure Letter sets forth a list of the Top Parent Customers. As of the date hereof, neither Parent nor any of its Subsidiaries has received any written notice from any Top Parent Customer that
such Top Parent Customer shall not continue as a customer of Parent and its Subsidiaries or that such Top Parent Customer intends to terminate, not renew or materially amend existing Contracts with Parent or any of its Subsidiaries or otherwise
materially modify its business relationship with Parent and its Subsidiaries, except as would not be material and adverse to Parent and its Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.23 <U>Finders or Brokers</U>. Except for Allen&nbsp;&amp; Company LLC and J.P. Morgan Securities LLC (&#147;<U>Parent Financial
Advisors</U>&#148;), neither Parent nor any of Parent&#146;s Subsidiaries has employed any investment banker, broker or finder in connection with the transactions contemplated by this Agreement who would be entitled to any fee or any commission in
connection with or upon consummation of the Mergers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.24 <U>Opinion of Financial Advisor</U>. The Parent Board has received
the opinion of J.P. Morgan Securities LLC to the effect that, as of the date of such opinion and based upon and subject to the assumptions, limitations, qualifications and conditions set forth therein, the Merger Consideration to be paid by Parent
pursuant to this Agreement was fair from a financial point of view to Parent. The Company and Parent have been authorized by Parent Financial Advisor to permit the inclusion of such opinion of Parent Financial Advisor in its entirety and references
thereto in the Form S-4 and the Joint Proxy Statement/Prospectus, subject to prior review and consent by Parent Financial Advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.25 <U>Takeover Laws</U>. The Parent Board has taken all action necessary to render inapplicable to this Agreement and the
transactions contemplated hereby all applicable state Takeover Laws (including Subchapter F of Chapter 25 of Pennsylvania Law) and any similar provisions in Parent&#146;s certificate of incorporation or bylaws. As of the date of this Agreement, no
&#147;fair price,&#148; &#147;business combination,&#148; &#147;moratorium,&#148; &#147;control share acquisition&#148; or other anti-takeover statute or similar statute or regulation enacted by any state will prohibit or impair the consummation of
the Mergers or the other transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.26 <U>Affiliate Transactions</U>. To the knowledge
of Parent, no officer, director or Affiliate of Parent or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate family (a)&nbsp;owns any property or right, tangible or intangible, that is material to the conduct of
the business of Parent or its Subsidiaries, (b)&nbsp;with the exception of liabilities incurred in the Ordinary Course of Business, owes money to, or is owed money by, Parent or its Subsidiaries, or (c)&nbsp;is a party to or the beneficiary of any
Contract with Parent or its Subsidiaries, except in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
each case for compensation and benefits payable under any Parent Benefit Plans to officers and employees in their capacity as officers and employees. Except as disclosed in the Parent SEC
Documents, there are no Contracts between Parent or any of its Subsidiaries, on the one hand, and any officer, director or Affiliate of Parent or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate family, on the
other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.27 <U>Financing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a fully executed debt
commitment letter, dated as of the date of this Agreement (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time to time in compliance with the terms
of this Agreement, the &#147;<U>Debt Commitment Letter</U>&#148;) and fully executed fee letters (together with all exhibits, schedules, annexes and joinders thereto, as the same may be amended, modified, supplemented, extended or replaced from time
to time in compliance with the terms of this Agreement, the &#147;<U>Fee Letters</U>&#148;) relating thereto (except that the fee amounts, pricing caps and other economic terms in the Fee Letters may be redacted so long as no such redaction covers
terms that would adversely affect the amount, conditionality, or availability of the Debt Financing) (such Debt Commitment Letter and Fee Letters are referred to collectively herein as the &#147;<U>Debt Financing Commitment</U>&#148;), among Parent,
JPMorgan Chase Bank, N.A. and JPM Securities LLC (together with JPMorgan Chase Bank, N.A., the &#147;<U>Debt Commitment Parties</U>&#148;), pursuant to which the Debt Commitment Parties have agreed, subject to the terms and conditions of the Debt
Financing Commitment, to provide or cause to be provided, on a several and not joint basis, the financing commitments described therein. The debt financing contemplated under the Debt Financing Commitment is referred to herein as the &#147;<U>Debt
Financing</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As of the date of this Agreement, Parent has delivered to the Company a true, complete and correct copy of a
fully executed Investment Agreement, dated as of the date of this Agreement, by and between BCPE Watson (DE) SPV, LP (the &#147;<U>Investor</U>&#148;, and together with the Debt Commitment Parties, the &#147;<U>Commitment Parties</U>&#148;) and the
Company (the &#147;<U>Investment Agreement</U>&#148; and together with the Debt Financing Commitment, the &#147;<U>Financing Commitments</U>&#148;) pursuant to the Investor has agreed to purchase from Parent, and Parent has agreed to issue to the
Investor, shares of Parent Preferred Stock (the &#147;<U>Equity Commitment Share Issuance</U>&#148;) for an amount of cash to be paid by the Investor to Parent (the &#147;<U>Equity Financing</U>&#148;) subject to the terms and conditions set forth
therein. The Equity Financing and Debt Financing are collectively referred to as the &#147;<U>Financing</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Financing
Commitments are, as of the date hereof, in full force and effect. The Financing Commitments are the legal, valid, binding and enforceable obligation of Parent and, to the knowledge of Parent, the other parties thereto (except to the extent
enforcement may be limited by the Remedies Exceptions). The Financing Commitments have not been or will not be amended, modified, supplemented, extended or replaced, except as permitted under <U>Section</U><U></U><U>&nbsp;5.17(f)</U>. As of the date
hereof, (i)&nbsp;neither Parent nor, to the knowledge of Parent, any other counterparty to the Financing Commitments is in breach of any of its covenants or other obligations set forth in, or is in default under, the Financing Commitments and
(ii)&nbsp;assuming the accuracy of the representations and warranties in <U>Article</U><U></U><U>&nbsp;III</U> (to the extent that a breach of such representation or warranty would adversely affect the satisfaction by Parent of the conditions set
forth in the Financing Commitments), no event has occurred which, with or without notice, lapse of time or both, would or would reasonably be expected to (A)&nbsp;constitute or result in a breach or default on the part of Parent (or, to the
knowledge of Parent, any of the Commitment Parties) under the Financing Commitments, (B)&nbsp;constitute or result in a failure to satisfy a condition or other contingency set forth in the Financing Commitments, or (C)&nbsp;otherwise result in any
portion of the Financing not being available on the Closing Date. As of the date hereof, Parent has not received any notice or other communication from any party to the Financing Commitments with respect to (i)&nbsp;any actual or potential breach or
default on the part of Parent or any other party to the Financing Commitments or (ii)&nbsp;any intention of such party to terminate the Financing Commitments or to not provide all or any portion of the Financing. Assuming the satisfaction of the
conditions set forth in <U>Section</U><U></U><U>&nbsp;6.1</U> and <U>Section</U><U></U><U>&nbsp;6.3</U> hereof and assuming the accuracy of the representations and warranties in <U>Article</U><U></U><U>&nbsp;III</U> (to the extent that a breach of
such representation or warranty would adversely affect the satisfaction by Parent of the conditions set forth in the Financing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Commitments), as of the date hereof, Parent and Merger Sub: (i)&nbsp;have no reason to believe (both before and after giving effect to any &#147;flex&#148; provisions contained in the Debt
Financing Commitment) that they will be unable to satisfy on a timely basis each term and condition relating to the closing or funding of the Financing and (ii)&nbsp;know of no fact, occurrence, circumstance or condition that would reasonably be
expected to (A)&nbsp;cause the Financing Commitments to be terminated, withdrawn, modified, repudiated or rescinded or to be or become unenforceable (except to the extent enforcement may be limited by the Remedies Exceptions) or (B)&nbsp;otherwise
cause the full amount (or any portion) of the funds contemplated to be available under the Financing Commitments to not be available to Parent and Merger Sub on the Closing Date. As of the date hereof, there are no conditions precedent or other
contingencies related to the funding of the full amount of the Financing other than as expressly set forth in the Financing Commitments. There are no side letters or other agreements, contracts or arrangements, whether written or oral, related to
the funding of the full amount of the Financing other than as expressly set forth in or expressly contemplated by the Financing Commitments. All commitment fees or other fees or deposits required to be paid under the Financing Commitments on or
prior to the date of this Agreement have been paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.28 <U>Available Funds</U>. Subject to the terms and conditions
of the Financing Commitments, and subject to the terms and conditions of this Agreement, the net proceeds contemplated by the Financing, together with cash on hand at Parent, will, in the aggregate, be sufficient for Parent to (i)&nbsp;pay the Cash
Consideration payable pursuant to this Agreement, any cash in lieu of fractional shares of Parent Common Stock and any funds to be provided by Parent to the Company to enable the Company to fund payments (if any) required to be made in connection
with the transactions contemplated by this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U> hereof, (ii)&nbsp;repay any indebtedness required to be repaid, redeemed, retired, cancelled, terminated or otherwise satisfied or
discharged pursuant to this Agreement (including the Company Indebtedness Payoff), and (iii)&nbsp;pay all fees, costs and expenses required to be paid by Parent, Merger Sub or the Surviving Corporation or any of their respective Affiliates pursuant
to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.29 <U>No Additional Representations</U>. Except for the representations and warranties contained in
<U>Article</U><U></U><U>&nbsp;III</U> or in any certificates delivered by the Company in connection with the Mergers, each of Parent and Merger Sub acknowledges that neither the Company nor any person on behalf of the Company makes, and none of
Parent, Merger Sub or any person acting on behalf of Parent or Merger Sub, has relied or is relying upon, any other express or implied representation or warranty with respect to the Company or any of its Subsidiaries, or with respect to any other
information provided or made available to Parent or Merger Sub in connection with the transactions contemplated hereby, including the accuracy, completeness or currency thereof. Except as otherwise expressly provided in this Agreement and to the
extent any such information is expressly included in a representation or warranty contained in <U>Article</U><U></U><U>&nbsp;III</U>, neither the Company nor any other person will have or be subject to any liability or obligation to Parent, Merger
Sub or any other person resulting from the distribution or failure to distribute to Parent or Merger Sub, or Parent&#146;s or Merger Sub&#146;s use of, any such information, including any information, documents, projections, estimates, forecasts or
other material, made available to Parent or Merger Sub in any electronic data room maintained by the Company for purposes of, or in expectation of, the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS AND AGREEMENTS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Conduct of the Company</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From and after the date hereof until the earlier of the Effective Time or the date, if any, on which this Agreement is terminated pursuant
to <U>Section</U><U></U><U>&nbsp;7.1</U> (the &#147;<U>Termination Date</U>&#148;), and except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any stock exchange or regulatory organization applicable to the
Company or any of its Subsidiaries, (ii)&nbsp;with the prior written consent of Parent (such consent not to be unreasonably conditioned, withheld or delayed), (iii)&nbsp;as may be expressly contemplated or required by this
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, (iv)&nbsp;in connection with a Company COVID Action or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Company Disclosure Letter, the Company covenants and agrees
that it shall use commercially reasonable efforts to conduct the business of the Company and its Subsidiaries in all material respects in the Ordinary Course of Business, and shall use commercially reasonable efforts to preserve intact their present
lines of business, and to maintain their rights, franchises and Company Permits; <U>provided</U> that no action by the Company or its Subsidiaries with respect to matters specifically addressed by any provision of
<U>Section</U><U></U><U>&nbsp;5.1(b)</U> shall be deemed a breach of this sentence unless such action would constitute a breach of such other provision. Notwithstanding the foregoing, the Company and its Subsidiaries shall be permitted to take, and
nothing in this Agreement shall prohibit the Company or its Subsidiaries from taking, any Company COVID Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company agrees
with Parent, on behalf of itself and its Subsidiaries, that, from the date hereof and prior to the earlier of the Effective Time and the Termination Date, except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any
stock exchange or regulatory organization applicable to the Company or any of its Subsidiaries or Company Benefit Plan, (ii)&nbsp;with the prior written consent of Parent (such consent not to be unreasonably conditioned, withheld or delayed),
(iii)&nbsp;as may be expressly contemplated or required by this Agreement, (iv)&nbsp;in connection with a Company COVID Action or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.1</U> of the Company Disclosure Letter, the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) shall not amend or restate any Company Organizational Document, and shall not permit any of such Subsidiaries to amend or
restate their respective certificate of incorporation, certificate of formation, bylaws, limited partnership agreement, limited liability company agreement or comparable constituent or organizational documents, except, in each case, for any
immaterial or ministerial amendments thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) shall not, and shall not permit any of such Subsidiaries to split,
combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any shares of its capital stock, except for any such transaction by a wholly owned (direct or
indirect) Subsidiary of the Company which remains a wholly owned (direct or indirect) Subsidiary following the consummation of such transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) shall not, and shall not permit any of such Subsidiaries that is not wholly owned (directly or indirectly) by the Company
or is not a wholly owned (direct or indirect) Subsidiary of any of such Subsidiaries to, authorize or pay any dividends on or make any distribution with respect to its outstanding shares of capital stock (whether in cash, assets, stock or other
securities of the Company or its Subsidiaries), except dividends or distributions by any Subsidiaries only to the Company or to any other wholly owned (direct or indirect) Subsidiary of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) shall not, and shall not permit any of such Subsidiaries to, adopt a plan of complete or partial liquidation, dissolution,
merger, consolidation, restructuring, recapitalization or other reorganization, or take any action with respect to any securities owned by such person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) shall not, and shall not permit any of such Subsidiaries to, make any acquisition of any other person or business or make
any loans, advances or capital contributions to, or investments in, any other person, except as made in connection with any transaction among the Company and its wholly owned (direct or indirect) Subsidiaries or among the Company&#146;s wholly owned
(direct or indirect) Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) shall not, and shall not permit any of such Subsidiaries to, sell, lease, license,
transfer, exchange or swap or otherwise dispose of or encumber (other than Permitted Liens) (or enter into, amend, modify, or terminate any Contract to do any of the foregoing with respect to) any Intellectual Property, any Real Property, or any
tangible properties or assets, except in connection with (A)&nbsp;sales, transfers and dispositions of inventory and products, <FONT STYLE="white-space:nowrap">(B)&nbsp;non-exclusive</FONT> licenses of Intellectual Property to customers and
suppliers, or (C)&nbsp;leases of Real Property under which the Company or any of its Subsidiaries is a tenant, in the case of each of clauses&nbsp;(A) through (C), in the Ordinary Course of Business or encumbrances under the Company Credit Agreement
(<U>provided</U> that prior to entering into any lease of Real Property in the Ordinary Course of Business with an annual rent amount exceeding $1,000,000, the Company will provide advance notice to, and reasonably consult with, Parent with respect
thereto); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) shall not, and shall not permit any of its Subsidiaries to, authorize
any capital expenditures except for capital expenditures (A)&nbsp;to maintain, replace or repair damaged assets or (B)&nbsp;otherwise provided for in the Company&#146;s capital expenditure budget set forth in
<U>Section</U><U></U><U>&nbsp;5.1(b)(vii)</U> of the Company Disclosure Letter; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) except as permitted under
<U>Section</U><U></U><U>&nbsp;5.1(b)(xi)</U> with respect to Company Material Contracts relating to indebtedness, or pursuant to <U>Section</U><U></U><U>&nbsp;5.15</U>, or in connection with any repayment, redemption or discharge of any Company
indebtedness, shall not, and shall not permit any of its Subsidiaries to enter into, modify, amend or terminate, or waive any material rights under any Company Material Contract or under any Company Permit, or enter into any new Contract which would
be a Company Material Contract if it were in effect on the date of this Agreement, in each case, other than in the Ordinary Course of Business (<U>provided</U> that (a)&nbsp;this Ordinary Course of Business exception shall not apply with respect to
any Contract of the nature described in <U>Section</U><U></U><U>&nbsp;3.19(a)(iv)</U>, <U>Section</U><U></U><U>&nbsp;3.19(a)(vi)</U> or <U>Section</U><U></U><U>&nbsp;3.19(a)(viii)</U> and (b)&nbsp;promptly following entering into, materially
modifying, materially amending or terminating any Company Material Contract of the nature described in <U>Section</U><U></U><U>&nbsp;3.19(a)(xii) (</U>including, for the avoidance of doubt, any modification or amendment of such Contract that would
result in such Contract having any of the provisions described in <U>Section</U><U></U><U>&nbsp;3.19(a)(viii)</U>), the Company will provide notice to Parent of such action to the extent permitted under the terms of the relevant Company Material
Contract); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) shall not, and shall not permit any of its Subsidiaries to, materially change any material accounting
policies or procedures or any of its methods of reporting income, deductions or other material items, except as required by GAAP, SEC rule or policy or applicable Law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) shall not, and shall not permit any of its Subsidiaries to, issue, sell, pledge, dispose of or encumber (other than
Permitted Liens), or authorize the issuance, sale, pledge, disposition or encumbrance of (other than Permitted Liens), any shares of its capital stock or other ownership interest in the Company or any of its Subsidiaries or any securities
convertible into or exchangeable for any such shares or ownership interest, or any rights, warrants or options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to cause to
be exercisable any otherwise unexercisable option under any existing Company Benefit Plans (except as otherwise provided by the terms of this Agreement or the express terms of any unexercisable or unexercised warrants outstanding on the date
hereof), other than (A)&nbsp;issuances of shares of Company Common Stock in respect of the settlement of any Company RSUs or the exercise of rights under the ESPP, (B)&nbsp;the sale of shares of Company Common Stock pursuant to the vesting and
settlement of Company RSUs for withholding of Taxes, (C)&nbsp;grants of service-based vesting Company RSUs (without performance-vesting goals or metrics) in the Ordinary Course of Business on terms consistent with past practices (including vesting),
which grants shall, in the aggregate with respect to all grants made to each group of employees having the same employment level, not exceed the aggregate grant date value of the Company RSUs granted during calendar year 2020 to each such group of
employees as set forth on <U>Section</U><U></U><U>&nbsp;5.1(b)(x)(C)</U> of the Company Disclosure Letter; <U>provided</U> that grants to CIC Plan participants following the date of this Agreement shall not provide for accelerated vesting upon a
qualifying termination or upon consummation of the Merger or any other transaction contemplate hereby, in each case, under the CIC Plan, <U>Section</U><U></U><U>&nbsp;2.5(c)</U> of this Agreement, or any other Contract, and (D)&nbsp;pledges under
the Company Credit Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) shall not, and shall not permit any of its Subsidiaries to, incur, assume, guarantee or
otherwise become liable for any additional indebtedness for borrowed money or any guarantee of such indebtedness, except for (A)&nbsp;additional indebtedness not to exceed $5,000,000 (provided that prompt written notice of any such indebtedness in
excess of $1,000,000 is provided to Parent), (B)&nbsp;any indebtedness among the Company and its wholly owned (direct or indirect) Subsidiaries or among the Company&#146;s wholly owned (direct or indirect) Subsidiaries and (C)&nbsp;any guarantees by
the Company of indebtedness of Subsidiaries of the Company or guarantees by the Company&#146;s Subsidiaries of indebtedness of the Company or any Subsidiary of the Company, which indebtedness is under the Company Credit Agreement or incurred in
compliance with this <U>Section</U><U></U><U>&nbsp;5.1(b)(xi)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) shall not, and shall not permit any of its
Subsidiaries to, commence or threaten (other than to protect a material right), or waive, release, assign, settle or compromise any pending or threatened action or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
proceeding, other than waivers, releases, assignments, settlements or compromises that do not (A)&nbsp;exceed $2,000,000 individually and $6,000,000 in the aggregate and (B)&nbsp;involve any
admission of wrongdoing or equitable relief; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) shall not, and shall not permit any of its Subsidiaries to, change or
revoke any material Tax election, change any material tax accounting method, file any material amended Tax Return, enter into any closing agreement, request any material Tax ruling, settle or compromise any material Tax proceeding or surrender any
claim for a material refund of Taxes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) except as permitted by <U>Section</U><U></U><U>&nbsp;5.1(b)(x)</U>, shall not,
and shall not permit any of its Subsidiaries to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) grant or provide any severance or termination payments or benefits to
any current or former employee, officer, <FONT STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor or consultant of the Company or any of its Subsidiaries (including any obligation to <FONT
STYLE="white-space:nowrap">gross-up,</FONT> indemnify or otherwise reimburse any such individual for any Tax incurred by any such individual, including under Section&nbsp;409A or 4999 of the Code), except for severance or termination payments or
benefits granted or provided in the Ordinary Course of Business in connection with retention, new hires, or promotions of employees of the Company or any of its Subsidiaries with a title of Vice President or below; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) accelerate the time of payment or vesting of, or the lapsing of restrictions with respect to, or fund or otherwise secure
the payment of, any compensation or benefits (including any equity or equity-based awards) to any current or former employee, officer, <FONT STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor or consultant of
the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) increase the compensation payable to any current or former employee, officer, <FONT
STYLE="white-space:nowrap">non-employee</FONT> director, individual independent contractor or consultant of the Company or any of its Subsidiaries, other than in the Ordinary Course of Business (including in connection with promotions in the
Ordinary Course of Business) for employees with a title of Vice President or below; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) establish, adopt, terminate or
amend any material Company Benefit Plan or any plan, program, arrangement, policy or agreement that would be a Company Benefit Plan if it were in existence on the date of this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) hire or retain any person to be an officer, employee, or individual independent contractor or consultant of the Company or
any of its Subsidiaries, other than the hiring or retention of: (i)&nbsp;employees with a title of Vice President or below, <FONT STYLE="white-space:nowrap">(ii)&nbsp;non-employee</FONT> directors or (iii)&nbsp;independent contractors and
consultants having annual compensation of less than $200,000 (excluding, for the avoidance of doubt, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors), in each case, in the Ordinary Course of Business; <U>provided</U> that, for
purposes of clause&nbsp;(iii), any such contractor or consultant shall enter into a service agreement on substantially a form made available to Parent prior to the date of this Agreement and any variation which has the net effect of a material
negative or detrimental impact on the Company shall be subject to review and approval by Parent; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) terminate the
employment of any current employee with a title of Vice President or above other than for cause; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) enter into, adopt,
materially amend, terminate or extend any local collective bargaining agreement or other similar labor-related agreement, except, in each case, as required by Law and expressly required pursuant to the terms of such agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) shall not, and shall not permit any of its Subsidiaries to, agree, in writing or otherwise, to take any of the foregoing
actions that are prohibited pursuant to clauses&nbsp;(i) through (xiv)&nbsp;of this <U>Section</U><U></U><U>&nbsp;5.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Conduct of Parent and Merger Sub</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From and after the date hereof until the earlier of the Effective Time or the Termination Date, and except (i)&nbsp;as may be required by
applicable Law or the regulations or requirements of any stock exchange or regulatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
organization applicable to Parent or any of its Subsidiaries, (ii)&nbsp;with the prior written consent of the Company (such consent not to be unreasonably conditioned, withheld or delayed),
(iii)&nbsp;as may be expressly contemplated or required by this Agreement, (iv)&nbsp;in connection with a Parent COVID Action or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.2</U> of the Parent Disclosure Letter, Parent covenants and
agrees that it shall use commercially reasonable efforts to conduct the business of Parent and its Subsidiaries in all material respects in the Ordinary Course of Business, and shall use commercially reasonable efforts to preserve intact their
present lines of business, and to maintain their rights, franchises and permits; <U>provided</U>, <U>however</U>, that no action by Parent or its Subsidiaries with respect to matters specifically addressed by any provision of
<U>Section</U><U></U><U>&nbsp;5.2(b)</U> shall be deemed a breach of this sentence unless such action would constitute a breach of such other provision. Notwithstanding the foregoing, Parent and its Subsidiaries shall be permitted to take, and
nothing in this Agreement shall prohibit Parent or its Subsidiaries from taking, any Parent COVID Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Parent agrees with the
Company, on behalf of itself and its Subsidiaries, that, from the date hereof and prior to the earlier of the Effective Time and the Termination Date, except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any
stock exchange or regulatory organization applicable to Parent or any of its Subsidiaries or Parent Benefit Plan, (ii)&nbsp;with the prior written consent of the Company (such consent not to be unreasonably conditioned, withheld or delayed),
(iii)&nbsp;as may be expressly required by this Agreement, (iv)&nbsp;in connection with a Parent COVID Action or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.2</U> of the Parent Disclosure Letter, Parent: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) shall not amend or restate any Parent Organizational Document or certificate of incorporation or bylaws of Merger Sub (or
equivalent documents), and shall not permit any of its other Subsidiaries to materially amend or restate their respective certificate of incorporation, certificate of formation, bylaws, limited partnership agreement, limited liability company
agreement or comparable constituent or organizational documents, except, in each case, for any immaterial or ministerial amendments thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) shall not, and shall not permit any of such Subsidiaries to split, combine or reclassify any of its capital stock or issue
or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any shares of its capital stock, except for any such transaction by a wholly owned (direct or indirect) Subsidiary of Parent which remains a wholly
owned (direct or indirect) Subsidiary following the consummation of such transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) shall not, and shall not
permit any of such Subsidiaries that is not wholly owned (directly or indirectly) by Parent or is not a wholly owned (direct or indirect) Subsidiary of any such Subsidiaries to, authorize or pay any dividends on or make any distribution with respect
to its outstanding shares of capital stock (whether in cash, assets, stock or other securities of Parent or its Subsidiaries), except dividends or distributions by any Subsidiaries only to Parent or to any other wholly owned (direct or indirect)
Subsidiary of Parent; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) shall not, and shall not permit any of such Subsidiaries to, adopt a plan of complete or
partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization or take any action with respect to any securities owned by such person, in each case, that would reasonably be expected to prevent,
materially impede or materially delay the consummation of the Merger; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) shall not, and shall not permit any of such
Subsidiaries to, acquire (by purchase, merger, joint venture, partnership, consolidation, dissolution, liquidation, tender offer, exchange offer, recapitalization, reorganization, share exchange, business combination or similar transaction) any
business or material amount of assets from any other person except for such acquisitions for an amount not to exceed $100&nbsp;million in value in the aggregate (for all such transactions), in each case that would not reasonably be expected to
(A)&nbsp;impose any material delay in the obtaining of, or materially increase the risk of not obtaining, any authorization, consent, order, declaration or approval of any Governmental Entity necessary to consummate the transactions contemplated by
this Agreement or the expiration or termination of any applicable waiting period, (B)&nbsp;materially increase the risk of any Governmental Entity entering an Order prohibiting the consummation of the transactions contemplated by this Agreement,
(C)&nbsp;materially increase </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the risk of not being able to remove any such Order on appeal or otherwise, or (D)&nbsp;prevent, materially delay or materially impair the ability of Parent or Merger Sub to consummate the
transactions contemplated by this Agreement, including the Merger and the Financing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) shall not, and shall not permit
any of its Subsidiaries to, issue, sell, pledge, dispose of or encumber, or authorize the issuance, sale, pledge, disposition or encumbrance of, any shares of its capital stock or other ownership interest in Parent or any of its Subsidiaries or any
securities convertible into or exchangeable for any such shares or ownership interest, or any rights, warrants or options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to
cause to be exercisable any otherwise unexercisable option under any existing Parent Benefit Plans (except as otherwise provided by the terms of this Agreement or the express terms of any unexercisable or unexercised options or warrants outstanding
on the date hereof), other than (A)&nbsp;issuances of shares of Parent Common Stock in respect of the exercise or settlement of any Parent stock awards outstanding on the date hereof, (B)&nbsp;the sale of shares of Parent Common Stock pursuant to
the exercise of Parent Options or the settlement of any Parent stock awards, if necessary to effectuate an option direction upon exercise or for withholding of Taxes in accordance with their terms on the date hereof, (C)&nbsp;grants of equity awards
in the Ordinary Course of Business, in amounts consistent with past practice, pursuant to any Parent Benefit Plan, and (D)&nbsp;the issuance of shares of Parent Common Stock or the grant of equity awards in connection with the acquisition of any
business or material amount of assets from any other person that is permitted by the terms of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) shall
not, and shall not permit any of its Subsidiaries to, incur, assume, guarantee or otherwise become liable for any indebtedness for borrowed money or any guarantee of such indebtedness (other than the Debt Financing) except any such incurrence,
assumption, guarantee or other liability which would not be reasonably expected to prevent, materially delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated by this Agreement, including the Merger
and the Financing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) shall not and shall not permit any of its Subsidiaries to directly or indirectly, purchase,
redeem or otherwise acquire any shares of the capital stock of Parent or any of its Subsidiaries or any rights, warrants or options to acquire any such shares, except for transactions among Parent and its wholly owned (direct or indirect)
Subsidiaries or among Parent&#146;s wholly owned (direct or indirect) Subsidiaries or in connection with the exercise of any options, or the vesting or settlement of any Parent equity awards issued in the Ordinary Course of Business; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) shall not, and shall not permit any of its Subsidiaries to, agree, in writing or otherwise, to take any of the foregoing
actions that are prohibited pursuant to clauses&nbsp;(i) through (viii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;5.2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Access</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) For purposes of facilitating the transactions contemplated hereby, each of the Company and Parent shall afford (i)&nbsp;the officers and
employees and (ii)&nbsp;the accountants, consultants, legal counsel, financial advisors, financing sources and agents and other representatives of the other Party such reasonable access during normal business hours, throughout the period prior to
the earlier of the Effective Time and the Termination Date, to its and its Subsidiaries&#146; personnel and properties, contracts, commitments, books and records and any report, schedule or other document filed or received by it pursuant to the
requirements of applicable Laws and with such additional accounting, financing, operating, environmental and other data and information regarding the Company and its Subsidiaries, as Company and Parent may reasonably request. Notwithstanding the
foregoing, neither Parent nor the Company shall be required to provide access to or make available to any person any document or information that, in the reasonable judgment of such Party, (A)&nbsp;violates any of its obligations with respect to
confidentiality, (B)&nbsp;is subject to any attorney-client, work-product or other legal privilege, (C)&nbsp;the disclosure of which would violate any Law or legal duty (<U>provided</U> that the withholding Party will use reasonable efforts to allow
such access or disclosure in a manner that does not result in loss or waiver of such privilege, including entering into appropriate common interest or similar agreements), or (D)&nbsp;will interfere with applicable operations of such Party&#146;s
(or its Subsidiaries&#146;) business; <U>provided</U>, <U>further</U>, that nothing herein shall authorize </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parent or its Representatives to undertake any environmental testing or sampling at any of the properties owned, operated or leased by the Company or its Subsidiaries and nothing herein shall
authorize the Company or its respective Representatives to undertake any environmental testing or sampling at any of the properties owned, operated or leased by Parent or its Subsidiaries. Each of Parent and the Company agrees that it will not, and
will cause its Representatives not to, use any information obtained pursuant to this <U>Section</U><U></U><U>&nbsp;5.3</U> for any competitive or other purpose unrelated to the consummation of the transactions contemplated by this Agreement (which
transactions shall include, with respect to Parent, the Financing). Each of the Company and Parent will use its commercially reasonable efforts to minimize any disruption to the businesses of the other Party that may result from requests for access.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Parties hereby agree that all information provided to them or their respective officers, directors, employees, agents and/or
representatives in connection with this Agreement and the consummation of the transactions contemplated hereby shall be governed in accordance with the confidential disclosure agreement, dated as of November&nbsp;13, 2020, by and between the Company
and Parent (the &#147;<U>Confidentiality Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Company No Solicitation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly permitted by this <U>Section</U><U></U><U>&nbsp;5.4</U>, the Company shall, and shall cause each of its Subsidiaries
to, and instruct its and their respective officers, directors, employees, agents, financial advisors, investment bankers, attorneys, accountants and other representatives (collectively, &#147;<U>Representatives</U>&#148;) to: (i)&nbsp;immediately
cease any solicitation, knowing encouragement, discussions or negotiations with any persons that may be ongoing with respect to a Company Takeover Proposal and (ii)&nbsp;from and after the date of this Agreement until the Effective Time or, if
earlier, the termination of this Agreement in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>, not, directly or indirectly, (A)&nbsp;solicit, initiate or knowingly facilitate or knowingly encourage any inquiries regarding, or the making of any
proposal or offer that constitutes, or would reasonably be expected to lead to, a Company Takeover Proposal, (B)&nbsp;engage in, continue or otherwise participate in any substantive discussions or negotiations regarding, or furnish to any other
person any <FONT STYLE="white-space:nowrap">non-public</FONT> information in connection with or for the purpose of encouraging or facilitating, a Company Takeover Proposal or (C)&nbsp;approve, recommend or enter into, or propose to approve,
recommend or enter into, any letter of intent or similar document, agreement, commitment, or agreement in principle providing for a Company Takeover Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as expressly provided by this Agreement, the Company shall not take any action to exempt any person from the restrictions on
&#147;business combinations&#148; contained in DGCL 203 or the Company Organizational Documents or otherwise cause such restrictions not to apply. Except (i)&nbsp;as necessary to take any actions that the Company or any third party would otherwise
be permitted to take pursuant to this <U>Section</U><U></U><U>&nbsp;5.4</U> (and in such case only in accordance with the terms hereof) or (ii)&nbsp;if the Company Board determines in good faith, after consultation with its outside financial
advisors and outside legal counsel, that any such action or forbearance would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law, (A)&nbsp;the Company and its Subsidiaries shall not release any third party from,
or waive, amend or modify any provision of, or grant permission under any (1)&nbsp;standstill provision in any agreement to which the Company or any of its Subsidiaries is a party or (2)&nbsp;confidentiality provision in any agreement to which the
Company or any of its Subsidiaries is a party (excluding any waiver under a confidentiality provision that does not, and would not reasonably be likely to, facilitate or encourage a Company Takeover Proposal) and (B)&nbsp;the Company shall, and
shall cause its Subsidiaries to, enforce the confidentiality and standstill provisions of any such agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding
anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;5.4</U>, if at any time from and after the date of this Agreement and prior to obtaining the Company Stockholder Approval, the Company, directly or indirectly receives a bona
fide, unsolicited written Company Takeover Proposal from any person that did not result from a material breach (or a deemed material breach) of this <U>Section</U><U></U><U>&nbsp;5.4</U> and if the Company Board determines in good faith, after
consultation with its outside financial advisors and outside legal counsel, that such Company Takeover Proposal constitutes or would reasonably be expected to lead to a Company Superior Proposal, and failure to take such action would reasonably be
expected to be inconsistent with its fiduciary duties </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under applicable Law, then the Company and its Representatives may, directly or indirectly, (i)&nbsp;furnish, pursuant to a Company Acceptable Confidentiality Agreement, information (including <FONT
STYLE="white-space:nowrap">non-public</FONT> information) with respect to the Company and its Subsidiaries, and afford access to the business, properties, assets, employees, officers, Contracts, books and records of the Company and its Subsidiaries,
to the person that has made such Company Takeover Proposal and its Representatives and potential sources of funding; <U>provided</U> that the Company shall substantially concurrently with the delivery to such person provide to Parent any <FONT
STYLE="white-space:nowrap">non-public</FONT> information concerning the Company or any of its Subsidiaries that is provided or made available to such person or its Representatives unless such <FONT STYLE="white-space:nowrap">non-public</FONT>
information has been previously provided or made available to Parent and (ii)&nbsp;engage in or otherwise participate in discussions or negotiations with the person making such Company Takeover Proposal (including as a part thereof, making
counterproposals) and its Representatives and potential sources of financing regarding such Company Takeover Proposal. &#147;<U>Company Acceptable Confidentiality Agreement</U>&#148; means any customary confidentiality agreement that contains
provisions that are no less favorable in the aggregate to the Company than those applicable to Parent that are contained in the Confidentiality Agreement; <U>provided</U> that such confidentiality agreement shall not prohibit compliance by the
Company with any of the provisions of this <U>Section</U><U></U><U>&nbsp;5.4</U>. Notwithstanding anything to the contrary in this Agreement, (A)&nbsp;the Company may grant a waiver, amendment or release under any confidentiality agreement,
standstill agreement or similar agreement to the extent necessary to allow a Company Takeover Proposal to be made to the Company or the Company Board (or any committee thereof), and (B)&nbsp;the Parties agree that, by execution of this Agreement,
the Company shall be deemed to have waived, as of immediately prior to the execution and delivery of this Agreement, any provision in any such agreement to the extent necessary to allow the applicable counterparty to convey a Company Takeover
Proposal to the Company or the Company Board (or any committee thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company shall promptly (and in no event later than 24
hours after receipt) notify, orally and in writing, Parent of any Company Takeover Proposal received by the Company or any of its Representatives, which notice shall include the identity of the person making the Company Takeover Proposal and the
material terms and conditions thereof (including copies of any written proposal relating thereto provided to the Company or any of its Representatives) and indicate whether the Company has furnished <FONT STYLE="white-space:nowrap">non-public</FONT>
information to, or entered into discussions or negotiations with, such third party. The Company shall keep Parent reasonably informed on a reasonably current basis as to the status of (including changes to any material terms of, and any other
material developments with respect to) such Company Takeover Proposal. The Company agrees that it and its Subsidiaries will not enter into any agreement with any person subsequent to the date of this Agreement which prohibits the Company from
providing any information to Parent in accordance with this <U>Section</U><U></U><U>&nbsp;5.4</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Except as expressly permitted by
this <U>Section</U><U></U><U>&nbsp;5.4(e)</U>, the Company Board shall not: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;fail to include the Company
Recommendation in the Joint Proxy Statement/Prospectus, (B)&nbsp;change, qualify, withhold, withdraw or modify, or authorize or publicly propose to change, qualify, withhold, withdraw or modify, in a manner adverse to Parent, the Company
Recommendation, (C)&nbsp;make or publicly propose to make any recommendation in connection with a tender offer or exchange offer other than a recommendation against such offer (it being understood that the Company Board may refrain from taking a
position with respect to such a tender offer or exchange offer until the close of business as of the 10th Business Day after the commencement of such tender offer or exchange offer pursuant to
<FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the Exchange Act without such action being considered a Company Adverse Recommendation Change so long as the Company reaffirms the Company Recommendation during such period), or
(D)&nbsp;other than with respect to the period of up to 10 Business Days applicable to formal tender or exchange offers that are the subject of the preceding clause&nbsp;(C), fail to recommend against a Company Takeover Proposal or fail to reaffirm
the Company Recommendation, in either case within five Business Days after a request by Parent to do so; <U>provided</U>, <U>however</U>, that (1)&nbsp;such five Business Day period shall be extended for an additional five Business Days following
any material modification to any Company Takeover Proposal occurring after the receipt of Parent&#146;s written request and (2)&nbsp;Parent shall be entitled to make such a written request for reaffirmation only once for each Company Takeover
Proposal and once for each material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
amendment to such Company Takeover Proposal; (any action described in this clause&nbsp;(i) being referred to as a &#147;<U>Company Adverse Recommendation Change</U>&#148;); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) authorize, cause or permit the Company or any of its Subsidiaries to enter into any letter of intent, agreement,
commitment or agreement in principle providing for any Company Takeover Proposal (other than a Company Acceptable Confidentiality Agreement entered into in accordance with <U>Section</U><U></U><U>&nbsp;5.4(c)</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary set forth in this Agreement, prior to the time the Company Stockholder Approval is obtained, after
receiving a bona fide unsolicited written Company Takeover Proposal that did not result from a material breach (or a deemed material breach) of <U>Section</U><U></U><U>&nbsp;5.4</U>, (x)&nbsp;the Company Board may make a Company Adverse
Recommendation Change if the Company Board has determined in good faith, after consultation with its outside financial advisors and outside legal counsel, that (i)&nbsp;such Company Takeover Proposal constitutes a Company Superior Proposal and
(ii)&nbsp;in light of such Company Takeover Proposal, the failure to take such action would reasonably be expected to be inconsistent with the Company Board&#146;s fiduciary duties under applicable Law and/or (y)&nbsp;the Company may terminate this
Agreement in order to enter into a binding written agreement with respect to a Company Superior Proposal in accordance with <U>Section</U><U></U><U>&nbsp;7.1(k)</U>; <U>provided</U> that the Company Board has determined in good faith, after
consultation with its outside financial advisors and outside legal counsel, that failure to take such action would reasonably be expected to be inconsistent with the Company Board&#146;s fiduciary duties under applicable Law; <U>provided</U>,
<U>however</U>, that, prior to making any Company Adverse Recommendation Change or terminating this Agreement as described in clauses&nbsp;(x) and (y)&nbsp;of this sentence, (A)&nbsp;the Company has given Parent at least four Business Days&#146;
prior written notice of its intention to take such action (which notice shall specify the material terms and conditions of any such Company Superior Proposal) and has contemporaneously provided to Parent a copy of the Company Superior Proposal and a
copy of any written proposed transaction documents with the person making such Company Superior Proposal, (B)&nbsp;the Company has negotiated in good faith with Parent during such notice period, to the extent Parent wishes to negotiate in good
faith, to enable Parent to propose revisions to the terms of this Agreement such that it would cause such Company Superior Proposal to no longer constitute a Company Superior Proposal, (C)&nbsp;following the end of such notice period, the Company
Board shall have considered in good faith any revisions to the terms of this Agreement proposed in writing by Parent, and shall have determined, after consultation with its outside financial advisors and outside legal counsel, that the Company
Superior Proposal continues to constitute a Company Superior Proposal if the revisions proposed by Parent were to be given effect, and (D)&nbsp;in the event of any change to any material terms of such Company Superior Proposal, the Company shall, in
each case, have delivered to Parent an additional notice consistent with that described in clause&nbsp;(A) above of this proviso and a new notice period under clause&nbsp;(A) of this proviso shall commence (except that the four Business Day notice
period referred to in clause&nbsp;(A) above of this proviso shall instead be equal to the longer of (i)&nbsp;three Business Days and (ii)&nbsp;the period remaining under the notice period under clause&nbsp;(A) of this proviso immediately prior to
the delivery of such additional notice under this clause&nbsp;(D)) during which time the Company shall be required to comply with the requirements of this <U>Section</U><U></U><U>&nbsp;5.4(e)</U> anew with respect to such additional notice,
including clauses&nbsp;(A) through (D)&nbsp;above of this proviso. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Other than in connection with a Company Superior Proposal (which
shall be subject to <U>Section</U><U></U><U>&nbsp;5.4(e)</U> and shall not be subject to this <U>Section</U><U></U><U>&nbsp;5.4(f)</U>), nothing in this Agreement shall prohibit or restrict the Company Board from making a Company Adverse
Recommendation Change in response to a Company Intervening Event if the Company Board has determined in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure of the Company Board to make a
Company Adverse Recommendation Change would be inconsistent with the Company Board&#146;s fiduciary duties under applicable Law; <U>provided</U>, <U>however</U>, that, prior to making such Company Adverse Recommendation Change, (i)&nbsp;the Company
has given Parent at least four Business Days&#146; prior written notice of its intention to take such action, which notice shall specify the reasons therefor, (ii)&nbsp;the Company has negotiated, and directed its Representatives to negotiate, in
good faith with Parent during such notice period after giving any such notice, to the extent Parent wishes to negotiate, to enable Parent to propose revisions to the terms of this Agreement such that it would not permit the Company Board to make a
Company Adverse Recommendation Change pursuant to this <U>Section</U><U></U><U>&nbsp;5.4(f)</U> and (iii)&nbsp;following the end of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notice period, the Company Board shall have considered in good faith any revisions to the terms of this Agreement proposed in writing by Parent, and shall have determined, after consultation with
its outside financial advisors and outside legal counsel, that failure to make a Company Adverse Recommendation Change in response to such Company Intervening Event would be inconsistent with the Company Board&#146;s fiduciary duties under
applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Nothing contained in this <U>Section</U><U></U><U>&nbsp;5.4</U> shall prohibit the Company or the Company Board from
taking and disclosing to the stockholders of the Company a position contemplated by <FONT STYLE="white-space:nowrap">Rule&nbsp;14e-2(a)</FONT> or Rule&nbsp;14d-9 promulgated under the Exchange Act or from making any &#147;stop, look and listen&#148;
communication or any other similar disclosure to the stockholders of the Company pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the Exchange Act if, in the determination in good faith of the Company Board, after
consultation with outside counsel, the failure so to disclose would reasonably be expected to be inconsistent with the fiduciary duties under applicable Law or obligations under applicable federal securities Law of the Company Board so long as such
communication <FONT STYLE="white-space:nowrap">re-affirms</FONT> the Company Recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Any action taken or omission made by any
Representative of the Company or any of its Affiliates that, if taken or made by the Company would be a breach of this <U>Section</U><U></U><U>&nbsp;5.4</U>, shall be deemed to be a breach of this <U>Section</U><U></U><U>&nbsp;5.4</U> by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Parent No Solicitation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly permitted by this <U>Section</U><U></U><U>&nbsp;5.5</U>, Parent shall, and shall cause each of its Subsidiaries to,
and instruct its and their respective Representatives to: (i)&nbsp;immediately cease any solicitation, knowing encouragement, discussions or negotiations with any persons that may be ongoing with respect to a Parent Takeover Proposal and
(ii)&nbsp;from and after the date of this Agreement until the Effective Time or, if earlier, the termination of this Agreement in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>, not, directly or indirectly, (A)&nbsp;solicit, initiate or
knowingly facilitate or knowingly encourage any inquiries regarding, or the making of any proposal or offer that constitutes, or would reasonably be expected to lead to, a Parent Takeover Proposal, (B)&nbsp;engage in, continue or otherwise
participate in any substantive discussions or negotiations regarding, or furnish to any other person any <FONT STYLE="white-space:nowrap">non-public</FONT> information in connection with or for the purpose of encouraging or facilitating, a Parent
Takeover Proposal or (C)&nbsp;approve, recommend or enter into, or propose to approve, recommend or enter into, any letter of intent or similar document, agreement, commitment, or agreement in principle providing for a Parent Takeover Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as expressly provided by this Agreement, Parent shall not take any action to exempt any person from the restrictions on
&#147;business combinations&#148; contained in Subchapter&nbsp;F of Chapter 25 of Pennsylvania Law or the Parent Organizational Documents or otherwise cause such restrictions not to apply. Except (i)&nbsp;as necessary to take any actions that Parent
or any third party would otherwise be permitted to take pursuant to this <U>Section</U><U></U><U>&nbsp;5.5</U> (and in such case only in accordance with the terms hereof) or (ii)&nbsp;if the Parent Board determines in good faith, after consultation
with its outside financial advisors and outside legal counsel, that any such action or forbearance would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law, (A)&nbsp;Parent and its Subsidiaries shall not release
any third party from, or waive, amend or modify any provision of, or grant permission under any (1)&nbsp;standstill provision in any agreement to which Parent or any of its Subsidiaries is a party or (2)&nbsp;confidentiality provision in any
agreement to which Parent or any of its Subsidiaries is a party (excluding any waiver under a confidentiality provision that does not, and would not reasonably be likely to, facilitate or encourage a Parent Takeover Proposal) and (B)&nbsp;Parent
shall, and shall cause its Subsidiaries to, enforce the confidentiality and standstill provisions of any such agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)
Notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;5.5</U>, if at any time from and after the date of this Agreement and prior to obtaining the Parent Stockholder Approval, Parent, directly or indirectly
receives a bona fide, unsolicited written Parent Takeover Proposal from any person that did not result from a material breach (or a deemed material breach) of this <U>Section</U><U></U><U>&nbsp;5.5</U> and if the Parent Board determines in good
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
faith, after consultation with its outside financial advisors and outside legal counsel, that such Parent Takeover Proposal constitutes or would reasonably be expected to lead to a Parent
Superior Proposal, and failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law, then Parent and its Representatives may, directly or indirectly, (i)&nbsp;furnish, pursuant to a
Parent Acceptable Confidentiality Agreement, information (including <FONT STYLE="white-space:nowrap">non-public</FONT> information) with respect to Parent and its Subsidiaries, and afford access to the business, properties, assets, employees,
officers, Contracts, books and records of Parent and its Subsidiaries, to the person that has made such Parent Takeover Proposal and its Representatives and potential sources of funding; <U>provided</U> that Parent shall substantially concurrently
with the delivery to such person provide to the Company any <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning Parent or any of its Subsidiaries that is provided or made available to such person or its Representatives unless
such <FONT STYLE="white-space:nowrap">non-public</FONT> information has been previously provided or made available to the Company and (ii)&nbsp;engage in or otherwise participate in discussions or negotiations with the person making such Parent
Takeover Proposal (including as a part thereof, making counterproposals) and its Representatives and potential sources of financing regarding such Parent Takeover Proposal. &#147;<U>Parent Acceptable Confidentiality Agreement</U>&#148; means any
customary confidentiality agreement that contains provisions that are no less favorable in the aggregate to Parent than those applicable to the Company that are contained in the Confidentiality Agreement; <U>provided</U> that such confidentiality
agreement shall not prohibit compliance by Parent with any of the provisions of this <U>Section</U><U></U><U>&nbsp;5.5</U>. Notwithstanding anything to the contrary in this Agreement, (A)&nbsp;Parent may grant a waiver, amendment or release under
any confidentiality agreement, standstill agreement or similar agreement to the extent necessary to allow a Parent Takeover Proposal to be made to Parent or the Parent Board (or any committee thereof), and (B)&nbsp;the Parties agree that, by
execution of this Agreement, Parent shall be deemed to have waived, as of immediately prior to the execution and delivery of this Agreement, any provision in any such agreement to the extent necessary to allow the applicable counterparty to convey a
Parent Takeover Proposal to Parent or the Parent Board (or any committee thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Parent shall promptly (and in no event later than
24 hours after receipt) notify, orally and in writing, the Company of any Parent Takeover Proposal received by Parent or any of its Representatives, which notice shall include the identity of the person making the Parent Takeover Proposal and the
material terms and conditions thereof (including copies of any written proposal relating thereto provided to Parent or any of its Representatives) and indicate whether Parent has furnished <FONT STYLE="white-space:nowrap">non-public</FONT>
information to, or entered into discussions or negotiations with, such third party. Parent shall keep the Company reasonably informed on a reasonably current basis as to the status of (including changes to any material terms of, and any other
material developments with respect to) such Parent Takeover Proposal. Parent agrees that it and its Subsidiaries will not enter into any agreement with any person subsequent to the date of this Agreement which prohibits Parent from providing any
information to the Company in accordance with this <U>Section</U><U></U><U>&nbsp;5.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Except as expressly permitted by this
<U>Section</U><U></U><U>&nbsp;5.5(e)</U>, the Parent Board shall not: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;(A) fail to include the Parent
Recommendation in the Joint Proxy Statement/Prospectus, (B)&nbsp;change, qualify, withhold, withdraw or modify, or authorize or publicly propose to change, qualify, withhold, withdraw or modify, in a manner adverse to the Company, the Parent
Recommendation, (C)&nbsp;make or publicly propose to make any recommendation in connection with a tender offer or exchange offer other than a recommendation against such offer (it being understood that the Parent Board may refrain from taking a
position with respect to such a tender offer or exchange offer until the close of business as of the 10th Business Day after the commencement of such tender offer or exchange offer pursuant to
<FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the Exchange Act without such action being considered a Parent Adverse Recommendation Change so long as Parent reaffirms the Parent Recommendation during such period), or
(D)&nbsp;other than with respect to the period of up to 10&nbsp;Business Days applicable to formal tender or exchange offers that are the subject of the preceding clause&nbsp;(C), fail to recommend against a Parent Takeover Proposal or fail to
reaffirm the Parent Recommendation, in either case within five Business Days after a request by the Company to do so; <U>provided</U>, <U>however</U>, that (1)&nbsp;such five Business Day period shall be extended for an additional five Business Days
following any material modification to any Parent Takeover Proposal occurring after the receipt of the Company&#146;s written request and (2)&nbsp;the Company shall be entitled to make such a written request for
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reaffirmation only once for each Parent Takeover Proposal and once for each material amendment to such Parent Takeover Proposal (any action described in this clause&nbsp;(i) being referred to as
a &#147;<U>Parent Adverse Recommendation Change</U>&#148;); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) authorize, cause or permit Parent or any of its
Subsidiaries to enter into any letter of intent, agreement, commitment or agreement in principle providing for any Parent Takeover Proposal (other than a Parent Acceptable Confidentiality Agreement entered into in accordance with
<U>Section</U><U></U><U>&nbsp;5.5(c)</U>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary set forth in this Agreement, prior to the time the
Parent Stockholder Approval is obtained, after receiving a bona fide unsolicited written Parent Takeover Proposal that did not result from a material breach (or a deemed material breach) of this <U>Section</U><U></U><U>&nbsp;5.5</U>, (x)&nbsp;the
Parent Board may make a Parent Adverse Recommendation Change if the Parent Board has determined in good faith, after consultation with its outside financial advisors and outside legal counsel, that (i)&nbsp;such Parent Takeover Proposal constitutes
a Parent Superior Proposal and (ii)&nbsp;in light of such Parent Takeover Proposal, the failure to take such action would reasonably be expected to be inconsistent with the Parent Board&#146;s fiduciary duties under applicable Law and/or
(y)&nbsp;the Parent may terminate this Agreement in order to enter into a binding written agreement with respect to a Parent Superior Proposal in accordance with <U>Section</U><U></U><U>&nbsp;7.1(j)</U>; <U>provided</U> that the Parent Board has
determined in good faith, after consultation with its outside financial advisors and outside legal counsel, that failure to take such action would reasonably be expected to be inconsistent with the Parent Board&#146;s fiduciary duties under
applicable Law; <U>provided</U>, <U>however</U>, that, prior to making any Parent Adverse Recommendation Change or terminating this Agreement as described in clauses&nbsp;(x) and (y)&nbsp;of this sentence, (A)&nbsp;Parent has given the Company at
least four Business Days&#146; prior written notice of its intention to take such action (which notice shall specify the material terms and conditions of any such Parent Superior Proposal) and has contemporaneously provided to the Company a copy of
the Parent Superior Proposal and a copy of any written proposed transaction documents with the person making such Parent Superior Proposal, (B)&nbsp;Parent has negotiated in good faith with the Company during such notice period, to the extent the
Company wishes to negotiate in good faith, to enable the Company to propose revisions to the terms of this Agreement such that it would cause such Parent Superior Proposal to no longer constitute a Parent Superior Proposal, (C)&nbsp;following the
end of such notice period, the Parent Board shall have considered in good faith any revisions to the terms of this Agreement proposed in writing by the Company, and shall have determined, after consultation with its outside financial advisors and
outside legal counsel, that the Parent Superior Proposal continues to constitute a Parent Superior Proposal if the revisions proposed by the Company were to be given effect, and (D)&nbsp;in the event of any change to any material terms of such
Parent Superior Proposal, Parent shall, in each case, have delivered to the Company an additional notice consistent with that described in clause&nbsp;(A) above of this proviso and a new notice period under clause&nbsp;(A) of this proviso shall
commence (except that the four Business Day notice period referred to in clause&nbsp;(A) above of this proviso shall instead be equal to the longer of (i)&nbsp;three Business Days and (ii)&nbsp;the period remaining under the notice period under
clause&nbsp;(A) of this proviso immediately prior to the delivery of such additional notice under this clause&nbsp;(D)) during which time Parent shall be required to comply with the requirements of this <U>Section</U><U></U><U>&nbsp;5.5(e)</U> anew
with respect to such additional notice, including clauses&nbsp;(A) through (D)&nbsp;above of this proviso. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Other than in connection
with a Parent Superior Proposal (which shall be subject to <U>Section</U><U></U><U>&nbsp;5.5(e)</U> and shall not be subject to this <U>Section</U><U></U><U>&nbsp;5.5(f)</U>), nothing in this Agreement shall prohibit or restrict the Parent Board
from making a Parent Adverse Recommendation Change in response to a Parent Intervening Event if the Parent Board has determined in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure of the
Parent Board to make a Parent Adverse Recommendation Change would be inconsistent with the Parent Board&#146;s fiduciary duties under applicable Law; <U>provided</U>, <U>however</U>, that, prior to making such Parent Adverse Recommendation Change,
(i)&nbsp;Parent has given the Company at least four Business Days&#146; prior written notice of its intention to take such action, which notice shall specify the reasons therefor, (ii)&nbsp;Parent has negotiated, and directed its Representatives to
negotiate, in good faith with the Company during such notice period after giving any such notice, to the extent the Company wishes to negotiate, to enable the Company to propose revisions to the terms of this Agreement such that it would not permit
the Parent Board to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
make a Parent Adverse Recommendation Change pursuant to this <U>Section</U><U></U><U>&nbsp;5.5(f)</U> and (iii)&nbsp;following the end of such notice period, the Parent Board shall have
considered in good faith any revisions to the terms of this Agreement proposed in writing by the Company, and shall have determined, after consultation with its outside financial advisors and outside legal counsel, that failure to make a Parent
Adverse Recommendation Change in response to such Parent Intervening Event would be inconsistent with the Parent Board&#146;s fiduciary duties under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Nothing contained in this <U>Section</U><U></U><U>&nbsp;5.5</U> shall prohibit Parent or the Parent Board from taking and disclosing to
the stockholders of Parent a position contemplated by <FONT STYLE="white-space:nowrap">Rule&nbsp;14e-2(a)</FONT> or Rule&nbsp;14d-9 promulgated under the Exchange Act or from making any &#147;stop, look and listen&#148; communication or any other
similar disclosure to the stockholders of Parent pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the Exchange Act if, in the determination in good faith of the Parent Board, after consultation with outside counsel, the
failure so to disclose would reasonably be expected to be inconsistent with the fiduciary duties under applicable Law or obligations under applicable federal securities Law of the Parent Board so long as such communication <FONT
STYLE="white-space:nowrap">re-affirms</FONT> the Parent Recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Any action taken or omission made by any Representative of
Parent or any of its Affiliates that, if taken or made by Parent would be a breach of this <U>Section</U><U></U><U>&nbsp;5.5</U>, shall be deemed to be a breach of this <U>Section</U><U></U><U>&nbsp;5.5</U> by Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Filings; Other Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As promptly as reasonably practicable following the date of this Agreement and in any event within 45 days after the date of this
Agreement, Parent and the Company shall prepare and file with the SEC the Form S-4, which will include the Joint Proxy Statement/Prospectus. Each of Parent and the Company shall use its respective reasonable best efforts to have the Form S-4
declared effective under the Securities Act as promptly as reasonably practicable after such filing and to keep the Form S-4 effective as long as necessary to consummate the Merger and the other transactions contemplated hereby in accordance
herewith. Parent and the Company shall each use their respective reasonable best efforts to cause the Form S-4 to comply as to form in all material respects with the applicable provisions of the Securities Act, the Exchange Act and other applicable
Laws. Each of Parent and the Company will cause the Joint Proxy Statement/Prospectus to be mailed to its respective stockholders, as applicable, as soon as reasonably practicable after the Form S-4 is declared effective by the SEC under the
Securities Act. Parent shall use its reasonable best efforts, and the Company shall reasonably cooperate with Parent, to keep the Form S-4 effective through the Closing in order to permit the consummation of the transactions contemplated by this
Agreement, including the Merger and the Share Issuance. Parent shall also take any action required to be taken under any applicable state securities Laws in connection with the issuance and reservation of shares of Parent Common Stock in the Merger,
and the Company shall furnish all information concerning the Company and the holders of Company Common Stock, or holders of a beneficial interest therein, as may be reasonably requested by Parent in connection with any such action. No filing or
mailing of, or amendment or supplement to the Form S-4 or the Joint Proxy Statement/Prospectus will be made by Parent or the Company, as applicable, without the other&#146;s prior consent (which shall not be unreasonably withheld, conditioned or
delayed) and without providing the other Party a reasonable opportunity to review and comment thereon (which comments shall be considered by the other Party in good faith); <U>provided</U>, <U>however</U>, that the Company, in connection with a
Company Adverse Recommendation Change, a Company Takeover Proposal or a Company Superior Proposal may amend or supplement the Joint Proxy Statement/Prospectus and/or the Form S-4 (including by incorporation by reference) pursuant to a Company
Qualifying Amendment, and in such event, this right of approval shall apply only with respect to information relating to Parent or its business, financial condition or results of operations; <U>provided</U>, <U>further</U>, <U>however</U>, that
Parent, in connection with a Parent Adverse Recommendation Change, a Parent Takeover Proposal or a Parent Superior Proposal may amend or supplement the Joint Proxy Statement/Prospectus and/or the Form S-4 (including by incorporation by reference)
pursuant to a Parent Qualifying Amendment, and in such event, this right of approval shall apply only with respect to information relating to the Company or its business, financial condition or results of operations. A &#147;<U>Company</U>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Qualifying Amendment</U>&#148; means an amendment or supplement to the Form S-4 or the Joint Proxy Statement/Prospectus (including by incorporation by reference) to the extent it contains
(i)&nbsp;a Company Adverse Recommendation Change, (ii)&nbsp;a statement of the reason of the Board of Directors of the Company for making such Company Adverse Recommendation Change, (iii)&nbsp;a factually accurate statement by the Company that
describes the Company&#146;s receipt of a Company Takeover Proposal or Company Superior Proposal, the terms of such proposal and the operation of this Agreement with respect thereto, and (iv)&nbsp;additional information reasonably related to the
foregoing. A &#147;<U>Parent Qualifying Amendment</U>&#148; means an amendment or supplement to the Form S-4 or the Joint Proxy Statement/Prospectus (including by incorporation by reference) to the extent it contains (A)&nbsp;a Parent Adverse
Recommendation Change, (B)&nbsp;a statement of the reason of the Parent Board for making such Parent Adverse Recommendation Change, (C)&nbsp;a factually accurate statement by Parent that describes Parent&#146;s receipt of a Parent Takeover Proposal
or Parent Superior Proposal, the terms of such proposal and the operation of this Agreement with respect thereto, and (D)&nbsp;additional information reasonably related to the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company and Parent shall promptly notify the other upon the receipt of any comments from the SEC or any request from the SEC
for amendments or supplements to the Form S-4 or Joint Proxy Statement/Prospectus, and shall, as promptly as practicable after receipt thereof, provide the other with copies of all written correspondence between it and its Representatives, on one
hand, and the SEC, on the other hand, and all written comments with respect to the Joint Proxy Statement/Prospectus or the Form S-4 and advise the other Party of any oral comments with respect to the Joint Proxy Statement/Prospectus or the <FONT
STYLE="white-space:nowrap">Form&nbsp;S-4.</FONT> Each of the Company and Parent shall use its reasonable best efforts to respond as promptly as practicable to any comments from the SEC with respect to the Joint Proxy Statement/Prospectus, and Parent
shall use its reasonable best efforts to respond as promptly as practicable to any comment from the SEC with respect to the Form <FONT STYLE="white-space:nowrap">S-4.</FONT> Parent or the Company, as applicable, will advise the other promptly after
it receives oral or written notice of the time when the Form&nbsp;S-4 has become effective or any supplement or amendment thereto has been filed, the threat or issuance of any stop order, the suspension of the qualification of the shares of Parent
Common Stock issuable in connection with the Merger for offering or sale in any jurisdiction, or any oral or written request by the SEC for amendment of the Joint Proxy Statement/Prospectus or the Form&nbsp;S-4 or comments thereon and responses
thereto or requests by the SEC for additional information, and will promptly provide the other with copies of any written communication from the SEC or any state securities commission. None of the Parties or their respective Representatives shall
agree to participate in any material or substantive meeting or conference (including by telephone) with the SEC, or any member of the staff thereof, in respect of the Form&nbsp;S-4 or the Joint Proxy Statement/Prospectus unless it consults with the
other Party in advance and, to the extent permitted by the SEC, allows the other Party to participate. Each of the Parties shall use its respective reasonable best efforts to take any other action required to be taken by it under the Securities Act,
the Exchange Act, the DGCL, Pennsylvania Law and the rules of Nasdaq in connection with the filing and distribution of the Joint Proxy Statement/Prospectus and the Form S-4, and the solicitation of proxies from the stockholders of each of the
Company and Parent thereunder. If at any time prior to the Effective Time any information relating to Parent or the Company, or any of their respective Affiliates, officers or directors, is discovered by Parent or the Company which should be set
forth in an amendment or supplement to any of the Form S-4 or the Joint Proxy Statement/Prospectus, so that any of such documents would not include a misstatement of a material fact or omit to state any material fact necessary to make the statements
therein (in light of the circumstances under which they were made), not misleading, the Party that discovers such information shall promptly notify the other Parties and an appropriate amendment or supplement describing such information shall be
promptly filed with the SEC and, to the extent required by Law, disseminated to the stockholders of the Company. At the Company&#146;s request, Parent shall reasonably cooperate in amending or supplementing the Joint Proxy Statement/Prospectus
pursuant to a Company Qualifying Amendment made in compliance with this Agreement. At Parent&#146;s request, the Company shall reasonably cooperate in amending or supplementing the Joint Proxy Statement/Prospectus pursuant to a Parent Qualifying
Amendment made in compliance with this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As promptly as reasonably practicable following the clearance of the Joint Proxy
Statement/Prospectus by the SEC and in any event within 45 days thereafter, the Company shall take all action necessary in accordance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with applicable Laws and the Company Organizational Documents to duly give notice of, convene and hold a meeting of its stockholders for the purpose of obtaining the Company Stockholder Approval
and holding the Company Stockholder Advisory Vote (the &#147;<U>Company Stockholders</U><U>&#146;</U><U> Meeting</U>&#148;) and not postpone or adjourn the Company Stockholders&#146; Meeting without the prior written consent of Parent (not to be
unreasonably withheld, conditioned, or delayed) except (i)&nbsp;to the extent required by applicable Law, or (ii)&nbsp;to solicit additional proxies or votes in favor of adoption of this Agreement if sufficient votes to constitute the Company
Stockholder Approval have not been obtained; <U>provided</U> that unless otherwise agreed by the parties, the Company Stockholders&#146; Meeting may not be postponed or adjourned to a date that is more than 10 days after the date for which the then
most-recent Company Stockholders&#146; Meeting was scheduled (excluding any adjournments or postponements required by applicable Law). The Company will, except in the case of a Company Adverse Recommendation Change, through the Company Board,
recommend that its stockholders adopt this Agreement and will use reasonable best efforts to solicit from its stockholders proxies in favor of the adoption of this Agreement and to take all other action necessary or advisable to secure the vote or
consent of its stockholders required by the rules of Nasdaq or applicable Laws to obtain such approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) As promptly as reasonably
practicable following the clearance of the Joint Proxy Statement/Prospectus by the SEC and in any event within 45 days thereafter, Parent shall take all action necessary in accordance with applicable Laws and Parent&#146;s Amended and Restated
Articles of Incorporation and Amended and Restated Bylaws to duly give notice of, convene and hold the Parent Stockholders&#146; Meeting for the purpose of obtaining the Parent Stockholder Approval and not postpone or adjourn the Parent
Stockholders&#146; Meeting without the prior written consent of the Company (not to be unreasonably withheld, conditioned, or delayed) except (i)&nbsp;to the extent required by applicable Law, or (ii)&nbsp;to solicit additional proxies and votes in
favor of the Share Issuance if sufficient votes to constitute the Parent Stockholder Approval have not been obtained; <U>provided</U> that unless otherwise agreed by the parties, the Parent Stockholders&#146; Meeting may not be postponed or
adjourned to a date that is more than 10 days after the date for which the then most-recent Parent Stockholders&#146; Meeting was scheduled (excluding any adjournments or postponements required by applicable Law). Parent will, except in the case of
a Parent Adverse Recommendation Change, through the Parent Board, recommend that its stockholders approve the Share Issuance and will use reasonable best efforts to solicit from its stockholders proxies in favor of the Share Issuance and to take all
other action necessary or advisable to secure the vote or consent of its stockholders required by the rules of Nasdaq or applicable Laws to obtain such approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company and Parent will use their respective reasonable best efforts to hold the Company Stockholders&#146; Meeting and the Parent
Stockholders&#146; Meeting on the same date and at the same time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Parent shall use its reasonable best efforts to cause the shares of
Parent Common Stock to be issued in the Merger to be approved for listing on Nasdaq, subject to official notice of issuance, prior to the Closing Date. Parent shall cause the Company&#146;s securities to be
<FONT STYLE="white-space:nowrap">de-listed</FONT> from Nasdaq and <FONT STYLE="white-space:nowrap">de-registered</FONT> under the Exchange Act as promptly as practicable following the Effective Time. Parent shall also use its reasonable best efforts
to obtain all necessary state securities law or &#147;blue sky&#148; permits and approvals required to carry out the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Each of the Company and Parent shall, upon request, furnish to the other all information concerning itself, its Subsidiaries, directors,
officers and (to the extent reasonably available to the applicable Party) stockholders and such other matters as may be reasonably necessary or advisable in connection with any statement, filing, notice or application made by or on behalf of the
Company, Parent or any of their respective Subsidiaries, to the SEC or Nasdaq in connection with the transactions contemplated by this Agreement, including the Form S-4 and the Joint Proxy Statement/Prospectus. In addition, each of the Company and
Parent shall use its reasonable best efforts to provide information concerning it necessary to enable the Company and Parent to prepare required pro forma financial statements and related footnotes in connection with the preparation of the Form S-4
and/or the Joint Proxy Statement/Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Regulatory Approvals; Efforts; Third-Party Consents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, prior to the Closing, Parent, Merger Sub and the Company shall take, or cause to be
taken, all actions, and do, or cause to be done, all things necessary, proper or advisable under this Agreement and any applicable Antitrust Laws, including the HSR Act, to consummate and make effective, as promptly as practicable after the date
hereof and in any event prior to the End Date, the Mergers, including (A)&nbsp;preparing and filing all documentation to effect all necessary and advisable filings, notifications, notices, petitions, statements, registrations, submissions of
information, applications and other documents (including any required or recommended filings under applicable Antitrust Laws) that are or may become necessary, proper or advisable in connection with the consummation of the transactions contemplated
by this Agreement, (B)&nbsp;satisfying the conditions to consummating the Merger, (C)&nbsp;defending any lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the transactions
contemplated by this Agreement, including seeking to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reversed, (D)&nbsp;taking all actions necessary to obtain (and cooperating with each other
in obtaining) as promptly as practicable any consent, authorization, Order or approval of, or any exemption by, or to avoid an investigation, action, proceeding or other challenge of the legality of the transactions contemplated by this Agreement
by, any Governmental Entity required to be obtained or made by Parent, Merger Sub, the Company or any of their respective Subsidiaries in connection with the Mergers or the taking of any action contemplated by this Agreement (collectively,
&#147;<U>Regulatory Approvals</U>&#148;), and (E)&nbsp;executing and delivering any additional instruments necessary to consummate the Merger and to fully carry out the purposes of this Agreement. Additionally, each of Parent, Merger Sub and the
Company and any of their respective Affiliates shall not take any action after the date of this Agreement that would reasonably be expected to (i)&nbsp;impose any material delay in the obtaining of, or materially increase the risk of not obtaining,
the expiration, termination or waiver of any applicable waiting period pursuant to the HSR Act, or any other Regulatory Approval necessary to consummate the transactions contemplated hereby, (ii)&nbsp;materially increase the risk of any Governmental
Entity entering an injunction or Order prohibiting the consummation of the transactions contemplated hereby or (iii)&nbsp;materially increase the risk of not being able to remove any such injunction or Order on appeal or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In furtherance and not in limitation of, and in addition to, the provisions of <U>Section</U><U></U><U>&nbsp;5.7(a)</U>, each Party shall
file, as soon as practicable and advisable after the date of this Agreement, all notices, reports and other documents required to be filed by such party with any Governmental Entity with respect to the Merger and the other transactions contemplated
by this Agreement, and shall submit as promptly as reasonably practicable any additional information requested by any such Governmental Entity. Without limiting the generality of the foregoing, each of Parent and the Company shall, in consultation
and cooperation with the other: (i)&nbsp;within 10&nbsp;Business Days after the date of this Agreement (or such other date as may be mutually agreed to by Parent and the Company), prepare and file the notifications required under the HSR Act; and
(ii)&nbsp;as promptly as practicable and advisable after the date of this Agreement, but in no event later than as required by applicable Antitrust Laws, prepare and file, or <FONT STYLE="white-space:nowrap">pre-file</FONT> with regard to any
Governmental Entity that requires such <FONT STYLE="white-space:nowrap">pre-filing</FONT> prior to any formal filing of, all other notifications required under any other Antitrust Laws. Parent and the Company shall respond as promptly as reasonably
practicable to any inquiries or requests for additional information or documentary material received from any state attorney general, antitrust authority or other Governmental Entity in connection with antitrust or related matters. Neither Party
shall extend any waiting period under the HSR Act or other Antitrust Laws without, or enter into any agreement with the Federal Trade Commission or the United States Department of Justice or any other Governmental Entity that would restrain, delay
or prevent the consummation of the transactions contemplated by this Agreement except with, the prior written consent of the other Parties (which shall not be unreasonably withheld, conditioned or delayed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the generality of Parent&#146;s and the Company&#146;s undertakings pursuant to <U>Section</U><U></U><U>&nbsp;5.7(a)</U>,
Parent and its Affiliates shall take any and all steps and agree to any and all regulatory remedies or commitments necessary to avoid or eliminate each and every impediment under any applicable Antitrust Laws that may be asserted by any Governmental
Entity so as to enable the Parties to close the Merger as promptly as practicable, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and in any event prior to the End Date. Notwithstanding the foregoing or anything to the contrary herein, with respect to any impediment under any applicable Antitrust Law that may be asserted by
the People&#146;s Republic of China or any of its related Governmental Entities, none of Parent and its Affiliates shall be required to take any steps or agree to (and the Company and its Affiliates shall not without Parent&#146;s prior written
consent take any steps or agree to) any regulatory remedies or commitments relating to any <FONT STYLE="white-space:nowrap">Non-Overlap</FONT> Business (as defined below) to sell, divest, license, hold separate, or otherwise dispose of any assets,
material Intellectual Property, licenses, product lines, operations or businesses (including any that are used in or a component of any <FONT STYLE="white-space:nowrap">Non-Overlap</FONT> Business).
&#147;<U><FONT STYLE="white-space:nowrap">Non-Overlap</FONT> Business</U>&#148; means any business or operations of a Party or any of its Subsidiaries, but excluding any business or operations of a Party or any of its Subsidiaries to the extent it
competes in China with any business or operations of the other Party or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Parent and the Company shall each
keep the other apprised of the status of matters relating to the completion of the Merger and work cooperatively in connection with obtaining all required Regulatory Approvals undertaken or in the defending of any lawsuits or legal proceedings
challenging the consummation of the Merger pursuant to the provisions of this <U>Section</U><U></U><U>&nbsp;5.7</U>. In that regard, prior to the Closing, each Party shall (i)&nbsp;consult with the other in good faith prior to taking a position with
respect to any filing required or advisable under <U>Section</U><U></U><U>&nbsp;5.7(a)</U> and <U>Section</U><U></U><U>&nbsp;5.7(b)</U>; (ii)&nbsp;permit the other to review and discuss in advance, and consider in good faith the views of the other
in connection with, any analyses, appearances, presentations, memoranda, letters, responses to requests, briefs, white papers, arguments, opinions and proposals before making or submitting any of the foregoing to any Governmental Entity by or on
behalf of any party in connection with any such filing or any lawsuits or legal proceedings in connection with this Agreement or the transactions contemplated hereby; (iii)&nbsp;coordinate with the other in preparing and exchanging such information;
(iv)&nbsp;promptly provide the other party&#146;s counsel with copies of all filings, notices, analyses, presentations, memoranda, letters, responses to requests, briefs, white papers, opinions, proposals and other submissions (and a summary of any
oral presentations) made or submitted by such party with or to any Governmental Entity in connection with any filing required by <U>Section</U><U></U><U>&nbsp;5.7(a)</U> and <U>Section</U><U></U><U>&nbsp;5.7(b)</U> in connection with this Agreement
or the transactions contemplated hereby; and (v)&nbsp;consult with the other Party in advance of any meeting, video conference or teleconference with any Governmental Entity or, in connection with any proceeding by a private party seeking to delay
or prevent the consummation of the Merger, with respect to such party, and to the extent not prohibited by the Governmental Entity or applicable Law, give the other Party the opportunity to attend and participate in such meetings, video conferences
and teleconferences. Each Party shall furnish the other Party with copies of all correspondence, filings and communications (and memoranda setting forth the substance thereof) between it and any such Governmental Entity or third party with respect
to this Agreement and the Merger and furnish the other Party with such necessary information and reasonable assistance as the other Party may reasonably request in connection with its preparation of necessary filings or submissions of information to
any such Governmental Entity; <U>provided</U>, <U>however</U>, that materials provided pursuant to this <U>Section</U><U></U><U>&nbsp;5.7</U> may be redacted (i)&nbsp;to remove references concerning the valuation of the Company and the Merger or
other confidential information, (ii)&nbsp;as necessary to comply with contractual arrangements, and (iii)&nbsp;as necessary to address reasonable privilege concerns, and the Parties may reasonably designate any competitively sensitive or any
confidential business material provided to the other under this <U>Section</U><U></U><U>&nbsp;5.7(d)</U> as &#147;counsel only&#148; or, as appropriate, as &#147;outside counsel only.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything herein to the contrary, Parent and the Company shall cooperate in good faith to jointly develop a strategy for
obtaining all necessary Regulatory Approvals; <U>provided</U> that each Party shall, in good faith, take into consideration the other Party&#146;s view regarding the strategies including, to the extent practicable and permitted by applicable Law,
advance notice, discussion and consideration of any suggestions or comments of the other Party, prior to any material interaction with any Governmental Entity in connection with a Regulatory Approval; <U>provided</U>, <U>further</U>, that, in the
event of any disagreement between Parent and the Company with respect to the strategy for obtaining all necessary Regulatory Approvals, the decisions and strategies of Parent shall control and the Company shall cooperate in good faith to implement
Parent&#146;s chosen strategy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Each of Parent and the Company shall, and shall cause its Subsidiaries to, use their
respective reasonable best efforts to obtain, and the other Party shall use its reasonable best efforts to cooperate with the requesting Party to obtain, any third-party consent or approval (other than the Regulatory Approvals) (collectively,
&#147;<U>Third-Party Consents</U>&#148;) that are necessary or desirable for consummation of the transactions contemplated by this Agreement; <U>provided</U>, <U>however</U>, that notwithstanding anything to the contrary in this Agreement,
(i)&nbsp;none of the Company and its Subsidiaries nor Parent and its Subsidiaries shall be obligated to obtain any Third-Party Consents, or pay any fees in connection therewith, pursuant to this Agreement and (ii)&nbsp;the conditions to the
obligations of Parent and Merger Sub, on the one hand, and the Company, on the other hand, to consummate the Merger set forth in <U>Section</U><U></U><U>&nbsp;6.3</U> and <U>Section</U><U></U><U>&nbsp;6.2</U>, respectively, shall not be deemed to
include the obtaining of any Third-Party Consents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) In the event Parent or the Company obtains knowledge of the other party having
breached any covenant or agreement contained in this <U>Section</U><U></U><U>&nbsp;5.7</U>, or becomes aware of any actions of failure to act on the part of the other party that they believe could constitute a breach of any covenant or agreement
contained in this <U>Section</U><U></U><U>&nbsp;5.7</U>, then Parent or the Company, as applicable, shall promptly send written notice to the other party of such breach or such action or failure to act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Takeover Statutes</U>. If any Takeover Laws may become, or may purport to be, applicable to the Merger or any other
transactions contemplated hereby, each of the Parties and the members of their respective boards of directors shall use their respective reasonable best efforts to grant such approvals and take such actions as are necessary so that the transactions
contemplated hereby may be consummated as promptly as practicable on the terms and conditions contemplated hereby and otherwise act to lawfully eliminate or minimize the effects of any Takeover Law on the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Public Announcements</U>. Unless otherwise required by applicable Law or by obligations pursuant to any listing agreement
with or rules of any securities exchange, each Party shall consult with the other before issuing any press release or public statement with respect to the Mergers or the transactions contemplated thereby and, subject to the requirements of
applicable Law or the rules of any securities exchange, shall not issue any such press release or public statement prior to obtaining the consent of the other Party. Parent and the Company agree to issue a materially acceptable initial joint press
release announcing this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Indemnification and Insurance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Parent and Merger Sub agree that all rights to exculpation, indemnification and advancement of expenses for acts or omissions occurring at
or prior to the Effective Time (including any matters arising in connection with the transactions contemplated hereby), whether asserted or claimed prior to, at or after the Effective Time, now existing in favor of the current or former directors,
officers or employees (or their functional equivalent), as the case may be, of the Company or its Subsidiaries as provided in their respective certificate of incorporation or bylaws or other organizational documents or in any agreement shall survive
the Mergers and shall continue in full force and effect. For a period of six years from the Effective Time, Parent and Surviving Corporation shall maintain in effect (to the fullest extent permitted under applicable Law) any and all exculpation,
indemnification and advancement of expenses provisions of the Company&#146;s and any of its Subsidiaries&#146; certificate of incorporation and bylaws or similar organizational documents in effect immediately prior to the Effective Time (to the
extent and for so long as such entities remain in existence following the Effective Time) or in any indemnification agreements of the Company or its Subsidiaries with any of their respective current or former directors, officers or employees (or
their functional equivalent) in effect immediately prior to the Effective Time, and shall not amend, repeal or otherwise modify any such provisions or the exculpation, indemnification or advancement of expenses provisions of the Surviving
Corporation&#146;s organizational documents in any manner that would adversely affect the rights thereunder of any individuals who immediately before the Effective Time were current or former directors, officers or employees (or their functional
equivalent) of the Company or any of its Subsidiaries; <U>provided</U>, <U>however</U>, that all rights to indemnification and exculpation in respect of any Action pending or asserted or any claim made within such period shall continue until the
disposition of such Action or resolution of such claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Surviving Corporation shall, and Parent shall cause Surviving Corporation to, to the
fullest extent permitted under applicable Law, indemnify and hold harmless (and advance funds in respect of each of the foregoing) each current and former director, officer or employee (or their functional equivalent) of the Company or any of its
Subsidiaries and each person who served as a director, officer, member, trustee or fiduciary of another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise if such service was at the request or for
the benefit of the Company or any of its Subsidiaries (each, together with such person&#146;s heirs, executors or administrators, an &#147;<U>Indemnified Party</U>&#148;), in each case against any costs or expenses (including advancing
attorneys&#146; fees and expenses in advance of the final disposition of any claim, suit, proceeding or investigation to each Indemnified Party to the fullest extent permitted by applicable Law; <U>provided</U>, <U>however</U>, that the Indemnified
Party to whom expenses are advanced provides an undertaking consistent with the Company Organizational Documents and applicable Law to repay such amounts if it is ultimately determined that such person is not entitled to indemnification), judgments,
fines, losses, claims, damages, liabilities and amounts paid in settlement in connection with any actual or threatened written claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative (an
&#147;<U>Action</U>&#148;), arising out of, relating to or in connection with any action or omission by them in their capacities as such occurring or alleged to have occurred whether commenced before, at or after the Effective Time (including any
matters arising in connection with the transactions contemplated hereby and including acts or omissions in connection with such Indemnified Party serving as an officer, director, employee or other fiduciary of any entity if such service was at the
request or for the benefit of the Company). In the event of any such Action, the First Step Surviving Corporation and Surviving Company shall reasonably cooperate with the Indemnified Party in the defense of any such Action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) For a period of six years from the Effective Time, Parent shall cause the Surviving Corporation to maintain in effect, and the Surviving
Corporation shall maintain in effect, the coverage provided by the directors&#146; and officers&#146; liability insurance and fiduciary liability insurance maintained by or for the benefit of the Company and its Subsidiaries as of the Effective Time
(the &#147;<U>D&amp;O Insurance</U>&#148;) or provide substitute policies for the Company, its Subsidiaries and the persons who are covered by the D&amp;O Insurance, in either case, with terms, conditions, retentions and limits of liability that are
not less favorable than the D&amp;O Insurance with respect to acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, including the transactions contemplated hereby; <U>provided</U>, <U>however</U>, that Parent
shall not be required to pay annual premiums in excess of 350% of the last aggregate annual premium paid by the Company for the D&amp;O Insurance (the &#147;<U>Maximum Amount</U>&#148;); <U>provided</U>, <U>further</U>, that if such insurance is not
available or the aggregate annual premium for such insurance exceeds the Maximum Amount, Parent shall cause the Surviving Corporation to obtain, and the Surviving Corporation shall obtain, the best coverage available for a cost not exceeding the
Maximum Amount. In lieu thereof, at or prior to the Effective Time, (i)&nbsp;the Company may, in its sole discretion, or (ii)&nbsp;Parent may, in each case, at Parent&#146;s cost, purchase directors&#146; and officers&#146; liability and fiduciary
liability &#147;tail&#148; insurance with terms, conditions, retentions and limits of liability that are not less favorable than the D&amp;O Insurance, and that is otherwise reasonably satisfactory to the Company, with respect to acts or omissions
occurring or alleged to have occurred at or prior to the Effective Time, including the transactions contemplated hereby; <U>provided</U> that in no event shall the cost of such &#147;tail&#148; insurance, if purchased by the Company, exceed the
Maximum Amount and, if such &#147;tail&#148; insurance is purchased, Parent shall have no further obligations under this <U>Section</U><U></U><U>&nbsp;5.10(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Parent shall pay all reasonable expenses, including reasonable attorneys&#146; fees, that may be incurred by any Indemnified Party in
enforcing the indemnity and other obligations provided in this <U>Section</U><U></U><U>&nbsp;5.10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The rights of each Indemnified
Party shall be in addition to, and not in limitation of, any other applicable rights such Indemnified Party may have under the certificate of incorporation or bylaws or other organizational documents of the Company or any of its Subsidiaries or the
Surviving Corporation, any other indemnification arrangement, the DGCL or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The obligations of Parent and the Surviving
Corporation under this <U>Section</U><U></U><U>&nbsp;5.10</U> shall not be terminated, amended or modified in any manner so as to adversely affect any Indemnified Party (including their successors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
heirs and legal representatives) to whom this <U>Section</U><U></U><U>&nbsp;5.10</U> applies without the consent of such Indemnified Party. It is expressly agreed that, notwithstanding any other
provision of this Agreement that may be to the contrary, (i)&nbsp;the Indemnified Parties to whom this <U>Section</U><U></U><U>&nbsp;5.10</U> applies shall be third-party beneficiaries of this <U>Section</U><U></U><U>&nbsp;5.10</U> and
(ii)&nbsp;this <U>Section</U><U></U><U>&nbsp;5.10</U> shall survive consummation of the Merger and shall be enforceable by such Indemnified Parties and their respective successors, heirs and legal representatives against Parent, the Surviving
Corporation and their respective successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) In the event the Surviving Corporation or any of their successors or assigns
(i)&nbsp;consolidates with or merges into any other person and is not the continuing or Surviving Corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any
person, then and in each such case, the Surviving Corporation shall cause proper provision to be made so that the successors and assigns of the First Step Surviving Corporation assume, succeed to and are bound by the obligations set forth in this
<U>Section</U><U></U><U>&nbsp;5.10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Control of Operations</U>. Without in any way limiting any Party&#146;s
rights or obligations under this Agreement, the Parties understand and agree that (a)&nbsp;nothing contained in this Agreement shall give Parent or the Company, directly or indirectly, the right to control or direct the other Party&#146;s operations
prior to the Effective Time and (b)&nbsp;prior to the Effective Time, each of the Company and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries&#146;
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Section</U><U></U><U>&nbsp;16 Matters</U>. Prior to the Effective Time, Parent and the Company shall
take all such steps as may be required to cause any dispositions of Company Common Stock (including derivative securities with respect to Company Common Stock) or acquisitions of shares of Parent Common Stock (including derivative securities with
respect to Parent Common Stock) resulting from the Merger by each individual who is subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act with respect to the Company or will become subject to such reporting requirements
with respect to Parent, to be exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Transaction
Litigation</U>. The Company shall promptly notify Parent of any stockholder litigation or other Action arising from this Agreement or the Merger that is brought against the Company or members of the Company Board or any officer of the Company
(&#147;<U>Transaction Litigation</U>&#148;) and shall keep Parent reasonably informed regarding any Transaction Litigation. Without limiting the preceding sentence, the Company shall give Parent (a)&nbsp;the opportunity to review and comment on all
Filings or responses to be made by the Company in connection with any Transaction Litigation, and the Company shall consider any such comments in good faith, and (b)&nbsp;the opportunity to consult on any settlement, understanding or other agreement
with respect to any Transaction Litigation. In no event shall any settlement with respect to Transaction Litigation be agreed, or offered, without Parent&#146;s prior written consent (which consent shall not be unreasonably withheld, conditioned, or
delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Nasdaq Listing</U>. Parent shall cause the shares of Parent Common Stock to be issued in the Merger to be
approved for listing on Nasdaq, subject to official notice of issuance, prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Company
Indebtedness</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries shall use reasonable best efforts to deliver to Parent and Merger Sub no later
than three Business Days prior to the Closing Date a payoff letter (i)&nbsp;with respect to that certain Credit Agreement, dated as of November&nbsp;7, 2016 (as amended, restated, supplemented, refinanced, renewed, replaced, extended or otherwise
modified from time to time, the &#147;<U>Company Credit Agreement</U>&#148;), by and among the Company, as borrower, the financial institutions and other parties thereto from time to time, and Barclays Bank PLC, as administrative agent, to the
extent requested by Parent, and (ii)&nbsp;with respect to any other third-party indebtedness for borrowed money of the Company or any of its Subsidiaries, individually, in excess of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
$10,000,000 (in terms of aggregate <FONT STYLE="white-space:nowrap">facility-size),</FONT> to the extent requested by Parent in a written notice delivered to the Company no later than 30 days
prior to the Closing Date (any such indebtedness specified in writing pursuant to this clause&nbsp;(ii), the &#147;<U>Additional Indebtedness</U>&#148; and the date the Company receives any such specified written notice with respect to any
Additional Indebtedness, the &#147;<U>Additional Indebtedness Date</U>&#148;) ((i) and (ii), collectively, the &#147;<U>Closing Date Indebtedness</U>&#148;) providing for (A)&nbsp;the satisfaction and release of all of the Company and its
Subsidiaries&#146; liabilities and obligations (including all indebtedness for borrowed money of the Company and its Subsidiaries outstanding as of the Closing Date, but excluding any obligations that are expressly provided to survive termination)
under the definitive documentation governing the Closing Date Indebtedness (the &#147;<U>Company Credit Documents</U>&#148;), (B)&nbsp;the termination of the Company Credit Documents, and (C)&nbsp;the release of all Liens, if applicable, held
pursuant to the Company Credit Documents (collectively, the &#147;<U>Company Indebtedness Payoff</U>&#148;), in form and substance customary for transactions of the type contemplated by this Agreement; <U>provided</U> that (A)&nbsp;in no event shall
this <U>Section</U><U></U><U>&nbsp;5.15(a)</U> (x)&nbsp;require the Company or any of its Subsidiaries to cause the Company Indebtedness Payoff unless the Closing has occurred or (y)&nbsp;require the Company or any of its Subsidiaries to pay any
fees, incur or reimburse any costs or expenses, or otherwise provide any funds required to effect any or all of the Company Indebtedness Payoff, (B)&nbsp;the definition of &#147;Closing Date Indebtedness&#148; shall not include Additional
Indebtedness (and such Indebtedness shall not be required to be repaid and/or terminated, none of the related Liens and/or guarantees shall be required to be released or terminated and no notices of prepayment submitted) or subject to this
<U>Section</U><U></U><U>&nbsp;5.15</U> to the extent such Additional Indebtedness requires prior notice of prepayment or termination to be delivered and the time between the Additional Indebtedness Date and the Closing Date does not allow for such
notice to be practically delivered or any such notice is irrevocable and the prepayment or termination contemplated thereby cannot be made subject to the occurrence of the Closing, (C)&nbsp;any payoff letter with respect to any Additional
Indebtedness shall be in form and substance customary for such type of Additional Indebtedness and (D)&nbsp;notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;5.15</U>, the Company and its Subsidiaries shall not
be required to take any action with respect to any Additional Indebtedness that, in the good faith determination of the Company, is not administratively feasible or would be unreasonably administratively burdensome to the Company and its
Subsidiaries or would unreasonably interfere with the conduct of the Company&#146;s business in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Subject to the
limitations set forth in <U>Section</U><U></U><U>&nbsp;5.15(a)</U>, to the extent requested by Parent and to the extent applicable, the Company and its Subsidiaries shall use reasonable best efforts to deliver notices of prepayment within the time
periods required by the relevant Company Credit Documents governing any Closing Date Indebtedness and obtain customary Lien terminations and instruments of discharge to be delivered at the Closing with respect to any such Closing Date Indebtedness;
<U>provided</U> that in no event shall this <U>Section</U><U></U><U>&nbsp;5.15(b)</U> (i)&nbsp;require the Company or any of its Subsidiaries to cause the Company Indebtedness Payoff unless the Closing has occurred or (ii)&nbsp;require the Company
or any of its Subsidiaries to pay any fees, incur or reimburse any costs or expenses, or otherwise provide any funds required to effect any or all of the Company Indebtedness Payoff. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Parent shall cause the Company Indebtedness Payoff to occur on the Closing Date, subject to the occurrence of the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <U>Employee Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) For a period commencing on the Closing Date and ending on the first anniversary of the Closing Date (the &#147;<U>Continuation
Period</U>&#148;), each employee of the Company or its Subsidiaries who remains employed by Parent or its Affiliates (each, a &#147;<U>Continuing Employee</U>&#148;) shall receive from Parent (or its applicable Affiliate) (i)&nbsp;at least the same
base salary that was provided to such Continuing Employee immediately prior to the Closing Date; (ii)&nbsp;target total direct compensation (<I>i.e</I>., base salary, target annual bonus opportunity, and long-term equity incentive opportunity) that
is at least as favorable in the aggregate as the target total direct compensation in effect for such Continuing Employee immediately prior to the Closing Date; and (iii)&nbsp;other compensation and employee benefits (excluding those contemplated by
clauses&nbsp;(i) and (ii), defined benefit pension, nonqualified deferred compensation, post-termination or retiree health or welfare, and severance (which is covered in <U>Section</U><U></U><U>&nbsp;5.16(b)</U>)) that are substantially as favorable
in the aggregate as the compensation and benefits provided to similarly situated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees of Parent or its Affiliates or, if more favorable, provided to such Continuing Employee by the Company under the Company Benefit Plans or otherwise under any applicable collective
bargaining agreement or other labor-related agreement or arrangement applicable to such Continuing Employee immediately prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Any Continuing Employee whose employment is terminated other than for cause during the Continuation Period shall be entitled to receive
the severance payments and benefits that Parent provides to similarly situated employees of Parent or its Affiliates or, if more favorable, such Continuing Employee would have been entitled to receive from the Company and its Affiliates under its
applicable written severance plans and policies as in effect immediately prior to the Closing and that are scheduled on <U>Section</U><U></U><U>&nbsp;5.16(b)</U> of the Company Disclosure Letter, subject to the limitation for CIC Plan participants
in <U>Section</U><U></U><U>&nbsp;5.1(b)(x)(C)</U>; <U>provided</U> that, to the extent such Continuing Employee holds Converted RSUs, such Converted RSUs shall vest in accordance with the terms of <U>Section</U><U></U><U>&nbsp;2.5(c)</U> or, if more
favorable, and subject to the limitation for CIC Plan participants in <U>Section</U><U></U><U>&nbsp;5.1(b)(x)(C)</U>, the terms of any vesting acceleration provided for in any plan or arrangement maintained by the Company, Parent or any of their
respective Subsidiaries or any agreement between the Company, Parent or any of their respective Subsidiaries, on the one hand, and any Continuing Employee, on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each individual who is employed by the Company or any of its Affiliates as of immediately prior to the Closing and is a participant in a
cash bonus or short-term incentive program maintained by the Company or any of its Affiliates for the year in which the Closing occurs shall be eligible to receive a cash bonus based on the higher of the target level achievement and actual level of
achievement of the applicable performance criteria in effect immediately prior to the Closing, determined immediately prior to the Closing by the Compensation Committee of the Company Board in its reasonable discretion based on its assessment of
such performance criteria, which bonus shall be <FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the number of days in the applicable performance period that have elapsed as of the Closing. Any such bonus shall be paid to the applicable
employee no later than the next payroll of the Company or the applicable Affiliate employing such employee that occurs following the Closing Date and, in any event, no later than 20 days following the Closing Date (in each case, unless prohibited by
Section&nbsp;409A of the Code, in which case, it shall be paid on the earliest date permitted by Section&nbsp;409A of the Code). Following the Closing, Continuing Employees will be eligible to participate in Parent&#146;s cash bonus or short-term
incentive programs on a <FONT STYLE="white-space:nowrap">pro-rated</FONT> basis for the remainder of Parent&#146;s fiscal year in which the Closing occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Parent shall, and shall cause any of its applicable Affiliates to (i)&nbsp;waive all limitations as to any preexisting condition or
waiting periods in its applicable welfare plans with respect to participation and coverage requirements applicable to each Continuing Employee under any welfare plans that such Continuing Employee may be eligible to participate in after the Closing
and (ii)&nbsp;credit each Continuing Employee for any copayments, deductibles, offsets or similar payments made under a Company Benefit Plan during the plan year that includes the Closing for purposes of satisfying any applicable copayment,
deductible, offset or similar requirements under the comparable plans of Parent or any of its Affiliates. As of the Closing, Parent shall, or shall cause its applicable Affiliates to, credit to Continuing Employees the amount of vacation time that
such employees had accrued under any applicable Company Benefit Plan as of the Closing, in each case, insofar as not prohibited by applicable Law. In addition, as of the Closing, Parent shall, and shall cause its applicable Affiliates to give
Continuing Employees full credit for purposes of eligibility, vesting and determination of level of benefits under any employee benefit and compensation plans or arrangements (including for purposes of vacation and severance but excluding for any
purpose benefits under defined benefit plans, nonqualified deferred compensation, post-termination or retiree medical plans or frozen or grandfathered benefit plans) maintained by Parent or its applicable Affiliates that such Continuing Employees
may be eligible to participate in after the Closing for such Continuing Employees&#146; service with the Company or any of its Subsidiaries to the same extent that such service was credited for purposes of any comparable Company Benefit Plan
immediately prior to the Closing, except, in each case, to the extent such treatment would result in duplicative benefits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary contained herein, from and after the Closing
Date, Parent shall cause the Company to honor, in accordance with their terms without giving effect to any amendments thereto after the Closing Date, all payments, benefits and obligations under any employment, change in control and severance plans,
agreements and arrangements of the Company and its Affiliates that are set forth on <U>Section</U><U></U><U>&nbsp;5.16(e)</U> of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The occurrence of the Closing shall be deemed to be a change in control (or a similar term) under all Company Benefit Plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Company shall terminate, effective as of the day immediately preceding the date the Company becomes a member of the same Controlled
Group of Corporations (as defined in Section&nbsp;414(b) of the Code) as Parent, any and all 401(k) plans maintained by the Company or any of its Subsidiaries (the &#147;<U>Company Qualified Plans</U>&#148;) and any Company Benefit Plan listed on
<U>Section</U><U></U><U>&nbsp;5.16(g)</U> of the Company Disclosure Letter, unless Parent provides written notice to the Company that such Company Benefit Plan(s) shall not be terminated at least 10 Business Days prior to the Closing Date. In such
event, prior to the Closing Date and thereafter (as applicable), the Company and Parent shall take any and all action as may be required, including amendments to a U.S. <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution plan
maintained by Parent or one of its Subsidiaries (each, a &#147;<U>Parent Qualified Plan</U>&#148;), to vest all account balances in the terminated Company Qualified Plans and permit each Continuing Employee to make rollover contributions of
&#147;eligible rollover distributions&#148; (within the meaning of Section&nbsp;401(a)(31) of the Code) in cash or notes (representing plan loans from the Company Qualified Plan) in an amount equal to the eligible rollover distribution portion of
the account balance distributable to such Continuing Employee from such Company Qualified Plan to the corresponding Parent Qualified Plan. If the Company Qualified Plan is terminated as described herein, (i)&nbsp;the Continuing Employees shall be
eligible to participate in a Parent Qualified Plan as soon as practicable following the Closing Date and (ii)&nbsp;the Company shall provide Parent evidence that the Company Qualified Plans have been terminated pursuant to resolutions of the Company
Board or the board of directors of its Subsidiaries, as applicable. The form and substance of such resolutions shall be subject to the reasonable review and approval of Parent, which shall not be unreasonably withheld or delayed. The Company and
Parent shall use their respective reasonable best efforts to take whatever actions are needed to cause each Continuing Employee to be immediately eligible, as of the Closing Date, to receive matching contributions consistent with the plan terms
under the <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution plan in which such Continuing Employee is eligible to participate from and after the Closing, and provided that, and subject to compliance with applicable Law, the
total matching contributions payable to a Continuing Employee for the calendar year in which the Closing Date occurs shall not exceed the maximum amount of matching contributions that such Continuing Employee otherwise could have received from the
Company had such Continuing Employee been participating in such <FONT STYLE="white-space:nowrap">tax-qualified</FONT> deferred contribution plan for the full calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Effective as of the Closing, the Company shall pay to each &#147;exempt&#148; employee (within the meaning of the Fair Labor Standards
Act, as amended) located in North America an amount equal to such employee&#146;s accrued or credited but unused vacation time. To the extent not paid at the Closing, Parent shall cause such amounts to be paid to the applicable employee no later
than the next payroll of the Company or the applicable Affiliate employing such employee that occurs following the Closing Date and, in any event, no later than 20 days following the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary set forth in this Agreement, this <U>Section</U><U></U><U>&nbsp;5.16</U> will not be deemed to
(i)&nbsp;guarantee employment for any period of time for, or preclude the ability of Parent or the Company or any of their respective Subsidiaries to terminate any Continuing Employee; (ii)&nbsp;subject to the limitations and requirements
specifically set forth in this <U>Section</U><U></U><U>&nbsp;5.16</U>, require Parent, the Company or any of their respective Subsidiaries to continue any Company Benefit Plan or prevent the amendment, modification or termination thereof after the
Effective Time; (iii)&nbsp;create any third-party beneficiary rights in any person, including any Continuing Employee of the Company or its Subsidiaries; or (iv)&nbsp;establish, amend or modify any benefit plan, program, agreement or arrangement.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Prior to the Closing, the Company shall, and shall cause its Subsidiaries to, comply
with any notice or consultation requirement under any collective bargaining agreement, works council agreement or similar labor-related agreement with respect to the Mergers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <U>Financing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Financing</U>. Parent shall take, or cause to be taken, all actions and do, or cause to be done, all things necessary, proper or
advisable to arrange, obtain and complete the Financing on or before the Closing Date on the terms and conditions described in the Financing Commitments (as amended, supplemented, modified, replaced, terminated, reduced or waived in accordance with
<U>Section</U><U></U><U>&nbsp;5.17(f)</U>), including by: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) complying with, maintaining in effect and enforcing the
Financing Commitments (and, in the case of the Debt Financing Commitment, once entered into, the Financing Agreements with respect thereto); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) negotiating Financing Agreements with respect to the Debt Financing on the terms and conditions contained in the Debt
Financing Commitment (including any &#147;flex&#148; provisions) or on other terms reasonably acceptable to Parent and not in violation of <U>Section</U><U></U><U>&nbsp;5.17(f)</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) satisfying on a timely basis (or obtaining the waiver of) all conditions applicable to the Financing in the Financing
Commitments (and, in the case of the Debt Financing Commitment, any Financing Agreements with respect thereto), in each case, that are within the control of Parent or any of its Subsidiaries; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) in the event of a failure to fund (or threatened failure to fund) by the Commitment Parties in accordance with the
Financing Commitments that prevents, impedes or delays the Closing, enforcing its rights under the Financing Commitments (and, in the case of the Debt Financing Commitment, any Financing Agreements with respect thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Company Support</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Prior to the Closing Date, the Company will, and will cause its Subsidiaries to, use reasonable best efforts, and will use
reasonable best efforts to cause its and their respective Representatives to use reasonable best efforts, in each case, to provide Parent and its Subsidiaries with all cooperation reasonably requested in writing by Parent to assist it in causing the
conditions set forth in the Financing Commitment to be satisfied or as is otherwise reasonably requested in writing by Parent in connection with the Financing and/or any permitted replacement, or amended, modified or alternative, financing
(including, solely for purposes of this <U>Section</U><U></U><U>&nbsp;5.17(b)</U>, one or more debt or capital markets (including private placement) financings, including any issuance of equity, equity-linked securities or securities that are not
equity-linked, to be issued or incurred in addition to or in lieu of the financing contemplated by the Debt Commitment Letter or pursuant to any &#147;market flex&#148; or securities demand provisions of the Fee Letters) (it being understood that
any such financing shall constitute &#147;<U>Financing</U>&#148; for purposes of this <U>Section</U><U></U><U>&nbsp;5.17</U>, including: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) causing its management team, with appropriate seniority and expertise, to participate in a reasonable number of meetings,
presentations, road shows, due diligence sessions (including with the Company&#146;s auditors), drafting sessions and sessions with lenders, investors and rating agencies, in each case in connection with the Financing and at times and locations
mutually agreed and reasonably coordinated in advance (it being understood that any such meetings, presentations, road shows and sessions may be by conference call or video conference); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) reasonably cooperating with the syndication and marketing efforts of Parent and its Financing Sources in connection with
the Financing, including assisting Parent and any Financing Sources with the preparation of appropriate and customary materials for rating agency presentations (and assisting in the obtaining of corporate credit and corporate family ratings from any
ratings agencies), bank information memoranda, road show materials, offering memoranda, prospectuses, registration statements and other customary marketing materials required in connection with the Financing;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
<U>provided</U> that any such documents in relation to securities shall not be issued by the Company or any of its Subsidiaries; <U>provided</U>, <U>further</U>, that any rating agency
presentations, offering documents, bank information memoranda, private placement memoranda, prospectuses and similar documents required in connection with the Financing shall reflect the Surviving Corporation and/or their Subsidiaries as the
obligors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) assisting Parent in connection with the preparation and registration of any pledge and security documents or
other documents relating to the pledge of collateral, indentures, supplemental indentures, currency or interest rate hedging agreements, credit agreements and other definitive financing documents as may be reasonably requested in writing by Parent
or the Financing Sources (including using reasonable best efforts to facilitate obtaining from the Company&#146;s auditors consents of such auditors for use of their reports in any materials relating to the Financing and comfort letters from such
auditors, in each case as reasonably requested in writing by Parent or the Financing Sources), and otherwise reasonably facilitating the pledging of collateral, including using reasonable best efforts to arrange for the delivery of stock
certificates of the Company&#146;s Subsidiaries (if applicable), and the granting of security interests in respect of the Financing, it being understood that such documents will not take effect until the Closing Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) to the extent required in connection with the Financing, furnishing Parent, as promptly as practicable following
Parent&#146;s request in writing, with (1)&nbsp;(x) the financial statements of the Company and its Subsidiaries set forth in clauses&nbsp;(1) and (2)&nbsp;of paragraph&nbsp;5 of Exhibit&nbsp;D of the Debt Commitment Letter and (y)&nbsp;to the
extent reasonably available to the Company, the historical financial information regarding the Company and its Subsidiaries necessary to permit Parent to satisfy the condition set forth in clause&nbsp;(3) of paragraph&nbsp;5 of Exhibit&nbsp;D of the
Debt Commitment Letter (or any analogous section in any amendment, modification, supplement, restatement or replacement thereof to the extent not exceeding the scope of the requirements set forth in the Debt Financing Commitment in effect on the
date hereof), (2)&nbsp;(x) all other historical financial statements, historical financial data and related audit reports of the Company&#146;s auditors for the Company and its Subsidiaries of the type that would be required by Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC and (y)&nbsp;all other information regarding the Company and its Subsidiaries of the type that would be required by Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by
the SEC, in each case, for a registered public offering of securities (whether equity, equity-linked securities or securities that are not equity-linked) on Form&nbsp;S-3 or a private placement of debt securities under Rule&nbsp;144 promulgated
under the Securities Act, by Parent to finance an acquisition of the Company and its Subsidiaries, in each case to the extent reasonably available to the Company, (3)&nbsp;such other pertinent and customary and reasonably available information
regarding the Company and its Subsidiaries as may be reasonably requested in writing by Parent (x)&nbsp;to the extent that such information is of the type and form customarily included in a prospectus, registration statement or offering memorandum
for the issuance of securities (whether equity, equity-linked securities or securities that are not equity-linked) pursuant to a registration statement filed with the SEC, an offering pursuant to Rule&nbsp;144A promulgated under the Securities Act
or an offering pursuant to some other exemption under the Securities Act, including historical financial statements of the Company necessary to prepare pro forma financial statements for historical periods, or (y)&nbsp;is otherwise necessary to
receive from the Company&#146;s independent accountants customary &#147;comfort&#148; (including &#147;negative assurance&#148; comfort), together with drafts of customary comfort letters that such independent accountants are prepared to deliver,
subject to completion of customary procedures, upon the &#147;pricing&#148; of any securities (whether equity, equity-linked securities or securities that are not equity-linked), and the closing of the offering thereof with respect to the historical
financial information of the Company and its Subsidiaries to be included in such prospectus, registration statement or offering memorandum, and (4)&nbsp;such other pertinent and customary and reasonably available information regarding the Company
and its Subsidiaries as is necessary or customary and as may be reasonably requested in writing by Parent for use in connection with any confidential information memorandum and any bank presentation used for the syndication of the Debt Financing or
other Financing (it being understood that for purposes of this <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U>, Parent, and not the Company or its Subsidiaries or their respective Representatives, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
shall be responsible for the preparation of any pro forma financial statements and any other pro forma information, including any pro forma adjustments) (all such information and documents in
clauses&nbsp;(1)(x), (2)(x) and (3)(y) of this <U>Section</U><U></U><U>&nbsp;5.17(b)(i)(D)</U>, but other than any Excluded Information, the &#147;<U>Required Financial Information</U>&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) no less than three Business Days prior to the Closing Date, furnishing Parent and the Financing Sources with all
documentation and other information about the Company and its Subsidiaries as is reasonably requested in writing by the Financing Sources at least 10 Business Days prior to the Closing Date and that is required by regulatory authorities pursuant to
applicable &#147;know your customer&#148; and anti-money laundering rules and regulations, including the USA PATRIOT Act of 2001; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) as promptly as reasonably practical following Parent&#146;s request in writing, furnishing Parent and the Financing Sources
with such information as may be reasonably necessary for the Required Financial Information to remain Compliant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G)
delivery of customary authorization letters that authorize a distribution of the confidential information memorandum to prospective lenders, which letters shall contain a customary <FONT STYLE="white-space:nowrap">&#147;10b-5&#148;</FONT>
representation by the Company with respect to the Company and its Subsidiaries and contain a representation that the public-side version does not include material <FONT STYLE="white-space:nowrap">non-public</FONT> information about the Company and
its Subsidiaries or their securities (<U>provided</U> that the Company shall be provided with a reasonable opportunity to review and comment on the disclosure with respect to the Company and its Subsidiaries contained in such confidential
information memorandum); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) taking all corporate and other actions, subject to the occurrence of the Closing,
reasonably requested in writing by Parent or any of its Subsidiaries and necessary and customary to permit the consummation of the Financing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding the provisions of <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U> or any other provision of this Agreement,
nothing in this Agreement will require the Company or any of its Subsidiaries to: (A)&nbsp;waive or amend any terms of this Agreement or agree to pay any fees, reimburse any expenses or incur any other liability in connection with the Financing
prior to the Closing Date unless it has received prior reimbursement or is otherwise indemnified by Parent in accordance with <U>Section</U><U></U><U>&nbsp;5.17(e)</U> hereof; (B)&nbsp;require the Company or any of its Subsidiaries, or any director
or manager on any of their respective boards of directors or managers (or equivalent bodies), to approve or authorize the Financing unless Parent shall have determined that such directors and managers (or members of equivalent bodies) are to remain
as directors and managers (or members of equivalent bodies) of the Company or such Subsidiary on and after the Closing Date and such resolutions are contingent upon the occurrence of, or only effective as of, the Closing or enter into any definitive
agreement, certificate, instrument or other document (other than customary authorization letters required pursuant to <U>Section</U><U></U><U>&nbsp;5.17(b)(i)(G)</U> the effectiveness of which is not conditioned on the Closing Date; (C)&nbsp;give
any indemnities that are effective prior to the Closing Date; (D)&nbsp;take any action that, in the good faith determination of the Company, would unreasonably interfere with the conduct of its business in any material respect or create an
unreasonable risk of damage or destruction to any material property or assets of the Company or any of its Subsidiaries; (E)&nbsp;provide any information the disclosure of which is prohibited or restricted under applicable Law, is legally privileged
or would result in the contravention of, or that would reasonably be expected to result in a violation or breach of, or default under, any obligation of confidentiality (not created in contemplation hereof) binding on the Company or any of its
Subsidiaries; (F)&nbsp;take any action that will conflict with or violate its organizational documents or any applicable Laws or would result in a violation or breach of, or default under, any material agreement to which the Company or any of its
Subsidiaries is a party; (G)&nbsp;take any action that would cause any representation or warranty in this Agreement to be breached or become inaccurate (unless such breach or inaccuracy is waived by Parent); (H)&nbsp;cause any director, officer,
employee or stockholder of the Company or any of its Subsidiaries to incur any personal liability; (I)&nbsp;require the Company or any of its Subsidiaries or any of their Representatives to deliver any legal opinions or reliance letters (other than
customary authorization letters required pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;5.17(b)(i)(G)</U>); (J)&nbsp;file or furnish any reports or information with the SEC in connection with the Financing, except, after consultation between Parent and
the Company and their Representatives, the furnishing on Current Reports on Form 8-K by the Company of information included in documents with respect to such Financing to the extent required in order to satisfy the Company&#146;s Regulation FD
disclosure obligations; (K)&nbsp;prepare or provide any Excluded Information; or (L)&nbsp;change any fiscal period or accelerate the Company&#146;s preparation of its SEC reports or financial statements to align with Parent&#146;s fiscal periods. No
person who is a director of the Company or any of its Subsidiaries at any time prior to the Closing (a &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Director</U>&#148;) shall be required to take any action to approve the Debt
Financing and neither the Company nor any of its Subsidiaries shall be obligated to take any action that requires action or approval by any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Director of the Debt Financing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The Company will be deemed to be in compliance with <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U> and
<U>Section</U><U></U><U>&nbsp;5.15</U> unless and until (A)&nbsp;Parent provides written notice (the &#147;<U><FONT STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice</U>&#148;) to the Company of any alleged failure to comply, or action or
failure to act which could be believed to be a breach of <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U> or <U>Section</U><U></U><U>&nbsp;5.15</U>, (B)&nbsp;Parent includes in such <FONT STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice
reasonable detail regarding the cooperation required to cure such alleged failure (which shall not require the Company to provide any cooperation that it would not otherwise be required to provide under <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U>
or <U>Section</U><U></U><U>&nbsp;5.15</U>) and (C)&nbsp;the Company fails to take the actions specified on such <FONT STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice within five Business Days from receipt of such <FONT
STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Use of Logos</U>. The Company hereby consents to the use of all logos of
the Company or any of its Subsidiaries in connection with the Financing so long as such logos (i)&nbsp;are used solely in a manner that is not intended to or likely to harm or disparage the Company or any of its Subsidiaries or the reputation or
goodwill of the Company or any of its Subsidiaries, (ii)&nbsp;are used solely in connection with a description of the business of the Company and its Subsidiaries or the Merger and (iii)&nbsp;do not appear on the cover of any rating agency
presentations, bank information memoranda and securities offering prospectuses or memoranda, road show presentations and similar documents used in connection with the Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Confidentiality</U>. All <FONT STYLE="white-space:nowrap">non-public</FONT> or other confidential information provided by the Company
or any of its Subsidiaries or any of their representatives pursuant to this Agreement will be kept confidential in accordance with, and will otherwise comply with, the terms of the Confidentiality Agreement, except that Parent or any of its
Subsidiaries will be permitted to disclose such information to any Financing Sources or prospective financing sources and other financial institutions and investors that are or may become parties to the Financing and to any underwriters, initial
purchasers or placement agents in connection with the Financing (and, in each case, to their respective counsel and auditors) so long as such persons are subject to confidentiality undertakings no less favorable in the aggregate to the Company than
those contained in the Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Company Reimbursement and Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Upon request by the Company, Parent shall promptly reimburse the Company for all reasonable and documented <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including reasonable and documented legal fees and expenses) incurred by the Company or any of its Subsidiaries in connection with providing
the support and cooperation contemplated by <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U> and/or <U>Section</U><U></U><U>&nbsp;5.15</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Parent shall indemnify and hold harmless the Company, its Subsidiaries and each of their respective directors, officers,
employees, agents and other Representatives, from and against any and all losses, damages, claims, interest, costs or expenses (including legal fees and expenses), awards, judgments, penalties and amounts paid in settlement suffered or incurred by
any of them in connection with providing the support and cooperation contemplated by <U>Section</U><U></U><U>&nbsp;5.17(b)(i)</U> and/or <U>Section</U><U></U><U>&nbsp;5.15</U> and any information utilized in connection therewith (other than
information provided by the Company or any of its Subsidiaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Subject to the terms and conditions of this Agreement, Parent shall
not agree to or permit any amendment, supplement or other modification or replacement of, or any termination or reduction of, or grant any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
waiver of, any condition, remedy or other provision under the Financing Commitments, in each case, without the prior written consent of the Company if such amendment, supplement, modification,
replacement, termination, reduction or waiver would or would reasonably be expected to (i)&nbsp;reduce the aggregate amount of the Financing below the amount required to consummate the Merger (taking into account other sources of funding (other than
cash of the Company and its Subsidiaries)), (ii)&nbsp;impose new or additional conditions or otherwise expand, amend or modify any of the conditions to the receipt of the Financing, in each case, in a manner that would reasonably be expected to
(A)&nbsp;materially delay or prevent the Closing, or (B)&nbsp;make the timely funding of the Financing or the satisfaction of the conditions to obtaining the Financing materially less likely to occur, or (iii)&nbsp;adversely impact in any material
respect the ability of Parent or Merger Sub to enforce its or their rights against the other parties to the Financing Commitments; it being understood that notwithstanding the foregoing, Parent and its Subsidiaries may (1)&nbsp;consent to, replace
or amend the Debt Financing Commitment to add lenders, lead arrangers, bookrunners, syndication agents or similar entities who had not executed the Debt Financing Commitment as of the date of this Agreement, (2)&nbsp;make or permit assignments and
replacements of an individual lender under the Debt Financing Commitment in connection with the syndication of the Debt Financing, and/or (3)&nbsp;terminate or reduce the aggregate amount of the commitments under the Financing Commitments (and enter
into any amendments, modifications of supplements of the Financing Commitments in connection therewith) if Parent and its Subsidiaries have a sufficient amount of available cash on hand from other sources (other than cash of the Company and its
Subsidiaries) to make the representation set forth in <U>Section</U><U></U><U>&nbsp;4.28</U> (as though made at the time of the effectuation of such amendment, supplement or modification). Promptly following any amendment, supplement, modification,
replacement, termination, reduction or waiver of the Financing Commitments in accordance with this <U>Section</U><U></U><U>&nbsp;5.17(f)</U>, Parent shall deliver a copy thereof to the Company and (x)&nbsp;references herein to the &#147;Investment
Agreement,&#148; &#147;Debt Commitment Letter,&#148; &#147;Fee Letters,&#148; and/or &#147;Debt Financing Commitment&#148; shall be deemed to include such documents as amended, supplemented, modified, replaced, terminated, reduced or waived in
compliance with this <U>Section</U><U></U><U>&nbsp;5.17(f)</U>, and (y)&nbsp;references to &#147;Equity Financing&#148; or &#147;Debt Financing&#148;, as applicable, shall include the financing contemplated by the Investment Agreement or Debt
Financing Commitment, as applicable, as amended, supplemented, modified, replaced, terminated, reduced or waived in compliance with this <U>Section</U><U></U><U>&nbsp;5.17(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Parent shall (i)&nbsp;give the Company prompt written notice of any default or material breach by any party of any of the Financing
Commitments (or, in the case of the Debt Financing Commitment, Financing Agreements related thereto) or any termination or threatened termination thereof of which Parent or Merger Sub has or have knowledge and (ii)&nbsp;otherwise keep the Company
reasonably informed of the status of its efforts to arrange the Financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Each of Parent and Merger Sub acknowledges and agrees that
the obtaining of the Financing is not a condition to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding anything to the contrary contained herein, neither
Parent nor any Affiliate of Parent may engage either Company Financial Advisor or any of their respective Affiliates to provide any portion of the Financing or to be any Financing Source of the Financing without the prior written consent of the
Company, which may be withheld in the Company&#146;s sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <U>Merger Sub; Parent Vote</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) During the period from the date of this Agreement through the earlier of the Effective Time or the date of termination of this Agreement,
Merger Sub shall not engage in any activities of any nature except as provided in or contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Parent shall
ensure that Merger Sub duly performs, satisfies and discharges on a timely basis each of the covenants, obligations and liabilities of Merger Sub under this Agreement, and Parent shall be jointly and severally liable with Merger Sub for the due and
timely performance and satisfaction of each such covenant, obligation and liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Immediately following the execution of this Agreement, Parent shall execute and deliver,
in accordance with the DGCL and in its capacity as the sole stockholder of Merger Sub, a written consent adopting this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <U>Subsidiary Director and Officer Resignations</U>. The Company shall cause to be delivered to Parent prior to the Closing
resignations, in form and substance reasonably satisfactory to Parent, executed by each director (or similar position) or officer of each Subsidiary of the Company, in each case, conditioned and effective upon the Effective Time; <U>provided</U>,
<U>however</U>, that any such resignation by an officer shall not require or be considered to be a termination of employment from the Company or any of its Subsidiaries and shall not waive any rights or entitlements that such officers may have as
employees under the CIC Plan or otherwise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONDITIONS TO THE MERGER</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Conditions to Each Party</U><U>&#146;</U><U>s Obligation to Effect the Merger</U>. The respective obligations of each
Party to effect the Merger shall be subject to the fulfillment (or waiver by all Parties, to the extent permissible under applicable Law) at or prior to the Effective Time of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Stockholder Approval</U>. (i)&nbsp;The Company Stockholder Approval and (ii)&nbsp;the Parent Stockholder Approval shall have been
obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U><FONT STYLE="white-space:nowrap">S-4</FONT> Effectiveness</U>. The Form S-4 shall have been declared effective by the
SEC under the Securities Act and no stop order suspending the effectiveness of the Form S-4 shall have been issued by the SEC and no proceedings for that purpose shall have been initiated or threatened by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Listing Approval</U>. The shares of Parent Common Stock to be issued in the Merger shall have been approved for listing on Nasdaq,
subject to official notice of issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Legal Prohibition</U>. No injunction by any court or other tribunal of competent
jurisdiction shall have been entered and shall continue to be in effect and no Law shall have been adopted or be effective, in each case, that prohibits the consummation of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Regulatory Approval</U>. Any applicable waiting periods shall have expired or been terminated, and any approvals required shall have
been obtained, in each case relating to the transactions contemplated by this Agreement under the HSR Act or under any other Antitrust Law specified in <U>Section</U><U></U><U>&nbsp;6.1(e)</U> of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Conditions to Obligation of the Company to Effect the Merger</U>. The obligation of the Company to effect the Merger is
further subject to the fulfillment (or waiver by the Company) at or prior to the Effective Time of the following conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<U>Representations and Warranties</U>. (i)&nbsp;The representations and warranties of Parent and Merger Sub set forth in <U>Section</U><U></U><U>&nbsp;4.1(a)</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.3(a)</U>,
<U>Section</U><U></U><U>&nbsp;4.23</U> and <U>Section</U><U></U><U>&nbsp;4.25</U> shall be true and correct in all material respects both when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly
made as of an earlier date, in which case as of such date) and (ii)&nbsp;the other representations and warranties of Parent and Merger Sub set forth in <U>Article</U><U></U><U>&nbsp;IV</U> shall be true and correct both when made and at and as of
the Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except with respect to this clause&nbsp;(ii) where the failure of such representations and
warranties to be so true and correct (without regard to &#147;materiality,&#148; &#147;Parent Material Adverse Effect&#148; and similar qualifiers contained in such representations and warranties) has not had or would not, individually or in the
aggregate, have a Parent Material Adverse Effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of Parent and Merger Sub</U>. Parent and Merger Sub shall
have in all material respects (i)&nbsp;performed all obligations and (ii)&nbsp;complied with all covenants required by this Agreement to be performed or complied with by them prior to the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Parent Material Adverse Effect</U>. Since the date of this Agreement, there has not been any event, change, effect, development or
occurrence that, individually or in the aggregate, has had or would reasonably be expected to have a Parent Material Adverse Effect; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Closing Certificate</U>. Parent shall have delivered to the Company a certificate, dated the Closing Date and signed by Parent&#146;s
Chief Executive Officer or Chief Financial Officer, certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.2(a)</U>, <U>Section</U><U></U><U>&nbsp;6.2(b)</U> and <U>Section</U><U></U><U>&nbsp;6.2(c)</U> have been
satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Conditions to Obligation of Parent to Effect the First Merger</U>. The obligation of Parent to effect the
First Merger is further subject to the fulfillment (or the waiver by Parent) at or prior to the Effective Time of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. (i)&nbsp;The representations and warranties of the Company set forth in
<U>Section</U><U></U><U>&nbsp;3.2(a)</U> shall be true and correct in all respects (except for only de minimis inaccuracies) both when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly made as
of an earlier date, in which case as of such date), (ii)&nbsp;the representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;3.1</U> (other than the second sentence of <U>Section</U><U></U><U>&nbsp;3.1(b)</U>),
<U>Section</U><U></U><U>&nbsp;3.2</U> (other than <U>Section</U><U></U><U>&nbsp;3.2(a)</U>), <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, <U>Section</U><U></U><U>&nbsp;3.23</U> and <U>Section</U><U></U><U>&nbsp;3.25</U> shall be true and correct in all
material respects, both when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in which case as of such date), and (iii)&nbsp;the other representations and
warranties of the Company set forth in <U>Article</U><U></U><U>&nbsp;III</U> shall be true and correct both when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in
which case as of such date), except with respect to this clause&nbsp;(iii) where the failure of such representations and warranties to be so true and correct (without regard to any qualifications or exceptions as to &#147;materiality,&#148;
&#147;Company Material Adverse Effect&#148; and similar qualifiers contained in such representations and warranties) has not had or would not have, individually or in the aggregate, a Company Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of the Company</U>. The Company shall have in all material respects (i)&nbsp;performed all obligations and
(ii)&nbsp;complied with all covenants required by this Agreement to be performed or complied with by it prior to the Effective Time (without giving any effect to (A)&nbsp;any breach of, or action or inaction of the Company of which Parent had
knowledge required under, <U>Section</U><U></U><U>&nbsp;5.17</U>, but for which Parent failed to deliver a <FONT STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice in accordance with <U>Section</U><U></U><U>&nbsp;5.17</U> or
(B)&nbsp;subclause&nbsp;(b) in the proviso to <U>Section</U><U></U><U>&nbsp;5.1(b)(viii)</U>, which shall be disregarded for purposes of this <U>Section</U><U></U><U>&nbsp;6.3(b)</U>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Company Material Adverse Effect</U>. Since the date of this Agreement, there has not been any event, change, effect, development or
occurrence that, individually or in the aggregate, has had or would reasonably be expected to have a Company Material Adverse Effect; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Closing Certificate</U>. The Company shall have delivered to Parent a certificate, dated the Closing Date and signed by its Chief
Executive Officer or Chief Financial Officer, certifying to the effect that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U>, <U>Section</U><U></U><U>&nbsp;6.3(b)</U> and <U>Section</U><U></U><U>&nbsp;6.3(c)</U> have been
satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Frustration of Closing Conditions</U>. Neither the Company nor Parent may rely, either as a basis for not
consummating the Merger or terminating this Agreement and abandoning the Merger, on the failure of any condition set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>, <U>Section</U><U></U><U>&nbsp;6.2</U> or <U>Section</U><U></U><U>&nbsp;6.3</U>, as
the case may be, to be satisfied if such failure was caused by such Party&#146;s Willful and Material Breach of any material provision of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Termination or Abandonment</U>. Notwithstanding anything in this Agreement to the contrary, this Agreement may be
terminated and abandoned at any time prior to the Effective Time, whether before or after the Company Stockholder Approval has been obtained (except as otherwise provided below): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) by the mutual written consent of the Company and Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) by either the Company or Parent, if the Merger shall not have been consummated on or prior to 5:00 p.m., Eastern time, on the date that is
the nine (9)&nbsp;month anniversary of the date of this Agreement (the &#147;<U>Original End Date</U>&#148;); <U>provided</U> that if on the Original End Date the conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or
<U>Section</U><U></U><U>&nbsp;6.1(e)</U> (in either case of <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U>, solely to the extent the matter giving rise to the failure of such condition is related to the approval
under the HSR Act or under any other Antitrust Law specified in <U>Section</U><U></U><U>&nbsp;6.1(e)</U> of the Company Disclosure Letter) shall not have been satisfied, then such date shall automatically be extended, without any action on the part
of any Party, to the twelve (12)&nbsp;month anniversary of the date of this Agreement (the &#147;<U>First Extended End Date</U>&#148;); <U>provided</U> that, if on the First Extended End Date, the conditions to Closing set forth in
<U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U> (in either case of <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U>, solely to the extent the matter giving rise to the failure
of such condition is related to the approval under the HSR Act or under any other Antitrust Law specified in <U>Section</U><U></U><U>&nbsp;6.1(e)</U> of the Company Disclosure Letter) shall not have been satisfied, but all other conditions to
Closing shall have been satisfied (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on the First Extended End Date) or waived by all parties entitled to the benefit of such
conditions, then such date shall automatically be extended, without any action on the part of any Party, to the fifteen (15)&nbsp;month anniversary of the date of this Agreement (the &#147;<U>Second Extended End Date</U>&#148;); <U>provided</U>
that, if on the Second Extended End Date, the conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U> (in either case of <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or
<U>Section</U><U></U><U>&nbsp;6.1(e)</U>, solely to the extent the matter giving rise to the failure of such condition is related to the approval under the HSR Act or under any other Antitrust Law specified in
<U>Section</U><U></U><U>&nbsp;6.1(e)</U> of the Company Disclosure Letter) shall not have been satisfied, but all other conditions to Closing shall have been satisfied (or in the case of conditions that by their terms are to be satisfied at the
Closing, shall be capable of being satisfied on the Second Extended End Date) or waived by all parties entitled to the benefit of such conditions, then such date shall automatically be extended, without any action on the part of any Party, to the
eighteen (18)&nbsp;month anniversary of the date of this Agreement (the &#147;<U>Third Extended End Date</U>&#148;) (the Original End Date, as such date may be extended to the First Extended End Date, the Second Extended End Date and the Third
Extended End Date, as applicable, the &#147;<U>End Date</U>&#148;); <U>provided</U> that if the conditions to Closing set forth in <U>Article</U><U></U><U>&nbsp;VI</U> are satisfied prior to the End Date (or in the case of conditions that by their
terms are to be satisfied at the Closing, shall be capable of being satisfied on Closing Date), neither Parent nor the Company may terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(b)</U> until the date that is 10 Business
Days after the End Date; <U>provided</U> that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.1(b)</U> shall not be available to a Party if the failure of the Closing to occur by such date shall have resulted
from a material breach by such Party of any representation, warranty, covenant or other agreement of such Party set forth in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) by either the Company or Parent, if an injunction shall have been entered permanently restraining, enjoining or otherwise prohibiting the
consummation of the Merger and such injunction shall have become final and nonappealable; <U>provided</U> that the party seeking to terminate the Agreement shall have used reasonable best efforts to prevent the entry of and to remove such relevant
legal restraint in accordance with <U>Section</U><U></U><U>&nbsp;5.7</U>; <U>provided</U>, <U>further</U>, that the right to terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;7.1(c)</U> shall not be available to a Party if such
injunction was primarily due to a material breach by such Party of any representation, warranty, covenant or other agreement of such Party set forth in this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) by either the Company or Parent, if the Company Stockholders&#146; Meeting (including
any adjournments or postponements thereof) shall have concluded and the Company Stockholder Approval shall not have been obtained; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) by
either the Company or Parent, if the Parent Stockholders&#146; Meeting (including any adjournments or postponements thereof) shall have concluded and the Parent Stockholder Approval shall not have been obtained; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) by the Company, if Parent or Merger Sub shall have breached or failed to perform any of its or their representations, warranties,
covenants or other agreements contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Closing Date, would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;6.2(a)</U> or <U>Section</U><U></U><U>&nbsp;6.2(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the End Date or, if such breach or failure is capable of being cured by the End Date, Parent has not cured
such breach or failure within 30 days after receiving written notice from the Company describing such breach or failure in reasonable detail (<U>provided</U> that the Company is not then in material breach of any representation, warranty, covenant
or other agreement contained herein that would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> or <U>Section</U><U></U><U>&nbsp;6.3(b)</U>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) by Parent, if the Company shall have breached or failed to perform any of its representations, warranties, covenants or other agreements
contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Closing Date, would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> or
<U>Section</U><U></U><U>&nbsp;6.3(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the End Date or, if such breach or failure is capable of being cured by the End Date, the Company has not cured such breach or failure within 30 days
after receiving written notice from Parent describing such breach or failure in reasonable detail (<U>provided</U> that Parent is not then in material breach of any representation, warranty, covenant or other agreement contained herein that would
result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.2(a)</U> or <U>Section</U><U></U><U>&nbsp;6.2(b)</U>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) by Parent, prior to receipt of the Company Stockholder Approval, in the event of a Company Adverse Recommendation Change; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) by the Company, prior to receipt of the Parent Stockholder Approval, in the event of a Parent Adverse Recommendation Change; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) by Parent, at any time prior to receipt of the Parent Stockholder Approval, in order to enter into an agreement with respect to a Parent
Superior Proposal pursuant to <U>Section</U><U></U><U>&nbsp;5.5</U>; <U>provided</U>, <U>however</U>, that Parent shall not terminate this Agreement pursuant to this paragraph, unless in advance of or concurrently with such termination Parent pays,
or causes to be paid, the Parent Termination Fee as provided in <U>Section</U><U></U><U>&nbsp;7.3</U>; <U>provided</U>, <U>further</U>, that Parent has otherwise complied in all respects (other than de minimis noncompliance unrelated to such Parent
Superior Proposal) with the provisions of <U>Section</U><U></U><U>&nbsp;5.5</U> and <U>Section</U><U></U><U>&nbsp;5.6</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) by the
Company, at any time prior to receipt of the Company Stockholder Approval, in order to enter into an agreement with respect to a Company Superior Proposal pursuant to <U>Section</U><U></U><U>&nbsp;5.4</U>; <U>provided</U>, <U>however</U>, that the
Company shall not terminate this Agreement pursuant to this paragraph, unless in advance of or concurrently with such termination the Company pays, or causes to be paid, the Company Termination Fee as provided in
<U>Section</U><U></U><U>&nbsp;7.3</U>; <U>provided</U>, <U>further</U>, that the Company has otherwise complied in all respects (other than de minimis noncompliance unrelated to such Company Superior Proposal) with the provisions of
<U>Section</U><U></U><U>&nbsp;5.4</U> and <U>Section</U><U></U><U>&nbsp;5.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Effect of Termination</U>. In the
event of termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;7.1</U>, notice thereof shall be given to the other Party or Parties, specifying the provisions hereof pursuant to which such termination is made and the basis therefor
described in reasonable detail, and this Agreement shall terminate (except for the provisions of this <U>Section</U><U></U><U>&nbsp;7.2</U>, <U>Section</U><U></U><U>&nbsp;7.3</U> and <U>Article</U><U></U><U>&nbsp;VIII</U>), and there shall be no
other liability on the part of the Company or Parent to the other except as provided in the Confidentiality Agreement and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provisions of this <U>Section</U><U></U><U>&nbsp;7.2</U> and <U>Section</U><U></U><U>&nbsp;7.3</U>, and liability arising out of or the result of, fraud or any Willful and Material Breach of any
covenant or agreement or Willful and Material Breach of any representation or warranty in this Agreement occurring prior to termination, in which case the aggrieved Party shall not be limited to Expense Payments or any fee payable pursuant to
<U>Section</U><U></U><U>&nbsp;7.3</U> and shall be entitled to all rights and remedies available at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3
<U>Termination Fee; Expenses</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If this Agreement is terminated: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) by Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.1(h)</U> in the event of a Company Adverse Recommendation Change;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) by the Company pursuant to <U>Section</U><U></U><U>&nbsp;7.1(k)</U>; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;(A) by the Company or Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.1(d)</U>, (B)&nbsp;if a Company Takeover
Proposal shall have been publicly announced or shall have become publicly known and shall not have been publicly withdrawn by a date that is at least 15&nbsp;Business Days prior to the Company Stockholders&#146; Meeting and (C)&nbsp;within
12&nbsp;months of the termination of this Agreement, the Company or any of its Subsidiaries enters into a definitive agreement with a third party with respect to or consummates a transaction that is a Company Takeover Proposal with a third party;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">then the Company shall pay to Parent the Company Termination Fee by wire transfer (to an account designated by Parent) in immediately
available funds in the case of clause&nbsp;(i), within two Business Days of such termination, or in the case of clause&nbsp;(ii), at or prior to such termination, or, in the case of clause (iii), upon the earlier of the entry into a definitive
agreement with respect to the transactions contemplated by such Company Takeover Proposal and the consummation of such transactions (it being understood that, for purposes of this <U>Section</U><U></U><U>&nbsp;7.3(a)</U>, each reference to
&#147;15%&#148; in the definition of &#147;Company Takeover Proposal&#148; in <U>Section</U><U></U><U>&nbsp;8.15(b)</U> shall be deemed to be a reference to &#147;50.1%&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If this Agreement is terminated: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) by the Company pursuant to <U>Section</U><U></U><U>&nbsp;7.1(i)</U> in the event of a Parent Adverse Recommendation Change;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) by Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.1(j)</U>; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;(A) by the Company or Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.1(e)</U>, (B)&nbsp;if a Parent Takeover
Proposal shall have been publicly announced or shall have become publicly known and shall not have been publicly withdrawn by a date that is at least 15 Business Days prior to the Parent Stockholders&#146; Meeting and (C)&nbsp;within 12 months of
the termination of this Agreement, Parent or any of its Subsidiaries enters into a definitive agreement with a third party with respect to or consummates a transaction that is a Parent Takeover Proposal with a third party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">then Parent shall pay to the Company the Parent Termination Fee by wire transfer (to an account designated by the Company) in immediately
available funds in the case of clause&nbsp;(i), within two Business Days of such termination, or, in the case of clause&nbsp;(ii), at or prior to such termination, or, in the case of clause&nbsp;(iii), upon the earlier of the entry into a definitive
agreement with respect to the transactions contemplated by such Parent Takeover Proposal and the consummation of such transactions (it being understood that, for purposes of this <U>Section</U><U></U><U>&nbsp;7.3(b)</U>, each reference to
&#147;15%&#148; in the definition of &#147;Parent Takeover Proposal&#148; in <U>Section</U><U></U><U>&nbsp;8.15(b)</U> shall be deemed to be a reference to &#147;50.1%&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If this Agreement is terminated: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;(A) by Parent or the Company pursuant to (x)<U>&nbsp;Section</U><U></U><U>&nbsp;7.1(b)</U> if, at the time of such
termination, the conditions to Closing set forth in <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U> (in either case of <U>Section</U><U></U><U>&nbsp;6.1(d)</U> or <U>Section</U><U></U><U>&nbsp;6.1(e)</U>, solely
to the extent the matter giving rise to the failure of such condition is related only to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
approval under an Antitrust Law of a Chinese Governmental Entity and no other Antitrust Law or other Law) shall not have been satisfied but all other conditions to Closing shall have been
satisfied (or in the case of conditions that by their terms are to be satisfied at the Closing, shall be capable of being satisfied on, shall have been satisfied or waived, on the date of such termination), or
(y)<U>&nbsp;Section</U><U></U><U>&nbsp;7.1(c)</U> (solely to the extent an injunction shall have been entered by a Chinese Governmental Entity (and no other Governmental Entity) pursuant to an Antitrust Law permanently restraining, enjoining or
otherwise prohibiting the consummation of the Merger and such injunction shall have become final and nonappealable), and (B)&nbsp;the Company has complied, in all material respects, with its covenants and agreements set forth in
<U>Section</U><U></U><U>&nbsp;5.7</U> (without giving any effect to any breach of, or action or inaction of the Company of which Parent had knowledge required under, <U>Section</U><U></U><U>&nbsp;5.7</U>, but failed to provide prompt notice in
accordance with <U>Section</U><U></U><U>&nbsp;5.7</U>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">then Parent shall pay to the Company the Parent China Regulatory Termination Fee
by wire transfer (to an account designated by the Company) in immediately available funds within two Business Days of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Expense Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) If this Agreement is terminated by either Parent or the Company pursuant to <U>Section</U><U></U><U>&nbsp;7.1(d)</U>, the
Company shall pay Parent $25,000,000 as payment for Parent&#146;s costs and expenses in connection with this Agreement (the &#147;<U>Parent Expense Payment</U>&#148;) by wire transfer (to an account designated in writing by Parent) in immediately
available funds within two Business Days after such termination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) If this Agreement is terminated by either Parent or
the Company pursuant to <U>Section</U><U></U><U>&nbsp;7.1(e)</U>, Parent shall pay the Company $25,000,000 as payment for the Company&#146;s costs and expenses in connection with this Agreement (the &#147;<U>Company Expense Payment</U>,&#148; and
together with the Parent Expense Payment, the &#147;<U>Expense Payments</U>&#148;) by wire transfer (to an account designated in writing by the Company) in immediately available funds within two Business Days after such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Parent Termination Fee</U>&#148; shall be an amount equal to $337,700,000. &#147;<U>Parent China Regulatory Termination
Fee</U>&#148; shall be an amount equal to $500,000,000. &#147;<U>Company Termination Fee</U>&#148; shall be an amount equal to $108,800,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The payment of the Parent Termination Fee, the Parent China Regulatory Termination Fee, the Company Termination Fee, as applicable (in
each case, a &#147;<U>Termination Fee Payment</U>&#148;) and the Expense Payments shall be compensation and liquidated damages for the loss suffered by the Company or Parent, as applicable, as a result of the failure of the Merger to be consummated
and to avoid the difficulty of determining damages under the circumstances and neither Party shall have any other liability to the other after the payment of such Termination Fee Payment or Expense Payment, except in the case of fraud or a Willful
and Material Breach. Notwithstanding anything to the contrary in this Agreement, if the Termination Fee Payment shall become due and payable in accordance with <U>Section</U><U></U><U>&nbsp;7.3(a)</U>, <U>Section</U><U></U><U>&nbsp;7.3(b)</U>,
<U>Section</U><U></U><U>&nbsp;7.3(c)</U> or <U>Section</U><U></U><U>&nbsp;7.3(d)</U>, as applicable, from and after such termination and payment of the Termination Fee Payment pursuant to and in accordance with
<U>Section</U><U></U><U>&nbsp;7.3(a)</U>,<U> Section</U><U></U><U>&nbsp;7.3(b)</U>, <U>Section</U><U></U><U>&nbsp;7.3(c)</U>, or <U>Section</U><U></U><U>&nbsp;7.3(d)</U>, as applicable, the paying Party shall have no further liability of any kind
for any reason in connection with this Agreement or the termination contemplated hereby other than as provided under <U>Section</U><U></U><U>&nbsp;7.3(a)</U>, <U>Section</U><U></U><U>&nbsp;7.3(b)</U>, <U>Section</U><U></U><U>&nbsp;7.3(c)</U> or
<U>Section</U><U></U><U>&nbsp;7.3(d)</U>, as applicable, except in the case of fraud or a Willful and Material Breach. Each of the Parties acknowledges that the Termination Fee Payment and Expense Payments are not intended to be a penalty, but
rather are liquidated damages in a reasonable amount that will compensate the Company or Parent, as the case may be, in the circumstances in which such Termination Fee Payment and/or Expense Payment is due and payable and which do not involve fraud
or Willful and Material Breach, for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the transactions contemplated hereby,
which amount would otherwise be impossible to calculate with precision. In no event shall any Party be entitled to more than one payment of the Termination Fee Payment in connection with a termination of this Agreement pursuant to which the
Termination Fee Payment is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payable, and if the Termination Fee Payment is payable at such time as the receiving Party has already received payment or concurrently receives payment from the paying Party in respect of the
Parent Expense Payment or the Company Expense Payment, as applicable, the amount of such Parent Expense Payment or the Company Expense Payment actually received by Parent or the Company, as applicable, shall be deducted from the Termination Fee
Payment due and payable to such Party. Without limiting <U>Section</U><U></U><U>&nbsp;8.13</U>, the Parent Termination Fee and the Parent China Regulatory Termination Fee shall be the sole and exclusive remedies of the Company against the Financing
Sources under this Agreement or in connection with the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Each of the Company, Parent and Merger Sub
acknowledges that the agreements contained in this <U>Section</U><U></U><U>&nbsp;7.3</U> are an integral part of the transactions contemplated hereby, and that, without these agreements, the Company, Parent and Merger Sub would not enter into this
Agreement. Accordingly, if a Party fails to pay in a timely manner any amount due pursuant to this <U>Section</U><U></U><U>&nbsp;7.3</U>, then such Party shall reimburse the other Party for all costs and expenses (including disbursements and
reasonable fees of counsel) incurred in the collection of such overdue amount, including in connection with any related Actions commenced and pay interest on such amount from and including the date payment of such amount was due to but excluding the
date of actual payment at the prime rate set forth in <I>The Wall Street Journal</I> in effect on the date such payment was required to be made. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>No Survival</U>. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Merger, except for covenants and agreements which contemplate performance after the Effective Time or which otherwise expressly by their terms survive termination of this Agreement or the
Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2 <U>Expenses</U>. Except as set forth in <U>Section</U><U></U><U>&nbsp;7.3</U>, whether or not the Merger
is consummated, all costs and expenses incurred in connection with the Merger, this Agreement and the transactions contemplated hereby shall be paid by the Party incurring or required to incur such expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3 <U>Counterparts; Effectiveness</U>. This Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each Party shall have received a counterpart hereof signed by all of the other Parties, it being
understood and agreed that all Parties hereto need not sign the same counterpart. Until and unless each Party has received a counterpart hereof signed by each other Party, this Agreement shall have no effect and no Party shall have any right or
obligation hereunder (whether by virtue of any other oral or written agreement or other communication). Signatures to this Agreement transmitted by electronic mail in PDF form, or by any other electronic means designed to preserve the original
graphic and pictorial appearance of a document (including DocuSign), will be deemed to have the same effect as physical delivery of the paper document bearing the original signatures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.4 <U>Governing Law</U>. This Agreement, and all claims or causes of action (whether at Law, in contract, in tort or otherwise)
that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof (&#147;<U>Relevant Matters</U>&#148;), shall be governed by and construed in accordance with the laws of the State of Delaware,
without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Notwithstanding
anything herein to the contrary, each of the Parties agrees that any right or obligation with respect to any Financing Source in connection with this Agreement, the Financing, the Commitment Letters and the transactions contemplated hereby and
thereby, and any claim, controversy, dispute, suit, action or proceeding relating thereto or arising thereunder, shall be governed by, and construed and enforced in accordance with, the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.5 <U>Jurisdiction; Specific Enforcement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Parties agree that irreparable damage would occur (for which monetary damages, even if available, would not be an adequate remedy) in
the event that any of the provisions of this Agreement were not performed (including failing to take such actions as are required of it hereunder to consummate the transactions contemplated by this Agreement), or were threatened to be not performed,
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that, in addition to any other remedy that may be available to it, including monetary damages, each of the Parties shall be entitled to an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement (including the Company seeking to cause Parent to comply with its obligations pursuant to
<U>Section</U><U></U><U>&nbsp;5.17(a)</U>) exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular
matter, any federal court within the State of Delaware) and all such rights and remedies at law or in equity shall be cumulative, except as may be limited by <U>Section</U><U></U><U>&nbsp;7.3</U>. Each of the Parties agrees that it will not oppose
the granting of an injunction, specific performance and other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity.
The Parties further agree that no Party to this Agreement shall be required to obtain, secure, furnish or post any bond, security or similar instrument in connection with or as a condition to obtaining any remedy referred to in this
<U>Section</U><U></U><U>&nbsp;8.5</U> and each Party waives any objection to the imposition of such relief or any right it may have to require the obtaining, securing, furnishing or posting of any such bond, security or similar instrument. In
addition, each of the Parties irrevocably agrees that any legal action or proceeding with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and
the rights and obligations arising hereunder brought by the other Party hereto or its successors or assigns or any other Relevant Matter, shall be brought and determined exclusively in the Delaware Court of Chancery and any state appellate court
therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court within the State of Delaware). Each of the Parties hereby irrevocably submits with regard to
any such action or proceeding for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any action relating to this Agreement or any of the
transactions contemplated by this Agreement or any other Relevant Matter in any court other than the aforesaid courts. Each of the Parties hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or
otherwise, in any action or proceeding with respect to this Agreement or any other Relevant Matter, (i)&nbsp;any claim that it is not personally subject to the jurisdiction of the above named courts, (ii)&nbsp;any claim that it or its property is
exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise)
and (iii)&nbsp;to the fullest extent permitted by applicable Law, any claim that (A)&nbsp;the suit, action or proceeding in such court is brought in an inconvenient forum, (B)&nbsp;the venue of such suit, action or proceeding is improper or
(C)&nbsp;this Agreement, or the subject matter hereof, may not be enforced in or by such courts. Each of Parent, Merger Sub and the Company agrees that a final judgment in any action or proceeding shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment or in any other manner provided by Law. To the fullest extent permitted by applicable Law, each of the Parties hereby consents to the service of process in accordance with <U>Section</U><U></U><U>&nbsp;8.7</U>;
<U>provided</U>, <U>however</U>, that nothing herein shall affect the right of any Party to serve legal process in any other manner permitted by Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything herein to the contrary, each of the Parties agrees that it will not bring or support any legal action or
proceeding, whether in Law or in equity, whether in contract or in tort or otherwise against the Financing Sources and their respective current, former or future directors, officers, general or limited partners, stockholders, members, managers,
controlling persons, Affiliates, employees or advisors in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance
thereof, in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable law jurisdiction is vested </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.6 <U>WAIVER OF JURY TRIAL</U>. EACH OF THE PARTIES IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR
PROCEEDING (WHETHER AT LAW, IN CONTRACT, IN TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR ANY OTHER RELEVANT MATTER (INCLUDING ANY ACTION, PROCEEDING OR COUNTERCLAIM AGAINST ANY FINANCING
SOURCE). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.7 <U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be deemed given
(a)&nbsp;upon personal delivery to the Party to be notified; (b)&nbsp;when received when sent by email by the Party to be notified; <U>provided</U>, <U>however</U>, that notice given by email shall not be effective unless either (i)&nbsp;a duplicate
copy of such email notice is promptly given by one of the other methods described in this <U>Section</U><U></U><U>&nbsp;8.7</U> or (ii)&nbsp;the receiving Party delivers a written confirmation of receipt for such notice either by email or any other
method described in this <U>Section</U><U></U><U>&nbsp;8.7</U> or (c)&nbsp;when delivered by a courier (with confirmation of delivery); in each case to the Party to be notified at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To Parent or Merger Sub: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Saxonburg, PA 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: <FONT
STYLE="white-space:nowrap">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chuck.Mattera@II-VI.com</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
&nbsp;&nbsp;&nbsp;Vincent D. Mattera, Jr., Chief Executive Officer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with copies to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Boulevard </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Saxonburg, PA 16056 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <FONT STYLE="white-space:nowrap">JoAnne.Schwendinger@II-VI.com</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp; Jo Anne Schwendinger, Chief Legal and Compliance Officer and Secretary </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Wachtell, Lipton, Rosen&nbsp;&amp; Katz </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">51 West 52nd Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY
10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ajnussbaum@wlrk.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;klcain@wlrk.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp; Andrew J. Nussbaum </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Karessa L. Cain </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Coherent, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Santa Clara, CA 95054 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
kevin.palatnik@coherent.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;bret.dimarco@coherent.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Kevin Palatnik </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bret DiMarco </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies to (which shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">525 University Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Palo Alto,
CA 94301 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mike.ringler@skadden.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
sonia.nijjar@skadden.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp; Michael S. Ringler </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sonia K. Nijjar </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as any Party shall specify by written notice so given, and such notice shall be deemed to have been delivered as of the date so
telecommunicated or personally delivered; <U>provided</U> that any notice received by electronic mail or otherwise at the addressee&#146;s location on any Business Day after 5:00 p.m. (addressee&#146;s local time) or on any day that is not a
Business Day shall be deemed to have been received at 9:00 a.m. (addressee&#146;s local time) on the next Business Day. Any Party to this Agreement may notify, in accordance with the procedures set forth in this
<U>Section</U><U></U><U>&nbsp;8.7</U>, any other Party of any changes to the address or any of the other details specified in this paragraph; <U>provided</U>, <U>however</U>, that such notification shall only be effective on the date specified in
such notice or five Business Days after the notice is properly given, whichever is later. Rejection or other refusal to accept or the inability to deliver because of changed address of which no notice was given shall be deemed to be receipt of the
notice as of the date of such rejection, refusal or inability to deliver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.8 <U>Assignment; Binding Effect</U>. Neither
this Agreement nor any of the rights, interests or obligations hereunder shall be assigned or delegated by any of the Parties without the prior written consent of the other Parties; <U>provided</U>, <U>however</U>, that Parent may assign its rights
under this Agreement to the Financing Sources as collateral security. Subject to the first sentence of this <U>Section</U><U></U><U>&nbsp;8.8</U>, this Agreement shall be binding upon and shall inure to the benefit of the Parties and their
respective successors and assigns. Any purported assignment not permitted under this Section shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.9
<U>Severability</U>. Any term, covenant, restriction or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without
rendering invalid or unenforceable the remaining terms, covenants, restrictions and provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to
be only so broad as is enforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10 <U>Entire Agreement</U>. This Agreement, together with the exhibits hereto,
schedules hereto and the Confidentiality Agreement, constitute the entire agreement and supersedes all other prior agreements and understandings, both written and oral, between the Parties, or among any of them, with respect to the subject matter
hereof and thereof, and, subject to <U>Section</U><U></U><U>&nbsp;8.13</U>, this Agreement is not intended to grant standing to any person other than the Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11 <U>Amendments; Waivers</U>. At any time prior to the Effective Time, any provision of this Agreement may be amended or
waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by a duly authorized representative of each of the Company, Parent and Merger Sub; <U>provided</U>, <U>however</U>, that after receipt of Company
Stockholder Approval, if any such amendment or waiver shall by applicable Law or in accordance with the rules and regulations of Nasdaq require further approval of the stockholders of the Company, the effectiveness of such amendment or waiver shall
be subject to the approval of the stockholders of the Company. Notwithstanding the foregoing, no failure or delay by any Party hereto in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise
thereof preclude any other or further exercise of any other right hereunder. Notwithstanding anything to the contrary contained herein, <U>Section</U><U></U><U>&nbsp;7.3(f)</U>, <U>Section</U><U></U><U>&nbsp;8.4</U>,
<U>Section</U><U></U><U>&nbsp;8.5(b)</U>, <U>Section</U><U></U><U>&nbsp;8.6</U>, <U>Section</U><U></U><U>&nbsp;8.8</U>, this <U>Section</U><U></U><U>&nbsp;8.11</U> and <U>Section</U><U></U><U>&nbsp;8.13</U> may not be amended, supplemented, waived
or otherwise modified in a manner materially adverse to any Financing Source without the prior written consent of such Financing Source. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12 <U>Headings</U>. Headings of the Articles and Sections of this Agreement
are for convenience of the Parties only and shall be given no substantive or interpretive effect whatsoever. The table of contents to this Agreement is for reference purposes only and shall not affect in any way the meaning or interpretation of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13 <U>No Third-Party Beneficiaries; Liability of Financing Sources</U>. Each of Parent, Merger Sub and the
Company agrees that their respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other Parties, in accordance with and subject to the terms of this Agreement and this Agreement is not
intended to, and does not, confer upon any person other than the Parties any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, other than: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) after the Effective Time, with respect to the provisions of <U>Section</U><U></U><U>&nbsp;5.10</U>, which shall inure to the benefit of
the persons or entities benefitting therefrom who are intended to be third-party beneficiaries thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) after the Effective Time, the
rights of the holders of Company Common Stock to receive the Merger Consideration in accordance with the terms and conditions of this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) after the Effective Time, the rights of the holders of Company RSUs to receive the Converted RSUs, as contemplated by the applicable
provisions of <U>Section</U><U></U><U>&nbsp;2.5</U>, in accordance with the terms and conditions of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that the Financing
Sources shall be express third-party beneficiaries of <U>Section</U><U></U><U>&nbsp;7.3(f)</U>, <U>Section</U><U></U><U>&nbsp;8.4</U>, <U>Section</U><U></U><U>&nbsp;8.5(b)</U>, <U>Section</U><U></U><U>&nbsp;8.6</U>,
<U>Section</U><U></U><U>&nbsp;8.8</U>, <U>Section</U><U></U><U>&nbsp;8.11</U> and this <U>Section</U><U></U><U>&nbsp;8.13</U>, and each of such Sections shall expressly inure to the benefit of the Financing Sources and the Financing Sources shall be
entitled to rely on and enforce the provisions of such Sections. Notwithstanding anything to the contrary contained herein, the Company agrees (on behalf of itself and its Affiliates and each officer, director, employee, member, manager, partner,
controlling person, advisor, attorney, agent and representative thereof) that (i)&nbsp;it shall not have any rights or claims against any Financing Source of Parent in connection with this Agreement, the Financing or the transactions contemplated
hereby or thereby, (ii)&nbsp;it will not bring or support any suit, action or proceeding against any Financing Source of Parent in connection with this Agreement, the Financing or the transactions contemplated hereby or thereby, and (iii)&nbsp;no
Financing Source shall have any liability for any claims or damages to the Company in connection with this Agreement, the Financing or the transactions contemplated hereby or thereby; <U>provided</U> that following consummation of the Merger, the
foregoing will not limit the rights of the parties to any Financing Agreement. Nothing in this <U>Section</U><U></U><U>&nbsp;8.13</U> shall in any way limit or qualify the obligations and liabilities of the parties to the Financing Commitments to
each other or in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14 <U>Interpretation</U>. When a reference is made in this Agreement to an Article
or Section, such reference shall be to an Article or Section of this Agreement unless otherwise indicated. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be
followed by the words &#147;without limitation.&#148; The words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement, unless the context otherwise requires. The phrases &#147;the date of this Agreement&#148; and &#147;the date hereof&#148; and terms or phrases of similar import shall be deemed to refer to March&nbsp;25, 2021,
unless the context requires otherwise. All terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant thereto unless otherwise defined therein. The definitions contained
in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. References in this Agreement to specific laws or to specific provisions of
laws shall include all rules and regulations promulgated thereunder, and any statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time to time amended, modified or supplemented,
including by succession of comparable successor statutes (<U>provided</U> that for purposes of any representations and warranties contained in this Agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that are made as of a specific date or dates, references to any statute shall be deemed to refer to such statute, as amended, and to any rules or regulations promulgated thereunder, in each case,
as of such date). Each of the Parties has participated in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must be construed as if it is drafted by all Parties, and no
presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of authorship of any of the provisions of this Agreement. The inclusion of any item in the Company Disclosure Letter or Parent Disclosure Letter shall not be
deemed to be an admission or evidence of materiality of such item, nor shall it establish any standard of materiality for any purpose whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.15 <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>General Definitions</U><I>. </I>References in this Agreement to &#147;<U>control</U>&#148; (including, with its correlative meanings,
&#147;<U>controlled by</U>&#148; and &#147;<U>under common control with</U>&#148;) means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a person, whether through the ownership of
securities or partnership or other ownership interests, by contract or otherwise. References in this Agreement (except as specifically otherwise defined) to &#147;<U>person</U>&#148; means an individual, a corporation, a partnership, a limited
liability company, an association, a trust or any other entity, group (as such term is used in Section&nbsp;13 of the Exchange Act) or organization, including a Governmental Entity, and any permitted successors and assigns of such person. As used in
this Agreement, &#147;<U>knowledge</U>&#148; means (i)&nbsp;with respect to Parent and its Subsidiaries, the actual knowledge of the individuals listed in <U>Section</U><U></U><U>&nbsp;8.15(a)</U> of the Parent Disclosure Letter and (ii)&nbsp;with
respect to the Company and its Subsidiaries, the actual knowledge of the individuals listed on <U>Section</U><U></U><U>&nbsp;8.15(a)</U> of the Company Disclosure Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Certain Specified Definitions</U>. As used in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Affiliate</U>&#148; means, as to any person, any other person which, directly or indirectly, controls, or is
controlled by, or is under common control with, such person. For the purpose of this definition, &#147;<U>control</U>&#148; (including with correlative meanings, &#147;<U>controlled by</U>&#148; and &#147;<U>under common control with</U>&#148;),
when used with respect to any specified person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such person, whether through the ownership of voting securities or
other interests, by contract, agreement, obligation, indenture, instrument, lease, promise, arrangement, release, warranty, commitment, undertaking or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Antitrust Law</U>&#148; means the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal
Trade Commission Act, as amended, and all other antitrust or other competition Laws of jurisdictions other than the United States and all other Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade or lessening of competition through merger or acquisition and any investment laws relating to foreign ownership and all investment laws relating to foreign ownership. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>Business Day</U>&#148; means a day, other than a Saturday, Sunday or other day on which commercial banks in the
County of New York, New York are authorized or required by applicable Law to be closed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) &#147;<U>Code</U>&#148; means
the U.S. Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Company Benefit Plan</U>&#148; means each &#147;employee
pension benefit plan&#148; (as defined in Section&nbsp;3(2) of ERISA), each &#147;employee welfare benefit plan&#148; (as defined in Section&nbsp;3(1) of ERISA) (in each case, whether or not such plan is subject to ERISA) and each other plan,
policy, agreement or arrangement (whether written or oral) relating to stock options, stock purchases, stock awards, deferred compensation, bonus, severance, retention, employment, change of control, fringe benefits, supplemental benefits or other
employee benefits, in each case, sponsored, maintained or contributed to, or required to be sponsored, maintained or contributed to, by the Company or its Subsidiaries, for the benefit of current or former employees, officers, directors or
consultants of the Company or its Subsidiaries, or with respect to which the Company or any of its Subsidiaries has any liability, other than any Multiemployer Plan and other than any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such benefit, plan, policy, agreement or arrangement if and to the extent required to be provided, maintained or contributed to under applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) &#147;<U>Company COVID Action</U>&#148; means any reasonable action taken or omitted to be taken after the date of this
Agreement that the Company reasonably determines to be necessary or prudent for the Company or its Subsidiaries to take in connection with or in response to COVID-19, including the establishment of any policy, procedure or protocol, in each case in
connection with or in response to: (A)&nbsp;events surrounding any pandemic or public health emergency caused by COVID-19; (B)&nbsp;reinitiating operation of all or a portion of the Company&#146;s and its Subsidiaries&#146; respective businesses;
(C)&nbsp;mitigating the effects of such events, pandemic or public health emergency on the business of one or more of the Company and its Subsidiaries; or (D)&nbsp;protecting the health and safety of customers, employees and other business
relationships and ensuring compliance with any legal requirements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) &#147;<U>Company Intervening Event</U>&#148;
means any material event or development or material change in circumstances first occurring or arising after the date of this Agreement and prior to the Company Stockholder Approval if and only if such event, development or change in circumstances
was neither known by the Company Board or those individuals listed on <U>Section</U><U></U><U>&nbsp;8.15(a)</U> of the Company Disclosure Letter nor reasonably foreseeable by such persons as of or prior to the date of this Agreement; <U>provided</U>
that in no event shall the following events, developments or changes in circumstances constitute a Company Intervening Event: (A)&nbsp;events, developments or changes that involve or relate to a Company Takeover Proposal (which matters shall be
addressed by and subject to <U>Section</U><U></U><U>&nbsp;5.4(b)</U>); or (B)&nbsp;the fact in and of itself that the Company or Parent meets or exceeds or fails to meet or exceed internal or published projections, forecasts or revenue or earnings
predictions for any period; <U>provided</U> that the exceptions in clause&nbsp;(B) shall not exclude any event, development or change in circumstance underlying any such change in market price or trading volume, or meeting or exceeding, or failure
to meet or exceed such projections, forecasts or predictions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) &#147;<U>Company Material Adverse Effect</U>&#148;
means an event, state of facts, circumstance, change, effect, development, occurrence or combination of the foregoing (an &#147;<U>Effect</U>&#148;) that individually or in the aggregate has had, or would reasonably be expected to have, a material
adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole; <U>provided</U> that the term Company Material Adverse Effect will not include any Effect to the extent resulting
from or arising out of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) changes after the date of this Agreement in general business, economic or market conditions in
the United States or elsewhere in the world (including changes generally in prevailing interest rates, credit availability and liquidity, currency exchange rates and price levels or trading volumes in the United States or foreign securities or
credit markets), changes in political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, or any outbreak or escalation of
hostilities, declared or undeclared acts of war or terrorism, in each case generally affecting the industries in which the Company and its Subsidiaries operate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any changes or developments generally in the industries in which the Company or any of its Subsidiaries are expected to
conduct their business from and after the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the announcement or the existence of, compliance with or
performance under, this Agreement or the transactions contemplated hereby (<U>provided</U>, <U>however</U>, that the exceptions in this clause&nbsp;(C) shall not apply to any representation or warranty contained in
<U>Section</U><U></U><U>&nbsp;3.3(a)</U> or <U>Section</U><U></U><U>&nbsp;3.3(c)(i)</U> to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or
the performance of obligations or satisfaction of conditions under this Agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any taking of any action or
failure to take an action at the request of Parent or its Affiliates or which is required by the terms of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) changes in applicable Law, GAAP or accounting standards; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) floods, hurricanes, tornados, earthquakes, fires or other natural disasters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) national or international disasters, acts of God, sabotage, calamities, emergencies, or any escalation or worsening
thereof, whether or not occurring or commenced before the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) any epidemic, pandemic or disease
outbreak (including COVID-19) and any political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, the Centers for Disease Control
and Prevention or the World Health Organization, &#147;sheltering in place,&#148; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law (including
COVID-19 Measures), directive, pronouncement or guideline or interpretation thereof, or the action of any third party arising out of or relating to any of the foregoing, in each case, following the date of this Agreement or any material worsening of
such conditions threatened or existing as of the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) any Actions arising from allegations of
breach of fiduciary duty or otherwise relating to this Agreement or the transactions contemplated hereby; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) failure
by the Company to meet any financial projections or forecasts or estimates of revenues, earnings or other financial metrics for any period (<U>provided</U> that the exception in this clause&nbsp;(J) shall not prevent or otherwise affect a
determination that any event, change, effect, development or occurrence underlying such failure has resulted in, or contributed to, a Company Material Adverse Effect); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>except</U>, in each case with respect to clauses&nbsp;(A), (B), (E), (F), (G)&nbsp;and (H), to the extent disproportionately affecting the
Company and its Subsidiaries, taken as a whole, relative to other similarly situated companies in the industries in which the Company and its Subsidiaries are expected to operate from and after the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) &#147;<U>Company RSU</U>&#148; means a restricted stock unit covering shares of Company Common Stock, including any
restricted stock units subject to performance-vesting goals or metrics. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) &#147;<U>Company Superior Proposal</U>&#148;
means a bona fide, unsolicited written Company Takeover Proposal (A)&nbsp;that did not result from a material breach (or a deemed material breach) of <U>Section</U><U></U><U>&nbsp;5.4</U>, (B)&nbsp;that if consummated would result in a third party
(or in the case of a direct merger between such third party and the Company, the stockholders of such third party) acquiring, directly or indirectly, more than 50.1% of the outstanding Company Common Stock or more than 50.1% of the assets or
revenues of the Company and its Subsidiaries, taken as a whole, (C)&nbsp;that the Company Board determines in good faith, after consultation with its outside financial advisor and outside legal counsel, is reasonably capable of being completed,
taking into account all financial, legal, regulatory, timing and other aspects of such proposal, including all conditions contained therein and the person making such Company Takeover Proposal, and (D)&nbsp;that the Company Board determines in good
faith after consultation with its outside financial advisor and outside legal counsel (taking into account any changes to this Agreement proposed by Parent in response to such Company Takeover Proposal, and all financial, legal, regulatory, timing
and other aspects of such Company Takeover Proposal, including all conditions contained therein and the person making such proposal, and this Agreement), is more favorable to the stockholders of the Company from a financial point of view than the
transaction contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) &#147;<U>Company Takeover Proposal</U>&#148; means (A)&nbsp;any inquiry,
proposal or offer for or with respect to (or expression by any person that it is considering or may engage in) a merger, consolidation, business combination, recapitalization, binding share exchange, liquidation, dissolution, joint venture or other
similar transaction involving the Company or any of its Subsidiaries whose assets, taken together, constitute 15% or more of the Company&#146;s consolidated assets, (B)&nbsp;any inquiry, proposal or offer (including tender or exchange
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
offers) to (or expression by any person that it is considering or may seek to) acquire in any manner, directly or indirectly, in one or more transactions, more than 15% of the outstanding Company
Common Stock or securities of the Company representing more than 15% of the voting power of the Company or (C)&nbsp;any inquiry, proposal or offer to (or expression by any person that it is considering or may seek to) acquire in any manner
(including the acquisition of stock in any Subsidiary of the Company), directly or indirectly, in one or more transactions, assets or businesses of the Company or its Subsidiaries, including pursuant to a joint venture, representing more than 15% of
the consolidated assets, revenues or net income of the Company, in each case, other than the Merger. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)
&#147;<U>Compliant</U>&#148; means, with respect to the Required Financial Information, that: (i)&nbsp;such Required Financial Information does not contain any untrue statement of a material fact regarding the Company and/or its Subsidiaries, or
omit to state any material fact regarding the Company and/or its Subsidiaries necessary in order to make such Required Financial Information not misleading in light of the circumstances under which they were made; and (ii)&nbsp;with respect to any
financial statements required to be delivered pursuant to the definition of Required Financial Information, (a)&nbsp;the Company&#146;s independent auditors shall not have withdrawn any audit opinion with respect to any such audited financial
statements (unless a new unqualified audit opinion has been received in respect thereof from such auditors or another nationally recognized independent registered accounting firm) and (b)&nbsp;the Company shall not have been informed by its
independent auditors that it is required to restate, and the Company has not restated, any financial statements required to be delivered pursuant to the definition of Required Financial Information (and is not actively considering any such
restatements); <U>provided</U> that such Required Financial Information shall be deemed Compliant if and when (x)&nbsp;any such restatement has been completed by the Company and updated financial statements delivered pursuant to the delivery of the
Required Financial Information or (y)&nbsp;the Company&#146;s independent auditors inform the Company that no such restatement is needed. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii) &#147;<U>Contract</U>&#148; means, with respect to a person, any contract, note, bond, mortgage, indenture, deed of
trust, license, lease, agreement, arrangement, commitment or other instrument or obligation, whether oral or written, that is binding on such person under applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv) &#147;<U>Controlled Group Liability</U>&#148; means any and all liabilities (A)&nbsp;under Title IV of ERISA,
(B)&nbsp;under Section&nbsp;302 of ERISA or (C)&nbsp;under Sections&nbsp;412, 430 or 4971 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv) &#147;<U><FONT
STYLE="white-space:nowrap">COVID-19</FONT></U>&#148; means <FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT> or COVID-19, and all evolutions thereof or related or associated epidemics, pandemics or disease outbreaks. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi) &#147;<U>COVID-</U><U>19</U><U> Measures</U>&#148; means any legally binding quarantine, &#147;shelter in place,&#148;
&#147;stay at home,&#148; workforce reduction, social distancing, shut down, closure, sequester or any other law, order or directive by any Governmental Entity in connection with or in response to COVID-19, including the Coronavirus Aid, Relief, and
Economic Security (CARES)&nbsp;Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii) &#147;<U>Debt Financing Sources</U>&#148; means the persons (other than Parent
or any Affiliate of Parent) that have committed to provide or have otherwise entered into agreements in connection with any of the Debt Financing and any joinder agreements, credit agreements or other definitive agreements entered into pursuant
thereto or relating thereto, and any arrangers or administrative agents in connection with the Debt Financing (including, but not limited to, the Debt Commitment Parties), together with their current and future Affiliates and their and such
Affiliates&#146; officers, directors, employees, attorneys, partners, controlling parties, advisors, members, managers, accountants, consultants, agents and representatives and funding sources of each of the foregoing involved in any of the Debt
Financing and their successors and assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xviii) &#147;<U>Director RSU</U>&#148; means a Company RSU granted to a <FONT
STYLE="white-space:nowrap">non-employee</FONT> member of the Company Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xix) &#147;<U>Environmental Law</U>&#148;
means any Law in effect prior to or as of the date hereof relating to pollution or protection of the environment (including ambient air, soil, surface water or groundwater, or subsurface strata), natural resources, endangered or threatened species,
human health or safety (as it relates to exposure to Hazardous Materials), or that prohibits, regulates or controls any Hazardous Material or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
products containing any Hazardous Material, including the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. &#167; 9601 et seq., the Resource Conservation and
Recovery Act, 42 U.S.C. &#167; 6901 et seq., the Toxic Substances Control Act, 15 U.S.C. &#167; 2601 et seq., the Federal Water Pollution Control Act, 33 U.S.C. &#167; 1251 et seq., the Clean Air Act, 42 U.S.C. &#167; 7401 et seq., the Federal
Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. &#167; 121 et seq., the Safe Drinking Water Act, 42 U.S.C. &#167; 300f et seq., the Oil Pollution Act of 1990, the European Union (&#147;<U>EU</U>&#148;) Directive 2012/19/EU on waste electrical
and electronic equipment, the EU Directive 2011/65/EU on the restriction on the use of certain hazardous substances, the Administrative Measures on the Control of Pollution Caused by Electronic Information Products, and the European Commission
Regulation 1907/2006, and analogous foreign, provincial, state and local Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx) &#147;<U>Equity Financing
Sources</U>&#148; means the persons (other than Parent or any Affiliate of Parent) that have committed to provide or have otherwise entered into agreements in connection with the Equity Financing and any joinder agreements or other definitive
agreements entered into pursuant thereto or relating thereto (including, but not limited to, the Investor), together with their current and future Affiliates and their and such Affiliates&#146; officers, directors, employees, attorneys, partners,
controlling parties, advisors, members, managers, accountants, consultants, agents and representatives and funding sources of each of the foregoing involved in the Equity Financing and their successors and assigns. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxi) &#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxii) &#147;<U>ERISA Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or
business that is, or was at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is,
or was at the relevant time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiii) &#147;<U>ESPP</U>&#148; means the Company&#146;s Employee Stock Purchase Plan, as amended and restated as of
February&nbsp;28, 2012. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiv) &#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, and
all regulations and rules issued thereunder, or any successor Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxv) &#147;<U>Exchange Ratio</U>&#148; means 0.91
share of Parent Common Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxvi) &#147;<U>Excluded Information</U>&#148; means (A)&nbsp;&#147;segment reporting&#148;
(to the extent not required in SEC filings) and financial statements and data that would be required by Rule&nbsp;3-05 (unless previously filed by the Company with the SEC), 3-09, 3-10 or <FONT STYLE="white-space:nowrap">3-16</FONT> of Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Securities Act, (B)&nbsp;information regarding officers or directors prior to consummation of the Merger (except information if any of such persons will remain officers, directors or managers after
consummation of the Merger), executive compensation and related party disclosure (unless the Company or any of its Subsidiaries was party to any such related party transactions prior to consummation of the Merger and such transactions will continue
in place after consummation of the Merger) or any Compensation Discussion and Analysis or information required by Item&nbsp;302 (to the extent not so provided in SEC filings) or 402 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the
Securities Act and any other information that would be required by Part&nbsp;III of Form&nbsp;10-K (except to the extent previously filed with the SEC and except any information relating to persons who will remain officers, directors or managers
after consummation of the Merger), (C)&nbsp;any description of all or any component of the Financing, including any such description to be included in liquidity and capital resources disclosure or in any &#147;description of notes&#148; or
&#147;description of other indebtedness&#148; section, or other information customarily provided by the Financing Sources or their counsel, (D)&nbsp;risk factors relating to all or any component of the Financing, (E)&nbsp;information regarding
affiliate transactions that may exist following consummation of the Merger (unless the Company or any of its Subsidiaries was party to any such transactions prior to consummation of the Merger), (F)&nbsp;information regarding any post-Closing pro
forma cost savings, synergies, capitalization, ownership or other post-Closing pro forma adjustments (excluding information that is historical financial information of the Company), it being understood that Parent, and not
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company or its Subsidiaries or their respective Representatives, shall be responsible for the preparation of the pro forma financial statements and any other pro forma information, including
any pro forma adjustments, (G)&nbsp;information that is not available to the Company without undue effort or expense and (H)&nbsp;in addition, in the case of a Rule&nbsp;144A financing, other information customarily excluded from a Rule&nbsp;144A
offering memorandum. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxvii) &#147;<U>Financing Agreement</U>&#148; means any credit agreement, note or similar agreement,
in each case, evidencing or relating to indebtedness to be incurred in connection with the Debt Financing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxviii)
&#147;<U>Financing Sources</U>&#148; means the Debt Financing Sources and Equity Financing Sources. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxix)
&#147;<U>Finisar Convertible Notes</U>&#148; means the 0.50% Convertible Senior Notes due 2036 of Finisar Corporation, a Delaware corporation and Subsidiary of Parent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxx) &#147;<U>Government Contract</U>&#148; means any prime contract, subcontract, blanket purchase agreement, reseller
agreement, task, purchase, or delivery order that is (a)&nbsp;between the Company and the U.S. Government or any Governmental Entity or (b)&nbsp;entered into by the Company as a subcontractor (at any tier) to provide supplies or services in
connection with a Contract between another entity and a Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxi) &#147;<U>Hazardous Materials</U>&#148;
means any substance, waste, liquid or gaseous or solid matter for which liability or standards of conduct may be imposed, or which is or is deemed to be hazardous, hazardous waste, solid or liquid waste, toxic, a pollutant, a deleterious substance,
a contaminant or a source of pollution or contamination, in each case regulated by, or otherwise subject to, any Environmental Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxii) &#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules
and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxiii) &#147;<U>Immaterial License</U>&#148; means, with respect to a Party, any
(a)&nbsp;permitted use right to confidential information in a nondisclosure agreement; (b)&nbsp;license, assignment, covenant not to sue, or waiver of rights granted by any current and former employees, consultants or contractors of such Party or
its Subsidiaries for the benefit of such Party or its Subsidiaries; (c)&nbsp;rights granted under any customer agreement in the Ordinary Course of Business; or (d)&nbsp;any <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license that is not
material to the business of such Party or its Subsidiaries and is merely incidental to the transaction contemplated in such license, the commercial purpose of which is primarily for something other than such license, such as: (w)&nbsp;sales or
marketing or similar Contract that includes a license to use the trademarks of such Party or its Subsidiaries for the purposes of promoting the goods or services of such Party or its Subsidiaries; (x)&nbsp;vendor Contract that includes permission
for the vendor to identify such Party or its Subsidiary as a customer of the vendor; (y)&nbsp;Contract to purchase or lease equipment or materials, such as a photocopier, computer or mobile phone that also contains a license of Intellectual
Property; or (z)&nbsp;license for the use of computer software that is preconfigured, preinstalled or embedded on hardware or other equipment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxiv) &#147;<U>Intellectual Property</U>&#148; means any of the following, as they exist anywhere in the world, whether
registered or unregistered: (i)&nbsp;patents, patentable inventions and other patent rights (including any divisions, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues,
reexaminations and interpretations thereof); (ii)&nbsp;trademarks, service marks, trade dress, trade names, taglines, brand names, logos and corporate names and all goodwill related thereto; (iii)&nbsp;copyrights, mask works and designs;
(iv)&nbsp;trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, processes, procedures, databases, confidential business information and other proprietary information and rights; (v)&nbsp;proprietary rights in computer software
programs, including all source code, object code, specifications, designs and documentation related thereto; and (vi)&nbsp;domain names and internet addresses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxv) &#147;<U>IRS</U>&#148; means the Internal Revenue Service of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxvi) &#147;<U>Material Government Contract</U>&#148; means any Government Contract for which: (i)&nbsp;the total contract
value, in the aggregate (including the exercise of any options), is $3,000,000 or greater and for which the original contract was executed since January&nbsp;1, 2018 through the date of this Agreement, and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
which either (a)&nbsp;is with respect to or involves the direct or indirect provision of any goods or services to any intelligence, defense or military branch of any U.S. Governmental Entity or
(b)&nbsp;to the knowledge of the Company, involves the direct or indirect provision of any Defense Article or Defense Service as defined in 22 C.F.R. 120.6 and 22 C.F.R. 120.9 to an <FONT STYLE="white-space:nowrap">end-user</FONT> that is an
intelligence, defense, or military branch of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Governmental Entity as determined by relevant <FONT STYLE="white-space:nowrap">end-user</FONT> statement on applicable license or authorization or
equivalent requirements in the jurisdiction from which the goods or services are provided; (ii)&nbsp;the total contract value, in the aggregate (including the exercise of any options) is $5,000,000 or greater; or (iii)&nbsp;any security clearance or
similar authorization is required, including due to the classified or secret nature of such work. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxvii)
&#147;<U>Multiemployer Plan</U>&#148; means any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxviii) &#147;<U>Multiple Employer Plan</U>&#148; means a plan that has two or more contributing sponsors at least two of
whom are not under common control, within the meaning of Section&nbsp;4063 of ERISA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxix) &#147;<U>Nasdaq</U>&#148;
means the Nasdaq Global Select Market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xl) &#147;<U>Order</U>&#148; means any charge, order, writ, injunction, judgment,
decree, ruling, determination, directive, award or settlement, whether civil, criminal or administrative and whether formal or informal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xli) &#147;<U>Ordinary Course of Business</U>&#148; shall describe any action taken by a person if such action is
(A)&nbsp;consistent with such person&#146;s past practices and/or is taken in the ordinary course of such person&#146;s normal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations, (B)&nbsp;in the
case of an action taken by the Company or any of its Subsidiaries, a Company COVID Action and (C)&nbsp;in the case of an action taken by Parent or any of its Subsidiaries, a Parent COVID Action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlii) &#147;<U>Parent Benefit Plan</U>&#148; means each &#147;employee pension benefit plan&#148; (as defined in
Section&nbsp;3(2) of ERISA), each &#147;employee welfare benefit plan&#148; (as defined in Section&nbsp;3(1) of ERISA) (in each case, whether or not such plan is subject to ERISA), and each other plan, policy, agreement or arrangement (whether
written or oral) relating to stock options, stock purchases, stock awards, deferred compensation, bonus, severance, retention, employment, change of control, fringe benefits, supplemental benefits or other employee benefits, in each case, sponsored,
maintained or contributed to, or required to be sponsored, maintained or contributed to, by Parent or its Subsidiaries, for the benefit of current or former employees, officers, directors or consultants of Parent or its Subsidiaries or with respect
to which Parent or any of its Subsidiaries has any liability, other than any Multiemployer Plan and other than any such benefit, plan, policy, agreement or arrangement if and to the extent required to be provided, maintained or contributed to under
applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xliii) &#147;<U>Parent Common Stock VWAP</U>&#148; means the volume weighted average price of a share of
Parent Common Stock for a 10 trading day period, starting with the opening of trading on the 11th trading day prior to the Closing Date to the closing of trading on the second to last trading day prior to the Closing Date, as reported by Bloomberg.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xliv) &#147;<U>Parent Convertible Notes</U>&#148; means the 0.25% Convertible Senior Notes due 2022 of Parent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlv) &#147;<U>Parent COVID Action</U>&#148; means any reasonable action taken or omitted to be taken after the date of this
Agreement that Parent reasonably determines to be necessary or prudent for Parent or its Subsidiaries to take in connection with or in response to COVID-19, including the establishment of any policy, procedure or protocol, in each case in connection
with or in response to: (A)&nbsp;events surrounding any pandemic or public health emergency caused by COVID-19; (B)&nbsp;reinitiating operation of all or a portion of Parent&#146;s and its Subsidiaries&#146; respective businesses;
(C)&nbsp;mitigating the effects of such events, pandemic or public health emergency on the business of one or more of Parent and its Subsidiaries; or (D)&nbsp;protecting the health and safety of customers, employees and other business relationships
and ensuring compliance with any legal requirements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlvi) &#147;<U>Parent Intervening Event</U>&#148; means any material
event or development or material change in circumstances first occurring or arising after the date of this Agreement and prior to the Parent Stockholder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Approval if and only if such event, development or change in circumstances was neither known by the Parent Board or those individuals listed on <U>Section</U><U></U><U>&nbsp;8.15(a)</U> of the
Parent Disclosure Letter nor reasonably foreseeable by such persons as of or prior to the date of this Agreement; <U>provided</U> that in no event shall the following events, developments or changes in circumstances constitute a Company Intervening
Event: (A)&nbsp;events, developments, or changes that involve or relate to a Parent Takeover Proposal (which matters shall be addressed by and subject to <U>Section</U><U></U><U>&nbsp;5.5(b)</U>); or (B)&nbsp;the fact in and of itself that the
Company or Parent meets or exceeds or fails to meet or exceed internal or published projections, forecasts or revenue or earnings predictions for any period; <U>provided</U> that the exceptions in clause&nbsp;(B) shall not exclude any event,
development or change in circumstance underlying any such change in market price or trading volume, or meeting or exceeding, or failure to meet or exceed such projections, forecasts or predictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlvii) &#147;<U>Parent Material Adverse Effect</U>&#148; means an Effect that individually or in the aggregate has had, or
would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of Parent and its Subsidiaries, taken as a whole; <U>provided</U> that the term Parent Material Adverse Effect will not
include any Effect to the extent resulting from or arising out of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) changes after the date of this Agreement in general
business, economic or market conditions in the United States or elsewhere in the world (including changes generally in prevailing interest rates, credit availability and liquidity, currency exchange rates and price levels or trading volumes in the
United States or foreign securities or credit markets), changes in political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, or
any outbreak or escalation of hostilities, declared or undeclared acts of war or terrorism, in each case generally affecting the industries in which Parent and its Subsidiaries operate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) any changes or developments generally in the industries in which Parent or any of its Subsidiaries are expected to conduct
their business from and after the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the announcement or the existence of, compliance with or performance under,
this Agreement or the transactions contemplated hereby (<U>provided</U>, <U>however</U>, that the exceptions in this clause&nbsp;(C) shall not apply to any representation or warranty contained in <U>Section</U><U></U><U>&nbsp;4.3(a)</U> or
<U>Section</U><U></U><U>&nbsp;4.3(d)(i)</U> to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the performance of obligations or
satisfaction of conditions under this Agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) any taking of any action or failure to take an action at the request
of the Company or its Affiliates or which is required by the terms of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) changes in applicable Law, GAAP
or accounting standards; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) floods, hurricanes, tornados, earthquakes, fires or other natural disasters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) national or international disasters, acts of God, sabotage, calamities, emergencies, or any escalation or worsening
thereof, whether or not occurring or commenced before the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) any epidemic, pandemic or disease
outbreak (including COVID-19) and any political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, the Centers for Disease Control
and Prevention or the World Health Organization, &#147;sheltering in place,&#148; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including COVID-19) or any change in such law (including
COVID-19 Measures), directive, pronouncement or guideline or interpretation thereof, or the action of any third party arising out of or relating to any of the foregoing, in each case, following the date of this Agreement or any material worsening of
such conditions threatened or existing as of the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) any Actions arising from allegations of
breach of fiduciary duty or otherwise relating to this Agreement or the transactions contemplated hereby; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) failure by Parent to meet any financial projections or forecasts or
estimates of revenues, earnings or other financial metrics for any period (<U>provided</U> that the exception in this clause&nbsp;(J) shall not prevent or otherwise affect a determination that any event, change, effect, development or occurrence
underlying such failure has resulted in, or contributed to, a Parent Material Adverse Effect); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><U>except</U>, in each case with respect to
clauses&nbsp;(A), (B), (E), (F), (G) and (H), to the extent disproportionately affecting Parent and its Subsidiaries, taken as a whole, relative to other similarly situated companies in the industries in which Parent and its Subsidiaries are
expected to operate from and after the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlviii) &#147;<U>Parent RSU</U>&#148; means a restricted stock unit
covering shares of Parent Common Stock, including any restricted stock units subject to performance-vesting goals or metrics. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xlix) &#147;<U>Parent Superior Proposal</U>&#148; means a bona fide, unsolicited written Parent Takeover Proposal
(A)&nbsp;that did not result from a material breach (or a deemed material breach) of <U>Section</U><U></U><U>&nbsp;5.5</U>, (B)&nbsp;that if consummated would result in a third party (or in the case of a direct merger between such third party and
Parent, the stockholders of such third party) acquiring, directly or indirectly, more than 50.1% of the outstanding Parent Common Stock or more than 50.1% of the assets or revenues of Parent and its Subsidiaries, taken as a whole, (C)&nbsp;that the
Parent Board determines in good faith, after consultation with its outside financial advisor and outside legal counsel, is reasonably capable of being completed, taking into account all financial, legal, regulatory, timing and other aspects of such
proposal, including all conditions contained therein and the person making such Parent Takeover Proposal, and (D)&nbsp;that the Parent Board determines in good faith after consultation with its outside financial advisor and outside legal counsel
(taking into account any changes to this Agreement proposed by the Company in response to such Parent Takeover Proposal, and all financial, legal, regulatory, timing and other aspects of such Parent Takeover Proposal, including all conditions
contained therein and the person making such proposal, and this Agreement), is more favorable to the stockholders of Parent from a financial point of view than the transaction contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Parent Takeover Proposal</U>&#148; means (A)&nbsp;any inquiry, proposal or offer for or with respect to (or
expression by any person that it is considering or may engage in) a merger, consolidation, business combination, recapitalization, binding share exchange, liquidation, dissolution, joint venture or other similar transaction involving Parent or any
of its Subsidiaries whose assets, taken together, constitute 15% or more of Parent&#146;s consolidated assets, (B)&nbsp;any inquiry, proposal or offer (including tender or exchange offers) to (or expression by any person that it is considering or
may seek to) acquire in any manner, directly or indirectly, in one or more transactions, more than 15% of the outstanding Parent Common Stock or securities of Parent representing more than 15% of the voting power of Parent or (C)&nbsp;any inquiry,
proposal or offer to (or expression by any person that it is considering or may seek to) acquire in any manner (including the acquisition of stock in any Subsidiary of Parent), directly or indirectly, in one or more transactions, assets or
businesses of Parent or its Subsidiaries, including pursuant to a joint venture, representing more than 15% of the consolidated assets, revenues or net income of Parent, in each case, other than the Merger. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(li) &#147;<U>Pennsylvania Law</U>&#148; means Title 15 of the Pennsylvania Consolidated Statutes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lii) &#147;<U>Permit</U>&#148; means a franchise, license, permit, authorization, variance, exemption, order, registration,
clearance or approval of a Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(liii) &#147;<U>Permitted Lien</U>&#148; means (A)&nbsp;any Lien for Taxes
not yet due or, if due, not yet delinquent or which are being contested in good faith by appropriate proceedings and for which adequate reserves have been made, (B)&nbsp;vendors&#146;, mechanics&#146;, materialmens&#146;, carriers&#146;,
workers&#146;, landlords&#146;, repairmen&#146;s, warehousemen&#146;s, construction and other similar Liens arising or incurred in the Ordinary Course of Business or with respect to liabilities that are not yet due and payable or, if due, are not
delinquent or are being contested in good faith by appropriate proceedings, (C)&nbsp;Liens imposed or promulgated by applicable Law or any Governmental Entity with respect to Real Property, including zoning, building or similar
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
restrictions, (D)&nbsp;pledges or deposits in connection with workers&#146; compensation, unemployment insurance, and other social security legislation, (E)&nbsp;Liens relating to intercompany
borrowings among the Company and its wholly owned (direct or indirect) Subsidiaries, the Company Credit Agreement, or any other existing indebtedness of the Company or its Subsidiaries, (F)&nbsp;Real Property easements, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> leases, encroachments, restrictions, rights, servitudes, encumbrances, conditions or imperfections of title or other matters of a similar nature and other
similar Liens, which, individually and in the aggregate, do not materially impair the present use of the Real Property or otherwise materially impair the present business operations at the Real Property, (G)&nbsp;purchase money Liens or Liens under
capital lease arrangements, (H)&nbsp;licenses of Intellectual Property, (I)&nbsp;Liens disclosed in the Company Financial Statements or in the Parent Financial Statements, as applicable, or (J)&nbsp;other
<FONT STYLE="white-space:nowrap">non-monetary</FONT> Liens that do not, individually or in the aggregate, materially interfere with the present use, or materially detract from the value of, the property encumbered thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(liv) &#147;<U>Personal Data</U>&#148; shall mean any information about an identifiable natural person that is defined as
&#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;biometric information,&#148; &#147;nonpublic personal information,&#148; &#147;protected health information,&#148; &#147;individually identifiable health
information,&#148; &#147;protected health information&#148; or &#147;personal information&#148; under any applicable Law relating to privacy, data protection, or information security. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lv) &#147;<U>Real Property</U>&#148; means any lands, buildings, structures and other improvements, together with all fixtures
attached or appurtenant to the foregoing, and all easements, covenants, hereditaments and appurtenances that benefit the foregoing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lvi) &#147;<U>Subsidiary</U>&#148; means, with respect to any person, any corporation, partnership, association, trust or
other form of legal entity of which (A)&nbsp;fifty percent (50%) or more of the voting power of the outstanding voting securities are directly or indirectly owned by such person or (B)&nbsp;such person or any Subsidiary of such person is a general
partner. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lvii) &#147;<U>Takeover Laws</U>&#148; means any &#147;moratorium,&#148; &#147;control share acquisition,&#148;
&#147;fair price,&#148; &#147;supermajority,&#148; &#147;affiliate transactions,&#148; or &#147;business combination statute or regulation&#148; or other similar state anti-takeover laws and regulations (including, as applicable, DGCL 203 and
Subchapter F of Chapter 25 of Pennsylvania Law). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lviii) &#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means any and
all U.S. federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, imposts, levies, duties, fees or other similar governmental assessments, including all net income, gross receipts, capital, sales, use, ad valorem, value
added, transfer, franchise, profits, inventory, capital stock, license, withholding, payroll, employment, social security, unemployment, excise, severance, stamp, occupation, property and estimated taxes, escheat, customs duties and other taxes of
any kind whatsoever, including any and all interest, penalties, additions to tax or additional amounts imposed by any Governmental Entity in connection with respect thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lix) &#147;<U>Tax Return</U>&#148; means any report, return, refund, claim, election, statement, estimate, disclosure,
document, declaration or information report or return filed or required to be filed with or supplied or required to be supplied to a Taxing Authority (including any amendments thereto and including any attachment, schedule or statement thereto).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lx) &#147;<U>Taxing Authority</U>&#148; means any Governmental Entity exercising any authority to determine, impose,
regulate, collect, levy, assess, enforce or administer any Tax. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lxi) &#147;<U>Top Company Customer</U>&#148; means one of
the 14 largest customers and resellers of the Company and its Subsidiaries by revenue for the fiscal year ended October&nbsp;3, 2020. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lxii) &#147;<U>Top Company Vendor</U>&#148; means one of the 10 largest vendors, suppliers and third-party service providers
to the Company and its Subsidiaries by expenditure for the fiscal year ended October&nbsp;3, 2020. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lxiii) &#147;<U>Top
Parent Customer</U>&#148; means one of the 14 largest customers and resellers of Parent and its Subsidiaries by revenue for the fiscal year ended June&nbsp;30, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(lxiv) &#147;<U>Willful and Material Breach</U>&#148; means a material
breach that is a consequence of an act undertaken or failure to act by the breaching party with knowledge that the taking of or failure to take such act would cause a material breach of this Agreement. Notwithstanding the foregoing, a Party&#146;s
failure to consummate the Closing when required pursuant to <U>Section</U><U></U><U>&nbsp;1.2</U> shall be a Willful and Material Breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of the following terms is defined in the Section set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Action</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Indebtedness Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anti-Corruption Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.14(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book-Entry Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(a)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(a)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(a)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(a)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CIC Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.5(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitment Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Acceptable Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.4(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.4(e)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.5</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Capitalization Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.5</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Credit Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Credit Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Data Processors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.8(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Designee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.7</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Article&nbsp;III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Financial Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.4(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Indebtedness Payoff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Insurance Policy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.18</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.17(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Material Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.19(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Organizational Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.1(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Owned IP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.20(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.17(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.8(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Qualified Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Qualifying Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.6(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Real Property Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.17(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(a)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholder Advisory Vote</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholders&#146; Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.6(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subleased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.17(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subleases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.17(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuation Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Converted RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Covered Continuing Employee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.5(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Suisse</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D&amp;O Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.10(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Privacy Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.8(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Commitment Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Commitment Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Commitment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL 203</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.25</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL 262</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director RSU Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.5(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dissenting Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;8.15(b)(viii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Commitment Share Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expense Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(d)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fee Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Filing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing Commitments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Form <FONT STYLE="white-space:nowrap">S-4</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.4(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Entity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnified Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.27(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.20(j)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joint Proxy Statement/Prospectus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.8(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Letter of Transmittal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.4(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lien</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maximum Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.10(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1(a)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Cooperation</FONT> Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.17(b)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Overlap</FONT> Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.7(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Original End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Acceptable Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.5(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.5(e)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.3(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Capitalization Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent China Regulatory Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Data Processors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.9(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Disclosure Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Article&nbsp;IV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Expense Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(d)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Financial Advisor(s)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.5(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.18(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Mandatory Convertible Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Organizational Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.1(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Owned IP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.21(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.18(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.9(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Qualified Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Qualifying Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.6(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Real Property Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.18(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.5(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Series One Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Stockholders&#146; Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Sublease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.18(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.17(b)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Qualifying Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.5(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.7(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Relevant Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;8.4</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remedies Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Required Financial Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.17(b)(i)(D)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarbanes-Oxley Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.4(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;1.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.1(a)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Fee Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third-Party Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.7(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.20(k)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE FOLLOWS] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed and delivered
as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COHERENT, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andy W. Mattes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Andy W. Mattes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vincent D. Mattera Jr.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Vincent D. Mattera Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WATSON MERGER SUB INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Walter R. Bashaw II</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Walter R. Bashaw II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Agreement and Plan of Merger] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="anxbcov"></A>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXECUTION VERSION</U> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED INVESTMENT AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and between </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BCPE Watson (DE) SPV, LP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated
as of March&nbsp;30, 2021 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TABLE OF CONTENTS </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE I Definitions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 &nbsp;&nbsp;&nbsp;&nbsp;Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE II Purchase and Sale</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B><FONT STYLE="white-space:nowrap">B-12</FONT></B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 &nbsp;&nbsp;&nbsp;&nbsp;Purchase and Sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 &nbsp;&nbsp;&nbsp;&nbsp;Initial and Subsequent Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE III Representations and Warranties of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 &nbsp;&nbsp;&nbsp;&nbsp;Organization; Standing; Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 &nbsp;&nbsp;&nbsp;&nbsp;Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03 &nbsp;&nbsp;&nbsp;&nbsp;Authority; Noncontravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04 &nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05 &nbsp;&nbsp;&nbsp;&nbsp;Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06 &nbsp;&nbsp;&nbsp;&nbsp;Absence of Certain Changes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07 &nbsp;&nbsp;&nbsp;&nbsp;Internal Controls and Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08 &nbsp;&nbsp;&nbsp;&nbsp;No Undisclosed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09 &nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 &nbsp;&nbsp;&nbsp;&nbsp;Compliance with Laws; Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 &nbsp;&nbsp;&nbsp;&nbsp;Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 &nbsp;&nbsp;&nbsp;&nbsp;Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 &nbsp;&nbsp;&nbsp;&nbsp;Labor Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 &nbsp;&nbsp;&nbsp;&nbsp;Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 &nbsp;&nbsp;&nbsp;&nbsp;Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 &nbsp;&nbsp;&nbsp;&nbsp;No Rights Agreement; Anti-Takeover Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 &nbsp;&nbsp;&nbsp;&nbsp;Customers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 &nbsp;&nbsp;&nbsp;&nbsp;Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 &nbsp;&nbsp;&nbsp;&nbsp;Sale of Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 &nbsp;&nbsp;&nbsp;&nbsp;Listing and Maintenance Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 &nbsp;&nbsp;&nbsp;&nbsp;Status of Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 &nbsp;&nbsp;&nbsp;&nbsp;Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 &nbsp;&nbsp;&nbsp;&nbsp;Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 &nbsp;&nbsp;&nbsp;&nbsp;Affiliate Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 &nbsp;&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE IV Representations and Warranties of the Investor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-25</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 &nbsp;&nbsp;&nbsp;&nbsp;Organization; Standing; Ownership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 &nbsp;&nbsp;&nbsp;&nbsp;Authority; Noncontravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 &nbsp;&nbsp;&nbsp;&nbsp;Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 &nbsp;&nbsp;&nbsp;&nbsp;Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 &nbsp;&nbsp;&nbsp;&nbsp;Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 &nbsp;&nbsp;&nbsp;&nbsp;Securities Act Representations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 &nbsp;&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE V Additional Agreements</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 &nbsp;&nbsp;&nbsp;&nbsp;Negative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 &nbsp;&nbsp;&nbsp;&nbsp;Reasonable Best Efforts; Filings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 &nbsp;&nbsp;&nbsp;&nbsp;Corporate Actions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 &nbsp;&nbsp;&nbsp;&nbsp;Public Announcements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS</U> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(CONT&#146;D)</U> </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 &nbsp;&nbsp;&nbsp;&nbsp;Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 &nbsp;&nbsp;&nbsp;&nbsp;NASDAQ Listing of Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">B-33</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 &nbsp;&nbsp;&nbsp;&nbsp;Standstill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 &nbsp;&nbsp;&nbsp;&nbsp;Transfer Restrictions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 &nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 &nbsp;&nbsp;&nbsp;&nbsp;Legend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 &nbsp;&nbsp;&nbsp;&nbsp;Board Matters; Election of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 &nbsp;&nbsp;&nbsp;&nbsp;Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 &nbsp;&nbsp;&nbsp;&nbsp;Use of Proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 &nbsp;&nbsp;&nbsp;&nbsp;Back Leverage Cooperation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 &nbsp;&nbsp;&nbsp;&nbsp;State Securities Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 &nbsp;&nbsp;&nbsp;&nbsp;Information Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 &nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16 Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 &nbsp;&nbsp;&nbsp;&nbsp;VCOC Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 &nbsp;&nbsp;&nbsp;&nbsp;Target Acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 &nbsp;&nbsp;&nbsp;&nbsp;Statement With Respect to Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 &nbsp;&nbsp;&nbsp;&nbsp;Pipeline Financings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VI Conditions to Subsequent Closing</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-43</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Company and the
Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VII Termination; Survival</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-44</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 &nbsp;&nbsp;&nbsp;&nbsp;Termination Prior to the Subsequent Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02 &nbsp;&nbsp;&nbsp;&nbsp;Effect of Termination Prior to Subsequent
Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03 &nbsp;&nbsp;&nbsp;&nbsp;Survival and Limitation on Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VIII Miscellaneous</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>B-46</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01 &nbsp;&nbsp;&nbsp;&nbsp;Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02 &nbsp;&nbsp;&nbsp;&nbsp;Extension of Time, Waiver, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03 &nbsp;&nbsp;&nbsp;&nbsp;Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04 &nbsp;&nbsp;&nbsp;&nbsp;Counterparts; Electronic Delivery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05 &nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement; No Third-Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06 &nbsp;&nbsp;&nbsp;&nbsp;Governing Law; Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.07 &nbsp;&nbsp;&nbsp;&nbsp;Specific Enforcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.08 &nbsp;&nbsp;&nbsp;&nbsp;WAIVER OF JURY TRIAL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.09 &nbsp;&nbsp;&nbsp;&nbsp;Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10 &nbsp;&nbsp;&nbsp;&nbsp;Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11 &nbsp;&nbsp;&nbsp;&nbsp;Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12 &nbsp;&nbsp;&nbsp;&nbsp;Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13
<FONT STYLE="white-space:nowrap">&nbsp;&nbsp;&nbsp;&nbsp;Non-Recourse</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14 &nbsp;&nbsp;&nbsp;&nbsp;Effectiveness of Amendment and Restatement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">B-51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS</U> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(CONT&#146;D)</U> </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exhibits </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Equity Commitment Letter</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;B:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Issuer Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;C:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Registration Rights Agreement</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx150472_126b"></A>AMENDED AND RESTATED INVESTMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIS AMENDED AND RESTATED INVESTMENT AGREEMENT</B>, is made as of March&nbsp;30, 2021 (this &#147;<U>Agreement</U>&#148;), by and between <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;<U>Company</U>&#148;), and BCPE Watson (DE) SPV, LP, a Delaware limited partnership (together with its successors and any Affiliate that becomes a party
hereto pursuant to <U>Section</U><U></U><U>&nbsp;5.08(b)</U> and <U>Section</U><U></U><U>&nbsp;8.03</U>, the &#147;<U>Investor</U>&#148;). Capitalized terms used in this Agreement shall have the meanings ascribed to such terms in <U>Article I</U> or
as otherwise defined elsewhere in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Investor previously entered into an Investment Agreement,
dated as of March&nbsp;25, 2021 (the &#147;<U>Original Investment Agreement</U>&#148;) and, pursuant to Section&nbsp;8.01(i) of the Original Investment Agreement, the parties wish to amend and restate the Original Investment Agreement in its
entirety; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, subject to the terms and conditions set forth herein, the Company desires to issue, sell and deliver to the Investor,
and the Investor desires to purchase and acquire from the Company, subject to the terms and conditions set forth in this Agreement, (i) 75,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred
Stock, having no par value per share (the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</U>&#148;), at the Initial Closing, (ii) 105,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock, having no par value per share (the &#147;<U>Series B</U><U><FONT STYLE="white-space:nowrap">-2</FONT> Preferred Stock</U>&#148; and together with the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock,
the &#147;<U>Series B Preferred Stock</U>&#148;), at the Subsequent Closing, and (iii)&nbsp;up to an additional aggregate number of 35,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock at
the Subsequent Closing, in each case, having the designation, preferences, rights, privileges, powers, and terms and conditions, as specified in the Statement With Respect to Shares; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution of the Original Investment Agreement, the Company entered into that certain Agreement and Plan of
Merger, dated as of March&nbsp;25, 2021 (as amended, restated, supplemented, waived or otherwise modified from time to time, the &#147;<U>Target Merger Agreement</U>&#148;), by and among the Company, Coherent, Inc., a Delaware corporation (the
&#147;<U>Target</U>&#148;), and Watson Merger Sub Inc., a Delaware corporation and a direct wholly owned Subsidiary of the Company, pursuant to which the Company will acquire all outstanding equity interests of the Target (the &#147;<U>Target
Acquisition</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution of the Original Investment Agreement, and as a condition and
inducement to the willingness of the Company to enter into the Original Investment Agreement, the Equity Provider executed and delivered an equity commitment letter attached as Exhibit A to the Original Investment Agreement (the &#147;<U>Original
Equity Commitment Letter</U>&#148;), and, concurrently with the execution of this Agreement, the Equity Provider has executed and delivered an equity commitment letter, a copy of which is attached hereto as <U>Exhibit A</U> (the &#147;<U>Equity
Commitment Letter</U>&#148;), which replaces and supersedes the Original Equity Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of
the mutual covenants, representations, warranties and agreements contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Definitions</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement (including the recitals hereto), the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>25% Beneficial Ownership Requirement</U>&#148; means that the Investor Parties continue to beneficially own at all times shares of
Series B Preferred Stock and/or shares of Company Common Stock that were issued upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conversion of shares of Series B Preferred Stock that represent, in the aggregate and on an as converted basis, at least 25% of the number of shares of Company Common Stock issued to the Investor
Parties, on an as converted basis, as of the Initial Closing (if the Subsequent Closing has not occurred) or the Subsequent Closing (if the Subsequent Closing has occurred), as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Activist Investor</U>&#148; means, as of any date, any Person identified on the most recently available &#147;SharkWatch 50&#148;
list (or, if &#147;SharkWatch 50&#148; is no longer available, then the prevailing comparable list as reasonably determined by the Company), or any Person who, to the knowledge of the Investor, is an Affiliate of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is
under common control with, such Person; <U>provided</U>, that (i)&nbsp;the Company and the Company&#146;s Subsidiaries shall not be considered Affiliates of the Investor or any of the Investor&#146;s Affiliates and (ii)&nbsp;for purposes of the
definitions of &#147;beneficially own&#148;, &#147;beneficial ownership of&#148;, &#147;beneficially owning&#148;, &#147;Bain Group&#148; and &#147;Standstill Period&#148; and <U>Section</U><U></U><U>&nbsp;4.06</U>,
<U>Section</U><U></U><U>&nbsp;5.02</U>, <U>Section</U><U></U><U>&nbsp;5.07</U> and <U>Section</U><U></U><U>&nbsp;5.11</U>, neither any Bain Excluded Entity, nor Bain Capital Investors, LLC, nor any of their respective Affiliates solely to the extent
that any such Person has not received any Confidential Information from any Investor and is not acting at the direction of the Investor or any of its Affiliates that have received Confidential Information, shall be deemed an Affiliate of the
Investor and its other Affiliates; provided that any such Person shall not be deemed to have received Confidential Information merely because any investment professional of the Bain Group is a director or manager of such Person and is not acting at
the direction of the Investor or any of its Affiliates who have received any Confidential Information. For this purpose, &#147;<U>control</U>&#148; (including, with its correlative meanings, &#147;<U>controlled by</U>&#148; and &#147;<U>under common
control with</U>&#148;) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests,
by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>as converted basis</U>&#148; means (i)&nbsp;with respect to the outstanding shares of Company Common
Stock as of any date, all outstanding shares of Company Common Stock calculated on a basis in which all shares of Company Common Stock issuable upon conversion of the outstanding shares of Series B Preferred Stock (at the applicable Conversion Price
in effect on such date as set forth in the Statement With Respect to Shares and without regard to any restrictions on conversion set forth therein) are assumed to be outstanding as of such date and (ii)&nbsp;with respect to any outstanding shares of
Series B Preferred Stock as of any date, the number of shares of Company Common Stock issuable upon conversion of such shares of Series B Preferred Stock on such date (at the applicable Conversion Price in effect on such date as set forth in the
Statement With Respect to Shares and without regard to any restrictions on conversion set forth therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Back
Leverage</U>&#148; means any (i)<I>&nbsp;bona fide</I> loan or lending transaction entered into by the Investor (or, after the Restricted Period, a Permitted Transferee thereof) to (a)&nbsp;finance a portion of its purchase of the Series B Preferred
Stock, (b)&nbsp;finance a return of capital with respect to its investment in the Series B Preferred Stock or the Company Common Stock issued upon conversion thereof, or (c)&nbsp;refinance or replace any indebtedness described in this clause (i),
and (ii)&nbsp;granting of Liens by the Investor to secure payment of such indebtedness and related obligations, including on the Series B Preferred Stock and any shares of Company Common Stock held by the Investor Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Affiliate</U>&#148; means any Affiliate of Bain Capital Investors, LLC or Bain Capital Private Equity, LP that serves as general
partner of, or manages or advises, any investment fund affiliated with Bain Capital Investors, LLC that has a direct or indirect investment in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Excluded Entity</U>&#148; means (i)&nbsp;any leveraged finance investment fund or any other investment fund associated or
affiliated with Bain Capital Investors, LLC, the primary purpose of which is to invest in loans or debt securities, or (ii)&nbsp;any hedge fund associated or affiliated with Bain Capital Investors, LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Group</U>&#148; means the Investor, together with its Affiliates, including Bain Affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>beneficially own</U>&#148;, &#147;<U>beneficial ownership of</U>&#148;, or
&#147;<U>beneficially owning</U>&#148; any securities shall have the meaning set forth in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the rules and regulations under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day except a Saturday, a Sunday or other day on which banks in the City of New York are authorized
or required by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the United States Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Benefit Plan</U>&#148; means each &#147;employee pension benefit plan&#148; (as defined in Section&nbsp;3(2) of ERISA), each
&#147;employee welfare benefit plan&#148; (as defined in Section&nbsp;3(1) of ERISA) (in each case, whether or not such plan is subject to ERISA) and each other plan, policy, agreement or arrangement (whether written or oral) relating to stock
options, stock purchases, stock awards, deferred compensation, bonus, severance, retention, employment, change of control, fringe benefits, supplemental benefits or other employee benefits, in each case, sponsored, maintained or contributed to, or
required to be sponsored, maintained or contributed to, by the Company or its Subsidiaries, for the benefit of current or former employees, officers, directors or consultants of the Company or its Subsidiaries, or with respect to which the Company
or any of its Subsidiaries has any liability, other than any Multiemployer Plan and other than any such benefit, plan, policy, agreement or arrangement if and to the extent required to be provided, maintained or contributed to under applicable Law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Charter Documents</U>&#148; means the Company&#146;s articles of incorporation and bylaws, each as amended, restated,
supplemented or otherwise modified to the date of the Original Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Common Stock</U>&#148; means the
common stock, having no par value per share, of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company COVID Action</U>&#148; means any reasonable action taken or
omitted to be taken after the date of the Original Investment Agreement that the Company reasonably determines to be necessary or prudent for the Company or its Subsidiaries to take in connection with or in response to
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the establishment of any policy, procedure or protocol, in each case in connection with or in response to: (i)&nbsp;events surrounding any pandemic or public health emergency caused by <FONT
STYLE="white-space:nowrap">COVID-19;</FONT> (ii)&nbsp;reinitiating operation of all or a portion of the Company&#146;s and its Subsidiaries&#146; respective businesses; (iii)&nbsp;mitigating the effects of such events, pandemic or public health
emergency on the business of one or more of the Company and its Subsidiaries; or (iv)&nbsp;protecting the health and safety of customers, employees and other business relationships and ensuring compliance with any legal requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company RSU</U>&#148; means a restricted stock unit covering shares of Company Common Stock including any restricted stock units
subject to performance vesting goals or metrics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stockholder Approval</U>&#148; has the meaning given the term
&#147;Parent Stockholder Approval&#148; in the Target Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competitor</U>&#148; means any of the Persons listed on
<U>Section</U><U></U><U>&nbsp;1.01(a)</U> of the Disclosure Schedules as a &#147;Competitor&#148; and any Person who, to the knowledge of the Investor, is an Affiliate or successor thereof, including any entity that acquires a controlling interest
in a Competitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means the Confidentiality and
<FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement by and between the Company, on behalf of itself and its Affiliates, and Bain Capital Private Equity, LP, on behalf of itself and its Affiliates, dated January&nbsp;14, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Price</U>&#148; has the meaning set forth in the Statement With Respect to Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Notes</U>&#148; means, collectively, (i)&nbsp;Finisar Convertible Notes
and (ii)&nbsp;the Senior Convertible Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</U>&#148; means any
legally binding quarantine, &#147;shelter in place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shut down, closure, sequester or any other law, order or directive by any Governmental Entity in connection with or in
response to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the Coronavirus Aid, Relief, and Economic Security (CARES)&nbsp;Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Percentage</U>&#148; means the portion, expressed as a percentage, of the outstanding shares of Company Common Stock held by
the Investor immediately as of the Initial Closing (if the Subsequent Closing has not occurred) or the Subsequent Closing (if the Subsequent Closing has occurred), as applicable, in each case assuming the conversion of the Series B Preferred Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Law</U>&#148; means any Law in effect prior to or as of the date of the Original Investment Agreement relating to
pollution or protection of the environment (including ambient air, soil, surface water or groundwater, or subsurface strata), natural resources, endangered or threatened species, human health or safety (as it relates to exposure to Hazardous
Materials), or that prohibits, regulates or controls any Hazardous Material or any products containing any Hazardous Material, including the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. &#167;&nbsp;9601 et seq.,
the Resource Conservation and Recovery Act, 42 U.S.C. &#167;&nbsp;6901 et seq., the Toxic Substances Control Act, 15 U.S.C. &#167;&nbsp;2601 et seq., the Federal Water Pollution Control Act, 33 U.S.C. &#167;&nbsp;1251 et seq., the Clean Air Act, 42
U.S.C. &#167;&nbsp;7401 et seq., the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. &#167;&nbsp;121 et seq., the Safe Drinking Water Act, 42 U.S.C. &#167;&nbsp;300f et seq., the Oil Pollution Act of 1990, the European Union
(&#147;<U>EU</U>&#148;) Directive 2012/19/EU on waste electrical and electronic equipment, the EU Directive 2011/65/EU on the restriction on the use of certain hazardous substances, the Administrative Measures on the Control of Pollution Caused by
Electronic Information Products, and the European Commission Regulation 1907/2006, and analogous foreign, provincial, state and local Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is, or was
at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is, or was at the relevant
time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fall-Away of Investor Board Rights</U>&#148; means the first day on which the 25% Beneficial Ownership Requirement is not
satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finisar</U>&#148; means Finisar Corporation, a Delaware corporation and subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finisar Convertible Notes</U>&#148; means the 0.50% Convertible Senior Notes due 2036 of Finisar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fraud</U>&#148; means common law fraud under the laws of the State of Delaware; <U>provided</U>, however, that the term
&#147;Fraud&#148; does not include the doctrine of constructive or equitable fraud. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fundamental Change</U>&#148; shall have the
meaning set forth in the Statement With Respect to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fundamental Representations</U>&#148; means the representations and
warranties set forth in <U>Section</U><U></U><U>&nbsp;3.01(a)</U> and <U>(c)</U> (<I>Organization; Standing</I>) (other than the second sentence of <U>Section</U><U></U><U>&nbsp;3.01(a)</U>), <U>Section</U><U></U><U>&nbsp;3.02</U>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(<I>Capitalization</I>) (other than <U>Section</U><U></U><U>&nbsp;3.02(a)</U>), <U>Section</U><U></U><U>&nbsp;3.03(a)</U> (<I>Authority;
<FONT STYLE="white-space:nowrap">Non-contravention</FONT></I>), <U>Section</U><U></U><U>&nbsp;3.16</U> (<I>No Rights Agreement; Anti-Takeover Provisions</I>), <U>Section</U><U></U><U>&nbsp;3.18</U> (<I>Brokers and Other Advisors</I>) and
<U>Section</U><U></U><U>&nbsp;3.21</U> (<I>Status of Securities</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means generally accepted accounting
principles in the United States, consistently applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Entity</U>&#148; means any United States, state of the
United States or local, foreign or multi-national governmental or regulatory agency, commission, court or authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous
Materials</U>&#148; means any substance, waste, liquid or gaseous or solid matter for which liability or standards of conduct may be imposed, or which is or is deemed to be hazardous, hazardous waste, solid or liquid waste, toxic, a pollutant, a
deleterious substance, a contaminant or a source of pollution or contamination, in each case regulated by, or otherwise subject to, any Environmental Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means any of the following, as they exist anywhere in the world, whether
registered or unregistered: (i)&nbsp;patents, patentable inventions and other patent rights (including any divisions, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues,
reexaminations and interpretations thereof); (ii)&nbsp;trademarks, service marks, trade dress, trade names, taglines, brand names, logos and corporate names and all goodwill related thereto; (iii)&nbsp;copyrights, mask works and designs;
(iv)&nbsp;trade secrets, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, processes, procedures, databases, confidential business information and other proprietary information and rights; (v)&nbsp;proprietary rights in computer software
programs, including all source code, object code, specifications, designs and documentation related thereto; and (vi)&nbsp;domain names and internet addresses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Director</U>&#148; means a member of the Board who was elected to the Board as an Investor Director Designee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Director Designee</U>&#148; means an individual designated in writing by the Investor and reasonably acceptable to the Board
to be nominated for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;5.11(a)</U> or <U>5.11(c)</U>, as applicable; <U>provided</U> that Stephen Pagliuca shall be deemed to be reasonably acceptable to the Board to serve as an Investor
Director, and each of Ken Hanau and Joseph Robbins shall be deemed to be reasonably acceptable to the Board to serve as an Investor Observer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Material Adverse Effect</U>&#148; means any effect, change, event or occurrence that would reasonably be expected to
prevent, impair or materially delay (i)&nbsp;the consummation by the Investor of any of the Transactions on a timely basis or (ii)&nbsp;the compliance by the Investor with its obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Parties</U>&#148; means the Investor and each Affiliate of the Investor to whom shares of Series B Preferred Stock or
Company Common Stock are transferred pursuant to <U>Section</U><U></U><U>&nbsp;5.08(b)(i)</U> or<U> Section</U><U></U><U>&nbsp;5.08(b)(viii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS</U>&#148; means the United States Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; means with respect to Company and its Subsidiaries, the actual knowledge of the individuals listed in
<U>Section</U><U></U><U>&nbsp;1.01(b)</U> of the Disclosure Schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means liens, encumbrances, mortgages,
charges, claims, restrictions, pledges, security interests, title defects, easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> covenants, encroachments or other adverse claims of any kind with
respect to a property or asset. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Management Services Agreement</U>&#148; means that certain Management Services
Agreement, to be dated as of the Initial Closing Date, providing for expense reimbursement and indemnification for any Investor personnel that provide services to the Company to the extent the Company requests such services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; means an event, state of facts, circumstance, change, effect, development, occurrence or
combination of the foregoing (an &#147;<U>Effect</U>&#148;) that individually or in the aggregate has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of the
Company and its Subsidiaries, taken as a whole; <U>provided</U> that the term Material Adverse Effect will not include any Effect to the extent resulting from or arising out of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes after the date of the Original Investment Agreement in general business, economic or market conditions
in the United States or elsewhere in the world (including changes generally in prevailing interest rates, credit availability and liquidity, currency exchange rates and price levels or trading volumes in the United States or foreign securities or
credit markets), changes in political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, or any outbreak or escalation of
hostilities, declared or undeclared acts of war or terrorism, in each case generally affecting the industries in which the Company and its Subsidiaries operate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any changes or developments generally in the industries in which the Company or any of its Subsidiaries are
expected to conduct their business from and after the closing under the Target Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the announcement or the existence of, compliance with or performance under, this Agreement, the Target Merger
Agreement or the transactions contemplated hereby or thereby (<U>provided</U>, <U>however</U>, that the exceptions in this clause (C)&nbsp;shall not apply to any representation or warranty contained in <U>Section</U><U></U><U>&nbsp;3.03(a)</U> or
<U>Section</U><U></U><U>&nbsp;3.03(c)(1)</U> to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the performance of obligations or
satisfaction of conditions under this Agreement); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any taking of any action or failure to take an action at the request of the Target or its Affiliates or which
is required by the terms of the Target Merger Agreement, or at the request of Investor or its Affiliates or which is required by the terms of this Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in applicable Law, GAAP or accounting standards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">floods, hurricanes, tornados, earthquakes, fires or other natural disasters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(G)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">national or international disasters, acts of God, sabotage, calamities, emergencies, or any escalation or
worsening thereof, whether or not occurring or commenced before the date of the Original Investment Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(H)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> and any
political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, the Centers for Disease Control and Prevention or the World Health
Organization, &#147;sheltering in place,&#148; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or any change in such law (including
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures), directive, pronouncement or guideline or interpretation thereof, or the action of any third party arising out of or relating to any of the foregoing, in each case, following the date of the
Original Investment Agreement or any material worsening of such </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
conditions threatened or existing as of the date of the Original Investment Agreement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(I)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any actions arising from allegations of breach of fiduciary duty or otherwise relating to this Agreement, the
Target Merger Agreement or the transactions contemplated hereby or thereby; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(J)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failure by the Company to meet any financial projections or forecasts or estimates of revenues, earnings or
other financial metrics for any period (<U>provided</U> that the exception in this clause&nbsp;(J) shall not prevent or otherwise affect a determination that any event, change, effect, development or occurrence underlying such failure has resulted
in, or contributed to, a Material Adverse Effect); <U>except</U>, in each case with respect to clauses&nbsp;(A), (B), (E), (F), (G)&nbsp;and (H), to the extent disproportionately affecting the Company and its Subsidiaries, taken as a whole, relative
to other similarly situated companies in the industries in which the Company and its Subsidiaries are expected to operate from and after the closing under the Target Merger Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Maximum Percentage</U>&#148; means the Current Percentage <I>plus</I> 3%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Multiemployer Plan</U>&#148; means any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Multiple Employer Plan</U>&#148; means a plan that has two or more contributing sponsors at least two of whom are not under common
control, within the meaning of Section&nbsp;4063 of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>NASDAQ</U>&#148; means the NASDAQ Global Select Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ordinary Course of Business</U>&#148; shall describe any action taken by the Company or any of its Subsidiaries if such action is
(i)&nbsp;consistent with such Person&#146;s past practices and/or is taken in the ordinary course of such Person&#146;s normal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations or (ii)&nbsp;a
Company COVID Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parity Stock</U>&#148; means any class or series of capital stock that ranks on a parity basis with any
series of the Series B Preferred Stock as to dividend rights, rights of redemption and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. &#147;<U>Parity
Stock</U>&#148; shall include any rights, options or warrants exercisable or exchangeable for or convertible into Parity Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PBCL</U>&#148; means the Pennsylvania Business Corporation Law of 1988, as amended, restated, supplemented or otherwise modified from
time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Issuances</U>&#148; means issuances of Parity Stock: (i)&nbsp;in connection with the closing of the
Target Acquisition if the Company shall have made the Upsize Offer contemplated by <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U> and the Investor shall not have made the election contemplated by <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U> of this
Agreement to purchase the full dollar amount of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock offered in the Upsize Offer, provided that such issuance(s) does not exceed (A)&nbsp;the dollar amount of the Upsize Offer, less
(B)&nbsp;the dollar amount, if any, as to which such election has been made to, and the holder(s) of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares do, purchase pursuant to such <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>,
(ii) in the form of a customary convertible preferred security that does not provide for a premium upon liquidation and that is issued on arms-length terms, provided that the amount of Parity Stock under this clause (<U>ii</U>)&nbsp;outstanding at
any time does not exceed $500&nbsp;million, and (iii)&nbsp;in the form of a customary public mandatory convertible preferred, provided that the amount of Parity Stock under this clause (<U>iii</U>)&nbsp;outstanding at any time does not exceed
$1.0&nbsp;billion (including the Company Mandatory Convertible Preferred Stock). Prior to making any Permitted Issuance pursuant to clause (<U>ii</U>)&nbsp;above, the Company shall offer the Investor the opportunity to purchase such securities. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means (i)&nbsp;any Lien for Taxes not yet due or, if due,
not yet delinquent or which are being contested in good faith by appropriate proceedings and for which adequate reserves have been made, (ii)&nbsp;vendors&#146;, mechanics&#146;, materialmens&#146;, carriers&#146;, workers&#146;, landlords&#146;,
repairmen&#146;s, warehousemen&#146;s, construction and other similar Liens arising or incurred in the Ordinary Course of Business or with respect to liabilities that are not yet due and payable or, if due, are not delinquent or are being contested
in good faith by appropriate proceedings, (iii)&nbsp;Liens imposed or promulgated by applicable Law or any Governmental Entity with respect to Real Property, including zoning, building or similar restrictions, (iv)&nbsp;pledges or deposits in
connection with workers&#146; compensation, unemployment insurance, and other social security legislation, (v)&nbsp;Liens relating to intercompany borrowings among the Investor and its wholly owned (direct or indirect) Subsidiaries or any other
existing indebtedness of the Investor or its Subsidiaries, (vi)&nbsp;Real Property easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> leases, encroachments, restrictions, rights, servitudes,
encumbrances, conditions or imperfections of title or other matters of a similar nature and other similar Liens, which, individually and in the aggregate, do not materially impair the present use of the Real Property or otherwise materially impair
the present business operations at the Real Property, (vii)&nbsp;purchase money Liens or Liens under capital lease arrangements, (viii)&nbsp;licenses of Intellectual Property, (ix)&nbsp;Liens disclosed in the Investor financial statements or in the
Company financial statements, as applicable, or (x)&nbsp;other <FONT STYLE="white-space:nowrap">non-monetary</FONT> Liens that do not, individually or in the aggregate, materially interfere with the present use, or materially detract from the value
of, the property encumbered thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Transferee</U>&#148; means, with respect to any Person, (i)&nbsp;any Affiliate of
such Person, so long as it remains such, and that is a U.S. Person or (ii)&nbsp;with respect to any Person that is an investment fund, vehicle or similar entity, any other investment fund, vehicle or similar entity that is controlled by or under
common control with such transferor and that is a U.S. Person; <U>provided</U> that portfolio companies of the Investor or any of its Affiliates shall not be Permitted Transferees of any Investor Party hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, corporation, limited liability company, partnership, joint venture, association, trust,
unincorporated organization or any other entity, including a Governmental Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Data</U>&#148; shall mean any
information about an identifiable natural person that is defined as &#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;biometric information,&#148; &#147;nonpublic personal information,&#148; &#147;protected health
information,&#148; &#147;individually identifiable health information,&#148; &#147;protected health information&#148; or &#147;personal information&#148; under any applicable Law relating to privacy, data protection, or information security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stock</U>&#148; means the preferred stock, having no par value per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property</U>&#148; means any lands, buildings, structures and other improvements, together with all fixtures attached or
appurtenant to the foregoing, and all easements, covenants, hereditaments and appurtenances that benefit the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Rights Agreement</U>&#148; means that certain Registration Rights Agreement to be entered into by the Company and the
Investor as of the Initial Closing in the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remedies Exceptions</U>&#148; means the
rules governing the availability of specific performance, injunctive relief or other equitable remedies and general principles of equity, regardless of whether considered in a proceeding in equity or at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, with respect to any Person, its officers, directors, principals, partners, managers, members,
employees, consultants, agents, financial advisors, investment bankers, attorneys, accountants, other advisors and other representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Senior Convertible Notes</U>&#148; means the Company&#146;s 0.25% Convertible
Senior Notes due 2022 with U.S. Bank National Association, as trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standstill Period</U>&#148; means the period from and
after the Initial Closing Date and ending on the six (6)&nbsp;month anniversary of the date on which no Investor Director is serving on the Board (and as of such time the Investor no longer has board nomination rights pursuant to this Agreement to
designate an Investor Director Designee or Investor Observer or otherwise has irrevocably waived in a writing delivered to the Company its rights under <U>Section</U><U></U><U>&nbsp;5.11</U> to nominate an Investor Director Designee and designate an
Investor Observer); <U>provided</U> that the Standstill Period shall (a)&nbsp;in the case of clauses (i)&nbsp;and (iii) below immediately terminate and expire (and the restrictions of <U>Section</U><U></U><U>&nbsp;5.07</U> shall cease to apply and
shall be of no further force and effect) and in the case of clause (ii)&nbsp;below shall be suspended during the pendency of such tender or exchange offer, at the earliest of: (i)&nbsp;the Company entering into a definitive written agreement to
consummate a Fundamental Change, (ii)&nbsp;the commencement of a tender offer or exchange offer for the Company Common Stock (other than by the Company or its Subsidiaries) recommended by or approved by the Board or (iii)&nbsp;the failure of the
stockholders of the Company, upon a vote duly taken thereupon, to elect an Investor Director Designee nominated in accordance with <U>Section</U><U></U><U>&nbsp;5.11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Statement With Respect to Shares</U>&#148; means the definitive Statement With Respect to Shares to be filed with the Pennsylvania
Department of State in the form agreed as of the date hereof by the Company and the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148;, when used
with respect to any Person, means, any corporation, partnership, association, trust or other form of legal entity of which (i)&nbsp;fifty percent (50%) or more of the voting power of the outstanding voting securities are directly or indirectly owned
by such person or (ii)&nbsp;such person or any Subsidiary of such person is a general partner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; or
&#147;<U>Taxes</U>&#148; means any and all U.S. federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, imposts, levies, duties, fees or other similar governmental assessments, including all net income, gross receipts,
capital, sales, use, ad valorem, value added, transfer, franchise, profits, inventory, capital stock, license, withholding, payroll, employment, social security, unemployment, excise, severance, stamp, occupation, property and estimated taxes,
escheat, customs duties and other taxes of any kind whatsoever, including any and all interest, penalties, additions to tax or additional amounts imposed by any Governmental Entity in connection with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any report, return, refund, claim, election, statement, estimate, disclosure, document, declaration or
information report or return filed or required to be filed with or supplied or required to be supplied to a Taxing Authority (including any amendments thereto and including any attachment, schedule or statement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Authority</U>&#148; means any Governmental Entity or any subdivision, agency, commission or entity thereof or any
quasi-governmental or private body having jurisdiction over the assessment, determination, collection or imposition of any Tax (including the IRS). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Top Company Customer</U>&#148; means one of the 10 largest customers and resellers of the Company and its Subsidiaries by revenue for
the fiscal year ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement, the Equity Commitment Letter,
the Registration Rights Agreement, the Statement With Respect to Shares, the Issuer Agreement, the VCOC Letters, the Management Services Agreement and the Closing Certificate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; means the transactions expressly contemplated by this
Agreement and the other Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer</U>&#148; by any Person means, directly or knowingly indirectly, to
sell, transfer, assign, pledge, encumber, hypothecate or otherwise dispose of or transfer (by the operation of law or otherwise), or to enter into any contract, option or other arrangement, agreement or understanding with respect to the sale,
transfer, assignment, pledge, encumbrance, hypothecation or other disposition or transfer (by the operation of law or otherwise), of any interest in any equity securities beneficially owned by such Person; <U>provided</U>, <U>however</U>, that,
notwithstanding anything to the contrary in this Agreement, a Transfer shall not include (i)&nbsp;the conversion of one or more shares of Series B Preferred Stock into shares of Company Common Stock pursuant to the Statement With Respect to Shares,
(ii)&nbsp;the redemption or other acquisition of Company Common Stock or Series B Preferred Stock by the Company or (iii)&nbsp;the transfer (other than any transfer by the Investor or an Affiliate of the Investor immediately following which such
subject equity securities are beneficially owned by any Person other than a member of the Bain Group) of any limited partnership interests or other equity interests in the Investor (or any direct or indirect parent entity of the Investor)
(<U>provided</U> that if any transferor or transferee referred to in this clause&nbsp;(iii) ceases to be controlled (directly or indirectly) by the Person (directly or indirectly) controlling such Person immediately prior to such transfer, such
event shall be deemed to constitute a &#147;Transfer&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S. Person</U>&#148; means any Person that is: (i)&nbsp;a U.S.
citizen or lawful permanent resident; or (ii)&nbsp;organized under the laws of the United States or any jurisdiction within the United States or any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> branch or affiliate thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warranties</U>&#148; means all obligations to service, repair (including to provide fixes to program errors), replace, credit, refund
and other obligations based upon or arising out of express or implied warranties made or deemed made in connection with the provision, license or sale of products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to the terms defined in <U>Section</U><U></U><U>&nbsp;1.01(a)</U>, the following terms have the meanings assigned thereto in
the Sections set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.03(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bankruptcy and Equity Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.03(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.03(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Capitalization Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Data Processors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.05(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Mandatory Convertible Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Owned IP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.23(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidential Information</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Covered Persons</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Disclosure Schedules</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Article III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DOJ</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Commitment Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Provider</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FTC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(d)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Forms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial HSR Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial HSR Form</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial Investment Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor First Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor Observer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor Original End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor Second Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investor Third Extended End Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuer Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.14</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT Systems</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.23(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Original Equity Commitment Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Original Investment Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permitted Purpose</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Real Property Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.08(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series One Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Specified Guidelines</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sublease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent HSR Form</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Investment Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subsequent Investment Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Target</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Target Acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Target Merger Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upsize Offer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upsize Offer Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Upsize Subsequent Investment Purchase Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VCOC Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;5.18</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Purchase and Sale</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <U>Purchase and Sale</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Initial Investment</U>. On the terms of this Agreement, at the Initial Closing, the Investor will and hereby does purchase and acquire,
and the Company will and hereby does issue, sell and deliver to the Investor, 75,000 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (such shares, the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Shares</U>&#148;) for a purchase price per share equal to $10,000.00 (the &#147;<U>Per Share Price</U>&#148;) for an aggregate purchase price of $750,000,000.00 (the &#147;<U>Initial Investment Purchase Price</U>&#148;) (such transaction,
the &#147;<U>Initial Investment</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Subsequent Investment</U>. Subject to <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, on
the terms of this Agreement and the Statement With Respect to Shares and subject to the satisfaction (or, to the extent permitted by applicable Law, waiver by the party entitled to the benefit thereof) of the conditions set forth in <U>Article
VI</U>, at the Subsequent Closing the holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall purchase and acquire from the Company an aggregate number of 105,000 shares of Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (such shares, the &#147;<U>Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>&#148;), and the Company shall issue, sell and deliver to such holders of the
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares for a purchase price per share equal to the Per Share Price for an aggregate purchase price of
$1,050,000,000.00 (the &#147;<U>Subsequent Investment Purchase Price</U>&#148;) (such transactions, the &#147;<U>Subsequent Investment</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Following the execution of this Agreement and prior to the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT>
anniversary thereof, the Company may offer (such offer, the &#147;<U>Upsize Offer</U>&#148;, and the date of such offer, the &#147;<U>Upsize Offer Date</U>&#148;) to the Investor an option to purchase up to an additional 35,000 shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, at a purchase price per share equal to the Per Share Price, exercisable in the sole discretion of the Investor by delivering an irrevocable written notice to the Company to such effect no later
than the sixty <FONT STYLE="white-space:nowrap">(60)-day</FONT> anniversary of the Upsize Offer Date and specifying the number of offered shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock as to which the Investor is making
such irrevocable election (any such shares elected to be purchased in such notice, the &#147;<U>Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>,&#148; and together with the Committed Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>&#148;; the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares together with the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Shares, the &#147;<U>Shares</U>&#148;; and the aggregate purchase price for the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, the &#147;<U>Upsize Subsequent Investment
Purchase Price</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <U>Initial and Subsequent Closing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Initial Closing</U>. The closing of the Initial Investment (the &#147;<U>Initial Closing</U>&#148;) shall take place remotely via the
electronic exchange of documents and signatures at 10:00 a.m. Eastern Time on March&nbsp;31, 2021, unless otherwise agreed to in writing by the Company and the Investor. The date on which the Initial Investment is to occur is herein referred to as
the &#147;<U>Initial Closing Date</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) At the Initial Closing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company shall deliver to the Investor (1)&nbsp;the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Shares free and clear of all Liens, except restrictions imposed by the articles of incorporation and bylaws of the Company, the Securities Act or any applicable state or foreign securities Laws, and Liens arising due to actions by or on
behalf of the Investor, including Liens contemplated by the Issuer Agreement, if any, or <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement, and (2)&nbsp;the Registration Rights Agreement, duly executed by the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will deliver to the Investor a customary legal opinion of the General Counsel of the Company or
outside corporate counsel to the Company as to the due authorization, valid issuance and <FONT STYLE="white-space:nowrap">non-assessability</FONT> of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Investor shall (1)&nbsp;pay the Initial Investment Purchase Price to the Company, by wire transfer in
immediately available U.S. federal funds, to the account designated by the Company in writing, and (2)&nbsp;deliver to the Company the Registration Rights Agreement, duly executed by the Investor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in each case if requested by the Investor, the Company shall have executed and delivered to the Investor
(1)&nbsp;the Issuer Agreement and (2)&nbsp;a VCOC Letter in a form reasonably acceptable to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Investor and the Company shall have received the Management Services Agreement duly executed by the other
party; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will file the Statement With Respect to Shares with the Pennsylvania Department of State.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Subsequent Closing</U>. Subject to the satisfaction or, to the extent permitted by applicable law, waiver by the
party entitled to the benefit thereof of all of the conditions to the Subsequent Closing set forth in <U>Article VI</U>, the closing of the sale of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares contemplated hereby (the
&#147;<U>Subsequent Closing</U>&#148;) shall take place, immediately prior to the consummation of the Target Acquisition, remotely via the electronic exchange of documents and signatures, or such other time and place as the Company and the Investor
may agree in writing. The date on which the Subsequent Closing is to occur is herein referred to as the &#147;<U>Subsequent Closing Date</U>.&#148; The Company shall provide the Investor with at least five (5)&nbsp;Business Days prior written notice
of the expected closing date of the Target Acquisition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) At the Subsequent Closing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on the terms of this Agreement and the Statement With Respect to Shares, the Company shall deliver to the
holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares, the Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares and, if an election has been made by the Investor pursuant to
<U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares free and clear of all Liens, except restrictions imposed by the articles of incorporation and bylaws of the Company, the
Securities Act or any applicable state or foreign securities Laws, and Liens arising due to actions by or on behalf of the Investor, including Liens contemplated by the Issuer Agreement, if any, or <U>Section</U><U></U><U>&nbsp;5.08</U> of this
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will deliver to the Investor a customary legal opinion of the General Counsel of the Company or
outside corporate counsel to the Company as to the due authorization, valid issuance and <FONT STYLE="white-space:nowrap">non-assessability</FONT> of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares shall pay the Subsequent
Investment Purchase Price and, if an election has been made by the Investor pursuant to <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, the Upsize Subsequent Investment Purchase Price to the Company, by wire transfer in immediately available U.S.
federal funds, to the account designated by the Company in writing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties of the Company</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except (x)&nbsp;as disclosed in the Company SEC Documents filed with or furnished to the SEC prior to the date of the Original Investment
Agreement and after January&nbsp;1, 2019 (excluding any risk factor or forward-looking disclosures contained in such documents under the heading &#147;Risk Factors,&#148; and any disclosure of risks included in any &#147;forward-looking
statements&#148; disclaimer, or other statements that are similarly nonspecific or predictive, cautionary, or forward-looking) or (y)&nbsp;as set forth in the confidential disclosure schedules delivered by the Company to the Investor prior to the
execution of this Agreement (the &#147;<U>Disclosure Schedules</U>&#148;) (each </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
section of which qualifies the correspondingly numbered representation, warranty or covenant if specified therein and such other representations, warranties or covenants where its relevance as an
exception to (or disclosure for purposes of) such other representation, warranty or covenant is reasonably apparent on the face of such disclosure), Company and its Subsidiaries represent and warrant to the Investor as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <U>Organization</U><U>; Standing; Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly incorporated and presently subsisting under the Laws of the Commonwealth of Pennsylvania. The
Company&nbsp;has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company&#146;s Subsidiaries is a legal entity duly organized, validly existing and in good standing under the Laws of its
respective jurisdiction of organization (to the extent the &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States) and has all requisite corporate or similar power and authority to own, lease and
operate its properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority or be in good standing would not reasonably be expected to have a Material Adverse Effect. The Company is
duly qualified or licensed and has all necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such
approvals, qualification or licensing necessary (to the extent the &#147;qualification to do business&#148; or &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States), except where the failure to be
so duly approved, qualified or licensed and in good standing would not reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
Company has made available to the Investor, prior to the date of the Original Investment Agreement, a true and complete copy of the Company Charter Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <U>Capitalization</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of Company consists of 300,000,000 shares of Company Common Stock, and 5,000,000 shares of Preferred Stock,
of which, immediately prior to the filing of the Statement With Respect to Shares, 2,300,000 shares are designated Series A Mandatory Convertible Preferred Stock (&#147;<U>Company Mandatory Convertible Preferred Stock</U>&#148;) and 300,000 shares
are designated Series One Preferred Stock (the &#147;<U>Series One Preferred Stock</U>&#148;). As of February&nbsp;26, 2021 (the &#147;<U>Company Capitalization Date</U>&#148;), (i)&nbsp;104,828,047 shares of Company Common Stock were issued and
outstanding, (ii)&nbsp;13,484,634 shares of Company Common Stock were held in treasury, (iii)&nbsp;2,300,000 shares of Company Mandatory Convertible Preferred Stock were issued or outstanding and (iv)&nbsp;no shares of Series One Preferred Stock
were issued and outstanding. As of the Company Capitalization Date, 13,867,704 shares of Company Common Stock were reserved for issuance under Company equity plans, of which amount (A)&nbsp;2,714,466 shares of Company Common Stock are issuable upon
the exercise of options to purchase or acquire shares of Company Common Stock (each a &#147;<U>Company Option</U>&#148;), (B)&nbsp;3,095,514 shares of Company Common Stock are issuable upon the settlement of outstanding Company RSUs (with respect to
performance-based awards, assuming performance is achieved at &#147;target&#148;), and (C)&nbsp;518,309 shares of Company Common Stock are subject to performance share awards (assuming performance is achieved at &#147;target&#148;). As of the
Company Capitalization Date, (A)&nbsp;up to 8,914,798 shares of Company Common Stock may be issuable upon conversion of the then outstanding shares of Company Mandatory Convertible Preferred Stock, (B)&nbsp;up to 7,330,940 shares of Company Common
Stock may be issuable upon conversion of the Company&#146;s then outstanding Senior Convertible Notes and (C)&nbsp;up to 74,814 shares of Company Common Stock may be issuable upon conversion of the then outstanding Finisar Convertible Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for the Target Merger Agreement, as set forth in <U>Section</U><U></U><U>&nbsp;3.02(a)</U> or as set forth on
<U>Section</U><U></U><U>&nbsp;3.02</U> of the Disclosure Schedules (and other than shares of Company Common Stock issued since the Company Capitalization Date pursuant to the terms of outstanding Company stock awards or in respect of any outstanding
shares of Company Mandatory Convertible Preferred Stock or any Convertible Notes), as of the date </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Original Investment Agreement, there are no outstanding shares of capital stock or other equity interests in the Company or subscriptions, options, warrants, calls, convertible securities,
exchangeable securities or other similar rights, agreements or commitments to which the Company or any of its Subsidiaries is a party (i)&nbsp;obligating Company or any of its Subsidiaries to (A)&nbsp;issue, transfer, exchange, sell or register for
sale any shares of capital stock or other equity interests of the Company or any Subsidiary of Company or securities convertible into or exchangeable for such shares or equity interests, (B)&nbsp;grant, extend or enter into any such subscription,
option, warrant, call, convertible securities or other similar right, agreement or arrangement, (C)&nbsp;redeem or otherwise acquire any such shares of capital stock or other equity interests, (D)&nbsp;provide a material amount of funds to, or make
any material investment (in the form of a loan, capital contribution or otherwise) in, any Subsidiary, or (E)&nbsp;make any payment to any person the value of which is derived from or calculated based on the value of Company Common Stock or
Preferred Stock, or (ii)&nbsp;granting any preemptive or antidilutive or similar rights with respect to any security issued by the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03 <U>Authority</U><U>; Noncontravention</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has the requisite corporate power and authority to enter into this Agreement and the other Transaction Documents and, subject
to the receipt of the Company Stockholder Approval, to consummate the Transactions. The execution and delivery by the Company of this Agreement and the consummation of the Transactions have been duly and validly authorized by the Board, and except
for the Company Stockholder Approval no other corporate proceedings on the part of the Company or vote of the Company&#146;s securityholders are necessary to authorize the consummation of the Transactions. The Board has unanimously
(i)&nbsp;determined that this Agreement and the transactions contemplated hereby, including the purchase and sale of the Series B Preferred Stock hereunder, are in the best interests of the Company and its stockholders, (ii)&nbsp;approved the
execution, delivery and performance by the Company of this Agreement, and the consummation of the transactions contemplated hereby, including the purchase and sale of the Series B Preferred Stock hereunder, and (iii)&nbsp;resolved to recommend the
approval by the Company&#146;s stockholders of the Share Issuance (as defined in the Target Merger Agreement) and submit the Share Issuance to the stockholders of the Company for approval. This Agreement has been duly and validly executed and
delivered by the Company, and assuming this Agreement constitutes the legal, valid and binding agreement of the Investor, constitutes the legal, valid and binding agreement of Company, enforceable against the Company in accordance with its terms,
except as such enforcement may be subject to general principles of equity, whether considered in a proceeding at law or in equity (the &#147;<U>Bankruptcy and Equity Exceptions</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than in connection with or in compliance with (i)&nbsp;the laws of the State of Delaware and the laws of the Commonwealth of
Pennsylvania, (ii)&nbsp;the Exchange Act, and the rules promulgated thereunder, (iii)&nbsp;the Securities Act, and the rules promulgated thereunder, (iv)&nbsp;applicable state securities, takeover and &#147;blue sky&#148; Laws, (v)&nbsp;the rules
and regulations of NASDAQ, (vi)&nbsp;the HSR Act and the antitrust Laws and any Laws with respect to foreign investment set forth on <U>Section</U><U></U><U>&nbsp;3.03(b)</U> of the Disclosure Schedules and (vii)&nbsp;the Company Stockholder
Approval (collectively, the &#147;<U>Company Approvals</U>&#148;), no other consent of, or filing with, any Governmental Entity is necessary, under applicable Law, for the consummation by the Company of the Transactions, except for such consents or
filings as are not required to be obtained or made prior to consummation of the Transactions or that, if not obtained or made, would not materially impede or delay the consummation of the Transactions and which would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The execution and delivery by the Company of this Agreement does
not, and (assuming the Company Approvals are obtained) the consummation of the Transactions and compliance with the provisions hereof will not (i)&nbsp;result in any loss, or suspension, limitation or impairment of any right of the Company or any of
its Subsidiaries to own or use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation, first
offer, first refusal, modification or acceleration of any material obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note, bond, mortgage, indenture, Real
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Property Lease, agreement, contract, instrument, permit, concession, franchise, right or license binding upon the Company or any of its Subsidiaries or by which or to which any of their
respective properties, rights or assets are bound or subject, or result in the creation of any Liens other than Permitted Liens (<U>provided</U> that no Lien shall be deemed created by this Agreement), in each case, upon any of the properties or
assets of the Company or any of its Subsidiaries, except for such losses, impairments, suspensions, limitations, conflicts, violations, defaults, terminations, cancellation, accelerations, or Liens which have not had and would not reasonably be
expected to have, individually or in the aggregate, a Material Adverse Effect, (ii)&nbsp;conflict with or result in any violation of any provision of the articles of incorporation or bylaws or other equivalent organizational document, in each case,
as amended or restated (whether by filing a statement with respect to shares or otherwise), of the Company or any of its Subsidiaries or (iii)&nbsp;conflict with or violate any applicable Laws, except for such conflict or violation as has not had
and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04
<U>[RESERVED]</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05 <U>Company SEC Documents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries have filed or furnished all forms, documents and reports required to be filed or furnished prior
to the date of the Original Investment Agreement by it with the SEC since January&nbsp;1, 2018 (all such forms, documents and reports, the &#147;<U>Company SEC Documents</U>&#148;). As of their respective dates or, if amended, as of the date of the
last such amendment, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the applicable rules and regulations promulgated
thereunder, and none of the Company SEC Documents at the time they were filed or furnished contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not materially misleading. None of Company&#146;s Subsidiaries is, or at any time since January&nbsp;1, 2018 has been, required to file any forms, reports or other documents with the
SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The consolidated financial statements (including all related notes and schedules) of Company included in the Company SEC
Documents (the &#147;<U>Company Financial Statements</U>&#148;) at the time they were filed or furnished (i)&nbsp;fairly present in all material respects the consolidated financial position of Company and its consolidated Subsidiaries, as at the
respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for the respective periods then ended (except, in the case of unaudited statements, subject to normal
<FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments, the absence of notes and to any other adjustments described therein, including in any notes thereto or with respect to pro forma financial information, subject to the qualifications
stated therein), (ii)&nbsp;were prepared in conformity with GAAP applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto) and (iii)&nbsp;comply in all material respects with the
applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the
date of the Original Investment Agreement, there are no outstanding or unresolved comments in any comment letters of the staff of the SEC received by Company relating to the Company SEC Documents. As of the date of the Original Investment Agreement,
none of the Company SEC Documents is, to the knowledge of Company, the subject of ongoing SEC review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither Company nor any of its
Subsidiaries is a party to, or has a commitment to effect, enter into or create, any joint venture, or <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangement&#148; (as defined in Item 303(a) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act), where the result, purpose or effect of such contract is to avoid disclosure of any material transaction involving, or material liabilities of, Company or any of its Subsidiaries in the
Company Financial Statements or other Company SEC Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06 <U>Absence</U><U> of Certain Changes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for the entry into the Target Merger Agreement and actions taken in relation to the transactions contemplated by the Target Merger
Agreement, (1)&nbsp;from January&nbsp;1, 2020, through the date of the Original Investment Agreement, the businesses of each of Company and its Subsidiaries, as applicable, have been conducted in all material respects in the Ordinary Course of
Business, and (2)&nbsp;from January&nbsp;1, 2020 through the date of this Agreement, none of Company or any Subsidiary of Company has undertaken any action that, if taken during the period from the date of this Agreement to the Subsequent Closing
Date, would constitute a breach of clauses&nbsp;(i) through (v)&nbsp;or (ix)&nbsp;(solely as it relates to clauses&nbsp;(i) through (v)) of <U>Section</U><U></U><U>&nbsp;5.01(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2020, through the date of the Original Investment Agreement, there has not been any event, change, effect,
development or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07 <U>Internal Controls and Procedures</U>. The Company has established and maintains disclosure controls and procedures and
internal control over financial reporting (as such terms are defined in paragraphs&nbsp;(e) and (f), respectively, of <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act) as required by
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act. Company&#146;s disclosure controls and procedures are reasonably designed to ensure that all material information required to be disclosed by Company in the reports
that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is accumulated and communicated to
Company&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. Company&#146;s management has completed an
assessment of the effectiveness of Company&#146;s internal controls over financial reporting in compliance with the requirements of Section&nbsp;404 of the Sarbanes-Oxley Act for the year ended December&nbsp;31, 2019, and such assessment concluded
that such controls were effective. Based on its most recent evaluation of internal controls over financial reporting prior to the date of the Original Investment Agreement, management of Company has disclosed to Company&#146;s auditors and the audit
committee of the Board (i)&nbsp;any significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting that are reasonably likely to adversely affect in any material respect Company&#146;s
ability to report financial information and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in Company&#146;s internal controls over financial reporting, in each case, that was
disclosed to Company&#146;s auditors or the audit committee of the Board in connection with its most recent evaluation of internal controls over financial reporting prior to the date of the Original Investment Agreement. Company maintains a system
of internal accounting controls designed to provide reasonable assurances regarding transactions being executed in accordance with management&#146;s general or specific authorization, the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP and the prevention or timely detection of unauthorized acquisition, use or disposition of Company&#146;s assets that could have a material effect on its financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08 <U>No Undisclosed Liabilities</U>. There are no liabilities or obligations of Company or any of its Subsidiaries, whether
accrued, absolute, determined or contingent, except for (i)&nbsp;liabilities or obligations disclosed, reflected or reserved against in the balance sheets included in the Company Financial Statements (or in the notes thereto) filed and publicly
available prior to the date of the Original Investment Agreement, (ii)&nbsp;liabilities or obligations arising under or in accordance with this Agreement or the Target Merger Agreement, (iii)&nbsp;liabilities or obligations incurred in the Ordinary
Course of Business since December&nbsp;31, 2019, and (iv)&nbsp;liabilities or obligations that have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09 <U>Legal Proceedings</U>. Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, (a)&nbsp;there are no actions, suits, inquiries, investigations, proceedings, subpoenas, civil investigative demands or other requests for information relating to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
potential violations of Law pending (or, to the Knowledge of the Company, threatened) against or affecting the Company or any of its Subsidiaries, or any of their respective properties and
(b)&nbsp;there are no orders of, or before, any Governmental Entity against the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10
<U>Compliance</U><U> with Laws; Permits</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries are in compliance with, and are not in default under or
in violation of, any applicable federal, state, local or foreign law, statute, ordinance, rule, regulation, judgment, order, injunction, decree or agency requirement of any Governmental Entity (collectively, &#147;<U>Laws</U>&#148; and each, a
&#147;<U>Law</U>&#148;), except where such <FONT STYLE="white-space:nowrap">non-compliance,</FONT> default or violation have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Since
January&nbsp;1, 2018, neither the Company nor any of its Subsidiaries has received any written notice or, to the knowledge of the Company, other communication from any Governmental Entity regarding any violation of, or failure to comply with, any
Law, except where such violation or failure has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and its Subsidiaries are in possession of all material franchises, grants, authorizations, licenses, permits, easements,
variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and orders of all applicable Governmental Entities, and all rights under any Company material contract with all Governmental
Entities, and have filed all tariffs, reports, notices and other documents with all Governmental Entities necessary for the Company and its Subsidiaries to own, lease and operate their properties and assets and to carry on their businesses as they
are now being conducted (the &#147;<U>Company Permits</U>&#148;), except where the failure to possess or file the Company Permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, all Company Permits are in all respects valid and in full force and effect and are not subject to any administrative or
judicial proceeding that would reasonably be expected to result in modification, termination or revocation thereof. Company and each of its Subsidiaries are in material compliance with the terms and requirements of all Company Permits, except where
such <FONT STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect:
(i)&nbsp;Company and each of its Subsidiaries are in compliance, and have since January&nbsp;1, 2018 complied, with all applicable Data Privacy Laws; (ii)&nbsp;neither Company nor any of its Subsidiaries has, since January&nbsp;1, 2018, received any
written notice from any applicable Governmental Entity alleging any violation of applicable Data Privacy Laws by Company, any of its Subsidiaries or, to the knowledge of Company, any third-party service providers, outsourcers, processors or other
third parties who process, store or otherwise handle Personal Data for or on behalf of Company or any of its Subsidiaries (&#147;<U>Company Data Processors</U>&#148;), nor has Company or any of its Subsidiaries been threatened in writing to be
charged with any such violation by any Governmental Entity; (iii)&nbsp;Company and each of its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps (including, as appropriate, implementing reasonable technical, physical
or administrative safeguards) designed to protect Personal Data in their possession or under their control against loss and unauthorized access, use, modification or disclosure, and, to the knowledge of Company, since January&nbsp;1, 2018, there has
been no incident of the same, or of the same with respect to any Personal Data maintained or otherwise processed for or on behalf of Company or its Subsidiaries; (iv)&nbsp;Company and each of its Subsidiaries have, since January&nbsp;1, 2018, taken
commercially reasonable steps with respect to Company Data Processors to obligate such persons to comply in all material respects with applicable Data Privacy Laws and to take reasonable steps to protect and secure Personal Data from loss or
unauthorized use, access, modification or disclosure; and (v)&nbsp;the execution, delivery and performance of this Agreement complies with all applicable Data Privacy Laws (including the General Data Protection Regulation (EU)&nbsp;2016/679, the
Data Protection Act 2018 (UK), and the California Consumer Protection Act) and Company&#146;s and each of its Subsidiaries&#146; applicable published policies, statements, and notices relating to privacy, data protection or information security
regarding Personal Data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>Tax Matters</U>.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
(i)&nbsp;Company and each of its Subsidiaries have prepared and timely filed (taking into account any valid extension of time within which to file) all Tax Returns required to be filed by any of them and all such Tax Returns are complete and
accurate, (ii)&nbsp;Company and each of its Subsidiaries have timely paid all Taxes that are required to be paid by any of them or that Company or any of its Subsidiaries are obligated to withhold from amounts owing to any employee, creditor,
stockholders or third party (in each case, whether or not shown on any Tax Return), (iii)&nbsp;as of the date of the Original Investment Agreement there are no effective waivers of any statute of limitations with respect to Taxes or extensions of
time with respect to a Tax assessment or deficiency, (iv)&nbsp;all assessments for Taxes due with respect to completed and settled examinations or any concluded litigation have been fully paid, (v)&nbsp;there are no audits, examinations,
investigations or other proceedings pending or threatened in writing in respect of Taxes or Tax matters of Company or any of its Subsidiaries, (vi)&nbsp;no claim has been made in writing or, to Company&#146;s knowledge, otherwise, by a Taxing
Authority in a jurisdiction where Company or any of its Subsidiaries does not file Tax Returns of a certain type that Company or any of its Subsidiaries is or may be subject to taxation of such type or required to file Tax Returns of such type in
that jurisdiction, (vii)&nbsp;there are no Liens for Taxes on any of the assets of Company or any of its Subsidiaries other than statutory Liens for Taxes not yet due and payable, (viii)&nbsp;neither Company nor any of its Subsidiaries is a party to
any agreement or arrangement relating to the apportionment, sharing, assignment or allocation of any Tax or Tax asset (other than an agreement or arrangement solely among members of a group the common parent of which is Company or commercial
agreements or arrangements not primarily related to Taxes and entered into in the ordinary course of business) or has any liability for Taxes of any person (other than Company or any of its Subsidiaries) under Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any analogous or similar provision of state, local or foreign Tax Law), as transferee, successor, by contract (other than commercial contracts not primarily related to Taxes and entered
into in the ordinary course of business) or otherwise, (ix)&nbsp;neither Company nor any of its Subsidiaries is bound with respect to any current or any future taxable period by any closing agreement (within the meaning of Section&nbsp;7121 of the
Code), private letter ruling, technical advice or other ruling or written agreement with a Governmental Entity, in each case, that could reasonably be expected to affect the liability for Taxes of Company or any of its Subsidiaries following the
Initial Closing, (x)&nbsp;none of Company or any of its Subsidiaries has been a party to any &#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">1.6011-4(b)(2),</FONT> and (xi)&nbsp;none of the
Company or any of its Subsidiaries has, within the two (2)-year period ending on the date of the Original Investment Agreement, been a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (as such terms are used in
Section&nbsp;355 of the Code) in a distribution intended or purported to qualify in whole or in part for tax free treatment under Section&nbsp;355 of the Code (or so much of Section&nbsp;356 of the Code as relates to Section&nbsp;355 of the Code).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provisions of this Agreement to the contrary, the representations and warranties made in this
<U>Section</U><U></U><U>&nbsp;3.11</U>, <U>Section</U><U></U><U>&nbsp;3.05</U>, <U>Section</U><U></U><U>&nbsp;3.06</U> (to the extent relating to Taxes) and <U>Section</U><U></U><U>&nbsp;3.12</U> (to the extent relating to Taxes) are the sole and
exclusive representations and warranties of Company with respect to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 <U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to result in, individually or in the aggregate, a material liability to Company and its
Subsidiaries, (i)&nbsp;each Company Benefit Plan has been established, operated and administered in all respects in accordance with its terms and the requirements of all applicable Laws, including ERISA and the Code, and (ii)&nbsp;all contributions
required to be made to any Company Benefit Plan by applicable Law or by any plan document or other contractual undertaking, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, have been timely made or
paid or, to the extent not required to be made or paid on or before the date of the Original Investment Agreement, have been reflected on the books and records of Company in accordance with GAAP. As of the date of the Original Investment Agreement,
there are no pending or threatened material claims (other than routine claims for benefits) by, on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
behalf of or against any of the Company Benefit Plans, except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, since January&nbsp;1,
2016, no Company Benefit Plan has been an employee benefit plan subject to Section&nbsp;302 or Title IV of ERISA or Section&nbsp;412, 430 or 4971 of the Code and (ii)&nbsp;none of Company or any of its ERISA Affiliates has incurred or is reasonably
expected to incur any Controlled Group Liability that has not been satisfied in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect, neither the Company, nor its Subsidiaries nor any of their respective ERISA Affiliates has, at any time since January&nbsp;1, 2016, contributed to, been obligated to contribute to or
had any liability (including any contingent liability) with respect to any Multiemployer Plan or Multiple Employer Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the execution of this Agreement and the consummation of the Transactions will not, either alone or in combination with another event,
(i)&nbsp;entitle any current or former employee, director, consultant or officer of Company or any of its Subsidiaries to any severance pay or any other similar payment, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of
compensation due any such employee, director, consultant or officer or (iii)&nbsp;trigger any funding obligation under any Company Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no Company Benefit Plan
provides for, and neither Company nor any of its Subsidiaries otherwise has any obligation to provide, a <FONT STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes imposed under Section&nbsp;4999 of the Code,
Section&nbsp;409A(a)(1)(B) of the Code, or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not, either individually or in the aggregate, reasonably be
expected to result in material liability to Company or its Subsidiaries, each Company Benefit Plan that is mandated by applicable Law or by a Governmental Entity outside of the United States or that is subject to the laws of a jurisdiction outside
of the United States (i)&nbsp;has been maintained in accordance with all applicable requirements, (ii)&nbsp;if intended to qualify for special Tax treatment, meets all the requirements for such treatment, and (iii)&nbsp;if required, to any extent,
to be funded, book-reserved or secured by an insurance policy, is fully funded, book-reserved or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 <U>Labor Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;neither the
Company nor any of its Subsidiaries is party to or bound by any collective bargaining agreement, works council agreement or similar labor-related agreement or arrangement, (ii)&nbsp;no strike, material work slowdown, work stoppage, or unfair labor
practice against Company or any of its Subsidiaries is pending, or to knowledge of Company, threatened and (iii)&nbsp;to the knowledge of Company, no activities or proceedings of any labor union to organize any employees of Company or any of its
Subsidiaries are pending or threatened. As of the date of the Original Investment Agreement, no labor union or works council represents any employees of Company or any of its Subsidiaries in connection with their employment with Company or any of
its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a Material Adverse Effect, Company and each of
its Subsidiaries is in compliance with all applicable Laws respecting hiring, employment and employment practices, terms and conditions of employment, harassment, retaliation, reasonable accommodations, leaves of absence, occupational safety and
health, workers&#146; compensation, employee classification, wages and hours, engagement of independent contractors (including the appropriate classification </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the same), payroll taxes, redundancy, &#147;mass layoffs,&#148; &#147;plant closings&#148; and immigration with respect to all employees, independent contractors, and other service providers
of Company and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date of the Original Investment Agreement, except as has not had, and would not reasonably
be expected to have, a Material Adverse Effect, (i)&nbsp;there are no charges, complaints, audits or investigations pending or scheduled by any Governmental Entity pertaining to the employment practices or actions of Company or any of its
Subsidiaries or, to Company&#146;s knowledge, threatened against Company or any of its Subsidiaries and (ii)&nbsp;to Company&#146;s knowledge, no complaints or charges relating to employment practices or actions of Company or any of its Subsidiaries
have been made since January&nbsp;1, 2018 to any Governmental Entity or submitted to Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the
knowledge of Company, neither Company nor any of its Subsidiaries is party to a settlement agreement with any employee of Company or any of its Subsidiaries that involves material allegations of sexual harassment by any employee of Company or any of
its Subsidiaries at the level of Senior Vice President or above. To the knowledge of Company, no material allegations of sexual harassment are pending against any employee of Company or any of its Subsidiaries at the level of Senior Vice President
or above in his or her capacity as such. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 <U>Environmental</U><U> Matters</U>. Company and its Subsidiaries are, and
since January&nbsp;1, 2018 have been, in compliance with all applicable Environmental Laws (which compliance includes the possession, and the compliance with the terms and conditions, by Company and each of its Subsidiaries of all Company Permits
required under applicable Environmental Laws to conduct their respective business and operations), and there are no investigations, actions, suits or proceedings pending or, to the knowledge of Company, threatened against Company or any of its
Subsidiaries, in each case, except as, individually or in the aggregate, has not had a would not reasonably be expected to have a Material Adverse Effect. Neither Company nor any of its Subsidiaries has received any written notice from a
Governmental Entity that alleges that Company or any of its Subsidiaries is violating, or has or may have, violated any Environmental Law, or may have any liability or obligation arising under, retained or assumed by contract or by operation of law,
except for such violations, liabilities and obligations that would not have, individually or in the aggregate, a Material Adverse Effect. To the knowledge of Company, there has been no release of any Hazardous Materials by Company or any of its
Subsidiaries at, to or from any facilities owned or leased by Company or any of its Subsidiaries as of or prior to the date of the Original Investment Agreement or at any other locations where any Hazardous Materials were generated, manufactured,
refined, transferred, stored, produced, imported, used, processed or disposed of by Company or any of its Subsidiaries and, in each case, for which Company or any of its Subsidiaries would reasonably be expected to be subject to any material
liability. Neither Company nor any of its Subsidiaries has, either through contract or by operation of law, assumed or agreed to guarantee, reimburse, pledge, defend, hold harmless or indemnify any other person with respect to any liabilities
arising under Environmental Laws except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect. Company has delivered or made available to the Company all material environmental
assessment reports, investigations and audits in its possession or control, which relate to environmental matters for which Company may reasonably be expected to have any material liability with respect to Company and its Subsidiaries&#146; business
and operations. The representations and warranties set forth in this <U>Section</U><U></U><U>&nbsp;3.14</U>, <U>Section</U><U></U><U>&nbsp;3.03</U>, <U>Section</U><U></U><U>&nbsp;3.05</U>, <U>Section</U><U></U><U>&nbsp;3.06</U> and
<U>Section</U><U></U><U>&nbsp;3.08</U> are Company&#146;s sole and exclusive representations and warranties relating to Environmental Laws or liabilities relating to the release or disposal of Hazardous Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 <U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have a Material Adverse Effect: (i)&nbsp;either Company or a Subsidiary of Company has good
and valid title, subject to Permitted Liens, to each material Real Property owned by Company or any Subsidiary of Company (such owned property collectively, the &#147;<U>Owned Real Property</U>&#148;) and (ii)&nbsp;either Company or a Subsidiary of
Company has a good and valid leasehold interest in each material lease, material sublease and other material agreement under which Company or any of its Subsidiaries </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
uses or occupies or has the right to use or occupy any Real Property (such property, the &#147;<U>Leased Real Property</U>&#148;) and such leases, subleases and other agreements (collectively,
the &#147;<U>Real Property Leases</U>&#148;), in each case, free and clear of all Liens other than any Permitted Liens and any Lien encumbering the interest of the landlord thereunder. Except as would not reasonably be expected to have a Material
Adverse Effect, each Real Property Lease and each Sublease (defined below) is valid, binding and in full force and effect, subject to the limitation of such enforcement by the Remedies Exceptions. Except as would not reasonably be expected to have a
Material Adverse Effect, no uncured default of a material nature on the part of Company or, if applicable, its Subsidiary or, to the knowledge of Company, the landlord, sublandlord or subtenant thereunder (as applicable), exists under any Real
Property Lease or Sublease, and no event has occurred or circumstance exists which, with the giving of notice, the passage of time, or both, would constitute a material breach or default under a Real Property Lease or Sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have a Material Adverse Effect, (i)&nbsp;there are no leases, subleases, licenses, rights or
other agreements affecting any portion of the Owned Real Property or the Leased Real Property (each, a &#147;<U>Sublease</U>&#148;) that would reasonably be expected to adversely affect the existing use of such Owned Real Property or Leased Real
Property by Company or its Subsidiaries in the operation of its business thereon; and (ii)&nbsp;there are no outstanding (A)&nbsp;options or (B)&nbsp;rights of first refusal in favor of any other party to purchase any Owned Real Property or any
portion thereof or interest therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 <U>No Rights Agreement; Anti-Takeover Provisions</U>. The Board has taken all
action necessary to render inapplicable to this Agreement and the Transactions all applicable state Laws (including Subchapter F of Chapter 25 of PBCL) and any similar provisions in the Company&#146;s articles of incorporation or bylaws. As of the
date of the Original Investment Agreement and as of the date of this Agreement, no &#147;fair price,&#148; &#147;business combination,&#148; &#147;moratorium,&#148; &#147;control share acquisition&#148; or other anti-takeover statute or similar
statute or regulation enacted by any state (including Pennsylvania) will prohibit or impair the Transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 <U>Customers</U>. <U>Section</U><U></U><U>&nbsp;3.17</U> of the Disclosure Schedules sets forth a list of the Top Company
Customers. As of the date of the Original Investment Agreement, neither Company nor any of its Subsidiaries has received any written notice from any Top Company Customer that such Top Company Customer shall not continue as a customer of Company and
its Subsidiaries or that such Top Company Customer intends to terminate, not renew or materially amend existing contracts with Company or any of its Subsidiaries or otherwise materially modify its business relationship with Company and its
Subsidiaries, except as would not be material and adverse to Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 <U>Brokers
</U><U>and</U><U> Other Advisors</U>. Except for Allen&nbsp;&amp; Company LLC and J.P. Morgan Securities LLC, neither the Company nor any of the Company&#146;s Subsidiaries has employed any investment banker, broker or finder in connection with the
Transactions who would be entitled to any fee or any commission in connection with or upon consummation of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 <U>Sale of Securities</U>. Based in part on the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.06</U>, the sale of the Shares pursuant to this Agreement is exempt from the registration and prospectus delivery requirements of the Securities Act and the rules and regulations promulgated thereunder. Without
limiting the foregoing, neither the Company nor, to the Knowledge of the Company, any other Person authorized by the Company to act on its behalf, has engaged in a general solicitation or general advertising (within the meaning of Regulation D of
the Securities Act) of investors with respect to offers or sales of Series B Preferred Stock, and neither the Company nor, to the Knowledge of the Company, any Person acting on its behalf has made any offers or sales of any security or solicited any
offers to buy any security, under circumstances that would cause the offering or issuance of Series B Preferred Stock under this Agreement to be integrated with prior offerings by the Company for purposes of the Securities Act that would result in
none of Regulation D or any other applicable exemption from registration under the Securities Act to be available, nor will the Company take any action or steps that would cause the offering or issuance of Series B Preferred Stock under this
Agreement to be integrated with other offerings by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 <U>Listing and Maintenance Requirements</U>. The Company Common Stock is
registered pursuant to Section&nbsp;12(b) of the Exchange Act and listed on the NASDAQ, and the Company has taken no action designed to, or which to the Knowledge of the Company is reasonably likely to have the effect of, terminating the
registration of the Company Common Stock under the Exchange Act or delisting the Company Common Stock from the NASDAQ, nor has the Company received as of the date of the Original Investment Agreement any notification that the SEC or the NASDAQ is
contemplating terminating such registration or listing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 <U>Status of Securities</U>. As a result of the approval by the
Board referred to in <U>Section</U><U></U><U>&nbsp;3.03(a)</U>, the shares of Series B Preferred Stock to be issued pursuant to this Agreement, and the shares of Company Common Stock to be issued upon conversion of the Series B Preferred Stock, have
been duly authorized and reserved for issuance by all necessary action. When issued and sold against receipt of the consideration therefor as provided in this Agreement or the Statement With Respect to Shares, such securities shall be validly
issued, fully paid and nonassessable (whether or not the Subsequent Closing occurs), will not be subject to preemptive rights of any other stockholder of the Company, and will be free and clear of all Liens, except restrictions imposed by the
Securities Act, the articles of incorporation and bylaws of the Company, <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement and any applicable state securities Laws and any Liens arising due to actions by or on behalf of the Investor,
including Liens contemplated by the Issuer Agreement. Upon any conversion of any shares of Series B Preferred Stock into Company Common Stock pursuant to the Statement With Respect to Shares, the shares of Company Common Stock issued upon such
conversion shall be validly issued, fully paid and nonassessable, and will not be subject to preemptive rights of any other stockholder of the Company, and will be free and clear of all liens, except restrictions imposed by the Securities Act, the
articles of incorporation and bylaws of the Company, <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement and any applicable state securities Laws and any Liens arising due to actions by or on behalf of the Investor, including Liens contemplated
by the Issuer Agreement. The respective rights, preferences, privileges, and restrictions of the Series B Preferred Stock and the Company Common Stock as of the Initial Closing and Subsequent Closing, as applicable, will be as stated in the articles
of incorporation and bylaws of the Company (including the Statement With Respect to Shares). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 <U>Indebtedness</U>. The
Company is not party to any contract, and is not subject to any provision in the Company Charter Documents or other governing documents or resolutions of the Board that, in each case, by its terms restricts, limits, prohibits or prevents the Company
from paying dividends in form and the amounts contemplated by the Statement With Respect to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 <U>Intellectual
Property</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, the Company and its Subsidiaries solely and exclusively own the Intellectual Property owned (or purported to be owned) by the Company and its Subsidiaries (&#147;<U>Company Owned IP</U>&#148;), free and clear of all Liens other than
Permitted Liens. All material issued patents, all registered copyrights and all registered trademarks that are registered or filed in the name of the Company or any of its Subsidiaries are subsisting and, to the knowledge of the Company, valid and
enforceable. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company Owned IP is not subject to any outstanding consent, settlement, Lien (other than Permitted
Liens), decree, order, injunction, judgment or ruling restricting the use thereof in a manner that would reasonably be expected to impair the continued operation of the businesses of the Company and its Subsidiaries as conducted as of the date of
the Original Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, as of the date of the Original Investment Agreement, (i)&nbsp;the conduct of the business of the Company and its Subsidiaries as conducted since January&nbsp;1, 2018 and as presently conducted does not infringe,
misappropriate or otherwise violate any Intellectual Property rights of any third party and (ii)&nbsp;since January&nbsp;1, 2018 through the date of the Original Investment Agreement, the Company has not received any written claim alleging any such
infringement, misappropriation or other violation. Since January&nbsp;1, 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through the date of the Original Investment Agreement, there is no and has not been any legal proceeding brought by a third party against the Company or any of its Subsidiaries (or against
another person who has sought indemnification from the Company or any of its Subsidiaries in connection with such legal proceeding) with respect to any material alleged infringement or other material violation by the Company, its Subsidiaries, its
or their current products or services, or other operation of the Company&#146;s or any of its Subsidiaries&#146; businesses, of the Intellectual Property of such third party, that is outstanding and unresolved as of the date of the Original
Investment Agreement, or which, if resolved, has resulted in any material liability or obligation (including ongoing payment), or the resolution of which required granting any license under any Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the
date of the Original Investment Agreement, to the knowledge of the Company, no person or entity is infringing, misappropriating or otherwise violating any Intellectual Property owned by the Company or any of its Subsidiaries. Neither the Company nor
any of its Subsidiaries have, since January&nbsp;1, 2018 through the date of the Original Investment Agreement, brought (or asserted or threatened in writing) any claim against any person alleging that such person is infringing or misappropriating
any material Company Owned IP, that is outstanding and unresolved as of the date of the Original Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as has
not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries have taken commercially reasonable steps to protect all material trade secrets of the Company or its
Subsidiaries. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;to the knowledge of the Company, there have been no unauthorized uses or disclosures of any such
trade secrets, and (ii)&nbsp;none of the Company or its Subsidiaries has published, provided or disclosed, nor are the Company or its Subsidiaries under any present or contingent obligation to so publish, provide or disclose, any software source
code for Company Owned IP, including through or in connection with any agreement requiring the Company or any of its Subsidiaries to place any software source code in escrow. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, none of
the Company or its Subsidiaries has received any support, funding, resources or assistance from any Governmental Entity, or from any university, college, other academic institutions, or <FONT STYLE="white-space:nowrap">non-profit</FONT> research
centers in the development of any Intellectual Property owned by the Company or its Subsidiaries, that resulted in, or is reasonably expected to result in, such third-parties being granted any rights or licenses to, or ownership interest in, any
such Intellectual Property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no rights have been granted to any Governmental Entity with respect to any Company Owned IP
other than substantially the same standard commercial rights as are granted by the Company to commercial end users in the Ordinary Course of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, none of
the Company or its Subsidiaries is a member or promoter of, or a contributor to, or made any commitments or agreements regarding, any patent pool, industry standards body, standard-setting organization or other similar organization, in each case
that requires or obligates the Company or any of its Subsidiaries to grant or offer to any other person any license or other right to any Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the
information technology systems (&#147;<U>IT Systems</U>&#148;) used by the Company and its Subsidiaries are designed, implemented, operated and maintained in accordance with reasonable and customary industry standards and practices for entities
operating businesses similar to the business of the Company and its Subsidiaries, including with the respect to redundancy, reliability, scalability and security, and constitute all the information and communications technology and other systems
infrastructure reasonably necessary to carry on the business of the Company and its Subsidiaries as conducted in the 12 months prior to the date of the Original Investment Agreement. Without limiting the foregoing, except as has not had and would
not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries have taken reasonable steps and implemented reasonable
procedures to ensure that their IT Systems are free from viruses, contaminants and other harmful code, (ii)&nbsp;the Company and its Subsidiaries have in effect industry standard disaster recovery plans, procedures and facilities for their
businesses and have taken all reasonable steps to safeguard the security and the integrity of their IT Systems, and (iii)&nbsp;there has been no failure, breakdown, loss or impairment of, or any unauthorized intrusions or breaches of the security
with respect to the IT Systems used by the Company or any of its Subsidiaries that (A)&nbsp;has resulted in a disruption or interruption in the operation of the business of the Company or its Subsidiaries or (B)&nbsp;to the knowledge of the Company,
has resulted in loss, unauthorized access to, or unauthorized modification or disclosure of any confidential information of or maintained by, for or on behalf of the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, there
exist no facts, and no events have occurred, that would reasonably be expected to form the basis of any present or future claim against the Company or its Subsidiaries, whether or not fully covered by insurance, for liability on account of
negligence or product liability or on account of any breach of Warranties of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 <U>Affiliate
Transactions</U>. To the knowledge of the Company, no officer, director or Affiliate of the Company or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate family (a)&nbsp;owns any property or right, tangible or
intangible, that is material to the conduct of the business of the Company or its Subsidiaries, (b)&nbsp;with the exception of liabilities incurred in the Ordinary Course of Business, owes money to, or is owed money by, the Company or its
Subsidiaries, or (c)&nbsp;is a party to or the beneficiary of any contract with the Company or its Subsidiaries, except in each case for compensation and benefits payable under any Company Benefit Plans to officers and employees in their capacity as
officers and employees. Except as disclosed in the Company SEC Documents, there are no contracts between the Company or any of its Subsidiaries, on the one hand, and any officer, director or Affiliate of the Company or its Subsidiaries or any
individual in such officer&#146;s or director&#146;s immediate family, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 <U>No Other Representations
or Warranties</U>. Except for the representations and warranties contained in <U>Article IV</U> or in any certificates delivered by the Investor in connection with the Transactions, the Company acknowledges that neither the Investor nor any person
on behalf of the Investor makes, and none of the Company or any person acting on behalf of the Company, has relied or is relying upon, any other express or implied representation or warranty with respect to the Investor or any of their respective
Subsidiaries or with respect to any other information provided or made available to the Company in connection with the Transactions, including the accuracy, completeness or currency thereof. Except as otherwise expressly provided in this Agreement
and to the extent any such information is expressly included in a representation or warranty contained in <U>Article IV</U>, neither the Investor nor any other person will have or be subject to any liability or obligation to the Company or any other
person resulting from the distribution or failure to distribute to the Company, or the Company&#146;s use of, any such information, including any information, documents, projections, estimates, forecasts or other material, made available to the
Company or any other person for purposes of, or in expectation of, the Transactions. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties of the Investor</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Investor represents and warrants to the Company, as of the date of the Original Investment Agreement (unless expressly stated as of the
date hereof, in which case as of the date hereof) and as of the Subsequent Closing Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <U>Organization; Standing;
Ownership</U>. The Investor is a limited partnership duly formed, validly existing and in good standing under the Laws of its organization, and is a U.S. Person. The Investor has all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
requisite power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Investor is duly qualified or licensed and has all necessary governmental approvals, to do business and is in good standing in each
jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such approvals, qualification or licensing necessary (to the extent the &#147;qualification to do business&#148; or &#147;good
standing&#148; concept is applicable in the case of any jurisdiction outside the United States), except where the failure to be so duly approved, qualified or licensed and in good standing would not reasonably be expected to have an Investor
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date of the Original Agreement and as of the date hereof, the Investor and its Affiliates do not
beneficially own any shares of Company Common Stock or any securities convertible into or exchangeable for Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <U>Authority; Noncontravention</U>. The Investor has the requisite corporate power and authority to enter into this
Agreement and the other Transaction Documents and to consummate the Transactions. The execution and delivery by the Investor and the other Transaction Documents of this Agreement and the consummation of the Transactions have been duly and validly
authorized by the board of directors (or equivalent) of the Investor, and no other corporate proceedings on the part of the Investor or vote of the Investor&#146;s equityholders are necessary to authorize the consummation of the Transactions. This
Agreement has been duly and validly executed and delivered by the Investor, and assuming this Agreement constitutes the legal, valid and binding agreement of the Company, constitutes the legal, valid and binding agreement of the Investor,
enforceable against it, in accordance with its terms, except as such enforcement may be subject to the Bankruptcy and Equity Exceptions. Neither the execution and delivery of this Agreement or the other Transaction Documents by the Investor, nor the
consummation of the Transactions by the Investor, nor performance or compliance by the Investor with any of the terms or provisions hereof or thereof, will (i)&nbsp;conflict with or violate any provision of the certificate or articles of
incorporation or bylaws (or other comparable charter or organizational documents) of the Investor or (ii)&nbsp;violate any law, order or judgment applicable to the Investor or violate or constitute a default (or constitute an event which, with
notice or lapse of time or both, would violate or constitute a default) under any of the terms, conditions or provisions of any contract to which the Investor is a party or accelerate the Investor&#146;s obligations under any such contract, except,
in the case of clause&nbsp;(ii), as would not, individually reasonably be expected to have an Investor Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <U>Governmental</U><U> Approvals</U>. Except for (a)&nbsp;the filing by the Company of the Statement With Respect to Shares
with the Pennsylvania Department of State and (b)&nbsp;filings required under, and compliance with other applicable requirements of, the HSR Act and the antitrust Laws and any Laws with respect to foreign investment set forth on
<U>Section</U><U></U><U>&nbsp;4.03</U> of the Disclosure Schedules, no consent or approval of, or filing, license, permit or authorization, declaration or registration with, any Governmental Entity is necessary for the execution and delivery of this
Agreement and the other Transaction Documents by the Investor, the performance by the Investor of its obligations hereunder and thereunder and the consummation by the Investor of the Transactions, other than such other consents, approvals, filings,
licenses, permits, authorizations, declarations or registrations that, if not obtained, made or given, would not, individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. The Bain Group does not hold five
percent (5%) or more of the voting securities or <FONT STYLE="white-space:nowrap">non-corporate</FONT> interests (as &#147;hold,&#148; &#147;voting securities,&#148; and <FONT STYLE="white-space:nowrap">&#147;non-corporate</FONT> interests&#148; are
defined under 16 CFR 801) of any entity that competes with the Company or the Target, to the extent that any such holdings would reasonably be expected to prevent or materially delay the expiration or termination of the waiting period or the
obtaining or receiving of any consent or approval under the HSR Act or any other antitrust or foreign investment Law in connection with the Transactions. For purposes of giving the representations and warranties in this
<U>Section</U><U></U><U>&nbsp;4.03</U>, it is acknowledged and agreed that the Investor has relied on the information regarding the Company and its Subsidiaries that has been provided to the Investor&#146;s Representatives by the Company and its
Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <U>Financing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date hereof, the Investor has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to
which Bain Capital Fund XII, L.P., Bain Capital Fund (DE) XII, L.P. and Bain Capital Fund (Lux) XII, SCSp (collectively, the &#147;<U>Equity Provider</U>&#148;), have committed, subject only to the terms and conditions thereof, to invest the amounts
set forth therein (the &#147;<U>Equity Financing</U>&#148;). The Equity Commitment Letter provides that (A)&nbsp;the Company is an express third party beneficiary thereof; and (B)&nbsp;the Investor and Equity Provider will not oppose the granting of
an injunction, specific performance or other equitable relief seeking to enforce the obligations under the Equity Commitment Letter on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an
appropriate remedy for any reason at law or in equity in connection with the exercise of such third party beneficiary rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
(i)&nbsp;The Equity Commitment Letter and the terms of the Equity Financing have not been amended or modified as of the date hereof and as of the date of the Subsequent Closing; (ii)&nbsp;as of the date hereof no such amendment or modification is
contemplated;&nbsp;and (iii)&nbsp;as of the date hereof the respective commitments contained therein have not been withdrawn, terminated or rescinded in any respect. There are no other contracts, agreements, side letters or arrangements to which the
Investor is a party relating to the funding or investing, as applicable, that would reasonably be expected to adversely affect the availability or conditionality of the Equity Financing, other than as expressly set forth in the Equity Commitment
Letter. Other than as set forth in the Equity Commitment Letter, there are no conditions precedent related to the funding or investing, as applicable, of the full amount of the Equity Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The net proceeds of the Equity Financing, when funded in accordance with the Equity Commitment Letter, will be, in the aggregate,
sufficient to pay the Initial Investment Purchase Price at the Initial Closing and the Subsequent Investment Purchase Price at the Subsequent Closing, on the terms and subject to the conditions contemplated in this Agreement. The Company
acknowledges (x)&nbsp;the separate corporate existence of the Investor and (y)&nbsp;that the sole asset of the Investor is cash in a <I>de minimis</I> amount and its rights under this Agreement and the Equity Commitment Letter, in each case in
accordance with, and subject to, the terms and conditions set forth herein and therein and that no additional funds will be contributed to the Investor unless and until the Initial Closing occurs pursuant to the terms and conditions of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, the Equity Commitment Letter (in the form delivered by the Investor to the Company) is in full
force and effect and constitutes the legal, valid and binding obligations of the Investor and Equity Provider, as applicable, enforceable against the Investor and Equity Provider, as applicable, in accordance with their terms, except as such
enforceability (i)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting or relating to creditors&#146; rights generally; and (ii)&nbsp;is subject to general principles of equity.
Assuming the accuracy of the representations and warranties set forth in <U>Article III</U> in all respects as of the date of the Original Investment Agreement, no event has occurred that, with notice or lapse of time or both, would, or would
reasonably be expected to, constitute a default or breach on the part of the Investor or Equity Provider pursuant to the Equity Commitment Letter. Subject to the Company&#146;s compliance with this Agreement, as of the date hereof, the Investor has
no reason to believe that it will be unable to satisfy on a timely basis any term or condition of the Equity Financing to be satisfied by it, whether or not such term or condition is contained in the Equity Commitment Letter. As of the date hereof,
the Investor has fully paid, or caused to be fully paid, all commitment or other fees that are due and payable on or prior to the date hereof, in each case pursuant to and in accordance with the terms of the Equity Commitment Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <U>Brokers and Other Advisors</U>. No broker, investment banker, financial advisor or other Person is entitled to any
broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Investor or
any of its Affilates, except for Persons, if any, whose fees and expenses will be paid by the Investor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <U>Securities Act Representations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Investor is an accredited investor (as defined in Rule 501 of the Securities Act), and is aware that the sale of the Shares is being
made in reliance on a private placement exemption from registration under the Securities Act. The Investor is not an underwriter within the meaning of Section&nbsp;2(a)(11) of the Securities Act. The Investor is acquiring the Shares (and any shares
of Company Common Stock issuable upon conversion of the Shares) for its own account, and not with a view toward, or for sale in connection with, any distribution thereof in violation of any federal or state securities or &#147;blue sky&#148; law, or
with any present intention of distributing or selling such Shares (or any shares of Company Common Stock issuable upon conversion of the Shares) and agrees not to reoffer or resell the Shares in violation of the Securities Act. The Investor has
sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of its investment in such Shares (and any shares of Company Common Stock issuable upon conversion of the Shares) and is
capable of bearing the economic risks of such investment. The Investor has been provided a reasonable opportunity to undertake and has undertaken such investigation and has been provided with and has evaluated such documents and information as it
has deemed necessary to enable it to make an informed and intelligent decision with respect to the execution, delivery and performance of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Investor nor any of its Affiliates is acting in concert, and neither the Investor nor any of its Affiliates has any agreement
or understanding, with any Person that is not an Affiliate of the Investor, and is not otherwise a member of a &#147;group&#148; (as such term is used in Section&nbsp;13(d)(3) of the Exchange Act), with respect to the Company or its securities, in
each case, other than with respect to any <I>bona fide</I> loan from one or more financial institutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <U>No Other
Representations or Warranties</U>. Except for the representations and warranties contained in <U>Article III</U> or in any certificates delivered by the Company in connection with the Transactions, the Investor acknowledges that neither the Company
nor any person on behalf of the Company makes, and none of the Investor or any person acting on behalf of the Investor has relied or is relying upon, any other express or implied representation or warranty with respect to the Company or any of its
Subsidiaries, or with respect to any other information provided or made available to the Investor in connection with the transactions contemplated hereby or the transactions contemplated by the Target Merger Agreement, including the accuracy,
completeness or currency thereof. Except as otherwise expressly provided in this Agreement and to the extent any such information is expressly included in a representation or warranty contained in <U>Article III</U>, neither the Company nor any
other person will have or be subject to any liability or obligation to the Investor or any other person resulting from the distribution or failure to distribute to the Investor, or the Investor&#146;s use of, any such information, including any
information, documents, projections, estimates, forecasts or other material, made available to the Investor in any electronic data room maintained by the Company for purposes of, or in expectation of, the transactions contemplated by this Agreement.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Additional
Agreements</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <U>Negative Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the date hereof until the earlier of the Subsequent Closing or the Investor End Date (or, if earlier, termination of the
Target Merger Agreement), and except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any stock exchange or regulatory organization applicable to the Company or any of its Subsidiaries, (ii)&nbsp;with the prior
written consent of the Investor (such consent not to be unreasonably conditioned, withheld or delayed), (iii)&nbsp;as may be expressly contemplated, required or permitted by this Agreement (including the Statement With Respect to Shares) or required
by the Target Merger Agreement, (iv)&nbsp;in connection with a Company COVID Action, or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.01</U> of the Disclosure Schedules, the Company covenants and agrees that it shall use commercially
reasonable efforts to conduct the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business of the Company and its Subsidiaries in all material respects in the Ordinary Course of Business; <U>provided</U>, <U>however</U>, that no action by the Company or its Subsidiaries with
respect to matters specifically addressed by any provision of <U>Section</U><U></U><U>&nbsp;5.01(b)</U> shall be deemed a breach of this sentence unless such action would constitute a breach of such other provision. Notwithstanding the foregoing,
the Company and its Subsidiaries shall be permitted to take, and nothing in this Agreement shall prohibit the Company or its Subsidiaries from taking, any Company COVID Action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company agrees with the Investor, on behalf of itself and its Subsidiaries, that, from the date hereof and prior to the earlier of the
Subsequent Closing and the Investor End Date (or, if earlier, termination of the Target Merger Agreement), except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any stock exchange or regulatory organization
applicable to the Company or any of its Subsidiaries or Company Benefit Plan, (ii)&nbsp;with the prior written consent of the Investor (such consent not to be unreasonably conditioned, withheld or delayed), (iii)&nbsp;as may be expressly
contemplated, required or permitted by this Agreement or required by the Target Merger Agreement, (iv)&nbsp;in connection with a Company COVID Action, or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.01</U> of the Disclosure Schedules,
the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) shall not amend or restate any Company Charter Document; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) shall not, and shall not permit any of such Subsidiaries to split, combine or reclassify any of its capital stock or issue
or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any shares of its capital stock, except for any such transaction by a wholly owned (direct or indirect) Subsidiary of the Company which remains a
wholly owned (direct or indirect) Subsidiary following the consummation of such transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) shall not, and shall
not permit any of such Subsidiaries that is not wholly owned (directly or indirectly) by the Company or is not a wholly owned (direct or indirect) Subsidiary of any such Subsidiaries to, authorize or pay any dividends on or make any distribution
with respect to its outstanding shares of capital stock (whether in cash, assets, stock or other securities of the Company or its Subsidiaries), except dividends or distributions by any Subsidiaries only to the Company or to any other wholly owned
(direct or indirect) Subsidiary of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) shall not, and shall not permit any of such Subsidiaries to, adopt a
plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization, in each case, that would reasonably be expected to prevent, materially impede or materially delay the consummation
of the Transactions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) shall not, and shall not permit any of such Subsidiaries to, acquire (by purchase, merger, joint
venture, partnership, consolidation, dissolution, liquidation, tender offer, exchange offer, recapitalization, reorganization, share exchange, business combination or similar transaction) any business or material amount of assets from any other
person except for such acquisitions for an amount not to exceed $100&nbsp;million in value in the aggregate (for all such transactions), in each case that would not reasonably be expected to (A)&nbsp;impose any material delay in the obtaining of, or
materially increase the risk of not obtaining, any authorization, consent, order, declaration or approval of any Governmental Entity necessary to consummate the transactions contemplated by this Agreement, the other Transaction Documents or the
expiration or termination of any applicable waiting period, (B)&nbsp;materially increase the risk of any Governmental Entity entering an order prohibiting the consummation of the Transactions, (C)&nbsp;materially increase the risk of not being able
to remove any such order on appeal or otherwise, or (D)&nbsp;prevent, materially delay or materially impair the ability of the Company to consummate the transactions contemplated by this Agreement and the other Transaction Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) shall not, and shall not permit any of its Subsidiaries to, issue, sell, pledge, dispose of or encumber, or authorize the
issuance, sale, pledge, disposition or encumbrance of, any shares of its capital stock or other ownership interest in the Company or any of its Subsidiaries or any securities convertible into or exchangeable for any such shares or ownership
interest, or any rights, warrants or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to cause to be exercisable any otherwise unexercisable option
under any existing Company Benefit Plans (except as otherwise provided by the terms of this Agreement, the Statement With Respect to Shares or the express terms of any unexercisable or unexercised options or warrants outstanding on the date of the
Original Investment Agreement), other than (A)&nbsp;issuances of shares of Company Common Stock in respect of the exercise or settlement of any Company stock awards outstanding on the date of the Original Investment Agreement, (B)&nbsp;the sale of
shares of Company Common Stock pursuant to the exercise of options or the settlement of any Company stock awards, if necessary to effectuate an option direction upon exercise or for withholding of Taxes in accordance with their terms on the date of
the Original Investment Agreement, (C)&nbsp;grants of equity awards in the Ordinary Course of Business, in amounts consistent with past practice, pursuant to any Company Benefit Plan, and (D)&nbsp;the issuance of shares of Company Common Stock or
the grant of equity awards in connection with the acquisition of any business or material amount of assets from any other person that is permitted by the terms of this Agreement or the Statement With Respect to Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) shall not, and shall not permit any of its Subsidiaries to, incur, assume, guarantee or otherwise become liable for any
indebtedness for borrowed money or any guarantee of such indebtedness (other than the Acquisition Debt Financing) except any such incurrence, assumption, guarantee or other liability which would not be reasonably expected to prevent, materially
delay or materially impair the ability of the Company to consummate the Transactions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) shall not and shall not
permit any of its Subsidiaries to directly or indirectly, purchase, redeem or otherwise acquire any shares of the capital stock of the Company or any of its Subsidiaries or any rights, warrants or options to acquire any such shares, except for
transactions among the Company and its wholly owned (direct or indirect) Subsidiaries or among the Company&#146;s wholly owned (direct or indirect) Subsidiaries or in connection with the exercise of any options, or the vesting or settlement of any
Company equity awards issued in the Ordinary Course of Business; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) shall not, and shall not permit any of its
Subsidiaries to, agree, in writing or otherwise, to take any of the foregoing actions that are prohibited pursuant to clauses&nbsp;(i) through (viii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;5.01(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <U>Reasonable Best Efforts; Filings</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, each of the Company and the Investor shall cooperate with each other and use (and
shall cause its Subsidiaries to use) its reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided for herein) to promptly (i)&nbsp;take, or cause to be taken, all actions, and do, or cause to
be done, and assist and cooperate with each other in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner reasonably practicable, the Transactions, including preparing and filing promptly
and fully all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of information, applications and other documents, (ii)&nbsp;obtain all approvals, consents, registrations, waivers, permits,
authorizations, orders, the expiration or termination of all applicable waiting periods, and other confirmations from any Governmental Entity or third party necessary, proper or advisable to consummate the Transactions, (iii)&nbsp;execute and
deliver any additional instruments necessary to consummate the Transactions and (iv)&nbsp;defend or contest in good faith any action brought by a third party that could otherwise prevent or impede, interfere with, hinder or delay in any material
respect the consummation of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and the Investor agree to make an appropriate filing of a Notification and
Report Form (the &#147;<U>Initial HSR Form</U>&#148;) pursuant to the HSR Act with respect to the transactions contemplated by the Initial Closing (which shall request the early termination of any waiting period applicable to the Transactions under
the HSR Act) as promptly as reasonably practicable following the date of the Original Investment Agreement and in any event no later than ten (10)&nbsp;Business Days (unless the parties mutually agree to a later
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
date), and to supply, as advisable, as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act, and the Company and
the Investor agree to use reasonable best efforts to promptly take any and all steps necessary to avoid or eliminate each and every impediment and obtain all consents that may be required pursuant to the HSR Act, so as to enable the parties hereto
to consummate the Transactions. The date upon which any applicable waiting periods shall have expired or been terminated, and any approvals required shall have been obtained, relating to the transactions contemplated by the Initial Closing, the
&#147;<U>Initial HSR Approval</U>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent required by Law, the Company and the Investor agree to make, if necessary, an
appropriate filing of a Notification and Report Form (the &#147;<U>Subsequent HSR Form</U>&#148;, and together with the Initial HSR Form, the &#147;<U>HSR Forms</U>&#148;) pursuant to the HSR Act with respect to the transactions contemplated by the
Subsequent Closing (which shall request the early termination of any waiting period applicable to the Transactions under the HSR Act) in no event later than such time as would permit the Subsequent Closing Date to occur prior to the closing of the
Target Merger Agreement, and to supply, as advisable, as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act, and the Company and the Investor agree to use reasonable
best efforts to promptly take any and all steps necessary to avoid or eliminate each and every impediment and obtain all consents that may be required pursuant to the HSR Act, so as to enable the parties hereto to consummate the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the Company and the Investor shall (i)&nbsp;cooperate in all respects with the other party in connection with any filing or
submission with a Governmental Entity in connection with the Transactions and in connection with any investigation or other inquiry by or before a Governmental Entity relating to the Transactions, including any proceeding initiated by a private
person, (ii)&nbsp;keep the other party informed in all material respects and on a reasonably timely basis of any material communication received by the Company or the Investor, as the case may be, from or given by the Company or the Investor to, as
the case may be, the Federal Trade Commission (&#147;<U>FTC</U>&#148;), the Department of Justice (&#147;<U>DOJ</U>&#148;) or any other Governmental Entity and of any material communication received or given in connection with any proceeding by a
private Person, in each case regarding the Transactions, (iii)&nbsp;subject to applicable Laws relating to the exchange of information, and to the extent reasonably practicable, consult with the other party with respect to information relating to
such party and its respective Subsidiaries, as the case may be, that appears in any filing made with, or written materials submitted to, any third Person or any Governmental Entity in connection with the Transactions, provided that materials
furnished pursuant to this <U>Section</U><U></U><U>&nbsp;5.02</U> may be redacted (a)&nbsp;to remove references concerning the valuation of the Company and the Transactions or other confidential information, (b)&nbsp;as necessary to comply with
contractual arrangements, and (c)&nbsp;as necessary to address reasonable privilege concerns, and the parties may reasonably designate any competitively sensitive or any confidential business material provided to the other under this
<U>Section</U><U></U><U>&nbsp;5.02</U> as &#147;counsel only&#148; or, as appropriate, as &#147;outside counsel only&#148;, and (iv)&nbsp;to the extent permitted by the FTC, the DOJ or such other applicable Governmental Entity or other Person, give
the other party the opportunity to attend and participate in such meetings and conferences. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary
in this Agreement, nothing in this <U>Section</U><U></U><U>&nbsp;5.02</U> or elsewhere in this Agreement shall require Investor to take any action with respect to any of its Affiliates or its direct or indirect portfolio companies or other
investments, including selling, divesting, conveying, holding separate, or otherwise limiting its freedom of action with respect to any assets, rights, products, licenses, businesses, operations, or interest therein, of any such Affiliates or any
direct or indirect portfolio companies or other investments of investment funds advised or managed by one or more Affiliates of the Investor. The parties understand and agree that all obligations of the Investor related the HSR Act and any other to
regulatory approvals shall be governed exclusively by this <U>Section</U><U></U><U>&nbsp;5.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each of the Company and the
Investor shall not take or agree to take, and shall cause their respective controlled Affiliates not to take or agree to take, any action that would be reasonably likely to prevent or materially delay the consummation of the Transactions or receipt
of any governmental approvals that are conditions to the Subsequent Closing pursuant to <U>Article VI</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <U>Corporate Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time that any Series B Preferred Stock is outstanding, the Company shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) from time to time take all lawful action within its control to cause the authorized capital stock of the Company to include
a sufficient number of authorized but unissued shares of Company Common Stock to satisfy the conversion requirements of all shares of the Series B Preferred Stock then outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) take such actions as reasonably requested by the Investor as may be necessary to render inapplicable any control share
acquisition, interested stockholder, business combination or similar anti-takeover provision in the Company Charter Documents or under Chapter 25 of the PBCL or other similar Law that is or could become applicable to the Investor Parties as a result
of the Transactions, including the Company&#146;s issuance of Company Common Stock upon conversion of the Series B Preferred Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) not effect any voluntary deregistration under the Exchange Act or any voluntary delisting with the NASDAQ (or any other
national securities exchange upon which the Company Common Stock may subsequently be principally listed) in respect of the Company Common Stock other than in connection with a Fundamental Change pursuant to which the Company satisfies in full its
obligations under the applicable provisions of the Statement With Respect to Shares, unless the prior written approval of the holders of a majority of the Series B Preferred Stock issued and outstanding has been obtained; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) so long as the Investor continues to beneficially own at least 5% of the aggregate number of shares of Series B Preferred
Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), unless the Investor otherwise consents in writing, not authorize or issue
any Parity Stock other than in connection with Permitted Issuances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If any occurrence since the date of this Agreement until the
Subsequent Closing would have resulted in an adjustment to the Conversion Price with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock pursuant to the Statement With Respect to Shares if such Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock had been issued and outstanding since the date of this Agreement, the Company shall adjust the Conversion Price with respect to such Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred
Stock effective as of the Subsequent Closing, in the same manner as would have been required by the Statement With Respect to Shares if such Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock had been issued and outstanding since the
date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <U>Public Announcements</U>. No press release or public announcement related to this Agreement
or the transactions contemplated herein shall be issued or made by the Investor or its Affiliates without the prior written approval of the Company, unless required by Law (based on the advice of counsel) in which case the Company shall have the
right to review and reasonably comment on such press release, announcement or communication prior to issuance, distribution or publication. Notwithstanding the foregoing (but subject to the terms of the Confidentiality Agreement and
<U>Section</U><U></U><U>&nbsp;5.05</U>), the Investor and its Affiliates shall not be restricted from (a)&nbsp;making any filings and disclosures required under applicable laws (including Sections 13 and 16 of the Exchange Act) and
(b)&nbsp;communicating with their respective investors and potential investors in connection with marketing, informational or reporting activities; provided that in the case of clause (b), the recipient of such information is subject to a customary
obligation to keep such information confidential. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <U>Confidentiality</U>. Until two years after the Investor no longer
owns any Series B Preferred Stock or Company Common Stock issued upon conversion of the Series B Preferred Stock, the Investor will, and will cause its Affiliates and its and their respective Representatives to, keep confidential any information
(including oral, written and electronic information) concerning the Company, its Subsidiaries or its Affiliates that has been or may be furnished to the Investor, its Affiliates or their respective Representatives by or on behalf of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company or any of its Representatives pursuant to this Agreement, the Confidentiality Agreement or the Target Merger Agreement (collectively referred to as the &#147;<U>Confidential
Information</U>&#148;) and to use the Confidential Information solely for the purposes of monitoring, administering or managing the Investor Parties&#146; investment in the Company made pursuant to this Agreement, including the enforcement of the
Investor Parties&#146; rights in respect of such investment and defending any claim or action made in relation to such investment (a &#147;<U>Permitted Purpose</U>&#148;), provided that the Confidential Information shall not include information that
(i)&nbsp;was or becomes available to the public other than as a result of a disclosure by the Investor, any of its Affiliates or any of their respective Representatives in violation of this <U>Section</U><U></U><U>&nbsp;5.05</U>, (ii) was or becomes
available to the Investor, any of its Affiliates or any of their respective Representatives from a source other than the Company or its Representatives, provided that that such source was not, to the Investor&#146;s knowledge after due inquiry,
subject to any legally binding obligation (whether by agreement or otherwise) to keep such information confidential, (iii)&nbsp;at the time of disclosure is already in the possession of the Investor, any of its Affiliates or any of their respective
Representatives, provided that such information is not, to the Investor&#146;s knowledge after due inquiry, subject to any legally binding obligation (whether by agreement or otherwise) to keep such information confidential, or (iv)&nbsp;was
independently developed by the Investor, any of its Affiliates or any of their respective Representatives without reference to, incorporation of, reliance on or other use of any Confidential Information. The Investor agrees, on behalf of itself and
its Affiliates and its and their respective Representatives, that Confidential Information may be disclosed solely (i)&nbsp;to the Investor&#146;s Affiliates and its and their respective Representatives to the extent required for a Permitted
Purpose, and in any event shall not be shared with any such Representative who, to the knowledge of the Investor, has an employment, director, officer, operating partner or similar relationship with a Competitor, (ii)&nbsp;to its stockholders,
limited partners, members or other owners (including any listed entity that is an investor in an Affiliate of the Investor), who are subject to customary confidentiality obligations, as part of ordinary course reporting or review procedure or in
connection with such Person&#146;s ordinary course fundraising, transactional or reporting activities, as the case may be, and (iii)&nbsp;in the event that the Investor, any of its Affiliates or any of its or their respective Representatives are
requested or required by applicable Law, regulation, judgment, stock exchange rule or other applicable judicial or governmental process (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar
process) to disclose any Confidential Information, in each of which instances the Investor, its Affiliates and its and their respective Representatives, as the case may be, shall, to the extent legally permitted, provide notice to the Company
sufficiently in advance of any such disclosure so that the Company will have a reasonable opportunity to timely seek to limit, condition or quash such disclosure (in which case the Investor shall use reasonable efforts to assist the Company in this
respect). The Confidentiality Agreement shall terminate simultaneously with the Initial Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <U>NASDAQ Listing of
Shares</U>. To the extent the Company has not done so prior to the date of the Original Investment Agreement, the Company shall promptly apply to cause the aggregate number of shares of Company Common Stock issuable upon the conversion of the Series
B Preferred Stock issued to the Investor pursuant to this Agreement and required to be issued to the Investor pursuant to the Statement With Respect to Shares to be approved for listing on the NASDAQ, subject to official notice of issuance, or such
other primary exchange as to which the Common Stock is then admitted for trading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 <U>Standstill</U>. The Investor
agrees that during the Standstill Period, without the prior written approval of the Board, the Investor will not, directly or indirectly, and will cause its Affiliates not to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) acquire, offer or seek to acquire, agree to acquire or make a public proposal to acquire, by purchase or otherwise, any securities of the
Company, any securities convertible into or exchangeable for any such securities, any options or other derivative securities or contracts or instruments in any way related to the price of shares of Company Common Stock or any assets or property of
the Company or any Subsidiary of the Company that results in the Investor having beneficial ownership of more than the Maximum Percentage of the shares of the Company Common Stock outstanding at such time (assuming the conversion of the Series B
Preferred Stock) (but in any case excluding (i)&nbsp;any issuance by the Company of shares of Company Common Stock or options, warrants or other rights to acquire Company Common Stock (or the exercise thereof) to any Investor Director as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation for their membership on the Board, and (ii)&nbsp;the acquisition of the shares of Company Common Stock issuable upon conversion of the Series B Preferred Stock); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) make or in any way encourage or participate in any &#147;solicitation&#148; of &#147;proxies&#148; (whether or not relating to the
election or removal of directors), as such terms are used in the rules of the SEC, to vote, or knowingly seek to advise or influence any Person with respect to voting of, any voting securities of the Company or call or seek to call a meeting of the
Company&#146;s shareholders or initiate any stockholder proposal for action by the Company&#146;s shareholders, or other than with respect to the Investor Director, seek election to or to place a representative on the Board or seek the removal of
any director from the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) make any public announcement with respect to, or seek or propose any merger or business combination,
tender or exchange offer, recapitalization, reorganization or purchase of a material portion of the assets, properties or securities of the Company, or any other extraordinary transaction involving the Company, or enter into any discussions,
negotiations, arrangements, understandings or agreements with any other Person regarding any of the foregoing; <U>provided</U>, however, that this clause (c)&nbsp;shall not preclude the tender by the Investor or its Affiliates of any securities of
the Company into any tender or exchange offer or the vote by the Investor or its Affiliates of any voting securities of the Company with respect to any Fundamental Change in accordance with the recommendation of the Board; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) otherwise act, alone or in concert with others, to control or seek to control, advise or knowingly influence, in any manner, management or
the board of directors, or the policies of the Company or any of its Subsidiaries (other than the Investor Director acting in his or her capacity as a member of the Board or voting at a meeting of the Company&#146;s shareholders); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) acquire, offer or seek to acquire, by purchase or otherwise, any debt securities of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) make any proposal or statement of inquiry or disclose any intention, plan or arrangement inconsistent with any of the foregoing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) advise, assist, knowingly encourage or direct any Person to do, or to advise, assist, encourage or direct any other Person to do, any of
the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) take any action that would or would reasonably be expected to require the Company to make a public announcement
regarding the possibility of a transaction or any of the events described in this <U>Section</U><U></U><U>&nbsp;5.07</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into
any discussions, negotiations, communications, arrangements or understandings with any third party (including security holders of the Company, but excluding, for the avoidance of doubt, the Investor Parties) with respect to any of the foregoing,
including, without limitation, forming, joining or in any way participating in a &#147;group&#148; (as defined in Section&nbsp;13(d)(3) of the Exchange Act) with any third party (excluding, for the avoidance of doubt, the Investor Parties) with
respect to the Company or any securities of the Company or otherwise in connection with any of the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) request the Company or
any of its Representatives, directly or indirectly, to amend or waive any provision of this <U>Section</U><U></U><U>&nbsp;5.07</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) contest the validity of this <U>Section</U><U></U><U>&nbsp;5.07</U> or make, initiate, take or participate in any demand, action (legal or
otherwise) or proposal to amend, waive or terminate any provision of this <U>Section</U><U></U><U>&nbsp;5.07</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>provided</U>,
<U>however</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;5.07</U> will limit (1)&nbsp;the Investor Parties&#146; ability to vote, Transfer (subject to <U>Section</U><U></U><U>&nbsp;5.08</U>), convert (in accordance with the limitations in
the Statement With Respect to Shares) or otherwise exercise rights under its Company Common Stock or Series B Preferred Stock or (2)&nbsp;the ability of any Investor Director to vote or otherwise exercise its fiduciary duties or otherwise act in its
capacity as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a member of the Board. Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;5.07</U>, the Investor and its Affiliates may at any time communicate privately with the
Company&#146;s directors, officers or advisors or submit to the Board one or more confidential proposals or offers for a transaction (including a transaction that, if consummated, would result in a Fundamental Change), so long as, in each case, such
communications and submissions are not intended to, and would not reasonably be expected to, require any public disclosure by the Company of such communications or submissions, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise permitted in this Agreement or as expressly contemplated by <U>Section</U><U></U><U>&nbsp;5.08(b)</U>, with respect to
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares until the later of (i)&nbsp;the twelve (12)-month anniversary of the Initial Closing and (ii)&nbsp;the first to occur of (A)&nbsp;the Subsequent Closing and (B)&nbsp;the
termination of the Target Merger Agreement and, with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, until the twelve (12)-month anniversary of the Subsequent Closing Date (such period, the &#147;<U>Restricted
Period</U>&#148;), the Investor Parties will not Transfer any Series B Preferred Stock or any Company Common Stock issued upon conversion of any Series B Preferred Stock. Following the expiry of the Restricted Period, the Investor Parties will not
at any time knowingly Transfer any shares of Series B Preferred Stock to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Person (other than in underwritten offerings and broadly distributed sales pursuant to Rule 144A and/or similar sales) or
knowingly Transfer any shares of Company Common Stock to (x)&nbsp;any Competitor (including any Activist Investor), or (y)&nbsp;any Person who, upon the occurrence of such Transfer, would beneficially own more than 5% of the outstanding shares of
Company Common Stock (in each case, other than in underwritten offerings and pursuant to Rule 144 under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Notwithstanding <U>Section</U><U></U><U>&nbsp;5.08(a)</U>, the Investor Parties shall be permitted to Transfer any portion or all of their Series B Preferred Stock or Company Common Stock issued upon conversion of the Series B Preferred Stock at any
time under the following circumstances: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Transfers of (A)&nbsp;Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Shares following the Restricted Period or (B)&nbsp;Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, in the case of each of clauses (A)&nbsp;and (B), to any Permitted Transferees of the Investor, but only if (x)&nbsp;the
transferee agrees in writing prior to such Transfer for the express benefit of the Company (in form and substance reasonably satisfactory to the Company and with a copy thereof to be furnished to the Company) to be bound by the terms of this
Agreement and (y)&nbsp;the transferee and the transferor agree in writing for the express benefit of the Company that the transferee shall Transfer the Series B Preferred Stock or Company Common Stock so Transferred back to the transferor at or
before such time as the transferee ceases to be a Permitted Transferee of the transferor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Transfers to the Company or
its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to <U>Section</U><U></U><U>&nbsp;5.07</U>, Transfers pursuant to a merger, tender offer,
recapitalization, consolidation or exchange offer or other business combination, acquisition of assets or similar transaction or otherwise, in each case, following an announcement of any Fundamental Change transaction involving the Company or any
Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Transfers in connection with, and only after the commencement of, bankruptcy, insolvency or other similar
reorganization proceedings; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Transfers for cash to a Person that is not an affiliate of the Investor to the extent
necessary to satisfy a <I>bona fide</I> prepayment requirement under any Back Leverage; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Transfers in connection with
a mortgage, hypothecation and/or pledge to a financial institution or other lender or any agent therefor to secure any Back Leverage and the exercise of any rights thereunder by any such financial institution or lender or any agent therefor,
including the foreclosure and subsequent sale of the securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) Transfers that have been approved in writing by the
Board; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) Transfers by the Investor, prior to the end of the Restricted Period,
of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares to an Affiliate of the Investor that is under common control with the Investor and which is a special purpose vehicle formed for the purpose of holding a portion of the Series B
Preferred Stock; <U>provided</U>, that prior to and as a condition of such Transfer, the Investor shall have delivered to the Company, in each case in form and substance satisfactory to the Company, (A)&nbsp;an amended and restated Equity Commitment
Letter, duly executed by the Equity Providers, the Investor and such Affiliate, that, for the express benefit of the Company, provides such Affiliate with a portion of the Subsequent Contribution (as defined in the Equity Commitment Letter) and
continues to provide the remaining portion of the Subsequent Contribution to the Investor, to permit such Affiliate and the Investor to satisfy in full their obligations at the Subsequent Closing and otherwise is consistent with the terms of the
Equity Commitment Letter and (B)&nbsp;a written agreement, duly executed by such Affiliate and the Investor, for the express benefit of the Company, pursuant to which (x)&nbsp;such Affiliate agrees to be bound by the terms of this Agreement as if it
were the Investor (including without limitation <U>Section</U><U></U><U>&nbsp;5.20</U> of this Agreement) and (y)&nbsp;such Affiliate and the Investor agree that such transferee shall not, prior to the Subsequent Closing, cease to be an Affiliate
under common control with the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any attempted Transfer in violation of this <U>Section</U><U></U><U>&nbsp;5.08</U> shall be
null and void <I>ab initio</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <U>[RESERVED]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Legend</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All certificates or other instruments representing the Series B Preferred Stock or Company Common Stock issued upon conversion of the
Series B Preferred Stock will bear a legend substantially to the following effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS, OR EXCEPT,
WITH RESPECT TO ANY COMPANY COMMON STOCK, WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS, OR. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN AN AMENDED AND RESTATED INVESTMENT
AGREEMENT, DATED AS OF MARCH&nbsp;30, 2021, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon request of the
applicable Investor Party, upon receipt by the Company of an opinion of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state securities laws, the Company
shall promptly cause the first paragraph of the legend to be removed from any certificate for any Series B Preferred Stock or Company Common Stock to be Transferred in accordance with the terms of this Agreement and the second paragraph of the
legend shall be removed upon the expiration of such transfer and other restrictions set forth in this Agreement (and, for the avoidance of doubt, at the request of the holder, in connection with any termination of this Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Board Matters; Election of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Following the Initial Closing and until the occurrence of the Fall-Away of Investor Board Rights, the Investor shall have the right to
nominate the Investor Director Designee. Effective as of the Initial Closing, the Company and the Board will increase the size of the Board to accommodate the election of such individual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(unless there is a vacancy in the Board at such time) and the Board shall elect Stephen Pagliuca to the Board to serve as the initial Investor Director Designee. The election or appointment of
the Investor Director Designee shall be subject to satisfaction of all requirements set forth in the Company&#146;s corporate governance guidelines, code of business conduct and ethics and insider trading policy in effect from time to time and
applicable to other <FONT STYLE="white-space:nowrap">non-executive</FONT> directors (the &#147;<U>Specified Guidelines</U>&#148;). No Investor Director Designee shall be required to qualify as an independent director under applicable stock exchange
rules and federal securities laws and regulations. Following the Initial Closing and until the occurrence of the Fall-Away of Investor Board Rights, the Investor shall continue to have the right to nominate the Investor Director Designee. The
Company will reimburse the Investor Director and any observer appointed pursuant to <U>Section</U><U></U><U>&nbsp;5.11(b)</U> for their respective reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with travel to or from and attendance at each meeting of the Board consistent with reimbursement policies of the Company
applicable to <FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Board. The Investor Director will receive compensation no less favorable than such compensation received by other
<FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Board. The Investor Director shall have the right to serve on all committees of the Board, subject to applicable legal and stock exchange requirements. The Investor agrees, upon
the Company&#146;s request, to timely provide the Company with accurate and complete information relating to the Investor Director as may be required to be disclosed by the Company under the Exchange Act and the rules and regulations promulgated
thereunder and to make any necessary independence determinations, including for service on Board committees. Upon the occurrence of the Fall-Away of Investor Board Rights, at the written request of the Board, the Investor Director shall resign, and
the Investor shall cause the Investor Director immediately to resign, from the Board effective as of the date of the Fall-Away of Investor Board Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Following the Initial Closing and until the occurrence of the Fall-Away of Investor Board Rights, the Investor shall have the right (in
addition to the rights set forth in <U>Section</U><U></U><U>&nbsp;5.11(a)</U>) to designate a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer of the Board (the &#147;<U>Investor Observer</U>&#148;) reasonably satisfactory to the Board
(it being agreed that Joseph Robbins is satisfactory to the Board). The Investor Observer shall be entitled to (i)&nbsp;attend, strictly as an observer, meetings of each committee of the Board, subject to applicable legal and stock exchange
requirements, other than the Subsidiary Committee of Board and any similar committee that may be formed in the future and (ii)&nbsp;receive notice of and have the right to attend, strictly as an observer, meetings of the Board, and the Company shall
provide the observer with copies of all notices, minutes, consents and other material in connection therewith at the same time as such materials are distributed to members of the Board; provided, that (A)&nbsp;the Investor shall cause the Investor
Observer to agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to the observer pursuant hereto and (B)&nbsp;the Company and the Board shall have the right to withhold any information and
to exclude the Investor Observer from any meeting or portion thereof if doing so is, in the opinion of outside counsel to the Company, advisable or necessary to protect the attorney-client privilege between the Company and counsel or work product
protection, violate any Law or violate the terms of any confidentiality agreement or other contract with a third party. In order to be eligible to serve in such capacity, the Investor Observer shall provide a written undertaking to the Company
agreeing to be subject to, bound by and duly comply with a standard confidentiality agreement in a form acceptable to the Company, the code of conduct and other policies of the Company, in each case, to the extent applicable to <FONT
STYLE="white-space:nowrap">non-executive</FONT> directors of the Company. The Investor Observer shall have no right to vote on any matters presented to the Board or any Board committee or be entitled to receive any compensation in his or her
capacity as Investor Observer. Any action taken by the Board at any meeting will not be invalidated by the absence of the Investor Observer at such meeting. All obligations of the Company pursuant to this <U>Section</U><U></U><U>&nbsp;5.11(b)</U>
shall terminate, and, upon request by the Board, the Investor shall cause the Investor Observer to resign promptly from his or position as a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer, in each case upon the Investor ceasing to have
the right to designate the Investor Observer pursuant to this <U>Section</U><U></U><U>&nbsp;5.11</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Following the Initial Closing
and until the occurrence of the Fall-Away of Investor Board Rights, at any annual meeting of the Company&#146;s stockholders at which the term of the Investor Director shall expire, the Investor shall have the right to designate, in accordance with
the articles of incorporation and bylaws of the Company and the PBCL and in accordance with the provisions of this <U>Section</U><U></U><U>&nbsp;5.11</U>, the Investor Director Designee. The Company and the Board shall (i)&nbsp;include each Investor
Director Designee designated by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Investor in accordance with this <U>Section</U><U></U><U>&nbsp;5.11</U> in the Company&#146;s slate of nominees for the applicable meeting of the Company&#146;s stockholders (whether in the
Company&#146;s proxy statement or otherwise), (ii) recommend that the Company&#146;s stockholders vote in favor of such Investor Director Designee, (iii)&nbsp;use its reasonable best efforts to support such nominees with substantially the same level
of efforts and support as is used and/or provided for the other director nominees of the Company with respect to the applicable meeting of stockholders, (iv)&nbsp;cause the Board to have sufficient vacancies to permit such Investor Director Designee
to be elected as a member of the Board and (v)&nbsp;so long as any Investor Director Designee is eligible to be so designated in accordance with this <U>Section</U><U></U><U>&nbsp;5.11</U>, not take any action to remove such person as such a
director without cause without the prior written consent of the Investor. The Investor shall not be required to comply with the advance notice provisions generally applicable to the nomination of directors by the Company so long as the Investor
provides reasonable advance notice to the Company of the Investor Director Designee prior to the mailing of the proxy statement by the Company (provided, that upon the request of the Investor the Company shall provide reasonable advance notice to
the Investor of the expected mailing date). For the avoidance of doubt, failure of the stockholders of the Company to elect any Investor Director Designee to the Board shall not affect the right of the Investor to nominate directors for election
pursuant to this <U>Section</U><U></U><U>&nbsp;5.11</U> in any future election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event of the death, disability,
resignation or removal of the Investor Director as a member of the Board (other than pursuant to <U>Section</U><U></U><U>&nbsp;5.11(c)</U>), the Investor may designate an Investor Director Designee (in accordance with the process set forth in
<U>Section</U><U></U><U>&nbsp;5.11(a)</U>) to replace such director and the Company shall cause such Investor Director Designee to fill such resulting vacancy. In the event of the death, disability, resignation or removal of the Investor Observer,
the Investor may designate an observer designee (in accordance with the process set forth in <U>Section</U><U></U><U>&nbsp;5.11(b)</U>) to replace such observer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees to negotiate in good faith the form of, and agrees to enter into, a customary director indemnification agreement with
the Investor Director no less favorable than with other <FONT STYLE="white-space:nowrap">non-executive</FONT> members of the Board and including customary provisions as agreed by the parties in good faith, and the Company shall indemnify the
Investor Director and provide the Investor Director with director and officer insurance to the same extent as it indemnifies and provides such insurance to other <FONT STYLE="white-space:nowrap">non-executive</FONT> members of the Board, pursuant to
the articles of incorporation and bylaws of the Company, the PBCL or otherwise. The Company acknowledges and agrees that the Company shall be the indemnitor of first resort with respect to any indemnification, advancement of expenses and/or
insurance provided in the Company&#146;s articles of incorporation, bylaws and/or any indemnification agreement entered into between the Company and the Investor Director (such that the Company&#146;s obligations to such indemnitees are primary),
and the Company agrees to include customary &#147;Levy Provisions&#148; with respect to the foregoing in any such indemnification agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the fullest extent permitted by the PBCL and subject to any express agreement that may from time to time be in effect, the Company
agrees that any Investor Director Designee, Investor Observer, the Investor and any other member of the Bain Group or any portfolio company thereof (collectively, &#147;<U>Covered Persons</U>&#148;) may, and shall have no duty not to,
(i)&nbsp;invest in, carry on and conduct, whether directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an officer, director, stockholder, equityholder or investor in any person, or as a participant in any
syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business
with any client, customer, vendor or lessor of any of the Company or its Affiliates; and/or (iii)&nbsp;make investments in any kind of property in which the Company may make investments. To the fullest extent permitted by the PBCL, the Company
renounces any interest or expectancy to participate in any business or investments of any Covered Person as currently conducted or as may be conducted in the future, and waives any claim against a Covered Person and shall indemnify a Covered Person
against any claim that such Covered Person is liable to the Company or its stockholders for breach of any fiduciary duty solely by reason of such person&#146;s participation in any such business or investment. The Company shall pay in advance any
expenses incurred in defense of such claim as provided in this provision except to the extent that a Covered Person is determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> order of a Delaware court having competent
jurisdiction (or any other judgement which is not appealed in the applicable time) that such Covered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Person is not entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;5.11(f)</U>, in which case any such advanced expenses shall be promptly reimbursed to the Company. The Company
agrees that in the event that a Covered Person acquires knowledge of a potential transaction or matter which may constitute a corporate opportunity for both (x)&nbsp;the Covered Person and (y)&nbsp;the Company or its Subsidiaries, the Covered Person
shall not have any duty to offer or communicate information regarding such corporate opportunity to the Company or its Subsidiaries, except for any corporate opportunity which is expressly offered to a Covered Person in writing stating that such
offer is intended for such Covered Person in his or her capacity as a member of the Board. To the fullest extent permitted by the PBCL, the Company hereby renounces any interest or expectancy in any potential transaction or matter of which the
Covered Person acquires knowledge. The Company shall pay in advance any expenses incurred in defense of such claim as provided in this provision, except to the extent that a Covered Person is determined by a final,
<FONT STYLE="white-space:nowrap">non-appealable</FONT> order of a Delaware court having competent jurisdiction (or any other judgment which is not appealed in the applicable time) to have breached this <U>Section</U><U></U><U>&nbsp;5.11(f)</U> in
which case any such advanced expenses shall be promptly reimbursed to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) For so long as an Investor Director Designee is on
the Board, (i)&nbsp;such Investor Director Designee shall be subject to the Specified Guidelines, but the Company shall not implement or maintain any trading policy, equity ownership guidelines (including with respect to the use of Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> plans and preclearance or notification to the Company of any trades in the Company&#146;s securities) or similar guideline or policy with respect to the trading of securities of the Company that applies to
the Investor or its Affiliates (including a policy that limits, prohibits or restricts the Investor or its Affiliates from entering into any hedging or derivative arrangements), in each case other than with respect to any Investor Director Designee
solely in his or her individual capacity, except as provided herein, or that imposes confidentiality obligations on any Investor Director Designee that are inconsistent with the Confidentiality Agreement, (ii)&nbsp;any share ownership requirement
for any Investor Director Designee serving on the Board shall be deemed satisfied by the securities owned by the Bain Group and/or its Affiliates and under no circumstances shall any of such policies, procedures, processes, codes, rules, standards
and guidelines impose any restrictions on the Bain Group&#146;s or its Affiliates&#146; transfers of securities pursuant to the terms and conditions of the Registration Rights Agreement and (iii)&nbsp;under no circumstances shall any policy,
procedure, code, rule, standard or guideline applicable to the Board be violated by any Investor Director Designee (A)&nbsp;accepting an invitation to serve on another board of directors of a company that competes (or whose Subsidiaries compete) in
any material respect with the business of the Company or failing to notify an officer or director of the Company prior to doing so (provided, however, that the Investor Director Designee shall be subject to customary recusal requirements of the
Board), (B) receiving compensation from the Bain Group or any of its Affiliates, or (C)&nbsp;failing to offer his or her resignation from the Board of Directors except as otherwise expressly provided in this Agreement or pursuant to any majority
voting policy adopted by the Board of Directors, and, in each case of (i), (ii) and (iii), it is agreed that any such policies in effect from time to time that purport to impose terms inconsistent with this <U>Section</U><U></U><U>&nbsp;5.11</U>
shall not apply to the extent inconsistent with this <U>Section</U><U></U><U>&nbsp;5.11</U>. Notwithstanding the foregoing, the Investor acknowledges and agrees, and will advise each Person who receive any Confidential Information subject to
<U>Section</U><U></U><U>&nbsp;5.05</U>, that the Confidential Information may include material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or its Subsidiaries, and the Investor hereby further acknowledges
that it is aware, and that it will advise such Persons, that the United States federal securities laws prohibit persons with material <FONT STYLE="white-space:nowrap">non-public</FONT> information about a company obtained directly or indirectly from
such company from purchasing or selling securities of such company on the basis of such information or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such other person is likely
to purchase or sell such securities on the basis of such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) At each meeting of the shareholders of the Company involving
the election of directors following the receipt of the Initial HSR Approval and at every postponement or adjournment thereof, the Investor shall, and shall cause the Investor Parties to, take such action as may be required so that all of the voting
equity securities of the Company beneficially owned, directly or indirectly, by the Investor Parties and entitled to vote at such meeting of shareholders are voted in favor of each director nominated or recommended by the Board for election. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its paying agent shall be entitled to withhold Taxes on all payments on the Series B Preferred Stock or Company Common
Stock or other securities issued upon conversion of the Series B Preferred Stock in each case to the extent required by applicable Law. The Company shall promptly notify the Investor if it determines that it has such requirement to withhold and give
the Investor a reasonable opportunity to provide any form or certificate to reduce or eliminate such withholding. Within a reasonable amount of time after making such withholding payment, the Company shall furnish the Investor with copies of any tax
certificate, receipt or other documentation reasonably acceptable to the Investor evidencing such payment. On the Initial Closing Date, the Investor shall deliver to the Company or its paying agent a duly executed, valid, accurate and properly
completed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> or an appropriate IRS Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Absent a change in law or IRS practice, or a contrary determination (as defined in Section&nbsp;1313(a) of the Code), the Investor and the
Company agree not to treat the Series B Preferred Stock (based on their terms as set forth in the Statement With Respect to Shares) as &#147;preferred stock&#148; within the meaning of Section&nbsp;305 of the Code and Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.305-5,</FONT> for U.S. federal and applicable state and local income Tax and withholding Tax purposes, and shall not take any position inconsistent with such treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall pay any and all documentary, stamp and similar issue or transfer Tax due on (i)&nbsp;the issuance of the Series B
Preferred Stock and (ii)&nbsp;the issuance of shares of Company Common Stock upon conversion of the Series B Preferred Stock. However, in the case of conversion of Series B Preferred Stock, the Company shall not be required to pay any Tax or duty
that may be payable in respect of any transfer involved in the issuance and delivery of shares of Company Common Stock or Series B Preferred Stock to a beneficial owner other than the beneficial owner of the Preferred Stock immediately prior to such
conversion, and no such issue or delivery shall be made unless and until the person requesting such issue has paid to the Company the amount of any such Tax or duty, or has established to the satisfaction of the Company that such Tax or duty has
been paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Use of Proceeds</U>. The Company shall use the proceeds from the issuance and sale of the Shares
(a)&nbsp;to finance the cash consideration payable and to pay for any costs, fees and expenses incurred in connection with the Target Acquisition and/or (b)&nbsp;for general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Back Leverage Cooperation</U>. If requested by the Investor, the Company will provide the following cooperation in
connection with the Investor obtaining any Back Leverage (i)&nbsp;subject to applicable law, using reasonable best efforts to (A)&nbsp;remove any restrictive legends on certificates representing the Shares (and any shares of Company Common Stock
issued upon conversion of the Shares) and record such Shares (and such shares of Company Common Stock) in book entry form on the books of Company or its transfer agent when eligible to do so or (B)&nbsp;without limiting the generality of clause (A),
if such Shares (or such shares of Company Common Stock issued upon conversion of Shares) are eligible for resale under Rule 144A, and eligible to be so deposited, depositing such pledged Series B Preferred Stock or Company Common Stock in book entry
form on the books of The Depository Trust Company or other depository with customary restrictive legends, (ii)&nbsp;if so requested by any applicable lender, agent or counterparty, as applicable, using commercially reasonable efforts to register the
pledged Series B Preferred Stock and/or shares of Company Common Stock to be issued upon conversion of the Series B Preferred Stock, as applicable, in the name of the relevant lender, agent, counterparty, custodian or similar party to Back Leverage,
in certificated or restricted book-entry format on the books and records of the Company&#146;s transfer agent, in each case, with respect to Back Leverage solely as secured party and only to the extent Investor or its Affiliates continues to
beneficially own such pledged Series B Preferred Stock or Company Common Stock, (iii)&nbsp;entering into an issuer agreement (an &#147;<U>Issuer Agreement</U>&#148;) with each lender or agent therefor with respect to such Back Leverage substantially
in the form attached hereto as <U>Exhibit B</U>, and subject to the consent of the Company (which will not be unreasonably withheld, conditioned or delayed), with such changes thereto as are requested by such lender or agent therefor,
(iv)&nbsp;entering into customary triparty agreements with the relevant lender or agent therefor and the Investor relating to the delivery of the Series B Preferred Stock and shares of Company Common Stock, in certificated format or restricted
book-entry format on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the books and records of the Company&#146;s transfer agent, as determined by the Investor, to the relevant Back Leverage lender or agent therefor, in each case, subject to applicable transfer
restrictions and related restrictive legends, or, if such Shares (or such shares of Company Common Stock) are eligible for resale under Rule 144A and eligible to be so deposited, the deposit thereof in book entry form on the books of The Depository
Trust Company or other depository for crediting to the relevant collateral accounts upon, funding of the relevant loan and payment of the purchase price of the Investor, including a right for such lender, agent or counterparty as a third party
beneficiary with respect to the Company&#146;s obligation under <U>Article II</U> hereof to issue the Series B Preferred Stock upon payment of the purchase price therefor in accordance with the terms of this Agreement and (v)&nbsp;such other
cooperation and assistance as the Investor may reasonably request that will not unreasonably disrupt the operation of the Company&#146;s business. Anything in the preceding sentence to the contrary notwithstanding, the Company&#146;s obligation to
deliver an Issuer Agreement is conditioned on (A)&nbsp;the Investor delivering to the Company a copy of the applicable loan agreement for the Back Leverage to which the Issuer Agreement relates and (B)&nbsp;the Investor certifying to the Company in
writing that (w)&nbsp;the loan agreement with respect to which the Issuer Agreement is being delivered constitutes Back Leverage being entered into in accordance with this Agreement, the Investor has pledged the Preferred Stock and/or the underlying
shares of Company Common Stock as collateral to the applicable lenders or agents therefor under such Back Leverage and that the execution of such Back Leverage and the terms thereof do not violate the terms of this Agreement or the Statement With
Respect to Shares, (x)&nbsp;to the extent applicable, whether the registration rights under the Registration Rights Agreement are being assigned to the applicable lenders or agents therefor under the Back Leverage, (y)&nbsp;an Exercise of Remedies
(as defined in the Issuer Agreement) constitutes the only circumstance under which the lenders under the Back Leverage may foreclose on the Shares (or shares of Company Common Stock issued upon conversion of Shares) and (z)&nbsp;the Investor
acknowledges and agrees that the Company shall be relying on such certificate when entering into the Issuer Agreement and any material inaccuracy in such certificate shall be deemed a breach of this Agreement; provided, that the Company shall, and
shall cause its Affiliates and its and their respective Representatives to, keep confidential the terms and the existence of any such loan agreement and related documents in connection with Back Leverage (and any amendments or supplements thereto),
other than in the case that the Company, any of its Affiliates or any of its or their respective Representatives are requested or required by applicable Law, regulation, judgment, stock exchange rule or other applicable judicial or governmental
process (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process) to disclose such information, in each of which instances the Company, its Affiliates and its and their respective
Representatives, as the case may be, shall, to the extent legally permitted, provide notice to the Investor sufficiently in advance of any such disclosure so that the Investor will have a reasonable opportunity to timely seek to limit, condition or
quash such disclosure (in which case the Company shall use reasonable efforts to assist the Investor in this respect). The Investor acknowledges and agrees that the statements and agreements of the Company in an Issuer Agreement are solely for the
benefit of the applicable lenders and agents party thereto and that in any dispute between the Company and the Investor under this Agreement, the Investor shall not be entitled to use the statements and agreements of the Company in an Issuer
Agreement against the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>State Securities Laws</U>. During the period from the date of this Agreement until
the Subsequent Closing Date (or such earlier date on which the Subsequent Investment Provisions may be terminated pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>), the Company shall use its reasonable best efforts to (a)&nbsp;obtain all necessary
permits and qualifications, if any, or secure an exemption therefrom, required by any state or country pursuant to applicable <U>securities</U> laws prior to the offer and sale by the Investor of Company Common Stock and/or Series B Preferred Stock
and (b)&nbsp;cause such authorization, approval, permit or qualification to be effective as of the Subsequent Closing and as of any conversion of Series B Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <U>Information Rights</U>. In order to facilitate (i)&nbsp;the Investor&#146;s compliance with legal and regulatory
requirements applicable to the beneficial ownership by the Investor and its Affiliates of equity securities of the Company, and (ii)&nbsp;oversight of the Investor&#146;s investment in the Company, from the date hereof, and so long as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the 25% Beneficial Ownership Requirement is satisfied by the Investor Parties, the Company agrees promptly to provide the Investor Parties with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) subject to the approval of the Chief Executive Officer of the Company, the right to visit any of the offices and properties of the
Company and its Subsidiaries, in each case upon reasonable notice and at such reasonable times and as often as the Investor may reasonably request, (ii)&nbsp;the right to, as reasonably requested by the Investor, inspect the books and records of the
Company and its Subsidiaries, in each case upon reasonable notice and at such reasonable times and as often as the Investor may reasonably request and (iii)&nbsp;such other information reasonably requested by the Investor in the Company&#146;s
possession related to the business, operations and financial condition of the Company and its Subsidiaries (including any projections or financial analysis prepared by or on behalf of the Company) (it being understood that the Company shall not be
required to create any new projections or analyses or other reports in response to a request pursuant to this clause (iii)); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Subject to the approval of the Chief Executive Officer of the Company, make appropriate officers, advisors and representatives of the Company and its Subsidiaries available periodically and at such times as reasonably requested by the Investor for
consultation with the Investor, its Affiliates and the representatives of the foregoing with respect to matters relating to the business, operations and affairs of the Company and its Subsidiaries; provided that in case of clause (a)&nbsp;and (b)
the Company shall not be obligated to provide materials, documents or information that it reasonably and in good faith considers to be a trade secret or the disclosure of which would reasonably be likely to jeopardize the attorney-client privilege
between the Company and its counsel or violate applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <U>Section 16 Matters</U>. If the Company becomes a
party to a consolidation, merger or other similar transaction that may result in the Investor, its Affiliates and/or the Investor Director being deemed to have made a disposition of equity securities of the Company or derivatives thereof for
purposes of Section&nbsp;16 of the Exchange Act, and if the Investor Director is serving on the Board at such time or has served on the Board during the preceding six months, then (i)&nbsp;the Board will
<FONT STYLE="white-space:nowrap">pre-approve</FONT> such disposition of equity securities or derivatives thereof for the express purpose of exempting the Investor&#146;s, its Affiliates&#146;, the Investor Director&#146;s &#145;interests (to the
extent the Investor or its Affiliates may be deemed to be &#147;directors by deputization&#148;) in such transaction from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> thereunder and
(ii)&nbsp;if the transaction involves (A)&nbsp;a merger or consolidation to which the Company is a party and capital stock is, in whole or in part, converted into or exchanged for equity securities of a different issuer, (B)&nbsp;a potential
acquisition by the Investor, the Investor&#146;s Affiliates and/or the Investor Director of equity securities of such other issuer or derivatives thereof and (C)&nbsp;an Affiliate or other designee of the Investor or its Affiliates will serve on the
board of directors (or its equivalent) of such other issuer, then if the Investor reasonably requires that the other issuer <FONT STYLE="white-space:nowrap">pre-approve</FONT> any acquisition of equity securities or derivatives thereof for the
express purpose of exempting the interests of any director or officer of the Company or any of its Subsidiaries in such transactions from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT>
thereunder, the Company shall require that such other issuer <FONT STYLE="white-space:nowrap">pre-approve</FONT> any such acquisitions of equity securities or derivatives thereof for the express purpose of exempting the interests of the
Investor&#146;s, its Affiliates&#146; and the Investor Director&#146;s&#146; (for the Investor and/or its Affiliates, to the extent such persons may be deemed to be &#147;directors by deputization&#148; of such other issuer) in such transactions
from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18
<U>VCOC Letters</U>. Upon request by the Investor, the Company shall deliver to the Investor at the Initial Closing and from time to time any Affiliate of the Investor to whom the Investor&#146;s rights and obligations under this Agreement are
assigned in accordance with this Agreement a letter substantially consistent with the form thereof furnished by the Investor and reasonably acceptable to the Company (the &#147;<U>VCOC Letters</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <U>Target Acquisition</U>. The Company shall at the Investor&#146;s request keep the Investor updated regarding the status
of the Target Acquisition, including progress toward the satisfaction of the closing conditions set forth in the Target Merger Agreement. The Company shall furnish to the Investor information regarding the Target Acquisition as is reasonably
requested by the Investor from time to time, subject to any limitations under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Target Merger Agreement. The Company shall not amend or otherwise modify, waive any term or condition of, or excuse performance under the Target Merger Agreement, in each case, in a manner
that is materially adverse to the Investor without the prior written consent of the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 <U>Statement With Respect
to Shares</U>(a) . The Investor hereby agrees to perform its obligations pursuant to the Statement With Respect to Shares. In the event the obligations of holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to purchase
the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock terminate pursuant to Section&nbsp;1(e) of the Statement With Respect to Shares, the parties will negotiate in good faith to amend this Agreement to provide for the purchase of
such securities by the Investor, subject to the conditions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 <U>Pipeline Financings</U>. Following any
termination of the Target Merger Agreement, so long as the Investor continues to beneficially own at least 50% of the shares of Series B Preferred Stock purchased by the Investor, in the event the Company proposes to issue any senior preferred
securities for cash to finance any material acquisition by the Company of a business or another company, the Company shall first offer to the Investor the right to purchase such securities and, in the event the Investor declines, the Company shall
be permitted to issue such securities on terms not more favorable in any material respect to the purchaser than were offered to the Investor. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Conditions to
Subsequent Closing </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01 <U>Conditions to the Obligations of the Company and the Investor</U>. The respective obligations
of each of the Company and the Investor to effect the Subsequent Closing shall be subject to the satisfaction (or waiver, if permissible under applicable Law) at the Subsequent Closing of each of the conditions set forth in this
<U>Section</U><U></U><U>&nbsp;6.01</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>No Legal Prohibition</U>. No injunction by any court or other tribunal of competent
jurisdiction shall have been entered and shall continue to be in effect and no Law shall have been adopted or be effective, in each case, that prohibits the consummation of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>HSR Act; Foreign Investment Laws</U>. Any applicable waiting periods shall have expired or been terminated, and any approvals required
shall have been obtained, in each case relating to the Transactions under the HSR Act or under any other antitrust Law or any Laws with respect to foreign investment specified in <U>Section</U><U></U><U>&nbsp;6.01(b)</U> of the Disclosure Schedules.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Target Acquisition</U>. The Target Acquisition shall have been consummated, or will be consummated substantially simultaneously
with the Subsequent Closing, in each case, in accordance with the terms and conditions of the Target Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02
<U>Conditions to the Obligations of the Company</U>. The obligation of the Company to effect the Subsequent Closing shall be further subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Subsequent Closing
Date of each of the conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>.
(i)&nbsp;The representations and warranties of the Investor set forth in <U>Article IV</U> shall be true and correct in all respects both when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the extent
expressly made as of an earlier date, in which case as of such date), except where the failure of such representations and warranties to be so true and correct would not have an Investor Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. The Investor shall have complied with or performed in all material respects its obligations required to be complied with
or performed by it pursuant to this Agreement at or prior to the Subsequent Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Certificate</U>. The Company shall have received a certificate, signed on
behalf of the Investor by an executive officer thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> and <U>Section</U><U></U><U>&nbsp;6.02(b)</U> have been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03 <U>Conditions to the Obligations of the Investor</U>. The obligation of the Investor to effect the Subsequent Closing shall
be further subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Subsequent Closing of each of the conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. (i)&nbsp;The Fundamental Representations shall be true and correct in all material respects both
when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in which case as of such date) and (ii)&nbsp;the representations and warranties of the Company set
forth in <U>Section</U><U></U><U>&nbsp;3.02(a)</U> shall be true and correct in all respects (except for only de minimis inaccuracies) both when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the
extent expressly made as of an earlier date, in which case as of such date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. The Company shall have complied with
or performed in all material respects its obligations required to be complied with or performed by it pursuant to this Agreement at or prior to the Subsequent Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Material Adverse Effect</U>. Since the date of the Original Investment Agreement, there shall not have been any event, change,
effect, development or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Debt Financing</U>. The Debt Financing (as defined in the Target Merger Agreement), or such other financing acceptable to the Board
acting reasonably<B> </B>and sufficient (assuming the payment of the Subsequent Investment Purchase Price and the Upsize Subsequent Investment Purchase Price (if any) by the Investor at the Subsequent Closing) to fund the cash portion of the merger
consideration payable under the Target Merger Agreement and transaction fees and expenses (together, the &#147;<U>Acquisition Debt Financing</U>&#148;), shall have been funded, or will be funded simultaneously with the Closing (as defined in the
Target Merger Agreement), in accordance with the Debt Commitment Letter (as defined in the Target Merger Agreement) or the definitive documentation providing for such other financing, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Closing Certificate</U>. The Investor shall have received a certificate, signed on behalf of the Company by an executive officer
thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.03(a)</U>, <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and <U>Section</U><U></U><U>&nbsp;6.03(c)</U> have been satisfied (the &#147;<U>Closing Certificate</U>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>NASDAQ Approval</U>. Any shares of Company Common Stock issuable upon conversion of the Series B Preferred Stock (other than any
additional shares of Series B Preferred Stock that may be issued as dividends payable in kind) at the applicable Conversion Price specified in the Statement With Respect to Shares as in effect on the Subsequent Closing Date shall have been approved
for listing on the NASDAQ, subject to official notice of issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Termination; Survival </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 <U>Termination Prior to the Subsequent Closing</U>. The rights and obligations of the parties in respect of the Subsequent
Closing and the provisions of this Agreement specifically related to the Subsequent Investment and the purchase and sale of the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares (if any) (collectively, the
&#147;<U>Subsequent Investment Provisions</U>&#148;) may only be terminated at any time prior to the Subsequent Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by the
mutual written consent of the Company and the Investor; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) automatically upon the valid termination of the Target Merger Agreement for any reason
in accordance with its terms and conditions, including as set forth in Section&nbsp;7.1 therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by either the Company or the
Investor upon valid delivery of written notice to the other, if the Subsequent Closing has not occurred on or prior to 5:00 p.m., Eastern time, on the <FONT STYLE="white-space:nowrap">nine-month</FONT> anniversary of the date of the Target Merger
Agreement (the &#147;<U>Investor Original End Date</U>&#148;); <U>provided</U> that if the Investor Original End Date is extended to the &#147;First Extended End Date&#148; under the Target Merger Agreement pursuant to the terms and conditions of
Section&nbsp;7.1 therein, the Investor Original End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;First Extended End Date&#148; as defined in the Target Merger Agreement (the
&#147;<U>Investor First Extended End Date</U>&#148;); <U>provided</U>, <U>further</U>, that if the &#147;First Executed End Date&#148; is extended to the &#147;Second Extended End Date&#148; in the Target Merger Agreement pursuant to the terms and
conditions of Section&nbsp;7.1 therein, the Investor First Extended End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;Second Extended End Date&#148; as defined in the Target Merger
Agreement (the &#147;<U>Investor Second Extended End Date</U>&#148;); <U>provided</U>, <U>further</U>, that if the Second Executed End Date is extended to the &#147;Third Extended End Date&#148; in the Target Merger Agreement pursuant to the terms
and conditions of Section&nbsp;7.1 therein, the Investor Second Extended End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;Third Extended End Date&#148; as defined in the Target Merger
Agreement (the &#147;<U>Investor Third Extended End Date</U>&#148;, and the Investor Original End Date, as such date may be extended to the Investor First Extended End Date, the Investor Second Extended End Date and the Investor Third Extended End
Date, as applicable, the &#147;<U>Investor End Date</U>&#148;); <U>provided</U> that (i)&nbsp;the right to terminate the Subsequent Investment Provisions pursuant to this <U>Section</U><U></U><U>&nbsp;7.01(c)</U> shall not be available to a party if
the failure of the Subsequent Closing to occur by such date shall have resulted from a material breach by such party of any representation, warranty, covenant or other agreement of such party set forth in this Agreement and (ii)&nbsp;the Investor
shall not have the right to terminate the Subsequent Investment Provisions pursuant to this <U>Section</U><U></U><U>&nbsp;7.01(c)</U> unless and until the Company has the right to terminate the Target Merger Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;7.1(b)</U> thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by either the Company or the Investor, if an injunction shall have been entered
permanently restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by the Subsequent Closing and such injunction shall have become final and nonappealable; <U>provided</U>, that the right to terminate the
Subsequent Investment Provisions under this <U>Section</U><U></U><U>&nbsp;7.01(d)</U> shall not be available to a party if such injunction was primarily due to a material breach by such party of any representation, warranty, covenant or other
agreement of such party set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by the Company, if the Investor shall have breached or failed to perform any of
its or their representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Subsequent Closing Date, would result in a failure of a
condition set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> or <U>Section</U><U></U><U>&nbsp;6.02(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the Investor End Date or, if such breach or failure is capable of being cured by the
Investor End Date, the Investor has not cured such breach or failure within thirty (30)&nbsp;days after receiving written notice from the Company describing such breach or failure in reasonable detail (<U>provided</U> that the Company is not then in
material breach of any representation, warranty, covenant or other agreement contained herein that would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.03(a)</U> or <U>Section</U><U></U><U>&nbsp;6.03(b)</U>); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Investor, if the Company shall have breached or failed to perform any of its representations, warranties, covenants or other
agreements contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Subsequent Closing Date, would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;6.03(a)</U> or <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the Investor End Date, if such breach or failure is capable of being cured by the Investor End Date, the
Company has not cured such breach or failure within thirty (30)&nbsp;days after receiving written notice from Investor describing such breach or failure in reasonable detail (<U>provided</U> that Investor is not then in material breach of any
representation, warranty, covenant or other agreement contained herein that would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> or <U>Section</U><U></U><U>&nbsp;6.02(b)</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02 <U>Effect of Termination Prior to </U><U>Subsequent Closing</U>. In the
event of the termination of the Subsequent Investment Provisions as provided in <U>Section</U><U></U><U>&nbsp;7.01</U>, written notice thereof shall be given to the other party, specifying the provision hereof pursuant to which such termination is
made, and the Subsequent Investment Provisions shall forthwith become null and void (other than <U>Section</U><U></U><U>&nbsp;5.04</U>, <U>Section</U><U></U><U>&nbsp;5.05</U>, this <U>Section</U><U></U><U>&nbsp;7.02</U> and <U>Article VIII</U> (for
the avoidance of doubt, all rights, obligations, terms and conditions of this Agreement which are not the Subsequent Investment Provisions shall survive termination of the Subsequent Investment Provisions)), and there shall be no liability on the
part of the Investor or the Company or their respective directors, officers and Affiliates in connection with the Subsequent Investment Provisions, except that&nbsp;(a) no such termination shall relieve any party from liability for damages for Fraud
or willful breach of the Subsequent Investment Provisions prior to such termination and (b)&nbsp;the parties hereto acknowledge and agree that nothing contained herein shall be deemed to affect their right to specific performance in accordance with
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03 <U>Survival and Limitation on Liability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All of the covenants or other agreements of the parties contained in this Agreement to be performed prior to the Subsequent Closing shall
terminate at the Subsequent Closing. Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;7.02</U>, all of the covenants or other agreements of the parties contained in this Agreement to be performed following the Subsequent Closing shall
survive until fully performed or fulfilled, unless and to the extent that <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such covenants or agreements is waived in writing by the party entitled to such performance. All representations
and warranties contained in this Agreement (including the schedules and the certificates delivered pursuant hereto) will survive (i)&nbsp;with respect to claims in respect of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares,
for twelve months following the date of the Original Investment Agreement and (ii)&nbsp;with respect to claims in respect of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares will survive for twelve (12)&nbsp;months following
the Subsequent Closing; provided further that nothing herein shall relieve any party of liability for any inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is made in
writing prior to such expiration by a Person entitled to make such claim pursuant to the terms and conditions of this Agreement. For the avoidance of doubt, claims may be made with respect to the breach of any representation, warranty or covenant
until the applicable survival period therefor as described above expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provision herein to the contrary,
except in the case of Fraud or willful breach in connection with the representations and warranties expressly set forth in <U>Article III</U>, (i)&nbsp;from and after the date of the Original Investment Agreement until the Subsequent Closing (if
any), the maximum liability of the Company under or relating to this Agreement to the extent relating to or arising out of any breach of the representations and warranties of the Company made herein (other than in respect of Fundamental
Representations of the Company) shall in no event exceed 30% of the Initial Investment Purchase Price and (ii)&nbsp;from and after the Subsequent Closing the maximum liability of the Company under or relating to this Agreement to the extent relating
to or arising out of any breach of the representations and warranties of the Company made herein (other than in respect of Fundamental Representations of the Company) shall in no event exceed 30% of the sum of the Initial Investment Purchase Price
and the Subsequent Investment Purchase Price. From and after the date of the Original Investment Agreement, the Investor hereby irrevocably waives any right of rescission it may otherwise have or to which it may become entitled in respect of the
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares. From and after the Subsequent Closing, the Investor hereby irrevocably waives any right of rescission it may otherwise have or to which it may become entitled in respect of the
Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Miscellaneous </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01 <U>Amendments</U>. Subject to compliance with applicable Law, (i)&nbsp;this Agreement may be amended or supplemented in any
and all respects only by written agreement signed by each of the parties hereto and (ii)&nbsp;any amendment to or waiver of the provisions, terms and conditions of this Agreement that are addressed in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Statement With Respect to Shares shall be permitted only as specified in the Statement With Respect to Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02 <U>Extension of Time, Waiver, Etc.</U> The Company and the Investor may, subject to applicable Law, (a)&nbsp;waive any
inaccuracies in the representations and warranties of the other party contained herein or in any document delivered pursuant hereto, (b)&nbsp;extend the time for the performance of any of the obligations or acts of the other party or (c)&nbsp;waive
compliance by the other party with any of the agreements contained herein applicable to such party or, except as otherwise provided herein, waive any of such party&#146;s conditions. Notwithstanding the foregoing, no failure or delay by the Company
or the Investor in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. Any agreement on the
part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03 <U>Assignment</U>. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in
whole or in part, by operation of Law or otherwise, by any of the parties hereto without the prior written consent of the other party hereto; <U>provided</U>, <U>however</U>, that (a)&nbsp;following the first to occur of the Subsequent Closing and
the termination of the Target Merger Agreement, without the prior written consent of the Company, the Investor or any Investor Party may assign its rights, interests and obligations under this Agreement, in whole or in part, in conjunction with a
permitted transfer of Shares to one or more Permitted Transferees as contemplated in <U>Section</U><U></U><U>&nbsp;5.08</U> so long as the assignee shall agree in writing to be bound by the provisions of this Agreement, including the rights,
interests and obligations so assigned, and (b)&nbsp;following written notice delivered to the Company, without the prior written consent of the Company, the Investor may grant to the lender(s) (or agents) under any such Back Leverage a security
interest in its respective rights (but not its obligations) under this Agreement in connection with any such Back Leverage; it being understood that in no event will the Investor be relieved of its obligations hereunder prior to the Subsequent
Closing. Subject to the immediately preceding sentence, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns. For the avoidance of doubt,
(i)&nbsp;no Transfer by any Investor Party of any Series B Preferred Stock or Company Common Stock to a third party that is not an Investor Party (including as contemplated under <U>Section</U><U></U><U>&nbsp;5.08(b)(iv)</U>) shall result in the
transfer or assignment of any of the Investor Parties&#146; rights hereunder and (ii)&nbsp;each holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares prior to the Subsequent Closing shall be subject to the Subsequent
Investment Obligation and the terms and conditions relating to the Upsize Investment (each as defined in the Statement With Respect to Shares). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04 <U>Counterparts; Electronic Delivery</U>. This Agreement may be executed in multiple counterparts, any one of which need not
contain the signature of more than one party, but all such counterparts taken together shall constitute one and the same instrument. This Agreement and any signed agreement entered into in connection herewith or contemplated hereby, and any
amendments hereto or thereto, to the extent signed and delivered by .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign, shall be treated in all manner and respects as an original contract and shall be considered to have
the same binding legal effects as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such contract, each other party hereto or thereto shall re&#150;execute original forms thereof and
deliver them to all other parties. No party hereto or to any such contract shall raise the use of a .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign to deliver a signature or the fact that any signature or contract was
transmitted or communicated through the use of .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign as a defense to the formation of a contract and each such party forever waives any such defense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05 <U>Entire Agreement; No Third-Party Beneficiaries</U>. This Agreement, including the Disclosure Schedules, together with the
Confidentiality Agreement and the other Transaction Documents, constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the parties and their Affiliates, or any of them, with
respect to the subject matter hereof and thereof, including the Original Investment Agreement. No provision of this Agreement shall confer upon any Person other than the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
parties hereto and their permitted assigns any rights or remedies hereunder; provided that (i)<U>&nbsp;Section</U><U></U><U>&nbsp;5.11(e)</U> shall be for the benefit of and fully enforceable by
the Investor Director, (ii)<U>&nbsp;Section</U><U></U><U>&nbsp;5.11(f)</U> shall be for the benefit of and fully enforceable by each of the Covered Persons and (iii)<U>&nbsp;Section</U><U></U><U>&nbsp;8.13</U> shall be for the benefit of and fully
enforceable by each of the <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06 <U>Governing Law;
Jurisdiction</U>. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might
otherwise govern under any applicable conflict of Laws principles. All legal actions or proceedings arising out of or relating to this Agreement shall be heard and determined in the Chancery Court of the State of Delaware (or, if the Chancery Court
of the State of Delaware declines to accept jurisdiction over any legal action or proceeding, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction and venue of such
courts in any such legal action or proceeding and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such legal action or proceeding. The consents to jurisdiction and venue set forth in this
<U>Section</U><U></U><U>&nbsp;8.06</U> shall not constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any
Person other than the parties hereto. Each party hereto agrees that service of process upon such party in any legal action or proceeding arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the
address set forth in <U>Section</U><U></U><U>&nbsp;8.09</U> of this Agreement. The parties hereto agree that a final judgment in any such legal action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by applicable Law; provided, however, that nothing in the foregoing shall restrict any party&#146;s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court judgment.
Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;8.06</U>, the Series B Preferred Stock shall be governed by the laws of the Commonwealth of Pennsylvania, regardless of the laws that might otherwise govern under an applicable conflict
of Laws principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.07 <U>Specific Enforcement</U>. The parties hereto agree that irreparable damage for which monetary
relief, even if available, would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached. Accordingly, subject to
<U>Section</U><U></U><U>&nbsp;7.03</U>, the parties acknowledge and agree that (a)&nbsp;the parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof (including, for the avoidance of doubt, the right of each party to cause the Subsequent Closing to be consummated on the terms and subject to the conditions set forth in this Agreement) in the
courts described in <U>Section</U><U></U><U>&nbsp;8.06</U> without proof of damages or otherwise (in each case, subject to the terms and conditions of this <U>Section</U><U></U><U>&nbsp;8.07</U>), this being in addition to any other remedy to which
they are entitled under this Agreement and (b)&nbsp;the right of specific enforcement is an integral part of the Transactions and without that right, neither the Company nor the Investor would have entered into this Agreement. The parties hereto
agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, and agree not to assert that a remedy of monetary damages would provide an adequate remedy or that the parties
otherwise have an adequate remedy at law. The parties hereto acknowledge and agree that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in
accordance with this <U>Section</U><U></U><U>&nbsp;8.07</U> shall not be required to provide any bond or other security in connection with any such order or injunction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.08 <U>WAIVER OF JURY TRIAL</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS
LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR
INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(A)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE
FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C)&nbsp;IT MAKES SUCH WAIVER VOLUNTARILY AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND
CERTIFICATIONS IN THIS <U>Section</U><U></U><U>&nbsp;8.08</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.09 <U>Notices</U>. All notices, requests and other
communications to any party hereunder shall be in writing and shall be deemed given (a)&nbsp;when delivered personally, (b)&nbsp;when transmitted via electronic mail to the <FONT STYLE="white-space:nowrap">e-mail</FONT> address set out below
(provided that no error message is generated), (c) the day following the day (except if not a Business Day, then the next Business Day) on which the same has been delivered prepaid to a reputable national overnight courier or (d)&nbsp;the third
Business Day following the day on which the same is sent by certified or registered mail, postage prepaid to the parties at the following addresses: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Company, to it at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-IV</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Saxonburg,
PA 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Mary Jane Raymond, Chief Financial Officer, Treasurer and Assistant Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">MaryJane.Raymond@II-VI.com</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-IV</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Saxonburg,
PA 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Jo Anne Schwendinger, Chief Legal and Compliance Officer and Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">JoAnne.Schwendinger@II-VI.com</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wachtell, Lipton,
Rosen&nbsp;&amp; Katz </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">51West 52nd Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Andrew J. Nussbaum, Karessa L. Cain </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: ajnussbaum@wlrk.com; klcain@wlrk.com </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Investor or any Investor Party, to the Investor at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o Bain Capital Private Equity, LP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">200 Clarendon Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Boston,
MA 02116 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: Stephen Pagliuca, Ken Hanau, Joseph Robbins, David Hutchins </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: spagliuca@baincapital.com; khanau@baincapital.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">jrobbins@baincapital.com; dhutchins@baincapital.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue, 53rd Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Sarkis Jebejian, P.C., Joshua N. Korff, P.C., Christopher M. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Thomas, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: sarkis.jebejian@kirkland.com; jkorff@kirkland.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">christopher.thomas@kirkland.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other address as such party may hereafter specify by like notice to the other parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10 <U>Severability</U>. If any term, condition or other provision of this Agreement is determined by a court of competent
jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any
term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest
extent permitted by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11 <U>Expenses</U>. Except as otherwise expressly provided herein, all costs and
expenses, including fees and disbursements of counsel, financial advisors and accountants, incurred in connection with this Agreement and the Transactions shall be paid by the party incurring such costs and expenses, whether or not the Subsequent
Closing shall have occurred; <U>provided</U> that the Company shall, upon the Initial Closing, reimburse the Investor for up to $2.0&nbsp;million of its and its Affiliates&#146; reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the Initial Investment (including the reasonable and documented fees and expenses of third-party consultants, legal counsel, accountants and
financing advisors in connection therewith); <U>provided</U>, <U>further</U>, that in the event that the reimbursement pursuant to the immediately preceding proviso clause was in an amount less than $2.0&nbsp;million, then the Company shall, upon
the Subsequent Closing, reimburse the Investor for all such reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the Subsequent
Investment by it and its Affiliates up to $2.0&nbsp;million in the aggregate. For the avoidance of doubt, the Company&#146;s aggregate reimbursement obligations set forth in this <U>Section</U><U></U><U>&nbsp;8.11</U> shall in no event exceed
$2.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12 <U>Interpretation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When a reference is made in this Agreement to an Article, a Section, Exhibit or Schedule, such reference shall be to an Article of, a
Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this
Agreement. Whenever the words &#147;<U>include</U>&#148;, &#147;<U>includes</U>&#148; or &#147;<U>including</U>&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;<U>without limitation</U>&#148;. The words
&#147;<U>hereof</U>&#148;, &#147;<U>herein</U>&#148; and &#147;<U>hereunder</U>&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement unless the
context requires otherwise. The words &#147;<U>date hereof</U>&#148; when used in this Agreement shall refer to the date of this Agreement. The terms &#147;<U>or</U>&#148;, &#147;<U>any</U>&#148; and &#147;<U>either</U>&#148; are not exclusive. The
word &#147;<U>extent</U>&#148; in the phrase &#147;<U>to the extent</U>&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;<U>if</U>&#148;. The word &#147;<U>will</U>&#148; shall be
construed to have the same meaning and effect as the word &#147;<U>shall</U>.&#148; The words &#147;<U>made available to the Investor</U>&#148; and words of similar import refer to documents (A)&nbsp;posted to the Datasite LLC&#146;s data room for
Project Watson by or on behalf of the Company or (B)&nbsp;delivered in Person or electronically to the Investor or its respective Representatives, in each case no later than one Business Day prior to the date of the Original Investment Agreement.
All accounting terms used and not defined herein shall have the respective meanings given to them under GAAP. All terms defined in this Agreement shall have the defined meanings when used in any document made or delivered pursuant hereto unless
otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. In the event that the
Company Common Stock is principally listed on a national securities exchange other than the NASDAQ, all references herein to NASDAQ shall be deemed to be references to such other national securities exchange. Any agreement, instrument or statute
defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by
waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. Unless otherwise specifically indicated, all references to
&#147;<U>dollars</U>&#148; or &#147;<U>$</U>&#148; shall refer to the lawful money of the United States. References to a Person are also to its permitted assigns and successors. When calculating the </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period of time between which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall
be excluded (unless, otherwise required by Law, if the last day of such period is not a Business Day, the period in question shall end on the next succeeding Business Day). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the event an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of the authorship of any provision of
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13 <U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U>. This Agreement may only be enforced
against, and any claim or cause of action based upon, arising out of, or related to this Agreement, or the Transactions may only be brought against the entities that are expressly named as parties hereto and their respective successors and assigns.
Except as set forth in the immediately preceding sentence, no past, present or future director, officer, employee, incorporator, member, partners, stockholder, Affiliate, agent, attorney, advisor or representative of any party hereto (collectively,
the &#147;<U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties</U>&#148;) shall have any liability for any obligations or liabilities of any party hereto under this Agreement or for any claim based on, in respect of, or by reason of, the
Transactions (whether in contract, in tort, in law or in equity or provided by statute, whether by or through attempted piercing of the corporate, limited partnership or limited liability company veil or otherwise), except to the extent expressly
set forth in the other Transaction Documents. For the avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;8.13</U> is intended to benefit and may be enforced by each <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party (and each such Person
shall be a third-party beneficiary of this <U>Section</U><U></U><U>&nbsp;8.13</U>) and shall be binding on all respective successors and permitted assigns thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14 <U>Effectiveness of Amendment and Restatement</U>. This Agreement amends and restates the Original Investment Agreement in
its entirety. All amendments to the Original Investment Agreement effected by this Agreement, and all other covenants, agreements, terms and provisions of this Agreement, shall have effect as of the date of this Agreement unless expressly stated
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Walter R. Bashaw II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Walter R. Bashaw II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page &#151; Investment Agreement </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">BCPE WATSON (DE) SPV, LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DocuSigned by:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph Robbins</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">8CD62C79FD544E7</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Joseph Robbins</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page &#151; Investment Agreement </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_126c"></A><A NAME="anxc"></A>Annex C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PENNSYLVANIA DEPARTMENT OF STATE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BUREAU OF
CORPORATIONS AND CHARITABLE ORGANIZATIONS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>&#9744;<B></B><B> Return document by mail to:</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">Statement with Respect to Shares<BR>Domestic Business Corporation<BR><FONT STYLE="white-space:nowrap">DSCB:15-1522</FONT> (rev. 7/2015)</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g40j37.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">1522</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address</P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">City State Zip Code</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&#9746; <B>Return document by email to: pados@klgates.com</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Read all instructions prior to completing. This form may be submitted online at https://www.corporations.pa.gov/. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fee: $70 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In compliance with the requirements of 15 Pa.C.S.
&#167;&nbsp;1522(b) (relating to statement with respect to shares), the undersigned corporation, desiring to state the designation and voting rights, preferences, limitations, and special rights, if any, of a class or series of its shares, hereby
states that: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">1. The name of the corporation is: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">2. <I>Check and complete one of the following:</I> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;</B>&#9744;<B></B><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The resolution amending the Articles under 15 Pa.C.S. &#167; 1522(b) (relating to divisions and
determinations by the board), set forth in full, is as follows: </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The resolution amending the Articles under 15 Pa.C.S. &#167; 1522(b) is set forth in full in Exhibit A
attached hereto and made a part hereof: </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:12pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">3. The aggregate number of shares of such class or series established and designated by (a)&nbsp;such
resolution, (b)&nbsp;all prior statements, if any, filed under 15 Pa.C.S. &#167; 1522 or corresponding provisions of prior law with respect thereto, and (c)&nbsp;any other provision of the Articles is 215,000 shares, consisting of 75,000 shares of
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, and 140,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P></div>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. The resolution was adopted by the Board of Directors or an
authorized committee thereon on:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>03/29/2021</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">Date (MM/DD/YYYY)</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">5. <I>Check, and if appropriate complete, one of the following:</I> </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The resolution shall be effective upon the filing of this statement with respect to shares in the Department of
State. </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The resolution shall be effective
on:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . </P></TD>
<TD WIDTH="1%">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; margin-right:1%; font-size:10pt; font-family:Times New Roman">Date (MM/DD/YYYY) Hour (if any) </P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN TESTIMONY
WHEREOF, the undersigned corporation has caused this statement to be signed by a duly authorized officer thereof this</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>30th</U></B> day of <B><U>March</U></B>, <B><U>2021</U></B>.</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Name of Corporation</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>/s/ Walter R. Bashaw II</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>President</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">Title</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT&nbsp;A TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT WITH RESPECT TO SHARES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDING THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED ARTICLES OF INCORPORATION OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES B CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE BE IT RESOLVED</B>, that pursuant to Section&nbsp;1522(b) of the Pennsylvania Business Corporation Law of 1988, as amended,
and Section&nbsp;5(C) of the Amended and Restated Articles of Incorporation (the &#147;<U>Articles</U>&#148;) of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;<U>Corporation</U>&#148;), there is
hereby designated and established a series of preferred stock of the Corporation denominated as the &#147;Series B Convertible Preferred Stock&#148;, and this Board of Directors of the Corporation hereby fixes and determines the number of such
shares and, subject to the provisions of such Section&nbsp;5(C) of the Articles, the relative rights and preferences of such shares as set forth in <B><U>Annex</U></B><B><U></U></B><B><U>&nbsp;A</U></B><B> </B>hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX&nbsp;A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(to Resolutions of the Board of Directors&#151;March&nbsp;29, 2021) </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX&nbsp;A</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STATEMENT WITH RESPECT TO SHARES </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STANDARD PROVISIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>General Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each share of Series B Convertible Preferred Stock with no par value per share (the &#147;<B><I>Series B
Convertible Preferred Stock</I></B>&#148;) shall be identical in all respects to every other share of Series B Convertible Preferred Stock, except as set forth in <U>Sections 1(c)</U>, <U>1(d)</U>, <U>1(e</U><U>)</U>, <U>3</U><U>(a)</U> and
<U>5(a)</U> and the definitions of certain defined terms herein. There shall be (i)&nbsp;a series of Series B Convertible Preferred Stock designated as &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock&#148; with
no par value per share (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock</I></B>&#148;) and (ii)&nbsp;a series of Series B Convertible Preferred Stock designated as &#147;Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock&#148; with no par value per share (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock</I></B>&#148;). The number of shares initially
constituting the Series B Convertible Preferred Stock shall be 215,000, consisting of 75,000 shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, and 140,000 shares of Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Series B Convertible Preferred Stock, with respect to
dividend rights and/or distribution rights upon a Liquidation Event, as applicable, shall rank (i)&nbsp;senior to each class or series of Junior Stock, (ii)&nbsp;on parity with each class or series of Parity Stock, (iii)&nbsp;junior to each class or
series of Senior Stock and (iv)&nbsp;junior to the Corporation&#146;s existing and future indebtedness and other liabilities (including trade payables). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Holder of a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall, at the Subsequent Closing
purchase from the Corporation 1.4 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in respect of each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by such
Holder, in each case, pursuant to, and subject to, all of the terms and conditions of the Investment Agreement (the &#147;<B><I>Subsequent Investment Obligation</I></B>&#148;). Except as provided in Section&nbsp;5.08 of the Investment Agreement,
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall not be transferred after issuance until the satisfaction or, with respect to such shares, termination of the Subsequent Investment Obligation pursuant to
<U>Section</U><U></U><U>&nbsp;1(e)</U>. The conditions precedent to the Holders&#146; Subsequent Investment Obligation (including, if applicable, the Upsize Investment) may be waived in writing by the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders. The conditions precedent to the Corporation&#146;s obligation to consummate the Subsequent Closing may be waived in writing by the Corporation. Any provision of the Investment Agreement
applicable to the Subsequent Investment Obligation, including the Upsize Investment, may be amended or otherwise modified in writing by the Corporation and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that the Corporation offers to the Investor the opportunity to purchase additional shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in accordance with Section&nbsp;2.01(b)(i) of the Investment Agreement, and the Investor elects to purchase additional shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock in accordance with Section&nbsp;2.01(b)(i) of the Investment Agreement, then, each Holder of a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall at the Subsequent Closing
purchase from the Corporation (in addition to the shares required to be purchased by such Holder pursuant to <U>Section</U><U></U><U>&nbsp;1(c</U>)) a number of shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
equal to the Pro Rata Amount of such Holder (the &#147;<B><I>Upsize Investment</I></B>&#148;). The Upsize Investment shall occur at the Subsequent Closing pursuant, and subject to, all of the terms and conditions of the Investment Agreement. The
obligation, if any, to purchase shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock pursuant to the Upsize Investment will constitute a component of the Subsequent Investment Obligation. &#147;<B><I>Pro Rata
Amount</I></B>&#148; means, with respect to any Holder, a number equal to (x)&nbsp;the number of shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock the Investor has elected to be purchased pursuant to
Section&nbsp;2.01(b)(i) of the Investment Agreement, multiplied by (y)&nbsp;a ratio, the numerator of which is the number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by such Holder and the
denominator of which is the number of outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by all Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding <U>Sections 1(c)</U> and <U>1(d)</U>, the obligation of each Holder of a share of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to purchase Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;1(c)</U> and Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Preferred Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant to <U>Section</U><U></U><U>&nbsp;1(d)</U> (and any obligation of the Corporation to issue or sell any such securities) shall terminate upon (i)&nbsp;a Transfer of such share upon a
foreclosure pursuant to Section&nbsp;5.08(b)(vi) of the Investment Agreement or (ii)&nbsp;a Transfer of such share pursuant to Section&nbsp;5.08(b)(iv) or Section&nbsp;5.08(b)(v) of the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Dividends</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Dividend Rate on Series B Convertible Preferred Stock</U>. From the Issue Date of such share, dividends shall accrue on the applicable Stated Value of each share of Series B Convertible Preferred Stock at the Annual Rate. Dividends on each share
of Series B Convertible Preferred Stock shall accrue daily from and after the Issue Date of such share, but shall compound on a quarterly basis on each Dividend Payment Date (i.e., no dividends shall accrue on other dividends unless and until the
first Dividend Payment Date for such other dividends has passed without such other dividends having been paid on such date), whether or not earned or declared, and whether or not there are earnings or profits, surplus or other funds or assets of the
Corporation legally available for the payment of dividends. Dividends that are payable on the Series B Convertible Preferred Stock on any Dividend Payment Date shall be payable to Holders as they appear on the stock register of the Corporation on
the record date for such dividend, which shall be the date fifteen (15)&nbsp;days prior to the applicable Dividend Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends payable at the
Annual Rate on the Series B Convertible Preferred Stock in respect of any Dividend Period shall be payable in arrears and shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day</FONT> months. The amount of dividends payable at the Annual Rate on the Series B Convertible Preferred Stock on any date prior to the end of a Dividend Period, and for the applicable initial Dividend Period, shall
be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months, and actual days elapsed over a <FONT STYLE="white-space:nowrap">30-day</FONT> month. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Payment of Dividends</U>. Until the first Dividend Payment Date after the fourth anniversary of the applicable Initial Issue Date in
respect of each series of Series B Convertible Preferred Stock (the &#147;<B><I>Mandatory PIK Date</I></B>&#148;) all dividend payments shall compound and be added to the applicable Stated Value on each Dividend Payment Date, as provided in the
definition of &#147;Stated Value&#148; in <U>Section</U><U></U><U>&nbsp;15</U> (a &#147;<B><I>PIK Dividend</I></B>&#148;). Following the applicable Mandatory PIK Date, dividends shall be payable in the form of, in the Corporation&#146;s sole
discretion (which election, in respect of each dividend, the Corporation may make separately as to each series of Series B Convertible Preferred Stock), (i) solely cash, if, as and when authorized by the Board of Directors or any duly authorized
committee thereof, to the extent permitted by applicable law, or (ii)&nbsp;solely a PIK Dividend, or (iii)&nbsp;any combination of cash and PIK Dividend. The election of the Corporation to pay a dividend solely in cash or in any combination of cash
and PIK Dividend on a Dividend Payment Date shall be made by irrevocable notice to the Holders on or prior to the record date with respect to such Dividend Payment Date. To the extent that the Corporation does not elect to pay a dividend solely in
cash or in any combination of cash and PIK Dividend on or prior to the record date with respect to such Dividend Payment Date, the Corporation shall be deemed to have elected to pay such dividend solely as a PIK Dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transactions</U>. In the event that the Board of Directors shall declare a dividend in
respect of a <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction, the Holders shall be entitled on the payment date for such dividend to receive such number of <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities per share of Series
B Convertible Preferred Stock as would be paid on the shares of the Common Stock into which a share of such Series B Convertible Preferred Stock held by such Holder could be converted pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, such number to
be determined as of the record date for the determination of holders of Common Stock entitled to receive the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities in the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Priority of Dividends</U>. Subject to <U>Sections 2(a)</U> and <U>2(c)</U>, any dividends (payable in cash, securities or other
property) as may be determined by the Board of Directors may be declared and paid on any capital stock, including Common Stock and other Junior Stock, from time to time out of any funds legally available for such payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Liquidation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Voluntary or Involuntary Liquidation</U>. In the event of any voluntary or involuntary liquidation, winding up or dissolution of the
Corporation (each, a &#147;<B><I>Liquidation Event</I></B>&#148;), (i) each Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall be entitled to receive for each share of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, an amount (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Liquidation Preference</I></B>&#148;) equal to the greater of (1)&nbsp;the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Stated Value plus an amount equal to all accrued or declared and unpaid dividends on such share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock that have not previously been
added to the Stated Value and (2)&nbsp;the amount per share as would have been payable in respect of the shares of Common Stock into which such share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock is then
convertible, assuming all outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock were converted into Common Stock immediately prior to such Liquidation Event in accordance with
<U>Section</U><U></U><U>&nbsp;5</U> (without regard as to whether sufficient shares of Common Stock are available out of the Corporation&#146;s authorized but unissued stock for the purpose of effecting the conversion of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock) and (ii)&nbsp;each Holder of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock shall be entitled to receive for each share of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, an amount (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference</I></B>&#148;) equal to the greater of (1)&nbsp;the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Stated Value plus an amount equal to all accrued or declared and unpaid dividends on such share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock that have not previously been
added to the Stated Value and (2)&nbsp;the amount per share as would have been payable in respect of the shares of Common Stock into which such share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock is then
convertible, assuming all outstanding shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock were converted into Common Stock immediately prior to such Liquidation Event in accordance with
<U>Section</U><U></U><U>&nbsp;5</U> (without regard as to whether sufficient shares of Common Stock are available out of the Corporation&#146;s authorized but unissued stock for the purpose of effecting the conversion of the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock), in each case, to be paid out of the assets of the Corporation legally available for distribution to its shareholders, after satisfaction of indebtedness and other liabilities owed
to the Corporation&#146;s creditors and holders of Senior Stock and before any payment or distribution is made to holders of Junior Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Partial Payment</U>. If, upon a Liquidation Event, the amounts payable with respect to (i)&nbsp;the applicable Liquidation Preference
to all Holders and (ii)&nbsp;the liquidation preference, and the amount of accumulated and unpaid dividends, whether or not declared, to, but excluding, the date fixed for such Liquidation Event, on all Parity Stock, if applicable, are not paid in
full, all Holders and all holders of any such Parity Stock shall share equally and ratably in any distribution of the Corporation&#146;s assets in proportion to their respective liquidation preferences and amounts equal to the accumulated and unpaid
dividends (if any) to which they are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) After the payment to any Holder of the full amount of the applicable Liquidation
Preference for each of such Holder&#146;s shares of Series B Convertible Preferred Stock, such Holder shall have no right or claim to any of the remaining assets of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither the sale, lease nor exchange of all or substantially all of Corporation&#146;s assets or business nor a Fundamental Change or the
Corporation&#146;s merger or consolidation into or with any other Person, shall be deemed to be a Liquidation Event (in each case, other than in connection with the liquidation, <FONT STYLE="white-space:nowrap">winding-up</FONT> or dissolution of
the Corporation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Corporation shall not be required to set aside funds to protect the respective Liquidation Preference of the
Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Voting</U>. Except as otherwise provided herein or by applicable law, on any matter presented
to the shareholders of the Corporation for their action or consideration at any meeting of shareholders of the Corporation and on which matter holders of the Common Stock shall be entitled to vote, each Holder shall be entitled to the number of
votes equal to the number of whole shares of Common Stock (rounded to the nearest whole share) into which the shares of Series B Convertible Preferred Stock held by such Holder are convertible on the record date for determining shareholders entitled
to vote on such matter (as adjusted from time to time </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
after the applicable Issue Date pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, but without regard as to whether sufficient shares of Common Stock are available out of the Corporation&#146;s
authorized but unissued stock for the purpose of effecting the conversion of the Series B Convertible Preferred Stock); <U>provided</U>, that each Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock will not be
entitled to vote until the condition set forth in Section&nbsp;6.01(b) of the Investment Agreement is satisfied, at which point such Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock will automatically be
entitled to vote. Holders shall be entitled to notice of any meeting of shareholders and, except as otherwise provided herein or otherwise required by law, to vote together with the holders of Common Stock as a single class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Conversion</U>. The Holders shall have conversion rights as follows (the &#147;<B><I>Conversion Rights</I></B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to Convert</U>. Each share of Series B Convertible Preferred Stock shall be convertible, at the option of the Holder, at any time
and from time to time after the applicable Issue Date, and without the payment of additional consideration by the Holder, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing (i)&nbsp;the applicable
Stated Value as of the Conversion Date by (ii)&nbsp;the applicable Conversion Price in effect as of the Conversion Date. The &#147;<B><I>Conversion Price</I></B>&#148; shall initially be equal to (i) $85.00, with respect to the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and (ii) $85.00, with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock; <U>provided</U>, that each share of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall not be convertible, and no Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall be entitled to deliver a Notice of Conversion in
respect of such share, until after the earliest to occur of (x)&nbsp;the Subsequent Closing, (y)&nbsp;the termination of the Target Merger Agreement in accordance with its terms and (z)&nbsp;the delivery of a Fundamental Change Repurchase Offer;
<U>provided</U>, that, in the case of clause (z), such share shall be convertible during the period from the date of receipt of such Fundamental Change Repurchase Offer until the earlier to occur of the relevant Fundamental Change and the applicable
Offer Consent Date, if any, in respect of such Share, until thereafter such share shall become exercisable pursuant to this <U>Section</U><U></U><U>&nbsp;5(a)</U>. The rate at which shares of Series B Convertible Preferred Stock may be converted
into shares of Common Stock shall be subject to adjustment as provided in <U>Sections</U> <U>5(d)</U>, <U>(e)</U>, <U>(f)</U>, <U>(g),</U> <U>(h)</U> and <U>(</U><U>i</U><U>)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of the delivery of a valid notice of redemption of any shares of Series B Convertible Preferred Stock pursuant to
<U>Section</U><U></U><U>&nbsp;8</U> (including a Holder Redemption Notice or Corporation Redemption Notice), the Conversion Rights of the shares designated for redemption shall terminate at the close of business on the date fixed for redemption,
unless the shares designated for redemption are not redeemed in full on the date of such redemption (including by way of deposit of funds in trust pursuant to <U>Section </U><U>8(e)</U>), in which case the Conversion Rights for all such shares shall
continue until such shares are redeemed in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event any shares of Series B Convertible Preferred Stock are to be repurchased by the Corporation
pursuant to <U>Section</U><U></U><U>&nbsp;9</U>, the Conversion Rights of the shares designated for repurchase shall terminate at the close of business on the Fundamental Change Repurchase Date, unless the applicable Fundamental Change Repurchase
Price is not paid in full on such date (including by way of deposit of funds in trust pursuant to <U>Section</U><U></U><U>&nbsp;9(d)</U>), in which case the Conversion Rights for such shares shall continue until such price is paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued upon conversion of the Series B Convertible Preferred
Stock. In lieu of any fractional shares to which the Holder would otherwise be entitled, the Corporation shall pay, to the extent of funds legally available therefor, cash equal to such fraction multiplied by the fair market value of a share of
Common Stock, which shall be the last reported closing sale price of a share of Common Stock on the Conversion Date if the Common Stock is then listed and trading on a Trading Market or, if the Common Stock is not then so listed and trading, as
determined in good faith by the Board of Directors. Whether or not fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Series B Convertible Preferred Stock the Holder is at the
time converting into Common Stock and the aggregate number of shares of Common Stock issuable to such Holder upon such conversion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Mechanics of Conversion</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Holders shall effect conversions by providing the Corporation with a written notice of conversion (a &#147;<B><I>Notice of
Conversion</I></B>&#148;) delivered in accordance with <U>Section</U><U></U><U>&nbsp;11</U> on the Trading Day on which such Holder wishes to effect such conversion (the &#147;<B><I>Conversion Date</I></B>&#148;). Each Notice of Conversion shall
specify the number of shares of each series of Series B Convertible Preferred Stock to be converted, the applicable Conversion Price for each series of Series B Convertible Preferred Stock to be converted, the number of shares of Common Stock to be
issued with respect to each series of Series B Convertible Preferred Stock to be converted, and the number of shares of each series of Series B Convertible Preferred Stock owned subsequent to the conversion at issue. The shares of Common Stock shall
be deemed to have been issued, and the Holder or any other person so designated to be deemed to have become a holder of record of such shares for all purposes, as of the close of business on the Conversion Date (prior to the close of business on the
Conversion Date, the Common Stock issuable upon conversion of Series B Convertible Preferred Stock shall not be outstanding, or deemed to be outstanding, for any purpose and Holders shall have no rights, powers, preferences or privileges with
respect to such Common Stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the Common Stock, by virtue of holding Series B Convertible Preferred Stock). To effect
conversions of shares of Series B Convertible Preferred Stock in certificated form, a Holder shall not be required to surrender the certificate(s) representing the shares of Series B Convertible Preferred Stock to the Corporation unless all of the
shares of Series B Convertible Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Series B Convertible Preferred Stock promptly following the Conversion Date at
issue. Conversions of less than the total amount of shares of Series B Convertible Preferred Stock represented by a certificate held by the Holder will have the effect of lowering the outstanding number of shares of Series B Convertible Preferred
Stock of the applicable series held by such Holder by an amount equal to the number of such shares so converted, as if the original stock certificate(s) were cancelled and one or more new stock certificates evidencing the new number of shares of the
applicable series of Series B Convertible Preferred Stock were issued; <U>provided</U>, <U>however</U>, that in such cases the Holder may request that the Corporation deliver to the Holder a certificate representing such <FONT
STYLE="white-space:nowrap">non-converted</FONT> shares of Series B Convertible Preferred Stock; <U>provided</U>, <U>further</U>, that the failure of the Corporation to deliver such new certificate shall not affect the rights of the Holder to submit
a further Notice of Conversion with respect to such Series B Convertible Preferred Stock and, in any such case, the Holder shall be deemed to have submitted the original of such new certificate at the time that it submits such further Notice of
Conversion. To effect conversion of shares of any Series B Convertible Preferred Stock held in book-entry form in accordance with <U>Section</U><U></U><U>&nbsp;14</U>, Holders must comply with the applicable procedures established from time to time
by DTC and the Transfer Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Not later than 10:00 am (New York City time) on the second Trading Day after each Conversion Date if
shares are to be delivered in book-entry form through the facilities of DTC or within five (5)&nbsp;Business Days otherwise (or, if later, the Trading Day after the Holder has paid in full any applicable transfer taxes and duties) (the
&#147;<B><I>Share Delivery Date</I></B>&#148;), the Corporation shall deliver, or cause to be delivered (through the facilities of DTC or in certificated form, as applicable), to the converting Holder the number of shares of Common Stock being
acquired upon the conversion of the applicable series of Series B Convertible Preferred Stock together with cash in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion (as provided in
<U>Section</U><U></U><U>&nbsp;5(b)</U>). If, in the case of any Notice of Conversion, such shares of Common Stock are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by
written notice to the Corporation in accordance with <U>Section</U><U></U><U>&nbsp;11</U> at any time on or before its receipt of such shares of Common Stock, to rescind such conversion, in which event the Corporation shall promptly return to the
Holder any original Series B Convertible Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the shares of Common Stock issued to such Holder pursuant to the rescinded Notice of
Conversion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Corporation shall at all times when Series B Convertible Preferred Stock shall be outstanding, reserve and keep
available out of its authorized but unissued capital stock, for the purpose of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effecting the conversion of the Series B Convertible Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the conversion
of all outstanding shares of Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) All shares of Series B Convertible Preferred Stock which shall
have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares, including the rights, if any, to receive notices and to vote, shall immediately cease and terminate at
the time of conversion, except only the right of the Holders thereof to receive shares of Common Stock in exchange therefor, to receive payment in lieu of any fraction of a share otherwise issuable upon such conversion and payment of cash dividends
declared but unpaid on the Series B Convertible Preferred Stock (to the extent the amount of any such cash dividends shall not then be reflected in the applicable Stated Value). Any shares of Series B Convertible Preferred Stock so converted shall
be retired and canceled and shall not be reissued as shares of such series, and the Corporation (without the need for shareholder action) may from time to time take such appropriate action as may be necessary to reduce the authorized number of
shares of the applicable series of Series B Convertible Preferred Stock accordingly and restore such shares to the status of authorized but unissued shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares
of Common Stock upon conversion of shares of Series B Convertible Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;5</U>. The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer
involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series B Convertible Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the
Person requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Adjustment for Stock Splits and Stock Combinations</U>. If the Corporation shall at any time or from time to time after the Issue Date
of a share of Series B Convertible Preferred Stock, effect a subdivision of the outstanding shares of Common Stock (a &#147;<B><I>Stock Split</I></B>&#148;), the applicable Conversion Price in effect immediately before such Stock Split shall be
proportionately decreased so that the number of shares of Common Stock issuable on conversion of each such share of Series B Convertible Preferred Stock shall be increased in proportion to such increase in the aggregate number of shares of Common
Stock outstanding. If the Corporation shall at any time or from time to time after the Issue Date of a share of Series B Convertible Preferred Stock combine the outstanding shares of Common Stock (a &#147;<B><I>Stock Combination</I></B>&#148;), the
applicable Conversion Price in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each such share shall be decreased in proportion to such decrease in
the aggregate number of shares of Common Stock outstanding. Any adjustment under this <U>Section</U><U></U><U>&nbsp;5(d)</U> shall become effective at the close of business on the date the Stock Split or Stock Combination becomes effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Adjustment for Certain Dividends and Distributions</U>. In the event the Corporation at any time or from time to time after the
applicable Issue Date of a share of Series B Convertible Preferred Stock shall make or issue, or, if earlier than the applicable issue date, fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other
distribution payable in additional shares of Common Stock (other than a dividend described in <U>Section</U><U></U><U>&nbsp;5(d)</U>), then, upon the first such event to occur, the applicable Conversion Price in effect immediately before such event
shall be decreased as of the time of such issuance or, in the event such a record date shall previously have been fixed, as of the close of business on such record date, by multiplying the applicable Conversion Price, then in effect by a fraction:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the numerator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of
such issuance or the close of business on such record date, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the denominator of which shall be the total number of shares of Common Stock issued
and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such dividend or distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that if such record date shall have been fixed and such dividend is not fully paid or if such distribution is not fully made
on the date fixed therefor, the applicable Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the applicable Conversion Price shall be adjusted pursuant to this
<U>Section</U><U></U><U>&nbsp;5(e)</U> as of the time of actual payment of such dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Adjustment for
Reclassification, Exchange, or Substitution</U>. If the Common Stock issuable upon the conversion of the Series B Convertible Preferred Stock shall be changed into the same or a different number of shares of any class or classes of stock, whether by
capital reorganization, reclassification, or otherwise (other than a Stock Split, Stock Combination or stock dividend provided for in <U>Section</U><U></U><U>&nbsp;5(e)</U> above, or a reorganization, merger, consolidation, or sale of assets
provided for below), then and in each such event the Holder of each such share of Series B Convertible Preferred Stock shall have the right thereafter to convert such share into the kind and amount of shares of stock and other securities and
property receivable, upon such reorganization, reclassification, or other change, by holders of the number of shares of Common Stock into which such share of Series B Convertible Preferred Stock might have been converted immediately prior to such
reorganization, reclassification, or change, all subject to further adjustment as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Adjustment for Merger or
Reorganization, etc</U>. If there shall occur any Reorganization Event involving the Corporation in which the Common Stock (but not the Series B Convertible Preferred Stock) is converted into or exchanged for securities, cash or other property
(other than a transaction covered by <U>Sections 5(d)</U>, <U>5(e)</U>, or <U>5(f)</U>), then, following any such Reorganization Event, each share of Series B Convertible Preferred Stock shall be convertible into the kind and amount of securities,
cash or other property which a holder of the number of shares of Common Stock issuable upon conversion of such share of Series B Convertible Preferred Stock immediately prior to such Reorganization Event would have been entitled to receive pursuant
to such transaction; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors) shall be made in the application of the provisions in this <U>Section</U><U></U><U>&nbsp;5</U> with respect to the rights and
interests thereafter of the Holders to the end that the provisions set forth in this <U>Section</U><U></U><U>&nbsp;5</U> (including provisions with respect to changes in and other adjustments of the applicable Conversion Price) shall thereafter be
applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Adjustment for Rights Offering</U>. If the Corporation shall, at any time or from time to time, while any shares of Series B
Convertible Preferred Stock are outstanding, distribute rights, options or warrants (&#147;<B><I>Rights</I></B>&#148;) to all or substantially all holders of Common Stock entitling them for a period of not more than sixty (60)&nbsp;days from the
record date of such distribution to purchase shares of Common Stock, or securities convertible into, or exchangeable or exercisable for, Common Stock (such distribution, a &#147;<B><I>Rights Offering</I></B>&#148;) at less than the closing sale
price (as determined pursuant to this <U>Section</U><U></U><U>&nbsp;5(h)</U>) on the Trading Day immediately preceding the first public announcement of the Rights Offering, then the applicable Conversion Price in effect immediately before such
Rights Offering shall be adjusted as of the date of the distribution of the Rights, by multiplying the applicable Conversion Price then in effect by a fraction: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the numerator of which shall be the sum of (A)&nbsp;the number of shares of Common Stock outstanding on the Trading Day immediately
preceding the record date for such Rights Offering, plus (B)&nbsp;the (1) product of (x)&nbsp;the total number of shares of Common Stock issuable in the Rights Offering and (y)&nbsp;the exercise price so offered, divided by (2)&nbsp;the closing sale
price of the Common Stock on the Trading Day immediately preceding the first public announcement of the Rights Offering; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
denominator of which shall be the number of shares of Common Stock outstanding at the close of business on the Trading Day immediately preceding the record date for the Rights Offering, plus the total number of additional shares of Common Stock
issuable pursuant to the Rights Offering; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, to the extent that shares of Common Stock are not delivered pursuant to
such Rights Offering or upon the expiration or termination of such Rights Offering, the applicable Conversion Price shall be readjusted to the Conversion Price that would then be in effect had the adjustments made upon the issuance of rights,
options or warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered; <U>provided</U>, <U>further</U>, in the event that such rights, options or warrants are not so distributed, the applicable
Conversion Price shall again be adjusted to be the Conversion Price which would then be in effect if the record date for such Rights Offering had not occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In determining whether any rights, options or warrants entitle the holders of Common Stock to purchase shares of Common Stock at less than the closing sale
price on the Trading Day immediately preceding the first public announcement of the Rights Offering, if (A)&nbsp;the Common Stock is then listed and trading on a Trading Market, such closing sale price shall be the last reported closing price on
such Trading Day and (B) if the Common Stock is not then so listed and trading, such closing sale price shall be determined in good faith by, or pursuant to a formula or method or subject to relevant criteria prescribed by, the Board of Directors.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Adjustment for Ordinary Dividends</U>. In the event the Corporation shall make or issue, or, if earlier, fix a record date for the
determination of holders of Common Stock entitled to receive, an Ordinary Dividend, then, upon the first such event to occur, the applicable Conversion Price in effect immediately before such event shall be decreased, as of the time of such payment
or, in the event such a record date shall previously have been fixed, as of the close of business on such record date, in each case, by the amount of such Ordinary Dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Certificate as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the applicable Conversion Price pursuant
to this <U>Section</U><U></U><U>&nbsp;5</U>, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than two (2)&nbsp;Trading Days thereafter (or in the case of an adjustment pursuant to
<U>Section</U><U></U><U>&nbsp;5(g)</U>, not later than five (5)&nbsp;Trading Days thereafter), compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment or
readjustment (including the kind and amount of securities, cash or other property into which each series of the Series B Convertible Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based.
The Corporation shall, as promptly as reasonably practicable after the written request at any time of any Holder specifying one or more series of Series B Convertible Preferred Stock, furnish or cause to be furnished to such Holder a certificate
setting forth (i)&nbsp;the Conversion Price then in effect for each requested series of Series B Convertible Preferred Stock, and (ii)&nbsp;the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then
would be received upon the conversion of a share of each requested series of Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Notice of
Record Date</U>. In the event: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Corporation declares a dividend (or any other distribution) on its Common Stock payable in Common
Stock or declares an Ordinary Dividend; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Corporation effects a Stock Split, Rights Offering or Stock Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of a Reorganization Event; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of a Liquidation Event; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then the Corporation shall cause to be filed at its principal office or at the office of the Transfer Agent (if the Corporation is not then serving as its own
transfer agent), and shall cause to be mailed to the Holders at their last addresses as shown on the records of the Transfer Agent, at least ten (10)&nbsp;days prior to the date specified in (A)&nbsp;below or twenty (20)&nbsp;days before the date
specified in (B)&nbsp;below, a notice stating </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the record date of such dividend, distribution, Stock Split, Rights Offering or Stock Combination, or, if a
record is not to be taken, the date as of which the holders of Common Stock of record to be entitled to such dividend, distribution, Stock Split, Rights Offering or Stock Combination are to be determined, or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date on which such Reorganization Event or Liquidation Event, and the date as of which it is expected that
holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such Reorganization Event or Liquidation Event. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Mandatory Conversion</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Trigger Event</U>. With respect to each series of Series B Convertible Preferred Stock, if, at any time following the third anniversary
of the applicable Initial Issue Date, the closing sale price of the Common Stock on the principal Trading Market exceeds <FONT STYLE="white-space:nowrap">one-hundred</FONT> and fifty percent (150%) of the Conversion Price of such series of Series B
Convertible Preferred Stock for twenty (20)&nbsp;Market Traded Days out of a period of thirty (30)&nbsp;consecutive Market Traded Days ending no later than two (2)&nbsp;Business Days prior to the date of the Mandatory Conversion Notice, then the
Corporation shall have the right to require conversion of all (but not less than all) of the applicable series of Series B Convertible Preferred Stock, at the then effective applicable Conversion Price in accordance with
<U>Section</U><U></U><U>&nbsp;5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Procedural Requirements</U>. All Holders of the applicable series of Series B Convertible
Preferred Stock shall be sent written notice of the Mandatory Conversion Time and the place designated for mandatory conversion of all such shares of Series B Convertible Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;6</U> (such
notice, the &#147;<B><I>Mandatory Conversion Notice</I></B>&#148;) (including to or through DTC, if applicable). The Corporation shall send such notice at least ten (10)&nbsp;days in advance of the occurrence of the conversion requested pursuant to
<U>Section</U><U></U><U>&nbsp;6(a)</U> (the time of such occurrence, the &#147;<B><I>Mandatory Conversion Time</I></B>&#148;). Prior to the Mandatory Conversion Time specified in the Mandatory Conversion Notice, each Holder shall surrender his, her
or its certificate or certificates (if any) for all such shares (or, if such Holder alleges that any such certificate has been lost, stolen or destroyed, a lost certificate affidavit and bond of indemnity, if requested, in each case reasonably
satisfactory to the Corporation) to the Corporation at the place designated in such notice (or comply with the applicable delivery procedures of DTC and the Transfer Agent, if applicable). If so required by the Corporation, certificates surrendered
for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form reasonably satisfactory to the Corporation, duly executed by the Holder or such Holder&#146;s attorney duly authorized in writing. All rights
with respect to the shares of Series B Convertible Preferred Stock converted pursuant to <U>Section</U><U></U><U>&nbsp;6(a)</U>, including the rights to receive notices and vote (other than as a holder of Common Stock), will terminate at the
Mandatory Conversion Time (notwithstanding the failure of the Holder or Holders thereof to surrender the certificates at or prior to such time or comply with the applicable procedures of DTC and the Transfer Agent), except only the rights of the
Holders thereof, upon surrender of their certificate or certificates (or lost certificate affidavit) therefor or compliance with the applicable procedures of DTC and the Transfer Agent, as applicable, to receive the items provided for in the next
sentence of this <U>Section</U><U></U><U>&nbsp;6(b)</U>. As soon as practicable after the Mandatory Conversion Time but no later than the Share Delivery Date, the Corporation shall deliver, or cause to be delivered (in certificated form or through
the facilities of DTC, as applicable), to the Holder, or to his, her or its nominees, the number of full shares of Common Stock being acquired upon the conversion of the Series B Convertible Preferred Stock pursuant to this
<U>Section</U><U></U><U>&nbsp;6</U>, together with cash in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion (as provided in <U>Section</U><U></U><U>&nbsp;5(b)</U>) and the payment of any declared but unpaid
cash dividends on the shares of Series B Convertible Preferred Stock converted (to the extent the amount of any such dividends shall not then be reflected in the applicable Stated Value). Such converted Series B Convertible Preferred Stock shall be
retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for shareholder action) as may be necessary to reduce the authorized number of shares of the
applicable series of Series B Convertible Preferred Stock accordingly and restore such shares to the status of authorized but unissued shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Protective Covenants</U>. (i)&nbsp;At any time when shares of Series B Convertible Preferred Stock are outstanding, the Corporation
shall not do any of the following without (in addition to any other vote required by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable law or the Articles) the written consent or affirmative vote of the Required Holders, given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as
a class: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) alter or change the rights, preferences or privileges of the Series B Convertible Preferred Stock; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) decrease the number of authorized shares of Series B Convertible Preferred Stock (except for such decrease as permitted under <U>Sections
5(c)</U>, <U>6(b)</U> or <U>8(f)</U> hereunder); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) issue any shares of Series B Convertible Preferred Stock, other than pursuant to the
terms of the Investment Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) authorize or issue any Senior Stock or securities convertible into Senior Stock, or amend or alter
the Articles to increase the number of authorized shares of Series B Convertible Preferred Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) amend, alter or repeal any
provision of the Articles (by operation of law or otherwise) or the Bylaws in a manner that adversely affects the rights, preferences or privileges of the Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) At any time when shares of Series B Convertible Preferred Stock are outstanding and the Investor continues to beneficially own at least
5% of the aggregate number of shares of Series B Convertible Preferred Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), the
Corporation shall not without the written consent of the Investor, pay any cash dividend on the Common Stock other than Ordinary Dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) At any time when shares of Series B Convertible Preferred Stock are outstanding and the Investor continues to beneficially own at least
25% of the aggregate number of shares of Series B Convertible Preferred Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), the
Corporation shall not without the written consent of the Investor, redeem, repurchase or otherwise acquire, or make or declare any dividend or other distribution in respect of, any outstanding Junior Stock other than (u)&nbsp;Ordinary Dividends,
(v)&nbsp;dividends or other distributions for which the Conversion Price is adjusted pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, (w) repurchases of Junior Stock totaling up to $100&nbsp;million on an aggregate annual basis, (x)&nbsp;repurchases
of unvested shares at cost following termination of an employee, advisor or consultant of the Corporation or its Subsidiaries, <FONT STYLE="white-space:nowrap">(y)&nbsp;non-cash</FONT> dividends or other distributions paid <I>pro rata </I>to all
holders of Common Stock and, if applicable, holders of the Series B Convertible Preferred Stock in accordance with <U>Section</U><U></U><U>&nbsp;2</U>, or (z)&nbsp;dividends or other distributions on Junior Stock in the form of such Junior Stock or
other Junior Stock or securities convertible into or exchangeable for Junior Stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Statement with
Respect to Shares, nothing herein shall prohibit or restrict or, except as may be required by applicable law, require any vote of the Series B Convertible Preferred Stock with respect to, Permitted Issuances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Redemptions</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U><FONT
STYLE="white-space:nowrap">Ten-Year</FONT> Redemption</U>. On or at any time after the tenth anniversary of the applicable Initial Issue Date, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each Holder shall have the right to require the Corporation to redeem all of such Holder&#146;s Series B Convertible Preferred Stock, for
cash, at a redemption price per share of the applicable series of Series B Convertible Preferred Stock equal to the sum of the applicable Stated Value plus an amount equal to all accrued or declared and unpaid dividends on such series of Series B
Convertible Preferred Stock that have not previously been added to the applicable Stated Value (the &#147;<B><I>Redemption Price</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Corporation shall have the right, with respect to one or more series of Series B
Convertible Preferred Stock, to redeem, in whole or in part, on a pro rata basis from all Holders thereof based on the number of shares of the applicable series of Series B Convertible Preferred Stock then held, the outstanding shares of such series
of Series B Convertible Preferred Stock, for cash, at the applicable Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Redemption Right</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any Holder may exercise the Holder&#146;s redemption right under <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U> by delivering to
the Corporation in accordance with <U>Section</U><U></U><U>&nbsp;11</U> a written notice stating the Holder&#146;s intention to exercise the Holder&#146;s redemption right and the number of each series of the Holder&#146;s shares of Series B
Convertible Preferred Stock to be redeemed (a &#147;<B><I>Holder Redemption Notice</I></B>&#148;). The Corporation shall be obligated to redeem the total number of shares of Series B Convertible Preferred Stock specified in the Holder Redemption
Notice on or before the 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day following its receipt of such Holder Redemption Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Corporation may exercise its redemption right under <U>Section</U><U></U><U>&nbsp;8(a)(ii)</U> by delivering to the applicable
Holder the notice specified in <U>Section</U><U></U><U>&nbsp;8(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Notice of Redemption</U>. The Corporation shall provide
notice of any redemption requested by the Corporation under <U>Section</U><U></U><U>&nbsp;8(a)(ii)</U>, specifying the time and place of redemption and the applicable Redemption Price (the &#147;<B><I>Corporation Redemption Notice</I></B>&#148;), to
each Holder of record of Series B Convertible Preferred Stock at the address for such Holder last shown on the records of the Transfer Agent therefor, not less than fifteen (15)&nbsp;days prior to each redemption date. In the case of redemptions
requested by a Holder under <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U>, the Corporation shall use its reasonable best efforts, and shall take all reasonable action necessary, to pay the applicable Redemption Price as provided in this
<U>Section</U><U></U><U>&nbsp;8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Insufficient Funds</U>. If the funds of the Corporation legally available for redemption by
the Holder pursuant to <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U> of the Series B Convertible Preferred Stock on any redemption date are insufficient to redeem all shares of the Series B Convertible Preferred Stock being redeemed by the
Corporation on such date, those funds which are legally available will be used first to redeem, on a pro rata basis from the Holders thereof based on the number of shares of Series B Convertible Preferred Stock then held, the maximum possible number
of shares of the Series B Convertible Preferred Stock being redeemed in accordance with the aggregate redemption proceeds payable with respect to the shares of Series B Convertible Preferred Stock to be redeemed. At any time thereafter when
additional funds of the Corporation become legally available for the redemption of the Series B Convertible Preferred Stock, such funds will be used to redeem the balance of the shares of Series B Convertible Preferred Stock which the Corporation
was theretofore obligated to redeem as provided in the immediately preceding sentence. Any shares of Series B Convertible Preferred Stock which are not redeemed as a result of the circumstances described in this
<U>Section</U><U></U><U>&nbsp;8(d)</U> shall remain outstanding until such shares shall have been redeemed and the Redemption Price therefor, as applicable, shall have been paid or set aside for payment in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Rights Terminated</U>. Upon (i)&nbsp;surrender of the certificate or certificates representing the shares of Series B Convertible
Preferred Stock being redeemed (or surrender of such shares in compliance with the procedures established by DTC and the Transfer Agent, if applicable) pursuant to this <U>Section</U><U></U><U>&nbsp;8</U> and delivery of the Redemption Price
therefor or (ii)&nbsp;irrevocable deposit in trust by the Corporation for Holders of the Series B Convertible Preferred Stock being redeemed pursuant to this <U>Section</U><U></U><U>&nbsp;8</U> of an amount in cash equal to the applicable Redemption
Price for the shares of Series B Convertible Preferred Stock being redeemed on any redemption date, each Holder will cease to have any rights as a shareholder of the Corporation by reason of the ownership of such redeemed shares of Series B
Convertible Preferred Stock (except for the right to receive the Redemption Price therefor upon the surrender of the certificate or certificates representing the redeemed shares or compliance with the procedures established by DTC and the Transfer
Agent, if such shares have not been so surrendered), and such redeemed shares of Series B Convertible Preferred Stock will not from and after the date of payment in full of the Redemption Price therefor be deemed to be outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Reacquired Shares</U>. Any shares of Series B Convertible Preferred Stock converted,
redeemed, purchased, or otherwise acquired by the Corporation in any manner whatsoever shall be retired and canceled promptly after the acquisition thereof, and shall not be reissued as shares of such series, and the Corporation (without the need
for shareholder action) may from time to time take such appropriate action as may be necessary to reduce the authorized number of shares of the applicable series of Series B Convertible Preferred Stock accordingly and restore such shares to the
status of authorized but unissued shares of Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Withdrawal Right</U>. Each Holder shall retain the right to
(i)&nbsp;convert shares of Series B Convertible Preferred Stock to be redeemed pursuant to <U>Section</U><U></U><U>&nbsp;8(b)(i)</U> at any time on or prior to the redemption date or (ii)&nbsp;withdraw its Holder Redemption Notice; <U>provided</U>,
<U>however</U>, that, where a Holder of Series B Convertible Preferred Stock exercises its rights under (i)&nbsp;or (ii) above, the applicable shares of Series B Convertible Preferred Stock of such Holder shall not be redeemed pursuant to this
<U>Section</U><U></U><U>&nbsp;8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Fundamental Change</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Offer to Repurchase</U>. In connection with any Fundamental Change, the Corporation shall, or shall cause the Survivor of a Fundamental
Change (such Survivor of a Fundamental Change, the &#147;<B><I>Acquirer</I></B>&#148;) to, make an offer to repurchase, at the option and election of the holder thereof, each share of Series B Convertible Preferred Stock then-outstanding (the
&#147;<B><I>Fundamental Change Repurchase Offer</I></B>&#148;) at a purchase price per share (such amount being the &#147;<B><I>Fundamental Change Repurchase Price</I></B>&#148;) in cash equal to (i)&nbsp;the applicable Stated Value plus an amount
equal to all accrued or declared and unpaid dividends on such share of Series B Convertible Preferred Stock that have not previously been added to the applicable Stated Value as of the Fundamental Change Repurchase Date plus (ii)&nbsp;if prior to
the fifth anniversary of the applicable Initial Issue Date, the aggregate amount of all dividends that would have been paid (excluding any such dividends that would be paid in light of the timing of such Fundamental Change Repurchase Offer and, for
the avoidance of doubt, without duplication of amounts in clause (i)) in respect of an outstanding share of such series of Series B Convertible Preferred Stock from the Fundamental Change Repurchase Date through the fifth anniversary of the
applicable Initial Issue Date. The Fundamental Change Repurchase Offer must be made in the Fundamental Change Notice delivered pursuant to <U>Section</U><U></U><U>&nbsp;9(b)</U> and shall become irrevocable from the date thereof unless otherwise
consented to by (i)&nbsp;with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders and (ii)&nbsp;with respect to the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Required Holders (any such consent, an &#147;<B><I>Offer Consent</I></B>&#148; and the date such consent is effective, the
&#147;<B><I>Offer Consent Effective Date</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Repurchase</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Corporation shall provide notice of any repurchases offered by the Corporation under <U>Section</U><U></U><U>&nbsp;9(a)</U> by
delivering to the applicable Holder (including notice to or through DTC, if applicable) a written notice in accordance with <U>Section</U><U></U><U>&nbsp;9(b)(ii)</U> (the &#147;<B><I>Fundamental Change Notice</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Fundamental Change Notice shall specify (i)&nbsp;the time and place of repurchase and the applicable Fundamental Change Repurchase
Price for each series of Series B Convertible Preferred Stock and (ii)&nbsp;the Holder&#146;s Conversion Rights pursuant to <U>Section</U><U></U><U>&nbsp;5</U> hereof, and shall be delivered to each Holder at the address for such Holder last shown
on the records of the Transfer Agent therefor, not less than fifteen (15)&nbsp;days prior to the Fundamental Change Repurchase Date. The &#147;<B><I>Fundamental Change Repurchase Date</I></B>&#148; shall be the date on which the Fundamental Change
is consummated (provided that in the case of a Fundamental Change described in clause (i)&nbsp;of the definition thereof, the Fundamental Change Repurchase Date shall be a date no later than thirty (30)&nbsp;days following the date of the first
public announcement of such Fundamental Change having occurred (including, for these purposes, the filing of a Schedule 13D pursuant to the Exchange Act)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Insufficient Funds</U>. If the funds of the Corporation legally available for the Fundamental Change Repurchase Offer by the
Corporation pursuant to <U>Section</U><U></U><U>&nbsp;9(a)</U> on any Fundamental Change Repurchase Date are insufficient to redeem all shares of the Series B Convertible Preferred Stock being repurchased by the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Corporation on such date, those funds which are legally available will be used first to repurchase, on a pro rata basis from the Holders thereof based on the number of shares of Series B
Convertible Preferred Stock then held, the maximum possible number of shares of the Series B Convertible Preferred Stock being repurchased in accordance with the aggregate repurchase proceeds payable with respect to the shares of Series B
Convertible Preferred Stock to be repurchased. At any time thereafter when additional funds of the Corporation or the Acquirer, as applicable, become legally available for the repurchase of the Series B Convertible Preferred Stock, such funds will
be used to redeem the balance of the shares of Series B Convertible Preferred Stock which the Corporation was theretofore obligated to repurchase as provided in the immediately preceding sentence. Any shares of Series B Convertible Preferred Stock
which are not repurchased as a result of the circumstances described in this <U>Section</U><U></U><U>&nbsp;9(c)</U> shall remain outstanding until such shares shall have been redeemed and the Fundamental Change Repurchase Price therefor, as
applicable, shall have been paid or set aside for payment in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Rights Terminated</U>. Upon (i)&nbsp;surrender of the
certificate or certificates representing the shares of Series B Convertible Preferred Stock being repurchased (or surrender of such shares in compliance with the procedures established by DTC and the Transfer Agent, if applicable) pursuant to this
<U>Section</U><U></U><U>&nbsp;9</U> and delivery of the Fundamental Change Repurchase Price therefor or (ii)&nbsp;irrevocable deposit in trust by the Corporation for Holders being repurchased pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> of
an amount in cash equal to the applicable Fundamental Change Repurchase Price for the shares of Series B Convertible Preferred Stock being repurchased on any Fundamental Change Repurchase Date, each Holder will cease to have any rights as a
shareholder of the Corporation by reason of the ownership of such repurchased shares of Series B Convertible Preferred Stock (except for the right to receive the Fundamental Change Repurchase Price therefor upon the surrender of the certificate or
certificates representing the repurchased shares or compliance with the procedures established by DTC and the Transfer Agent, if such shares have not been so surrendered ), and such repurchased shares of Series B Convertible Preferred Stock will not
from and after the date of payment in full of the Fundamental Change Repurchase Price therefor be deemed to be outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Offer
Made by Affiliate</U>. The Corporation shall not be required to make a Fundamental Change Repurchase Offer if an affiliate in control of the Corporation makes the Fundamental Change Repurchase Offer in the manner, at the times and otherwise in
compliance with the requirements set forth in this <U>Section</U><U></U><U>&nbsp;9</U> and purchases all shares of Series B Convertible Preferred Stock validly tendered and not withdrawn under such Fundamental Change Repurchase Offer;
<U>provided</U>, that if an affiliate in control of the Corporation makes such repurchase, the shares of Series B Convertible Preferred Stock so purchased shall remain outstanding in the hands of such affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Withdrawal Right</U>. Each Holder shall retain the right to (i)&nbsp;convert shares of Series B Convertible Preferred Stock to be
repurchased pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> at any time on or prior to the Fundamental Change Repurchase Date or (ii)&nbsp;withdraw a tender of such shares in the Fundamental Change Repurchase Offer on or prior to the
Fundamental Change Repurchase Date; <U>provided</U>, <U>however</U>, that, where a Holder exercises its rights under (i)&nbsp;or (ii) above, the applicable shares of Series B Convertible Preferred Stock of such Holder shall not be repurchased
pursuant to this <U>Section</U><U></U><U>&nbsp;9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Events of Noncompliance</U>. Notwithstanding anything to the contrary
contained here, if one or more of the following events (each, an &#147;<B><I>Event of Noncompliance</I></B>&#148;) shall occur with respect to any Holder: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Corporation shall fail to pay when due any dividend payment in full pursuant to <U>Section</U><U></U><U>&nbsp;2</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Corporation shall fail to pay when due the applicable Redemption Price pursuant <U>Section</U><U></U><U>&nbsp;8</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Corporation shall fail to pay when due the applicable Fundamental Change Repurchase Price pursuant to
<U>Section</U><U></U><U>&nbsp;9</U>, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, and in each case, unless such Event of Noncompliance is cured within thirty (30)&nbsp;days (the
&#147;<B><I>Cure Period</I></B>&#148;) of such Event of Noncompliance, the Annual Rate (i)&nbsp;shall increase to 8% per annum as of the date of the Event </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Noncompliance and (ii)&nbsp;so long as such Event of Noncompliance remains uncured, shall increase by an additional 2% per annum with respect to each Dividend Period ending subsequent to the
Dividend Period in which the Event of Noncompliance occurred; <U>provided</U>, <U>however</U>, that at no time shall the Annual Rate on the Series B Convertible Preferred Stock exceed 14% per annum; <U>provided</U>, <U>further</U>, the Annual Rate
shall be reduced to 5% per annum immediately after all Events of Noncompliance are cured (if any shares of Series B Convertible Preferred Stock remain outstanding). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Notices</U>. All notices or communications in respect of Series B Convertible Preferred Stock shall be sufficiently given if given in
writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Statement with Respect to Shares, in the Articles or the Bylaws and by applicable law. Any Notice of Conversion or
Holder Redemption Notice shall be given by the Holder to the Corporation (i)&nbsp;in the case of any Series B Convertible Preferred Stock held in certificated form, by transmittal, by overnight carrier (in the case of a Notice of Conversion for
receipt prior to 5:00 p.m., Eastern Time, on the Conversion Date) to the Corporation&#146;s then principal offices, Attention: Chief Financial Officer, of such Notice of Conversion or Holder Redemption Notice, as applicable, executed by such Holder,
together with the applicable stock certificate or certificates duly endorsed (unless delivery of certificates is not required pursuant to <U>Section</U><U></U><U>&nbsp;5(c)(</U><U>i</U><U>)</U>) and any additional instruments required to be
delivered hereunder and (ii)&nbsp;in the case of any Series B Convertible Preferred Stock held through the facilities of DTC, by complying with the applicable procedures established from time to time by DTC and the Transfer Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>No Preemptive Rights</U>. The Holders shall have no preemptive or preferential rights to purchase or subscribe for any stock,
obligations, warrants or other securities of the Corporation of any class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>No Other Rights</U>. The shares of Series B Convertible
Preferred Stock shall not have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof, other than as set forth herein or in the
Articles or as provided by applicable Pennsylvania law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Book-Entry Form</U>. Shares of each series of the Series B Convertible
Preferred Stock may be issued (or reissued) in the form of one or more global certificates (&#147;<B><I>Global Preferred Shares</I></B>&#148;) to be deposited on behalf of one or more Holders thereof with the Transfer Agent, as custodian for DTC (or
with such other custodian as DTC may direct), and registered in the name of DTC or its nominee. The number of shares of any series of Series B Convertible Preferred Stock represented by Global Preferred Shares may from time to time be increased or
decreased by adjustments made on the records of the Transfer Agent and DTC to reflect such changes as provided for herein. Members of, or participants in, DTC shall have no rights under the terms of the shares of Series B Convertible Preferred Stock
with respect to any Global Preferred Shares held on their behalf by DTC or any custodian of DTC or under such Global Preferred Shares, and DTC may be treated by the Corporation, the Transfer Agent and any agent of the Corporation or the Transfer
Agent as the absolute owner of such Global Preferred Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Corporation, the Transfer Agent or any agent of the Corporation or the Transfer Agent from
giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its members and participants, the operation of customary practices of DTC governing the exercise of the rights of a holder of a
beneficial interest in any Global Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Definitions</U>. The following terms shall have the following respective
meanings: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Acquirer</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>affiliate</I></B>&#148; means, with respect to any Person, any other Person that, directly or indirectly, through one or more
intermediaries, controls, or is controlled by, or is under common control with, such Person. The term &#147;<B><I>control</I></B>&#148; includes, without limitation, the possession, directly or indirectly, of the power to direct the management and
policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Annual Rate</I></B>&#148; means 5% per annum, subject to increase pursuant to
<U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Articles</I></B>&#148; means the Amended and Restated Articles of Incorporation of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Board of Directors</I></B>&#148; means the Board of Directors of the Corporation or an authorized committee
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Business Day</I></B>&#148; means any day other than a Saturday or Sunday or any other day on which commercial banks
in New York City are authorized or required by law or executive order to close or be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Bylaws</I></B>&#148; means the
Amended and Restated Bylaws of the Corporation, as they may be amended or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Common
Stock</I></B>&#148; means the common stock, no par value, of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Date</I></B>&#148; shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Price</I></B>&#148; shall have the meaning set forth
in <U>Section</U><U></U><U>&nbsp;5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Rights</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Corporation</I></B>&#148; means <FONT STYLE="white-space:nowrap">II-VI</FONT>
Incorporated, a Pennsylvania corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Corporation Redemption Notice</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Cure Period</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Dividend Payment Date&#148;</I></B> means, with respect to the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, as applicable, January&nbsp;1, April&nbsp;1, July&nbsp;1 and October&nbsp;1 of each year,
commencing on, for the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, July&nbsp;1, 2021 and, for the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the first such date that occurs
after the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Issue Date; <U>provided</U>, that if any such Dividend Payment Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any dividend
payable on Series B Convertible Preferred Stock on such Dividend Payment Date shall instead be payable on) the immediately succeeding Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Dividend Period</I></B>&#148; means the period commencing on and including a Dividend Payment Date and shall end on and include
the day immediately preceding the next Dividend Payment Date; <U>provided</U>, that the initial Dividend Period with respect to a series of Series B Convertible Preferred Stock shall commence on and include the applicable Initial Issue Date and
shall end on and include the day immediately preceding the first applicable Dividend Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>DTC</I></B>&#148; means
The Depositary Trust Company or its nominee or any successor appointed by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Event of
Noncompliance</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange
Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange Property</I></B>&#148; shall have the meaning set forth in the definition of Fundamental Change hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;<B><I>Fundamental Change</I></B>&#148; shall be deemed to have occurred, at any time
after the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, if any of the following occurs: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any &#147;person&#148; or
&#147;group&#148; (as such terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act, whether or not applicable), other than the Corporation, any of its Wholly-Owned Subsidiaries or any of the Corporation&#146;s or its Wholly-Owned
Subsidiaries&#146; employee benefit plans, has become the &#147;beneficial owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of
the Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the consummation of (A)&nbsp;any recapitalization, reclassification or change of the Common Stock (other than
changes resulting from a subdivision or combination or change in par value) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash or a combination thereof);
(B) any consolidation, merger or other combination of the Corporation or binding share exchange pursuant to which the Common Stock will be converted into, or exchanged for, stock, other securities or other property or assets (including cash or a
combination thereof); or (C)&nbsp;any sale, lease or other transfer or disposition in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its Subsidiaries taken as a whole, to any
person other than one or more of its Wholly-Owned Subsidiaries; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Common Stock (or other common equity underlying the Series B
Convertible Preferred Stock) ceases to be listed or quoted for trading on any of The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, a transaction or transactions described in clause (i)&nbsp;or clause (ii)&nbsp;above shall not constitute a Fundamental Change if at least 90% of the
consideration received or to be received by holders of Common Stock, excluding cash payments for fractional shares or pursuant to statutory appraisal rights, in connection with such transaction or transactions consists of shares of common stock that
are listed or quoted on any of The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors) or shall be so listed or quoted when issued or exchanged in connection with such
transaction or transactions and as a result of such transaction or transactions such consideration (excluding cash payments for fractional shares or pursuant to statutory appraisal rights) becomes the consideration that a Holder would have been
entitled to receive if such Holder had immediately converted its Series B Convertible Preferred Stock prior to such transaction or transactions (such consideration, &#147;<B><I>Exchange Property</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Notice</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Offer</I></B>&#148; shall have meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Price</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Global Preferred Shares</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder</I></B>&#148; means each Person in whose name shares of Series B Convertible Preferred Stock are registered, who shall be
treated by the Corporation as the absolute owner of those shares of Series B Convertible Preferred Stock for the purpose of making payment and settling conversions and for all other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder Redemption Notice</I></B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial Closing</I></B>&#148; shall have the meaning set forth in the definition of Investment Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial Issue Date</I></B>&#148; means (i)&nbsp;with respect to the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date and (ii)&nbsp;with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock,
the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Issue Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Investment Agreement</I></B>&#148; means that certain
Amended and Restated Investment Agreement, dated as of March&nbsp;30, 2021, by and between the Corporation and BCPE Watson (DE) SPV, LP, a Delaware limited partnership (the &#147;<B><I>Investor</I></B>&#148;), the text of which agreement is on file
at the Corporation&#146;s principal place of business at 375 Saxonburg Blvd., Saxonburg, PA 16056 (or at such other address as is the principal place of business of the Corporation from time to time following the Initial Issue Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Investor</I></B>&#148; shall have the meaning set forth in the definition of Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Issue Date</I></B>&#148; means, with respect to each share of Series B Convertible Preferred Stock, the date on which such share
of Series B Convertible Preferred Stock was issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Junior Stock</I></B>&#148; means&nbsp;(i) the Common Stock and
(ii)&nbsp;each other class or series of capital stock of the Corporation, the terms of which do not expressly provide that such class or series ranks either (x)&nbsp;senior to the Series B Convertible Preferred Stock as to dividend rights or
distribution rights upon a Liquidation Event or (y)&nbsp;on parity with the Series B Convertible Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liquidation Event</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liquidation Preference</I></B>&#148; means, with respect to a particular share of Series B Convertible Preferred Stock, the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Liquidation Preference or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory Conversion Notice</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory Conversion Time</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory PIK Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Market Traded Days</I></B>&#148; shall have the meaning set forth in the definition of Trading Day hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Notice of Conversion</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Offer Consent</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a).</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Offer Consent Effective Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Ordinary Dividends</I></B>&#148; means cash dividends on the Common Stock in the aggregate not exceeding (i)&nbsp;in calendar year
2021, $3.00 per share (the &#147;<B><I>Maximum</I></B>&#148;), and (ii)&nbsp;in each subsequent calendar year, 105% of the prior year&#146;s Maximum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Parity Stock</I></B>&#148; means (i)&nbsp;the 6% Series A Mandatory Convertible Preferred Stock, no par value per share, of the
Corporation and (ii)&nbsp;any class or series of capital stock of the Corporation established after the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, the terms of which expressly provide that such class or series shall rank on
parity with the Series B Convertible Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Permitted Issuances</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Person</I></B>&#148; means any individual, partnership, firm, corporation, limited liability company, business trust, joint stock
company, trust, unincorporated association, joint venture, governmental authority or other entity of whatever nature. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>PIK Dividend</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Preferred Stock</I></B>&#148; shall have the meaning set forth in the Articles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Pro Rata Amount</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Purchase Price</I></B>&#148; means $10,000 per share of Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Redemption Price</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Reorganization Event</I></B>&#148; means a recapitalization, reclassification, consolidation or merger that is not a Fundamental
Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Required Holders</I></B>&#148; means the Holders of a majority of the then outstanding shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, voting together as a single class; <U>provided</U>, that if the relevant action adversely affects
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in a manner different from the other series of Series B Convertible Preferred
Stock (taking into account such series&#146; relative Initial Issue Dates) (a series of Series B Convertible Preferred Stock so adversely affected, an &#147;<B><I>Affected Series</I></B>&#148;) and provided that there remain outstanding at such time
at least 10% of the shares of such Affected Series issued on the Initial Issue Date for such Affected Series, then Required Holders shall in addition mean the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders if the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock is an Affected Series or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Required Holders if the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
is an Affected Series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Rights Offering</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Senior Stock</I></B>&#148; means each class or series of capital stock of the
Corporation established after the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, the terms of which expressly provide that such class or series shall rank senior to the Series B Convertible Preferred Stock as to dividend rights or
distribution rights upon a Liquidation Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series B Convertible Preferred Stock</I></B><B>&#148; </B>shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue
Date</I></B>&#148; means March&nbsp;31, 2021, the first Issue Date of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Issue Date</I></B>&#148; means the first Issue Date of shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Liquidation Preference</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders</I></B>&#148; means the Holders of a majority of the then
outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Required Holders</I></B>&#148; means the Holders of a majority of the then outstanding shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Stated Value</I></B>&#148; shall have the meaning set forth in the definition
of Stated Value hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Stated Value</I></B>&#148; shall have the meaning
set forth in the definition of Stated Value hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Share Delivery Date</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities</I></B>&#148; shall
have the meaning set forth in the definition of <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Transaction</I></B>&#148;<B><I> </I></B>means a payment by the Corporation of a dividend or other distribution on the Common Stock of shares of capital stock of any class or series, or similar equity
interest, of a Subsidiary of the Corporation, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange (the securities so dividended or distributed, the
&#147;<B><I><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stated Value</I></B>&#148; means,
(i)&nbsp;with respect to each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, the sum, subject to appropriate adjustment pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, of (x)&nbsp;the Purchase Price plus
(y)&nbsp;on each Dividend Payment Date (A)&nbsp;on which a dividend is paid in whole in the form of a PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> or (B)&nbsp;on which a dividend is paid in part in the form of a
PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously
added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> less the amount of cash dividends actually paid with the respect to such share on the applicable Dividend Payment Date (the &#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Stated Value</I></B>&#148;) and (ii)&nbsp;with respect to each share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the sum, subject to appropriate adjustment pursuant to
<U>Section</U><U></U><U>&nbsp;5</U>, of (x)&nbsp;the Purchase Price plus (y)&nbsp;on each Dividend Payment Date (A)&nbsp;on which a dividend is paid in whole in the form of a PIK Dividend, an additional amount equal to the dollar value of any
dividends on a share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to
<U>Section</U><U></U><U>&nbsp;2(a)</U> or (B)&nbsp;on which a dividend is paid in part in the form of a PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> less the amount of cash dividends actually paid with the respect
to such share on the applicable Dividend Payment Date (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Stated Value</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stock Combination</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stock Split</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsequent Closing</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsequent Investment Obligation</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to any Person, any corporation, association, partnership or other business entity of
which more than 50% of the total voting power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general
partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (i)&nbsp;such Person; (ii)&nbsp;such Person and one or more Subsidiaries of such Person; or (iii)&nbsp;one or more Subsidiaries of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Survivor of a Fundamental Change</I></B>&#148; means the issuer of the securities received by the holders of Common Stock (or
Exchange Property, to the extent applicable) (in their capacities as such) upon the consummation of a Fundamental Change described in <U>clauses</U> <U>(i)</U>&nbsp;and <U>(ii)</U> of the definition thereof, to the extent the holders of Common Stock
(or Exchange Property, to the extent applicable) receive other securities in exchange, conversion or substitution of their Common Stock (or Exchange Property, to the extent applicable) in the transaction that resulted in such Fundamental Change.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Target Merger Agreement</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Day</I></B>&#148; means (i)&nbsp;any day on which the Common Stock is listed or quoted and traded on its primary Trading
Market (&#147;<B><I>Market Traded Days</I></B>&#148;) or (ii)&nbsp;if the Common Stock is not then listed or quoted and traded on any Trading Market, then a day on which trading occurs on the Nasdaq Global Market (or any successor thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Market</I></B>&#148; means the following market(s) or exchange(s) on
which the Common Stock is listed or quoted for trading on the date in question (as applicable): the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the NYSE MKT or any successor
markets thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer Agent</I></B>&#148; means such agent or agents of the Corporation as may be designated by the Board of Directors or its
duly authorized designee as the transfer agent, registrar and dividend disbursing agent for one or more series of the Series B Convertible Preferred Stock or, if the Corporation is serving as its own transfer agent, the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Upsize Investment</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Wholly-Owned Subsidiary</I></B>&#148; means, with respect to any Person, any Subsidiary of such Person, except that, solely for
purposes of this definition, the reference to &#147;more than 50%&#148; in the definition of &#147;Subsidiary&#148; shall be deemed to be replaced by a reference to &#147;100%&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_127"></A>Annex D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Section&nbsp;262 of the DGCL </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any stockholder of a corporation of this State who holds shares of stock on the date of the making of a demand
pursuant to subsection (d)&nbsp;of this section with respect to such shares, who continuously holds such shares through the effective date of the merger or consolidation, who has otherwise complied with subsection (d)&nbsp;of this section and who
has neither voted in favor of the merger or consolidation nor consented thereto in writing pursuant to &#167; 228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#146;s shares of stock
under the circumstances described in subsections (b)&nbsp;and (c) of this section. As used in this section, the word &#147;stockholder&#148; means a holder of record of stock in a corporation; the words &#147;stock&#148; and &#147;share&#148; mean
and include what is ordinarily meant by those words; and the words &#147;depository receipt&#148; mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a
corporation, which stock is deposited with the depository. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appraisal rights shall be available for the shares of any class or series of stock of a constituent corporation
in a merger or consolidation to be effected pursuant to &#167; 251 (other than a merger effected pursuant to &#167;&nbsp;251(g) of this title), &#167; 252, &#167; 254, &#167; 255, &#167; 256, &#167; 257, &#167; 258, &#167; 263 or &#167; 264 of this
title: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Provided, however, that no appraisal rights under this section shall be available for the shares of any class
or series of stock, which stock, or depository receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of the meeting of stockholders to act upon the agreement of merger or consolidation (or, in
the case of a merger pursuant to &#167; 251(h), as of immediately prior to the execution of the agreement of merger), were either: (i)&nbsp;listed on a national securities exchange or (ii)&nbsp;held of record by more than 2,000 holders; and further
provided that no appraisal rights shall be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its approval the vote of the stockholders of the surviving corporation as provided in
&#167; 251(f) of this title. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding paragraph (b)(1) of this section, appraisal rights under this section shall be available for
the shares of any class or series of stock of a constituent corporation if the holders thereof are required by the terms of an agreement of merger or consolidation pursuant to &#167;&#167; 251, 252, 254, 255, 256, 257, 258, 263 and 264 of this title
to accept for such stock anything except: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of stock of the corporation surviving or resulting from such merger or consolidation, or depository
receipts in respect thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of stock of any other corporation, or depository receipts in respect thereof, which shares of stock (or
depository receipts in respect thereof) or depository receipts at the effective date of the merger or consolidation will be either listed on a national securities exchange or held of record by more than 2,000 holders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Cash in lieu of fractional shares or fractional depository receipts described in the foregoing paragraphs
(b)(2)a. and b. of this section; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any combination of the shares of stock, depository receipts and cash in lieu of fractional shares or fractional
depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event all of the stock of a subsidiary Delaware corporation party to a merger effected under
&#167;&nbsp;253 or &#167; 267 of this title is not owned by the parent immediately prior to the merger, appraisal rights shall be available for the shares of the subsidiary Delaware corporation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any corporation may provide in its certificate of incorporation that appraisal rights under this section shall
be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation or the sale of all or substantially
all of the assets of the corporation. If the certificate of incorporation contains such a provision, the provisions of this section, including those set forth in subsections (d), (e), and (g)&nbsp;of this section, shall apply as nearly as is
practicable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appraisal rights shall be perfected as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a proposed merger or consolidation for which appraisal rights are provided under this section is to be
submitted for approval at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, shall notify each of its stockholders who was such on the record date for notice of such meeting (or such members who received notice
in accordance with &#167; 255(c) of this title) with respect to shares for which appraisal rights are available pursuant to subsection (b)&nbsp;or (c) of this section that appraisal rights are available for any or all of the shares of the
constituent corporations, and shall include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of &#167; 114 of this title. Each stockholder electing to demand the appraisal of such
stockholder&#146;s shares shall deliver to the corporation, before the taking of the vote on the merger or consolidation, a written demand for appraisal of such stockholder&#146;s shares; provided that a demand may be delivered to the corporation by
electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and
that the stockholder intends thereby to demand the appraisal of such stockholder&#146;s shares. A proxy or vote against the merger or consolidation shall not constitute such a demand. A stockholder electing to take such action must do so by a
separate written demand as herein provided. Within 10 days after the effective date of such merger or consolidation, the surviving or resulting corporation shall notify each stockholder of each constituent corporation who has complied with this
subsection and has not voted in favor of or consented to the merger or consolidation of the date that the merger or consolidation has become effective; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the merger or consolidation was approved pursuant to &#167; 228, &#167; 251(h), &#167; 253, or &#167; 267 of
this title, then either a constituent corporation before the effective date of the merger or consolidation or the surviving or resulting corporation within 10 days thereafter shall notify each of the holders of any class or series of stock of such
constituent corporation who are entitled to appraisal rights of the approval of the merger or consolidation and that appraisal rights are available for any or all shares of such class or series of stock of such constituent corporation, and shall
include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of &#167; 114 of this title. Such notice may, and, if given on or after the effective date of the merger or consolidation,
shall, also notify such stockholders of the effective date of the merger or consolidation. Any stockholder entitled to appraisal rights may, within 20 days after the date of giving such notice or, in the case of a merger approved pursuant to &#167;
251(h) of this title, within the later of the consummation of the offer contemplated by &#167; 251(h) of this title and 20 days after the date of giving such notice, demand in writing from the surviving or resulting corporation the appraisal of such
holder&#146;s shares; provided that a demand may be delivered to the corporation by electronic transmission if directed to an information processing system (if any) expressly designated for that purpose in such notice. Such demand will be sufficient
if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holder&#146;s shares. If such notice did not notify stockholders of the effective date of the merger
or consolidation, either (i)&nbsp;each such constituent corporation shall send a second notice before the effective date of the merger or consolidation notifying each of the holders of any class or series of stock of such constituent corporation
that are entitled to appraisal rights of the effective date of the merger or consolidation or (ii)&nbsp;the surviving or resulting corporation shall send such a second notice to all such holders on or within 10 days after such effective date;
provided, however, that if such second notice is sent more than 20 days following the sending of the first notice or, in the case of a merger approved pursuant to &#167; 251(h) of this title, later than the later
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of the consummation of the offer contemplated by &#167; 251(h) of this title and 20 days following the sending of the first notice, such second notice need only be sent to each stockholder who is
entitled to appraisal rights and who has demanded appraisal of such holder&#146;s shares in accordance with this subsection. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation that is required to give
either notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation may fix,
in advance, a record date that shall be not more than 10 days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger or consolidation, the record date shall be such effective date.
If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Within 120 days after the effective date of the merger or consolidation, the surviving or resulting corporation
or any stockholder who has complied with subsections (a)&nbsp;and (d) of this section hereof and who is otherwise entitled to appraisal rights, may commence an appraisal proceeding by filing a petition in the Court of Chancery demanding a
determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time within 60 days after the effective date of the merger or consolidation, any stockholder who has not commenced an appraisal proceeding or
joined that proceeding as a named party shall have the right to withdraw such stockholder&#146;s demand for appraisal and to accept the terms offered upon the merger or consolidation. Within 120 days after the effective date of the merger or
consolidation, any stockholder who has complied with the requirements of subsections (a)&nbsp;and (d) of this section hereof, upon request given in writing (or by electronic transmission directed to an information processing system (if any)
expressly designated for that purpose in the notice of appraisal), shall be entitled to receive from the corporation surviving the merger or resulting from the consolidation a statement setting forth the aggregate number of shares not voted in favor
of the merger or consolidation (or, in the case of a merger approved pursuant to &#167; 251(h) of this title, the aggregate number of shares (other than any excluded stock (as defined in &#167; 251(h)(6)d. of this title)) that were the subject of,
and were not tendered into, and accepted for purchase or exchange in, the offer referred to in &#167; 251(h)(2)), and, in either case, with respect to which demands for appraisal have been received and the aggregate number of holders of such shares.
Such statement shall be given to the stockholder within 10 days after such stockholder&#146;s request for such a statement is received by the surviving or resulting corporation or within 10 days after expiration of the period for delivery of demands
for appraisal under subsection (d)&nbsp;of this section hereof, whichever is later. Notwithstanding subsection (a)&nbsp;of this section, a person who is the beneficial owner of shares of such stock held either in a voting trust or by a nominee on
behalf of such person may, in such person&#146;s own name, file a petition or request from the corporation the statement described in this subsection. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon the filing of any such petition by a stockholder, service of a copy thereof shall be made upon the
surviving or resulting corporation, which shall within 20 days after such service file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of all stockholders who have
demanded payment for their shares and with whom agreements as to the value of their shares have not been reached by the surviving or resulting corporation. If the petition shall be filed by the surviving or resulting corporation, the petition shall
be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to the surviving or resulting
corporation and to the stockholders shown on the list at the addresses therein stated. Such notice shall also be given by 1 or more publications at least 1 week before the day of the hearing, in a newspaper of general circulation published in the
City of Wilmington, Delaware or such publication as the Court deems advisable. The forms of the notices by mail and by publication shall be approved by the Court, and the costs thereof shall be borne by the surviving or resulting corporation.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the hearing on such petition, the Court shall determine the stockholders who have complied with this section
and who have become entitled to appraisal rights. The Court may require the stockholders who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
certificates of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any stockholder fails to comply with such direction, the Court may
dismiss the proceedings as to such stockholder. If immediately before the merger or consolidation the shares of the class or series of stock of the constituent corporation as to which appraisal rights are available were listed on a national
securities exchange, the Court shall dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1)&nbsp;the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the
class or series eligible for appraisal, (2)&nbsp;the value of the consideration provided in the merger or consolidation for such total number of shares exceeds $1&nbsp;million, or (3)&nbsp;the merger was approved pursuant to &#167; 253 or &#167; 267
of this title. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">After the Court determines the stockholders entitled to an appraisal, the appraisal proceeding shall be
conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of any element of value
arising from the accomplishment or expectation of the merger or consolidation, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take into account all relevant
factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in this subsection, interest from the effective date of the merger through the date of payment of the judgment shall be compounded
quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date of the merger and the date of payment of the judgment. At any time before
the entry of judgment in the proceedings, the surviving corporation may pay to each stockholder entitled to appraisal an amount in cash, in which case interest shall accrue thereafter as provided herein only upon the sum of (1)&nbsp;the difference,
if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2)&nbsp;interest theretofore accrued, unless paid at that time. Upon application by the surviving or resulting corporation or by any stockholder
entitled to participate in the appraisal proceeding, the Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the stockholders entitled to an appraisal. Any stockholder whose name appears on the list
filed by the surviving or resulting corporation pursuant to subsection (f)&nbsp;of this section and who has submitted such stockholder&#146;s certificates of stock to the Register in Chancery, if such is required, may participate fully in all
proceedings until it is finally determined that such stockholder is not entitled to appraisal rights under this section. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Court shall direct the payment of the fair value of the shares, together with interest, if any, by the
surviving or resulting corporation to the stockholders entitled thereto. Payment shall be so made to each such stockholder, in the case of holders of uncertificated stock forthwith, and the case of holders of shares represented by certificates upon
the surrender to the corporation of the certificates representing such stock. The Court&#146;s decree may be enforced as other decrees in the Court of Chancery may be enforced, whether such surviving or resulting corporation be a corporation of this
State or of any state. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The costs of the proceeding may be determined by the Court and taxed upon the parties as the Court deems
equitable in the circumstances. Upon application of a stockholder, the Court may order all or a portion of the expenses incurred by any stockholder in connection with the appraisal proceeding, including, without limitation, reasonable
attorney&#146;s fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares entitled to an appraisal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">From and after the effective date of the merger or consolidation, no stockholder who has demanded appraisal
rights as provided in subsection (d)&nbsp;of this section shall be entitled to vote such stock for any purpose or to receive payment of dividends or other distributions on the stock (except dividends or other distributions payable to stockholders of
record at a date which is prior to the effective date of the merger or consolidation); provided, however, that if no petition for an appraisal shall be filed within the time provided in subsection (e)&nbsp;of this section, or if such stockholder
shall deliver to the surviving or resulting corporation a written withdrawal of such stockholder&#146;s demand for an appraisal and an acceptance of the merger or consolidation, either within 60 days after the effective date of the merger or
consolidation as provided in subsection (e)&nbsp;of this section or thereafter with the written approval of the corporation, then the right of such </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
stockholder to an appraisal shall cease. Notwithstanding the foregoing, no appraisal proceeding in the Court of Chancery shall be dismissed as to any stockholder without the approval of the
Court, and such approval may be conditioned upon such terms as the Court deems just; provided, however that this provision shall not affect the right of any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a
named party to withdraw such stockholder&#146;s demand for appraisal and to accept the terms offered upon the merger or consolidation within 60 days after the effective date of the merger or consolidation, as set forth in subsection (e)&nbsp;of this
section. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares of the surviving or resulting corporation to which the shares of such objecting stockholders would
have been converted had they assented to the merger or consolidation shall have the status of authorized and unissued shares of the surviving or resulting corporation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_128"></A>Annex E </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">BofA Securities, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g150472g02a45.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>GLOBAL
CORPORATE</B>&nbsp;&amp; <BR><B>INVESTMENT BANKING </B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;24, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board
of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, CA 95054 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the Board of Directors: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We understand that Coherent, Inc. (&#147;Coherent&#148;) proposes to enter into an Agreement and Plan of Merger, dated as of March&nbsp;24, 2021 (the
&#147;Agreement&#148;), by and among Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated <FONT STYLE="white-space:nowrap">(&#147;II-VI&#148;),</FONT> and Watson Merger Sub Inc., a direct wholly owned subsidiary of <FONT
STYLE="white-space:nowrap">II-VI</FONT> (&#147;Merger Sub&#148;), pursuant to which, among other things, Merger Sub will merge with and into Coherent (the &#147;Merger&#148;), and each outstanding share of the common stock, par value $0.01 per
share, of Coherent (&#147;Coherent Common Stock&#148;), other than any shares of Coherent Common Stock to be cancelled in accordance with the terms of the Agreement or as to which dissenters&#146; rights have been properly exercised (&#147;Cancelled
Shares&#148;), will be converted into the right to receive (a) $220.00 in cash (the &#147;Cash Consideration&#148;) and (b) 0.9100 share<B>s</B> (such number of shares, the &#147;Stock Consideration&#148; and, together with the Cash Consideration,
the &#147;Consideration&#148;) of the common stock, no par value per share, of <FONT STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">(&#147;II-VI</FONT> Common Stock&#148;). The terms and conditions of the Merger are more
fully set forth in the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinion as to the fairness, from a financial point of view, to the holders of Coherent Common
Stock, other than holders of Cancelled Shares,<B> </B>of the Consideration to be received by such holders in the Merger.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this
opinion, we have, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reviewed certain publicly available business and financial information relating to Coherent and <FONT
STYLE="white-space:nowrap">II-VI;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reviewed certain internal financial and operating information with respect to the business, operations and
prospects of Coherent furnished to or discussed with us by the management of Coherent, including certain financial forecasts relating to Coherent prepared by or at the direction of and approved by the management of Coherent (such forecasts,
&#147;Coherent Forecasts&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>reviewed certain internal financial and operating information with respect to the business, operations
and prospects of <FONT STYLE="white-space:nowrap">II-VI</FONT> furnished to or discussed with us by the management of <FONT STYLE="white-space:nowrap">II-VI,</FONT> including certain financial forecasts relating to
<FONT STYLE="white-space:nowrap">II-VI</FONT> prepared by the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> (such forecasts, <FONT STYLE="white-space:nowrap">&#147;II-VI</FONT> Forecasts&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>reviewed an alternative version of the <FONT STYLE="white-space:nowrap">II-VI</FONT> Forecasts
incorporating certain adjustments thereto made by the management of Coherent and certain extrapolations thereto prepared by or at the direction of and approved by the management of Coherent (such forecasts, &#147;Adjusted <FONT
STYLE="white-space:nowrap">II-VI</FONT> Forecasts&#148;) and discussed with the management of Coherent its assessments as to the relative likelihood of achieving the future financial results reflected in the
<FONT STYLE="white-space:nowrap">II-VI</FONT> Forecasts and the Adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> Forecasts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>reviewed certain estimates furnished to us by the management of Coherent as to the amount and timing of
cost savings and the costs of achieving such results (collectively, the &#147;Cost Savings&#148;) anticipated by the managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> to result from the Merger; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>discussed the past and current business, operations, financial condition and prospects of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> with members of senior management of Coherent; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reviewed the potential pro forma financial impact of the Merger on the future financial performance of <FONT
STYLE="white-space:nowrap">II-VI,</FONT> including the potential effect on <FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> estimated earnings per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reviewed the trading histories for Coherent Common Stock and <FONT STYLE="white-space:nowrap">II-VI</FONT>
Common Stock and a comparison of such trading histories with each other and with the trading histories of other companies we deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">compared certain financial and stock market information of Coherent and
<FONT STYLE="white-space:nowrap">II-VI</FONT> with similar information of other companies we deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">compared certain financial terms of the Merger to financial terms, to the extent publicly available, of other
transactions we deemed relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">considered the results of our efforts on behalf of Coherent to solicit, at the direction of Coherent,
indications of interest and definitive proposals<B> </B>from third parties with respect to a possible acquisition of Coherent prior to the entry by Coherent into the Original Agreement (as defined in the &#147;First Restated Lumentum
Agreement&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">considered the definitive proposals received from Lumentum Holdings Inc. and other third parties with respect
to a possible acquisition of Coherent after the entry by Coherent into the Original Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reviewed the Agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(*)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">performed such other analyses and studies and considered such other information and factors as we deemed
appropriate. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In arriving at our opinion, we have assumed and relied upon, without independent verification, the accuracy and
completeness of the financial and other information and data publicly available or provided to or otherwise reviewed by or discussed with us and have relied upon the assurances of the managements of Coherent<B> </B>and
<FONT STYLE="white-space:nowrap">II-VI</FONT> that they are not aware of any facts or circumstances that would make such information or data inaccurate or misleading in any material respect. With respect to the
<FONT STYLE="white-space:nowrap">II-VI</FONT> Forecasts, we have been advised by <FONT STYLE="white-space:nowrap">II-VI,</FONT> and have assumed, with the consent of Coherent, that they have been reasonably prepared on bases reflecting the best
currently available estimates and good faith judgments of the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> as to the future financial performance of <FONT STYLE="white-space:nowrap">II-VI.</FONT> With respect to the Coherent Forecasts
and the Adjusted <FONT STYLE="white-space:nowrap">II-VI</FONT> Forecasts, we have been advised by Coherent, and have assumed, that they have been reasonably prepared on bases reflecting the best currently available estimates and good faith judgments
of the management of Coherent as to the future financial performance of Coherent and <FONT STYLE="white-space:nowrap">II-VI.</FONT> With respect to the Cost Savings, we have been advised by Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT>
and have assumed, with the consent of Coherent, that they have been reasonably prepared on bases reflecting the best currently available estimates and good faith judgments of the managements of Coherent and
<FONT STYLE="white-space:nowrap">II-VI</FONT> as to the matters covered thereby. We have relied, at the direction of Coherent, on the assessments of the managements of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> as to <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> ability to achieve the Cost Savings and have been advised by Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> and have assumed, with the consent of Coherent, that the Cost Savings will be
realized in the amounts and at the times projected. We have not made or been provided with any independent evaluation or appraisal of the assets or liabilities (contingent or otherwise) of Coherent<B> </B>or
<FONT STYLE="white-space:nowrap">II-VI,</FONT> nor have we made any physical inspection of the properties or assets of Coherent<B> </B>or <FONT STYLE="white-space:nowrap">II-VI.</FONT> We have not evaluated the solvency or fair value of Coherent or <FONT
STYLE="white-space:nowrap">II-VI</FONT> under any state, federal or other laws relating to bankruptcy, insolvency or similar matters. We have assumed, at the direction of Coherent, that the Merger will be consummated in accordance with its terms,
without waiver, modification or amendment of any material term, condition or agreement and that, in the course of obtaining the necessary<B> </B>governmental, regulatory and other approvals, consents, releases and waivers for the Merger, no delay,
limitation, restriction or condition, including any divestiture requirements or amendments or modifications, will be imposed that would have an adverse effect on Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> or the contemplated benefits of
the Merger.&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We express no view or opinion as to any terms or other aspects of the Merger (other than the Consideration
to the extent expressly specified herein), including, without limitation, the form or structure of the Merger. Our opinion is limited to the fairness, from a financial point of view, of the Consideration to be received by holders of Coherent Common
Stock, other than holders of Cancelled Shares, and no opinion or view is expressed with respect to any consideration received in connection with the Merger by the holders of any class of securities, creditors or other constituencies of any party. In
addition, no opinion or view is expressed with respect to the fairness (financial or otherwise) of the amount, nature or any other aspect of any compensation to any of the officers, directors or employees of any party to the Merger, or class of such
persons, relative to the Consideration. Furthermore, no opinion or view is expressed as to the relative merits of the Merger in comparison to other strategies or transactions that might be available to Coherent or in which Coherent might engage or
as to the underlying business decision of Coherent to proceed with or effect the Merger. We also are not expressing any view or opinion with respect to, and have relied, with your consent, upon the assessments of representatives of Coherent
regarding, legal, regulatory, accounting, tax and similar matters relating to Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and the Merger (including the contemplated benefits thereof), as to which we understand that Coherent obtained such
advice as it deemed necessary from qualified professionals. We are not expressing any opinion as to what the value of <FONT STYLE="white-space:nowrap">II-VI</FONT><B> </B>Common Stock actually will be when issued or the prices at which Coherent<B>
</B>Common Stock or <FONT STYLE="white-space:nowrap">II-VI</FONT><B> </B>Common Stock will trade at any time, including following announcement or consummation of the Merger. In addition, we express no opinion or recommendation as to how any
stockholder should vote or act in connection with the Merger or any related matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as financial advisor to Coherent in connection with the
Merger and will receive a fee for our services, portions of which became payable upon the rendering of two opinions in connection with that certain Amended and Restated Agreement and Plan of Merger, dated as of March&nbsp;9, 2021, by and among
Coherent, Lumentum Holdings Inc., Cheetah Acquisition, Sub, Inc. and Cheetah Acquisition Sub LLC (the &#147;First Restated Lumentum Agreement&#148;) and the Original Agreement, a portion of which is payable upon the rendering of this opinion, and a
significant portion of which is contingent upon consummation of the Merger. In addition, Coherent has agreed to reimburse our expenses and indemnify us against certain liabilities arising out of our engagement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our affiliates comprise a full service securities firm and commercial bank engaged in securities, commodities and derivatives trading, foreign exchange
and other brokerage activities, and principal investing as well as providing investment, corporate and private banking, asset and investment management, financing and financial advisory services and other commercial services and products to a wide
range of companies, governments and individuals. In the ordinary course of our businesses, we and our affiliates may invest on a principal basis or on behalf of customers or manage funds that invest, make or hold long or short positions, finance
positions or trade or otherwise effect transactions in equity, debt or other securities or financial instruments (including derivatives, bank loans or other obligations) of Coherent, <FONT STYLE="white-space:nowrap">II-VI</FONT> and certain of their
respective affiliates.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and our affiliates in the past have provided, currently are providing, and in the future may provide, investment
banking, commercial banking and other financial services to Coherent and/or certain of its affiliates and have received or in the future may receive compensation for the rendering of these services, including (i)&nbsp;acting as financial advisor to
Coherent in connection with the Merger, (ii)&nbsp;having acted or acting as joint lead arranger, joint bookrunner for, and a lender under, certain term loans, letters of credit and other credit facilities of Coherent and/or certain of its
affiliates, (iii)&nbsp;having provided or providing certain treasury management services and products to Coherent and/or certain of its affiliates, and (iv)&nbsp;having provided or providing certain derivatives and foreign exchange trading services
to Coherent and/or certain of its affiliates.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we and our affiliates in the past have provided, currently are
providing, and in the future may provide, investment banking, commercial banking and other financial services to <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates and have received or in the future may receive
compensation for the rendering of these services, including (i)&nbsp;having acted as financial advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with its acquisition of Finisar Corporation,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii)&nbsp;having acted or acting as administrative agent, collateral agent, <FONT STYLE="white-space:nowrap">co-lead</FONT> arranger, joint bookrunner for, and/or a lender under, certain term
loans, letters of credit and credit facilities of <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates, (iii)&nbsp;having acted as manager or underwriter for various debt and/or equity offerings of <FONT
STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates, (iv)&nbsp;having provided or providing certain treasury management services and products to <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates, and
(v)&nbsp;having provided or providing certain derivatives and foreign exchange trading services to <FONT STYLE="white-space:nowrap">II-VI</FONT> and/or certain of its affiliates.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we and our affiliates in the past have provided, currently are providing, and in the future may provide, investment banking, commercial banking
and other financial services to Bain Capital, LP (&#147;Bain&#148;), an affiliate of the Investor (as defined in the Agreement), and/or certain affiliates and/or portfolio companies of Bain, and have received or in the future may receive
compensation for the rendering of these services, including (i)&nbsp;having acted or acting as administrative agent, collateral agent, arranger, bookrunner and/or lender for Bain and/or certain of its affiliates and/or portfolio companies under
various credit, leasing and other facilities of Bain and/or certain of its affiliates and/or portfolio companies (including, without limitation, in connection with the financing for certain acquisition transactions), (ii) having acted or acting as
manager or underwriter for various equity and debt offerings undertaken by Bain and/or certain of its affiliates and/or portfolio companies, (iii)&nbsp;having provided or providing certain treasury management services and products to Bain and/or
certain of its affiliates and/or portfolio companies, and (iv)&nbsp;having provided or providing certain derivatives and foreign exchange trading services to Bain and/or certain of its affiliates and/or portfolio companies. In addition, certain of
our affiliates maintain certain commercial (including vendor and/or customer) relationships with Bain and/or certain of its affiliates and/or portfolio companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is understood that this letter is for the benefit and use of the Board of Directors of Coherent (in its capacity as such) in connection with and for
purposes of its evaluation of the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is necessarily based on financial, economic, monetary, market and other conditions and
circumstances as in effect on, and the information made available to us as of, the date hereof. It should be understood that subsequent developments may affect this opinion, and we do not have any obligation to update, revise, or reaffirm this
opinion. The issuance of this opinion was approved by a fairness opinion review committee of BofA Securities, Inc.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing, including the various assumptions and limitations set forth herein, we are of the opinion on the date hereof that the
Consideration to be received in the Merger by holders of Coherent Common Stock, other than the holders of Cancelled Shares, is fair, from a financial point of view, to such holders.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ BOFA SECURITIES, INC.</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_129"></A>Annex F </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g150472g02a50.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>CREDIT SUISSE SECURITIES (USA) LLC</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Eleven
Madison Avenue&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phone 1 212 325 2000</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">New York, NY
10010-3629&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;www.credit-suisse.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;24, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent,
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, California 95054
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the Board: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have asked us to advise you in your capacity as the Board of Directors (the &#147;Board&#148;) of Coherent, Inc., a Delaware corporation (the
&#147;Company&#148;), with respect to the fairness, from a financial point of view, to the holders of shares of the Company&#146;s common stock, par value $0.01 per share (&#147;Company Common Stock&#148;), other than the holders of any Cancelled
Shares (as defined in the Agreement (as defined below)) or any Dissenting Shares (as defined in the Agreement), of the Per Share Consideration (as defined below) to be received by such stockholders pursuant to the Agreement and Plan of Merger (the
&#147;Agreement&#148;) to be entered into by and among the Company, <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;Acquiror&#148;), and Watson Merger Sub, Inc., a Delaware corporation (&#147;Merger
Sub&#148;). We understand that the Agreement provides for, among other things, (i)&nbsp;the merger of Merger Sub with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of the Acquiror (the
&#147;Transaction&#148;), pursuant to which each share of Company Common Stock issued and outstanding immediately prior to the effective time of the Transaction (other than any Cancelled Shares and any Dissenting Shares) will be converted into the
right to receive (a) 0.91 shares of the Acquiror&#146;s common stock, no par value per share (&#147;Acquiror Common Stock&#148;), and (b) $220.00 in cash (the stock and cash consideration described in the foregoing clauses (a)&nbsp;and (b)
collectively, the &#147;Per Share Consideration&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In arriving at our opinion, we have reviewed an execution copy of the Agreement and certain
publicly available business and financial information relating to the Company and the Acquiror. We have also reviewed certain other information relating to the Company and the Acquiror, including (i)&nbsp;financial forecasts relating to the Company
for the 2021 through 2026 fiscal years of the Company, prepared by the management of the Company (the &#147;Company Projections&#148;), (ii)&nbsp;financial forecasts relating to the Acquiror for the 2021 through 2026 fiscal years of the Acquiror
prepared by the management of the Company (the &#147;Company Projections for the Acquiror&#148;) and (iii)&nbsp;financial forecasts relating to the Acquiror for the 2021 through 2025 fiscal years of the Acquiror prepared by the management of the
Acquiror (the &#147;Acquiror Projections&#148;), and have met with the management of each of the Company and the Acquiror, and certain of their respective representatives and affiliates, to discuss the business and prospects of the Company and the
Acquiror. We also reviewed estimates prepared by the Company&#146;s management with respect to the potential synergies of the Transaction, including the costs necessary to achieve such synergies (the &#147;Synergies&#148;), anticipated by the
Company&#146;s management to result from the Transaction. We have also considered certain financial and stock market data of the Company and the Acquiror, and we have compared that data with similar data for other companies with publicly traded
equity securities in businesses we deemed similar to those of the Company and the Acquiror, respectively, and we have considered, to the extent publicly available, the financial terms of certain other business combinations and other transactions
that have been effected. We also considered such other information, financial studies, analyses and investigations and financial, economic and market criteria which we deemed relevant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our review, we have not independently verified any of the foregoing information and, with your consent, we have assumed and relied upon
such information being complete and accurate in all respects material to our analyses and this opinion. With respect to the Company Projections and the Company Projections for the Acquiror, we have been advised by the management of the Company, and
we have assumed with your consent, that such forecasts have been reasonably prepared in good faith on bases reflecting the best currently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
available estimates and judgments of the management of the Company as to the future financial performance of the Company and the Acquiror, respectively. With respect to the Synergies, we have
been advised by the management of the Company, and we have assumed with your consent, that they have been reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of the management of the Company as
to the potential synergies, including the costs necessary to achieve such synergies, estimated to result from the Transaction and have assumed that the Synergies will be realized in the amounts and at the times indicated thereby. In addition, we
have relied upon, without independent verification, the assessment of the management of the Company as to (i)&nbsp;its ability to retain key employees, (ii)&nbsp;the strategic benefits anticipated to result from the Transaction, (iii)&nbsp;the
existing technology, products and services of the Company and the validity or marketability of, and risks associated with, the future technology, products and services of the Company and (iv)&nbsp;the ability of the Company and the Acquiror to
integrate their respective businesses. At your direction, we have assumed that the Company Projections, the Company Projections for the Acquiror and the Synergies are a reasonable basis upon which to evaluate the Company, the Acquiror and the
Transaction and, at your direction, we have relied upon the Company Projections, the Company Projections for the Acquiror and the Synergies for purposes of our analyses and this opinion. We express no view or opinion with respect to the Company
Projections, the Company Projections for the Acquiror, the Acquiror Projections or the Synergies, or the assumptions and methodologies upon which they are based. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of our analyses and this opinion, we have assumed, with your consent, that, in the course of obtaining any regulatory or third party consents,
approvals or agreements in connection with the Transaction, no modification, delay, limitation, restriction or condition will be imposed that would have an adverse effect on the Company, the Acquiror, or the contemplated benefits of the Transaction.
In addition, for purposes of our analyses and this opinion, we have assumed, with your consent, that the Transaction and any related transactions will be consummated in compliance with all applicable laws and regulations and in accordance with the
terms of the Agreement without waiver, modification or amendment of any term, condition or agreement thereof that is material to our analyses or this opinion. In addition, we have not been requested to make, and have not made, an independent
evaluation or appraisal of the assets or liabilities (contingent or otherwise) of the Company or the Acquiror, nor have we been furnished with any such evaluations or appraisals. With your consent, we have further assumed that the final form of the
Agreement, when executed by the parties thereto, will conform to the execution copy reviewed by us in all respects material to our analyses and this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion addresses only the fairness, from a financial point of view, to the holders of shares of Company Common Stock, other than the holders of any
Cancelled Shares or any Dissenting Shares, of the Per Share Consideration set forth in the Agreement, and does not address any other aspect or implication of the Transaction or any aspect or implication of any agreement, arrangement or understanding
entered into in connection therewith or otherwise, including, without limitation, the form or structure of the Transaction and the fairness of the amount or nature of, or any other aspect relating to, any compensation or consideration to be received
or otherwise payable to any officers, directors, employees, security holders or affiliates of any party to the Transaction, or class of such persons, relative to the Per Share Consideration or otherwise. Furthermore, we are not expressing any advice
or opinion regarding matters that require legal, regulatory, accounting, insurance, intellectual property, tax, environmental, executive compensation or other similar professional advice. We have assumed that the Company has or will obtain such
advice or opinions from the appropriate professional sources. The issuance of this opinion was approved by our authorized internal committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion
is necessarily based on information made available to us as of the date hereof and upon financial, economic, market and other conditions as they exist and can be evaluated on the date hereof. We have not undertaken, and are under no obligation, to
update, revise, reaffirm or withdraw this opinion, or otherwise comment on or consider events occurring or coming to our attention after the date hereof. Our opinion does not address the relative merits of the Transaction as compared to alternative
transactions or strategies that might be available to the Company, nor does it address the underlying business decision of the Board or the Company to proceed with or effect the Transaction. We are not expressing any opinion as to what the value of
shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Acquiror Common Stock actually will be when issued pursuant to the Transaction or the price or range of prices at which Company Common Stock or Acquiror Common Stock may be purchased, sold or
otherwise transferred at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as financial advisor to the Company in connection with the Transaction and will receive a fee for our
services, a portion of which we became entitled to receive upon the rendering of our opinion and a substantial portion of which is contingent upon the consummation of the Transaction. In addition, the Company has agreed to reimburse us for certain
of our expenses and to indemnify us and certain related parties for certain liabilities and other items arising out of or related to our engagement. We and our affiliates have in the past provided and currently are providing investment banking and
other financial advice and services to Bain Capital LP (together with its affiliates, &#147;Bain&#148;), which is providing financing to the Acquiror, for which advice and services we and our affiliates have received and would expect to receive
compensation, including among other things, during the past two years, having provided and continuing to provide financial advisory, financing and equity capital markets services, and having been and continuing to be a lender, to Bain and one or
more of its affiliates. We and our affiliates may in the future provide investment banking and other financial advice and services to the Company, the Acquiror and their respective affiliates for which advice and services we and our affiliates would
expect to receive compensation. We are a full service securities firm engaged in securities trading and brokerage activities as well as providing investment banking and other financial advice and services. In the ordinary course of business, we and
our affiliates may acquire, hold or sell, for our and our affiliates&#146; own accounts and the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of the Company, the
Acquiror and their respective affiliates, and any other company that may be involved in the Transaction, as well as provide investment banking and other financial advice and services to such companies and their affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is understood that this letter is for the information of the Board (in its capacity as such) in connection with its consideration of the Transaction and
does not constitute advice or a recommendation to any security holder of the Company or the Acquiror as to how such security holder should vote or act on any matter relating to the proposed Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the Per Share Consideration set forth in the Agreement is fair, from a
financial point of view, to the holders of shares of Company Common Stock, other than the holders of any Cancelled Shares or any Dissenting Shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CREDIT SUISSE SECURITIES (USA) LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">/s/ Credit Suisse Securities (USA) LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx150472_130"></A>Annex G </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g150472g24a03.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;17, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375
Saxonburg Boulevard </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania 16056 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members
of the Board of Directors: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinion as to the fairness, from a financial point of view, to
<FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated <FONT STYLE="white-space:nowrap">(&#147;II-VI&#148;)</FONT> of the consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the proposed merger (the
&#147;Transaction&#148;) of a wholly-owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> with and into Coherent, Inc. (&#147;Coherent&#148;). Pursuant to the Agreement and Plan of Merger (the &#147;Agreement&#148;) proposed to be
entered into among <FONT STYLE="white-space:nowrap">II-VI,</FONT> Watson Merger Sub (&#147;Merger Sub&#148;) and Coherent, Coherent will become a wholly-owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI,</FONT> and each outstanding share of
common stock, par value $0.01 per share, of Coherent (&#147;Coherent Common Stock&#148;), other than shares of Coherent Common Stock held in treasury, owned by <FONT STYLE="white-space:nowrap">II-VI,</FONT> its subsidiaries or Merger Sub and
Dissenting Shares (as defined in the Agreement), will be converted into the right to receive consideration per share equal to $220.00 in cash (the &#147;Cash Consideration&#148;) and 0.91 of a share (the &#147;Stock Consideration&#148; and, together
with the Cash Consideration, the &#147;Consideration&#148;) of the common stock, with no par value per share, of <FONT STYLE="white-space:nowrap">II-VI</FONT> <FONT STYLE="white-space:nowrap">(&#147;II-VI</FONT> Common Stock&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with preparing our opinion, we have (i)&nbsp;reviewed an execution version, provided to us on March&nbsp;17, 2021, of the Agreement;
(ii)&nbsp;reviewed certain publicly available business and financial information concerning Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> and the industries in which they operate; (iii)&nbsp;compared the proposed financial terms of the
Transaction with the publicly available financial terms of certain transactions involving companies we deemed relevant and the consideration received for such companies; (iv)&nbsp;compared the financial and operating performance of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> with publicly available information concerning certain other companies we deemed relevant and reviewed the current and historical market prices of Coherent Common Stock and
<FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock and certain publicly traded securities of such other companies; (v)&nbsp;reviewed certain internal financial analyses and forecasts prepared by the management of <FONT
STYLE="white-space:nowrap">II-VI</FONT> relating to the businesses of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> including the potential financial benefit to <FONT STYLE="white-space:nowrap">II-VI</FONT> of preserving <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> aerospace and defense growth plan as a result of the Transaction as well as the estimated amount and timing of the cost savings and related expenses and revenue enhancements expected to result from the
Transaction (such financial benefit, cost savings and revenue enhancements, collectively, the &#147;Synergies&#148;); and (vi)&nbsp;performed such other financial studies and analyses and considered such other information as we deemed appropriate
for the purposes of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we have held discussions with certain members of the managements of Coherent and <FONT
STYLE="white-space:nowrap">II-VI</FONT> with respect to certain aspects of the Transaction, and the past and current business operations of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> the financial condition and future prospects and
operations of Coherent and <FONT STYLE="white-space:nowrap">II-VI,</FONT> the effects of the Transaction on the financial condition and future prospects of <FONT STYLE="white-space:nowrap">II-VI,</FONT> and certain other matters we believed
necessary or appropriate to our inquiry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In giving our opinion, we have relied upon and assumed the accuracy and completeness of all information that was
publicly available or was furnished to or discussed with us by Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> or otherwise reviewed by or for us. We have not independently verified any such information or its accuracy or completeness
and, pursuant to our engagement letter with <FONT STYLE="white-space:nowrap">II-VI,</FONT> we did not assume any obligation to undertake any such independent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">G-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
verification. We have not conducted or been provided with any valuation or appraisal of any assets or liabilities, nor have we evaluated the solvency of Coherent or
<FONT STYLE="white-space:nowrap">II-VI</FONT> under any state or federal laws relating to bankruptcy, insolvency or similar matters. In relying on financial analyses and forecasts provided to us or derived therefrom, including the Synergies, we have
assumed that they have been reasonably prepared based on assumptions reflecting the best currently available estimates and judgments by the management of <FONT STYLE="white-space:nowrap">II-VI</FONT> as to the expected future results of operations
and financial condition of Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> to which such analyses or forecasts relate. We express no view as to such analyses or forecasts (including the Synergies) or the assumptions on which they were
based. We have also assumed that the Transaction and the other transactions contemplated by the Agreement will be consummated as described in the Agreement and that the definitive Agreement will be executed by Coherent and will not differ in any
material respects from the execution version thereof furnished to us. We have also assumed that the representations and warranties made by <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent in the Agreement and the related agreements are and
will be true and correct in all respects material to our analysis and that the Transaction and the other transactions contemplated by the Agreement will not have any tax consequences in any respect material to our analysis. We are not legal,
regulatory or tax experts and have relied on the assessments made by advisors to <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect to such issues. We have further assumed that all material governmental, regulatory or other consents and
approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on Coherent or <FONT STYLE="white-space:nowrap">II-VI</FONT> or on the contemplated benefits of the Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is necessarily based on economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. It
should be understood that subsequent developments may affect this opinion and that we do not have any obligation to update, revise, or reaffirm this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is limited to the fairness, from a financial point of view, of the Consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in
the proposed Transaction and we express no opinion as to the fairness of the Consideration to the holders of any class of securities, creditors or other constituencies of <FONT STYLE="white-space:nowrap">II-VI</FONT> or as to the underlying decision
by <FONT STYLE="white-space:nowrap">II-VI</FONT> to engage in the Transaction. Furthermore, we express no opinion with respect to the amount or nature of any compensation to any officers, directors or employees of any party to the Transaction, or
any class of such persons relative to the Consideration to be paid by <FONT STYLE="white-space:nowrap">II-VI</FONT> in the Transaction or with respect to the fairness of any such compensation. We are expressing no opinion herein as to the prices at
which <FONT STYLE="white-space:nowrap">II-VI</FONT> Common Stock or Coherent Common Stock will trade at any future time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as financial
advisor to <FONT STYLE="white-space:nowrap">II-VI</FONT> with respect to the proposed Transaction and will receive a fee from <FONT STYLE="white-space:nowrap">II-VI</FONT> for our services, a substantial portion of which will become payable only if
the proposed Transaction is consummated. In addition, <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to indemnify us for certain liabilities arising out of our engagement. Please be advised that during the two years preceding the date of
this letter, neither we nor our affiliates have had any material financial advisory or other material commercial or investment banking relationships with Coherent. During the two years preceding the date of this letter, we and our affiliates have
had commercial or investment banking relationships with <FONT STYLE="white-space:nowrap">II-VI</FONT> for which we and such affiliates have received customary compensation. Such services during such period have included acting as joint lead
bookrunner on an offering of equity securities and convertible equity securities in July 2020. We anticipate that we and our affiliates will arrange and/or provide financing to <FONT STYLE="white-space:nowrap">II-VI</FONT> in connection with the
Transaction for customary compensation. In addition, we and our affiliates hold, on a proprietary basis, less than 1% of the outstanding common stock of each of <FONT STYLE="white-space:nowrap">II-VI</FONT> and Coherent. In the ordinary course of
our businesses, we and our affiliates may actively trade the debt and equity securities or financial instruments (including derivatives, bank loans or other obligations) of <FONT STYLE="white-space:nowrap">II-VI</FONT> or Coherent for our own
account or for the accounts of customers and, accordingly, we may at any time hold long or short positions in such securities or other financial instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of and subject to the foregoing, it is our opinion as of the date hereof that the Consideration to be paid by
<FONT STYLE="white-space:nowrap">II-VI</FONT> in the proposed Transaction is fair, from a financial point of view, to <FONT STYLE="white-space:nowrap">II-VI.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuance of this opinion has been approved by a fairness opinion committee of J.P. Morgan Securities LLC. This letter is provided to the Board of
Directors of <FONT STYLE="white-space:nowrap">II-VI</FONT> (in its capacity as such) in connection with and for the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">G-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purposes of its evaluation of the Transaction. This opinion does not constitute a recommendation to any shareholder of <FONT STYLE="white-space:nowrap">II-VI</FONT> as to how such shareholder
should vote with respect to the Transaction or any other matter. This opinion may not be disclosed, referred to, or communicated (in whole or in part) to any third party for any purpose whatsoever except with our prior written approval. This opinion
may be reproduced in full in any proxy or information statement mailed to shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> but may not otherwise be disclosed publicly in any manner without our prior written approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">G-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;20. Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pennsylvania statutory law regarding directors and officers insurance and indemnification is embodied in Chapter 17, Subchapter D (Sections
1741 through 1750) of the BCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1741 (relating to third-party actions) and 1742 (relating to derivative and corporate actions) of
the BCL provide that a business corporation may indemnify any director, officer, employee or agent who is or was a representative of, or serving at the request of, the corporation (referred to as a &#147;Representative&#148;), so long as the
Representative acted in good faith and with a reasonable belief that his or her actions were in the best interests, or not opposed to the best interests, of the corporation, and with respect to any criminal proceeding under Section&nbsp;1741 of the
BCL, the Representative must have had no reasonable cause to believe his or her conduct was unlawful. In general, the power to indemnify under these sections does not exist in the case of actions against a director or officer by or in the right of
the corporation if the person otherwise entitled to indemnification shall have been adjudged to be liable to the corporation unless it is judicially determined that, despite the adjudication of liability but in view of all the circumstances of the
case, the person is fairly and reasonably entitled to indemnification for specified expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1743 of the BCL provides
mandatory indemnification for a Representative if he or she succeeds on the merits or otherwise in the defense of any claim or action or proceeding, or in defense of any claim, issue or matter therein. The corporation must indemnify him or her to
the extent of his or her actual and reasonable expenses (including attorney&#146;s fees) incurred in connection with the claim or action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1745 of the BCL states that expenses (including attorneys&#146; fees) incurred in defending any third-party or derivative action
or proceeding may be paid by a business corporation in advance of the final disposition of the action or proceeding upon receipt of an undertaking by or on behalf of the Representative to repay the amount if it is ultimately determined that such
person is not entitled to be indemnified by the corporation as authorized by the BCL or otherwise. Except as otherwise provided in the corporation&#146;s articles or bylaws, advancement of expenses must be authorized by the board of directors of the
corporation. The BCL provisions ordinarily governing transactions with interested directors or officers, or interested shareholders (Sections 1728 and 2538 of the BCL) do not apply to the authorization of advancement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1746(a) states that the statutory rights of indemnification and advancement of expenses shall not be deemed exclusive of any
other rights to which a person might be entitled under any bylaw, agreement, vote of shareholders or disinterested directors, or otherwise, both as to the action in his or her official capacity and as to the action or proceeding in another capacity
while holding that office. Section&nbsp;1746(c) specifies that indemnification pursuant to Section&nbsp;1746(a) may be made even if the corporation would not have the power to make such indemnification under other provisions of law, and may be made
even in the case of an action by or in the right of the corporation. Such indemnification is declared to be consistent with Pennsylvania&#146;s public policy. However, Section&nbsp;1746(b) forbids indemnification under subsection 1746(a) to be made
in any case where the act or failure to act giving rise to the claim is determined by a court to be willful misconduct or recklessness. A corporation&#146;s articles of incorporation may not provide for indemnification in the case of willful
misconduct or recklessness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The BCL, in Section&nbsp;1747, also authorizes corporations to purchase and maintain insurance on behalf of a
Representative or a person who is or was serving at the request of the corporation as a Representative of another domestic or foreign entity, whether or not the corporation would have the power to indemnify him or her, unless otherwise restricted in
its bylaws. Such insurance is declared to be consistent with Pennsylvania&#146;s public policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1750 of the BCL provides that the indemnification and advancement of expenses
provided by, or granted pursuant to Subchapter D of the BCL shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a Representative and shall inure to the benefit of the heirs and personal
representatives of that person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02 of the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws provides that a director
will not be personally liable for monetary damages for any action taken, or any failure to take any action, unless the director has breached or failed to perform the duties of his or her office under Section&nbsp;9.01 of the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws (relating to standard of care and justifiable reliance) and the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness. A director&#146;s criminal or tax liability is
not limited by the foregoing provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03 of the <FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws requires <FONT
STYLE="white-space:nowrap">II-VI</FONT> to indemnify any director or officer of <FONT STYLE="white-space:nowrap">II-VI</FONT> to the fullest extent not prohibited by law in connection with any actual or threatened action, suit or proceeding for
indemnification, or that may give rise to indemnification, that (1)&nbsp;is brought against a person entitled to indemnification under Article IX of the bylaws, and (2)&nbsp;arises out of the service of that person to
<FONT STYLE="white-space:nowrap">II-VI,</FONT> or to another enterprise at the request of <FONT STYLE="white-space:nowrap">II-VI</FONT> (referred to as an &#147;indemnification action&#148;). <FONT STYLE="white-space:nowrap">II-VI</FONT> may not
indemnify any director or officer in connection with an indemnification action initiated by that director or officer (other than a successful indemnification action to enforce that individual&#146;s right to indemnification under the <FONT
STYLE="white-space:nowrap">II-VI</FONT> bylaws) unless the <FONT STYLE="white-space:nowrap">II-VI</FONT> board authorizes the indemnification action. The right to indemnification under Section&nbsp;9.03 includes the right to be reimbursed for
expenses before the final disposition of an indemnification action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06 of the
<FONT STYLE="white-space:nowrap">II-VI</FONT> bylaws permits <FONT STYLE="white-space:nowrap">II-VI</FONT> to purchase insurance to protect against any liability asserted against <FONT STYLE="white-space:nowrap">II-VI</FONT> or any individual,
whether or not <FONT STYLE="white-space:nowrap">II-VI</FONT> would have the power to indemnify that individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">II-VI</FONT> has entered into agreements with its directors and officers pursuant to which <FONT STYLE="white-space:nowrap">II-VI</FONT> has agreed to provide for the indemnification of and the advancing of expenses to
each such indemnitee to the fullest extent (whether partial or complete) permitted by law and as set forth in the applicable agreement, and, to the extent insurance is maintained, for the continued coverage of each such indemnitee under <FONT
STYLE="white-space:nowrap">II-VI&#146;s</FONT> directors&#146; and officers&#146; liability insurance policies. To the fullest extent permissible by applicable law, if the indemnification provided for in each such agreement is unavailable to the
applicable indemnitee for any reason whatsoever, <FONT STYLE="white-space:nowrap">II-VI,</FONT> in lieu of indemnifying such indemnitee, shall contribute to the amount incurred such indemnitee, whether for judgments, fines, penalties, excise taxes,
amounts paid or to be paid in settlement and/or for expenses, in connection with any claim relating to an indemnifiable event under such agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such
claim in order to reflect (i)&nbsp;the relative benefits received by <FONT STYLE="white-space:nowrap">II-VI</FONT> and such indemnitee as a result of the event(s) and/or transaction(s) giving rise to such claim; and/or (ii)&nbsp;the relative fault
of <FONT STYLE="white-space:nowrap">II-VI</FONT> (and its directors, officers, employees and agents) and such indemnitee in connection with such event(s) and/or transaction(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnification described in the preceding paragraphs may include indemnification against liabilities arising under the Securities Act.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling <FONT STYLE="white-space:nowrap">II-VI</FONT> pursuant to the foregoing provisions, <FONT
STYLE="white-space:nowrap">II-VI</FONT> has been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;21. Exhibits and Financial Statement Schedules </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following exhibits are filed herewith or incorporated herein by reference: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#tx150472_126a">Agreement and Plan of Merger, dated as of March&nbsp;
25, 2021, by and among Coherent, Inc., <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Watson Merger Sub Inc. (included as <U>Annex A</U> to the joint proxy statement/prospectus contained in this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312511302244/d253525dex31.htm">Amended and Restated Articles of Incorporation of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (incorporated by reference to Exhibit
 3.1 to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;0-16195)</FONT> filed on November&nbsp;8, 2011)
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521062382/d22272dex31.htm">Amended and Restated Bylaws of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (incorporated by reference to Exhibit 3.1 to <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39375)</FONT> filed on March&nbsp;1, 2021) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031820000023/ex-303063020statementw.htm">Statement with Respect to Shares, filed with the Pennsylvania Department of State Corporations Bureau and effective July&nbsp;
6, 2020 (incorporated by reference to Exhibit 3.03 to <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;
001-39375)</FONT> filed on August&nbsp;26, 2020) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#tx150472_126c">Statement with Respect to Shares, filed with the Pennsylvania Department of State Corporations Bureau and effective March&nbsp;
30, 2021 (included as <U>Annex C</U> to the joint proxy statement/prospectus contained in this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521134433/d150472dex51.htm">Form of Opinion of K&amp;L Gates LLP regarding the validity of <FONT STYLE="white-space:nowrap">II-VI</FONT> common stock being registered (previously
 filed)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>*10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#tx150472_126b">Amended and Restated Investment Agreement, dated as of March&nbsp;
30, 2021, by and between <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and BCPE Watson (DE) SPV, LP (included as <U>Annex B</U> to the joint proxy statement/prospectus contained in this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000082031820000023/ex-210106302020.htm">List of Subsidiaries of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (incorporated by reference to Exhibit 21.01 to <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-39375)</FONT> filed on August&nbsp;26, 2020) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521134433/d150472dex51.htm">Consent of K&amp;L Gates LLP (included in Exhibit&nbsp;5.1 of the initial filing of this registration statement)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex232.htm">Consent of Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex233.htm">Consent of Deloitte&nbsp;&amp; Touche LLP, independent registered public accounting firm of Coherent, Inc. (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex234.htm">Consent of BDO USA, LLP, independent registered public accounting firm of Finisar Corporation (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521134433/d150472ds4.htm#sig">Power of Attorney of the Directors of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (included in the signature pages of the initial
 filing of this registration statement)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex991.htm">Form of Proxy Card of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex992.htm">Form of Proxy Card of Coherent, Inc. (filed herewith)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex993.htm">Consent of BofA Securities, Inc. (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d150472dex994.htm">Consent of Credit Suisse Securities (USA) LLC (filed herewith) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/820318/000119312521134433/d150472dex995.htm">Consent of J.P. Morgan Securities LLC (previously filed)</A></TD></TR>
</TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Schedules and similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation <FONT
STYLE="white-space:nowrap">S-K.</FONT> <FONT STYLE="white-space:nowrap">II-VI</FONT> agrees to furnish to the SEC a copy of any schedule or similar attachment omitted upon request. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;22. Undertakings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement; notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the
effective registration statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) to include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material change to such information in the registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of
a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) That, for
the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of securities, in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser: (i)&nbsp;any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii)&nbsp;the portion of any other free writing prospectus relating to the offering
containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv)&nbsp;any other communication that is an offer in the offering made by the undersigned registrant to
the purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#146;s
annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Securities Exchange
Act of 1934) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
initial <I>bona fide </I>offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) That prior to any public reoffering of the securities registered hereunder through use of
a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for
by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) That every prospectus (i)&nbsp;that is filed pursuant to paragraph (6)&nbsp;immediately
preceding, or (ii)&nbsp;that purports to meet the requirements of Section&nbsp;10(a)(3) of the Securities Act of 1933 and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the
registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) To respond to requests for information that is incorporated by reference into this prospectus pursuant to Items 4, 10(b), 11, or 13 of
this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means; this includes information contained in documents filed subsequent to the effective date of this
registration statement through the date of responding to the request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) To supply by means of a post-effective amendment all
information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in this registration statement when it became effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Insofar as indemnification for liabilities under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities
Act of 1933 and is therefore unenforceable. In the event a claim of indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in a
successful defense of any action, suit or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of
such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the Borough of Saxonburg, Commonwealth of Pennsylvania on May 4, 2021. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Vincent D. Mattera, Jr.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vincent D. Mattera, Jr.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title: </TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer</TD></TR>
</TABLE></DIV>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been
signed by the following persons in the capacities indicated on May 4, 2021. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="51%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vincent D. Mattera, Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vincent D. Mattera, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director
<I>(Principal Executive Officer)</I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mary Jane Raymond</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mary Jane Raymond</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer and Treasurer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(<I>Principal Financial and Accounting Officer</I>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Francis J.
Kramer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">* </P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Joseph J.
Corasanti</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Enrico
Digirolamo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">* </P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Michael L.
Dreyer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">* </P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Patricia
Hatter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">* </P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">David L.
Motley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-bottom:0pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Stephen Pagliuca</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director </P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marc Y. E. Pelaez</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Rear Admiral, U.S. Navy (retired)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Shaker Sadasivam</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Howard H. Xia</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">*By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Vincent&nbsp;D.&nbsp;Mattera&nbsp;Jr.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Vincent D. Mattera Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Attorney-in-Fact</FONT></FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>2
<FILENAME>d150472dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; in this Amendment No.&nbsp;1 to the Registration Statement <FONT
STYLE="white-space:nowrap">(Form&nbsp;S-4</FONT> No.&nbsp;333-255547) and related Joint Proxy Statement/Prospectus of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated for the registration of its common stock and to the incorporation by
reference therein of our reports dated August&nbsp;26, 2020, with respect to the consolidated financial statements and schedule of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries, and the effectiveness of internal control
over financial reporting of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Subsidiaries, included in its Annual Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended June&nbsp;30, 2020, filed with the
Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">/s/ Ernst&nbsp;&amp; Young LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pittsburgh, Pennsylvania </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 4, 2021 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>3
<FILENAME>d150472dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the incorporation by reference in this Registration Statement No. 333-255547 of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated on
Form <FONT STYLE="white-space:nowrap">S-4</FONT> of our reports dated December&nbsp;1, 2020, relating to the consolidated financial statements of Coherent, Inc. and the effectiveness of Coherent, Inc.&#146;s internal control over financial reporting
appearing in the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of Coherent, Inc. for the year ended October&nbsp;3, 2020. We also consent to the reference to us under the heading &#147;Experts&#148; in such Registration
Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ DELOITTE&nbsp;&amp; TOUCHE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Jose,
California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 4, 2021 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>4
<FILENAME>d150472dex234.htm
<DESCRIPTION>EX-23.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.4 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Consent of Independent Registered Public Accounting Firm </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Saxonburg, Pennsylvania </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation
by reference in the Prospectus constituting a part of this Registration Statement of our report dated June&nbsp;14, 2019, relating to the consolidated financial statements and schedule of Finisar Corporation appearing in Finisar Corporation&#146;s
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended April&nbsp;28, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also consent to the reference to us under
the caption &#147;Experts&#148; in the Prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ BDO USA, LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">San Jose, California</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">May 4, 2021</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d150472dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g07a50.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Exhibit 99.1 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY INTERNET </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Before The Meeting - Go to www.proxyvote.com </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use the Internet to transmit your voting
instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the meeting <FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED date. Have your proxy card in hand when you access the web site and follow
375 SAXONBURG BOULEVARD the instructions to obtain your records and to create an electronic voting </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SAXONBURG, PA 16056-9499 instruction form. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">During The Meeting&#151;Go to www.virtualshareholdermeeting.com/IIVI2021SM </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">You may attend the
Meeting via the Internet and vote during the Meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT>
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy card in hand
when you call and then follow the instructions. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY MAIL </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Mark, sign and
date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">51 Mercedes Way, Edgewood, NY
11717. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54482-S24044 KEEP THIS PORTION FOR YOUR RECORDS </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY CARD IS VALID
ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSALS NUMBERED 1 AND 2. For Against Abstain </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. Proposal to approve the issuance of shares of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s common stock, no par value, pursuant to the terms of the
Agreement and Plan of Merger, dated as of March&nbsp;25, 2021, as may be amended from time to time, by and among <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation, Watson Merger Sub Inc., a Delaware corporation
and a wholly owned subsidiary of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, and Coherent, Inc., a </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Delaware corporation, in the amounts necessary
to complete the merger contemplated thereby, the issuance of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Series ! ! ! <FONT STYLE="white-space:nowrap">B-2</FONT> convertible preferred stock pursuant to the terms of the Amended
and Restated Investment Agreement, dated as of March&nbsp;30, 2021, as may be amended from time to time, by and between <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated and BCPE Watson (DE) SPV, LP, and the issuance of shares of <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s common stock upon any conversion of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s Series B convertible preferred stock issued pursuant to such Amended and Restated
Investment Agreement. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. Proposal to adjourn <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s special meeting to a later date or dates, if
necessary or appropriate, including to solicit additional ! ! ! proxies in the event there are not sufficient votes at the time of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated&#146;s special meeting to approve the share issuance
proposal described above. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NOTE: Such other business as may properly come before the meeting or any adjournment thereof. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PLEASE MARK, SIGN, DATE AND RETURN IMMEDIATELY. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Important: Shareholders sign here exactly as
name appears hereon. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g08o09.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding Internet Availability of Proxy Materials for the Special Meeting to be held on </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">June&nbsp;24, 2021: The Notice and Proxy Statement is available at www.proxyvote.com. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please
date, sign and mail your Proxy card back as soon as possible! </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54483-S24044
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PROXY </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED Special
Meeting of Shareholders </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">June&nbsp;24, 2021 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY IS SOLICITED ON BEHALF
OF THE BOARD OF DIRECTORS OF THE COMPANY </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The undersigned hereby appoints Dr.&nbsp;Vincent&nbsp;D. Mattera, Jr., Mary Jane Raymond, and Jo Anne Schwendinger, or any
of them, with power of substitution to each, as proxies to represent and to vote, as designated on the reverse, all of the shares of Common Stock held of record at the close of business on May&nbsp;17, 2021 by the undersigned at the special meeting
of shareholders of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated to be held online at www.virtualshareholdermeeting.com/IIVI2021SM, on June&nbsp;24, 2021 at 11:30 a.m. Eastern U.S. time, and at any adjournment thereof. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This proxy will be voted by the proxies as directed, or if no direction is indicated herein, the proxies shall vote FOR Proposals Numbers 1 and 2. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(PLEASE SIGN ON REVERSE SIDE AND RETURN PROMPTLY) </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>d150472dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g43x34.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Exhibit 99.2 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY INTERNET </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Before The Meeting - Go to www.proxyvote.com </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use the Internet to transmit your voting
instructions and for electronic delivery of information. Vote by 11:59 p.m., Eastern Time, on June&nbsp;23, 2021. Have your C/O AMERICAN STOCK TRANSFER proxy card in hand when you access the website and follow the instructions to </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">59 MAIDEN LANE obtain your records and to create an electronic voting instruction form. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NEW
YORK, NY 10038 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">During The Meeting&#151; Go to www.virtualshareholdermeeting.com/COHR2021SM </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT>
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 p.m., Eastern Time, on June&nbsp;23, 2021. Have your proxy card in hand when you
call and then follow the instructions. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY MAIL </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Mark, sign and date your
proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">51 Mercedes Way, Edgewood, NY 11717.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54479-S23671
KEEP THIS PORTION FOR YOUR RECORDS </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">COHERENT, INC. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Coherent&#146;s Board of Directors recommends you vote &#147;FOR&#148; the
following proposals: For Against Abstain </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. To adopt the Agreement and Plan of Merger, dated as of March&nbsp;25, 2021, by and among Coherent, Inc., <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated and Watson Merger Sub ! ! ! Inc. (the &#147;merger agreement&#148;) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. To approve, on an advisory <FONT
STYLE="white-space:nowrap">(non-binding)</FONT> basis, the executive officer compensation that will or may be paid to Coherent&#146;s named executive officers in ! ! ! connection with the transactions contemplated by the merger agreement </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3. To adjourn Coherent&#146;s special meeting of stockholders (the &#147;Special Meeting&#148;), if necessary or appropriate, to solicit additional proxies if, immediately ! ! !
prior to such adjournment, there are not sufficient votes to approve the Coherent merger proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to Coherent stockholders
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NOTE: The shares represented by this proxy when properly executed will be voted in the manner directed herein. If any other matters properly come before the
Special Meeting, the person named in this proxy will vote in their discretion. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Coherent&#146;s stockholders of record at the close of business on May&nbsp;17, 2021
are entitled to vote at the Special Meeting via webcast at www.virtualshareholdermeeting.com/COHR2021SM. However, to assure your representation at the Special Meeting, you are urged to complete, sign, date and return the enclosed proxy card as
promptly as possible in the postage-prepaid envelope for that purpose, or vote by telephone or via the Internet. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please sign exactly as your name(s) appear(s)
hereon. When signing as attorney, executor, administrator or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or
partnership name by authorized officer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g150472g34w73.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Special Meeting: </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The Notice and Joint Proxy Statement/Prospectus are available at www.proxyvote.com. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PLEASE
COMPLETE, SIGN AND DATE THIS PROXY CARD ON THE REVERSE SIDE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD
ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54480-S23671 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PROXY </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF COHERENT, INC.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Special Meeting of Stockholders June&nbsp;24, 2021, 8:30 a.m., Pacific Time via virtual meeting </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The undersigned stockholder of COHERENT, INC., a Delaware corporation, hereby acknowledges receipt of the Notice and Proxy Statement, each dated May&nbsp;6, 2021, and hereby
revokes all previous proxies and appoints Andreas W. Mattes and Bret M. DiMarco, and each of them, proxies and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact,</FONT></FONT> with full power to each of
substitution, on behalf and in the name of the undersigned, to represent the undersigned at the Special Meeting of Stockholders of COHERENT, INC. to be held on Thursday, June&nbsp;24, 2021, at 8:30 a.m., Pacific Time, by means of remote
communication via live webcast at www.virtualshareholdermeeting.com/COHR2021SM and at any postponement(s) or adjournment(s) thereof and to vote all shares of Coherent, Inc. common stock which the undersigned would be entitled to vote if then and
there personally present, on all the matters set forth on the reverse side. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE STOCKHOLDER(S). IF
NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS 1, 2 AND 3 AND AS THE PROXIES NAMED ABOVE DEEM ADVISABLE ON ANY OTHER BUSINESS THAT MAY PROPERLY COME BEFORE THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT THEREOF. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CONTINUED AND TO BE SIGNED ON THE REVERSE SIDE </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>7
<FILENAME>d150472dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BOFA SECURITIES, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May 4, 2021
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, CA 95054 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the Board: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of
our opinion letter, dated March&nbsp;24, 2021, to the Board of Directors of Coherent, Inc. (&#147;Coherent&#148;) as Annex E to, and to the reference thereto under the headings &#147;SUMMARY &#151; Opinions of Coherent&#146;s Financial Advisors
&#151; Opinion of BofA Securities&#148;, &#147;THE MERGER &#150; Background of the Merger&#148;, &#147;THE MERGER &#150; Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148;, &#147;THE MERGER &#151; Opinions of
Coherent&#146;s Financial Advisors &#151; Opinion of BofA Securities&#148; and &#147;THE MERGER &#151; Certain Unaudited Prospective Financial Information&#148; in, the&nbsp;joint proxy&nbsp;statement/prospectus relating to the proposed merger
involving Coherent and <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated <FONT STYLE="white-space:nowrap">(&#147;II-VI&#148;),</FONT> which&nbsp;joint proxy&nbsp;statement/prospectus forms a part of
<FONT STYLE="white-space:nowrap">II-VI&#146;s</FONT> Registration Statement <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-4&nbsp;to</FONT> which this consent is filed as an exhibit. In giving the foregoing consent, we do not admit
(1)&nbsp;that we come within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the rules and regulations of the Securities and Exchange Commission
(the &#147;Commission&#148;) promulgated thereunder, or (2)&nbsp;that we are experts with respect to any part of the Registration Statement within the meaning of the term &#147;experts&#148; as used in the Securities Act and the rules and
regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ BOFA SECURITIES, INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>8
<FILENAME>d150472dex994.htm
<DESCRIPTION>EX-99.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF CREDIT SUISSE SECURITIES (USA) LLC </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 4, 2021 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coherent, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5100 Patrick Henry Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Santa Clara, California 95054 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the Board: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of
our opinion letter, dated March&nbsp;24, 2021, to the Board of Directors of Coherent, Inc. (&#147;Coherent&#148;) as Annex F to the joint proxy statement/prospectus, which forms a part of Amendment No. 1, dated as of the date hereof (&#147;Amendment
No. 1&#148;), to the Registration Statement on Form S-4 of II-VI Incorporated (&#147;II-VI&#148;) filed with the Securities and Exchange Commission as of April&nbsp;27, 2021 (as amended by Amendment No. 1, the &#147;Registration Statement&#148;),
relating to the proposed merger involving Coherent and II-VI, and reference to such opinion letter under the headings &#147;Summary &#150; Opinions of Coherent&#146;s Financial Advisors &#150; Opinion of Credit Suisse&#148;, &#147;The Merger &#150;
Background of the Merger&#148;, &#147;The Merger &#150; Coherent&#146;s Reasons for the Merger; Recommendation of the Coherent Board&#148;, &#147;The Merger &#150; Opinions of Coherent&#146;s Financial Advisors &#150; Opinion of Credit Suisse&#148;,
&#147;The Merger &#150; Certain Unaudited Prospective Financial Information&#148; and &#147;Risk Factors &#150; Risks Relating to the Merger&#148; in such joint proxy statement/prospectus. The foregoing consent applies only to the Registration
Statement and not to any amendments or supplements thereto, and our opinion is not to be used, circulated, quoted, or otherwise referred to for any other purpose, nor is it to be filed with, included in or referred to in whole or in part in any
other registration statement (including any amendments to the above-mentioned Registration Statement), proxy statement or any other document, except in accordance with our prior written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In giving our consent, we do not admit that we come within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act of
1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we admit that we are experts with respect to any part of such Registration Statement within the meaning of the term &#147;experts&#148; as
used in the Securities Act of 1933, as amended, or the rule and regulations of the Securities and Exchange Commission thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Credit Suisse
Securities (USA) LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CREDIT SUISSE SECURITIES (USA) LLC </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g150472g02a45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g02a45.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1*Z4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $IZ^1V8X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (@ !P"
M4  (<G(S-3DP.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!7871S
M;VY?($9O<FT@4RTT7U5315]!8W1I=F4P,5\S,#DT-C P.#0 .$))300E
M   03TJB_62P#I.2Y9%0@A)'6CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!E),1
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _0
M     !( -0    $ +0    8       $X0DE- _<      !P  /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      S4    &               E
M   !,          !                          $              3
M   E                      $                         $     $
M      !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
M   E     %)G:'1L;VYG   !,     9S;&EC97-6;$QS     4]B:F,    !
M       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$
M;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T
M;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
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M!"@       P    "/_         X0DE-!!$       $! #A"24T$%
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M  $%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M.M=&4<#@Q#=)7"#<>FBBAHFG<[_CP<!6;:-S6+.SW4I^.="7R<Z1N6A\=&3
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9TTUQKKKC&-==<8QC&,?\QC&/_,8^<OG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g150472g02a50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g02a50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[18P4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %A2^5E(X0DE-! 0      &$< 5H  QLE1QP"   "(  < E  "')R,S4Y
M,#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@5V%T<V]N7R!&;W)M
M(%,M-%]54T5?06-T:79E,#%?,S Y-#8P,#@T #A"24T$)0      $$H,XG.7
M)7[.$NR-6#5#)^XX0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L  ,         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    %HX0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              !_   "(@         !
M      $              B(   !_                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     4X0DE-! P     "X@    !    H
M "4   '@  !%8   "VP &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( "4 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M$0 _ /54DDDE*22224I))))2DDDDE*22224I))))2DDDDE*47MW,+9(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 04! 0$            '" D! @,&"@0%"__$ #@0  $$ P "  (&" 0'
M  4#! 8' 0((  D1$A05%C%QP1,A,D%"<H&Q"A=1@A@B(S-28='_Q  ; 0$
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MGC33QIIXTT\::>--/&FGC33QIK^=W[[^*]>..U\6=6K12-5CT4F^M&&_4>'
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M1*"PW5^BJ.3.2$VAEV^35;C63]1%;5.YQ^%GO5YKTD]:ACJ\BPRW;C2+%WF
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MU'JD9..[$@>X).WOMK?F&ICJ6&/(2RQ4WQZ,X2:Q$#+RM!&WKL)/95!V^$[
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M])63".@*FN7'/D@&0Z24I>]>U3+;6B+-_P#9AD/G5>R]G5H&3R>/OT)$P<G
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g150472g03a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g03a01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[11:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %#Z^48(X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (@ !P"
M4  (<G(S-3DP.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!7871S
M;VY?($9O<FT@4RTT7U5315]!8W1I=F4P,5\S,#DT-C P.#0 .$))300E
M   03TJB_62P#I.2Y9%0@A)'6CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!7M4U
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M   V    9@         !                          $
M &8    V                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<    V     %)G:'1L;VYG    9@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    -@    !29VAT
M;&]N9P   &8    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     ,X0DE-! P     "9,    !    9@   #8   $T  ! ^   "7<
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M PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                _^$_>VAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
M/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C
M>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@
M>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XV+6,P-C<@-SDN,34W-S0W+" R
M,#$U+S S+S,P+3(S.C0P.C0R(" @(" @(" B/@H@(" \<F1F.E)$1B!X;6QN
M<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A
M>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P
M=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(@H@(" @(" @(" @("!X;6QN<SIX
M;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @
M(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W12
M968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C
M95)E9B,B"B @(" @(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP9&8Z4')O
M9'5C97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN9&]W<RD\+W!D
M9CI0<F]D=6-E<CX*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0
M:&]T;W-H;W @0T,@,C Q-2 H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*
M(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C$M,#0M,C14,3,Z,#@Z,3<K
M,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A
M=&4^,C R,2TP-"TR-%0Q,CHP-CHT-2LP-3HS,#PO>&UP.D-R96%T941A=&4^
M"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C$M,#0M,C14,3,Z,#@Z
M,3<K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC<F]S;V9T(%=O<F0@+2!0<F]J
M96-T(%=A='-O;E\@1F]R;2!3+31?55-%7T%C=&EV93 Q7S,P.30V,# X-%\Q
M-#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO
M9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \
M<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR<C,U.3 Y,SPO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E
M871O<CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M
M870^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z8C1E-F)F
M,C0M9C!F-"TU,30Y+6$P,S(M8S-C-#=F9# S8S8T/"]X;7!-33I);G-T86YC
M94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP
M:&]T;W-H;W Z,#,S,&1F-38M831D,"TQ,65B+3EA,S(M9C8X-#8S,C1B9&$Q
M/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$
M;V-U;65N=$E$/GAM<"YD:60Z9#AF93(W-&0M-&(P,BTY,C1A+6%B83 M86$S
M-C5E,#5B93=C/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C
M=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP
M+FEI9#ID.&9E,C<T9"TT8C R+3DR-&$M86)A,"UA83,V-64P-6)E-V,\+W-T
M179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N
M/C(P,C$M,#0M,C14,3(Z-#@Z,S@K,#4Z,S \+W-T179T.G=H96X^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O
M<VAO<"!#0R R,#$U("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z9C0Y
M83DT8F,M,#0Y-BUA-30X+6$T.#(M-#9A-C@X9#(Y8C)E/"]S=$5V=#II;G-T
M86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 T
M+3(T5#$S.C X.C$W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0T,@
M,C Q-2 H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO
M;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A
M<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E
M<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@
M:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#II;G-T86YC94E$/GAM<"YI:60Z8C1E-F)F,C0M9C!F-"TU,30Y+6$P,S(M
M8S-C-#=F9# S8S8T/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(Q+3 T+3(T5#$S.C X.C$W*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0T,@,C Q-2 H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES
M=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^
M>&UP+FEI9#IF-#EA.31B8RTP-#DV+6$U-#@M830X,BTT-F$V.#AD,CEB,F4\
M+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N
M=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#HT839C,#0U8RUA-&-D+3$Q96(M
M.6$S,BUF-C@T-C,R-&)D83$\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @
M(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#ID.&9E,C<T
M9"TT8C R+3DR-&$M86)A,"UA83,V-64P-6)E-V,\+W-T4F5F.F]R:6=I;F%L
M1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @
M(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R
M36]D93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*
M/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  W &<# 1$  A$! Q$!_\0
M'    P #  ,             "0H+! <(  4&_\0 41    4# @,#! H,"PD
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M#MB/]E(S1VH/M+2_>,;ZI.)*[6/*9GSX5UO[>]A,CB\>^$Y#_*./_9"L _\
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)@SPD66XFW__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g150472g03a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g03a02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1364&AO=&]S:&]P(#,N,  X0DE-! 0
M    %+J^4P8X0DE-! 0      &$< 5H  QLE1QP"   "(  < E  "')R,S4Y
M,#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@5V%T<V]N7R!&;W)M
M(%,M-%]54T5?06-T:79E,#%?,S Y-#8P,#@T #A"24T$)0      $$H,XG.7
M)7[.$NR-6#5#)^XX0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;KF7P         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    %HX0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _0      !( -0    $ +0    8       $X0DE- _<
M     !P  /____________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      S4
M   &              "'   "60         !
M  $              ED   "'                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "'     %)G:'1L;VYG   "60    9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    AP    !29VAT;&]N9P   ED    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
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M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     @X0DE-! P     "K<    !    H    "0
M  '@  !#@   "IL &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( "0 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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M /1^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MX2R?@Z6RMAC7/&\1;T4'#DU5DKSLKEBKL+(FV:.X]TN>$<RB4H5%J^9+JBV
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?Q1(F ]NI:].G3ITZ=.G3ITZ=.G3ITZ=.G3ITZ=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g150472g07a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g07a01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1J44&AO=&]S:&]P(#,N,  X0DE-! 0
M    &GB^9W8X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (@ !P"
M4  (<G(S-3DP.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!7871S
M;VY?($9O<FT@4RTT7U5315]!8W1I=F4P,5\S,#DT-C P.#0 .$))300E
M   03TJB_62P#I.2Y9%0@A)'6CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  "-   !"0         !                          $
M 0D   "-                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   "-     %)G:'1L;VYG   !"0    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    C0    !29VAT
M;&]N9P   0D    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     DX0DE-! P     #\T    !    H    %4   '@  "?8   #[$
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MZP6T4W6OLJI#K88QSMS*QMM#?8WVKGOK+B?6CZNLQW7==R<C[2Y[0&66-C8
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M%BG)B3$B0W!MX?\ YF?7#_YY
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ +0!5 P$1  (1 0,1 ?_$ !@   ,! 0                D*"P@'_\0
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MFV"Y0.B]B)M@XC9)HJ0WZ3)N6;E9$Y1]PE.(#[N&@M"7$+;6-R'$J0L'N*5
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?9VVXOEGM/^5[/P_\(I_9N#E_?^6XW%3^3X7S_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g150472g07a50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g07a50.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M;Z#T9V&<ZE8K &\R\ZZ'U.1)37[ Z(I7-J)YZ;*URJS9)*7-L!8EI$T6P_\
M,\+NEF/-N%XAXS>>&<VZ?4[V*@AY%A]0^G>H5:$//_M$TSS_ *OV>V]!HS#\
MOY=*B3X5<L#$>3$^*T17F5-MN.-:0M1-UENG9N3AR8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U0]2>M:;Y,
MC4H[T< ;>I-NC]4;?N(Z0.0. 6#FW);=V$=69[$U]A]XG?Z]0B\43]+>].$H
M[4?>OGD-X=3;RZ-<X?Y'"10M%&C/,]]U'-=$LGGVM%S%XH8F"1]14GEI7J=Q
MXZ2BZFS30(2(BU<V&:LCD1R#(-B'6_HMQ'HTQXO%]O/OY&'NZ].X%S&1PZ9S
MXGW?SC4?4(]T]TRMDY0CF_0WK_\ L4Q&'!Q+WZ]8Y$*B*D$HR'H[8YN8WK3L
MA2%ZT+LQ+<]*K7?Y?N<C#/?7+/QF_B^=>;.B3ZGU?HP4P MK-2J(WL?3.$2>
M@&ZB'W^U;+#=^YXV\H=%CS9* 11J>I6M,2&$#A=/-:GI#\C4;S!SWDMOO_G?
MJTRU=1Y:OIC_ "JOS:S.O53>8ZCYTYA-HD^,Y.8A%;K"G^BH;JHT1UQM;@J3
M';<6XMC:QMV<J@6ORHC2Y)HG1N$FKMRB56O75T'=1&])J$:*8J7C@K#&WTT)
MKSL5R=+;M;9\.^"1MU&Y#<]?U]Q]QU_,.'GKI^;#5[\N52*7CSE12'%S*2?H
MOETSJX9RK]#JMH_0J^V[U/Z2G(;\0!..-!(7)YTFPO16_E",/-JUJ4G2]I'#
MK>R-4_\ -#S;H5<Y46JG&+;$,=-/<4J<H!>;A6:ENAVOKO+>R=1EUNVD([-@
M^B5J,'C4J)O3#+K1)TG!>87J,[MU);]NQOQYN]%W#N]H[[7;'QF5RYC@_4WN
M0RRLJ^@+@W:[/$K%:NDQ\9$#08KX\4U6+J(>2[(WI:WY#K/R:^AM:SFS$GFV
MNPY,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#2/WC/X,GE=1!^
M@>6">R5HKU*JFZ[22Y#0UO=SYI'*]4KYR))VMO2R8R72]-PXZU(8GS9+,-]6
MH\AW>'6W.=%%D;KX)&]E#=LIM'@VOJ5MZ,6#6BTAV.@.5VDF2_."H>Y]2G Q
MT4O1XUP/4FLJK#9X8/V6L;SC8M$]QE;NT%QNQB]$E$6'\>_*K)2^@!99'GYS
MB7,:GP8&N$_W:MC*Y0:,QT)-8Y/;ZLEZ)6[*5H,&)9)WZ6=ASRP:.T_.<0RG
MZ;VQC=4*ZAS;S!R&Y]F -^5VKI7>XTJ!9.KV6'?K=895BA]:[F]N-3*_3G7S
MQ@$W?.TWZ67T-KNH4,C.=E2=M*D)0AP3-\6Q)<_XK]+]#J2C4NK] O\ S6M*
MNU6>F)M Z35PXZW\<[#,<5M2142.5#VNBTLS,'RM;G1-Q8WUF4-N.H63U2>3
M46BV/P!7*=QH%#\\-\WJ/2:%ZB)%@,E3T>!R:O>B+O!1V"K6(:-/RU/&._\
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M'$1T".%:C.%99$C'+Q=1X[3*WGWGT,H2IY6D8,57T?UKPF9)))BW:*X.$E8
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M!HAF.-LA!R,7:BQ.F545"CNB"LDVLD+8D&&9$3XQ9'U9/V\I#F]+92,V,2S
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M5>?7'SR-O02L@ZQ-K[!R!,LP,,6!/3#!0)076;(.U'ARYS#O+7-0]O/22+3
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ML)ADU/\ W9!MR"A*GI#^TM-QUM:PFO5K_.Y#X<LEN+)9ZX+&[9<=L":F,O\
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MQ T^XM('$^B_J2-I"R0I.?$FM?33M^1 0]\Z$QE1\'*_-]J'XVJ$.P6(E ]
M/W&URAT0?=I6XP @4D5^QUQ$ ]**1(QF0V%/7*)MUQN>RU&BZBR7OA$><7J0
MDMODE_'/-G.N>%X%QH'9X9L8)C.6HY->56K#(G-20ES!0BCMF20>2*J[\^9)
MF/HTWMN7*!QM:>0F(_ITEJN0'CGD]5#P*Y_'N%?F1YU6/*EDFZ^\4=M8N&;.
MUY$5^=99!6-2K,$DN22H;Z[CIF-'4I$UF+\[>%Y6^"4->;Z,5BF)\OT'7SHA
MM'4^A$2>F@BW(1+L%2"@7.A$I[%N6$4P!)UIV:,>?B?9_3>=95\ZD)?23./!
MXK!Y$Y5-GSE'/0)3]0MK@0V8BE"M,0FPS C5R.TR<II"8)*<+;T;-DY4=Y^2
MR2?>FRD[9^=WX#E6TWG_ )6$Y93-Q@EE@6QBQ?H951P+!B"@!%@;5 %8'$!8
M^ 0*Q5NE1H)J7,F?<ONSYK[KVUZ1MMMLEN5ZX0P& P& P& P& P& P& P& P
M& P& P& P& P->?0-5Y=;1P2#U*U/TX,S!O;3QC]?K5?&*"V>EE*!9AYF796
MY#*(<T7</E:<9;TZU+TSOZB4[VAPLSX*?B4[R-1>T!NLJZ=4FKU;2Y%P;')V
MBDF()$S8PW4.ICR4!Z2.E$ZVN-3K98Y<.3#F069(I]6GE2$[1M1?59A)C?//
M-)LC;NK3^D /M[Q-J=D*G=WBG/5G_P"XHOSV:*<B.S690U8IPE""-RFWEOL2
M-3VVU:^$EO6QFS17%/I/D[4.$19[/NP5BO;ETO1:R= ID>NR; ,5Z Y%*!QY
M:8@B4-GAH/0+('BP!_V8R/!AQ$0FM-QM_$9W/[,Y;YSI-([9>)7=[$;"5WG=
MZK'>3,2W<Y,SMTU%(BUIVO6".*J[<:MDZN+JG_T;J$T.FN3=.)DJDZ5]-,,V
MWH^)/C/E6TP[++L?8E06;;*'KZ:#*=%YK!>G7&S[Z!8:M^U*8T%W8&S#9E[-
M2(,(=(B0I2F_@ZS+9CZ3E,U<O+Z9PF=TTAT'EW4A]G/MQK7-- JE=*>7&OLW
MRR/FY,NPLUN+^MDQP\PA_0EB=+>A#W'9"X[:7GGG%DMN-7O)>5Z"4M,VT/G;
MHWLK:46<R$9( _T<JEFZU_I,0#(4[773$8+"O]>241N-+8F;7)>CKD+B;;CM
M#-.K>5.<]A+64E9REPA1[>&;&V .")BX8^<2@U2X4L):$O2PA M#. 0-XG(C
MH9E-CW7--.2(KZF_X1+8C%@\8T&RB+$((WGJ*-71J5J\S()BKPWKE*FV"[V*
M3,.PV:?H*O2Y70B*-1&(K _6OMW-1_N(K#R!RJ84ORWS*AE@YD&Y9%309^#8
MX2IQ2+(3N>.C]9C1FW_D&LN.Q$M]G,_%'S:W\?H;^.OD7]0<JCL_RJ$.=/Z1
MU2?9S@&R6NP4\O4YU24-3)INJO0S-%)S(\>SB;""D%+J-M$Y@II<%;#C#$):
M=:E1D2-#EICP?:H>/N6TH[5RX<C<G!]%F1IE(JT\J+EU^K.-2I1&4F#M0-)V
M=^HE9KDEU<Z=*>0YO265M-)TWHO*I/UKS/S?LTV>3MNBR"4U//TIE0U!Y#47
M?-YG1)(+X"S@8R'(-2F.IF8TMF;'E1W69"=H;;=0ES"2V=$9E^1>?2!R@46R
M7@16D;Z'!@5L4_4HXH14>NRD3^H4,9MRH/SV*Q<B+2'E*4^LB,VA+8V7"8U]
M+!EYI7C;ESSP+44I;( P)&AL.U]*JB4 GW1:>FH#2;&/L-0,Z(Z&)ZX:^,?2
MFX<W3K>IC,G3?PV.59^[>7J9?^-UGB!^W=*<JE;B_8N$6[0P]8;' 4 ,UUV%
M:)A$5/@%8VX9I;K*?M4:ARF(SL;Z*H[7RC.N47M'BWE5E'38*#5[K[I"MVJG
M2B0,H!U.76+S.ZI/MXE*3%:+P&_UU?7BB5R=,?=LZ:C*8=:6VXMTO*K6Z?PZ
MJ]5U7]G"=C%N5H>3'#G0,P<PO;9 A5SD9Z0DF**M.R0UEI(DC&WI*4[?A:;>
M2]%=?CNDEP\3W ZRY2 E/:L%LB3:_P! G=5&W:/( [M*.AE[.<MINRNQY%>?
MJ#RC!6S$-.P]BOT]MF5M#+#7R-;;&5=E/%_)299H[J=;X!ML!<@23$">":+L
M.7&S="N*["(*.5UZ?6+2 L/4C3\"<)<@NZ3+^G(^X;2E.B\JP+GA#C;P)JOO
MDKA*@-$V3GTYJZ=.BN'$V3K=AE$7P\RFOU^0V19[?8AST-<14#<"2WI#"'V&
MW]$Y5:G6_-]&[+NDLV0I;!0FB.1'!=>K1. / 2UCCM6L(IV<+EB2+")0F=48
MR(\B+]M(:BNR&-+^D^XG8EL?17FWFSG,;_R1YHT]4.D"! 8^THBTB<U&!<ZI
MW,AC@R0Q#9:C/1P%&@.?!;;K:Y25J4C;2_I:&;G*N7/#O#Y!6O&9D(A-E MJ
MU(C/0*8@(=8E.!)A=HC78M1C@8#YLW789)^6,CP)[9!K;S#[*G'/F+RJ8#?,
M%/A+H2IMIO!U'.H%4$ &BTFK?3<#T&UAK=0QY+]-J8Y4K53(!4-L2$[;ER67
M7-RW9#NFW6R98$+XXY:(5]1PK="S[-'%\S&2"9,+]4-SZO$*F1J]6@?I]>'M
MKCUQRGL(9ER$OD9"'WONI$A6VE-#E5E\FXA7.,;-QJ:;L^P)YV$0F5DM("SA
MC=@BAPP!^QQIB 4>P-D"(D!$:>8W-4/UMO:VH[:UK4H6Y5@,\8\D"[@H$S;E
M"A-'%EC(])<;(CV>#$Z&,Z55:N7?EA'R,2N4,T#@Q!#8U^!)9$0F83SS[*?A
M@Y5^QWC7DT**U%E3;B8TV%KM>6\2+#4OOAZO(XRZ)ANK&A!WR_+'X. 8=<;T
MAQUM+ZE*^J[IQ Y5(O.'#2G%!5P:.6;5D(VHS7GHR&6640P%:I="JO.JI7XT
MAL>,>(JAA*JVX[)>:T\XX[O2U.*3MUP6Y;(80P& P& P& P& P& P& P/)/C
M;FP9L-+B652XDF,EY3#,I+6WV5M:<5%DH<CR4HVOX[;<2I"_A\%:WK>\#2??
MA.B28S\<GT'I)'4^O.4\HTL@&9@+IT(P%LM/IP6 V'VW6JQ0[* C2AL:'M&U
M-_4CR5R&'G4+.N5?JP>$N>6?YG2MRNR9L& 3$U8@.36!\FJBS5LE6@RS"^C7
M]M$)AE@V8$RY,Q+[KPDQ)9_M5J^K@Y5Y!_@;FL.L-4QZXWQZM+=#DR,"+-&B
MY,ZQ!)!7< PV:A0$'1Z8PTW*B-1V9*4--N[6G?SZTK0Y5:-&\U0N?B[550-[
MLK=*L]+*TYJO_;C(ZJYHA*-36C->D0H\:%'+LR+1/TZ^]$>>D--P&EK^2%K3
MI,L11_'/+^=Q.F0*L0MD6#U:FEZ19H<TN@PPD6045;'OP5&(TZ3J6"@F9##'
MUW'T._5<=?2X\ZZXLO*WJB\WPSSJ4:/$D6:T_I9^>4FR:>02'+U/2"!458$1
M=C9X]R1IMDP!@-N.-/,O2 \",-<7N*UI.QROS9 7XOJ @/=!4?H73)+ES_9N
M1*GD++)??CF:W'AL0;"^TPN(P:+PM#X^X*IJ7VAVHD;3*-?01@Y?!$9'X].2
MK^JVBTW^5$<2 :^@<+QC$C<&HBQD&I@))5,2"7)5<//#0YWV,I]_2GX;"4+:
M9;^FH<JW"YQ0Q/,J17:($E%)X^NPE1D$3<YPD9*2I$A^<1*E9SOP5)(%",IV
M0\K6DH^=S>DI2G6DZ);FIMA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# JO
MHG'ZGTXM23%E43^XH1N$>#,PGXC<1^;!LE5M+"23,F%+W)C_ *G3XFMI3MO?
MT]KUK>E;2I)9<*-5XGYI]G.&,V>^Q!$\8P'?%0Y=7CP'HFZ'>N:E),Z*BJ:C
MECQJF]!F07B<M#Y!N-'ALM/-LQ6V]%Y5FS'DBED[@J[0[C?016"7U9*G%%OU
M%8BF6=]-$:+'A \G42&B#YJ-SR"R[')*G0V4./;C,L.*;6T.3'GO&O/CY.<;
M=MM_A&)O[;Q-3XDJJ+W$ =),]$.7BNQXLZI382H)N9U$MK3[K;DV(VMI,=]O
M3>_G'),:_P"8>:UBGW"CAG+%%!73FS_*R2/U&(Y*B5A\]TRQ?./DK&[5HLW/
MZL3UI]_3_P R$L[6E2TN+=)FHS(\=\QG')!HB5M\]+<B_NUX8_, Z@51GJ&N
M@OW6*)6W7D$)J"9?I1":TZ1?G28CR&4,.(8TZT\7E4]J/G^F46QM6FK3SPPJ
MC]::>VE81V/,A6'?.$EX,AEP'O\ N,F/RX:RE:-H>:;6]\BTJ4A39+<KSPA@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@02_=)J7,X(DA;91
M5EL\8V!#Q0=9L]O+$BB Y>PR&(@.HASAEYN&! 39DAW3'TF(T5Q;BDIU@DR]
MK%^I$D"-M#%MKKE>,PHA$08T8@)@$X<YB)*A/P9"WTHDZE,3V%-Z3\=J^LCX
M:_MD_$8?F-T"DR(#1+=I!1(ZWX,-Q)$I"&R81(C$^^B!R,2:^Q('&G(VE*W#
M>2B0GY5?%']KOX%Q5>'?1_(ZQ?7N;6$X9#6:/)J\5YPG2;O!JZ';I^K?LM\+
MU*KS5)<0:4 GI9VD@K6UP9"=_!32]:&+4QN?5^<\^ E[/;K>'$@P!VM5DY-T
M\LAL0?N!T-6JV+)11;<Z;#E%#-AAM)TXVG2$OZ=<VEK2EZ$EKYA^N<V/V^WT
M,3;Q,JV4,T$K=I$;6]&6.L5AK^K6) M2I3+$$F9?KBDS'(L1U]Z.RI.W4H^.
MM;&+C/@_CG7N8)*H!LWNK32^QT(T\.&FQY&5" $9)B%$L9!J'(>5 KCDVOS&
M-SW?DBI>CK1M>E:^&#%2J):*R0F,#H%B!32$H?&+18,0N/DS)(J8VMV&38BL
MR%OO#Y33:E-O)3MM:4[VG>]:WA&"G=(J<"YP^?*E%9MLE0X1%X<%K-GL$<*.
M)O3XXN?:2P,.0#U&$5?%2D172<B(B0J.[]/:OIK^!<>+[O=%H$=RMM/7:J(7
M<"1,-5=;/B]ZL14(-)&# X,I,K:",P4+#RGY#;6U*9:CN*7K6D[PCW_ME3]0
MXQ'=KK>A\V%LG#G?KHO[.6-U,B#MD(TK[KZ#\+1 @PQ]5*MM_6?;1\?F6G6P
M_F[I3M*D(W;*UI4.67@2T[.B]*BSJ_$^_/0I&ONOBQ+"0=_6EMJ^"XS7]NYI
M*?X<#ZQ+;59ZXS<&S5^:Y,0-<B(B&1LE<ILS&ES0ZXR69*]OH+0Q[[L;:?CI
M]IAQ2/F2A6]!&B?6>>""]:#3;0.U(MD&>3$3(ZU3 NAH]C;ZR!0]$2\&"0IN
MD*;ANS'V&YKR%-L;<<2I.BXKX4SM'(>BPB)*A=/H-Q'B;"1J9.;6[:#,18-F
M$FG*V1!27H,YYMHG%/M*A*:WOY_N=?3UK:OX,&+.K%-=_P".R+NCGK%_ /6-
MVC1^CLJ:E?4 O5&7<W>>1I[%J0G=9>DO71E0],1,O<O<C^U^G_#K!B]7UYMW
MCD/6Z!2>G4.^U\M3.B,AG*@3D3$AWRLFP0&"8D1L49U +0[!+@R6W-#GV6YJ
M=*U\S6L%EG5\>A^@..<LI=GZ!<^@5Z%6*<+E&;#*&R]6&= &09PP;.F:# -$
MC$EF!--1&W]M,+^CN0CY_ETK6#%NC*W7LO+^?4JP="M%V Q*K6:-;^DDIT.:
MV8DNTFA"9)RW'A L1N<4/10@V(M;NH3+Z_F^"-)VM24[&+6 '>B^+%+S)YQ$
MZ $_:Z%1*UTB</D./0XX^JW ^]5ZV\0*RVF14$L5.L_;MCG7D$/F6C>V=)<1
MM0Q>J<RNC\]@RY4";?*9#G0E2TS(4JT X\N(J U*D3DRH[LY#S"H3$)Y;VEZ
MU]-#*]J^&DJWH8KU.WFE,-D'G[A5F61,,41*.NV 2VV-'G=IT$G$'%R])APS
M&U:^U=<VE$CXZ^GM6$Q5?,>B^(2[.6J$+IE3GF:X7M%=M>X)6/,%TRRTV'5B
M!^L70Y'4X&J5EC0+F/>;@$'X\N0VZM33:],O?(7%QE9;%KJTHJR"C64!(-R(
M+!2.'8,#G2KXR4VX]&(LCVY*I;L&0RRM;;R4;;6E.]ZWO6MX1XTWRCK<4RBY
MU1;R%GFUM)L0A3B'*MI"K.A2-3-J2NN:<3N?K>OC#TK7U?D^.L+BH\?[+RNM
M5PQ;2M^K/Z  C"I96:,)L'7(K!TPFOA%:@ MD2,E9D\K[*(AII:Y,KXM-Z4O
M6TX,5K\"_(3XXLJ+,L)V\).34.=C>KGMZK]UC_;T(O"H4\<;AZE5IC9AV3&Z
ME7?A"A_<3TN&8C:F-..I3A>.Y^_Z0+R/II;Z^K/-,KK<ZU"'G^>=2CM6\8+N
ME?YR2B\]=?I+:.DV2!>[8*$O!@&R1=N<2BM*C:4^U\PX[GC+_D5\95^N62WG
MNW# E5JW-P_7IUC+53H X(5YN=(@0T*U4PG+J;,3H4)@Y:!T"8V 62D#B$QJ
M++;9?5IO!QW5GK9[M\I46788ULZNR%CU;L=*\]G#TBG] =I\7MG0);,&N\T9
MO$6J/T\A:6Y<AM!-B-.>_0]K3LEN)K>MX..ZK:Y/WOD7<I/48?*+I!N4CB_4
M[)Q3IJ(,$Q$35>H5".-E62IONE1T!DA*$LEX_P!1^&J1$VI>T)=4M"TI)99U
M6]A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# I/K/)3/1S5 / NBE^?$*))M3S$@4$"FGG]VRNO5B3/A?K;
M;\48?$C)<G4&4IJ2TUN2Y]1AU.]:T67#6YG\?7.TOPXDBXV.;4JT%OP6@5"8
M*K<J%3M]#'V>"5.)(RAKY0W91VK(C[*9)<VIAL7!3\JELN.O%Y()?/QX!YCU
M?'4.8#8"DZ@KFO1I%LAAYS<JDF>@2+W?B0FK(ILV'/Z'=5FR<;1A<^"Z/9E;
M;1IQ"]_(6;FS?1O+=/Z<;M!RQF";[UEGJ(IC/#P9"()D1>0VKDH'[%DB/E)6
MBNM7HP7C:<TKX$YOS[^*&T)T<S=8KD'X0YH"I5EHK!ZPNC[(?V6E%9+SI _+
MA#X=]<J8XW-,S"T0J_4K1T&47C26X\7;LMAGZR%Z2O:R\D8/_CHY;9I$Z0:N
M-Z).G1AJ#9ITHH^P7*%#0:HM2+I&(!I0AJ%>7+=46SCLYUF4V[+DN-_02TEE
M+8YU[QOX^>719XV5.)KF06BM-/G@*  U0FRF*B6,SW$D-FWCY7]"/Q#TN-*'
MKE.LZU)>4WM.EZ0@<J\G'?%'\7?42ITH1'3*&/$=28JOVLYQKHTFR=D>J#=Q
ML3UO UZG%J=!@B:JJ**'CYDC]/;G*2S(0B-%T@7=F+9Z3Y2 ]!GR_M[S<:J"
ML$2CP[B,%S5S3)G?/4388 D,NA-^39@AJ:$(O#"<E;TS1""K>E(2^IQ]8FY$
MYWB6I%J)^QA.WDMO/V\G:II@76JL&:TDEQS?$'!@<#$'[# VEU)F.^^MEO?W
M9!MQ;R5L/*CZ'*YRH/T=^,T'WD+S4+-M;3K-3L78K!<4OLI "[S%[#(&'R-+
M< "!LZ$&I0/HU6KEKA1XZTO)-UB$XZX]]66IV+-^&LY#\++9-ZHS)73]J) *
MY4QUC)(F/MR>BW']2<9[UU&VI36M-JNOJWGKRZE=5L:0PL*K7VB6GDI7AU[G
MX_'98'._Q26+DG87^V<XZ:'KMIBS^ED*F*D1=F:E3G+,(+UKCT,< FUU,>>)
M\NU*YVD53(LC>VTP[1,3*^KM#&T$N^68J,V#\-P^QR)>YUJK3PM_KQOH\2O3
MV'2P4122-DJUK#\ &Q)M<VVCC]2,!BBH$1>EO?3LDY"U*3IG21S>PG^(^UN7
M&R6:J=A#\Z%V;I+G1I=8I=: 06H;D?OKOIBN QYB32Y,F.Q4.LDB#\"5IGZV
MATB/"<2MJ$WMRG.8Q46KGX8SE<VJ2SV6 ^9U9:C;H)_0QQ@I6[%5+/7K2H]3
ME*&2F )XS+!O-OR'436OIE)OS,.?5^"8ON9>IW\-$^/3A-$KO4Q-2K4*%R%!
M477Q;,&!93_':@]5 =\+1HU>CJ_;TDM:)L@BES>_KI5I2'?[DM@G-BS?X10!
MB/J,BT5<>B71BM./J8CE?@;(%;1T^QR;E]BQ"AAXY\I&ZT3'%DOQ9K)>*U'4
M[IMUM:G"^Y4HL_X=E6,M89T>^ *X-L.^NKT!!P&6(E:UT^Q^C;$+%46:NK[(
MTFG4YSTZ=CO@ASC VR1X(Y)%"M,O)D$YJ[(?@RC$9DR3)ZB,?C[1(BC!SPY<
M>.L:2L_7;0:B7N>!$@+!U.9->[:;CQYQ>;N9 9;A?27O<=S[@ON+;1^'^MJN
M06ZSF>4F"0GH<OH\ILS6(Y55@*3_ $^7].389\C/K4D@38FRRC=5?>=6M]^N
M0V6W%*<UO>$Y_%3(;\$8D'5WZQ'Z>B?I+556-+&2=NES8\RNPJP.F03$6$^,
M&6&BF8=5CZ;!+982+7I*HDI"6(Z&R^XM*?\ AUB$>B4VYR[#09%:I/61788/
M,YM=04K1<_$KWG\ 7#6:>4!3"EAKAS^;H'D_2E[>?C/S9OP>=TXCY+JG/3S1
MCC7XH._\-[_S;HE"ZQR\?4>3TN&&"'3$&19NIV(LKCW)N&%ATL@[SP/(J]+D
M43E#&H\%!HK&A3)K[\*-#<4C;8N^68\7Q-_A0D6"HP:-.ZJ#9KPSG*^6P%#:
MN!&6!JKBAG4!E+?<L\.GMEMV&"UUTJNU3F51U]#4U$_6TN:97]8ON>*[J!^+
MASFG20?1*@2YR";'72ZW(U4@895?!7#=F[16^]5JNV!P/7HLQZO\SO\ 4!KH
M5K6]_38C[;5\-..?,2[\S"&4[\1,VG+XVXST: 0<X]T_F70TJ==E1?V^"<RY
M9QSG<;EMU0S7G&I="L1_@%1M4YIM*7OUH.VA._ME+;5#F^8'\4W801!,O^<E
M +QZX&J4+D,8S30\V1Q(S2.XB/1H8]1YNP26I*377 42?8XT^/(58HL2)#D/
MHC0HB&:<YV9BF_BTZ74:KW&A2.X![72^R>:'_+ F!8Z]&=L'(N=2 K\&4CGU
MG@!(2D:*V(J3L!&/(B*03,$$KD.+8@P&8XYS.?-[>L_BQL?:>B]%O]RZ!5(<
M;HQBK&2M*IXG=1JK\^I5J[5L78K-'%@DNWSI46/=5)C6LE\QF)#@QX:5K93O
M>";\3#<#PSY!<\=4J]U)=K7<7KQ::M<"AN4XX^4*60/RCGW-;)934I<"!]X>
MOA.AJL)-WY/@LJ5E?)\K7TTI.=V[DW@PY,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,")V6]TZFKCMVNRB*]
MN4+L1J.HO,:@MO"ZD.27LLU#S^T-;:"B=[E/_P!M\R(Z%N?#Y$+VD)%$FQ9\
M=F5$>2\P^RQ(;7KYD[VU(91(94MM>DN-;6PXE7RJUI6M;_AU@?=3K2%:0MQM
M*M_#X)4M*5;^96D)^&M[UO?S+5K6O_7>_A@$N-KUO:7$*UI6T;VE2=ZTM*OD
MVG?PWOX*TO7PWK^S\?X,#!&+95J]K6S]E  ];C$INMF#(X;K<,.AAPO+U][)
M9^,86W*:5)7_ /"QIQ.U[3I6OB,5G-NM:^.MNMZVEQ+6];6G7P=7I.T-[_A_
M@<7I>OAK^SOXZ_\ 7 CLFYU2$4)!IMA%0B0>)6IQ./-F-1-0H]Q,$Z]5E//R
M%-1M.GC@>3$C-Z7MQV0W\FD_,I&E!Z:_9@-J##[#7BD4H%*Z7L<0CJ5IB7]-
MYV.O37U4MN;4EYA:?AO6M_%.\"(/]FY3%2>5(Z!5F=5?HE=Y)8=.%8Z%!^F6
MYRL-5FCSD;5I;-C.KN@K[:-O7SNZGL[U_ KXX7%3Z<4&#(4LD2(P1XX?&F39
M\^=+CQ(4*&.:6\0ERY3[C;$:-!9:4MYQ:M):2G>U;UK6\(_ \L/*L_<0)&GV
M-NR64.[;=92]N*Y])YV-M]MK[J+M7PVAYOYF74;TI"E)5K>P]#TN.S%=F+<T
MJ,S'<E+<92N1O;#2-N+6TVPEQQ[^TU_!I&E*5_8UK>]X'BDG@L$6LV1*01@E
MEF._((%9+8N-$;EZ9W'W-<(*C:A+=W(;UI+OR*^9>M?#X[^&!\0-E!6<5'.
M2<8D)E2)D2/-9VI+3LD>0DBIC"=/);7]1@C#=:WKX?PK1OX?' _$6U5N:DZN
M,<%NMU@A,$V)S[QE#04B/'Q"TZ(1<<4A$5V&,GLON?-O6D-.:5O>M;P,G$(C
MY\6//@3H<V#,C1IL29$E,28LJ'-;2[#EQY#*ULOQI;2M*:<3O:7$[UM.]ZP$
MHB/@Q9$Z;.APX41F3(E3)4IB/%C1X3;CTQ^1(=6AIEF(TTI3JE;TEM*=[5O6
MM;P/U%G0IL>+*AS(LN+.C-S84F-(:?8F0WFVW6I<5YI:FY$9UIU*DN(WM.TJ
MUO6_AO6!CB=D!!GP,8F3C1'[060"K[:U*5LH7<&$S*(4;;:5IVZH8&E/:WO>
MD_(RK^'X_#6PR4F;#A,NR9DN-$CL,O2'WY+[3#+,>,UM^0^ZZZM"&V6&$[6M
M6]Z2E&OCO>M8'YA$(!*+'G#IL2?"EQ8TZ),A269465"F-:?B3(\AA;C3T64S
MO2VW$[VA:=_%.]ZP/ $L82QM$7P9&.1:$F2M>(N,?/\ +$- Y2X)8>Y]1"/[
MO!EMJ0OX?%/QU_!O>L#UQ"<*<AQR.]O:6Y$V,KZK3T96W!TA<66IM$EME;K#
M;R-_*ZC2FG$[TI"E)5K>PPEGO%0I@]12TV,0#A:@SR2')TUIMR1 %L(E$I4.
M,E2I4YF!&<2X]ME"_IH5I2OAK?QP8293K2/CI3B$[2VIU6MJUK>FT?\ Q.;U
M\?C\B=_V=_V,"MZ]V;E-L1SYVL] JQQOJU6+7;G"QI:-)3<ZD!;"NF["!VVK
M>IHL4BQP?N'=?VK6Y3>E?#:OAA<5-BAX*$::=+E8 Y,B5'@Q=2I+33LPA+TY
MN&.@L*5]::1F_15IB.TE;SVT[TA*M_P81ZV)T61&:EMO)TP\S'?2I[2XZTMR
MD(6Q]9F0EIZ.MQ*]?VCB4KUO?PWK6_X,#'EK&!!2!,0P5A#9)V3-AAV);R6G
M"4H:'(V">Q$2K^%UV($$292]:_\ A986K^QK ^X<V(L L<;"$H9027'0"XPA
M#?0]&FC"<1N</G,.)W\%QID-Y+K:O["D*UO6!DDK0OX_(I*_E4I"OE5I7RK3
MOX*3OX;W\%)W_9U_9U@?K 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%$^@JIS>WU$)'Z:;" PM3NU4Z@T^
M:1&?0\GF)9BWF8C<1Y]ER3#(UL?,AD-(2ZG],DR-.MN,J<0HLSX-=#?A^?.)
M6LL%Z[^AE+$WT$>U-W2-S9$T7TJ-U"&;*7I;5P'N7B]@(O35QPA=2H3<"+ :
M9<B2$N+PO)E.K^9.5V.3=NRVRWQPC8\09?EVDG6T+EU&%4^>/4-!")-E2&)Z
M458P.<.PU-(3K1!*76/[?Z;V#E>C!4'R)8ZWU:HWR3T>=:PDRX6/IE^=?#II
M[-AEO5FDPZ/7':@Q*DHARHMW _M7)?:3 8;GH<8U$2E_:4%Y:8>$KX"'V6?T
M$Q<>B!;D3OR>AL//V+EH2;%%,= K:0;TF$.T?;'L%M31@QZ:[&;BQR+,+;6V
M&W'$R&B<GV'>*J*:-W6>[T1%C+%S/2SK!%(<F2:!'[B5M\$=-2J=;RM;U:.4
MV2=/AC'H+$ C"BPXT1_?S1F7=#DE4/QR!!A.J-&;=5)T&VN<J*[(&^>COI,N
M\7ZQ<.RC+)TZ3+LBT7^QEB%H^W*$U*%*5&AH<0EI>]J2.2&5WQAS<P3K)&H]
M-W,$<[MX^39@(>&1& S%RB/-68E993U7M8"5'Z!+CDAVXY7Z\E+</:VW&Y+;
M_P K8Y5*++Y(I]JN5FO3'4R+,&P=0'6H\' "X4]EOI=?N=19J!)R;#ER9,&Q
M4L5&,!?J*0G3>B[4A]*=C&=*'+1" _XXZI"@C!QCH9"PCF*+:Z23B$8=H?@S
MY5AK)"J-W*,-G=$("(EE*P9R=V)EV/*$6%QAM:X4=SYW%CE67+^(PTB/9VFK
MO)7=9%:EI@O5ZK,UE(X26@]U'O5&M3Y94BP"K)^?U1+<B#J2XG<<-&0]I25-
MK:')]*5Y+?M/*P *PVP!49\7J7:;%9 '+X,7]CE5J\VTJ7F\E3 CF'HPJ-7[
M>%!3)R&'WMMS SL/X[0\XY@Y/L \NU\J [>,*=>8Z#!Z]&K?*E(FT&/*$ [)
MR"QVYV"JQ!6"CHNPDQ,EQH9*>4@<MV.(:^J^N2O<C8R\EH\/T.'& SIO1V*N
M'AV2$</BV!\NLURXV.8>ZR3E%YC==N-=+*NCNNGMQQ$U$UR5"4)8^&I&E);:
M').9_D^A=+LAGJR;<T:B=$D#[.$D:K\"8W$K9T<T@R/$RY<I>UCKM7'DQIBM
MM)U(B*TVZAQO^TP9QHK[G_B:A-GY\U70H%K?IA^J#"0V/724(:",U#D@NM0*
MS^@OW(A6(H8']Z,.A6-0520SBMM-25I>6K0NZL@U^/BF-E@BU7&4]51=7>K2
MJ3^CRX0%EZ1SRG4@C90\(39QXV,?L4ZK.33.Y\8G#+MSEQY+"_@MUV'*L[T7
MQ<_T:)RT3.ZDR"KW->9P>=J U^BQ!T$DTBI6JFF78JF;(V^-K]B@GHNWA,A4
M]AE0B/IA;>U/J<I-V'\!^5*:%[E6RH^] W95+,$.E1Z'*I,1XL"JEAE]X!AJ
MG3S*#3,6G\XU_&G*9>'M07T2I A"T_00XIM(Y7"+R_%=3$_LH#L_6%&%6<BW
M4F9=GJT4G:",4!*,VBL5NA%WC*XU3D[Y/5F*U87%QIR;'7PNDNH8<6O>QR9/
MF7CVK1:WU9H-U!19N_T*=Q=1FN"RX1FJ.5,2#YI8@P\)^V4^N+KP0YSY3<4;
M]FV^/2],BHFJ:?7M0NY#9WC6NCUSZ$0[=6 ;723UJ?+TFMT!D#'=.7>M>DG
MXFJA&;S-U5ZRS7^B''_MGT2G""Z\E2)+7P?;V7EXII=/#(4@S>S0.R/Z/&"!
M0D!A00@L:L>$?1U^2WR^-.<((98HY=_J++$^'_<(TN&,;:6A.EI6P3D^<#Q?
MNW<BI=4ODBD5\^*)>C9DN#7:;$)5X"!]%'K<2(UBFL/%8ZZYH"./0XVE,OR(
MSC<=UGY7$+;=0.6NBPJ+Y#"4CK<WI\*WS9L10RU"Z]5MQ28\=28-AL-V)QP-
M58%6>)7XU0&C;C]O^F2!DEO<J$U*97'5I+;8N[,PIY_\=@?8,,$C=9---5B
M'$5.*[764BAH*)JIG++594$>?&S"%4O?0 I$P6B)E,*=:*:AH=0U$96HO)Z"
MOARBU>/8[&8OVWH[).A' Q2VA;1=54^/3!@80N$]HS>B2)X@=#$+4&FNMMDP
M"'7/GG26MOZ>)RJ)7ORB @U,$SS^SUNZ6WI#9E04)< P[=4ZA.(B;\6A6*Z0
MI!)"K+^PM4NKD@9\SFWX2X,>0RE?T_MEEY7.K96#Q,!U3E_$@Q"_O&P_+D2H
MT(S2Y=DK+IY0_F5JXY+8>-"+*/.)5$FEY3[SB'6VY3C'TELI3O:M'.<544#P
M0IFP#CD[M1F4D8%H=+:8@U6*'=(T.JPX->/U$T]#L&XQ%%IHS<P+]YJ.W-BL
M2M.K<D/-:4HO)?'F7D59XF)O5'#75Z[FXULCS+80EK-)*MSIU>$2A2[%&)6$
MZ/79R(%V-)G38+<!D@X[IY<="][^)+<MF\(8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&J7J'C=+[*GG=?L
MUA!U\S.E])I]943JZ;.4(IZ%R.ZU>R1:YIN:/F!R,$#(=GKE)<^AIF$I#NO@
MM*T%EP@%'X#0>?>DQAQGJ3$HY %65^K<I4V1$ZJ@:RV+J]@A#:I %6.,&8J+
M(BX28[L"2/DL.O!8TIK4=;#262VYC^6+PS6K1^WSIJV-%)E_)WI<^47J44MM
MJL7,5T&,FE/-S3#B)]>%'+K&*)85\C+LP1'7MM*](<:')#Y_CJG'[>>!3>M"
MGR17^,HN-K@^NM:*NNS!'1!/[57G:;.\W9[QS.1Z&%?II#Z,!<*'%@MH91MQ
MEZ..3V7GPV(57;37:5T=CFT/HLDX'*-#.?L$8SS!XM)*UF.RU&-PGQ\RB3'-
M.B9;#L5<9:%)2MII]YMP3=XOB?\ #0]B%-TSTRO 1,HI;FV!I"B,)K>Y_3;C
MU UNRSAS-O$Q9W519WKNT@S"5-+9EPV%?0==<U\@Y+KI7E8#4*_UFMN622<'
M]@IYVKVMPB(BN2RDVP6OK1XA:3[CTJ2S8CLH/TYD6\N0WKZT4.PG?P:^1A@F
M5&3O%(J0"L%.JO4J_6+/:Q$^NWIZO\XAN"R@Z+7^(P80::)197'0FJI I,>6
M(;^];EQ$FEJCK0C;JGR\EZ5;S%&J_*K#RZ-9XNF#W417391V!7' I K,CVJI
MW$\Q9/TL]&DE25H)U^0Q)(M2(TG[66G6_F=:VZZ3.N5?W/RA:#O(.)<<BVBI
M$(- LMQ>.&SE,7($1ZT<YUU>K5]@13X]BB/3R]2E74<F!-F$WYGW$!)&2Y)E
M_.I99=<O"1\'UXBS)8>OL^1J6J]$ID@F :(SB=LMG\>WZ5=S$I9EK]2M-47V
M.(Y%E+1IQ+M=B+9W'W]+48<F&.> X!<R5GQNC.@X,U749$ >" $@:1A3I-QO
M-WG&7&P5O%0#$TO-OT@;8D2F'&+ &A0V%HCNL:?V.2P9/D/4_A;G&%WF("3+
MZ!T^^2R-.J"Z\#C(Z;-Z%,DU@)6$6B2X,!@_V]VW'U]\YM28:-_!'S_!L<M<
MI:>\P@RO,H_-HT\(V."]E1UVHLDZ?#)@*LIGH<B\PJT+KFB,1B)"%,37X<1V
M,]&^WVK3J&])UME1,ZY5=3?"X6D7KFEH%7N=^SO-V@6A](CCR@0+') ZCSVO
MOV,,D#:A[0\]:"5%7),JD-38Y-@@ZP^TO>G'7RW=IA][MXN=MG3+ET9F\@(>
MK-<(]TW7YO/5D(-B6V&Y8%72>L.HN$+72.;,)YDF9$&?2';C$)OUMNN:9VA\
M<M,)3RCR?)YC!Z5"5TXM9%='YX$HBY,\0ZR]5W %<D5J,8K?_P!/2=P]E8\G
M[DDS\VU2Y<=ASZJ/I[^86Y5P:\"B]5HU7*-?8=*8L@\@$L26:%"(1# *8+YO
M#@CY#'Z_$?CN5\M1)!6"_'=:?9GF)2D+1MZ4J2.3\J\"QFE2Y@WKUA'&3//>
MG4.QF6 OPG%YO33=R+O]$5(T>U,:Z)68UE8'#2"GG%1Q34N,G6D3?_EQR\$N
MH/C9FC=!YK=F+:'E,4$A^M_I[E4+S"D>8NF]2J,BMTFRF[P8F4OG$Q[I[I-8
M7Z4UMN=%UIEQIE:&V!RTPA%B\4'-V686!7*,TBX=B(V.SO@@RJ@]_%K<^@]*
MOW30MQ?2?+N7RP'Z[?':B.FLLCUP(.VG]HWMK^U');_5/)-3ZKT@M?3#M?0T
M<!5<>4'RJ9")$)I2G5+N=4KY&4961B[EQ!O\=7WK,=YAQ3$L0RIMU/U/BT)N
MQ,/ERWRX2Y=7NSCX743!FU=6'DH<>^FH$TL7&3)>[5+'F#@8W8BU9LI('/M:
MVF7-1(:GQL2-$D;=0RWM MRK:L>!@8N'"0>Z#--$H"YNAQ:)7_TZ;7(3B?0L
M@,.J;TT\:4$8JAGNL>>.WKZFF9=9@N?+\Z6=QAR[,=+\&%'V52179WJ,6TW^
MHPHG/Z2L!3 EQKX@$$YU; =3>N,_[)VMM?M#-(QE2W6S12S/R'%-?0;0H<EJ
M]G\G(ZW,YC CWZ74Z-S4/'$0JW"!IEF%ZBLH@)?@7!HN-+P=S!#3<:0T[J4P
MO3*5Z1]3:E8)NPK61X;LA,X",F^\DYZQM2:!F'&J3''S[4:)6"L7.Y&3<J'9
MFTRX-AO <B3CPY").QWZRY&:>W'8;0H<O)'"/X^3)4RX:)=G@$GMZCQ&69_,
M&/H18\6I=*I0^Q08XZYCH4#HM>!] CZ&&D,[<9?"17GFY#JE+3#DO'B/E!CC
M?2CW0E7XQ<'"P<D+@QRB"T*4*9+3 TN:-U]M9'0)  V\#1*CL/#E2(Q"7,?;
M?3J4ZWNEW9F%8 ?!\F*8+V.R=BGF;%/,)/C"XJG1:X_63[U@Y&6,VFLQXI^4
M.K]IL,+ESL:3)A,1T:T9D?*W]+2V7QR7[YPX!O@0BWC5'0AM=K-5PHK]GZBJ
MG08Z:USVH<_;?E0EV"Q+(G3C=2T0(S=NM?<3)3F_IZ^'S*);ELAA# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MXT=!@%7I[[TM;K0^(UIC:_E_^6TWI.M)UK"6Y7_A# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# I[L?/HO2(
M%#&;4 T5JW6>9=+#[.:TMQG^+^XB3AI\,A+,AY)ARNHEQF7$IUI.Y/P6M"%;
M5HLT5(5\^Q%U[MU+>"ULL+[%T2Y]%8KD"[G>?;D-&*C2A\YTHX'KQ?4TG-N
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MK5>9<MRM<RI]++EB)BVBA4Z$Y8K  ED&AS"7(@]F4EEI?PU\J26YZ-IL(8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M6I7SBXQHKDG"]?'K]U"2 (VV!0H'09XID>_,HHB>=H,6?R^3 9X\LH%C.![
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MYM2G$);1I"]K_P#CVM.M?!6U_P#M^/\ 9P/I\-?P?P:_@_L?P?V/AKX?P?\
MI_!@?-3#"M?*IEI2?J?6^"FT;U]7X[W]7X;U\/J?'?\ \7]G _2VVW$[2XA"
MTJUK2DK3I25:UOXZUO2M;UO6M_PX'Z^&M[UO>M;WKX_#?PU\=?'^S\-_V=?'
MX8']P/YI*=?V$ZU_9W_!K6O_ (M_,K_^[?\ #O\ ]=X'\2A"/F^1*4_,KYE?
M*G2?F5\-:^97PUKXJ^&M:^/_ +L!M"-J^;:$[5\NT?-M.MJ^3>_CM'Q^'Q^7
M>_\ V?V,#Y)BQDZ^"8["=?2VS\$M-ZU]'>]JVU\-)_\ \6][WOY?['QP/O\
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M60EAK?SX,5D:OZ5Y;:J/+Z)%F'1=8&GJJ!+RK#7"H1\,J[PZN4JYHM'FL(7
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M1N-R)=FHZ+J.YOU6^] CDBA=6X\ET!%AI):>2U/WN,GXH%TUS+?FR141/X,
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MY'SO_+WQ?_.E1_\ 'N#%['\Y'SO_ "]\7_SI4?\ Q[@Q>Q_.1\[_ ,O?%_\
M.E1_\>X,7L?SD?._\O?%_P#.E1_\>X,7L?SD?._\O?%_\Z5'_P >X,7L?SD?
M._\ +WQ?_.E1_P#'N#%['\Y'SO\ R]\7_P Z5'_Q[@Q>Q_.1\[_R]\7_ ,Z5
M'_Q[@Q>Q_.1\[_R]\7_SI4?_ ![@Q>Q_.1\[_P O?%_\Z5'_ ,>X,7L?SD?.
M_P#+WQ?_ #I4?_'N#%['\Y'SO_+WQ?\ SI4?_'N#%['\Y'SO_+WQ?_.E1_\
M'N#%['\Y'SO_ "]\7_SI4?\ Q[@Q>Q_.1\[_ ,O?%_\ .E1_\>X,7L?SD?._
M\O?%_P#.E1_\>X,7LF]2Z'0+^U+>HEYIUU9'K;;GNU*S!;(U"<=UM33<MP--
MFHC+<2G>TZ7M.]ZU_!A,6)C@,!@,!@?YO_2'&*G^2W\T%D\<^HW3ML\C>/?'
MO/>[C?/L&QG0%&ZOV7KEX,@D6WJ#( @,FV.'4*^/2S @K>TPV[KYOA\CLEMX
MUEX?;Y3]UK/1_P 97X'9/I0AY8U^//FS721JR:9,]ZL%&JAK])Y[2>F2E(,?
MMU]W\NZ[?H*4[W$U\9274;^"4:6LG+[F,YT56+\3_P#3\ES=*KD7\<E62;M]
MQCT">.?I$YN10+?.]&&O+@X'T!.NC*T%F$NH58QN.EC<O;HP3)E)_M4MI<+G
M[G=$;]Y?_P"G5YMTVV<FL_X\*RS::DYT2(^[&H))\*8+\SL_,ZP= A"BNBM-
MOFR"NH1YPYA],?<P>+).)WI<;3;HE^[9G*;R?!OX+5O-ZK?XI4W>'8NPV+@O
M(RM8IP;0_N_4:3-NT/H 7ERK!VD!*T%H;?-K!)('K T K[D42\Y$FRM*9TZ.
M7W.ZDS/&?^G"#$5#E?CC%D%,<0L_<B6X% _^>""Z6"[0:MU-.5F=U>#<A5MK
M$O@5D%$9+PU-;@FF8L-\LV[/A_6+_P"O=)P7FC_IYK&.)&!7XT1TP/1M.2.Z
M&8-'C%@?G@2GJM@XXQ8.EG0G7288\!F6ZI%76Y-+?MJ?TH;)GKTB*RMS1,_<
M[L:)\_?].L7Y=V_J\;\;(MP-PNR5*JF00ZCQK-:[D8NMTMU'"CJ&+I_7;%&(
M'FIU%)SIP0A(&6 :'9;G2H#,>3%6\7/W,R9ZLMT+RM^ WFYJ\#3?XK!<@/2[
M#Q.NL7R/OD WGMO=]%:G2>.EZY;+1Z<KP^'7+<'%R9_WYK](8@1VOEF;CR'&
M6'"2_<OBM?GGX_/P0="[''XQK\9%?J1,O?\ H_**C=;14F'>>77I_):G$O%_
MHH$_4NK6J;%-!ZJ])FQW"D,="+,#9BQ[\I+"M[%W?<DSENW_ $!?X<OZOWA'
M^ 6/]XL.?<W]Z?T!?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]7[PC_ +'^\6#W-_
M>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#E_5^\(_P"Q_O%@]S?WI_0%_AR_J_>
M$?X!8_WBP>YO[T_H"_PY?U?O"/\  +'^\6#W-_>G] 7^'+^K]X1_@%C_ 'BP
M>YO[T_H"_P .7]7[PC_ +'^\6#W-_>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#
ME_5^\(_P"Q_O%@]S?WI_0%_AR_J_>$?X!8_WBP>YO[T_H"_PY?U?O"/\ L?[
MQ8/<W]Z?T!?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]7[PC_  "Q_O%@]S?WI_0%
M_AR_J_>$?X!8_P!XL'N;^]/Z O\ #E_5^\(_P"Q_O%@]S?WI_0%_AR_J_>$?
MX!8_WBP>YO[T_H"_PY?U?O"/\ L?[Q8/<W]Z?T!?X<OZOWA'^ 6/]XL'N;^]
M/Z O\.7]7[PC_ +'^\6#W-_>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#E_5^\(
M_P  L?[Q8/<W]Z?T!?X<OZOWA'^ 6/\ >+![F_O3^@+_  Y?U?O"/\ L?[Q8
M/<W]Z?T!?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]7[PC_ +'^\6#W-_>G] 7^'+
M^K]X1_@%C_>+![F_O3^@+_#E_5^\(_P"Q_O%@]S?WI_0%_AR_J_>$?X!8_WB
MP>YO[T_H"_PY?U?O"/\  +'^\6#W-_>G] 7^'+^K]X1_@%C_ 'BP>YO[T_H"
M_P .7]7[PC_ +'^\6#W-_>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#E_5^\(_P
M"Q_O%@]S?WI_0%_AR_J_>$?X!8_WBP>YO[T_H"_PY?U?O"/\ L?[Q8/<W]Z?
MT!?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]7[PC_  "Q_O%@]S?WI_0%_AR_J_>$
M?X!8_P!XL'N;^]/Z O\ #E_5^\(_P"Q_O%@]S?WI_0%_AR_J_>$?X!8_WBP>
MYO[T_H"_PY?U?O"/\ L?[Q8/<W]Z?T!?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]
M7[PC_ +'^\6#W-_>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#E_5^\(_P  L?[Q
M8/<W]Z?T!?X<OZOWA'^ 6/\ >+![F_O3^@+_  Y?U?O"/\ L?[Q8/<W]Z?T!
M?X<OZOWA'^ 6/]XL'N;^]/Z O\.7]7[PC_ +'^\6#W-_>G] 7^'+^K]X1_@%
MC_>+![F_O3^@+_#E_5^\(_P"Q_O%@]S?WI_0%_AR_J_>$?X!8_WBP>YO[T_H
M"_PY?U?O"/\  +'^\6#W-_>G] 7^'+^K]X1_@%C_ 'BP>YO[T_H"_P .7]7[
MPC_ +'^\6#W-_>G] 7^'+^K]X1_@%C_>+![F_O3^@+_#E_5^\(_P"Q_O%@]S
M?WI_0%_AR_J_>$?X!8_WBP>YO[T_H"_PY?U?O"/\ L?[Q8/<W]Z?T!?X<OZO
MWA'^ 6/]XL'N;^]/Z O\.7]7[PC_  "Q_O%@]S?WKFC^2WP5YD_%)2.(_D&_
M'ISQKRWU_DGI7@]*NH'FYZSPN?\ <^1]:Z*%H5TYQTRGSC,\.5B/QC*7XLI+
M;;\=QO>_BI>F%L'>S==_HW:S#_55AB8# 8# X-\-_P#(I]V_\NKRO_I'M>1I
M?ZI\73:R^)O-UUZX=[5=>>PKI;K-N1L\.MS[MEI17[BI4NE?"=1S/WM9DZ8"
M\_%;9^>,KZ,J/]='P=5M65QRN,,5$\(>;8%[Z3T>#42T2U=9[IR;T7<Y3-LL
M6H<KI_%76YE%GCAJB"H(4*R7W((S1L5#4,@2GS)+[:WI+RE%Y7&/)"^B?C3\
ME=4+W@[=:78"17H%N@WL[+9N]H@NL6H=T6A]1BE@BH9%E01[5HYR.2M,;:$.
MP%28:]*C2GVUB;]T9HE^/[@DQXLL=/Z[5XS_ $DGV2H#*GV&]@Q?(NKV(C:2
M=OO7'(48MMOG9*[2+R;27B0?E%36"\QI<3Z<AQ*ARJ&&/Q9^-#(Q0M=!/CVG
M.?.<ND31E\MT8U.I$^I=DIUF#E#JRKQ@ON]0N\6*8?>E/O/F"[T<A)6Y+B1W
M6R\]RTNB>%O.'2SX0Z9J98)'&U:J4,Y4Z/:[#1Z%T/G]%M$VZ4RA]+I%9GC:
MW<ZE6;24F2HT.5'VC:9\N,YMR)*D1W23=8K)G\6WBS4H9LARUT^#@E1UCG4J
MPV(T8HMIMP9OJT<+<[C4Y<I8BSVT1![,:CL3Y;;CR6/LT;VK]/A[9'/<]ZOQ
MK^96:1 H@F-TBOP0W\0'[/F@W3+0U:*]OS#"-"^*[$FY<J8^U^R0@Z]$^#B7
M=2HZ6TO_ %/IIWHO.YS^-4\H'ASA7.^Q2.Y#6[\=O'[4W:]AF;=T6UV"I5.^
M=+ PJQT2[U:ERB":R*MMR!0OM9<_[9<AN/(DM1U,-RI*'27=;,-P,.3 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8'!_\ ZCC_ (:TO_6D\??[PE&R5I]K]_RO
MZ.\&5F8# 8# X-\-_P#(I]V_\NKRO_I'M>1I?ZI\7>3*S,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,#"6: 7*5RP#*^;W6CQ$(5@!+'J!'*; %YD!^.-
M-Z&2]IBD=BIKB'_H.[TV]]/Y%?P;W@<0VO /YDD-MI<_.>2=<2A"5N?S O/*
M/J+TG6E+^71KX)^=7\/PU_!K#3E]O^/YOI_,"_,?_7F$O]@3SU_CK!R^W_'\
MS^8%^8_^O,)?[ GGK_'6#E]O^/YH%XZN7OOCGY;;%XD]1^WY7KSGJ_!TCT@+
ME2.#<MXQH7;)_;0G/H;&F*1%EDY?Z8-@3-Z6N?\ 1=U-_MF-*:0O!NFV[.6V
M8N7^A##-P?\ ^HX_X:TO_6D\??[PE&R5I]K]_P K^CO!E9F P& P.#?#?_(I
M]V_\NKRO_I'M>1I?ZI\7>3*S,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,#A7$_\D(M_P H*#_O6[PT_P#R^;NIAFX/_P#4<?\ #6E_ZTGC[_>$
MHV2M/M?O^5_1W@RLS 8# 8'!OAO_ )%/NW_EU>5_](]KR-+_ %3XN\F5F8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'"N)_P"2$6_Y04'_ 'K=
MX:?_ )?-W4PS<'_^HX_X:TO_ %I/'W^\)1LE:?:_?\K^CO!E9F P& P.#?#?
M_(I]V_\ +J\K_P"D>UY&E_JGQ=Y,K,P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P.(L6M637_41%;;NN6'525^)>$!3;-@RFJNH]KU'N;L%JQ?:
M?HVS>H7]W^T^O]Q]'^W^3Y?X<-/_ ,_F[=89N#__ %''_#6E_P"M)X^_WA*-
MDK3[7[_E?T=X,K,P& P&!P;X;_Y%/NW_ )=7E?\ TCVO(TO]4^+O)E9F P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P&!P?_P"HX_X:TO\ UI/'
MW^\)1LE:?:_?\K^CO!E9F P& P.#?#?_ "*?=O\ RZO*_P#I'M>1I?ZI\7>3
M*S,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#@__ -1Q_P -
M:7_K2>/O]X2C9*T^U^_Y7]'>#*S,!@,!@<&^&_\ D4^[?^75Y7_TCVO(TO\
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MZK3J!>2L04.>6N-$D37IFD[FNN2%B[K='TO/A'SKTGKMA[3= =M-V>T;!S#
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M;;UJ25#T#Y/IXJ;0/6WASFG-6Z40I-2JO+P%;AF[*$A]^%3$]'ZB9I=Y)!+
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M-\)@*\+ODN-SY3([H6N5W'U>*BPZZ/ LR"-/;_9$J4%6./(TS,GR81",Q_\
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M_=.,G'7&5_\ ?^H\(\@^<.177E?-N7=OY79;WZ@3U1K16!V,C>(Q/@/IKO\
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M6OFQZBFV25L?V9FSI<8*BU@52)@HM$<?;6X,3-E8R9^0[TS<Z5:'A7BXE3+
MS:^\5]ETR7GR;)31?->&]$Z:[+D"(_-;@VQTR45I44/#B3H?Z63FEXBVU/MZ
MVP\.,[L=6_R']EJ@:348WAV;6:=S&Z\?YQ!COI>;LD>M6=XB!FGZSR&GT:'*
M/S"\2''*!H :/#86)GNJ^'SPU1WQQG?5W6PS4IZ4KYNV^<^_56LCI)>R6;BG
M5*_7Q,/Y?NRALS13HT4.B_.MM'W,V?);:1\5)U\RM?'>O[.%G5RTI?<^9=T1
M^,/D/*8MX-=#XKTR@VKI5>F\<ZM3D\NK5&\F=HH5LEVDQ<*/7@-=2,M-D@A]
MQURDO2)DM##3;F][UH[Q9FW\:NVV&9@<QNI]CY[YL]\6GI7:%6:JTCH?D+D-
M&I=WA\XZ#<@)2U43L_=S]RJNR]'JME:%%AHB]!IBH\O<=4AB1IQK3FF7=MG4
MF=N)URMS\>,.6QY@&$G@1NN0+?V3U'T2L#;%7BM3+N4CI/I_L%]HIB163L(:
M:!LV.H6*$18CRXT>0AB4C;C:%;VG0W=6[N'+2W\BU7L-S\.>G*U5:\6MATCR
MH\J%6@(Z08-&D0=QR,T>+#PVWIIB<_ B.Z;B,-N/RE?!IM"UK2C9UMTW1KY"
M[US#U/[<\EG>$R+7=17(J+Z9)=&L<GE_3*<&IP^\5_G(.L0R9N]T^L0OU"S&
M8*DQX#+CLIW4)UW;6D1UK07%FVY=5<.'!_\ ZCC_ (:TO_6D\??[PE&R5I]K
M]_ROZ.\&5F8# 8# X-\-_P#(I]V_\NKRO_I'M>1I?ZI\7>3*S,!@8.SJ)(K5
MA6&T]LN@&64*U&0ER1LDF!(W!TPVO6T./?=:3\J=_P &U?#6\#A%Y!ZS[R ^
M2^MS_27-O75_E0ZU7S&S0,:\#]&C#3GG_GDZT4WC=)N7*ZM;[M8BW<-&(CTA
MX>R"!KF*V+(3Q\73S9INFWEZ<-I:-U[V;1//GBQJ=4+'U2Z79FT1>]W"V\GZ
M(Y:ZX5$C2Y2C<Z,U&((YO9*S+MQA#5:>Z*8#L 8'V>C,X?\ ;SV_IDLVYJJ*
M_P"NOR:F(((DYY6"QQX^(JP6MPCQSK5>,6;Z9[R@*.<WJM:)="=*50]4Y'7K
M_&8L,[]3'6:-0E%A\)$%Y2=%X[.[)R_6GY-62U:@M>/ZRB SVDOQRVFYE=Z8
MH>3;H+@&.8Z< CU^;9#(/DO97#LERJGI$2=&#MA'M$M/:ELK;)C9W02R=L_)
MZ=TR0L7-B D-=>;UTI7N=<RXWT0 6JER%>UJI23*+)T]J]'BP\]%\YR-V1^)
M+8'BB\)<AIAAUN-)6]%DV?CX*+H'9?R<Q0_$.F$_-ERO72./><3-"+G[%R>X
M44[?3UII_D@C=X72 5@)S[E;S/,+<W9IS+X::-&WP@->2-C-.Q_FPMFSIG1N
M'USVE[+HH?QX!!<3JA+M?<^7=EO5XYI"Y]UJT2)%CY9:^'! M4#:V3IACD8:
MXCNHR'2!ZT0YD*K.)9^[0\A"]O5S-NVY[(-:/3/Y4BPU-='>=*Q5Y%XY'WJP
MC[D*YOT^83HUG"2.X!.<UMN"Z</"OV\@0Z/5#32#6APVS;M>HL)3*H6_N7Z+
MC9W*/WK\G5,CQ.0L<#'V5NH4[S54@W7.DU?KUA-6TO="7F\!TCK-LF0#[@DV
MQ7FN@W>88!_K \N&554O.+?C.N;;&-G7\>++2/4OY0*X2K< =X]HEG'&(?H
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MJK&JQS>MCQ-D,\KOI]GYSHB\RGY;]-Z'6@0B"VXW]M/=..JEKW&2EZ'-5_\
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M:_)7V.[\)WW6&4H5,H'K6@7J_0*;)H=<A&JN&YAZ!G6VMZ56[J=)W3@-?Z-
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M_9P.*/%/&?KX7Y"ZUR(ET&B1+JA[GUQHZ(]DL%LM$;OG#.">4HO/-[ZA%M3
MVI5%KMW$R<:P#) 2=)GP9:I'UFTR'67(TN[;G+TQ?$OK.1S+MK9J>+5TKN_G
M#D+]H:@]**($B_1YOU5WCO\ W $#G[2TJ%5*F!Z>.!B"+*&=31PUEA+3:&DI
MT.4S\*ED.D_D\II6KF;]VN*;Y[/O_/3O1X6[-Q>JV:"HK?/1()VD4(_*YP+
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M %''_#6E_P"M)X^_WA*-DK3[7[_E?T=X,K,P& P&!P;X;_Y%/NW_ )=7E?\
MTCVO(TO]4^+O)E9F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M&!P?_P"HX_X:TO\ UI/'W^\)1LE:?:_?\K^CO!E9F P& P.#?#?_ "*?=O\
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MB@PNBI)V#PW2(02^R+%4I]CVF;0@?4XS*8LZ$3>G?I;:9&][AMZ)+MQB]?\
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MZZ?Y@Z.<M RQP:E2;7%-./UF]1B4+[=8F2QJ)J.Z_J0A,6&=D^+NIE9F P&
MP& P& P& P.#_P#U''_#6E_ZTGC[_>$HV2M/M?O^5_1W@RLS 8# 8'!OAO\
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M:7^J?%WDRLS 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X/_
M /4<?\-:7_K2>/O]X2C9*T^U^_Y7]'>#*S,!@,!@<&^&_P#D4^[?^75Y7_TC
MVO(TO]4^+O)E9F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M# 8# 8# 8# 8# 8'!_\ ZCC_ (:TO_6D\??[PE&R5I]K]_ROZ.\&5F8# 8#
MX-\-_P#(I]V_\NKRO_I'M>1I?ZI\7>3*S,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#@_\ ]1Q_PUI?^M)X^_WA*-DK3[7[_E?T=X,K,P&
MP&!P;X;_ .13[M_Y=7E?_2/:\C2_U3XN\F5F8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8'!_P#ZCC_AK2_]:3Q]_O"4;)6GVOW_ "OZ.\&5
MF8# 8# X-\-_\BGW;_RZO*_^D>UY&E_JGQ=Y,K,P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MM/M?O^5_1W@RLS 8# 8'!OAO_D4^[?\ EU>5_P#2/:\C2_U3XN\F5F8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!__ *CC_AK2_P#6D\??
M[PE&R5I]K]_ROZ.\&5F8# 8# X-\-_\ (I]V_P#+J\K_ .D>UY&E_JGQ=Y,K
M-I][8];B_&?*J[TTK447)-FZ75^:0ALFWB:*.BS[-".3V"!*R&8D^'%82@$M
MEEO32W),M]EI/R_/\VCK;.5PUJF?E$"N<8YGUH3PVY#9G4?3QSS$,I'2C;5$
M-UBP :9=[K++WA(X!<R %]$6CO0G!K<*3)CD'DMNJ0VEQU)>%SCR9&V?E(YR
M$N_L'GE9YG<^AVGR>+J\_4"GSQAE[INW['6*=U>4'&"4$['7:]Y\L]R'MVZ=
M+@+5'A;?E16)28ZD*'"XE[K/\^^Y1/H3O-NXQ6*E7EBZ5S'F/0Y_1 '2XER
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M;E7H-@<H5S$=#IZINW]; W4#&(Q ]AA_0>9^,Z!&+24(^?YV_@[OXIW_  ?
M9PUY+>$_+1DZ=LLOFY".;L73GNT3YH;I/5J]N+U65!L(PC>P$<!>!D6J6$R-
MM9&.0>%HA[(,3'&Y.G4;^&F%Y5ZE^&_*/SZEP>,5X"9^GT-MVUU,C9:?>IFN
MKVB'=>AN$;]5C8>Z$W[3:QS$]]V1/=<3(90IM2/AK6%Y;DGY=Y/\^\3M2KCR
M7G47GQ9=0K5%=AU@]:QM5>K5. ":M5XK]%:._L2_/!UT'%A1YZQZB"([7R?7
M^"E_,2[K>JM5?CK\2J'2Q7\W+GZ8! 75P9%AM@JULD&I?.K#R.M"B+S1-#Y
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ME9;<>9)?:=3,6P\ER-I+*29J_,(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X/\ _4<?\-:7_K2>/O\ >$HV
M2M/M?O\ E?T=X,K,P& P&!P;X;_Y%/NW_EU>5_\ 2/:\C2_U3XN\F5FUV]*1
M.R/U&O2^&ID.7019"Y-+2)4-F \TCF71(89!J%/)"HAH3JYS12EQ%N_*XXE"
MU?*E&UH+,>+6*\6GVI2R08#'FE[0BV6F\B@)0+2N9OFFDUR'WZ31XTQF23&
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M^4-&_>7 ?M9</Y+;%_E#1OWEP'[67#^2VQ?Y0T;]Y<!^UEP_DML7^4-&_>7
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M!@,!@,!@,!@,!@,"N@W_ .-"^_\ X)<Y_P#M_H&#P6+@,!@0_H7_ -X-X_\
MP/LO_P"Q9N%G5E*S_P#>W7O_ ,AB?_M"/@O5G,(8# 8# 8# 8# 8# KJ9_\
MC:KO_P"[JY?_ )RT3"^"Q<(8# 8# 8# 8# 8# 8# 8# 8# 8$ I__P!\?5O_
M ,.QG^C'G6%3_"& P*T[%_\ BSMW_P"3VO\ [>B86=5EX0P& P& P& P& P&
M!P?_ .HX_P"&M+_UI/'W^\)1LE:?:_?\K^CO!E9F P& P.#?#?\ R*?=O_+J
M\K_Z1[7D:7^J?%WDRLU=6C_[^^8__KML_P#S9DX%BX# 8# 8# 8# 8# 8# 8
M# 8# 8# KH-_^-"^_P#X)<Y_^W^@8/!8N P&!#^A?_>#>/\ \#[+_P#L6;A9
MU92L_P#WMU[_ /(8G_[0CX+U9S"& P& P& P& P& P*ZF?\ XVJ[_P#NZN7_
M .<M$PO@L7"& P& P& P& P& P& P& P& P&! *?_P#?'U;_ /#L9_HQYUA4
M_P (8# K3L7_ .+.W?\ Y/:_^WHF%G59>$,!@,!@,!@,!@,!@<'_ /J./^&M
M+_UI/'W^\)1LE:?:_?\ *_H[P969@,!@,#@WPW_R*?=O_+J\K_Z1[7D:7^J?
M%WDRLVEOMV+=M46@EN>=RNO +9$Z8'$0+G2N><CZ(_.1:1)H)NN&8W<'8G.Z
MX'(RGV5Z)2Y,5W[MEB(PM;TM##IUM^&6DTX1Z*$3)@T_^:FP 28_]HMS8,[R
MIY!=W%_9>278+,OS!]'F#D$F(X.1)5!^M]\B.GYU,IUA=/XOV>!>E*Y !$9_
MYEN@/,V9FOR:^T,\6>9"DPQ&LEU$<\ANCX4#F;\J2J!;3L:*0:2G;PS:]JE(
M:3K>\&G;\V1,5+T@!_3OU;\UQR'^KC%&1FE>4?)#JIHE+$^3LBPEB@NJ7#VV
M+?UISX?*I:-(UO:U(2H:?Q1R]!_7%) UVU-?E?ZQ<*U9ZH9N P[5_)WB) S]
M*#6SGM)6W)G68+78$.5)L72Q[/QD/,,1$M252W&-,[ULLX]OSJ/"97K,[4*M
M<A/Y2NZ2(%OZ7&Y2*ASO(7A:N2D6=^B2NAJ=DSK3&"5W8EL#"<2V\S.=5-D?
M*F&B2AQIQ8]/;\Z]97^=H+F74<G\IW=ITVC]( <PG)1XS\6AQY,O8VRD>";%
MV*TAJ_5V*DW9:X6 +GSYL%"[ )D0&DN/JC)D#3M^=9IBO>R7J1U?H']*/V_0
M#CYZV5VQ(9\A^&R9:=/I=C+U8ZY"$AH)*:%A,%0KROJG4ATHA_"4Y].-I;J!
MZ<XQ^=8Y _V.^8578/Y0>X3SD1 Z8=AM>4? <8?6P90!ST_%LA6UDG(-*DA7
MM=,&Q&-P"4V1/EID:AM2&F5.X/3V_5^JO#];7%JS_H/Y4>\2B-2C=ODEP2_$
MOD%@WK^(>S!*S8F8L%VK)^X7:U62#-KR]*TR1@2$N*6RO2VTCT]I]6#67]0K
M(&A@W\K/=3<P-;.>U1+8OQ7XX4@OKIE:'V*N6<,_-KT-B546Y,_8F7,6IK[<
MQ&>C[1O2-+4-.WYU^(Y3UBTPZJS_ )1N[T.=_P#=!H>&MGD;P<DH<76>I-<>
M+,A&P&CT6?(:NSOTD-:=TXXQKZND_*MOYQZ>WYUD^:N>JNJ6!NKUW\K/=(AM
MZV"*E'AG/$_D$?N2X;Y03Z]!/Q%HJ\E$JM_H@2:/=D-[4MDS%7'6VE.T.K%Q
M/#\V"JIOUQ>I!(72?R:^A[998-M(4Z/5 ?D'P1*+DYPF':B!66W+4ZU70;0R
M#4)+LB(8G#2S&I$)*XB5SHB7AZ>VGQKT;,>J7TD-"?RF]\-RAE'K'3YD&+XL
M\;P)+?-;G^ALUB\;V8KD!M(DV5*RAT=A6]3UD@A2/MA*H+RDC$[?FVU_FE^_
M_P"MAZ/_ +(/DG]Q<.<[>Q_-+]__ -;#T?\ V0?)/[BX,[>Q_-+]_P#];#T?
M_9!\D_N+@SM['\TOW_\ UL/1_P#9!\D_N+@SM[->>A\P]E<HO$]LK^3GOL^3
M(I0:T72U@?'7BV97ZC21MEF (9D_%(!H!QR*/GFI+TG]*'D'FHB%NNITE&L.
MI=M\)]:]9,%Z2#6694B7YG;_ !3(R'<9A=MSQ?Y>U%#?L+-IP\Y"+3?XL/MH
M!-Z3?1.A\9:M/%=3&]PTOZ4GXC.W^/YU<%>\U>Y+8#$V:M?EYOAROG8$8H'+
MC?)'D*5!(CYC27HTJ,^W0MI<;=;5K?\ ZZW_  ;UK>MZP<MG\?SK,?S2?R ?
MULG2O]D'R+^X.$Y;/X_G7DG^.O>A6#,&$?RO=+D#R,61 GQ]>1?)+.Y$*6TN
M/+8T\S0TNL[>8<4GYT[TI/Q^.M_'6#EL_C^==-($1 ^#"@-*4IN%$C1&U*_^
M)2(S*&4*5\/X/FVE'\.'#UX# 8# 8# 8# 8# 8&AWLH)T\E:.#M\D])WWSA:
MK+8++S_1.G\HXETH?:F[!'"F&()^7W33=?KZA#E:6]$8&N+,%5.N-QXTG;6T
MH.MN/&9:<HC]^TU\TG\V%@B2="AA9<'7D_R01>VR5DU>#&BP'Q-"G0CI!!*[
M"(KC$!R4XB02C-[3I3S>E%T_BR1RO^E*^2KXF=^9F].SK/+JL<,V.\:>72C4
MJ)=0Y,]7#VI4#F\B+JK3A@EY:BFE[@1U?*AUU"UH3L:?Q_-]S=;]%UV1N(8_
M->>B2]#(YG[5/DSR;*D[&3(E:G0I26(?/I#JDSXMQ%JCIUK:W_OV=-Z4I>M8
M-/XO38J#Z_KKPY*_RW=.,P2(6BV)!H%Y!\>3PL<)TJ]@^?4DJ^254F(VQYXN
M9<D-/-J6W]@/E/;W_:-I<&G;]6!=@^A68FB:_P U5CT(VC>]DOYI_D;YOKK4
M)5"C-!_V#_7Y7ZK!-1ID1]J*N-)A.H?;<4VXVI1=/XO8NJ^N'ZZ?L-?_ "S=
MAMJ 73(7'VQ8+Q9Y+9(6'H1*0$8@!JT_8*6#"%(4I)^.]HG]XV*3&^H^J2EI
MM:TDT[?F^( 'Z=,1E_J?YC+S3#L2QV>GF*?<?)WC8;: =JIH>QV.R B$6%52
M0]^0/K52($DO1),J))'QE2&'G&O@K8T_B^\0-Z!FQ(L^/^;@PJ'-/1:U$D+\
MH^2F&Y!::C;D9+6WZ WM0YW6MI^^_P#L'2];1M[2];U@T_B^HBK^H;(L-NJ_
MF-OMIAES=7!+*@O'WDZ4+$RKO$(2:8Z6F.4%EMF-:7(3;4+;>W%N[G1'=)^W
MD(>V-/X_FO#^:7[_ /ZV'H_^R#Y)_<7"9V]C^:7[_P#ZV'H_^R#Y)_<7!G;V
M/YI?O_\ K8>C_P"R#Y)_<7!G;V/YI?O_ /K8>C_[(/DG]Q<&=O8_FE^__P"M
MAZ/_ +(/DG]Q<&=O8_FE^_\ ^MAZ/_L@^2?W%P9V]C^:7[__ *V'H_\ L@^2
M?W%P9V]C^:7[_P#ZV'H_^R#Y)_<7!G;V/YI?O_\ K8>C_P"R#Y)_<7!G;V:]
MEN7^S:1TH[3G_P G7?4KG&N:JMEYB^.O%<JEA[!T_:J-0HA+3P5-IC[+3*M%
M@J>C"W8,=^0PIYU&G'%H.I=N.GYUYUL>@6II>$_^:B]Q= @4,^5G2O&'E^,-
MAQIUI-TUL<[-?Y>VSJQ,GJ[+;>&?_9[++6WUM:9_NF%]/\?SK8"'Y5]ZD8<4
M@/\ RW=!G0)T9B9"FP_(_D&3$F1)327XTJ+(9H:V9$>0RM*T+1O:5IWK>M[U
MO#GEL_C^=>G^:3^0#^MDZ5_L@^1?W!P<MG\?SK[Q/'_MF60$MW;\G_1;I4&C
M(699J>]Y7\M &+6#'E8<\G6WS@*DQ38=@W$C*C+E0W6Y+"7=K:4E:4[P<MOA
MMU^+I;AP8# 8# 8# 8# 8# X/_\ 4<?\-:7_ *TGC[_>$HV2M/M?O^5_1W@R
MLS 8# 8'^=CUG:KK^-[\K)K\BEQXUUKK_D#TIY3IGGCK%SXE2R71K;YZZ'RZ
MZ$K#6+#:Z,!0^=G\\M8DIIA<Z.A6X\KY];UM2&FGS7;.>SC+ZI5C_P#<;_C6
M_OSU'O\ ]^O'WH7^'_\ T7![._R^J#]%_/S^+_IU3*4H^9]@0P1QAZ";: >4
M?1(F06#S(S\(H#FR6J$MQ0HO E.,2$)^1>T*^*%H7I*]"?:WSM]6MB_RQ_B5
M_;F :BV#UN-H$&69L+O-AWDCU,W$+W@U"GBG+6:+RALQF0[!$$%1HS3$&,XE
MIEE*WG$M[2HOM[_+ZQ*)/Y=?PVR+;(O"$^RHMC<5.D0YT7S1Z;3L.1(7$;?9
M),.AVE/?8O[LX:+)2SKXPTJ:5O3&E//J='M[\8TQ\7R<_+=^&61&L4.?%]C%
M8EB"RJVJ*5\T>GI\4+7W"C1L<'K\:135L#(0 O';D0=:2M33B-?,I>OX,'M_
M<\OJE!O\U?XGCK-"%3)OJM56I%7-55=:3XT[I&AGX9:U<ZNS<H@L;SL>F-+B
M6?F4&0K4=MN/)2Z^VZWM+G\ ]O?Y?5^3'YIOQ0%[',L^K/[<&S9/08/4HT0=
MY=[]H4)O$2G.T%XP+'3N9SF6-$JH\J+(87]1CX[^HVAMW^WP>WO\OJCJ/RY?
MAE@P"<"O0?7]2W8JI/I%QGUKS!Z6@$[U6BYJ?83,&Y37J3*<.OEBYHD^]+<^
M$S3A68MMU"Y"U;'M_<\OJL*H?G*_%?0J];JO4+'[1!"+84+F$(A^5_0/W58G
M'"I(V1<J\]WG#DR(ETH5>=3J2N7I&MI1KX-ITC"7[6^]OJK-7Y:/PQHK[]:'
M,>R0P\@/(!#BQ7FGTZQ*LE<-!*T!/5L\\]3)"9P8S'J<-Y:/E2Y'F:<?BKCN
M.N;4T7V_N>7U6)4OS;?B'I%Z:Z-7(7K*%:6ZC9J.Y*7Y8]-R8<NOVN]KZ.38
MFC)%0<'RYC5G><5&DK;V_'C.*CH7IG>D:'M[^FGUB#UW\N7X7ZJL,X%$^O6'
M 55&4N M[S5ZIF*U7PW54=F%Q9.Y57>^[?@7I.W6GG/F>1$6J+I7VZMMX/;^
MYY?6)9-_--^'LC]?<X3ZJE*?8/,?4>\H^DW7&467IJNO%E17%TM2XKKUZWJ2
ME:-I4VVE+2=Z;3I.A[>_R^L8ZL_F2_#E4+#1+4!'>N(AWG)JQ':O-WYA]0.[
M9E6JAP.<&HQ!ERI*8+C7ZV+C_)'DI<:9ELID-Z2]\5;:'M_<\OK&'A_F _$$
M-2^^+,^XA1O1=10/:AOG;T]#LU6C*=N;BZ_6B;-)3^FUUS^,,SI<;:'/J;F_
M.I2G8\5; ]O?Y?D\QC\O'X>Y B5 K._6]/)21D*M_KX[R=Z/GST4R%&J0UBE
M.(*TR4Q-K4 53(:8$:1IU$"8E<UO7W3TAQX>W]SR^K:C_N-_QK?WWZD_V/?0
MO[BX3V=_E]3_ +C?\:W]]^I/]CWT+^XN#V=_E]3_ +C?\:W]]^I/]CWT+^XN
M#V=_E]3_ +C?\:W]]^I/]CWT+^XN#V=_E]5.7O\ .'^)WH]I@6JSS?8CKT8(
MS6R86!Y=]*#:Y:0,8['LD41:A42D-H,#63$;3BV%+2U):4MB0EYA:VMCVM_E
M]53,_E7_  MLCS([4;V2ZU8)DV>6>E^9_2\V1.E2%4*1!?EN3*.^F;)"$N8
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MRX"'YH]/"JR2DT]9MVJ&98L73HBW#-=DGWGX;NG=)9EML2=(^XC1W6R^UO\
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G!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g150472g08a08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g08a08.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1  4&AO=&]S:&]P(#,N,  X0DE-! 0
M    #^2^0&@X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (@ !P"
M4  (<G(S-3DP.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!7871S
M;VY?($9O<FT@4RTT7U5315]!8W1I=F4P,5\S,#DT-C P.#0 .$))300E
M   03TJB_62P#I.2Y9%0@A)'6CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!JX8E
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  !>   %3          !                          $
M!4P   !>                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   !>     %)G:'1L;VYG   %3     9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    7@    !29VAT
M;&]N9P  !4P    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    \
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MD:$5,D>Q\!<S-T-7E\'1&"0E)B<T-4)$15)38G?A\1IC9X<V5&1EDL72_\0
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M)!QSW&^45=:*F9F(</4[3?LHCQD)2-'+&+)2M02'-/<LD#)43WDE^+T;79W
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M',WO XCF ..A!M'(:R\A@#X#+C.V_P!P(R0YY-PQ%C)([3:#;73TD&P,#C.
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M'CNV<OPQ!@ $B\  '@)GC)[-)L8C <XW\<?:<$G)(.P/(XV8D6OIV>?0R (
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M%%M*2M:CQ++I<S2^CG-=%ZE7G)4NXI6^*7IM4:VFOU2;D+@@W7#\VNZI5&'
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M6.48?FT?E C.0&^K5A]_$[N-_ YXC=5X*O0<-X<5)B28WA>-.SLX3RMA>;S
M'[Q%/?\ 05NS/D%P<#/<[<-U7@GT'$2DGY21Q%Q$3I:((N;7OKQP_-H^?J(K
M 8:&LG#Y_-WW^U]\,W5>"?0?UP/H.&\#\Y,R29( [1K<&!S!&D0<+S>/GZB*
MV2!Y-3/L'QR\#G!P7X;JN1]!Q.\FW?IFP)WAH(F-=3S[>&@9:8+?4QF#?Q:@
MY+<@.0\?9WENJ\$^@X!:1)E,]AT$6N>),'3F3V/S:.?XB+S+"&IR[OR.X8;@
M!]\ !NJ\%7H.(WTCYP-AQ'"/P,Q()/*\F$RTP?XF+S_S%D'FV0/ ;>+OPW5>
M"K6-#KR\N*@I/A)O_G)!!F">/:=2(M$89EIC/U$5]OWM9Q]H!QXY?;EV6ZKP
M3Z#B I-AO)TFY @Z=H$\N6HUW@2\< ?417&WU:]GYXWR3C'AMPW5>"?0<"I,
MD;P@]HU\UHL!>/+$G 9>9('U,;?_ &%8.&/YOM+#V^'#=5X)]!P!2#\I/I':
M?"\@D_WX/-HX<>1C;8/DU ^')_MQ@8&<SNJ\%7H/LQ&\DQ*DZW$R.T\A/GF2
M9M8\VF''U,5@7<0U\QG<>'-]^['$;JO!/H.)WTD&X)XRH<#;E(-]/YS@\WF6
M/U,7?<PU;'&P26RS\G;</PW5<CZ#A*)G>3$"P4!>9XD<_P ="!@\WF.4&+AP
M_DU;<N1+ ^+MN#L&ZKP3Z#B"I)![Y(\XUX\1)CC$3H1$D\WCN?J(N1GZI6_>
MQQXCVYSPW5>"?0<-Y) [X6-N^BUK2!-P8)YB1@\VF-A B\G:&MW\"4GN?+;.
M^_$[JO!5Z#[, I)U4.R2(@Z2 1S.DQ)D"V 2\<!_(17Y#R:\!W9R,[?87(XC
M=5R/H.)WDDQO"(N2I(FQ$P#;R<1 ,8?F\?G!C!\D>34&+X_S=Q^+9[N&ZKP3
MZ#BG>$:IM;Y5SP-IF#R@1-HN<0F6CC_1XI.S%"W?.26&,>USRVX;JN1]!Q7O
MC3?2(GP0($<_+ ,\-#@\VF!CR$3.[PUX\,)!_7GNX;JAJD^@X;R9NL"!:"+\
M.:I/WWXX8EY@']YBMR/DU[.,;>'V%^&ZKP3Z#BDJ21\H<9$C6#?7_G88#+3)
MW@Q?$"&O!^T=Y;?<@;<-U7@GT'$A:!,%/EWDR;QPOVZ7UUP>;3'^YC [-Y-1
M]F&WVR2[^P'ANJF-U4\H,XC?2.*3-YGGK.NM[0+<+Q@,M,[^1C$MRAK9W '^
M:!D8\>)W5>"KT'V8D*1I*8F+E.GIFQO,^3EAF7F"S0(C=QAKSM@?1P>7VC[(
MW5>"KT'$ IXJ )XA2;:ZWTT[9'DD\VF",0(WC]6L\@Q.&PP)?=CEMVZJ_>JM
MK8V\N 4F3*D]D$6N9'.#>")@$&-(0EI@#]XBG&_DU[<V^CS)8.-W<LPX;JO!
M//0Z<\25)GY8'.%#C83"KQ%X.D0!<X/-ICE"BOAOJU]S#_-&V6+.?L'#=5X)
M]!PWT\P>??)XZQ>X-I&@O<WP>;S ;ZF*2-FAJ^UW3SV??GESPW5:;IGE!PWD
MWND3S4.&D7M$2)L=) B69>8< P(C;OY)8[\$-G.['O',\-U7@J]!Q$I@G>'8
M-X=EQI%A:1R(T&%YO,.'A1L?\"__ .1R<8SMXDMU7(^@XG?0.*3/D[;6)XP8
MG3S /S>/S@1F(9PA0&,;,.1<C(SMPW5<CZ#B-Y.H4FQ-C<G0ZW\@-O+A>;1V
M+P(@/)H:N>6/T1['\0=P_#=4-4GT'#>3(A8\YY6D7,3,WY<C!!+3!_B8SG_R
ME%AS&Q)VQOXY+ANJ\$^@XG>1S3%S\H28T(T@WTL;6D",,2\P&^HBY?9"VW'>
MDOC^K?/#=5X)]!P*DGYR=.)3R/(B+F"#Y=)& 0([DF!$Y!^PH-OS*1W@/[-V
M/ I5R/G!_5_U."5H3$K $&;CC$<3Z/+ICV0?)NP8?1@UX"TJ03KT&"DJ26&G
MMH9#C(=Q[01QUWH^2HY54B(BL4;ZD%">7D[,?G-^V(I*MO-GMT@QLRD&"")]
MT*L\.PB?[L>A*=MJW*E,+FZC;]$GYM82E<U.TJ0FIA:4)"4)7&CP(D100D!*
M05$)2  P#<= *$*,E"2>92"?21CY+14U#:0EM]YM(F$H=6A(DR8"5 7-SS.*
M7T,L_P!4[:]Q4OX7B.K;\6CU4^S%?=E9]*J?KW?SX/0RS_5.VO<5+^%XCJFC
MJVV?]1/LP[MK/I=3]>[^?$0LZT4OV;5MM/:'94U#I@=)()26E<AP"QPX!Y<.
MJ:\6WZB?9AW;6?2ZGZ]W\^(?0RS_ %4MKW%2_A>'5-'5ML_ZB?9AW;6?2ZGZ
M]W\^(39-F$N;1M@D[DT"E$GEN93NQQ(;0-$('D2!_+%!J*A1E3[Q/,NK)])5
MA>A%E^J%K^X*3\)Q.XCP4^J/9B.O?\<[]8OVXB]"K-]4K9]PTKX3B.K;\!'J
MI]F*Q5U0$"IJ .0>< ^Y6)L.T;3@DF%;%O0B6!,.BTU!(&P)3+!VY/PZMOQ:
M/53[,3W;6?2ZGZ]W\^)IM>VB[V[0BX8O29#([C_:^W#JV_%H]1/LP[MK-.ZZ
MF.77N_GQ2&R+,)<VC;!/>:!2B?O,IQ.XCP$^J/9B@U-0227WB3J2ZLD^4[TG
M"]![+]4+7]P4GX3AN(\%/JCV8=T5'CWOK5_FP>A%E^J%K^X*3\)PW$>"GU1[
M,.Z'_'O?6+_-A^A%EEGM"URVW]P*5CV?VIQ'5H&B$#_5'LP-34'5]XP($NK,
M#E\K3"]![+]4+7]P4GX3B=Q'@I]4>S#NBH\>]]:O\V#T'LOU0M?W!2?A.&XC
MP4^J/9AW14>/>^M7^;$<.S+/A*"X5J6U#6-E0Z%2T*#X+*3*@AQC?B"VV=6T
M'RH3[,5)JZI/R:FH3_HO.#\%8J/1>V?5VA>Z*?\ #\.J;\6CU$^S%7=U;],J
MOM#OY\2(MG6A&(5&M6VXR@&"HM#ID0@;L"N5) ?+;< VV-$('D2D?RQ0JJJE
MD%=2^HC0J><41Y)48Q+]"++]4+7]P4GX3B=Q'@I]4>S$&H?.K[Q\KB_S8B%E
M6: PM*V0.X4&E =_*4[^(ZM!U0@_ZH]F)3552?DU+Z?]%YP?@K$:+.M&&KMP
M[6MR&L @*10Z8E3'<=I,J"QYYSPZMOQ:/53[,5"MK!I5U(\C[OY\3_1BVO5Z
MA^Z9#X?B.J:\6W;3O$V^[$]VUOTNJOK_ $AV_P#W\2TVE:J%*6BV;?0M;]M2
M:+34J4^3VE"6!4YR7)XGJV_%H]5/LQ'=M9]+J?KW?SXF>C%M>KU#]TR'P_#J
MV_%H]5/LP[MK/I=3]>[^?!Z+VUZNT+W3(?#\.K;\6CU4^S$]VUGTNJ^T._GP
M>C%M>KU#]TR'P_#JV_%H]5/LQ'=M9]+J?KW?SX/1BVO5ZA^Z9#X?AU;?BT>J
MGV8=VUGTNI^O=_/A>B]L^KM"]T4_X?AU;?BT>JGV8GNZM^F57VAW\^'Z,6UZ
MO4/W3(?#\.K;\6CU4^S$=VUGTNI^O=_/@]&+:&UO4/W3(?#\.K;\6CU4^S#N
MVL.M74_7N_GP>C%M>KU#]TR'P_#JV_%H]5/LP[MK/I=3]>[^?!Z,6UZO4/W3
M(?#\.K;\6CU4^S#NVL^EU/U[OY\'HQ;7J]0_=,A\/X#[N'5M^+1ZJ?9AW;6?
M2ZGZ]W\_:?3@]&+:]7J'[ID/A^'5M^+1ZJ?9AW;6?2ZGZ]W\^%Z+VSZNT+W1
M3_A^'5M^+1ZJ?9B>[JWZ95?:'?SX?HQ;7J]0_=,A\/PZMOQ:/53[,1W;6?2Z
MGZ]W\^%Z+VUZNT+._P#<BG_#\.K;\6CU4^S$]VUOTNJMI_2'?SX/1>VO5VA>
MZ*?\/PZMOQ:/53[,.[:WZ75?:'?SX?HO;7J[0O=,A\/PZMOQ:/53[,.[:SZ7
M5?:'?SX/1BVO5ZA^Z9#X?AU;?BT>JGV8CNVL^EU/U[OY\'HQ;7J]0^[_ "3(
M;=W^+\.K;\6CU4^S#NVL^EU//^O=UY_+P>B]M>KM"Y_ZID.>_P#H_/GPZMOQ
M:/53[,3W;6?2ZK[0[PT^?PPO1>VO5VA=_P#DBG[]_P#B_#JV_%H]5/LP[MK?
MI=5R_P (=TY?+P>B]M>KM"]T4_V__+]^>'5M^+1ZJ?9AW;6_2ZK[0[Y/#Y6P
M_1>VO5VA>Z9#X?AU;?BT>JGV8=VUGTNJ^T._GPO1>VO5VA=W^2*?MW?XOPZM
MOQ:/53[,.[:WZ75<_P#"'=>?R\/T8MK?T>H;]_Y)D/A^'5M^+1ZJ?9B.[:S3
MNNICEU[OY\'HQ;7J]0_=,A\/PZMOQ:/53[,.[:SZ74_7N_GPO1>VO5VA>Z*?
M\/PZMOQ:/53[,3W;6_2ZK[0[^?#]&+:]7J'[ID/A^'5M^+1ZJ?9B.[:SZ74_
M7N_GP>C%M>KU#]TR'P_#JV_%H]5/LP[MK/I=3]>[^?"]%[:]7:%[HI_P_#JV
M_%H]5/LQ/=M;]+JOM#OY\/T8MKU>H?NF0^'X=6WXM'JI]F([MK/I=3]>[^?!
MZ,6UZO4/W3(<MO\ 1^7#JV_%H]5/LP[MK/I=3]>[QU^?QP>C%M;^CU#?O_),
MA\/PZMOQ:/53[,.[:S3NNICEU[OY\'HQ;7J]0^[_ "3(;=W^+\.K;\6CU4^S
M#NVL^EU//^O=UY_+P>C%M>KU#]TR'P_#JV_%H]5/LP[MK/I=3]>[^?!Z+VUZ
MNT+W3(?#\.K;\6CU4^S$]VUGTNJ^T._GP&U[:.]NT(^VDR'P_#JV_%H]5/LP
M[MK!I5U0_P!X=_/@]&+:]7J'[ID/A^'5M^+1ZJ?9B.[:SZ74_7N_GP>B]M>K
MM"]TR'P_#JV_%H]5/LQ/=M9]+JOM#OY\'HQ;7J]0_=,A\/PZMOQ:/53[,1W;
M6?2ZGZ]W\^#T7MKU=H7NF0^'X=6WXM'JI]F)[MK/I=5]H=_/@]&+:]7J'[ID
M/A^'5M^+1ZJ?9B.[:SZ74_7N_GP>C%M>KU#]TR'P_#JV_%H]5/LP[MK/I=3]
M>[^?!Z+VUZNT+W3(?#\.K;\6CU4^S$]VUGTNJ^T._GPO1>VMO1VA-W?DBG_#
M\.K;\6CU4^S#NVMU[KJIY]T._GP>B]L^KM"]T4_X?AU;?BT>JGV8=W5OTRJ^
MT._GP>B]M>KM"]T4_P"'X=6WXM'JI]F'=M;]+JOM#OY\/T8MKU>H?NF0^'X=
M6WXM'JI]F([MK/I=3]>[^?"]%[9]7:%[HI_P_#JV_%H]5/LQ/=U;],JOM#OY
M\/T8MKU>H?NF0^'X=6WXM'JI]F([MK/I=3]>[^?"]%[:]7:%[HI_P_#JV_%H
M]5/LQ/=M;]+JOM#OY\'HO;/J[0O=%/\ A^'5-G5M!_U$^S#NZM^F57VAW\^+
MC)TZGTY"X5/D9.0AQ%^4B0Y.6@2J%K8)[:T0$(2I?9 3VB"6 #L!Q*4I2(2E
@*1R2 !Z!&/%QUUXA3KKCJ@("G%J60-8!420)),:8_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g150472g08o09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g08o09.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0-S:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I/
M<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z.#E!-4)#-C,S1$(Y13 Q,3@V
M138Y,3,S-C(Q-44T038B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z,S,Q
M-44Y1#A!0T8Q,3%%0CE%-4%"1CA&148T,#$X-T8B('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z,S,Q-44Y1#=!0T8Q,3%%0CE%-4%"1CA&148T,#$X-T8B
M('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26Y$97-I9VX@,38N," H5VEN9&]W
M<RDB/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB=75I
M9#HY9C(S-&0S,BUC835D+31F,#,M.#!C82TT,6,T9&%E-3-E8F(B('-T4F5F
M.F1O8W5M96YT240](GAM<"YI9#IF8S8W83<R,BTU-C$V+6(Q-#0M.#8S9BTV
M.&1C,&4P8S$S-S4B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@
M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M,@.AP2(SX4)2T?%B_]H # ,!  (1 Q$ /P#^_C 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# T!7:==H;.9:75R]F3VK(X3(+'8H*8I\L@=(+%7I@CLBE"1)Y
M? QI9WR4MR4XSS?>FJR]>'TX7%QGHW_"& P,%')1&I@V:>XE(6.4,VUSLUZ=
MXZ[('ILVYL+HL8WQOTO;3U*7:YF>FY0C5E>?U$ZH@PHS03 "#H,[@8*.2B-3
M!K ^1*0L<H9#%KJW%O$==D#VUC<&)T6,;VA X-IZE(-8SO3<H1JBM#\Z=408
M49H)@!!T$"UWV1RU;3-5\AK2]:\FS+=4XF=:56XQY\*7IYM/Z[;),]3>(LVR
M@>8;[&&F&NBE609HL99*(P7W/#Q+BQ/4FE$:A;$XRB8R%CB<99R0J7>125V0
M,3&UIQFED /<79T4)4"(D9YP :$88'6QBUK[N]:PG-B(O841F3W/(['',]<\
M5G)$L1FJ4UH>FT#3(%L;8Y:F1)UCHW(D3T48P2-&=M0@,5)@B-V4(S1Q9I8
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M=#=W0DBQ+[\,O0N3%7KQ)*[>YR08].8%']8Q*E;'\M3G%:-,^,7)@C#K0AB
M3'&R(9BG<-.R-WK*4N%:RJ'N$YB;Z5+I7*&F+)72G$[6LLDYFA%D+T;LM<DA
M\K=:ED&T"9(-4GVH2 $/R[/*V(NVLW$>\JYDX:W/<(;.H8BF300LF2N5$L*0
M--/2X^U&YLBED%(GI<:E>US[3;X@UI'I62!261YAZ H+%L;:DFANH8U?VV0A
MAATTC+BL@!DYDS3*D[2F<8"HW.9# 44/E9+<ZN(").X.\/>#"RR1'$_#MXQ[
M,UYR]"%TX0DV>X(QN$4C<F-HNW$)UCQN$2JGH\>= 1/5EM4UMF TN7I'H$PV
MW1I8S2^SF,]46Z'I0_*' "H Q"+4$DC:W57V40F4G;)IBQW)G42ZQ*MB[XW+
MH4:1,KEJJ/2Q^FE;,:!1)$SJ6H"KK]_:6UR5$IVYP>&DPG1A91Z,]2-K#1SO
MJMIG'DDDA\/FT@035!7SW1@2BV5O/OB-618#W7S%(H02Z.B,QM;DY[)\V5A=
MM(3TS$K3*S"P^KLL VUDF[MV+S!QBS!5E;SNR)/-(O&Y4P,K>IB3 6-&Z0)K
MLF2I'-XDL@;6MJ<(-&Y9'"UY1AF][<)*@(+\P=*C4PV]T6H?<88/7F\C>(/M
MJK(9'/":F7]UE<7C;I.I)>S&^.XF*5AD3PA8X!N)_(5GQQRU4$HD#>HT#9YN
MR"C2[?5T41U="'.CZ[NJ/,$GD +8?V2%U_!T068J2OTZ>WI<P!C@5ZIW)BA*
M9L6M"X]4Z?,!-NVY":J(./+V3ZI-O'#6%_8:%C<W,F1U3-VJ/1&9PFJ[)F9+
MK#7-A@EM6 S1AWCT,4%)'_YR^HPFSAB0JW9$E,0IESP0#>Q *6F)!M:E#>[4
M4K,C9ZVB+6BK&^MG/4E7/KTOKHY/'HEU._"B%+O#@C:9FX."I<YRX@Y(ZMZ8
MLY2SE%Z4&^<LP&A#;X_$=[X9,#TA3IPGF*@D$A4FEEDFJ E T>822(P111AV
M@^H,LH1HMA#O>]!V+?A]W>![L!@,!@,!@,#$/L?890V*&62LC1(F97Y/BVE]
M;4;NV*?2&$POXA X$J$IWIF!T(/F!OP%K6]?3@9%.G3I$Y"1(02E2I22DZ9,
MG* 2G3IR0!+)(()+"$LDDDL.@A"'6@A#K6M:\,#W8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8',-E<ATU;]YUU?]D)IA*Y34\2FD3@43<)W*-52QBL*/2*&S"6
M K$AQ)B2N=O,)EC@RC=SDYBL+8I$2 0? .PEFJR8CG. >TSQI7C"X1Y!'+-D
MB-?'^?X<%1.KMM.8KVN#\KVB1;_/L'853U*5&V&)5C,$I6T2-)HH!Z,'H*MG
M@$/S&M^INLK]M[FB1/ZZ:,Q-HUG8CA9]M6P?9=46]/H)/0R"]T$2;K>:27]K
M>?4)ATY3P-G&H:= ^#3J6XA2E G4EZ-PF^MVZ/X<H;JI'2R2VB[+,.Y[DX)M
M4[M"KBL^NWV-3(AF"PH988]0N4LK@\21J;M#TC7+##U*,TXTTD8##1C$)JNG
MEU8*6^WAR9,W*KY>^5-''6UZ;=V^502ZY A)D]N&SAC@CM (Y-+"GSZ%;)K;
M?&)O= K2A292Z &ZHTJTS0E*8DP W:O)\,U]O6B[9Y*JSCFZG:V+6KJL 5PN
MW)7VV)XTV-.9;6GE6-,RGLTC+ZSO,D=5\CUMV5$*#!H1N&BS-$Z] G18W6:M
MTYL#+/;&Y;GKI7SS.BKAFSG!&AIC+HMF-\6S*E=O0Z-6<;<L.A-]K)!*W%9<
ML1A5EFB<VE"^&*BD?B)*'Q1#&F$-];K2? ]!\]7#8UW5:KN1FEUN3B:659+0
MXWW;\BKZ93R>;+"]RE]KE^F#A#%[NF3$EIVXTQ&+;4E*+(2>B4 (-"ZK9BMZ
MKKD:EZF4Q$^OD,RC9$,L^\K@;FE#9$]"P.D[Z)=Y*_V>X2UA%(1-$R0+7N6K
ME;<B<R52-F4C 8A+3C*+V$EU6\V_S*D*XGKI,GF3LRE<X3VI76D).:4[NJ(*
MZN'E0Z*G!F**1JR2D2DX]Y4;TK)T!6#SZT$S6@A\!FM5EG,542]\.E:E+*&.
M8B7QES13&)323Q>3,ZR*1=^A3<)G=&AS3F(2%44DRY$M(UK9"XL[0C@#,*)&
M6,U([M6L2?9#7<J=T:M>^U:8^&PY>H='(PQ(=(XVHBCR<X!$IV!Z-6LBHPL0
ME>CMZ&+U-??_ 'V#+G-OX)YI98P3#8]%I+&XUK=CHG%JCUASMH*D,3MB9+YY
M-J[D9R.0%JGFNELB<CMI6<XS:1L2&#2(@ITIII)A=U;VOY/HYU=Y0Z.L54N2
M:8+Y8Y/4<6/SV;%!J)Y7!53S4M''=+@MS>BE$'( F5IR0 ($8'UP  =L0]DS
M7XS\NU\R/<6DZ21VT;)XFGTTI9*NMN>+WYZBA3FD>44(E[HJ>3%4OB;:YI/6
M3)W$2@PD1ZGRF?\ N*_7&Z\F4L7FJJK2FB">RQ!(1/Z5'!F];IFF,GC[7(D-
M93P5G5XDD[0S.B-O?4T0G1QS@D+/ (&QJ30&Z,*'LO!+8QCCRA2+I'F*,J8X
MY@;HO''^,QHY'*I,A=&%)(;!AMJ'N32[HW4EQ12%LL& -#HWN #-*T"A$'T1
M@#L81#-?<R<R5*QU59E-$MK^XPNXE<[<;)T^S"3O<@E+G9:02.;.2N3.+H>^
M)E;R4/?A\.<2!-O>M$!*"$(0C-SEOLHJJ!31[$_2I@3OBLVO)M52I,X&J#FI
M? K%5QI9,6!P:=F_+UR=Y-B2$(QF%B,"6 0 BT$PS0AFQ!HN(^?5J,]#)6&4
M3HE2B(:CQS^P)K,U)C.V1>40Z,,XE;^]K50F^%,DV>-LP=CV- O<U#@ 7S S
M:K"[JSU0<^IZZMNZ[A<E25PDMI)*VAZ(\M6\NB\F!U+'U;+&E,B=WU0>J<YN
M_'NJDYW5E!+ I+(1%CV<)+HX1+<R1YOW*-2RU7.ETQ%/9@JG<9E<,--D]ESE
MX^J,6FKPT2"2,U=A5/@@08A>]QYM4^JWZ*4%B;$8 F:)3$E@&:P9?%=#?%2=
M2L:9:[%RV/6Y&79N=;!FBQH"AOO;<HN54VM6WH"%J>+$=FLM>N6IP%J0+A&&
MD#)]0>MEW5L N5ZN,!.4YZJP%+;:$/7P^RF4ZQYCMCG?S6#(:W=)9(V@#L!"
MIG;E#FQ.E4.Y8"E9XB"SQB$H $W1,ULSISU4[VYNCL[1K;@I>IQ'+$=2E;FY
MGH'"3Q6 D5DT'*VXQ4)$>W!A:<*0]$(&TBGQV,TL8Q;%L9K'0GF^MH'N#_*Q
MS-T#62EW,KT,KGLMEGU0;WF+ A9S"T#?G5:;IA2QPO1!"<X1OI[_ *SS;,^_
MP6VLO :&KJL7AC>H4C>6<Y@J:&4HE0ZD;TK:5<#KQ0XJ(.F=6Q:M4)'-YC/S
MI<6F<30B6^BN. ,P81:T$9M8*/<RU3&)+ Y,V))*(RL5$F<H$Q+IE)5\5C,@
MF 9>1(Y4@CBIR,;125S;9X[(Q*C0&" D6#+!H/@'>AFL2/D>CSIV\6"H8'E4
MZ/CI.7Q:R*9=)SH9I\LZ)AA%AO!$-&Z;CY;A+XX6$A6/9&_ 6A#*T6,TX1@W
M5@D?$O/S<EK] V,,H;6^NHS6$2:T*&P9NG3O[/3,Y,LRM-3G07WU)NNC,_5*
MG;2ER$H.6+%J@2L1^C1:P;JR)W'-&;#'AM[1)V!QB0(V5&7Z.SJ7LL@8RHN1
M:R%"6WO*%X*6D:5M-W2=$KWH7F4I7/81;\Q*<11=U8Z,<2<^PYY9'>/L,H2$
M,)=9_"QLZPINNAZM=34&9ZZJQZ=HLN?5+.[/D(B["D C5GE#.$K(*5G;-5$D
M'%#=:WFN^;:SJ=\;WFO=2^-$(H[&HXHC22<RLV'/8(?"V>NXX]R"+*W10T.\
MG;H5'D#?MP-+VH/*0IQ'",,(*& EMO-C%O*5+N-B.5EK65\4/3M(7R7KV<4P
ME((8?+I16"FFI+)QPXIV+CXGI\K51\K/-V1OP+!HPO0#A&&#&ZXPRC[S95<I
MHE%SC*$#_(:N0-4;94Z)TEDB-D&FZ(NK<[QPD<N*<29*,QL4-"<L)NU/JF$%
M^F8(8!#T(9N<]6!D_(- S!)<"%]A9JA/>TO@LYLD)$AD2$;I(:Y"P:BYS8:B
M<R#8XA),CI9BE*W[3)EQJI8-0 P2U5LT;K'[(^0Z"E;-<["]0T\YNO\ FD;G
M]G 3R.1HE#O)HF&.?)5+8L1NA*J-(RE$8)4&I6X:9,H4J5AI@!&+50C1NK<F
M*A:XBTJGTTBZ%ZCLCL^>1FQ9TO9I,_HM/[]%&1"PMB0]*!PVE31H]&AV8L:R
M %H%JM0I4'%#/4G&#&:@>B^&JPJJ U_'Y&8]365PMDKMO*?5TJEZEK:E->3M
MCM-"FA#.Z/:TN(QM?8\<1.:I FV$E5\(G(.T-,G()++=5K?9#Q[1\G>)&ZNK
M5*=II.Y2U^6QM'/IDWQ!#*; 9ET;GLO88PB>B6A@E4RCSLO1KUR0LHX9;FN&
M#8#ERLTX;K&NHN1(6T7A5%B,+>UL4*I@NX))"8JB5/9AC?85W#;T4LVW-YRK
MZO1^!HFQ(I5)6M*3Z879S./*"FT7X'#=P9\CCJBVUG):HTRR6%J$=A6!9K9)
M(7.9?&9>T2:T33]SDIJD[8\$NZ*.O*$TM&%J 9\N2)$B,M,23\$CV03=7XIX
MXH<91:=JCSY%TZ..UC'V4F*S&4,6HT*FS5HJUD4;-1N@5#/+8VD<5"/;B4/2
MA>@/,3+=J"#!@$-U;U**$@TUC9<7E2V;O:%*B@P&I<LGLLT_,+]73PM?HQ.H
M^_D.I+LRS\IU6^=4[IS0*UY1)1"D1J<&BL&;&GF<DT\K?"']U*FKXKVMCKZ]
MHWBP9<M8YA,XBR)8[&+"F<?VZ@99)/&-H0)"R')00([0T"(T7F.0HS"!NK8T
M/-E0M[>F:TL=5A0I&*A(T22-]>S?!GYGE1TTI],(9B\0S!1Z0GB./'O>QN =
M^FJV:#[W!FI?8&4F/-9#2G7/#D40<M."L?W=<^NAFURY2O& ]S<CE"PXE.8J
MV60 0]A)(  H'@  =:(S& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P&!JI\ZA*5<]-:J8Q5,YQMN.>)$W'R%H)7,+0G3Z6*'1
MZ2&*PJ&MN(2"T:,\\)902]^;8M!^G!BLLQOC))V5GDL:>&N0QR0M:![8']C<
M$CLROC*ZI2ES6[L[J@.4(7-K<D)X#DZ@DP91Q0PC +8=ZW@93 8&ORB616#L
M:N33631^'QM :@(72"4/+='V-$>ZN*1H:R5;L[*4B!.:Y.R\A*G",S6SE!Q9
M8/$8PAV&P8# 8&&32*/K'QTC"1]9E4D8T36YO4>3.:(]\:&Y[&O+97!T:2CQ
M+V]$[F-:H*4TTL!:C:8W1>Q;+'X!F<!@,#7UTLBS9(6&(N4EC[?+)4D>W",1
MA<\MR20R-!&@MXI&M864]26Y/"1@"[)=K3$Y1@$NE)7J[#Z@/$-@P&!I#)9E
M;R9Y+CD;L&$2"0FMCP]E,+)*V%U>36:/20Z&O[N6UH%ZA<-L8Y>G,:EBC0-E
M)G(L28P03P[!HN*W?"& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/YD9A[?5K
M6_W![A712F.M4#CE8WB;9M<OR*FW\%^=!*#O;>CM/ZK6%W )W1H5G/#I(9.>
M!Z94C8Z"<WYJV1ZI PB\L==TFF3P].+3^8YY[C%=V+R;5+ANPZR@E9T=PHR0
MFFGFM;*/BUJU$V<IQ$WH*(N!;'S;*HNRW819Y+FVA<938T,#%%K6A).0C1JC
M#556S3<WQOU^;4F3I3W'Y'5'0#XFGO2-81M5".4[6C0K1J&WY+-FZ;.]C6DC
MZ$Y7C5EQOB9B>(E-W2+,;,W+'9I@<IC\7==A$B4F)U8C]0QISTS\<>;HBJKX
M]QJ:=ATJBEAMP4+ G4/)SA':AN"&S68$S"D9/13$[] -EB/=7\MO]?'7ZTV8
MM=2G!]=9U""X^N:4I.V<"59O2BI9IDN/C]6K>[ HZELNV^A*.,/Z?-@)S7PD
MX\NU-3E%K;!IJZD6^A&B0]02"VYPT5I*E3'(*R!'&]066=((^-M;DY*A.2LT
MJ/"*+HVR2\.N7RS2R>\;\M_KNK(ZAZWB5:6)0_N(0WZH.3&_:5UU9M6/; W\
MT[@]B!Y\KR#P]7<; ->:S(6.4S0#E'G L:IPTY  <$DFF27AT_RTNFK1[_:I
M5QI7T+L2Z855;92G%*:NUMU59=9R*S7Q5)W-H[ @]SMC-R5,W<$EBR9!I@;C
M)'(J_(C;24B>R#W$@:I9LMFG%O7C_CJM8ZHZ1DUX>W>=T1QY:LFJGZXO46<X
M=-U]4V,\O\GA#3:!3+)F=J:856=OS:$I[28&96F:)65%GD#8E7IW+X;9>PC#
M6),:L:E:;U9G?+P_1Z>LU:=@TW7-G5G[72.]W^/T]';*ZTKJ!.Q'5Y]Y$-3V
MPTZJ<[)G['*28:1)](X^L7QYG=C52=F;E"DX 36-/AU^71HU?6U[C705%1J3
M0*_.L228]1_O#2K<UB]95T9*YQ<//'3[7%N0Z[GB;572&,-<K4,#<K1[8&Q,
MC5NY258E!] 3=ABXTR\9.<_RL_[,NCHMJY7Y,$RL=Y1:R;I4PA-:\]J)ID#8
MJJ1_44R^2I:EF\>B]$]"3Q*ADEA$IV9&@11],'3R8F(7.2)+L[1U8TR9O+$5
M_P!?V-[K4P8(W=<KDW3L8E,)AOM!+E-*DTLR,\)L.56_8!L*[CW-(^X5FIEH
MOJ]"SA.#ZC:%[85%U7@L$$@L!0 1NS1.$QU_P^[C93U':ON#<H6+?ZCJ&3V%
M 8A[C#'T$R6+1:R%T1SK,)%9%=M%50NH;#2UM%F5]C<VK6)I#T&RWN2%.25(
M6N^*+4J#RMTU;9IN,8X)CG3=[ADRZOE*1HN_J^NZ>DGN,JZ 3M,,KJ [B,7Y
M&<N&VRQW2SHR_P HJ22+DN]7^TZ:4$I/5J&]N7J5",L E!G@&,S;)TSC]<N<
M6WJ7W+U9'#*=WC'4S-;C)#>*EURI5]7R'<*NANL#H-=!NB5LGKV-\YO+-&WB
M!582!5*5SQ-(F<V&*4BII:_+ZAY]:VZ./+'%T[[?$!O=/VJR3^UJUFT<1)N:
M>[(2*2O%9_41A+VJ]U"?R.MV4>VR.Q]@"[2*JRT3RD%Z?QCPW&:<AB4;.&H&
M359MQ.\^B 9Y?/N>HK5[PH"G9!8\UF7"C#>5M1=_(C40E"^XXOUDZPE^Y,B"
M)G,:$J:7RKG:K#['-1-F@@$[O<;925(56C3 &PDT8EO7XK<X[T?UU#W5OED>
MF?8-K\6P3NOF5M3W%9W/,G3WO+Z0F7/]J)^A6*1UTQ4C"K&DU3PF_ET3+(=T
M\13+"%9ZE,6H4(D6S TVZ?#=A)_ $A[^N"[Z/=>@YATW7]7L_-]I6=*XE,ZU
M9H2EFUIG]J=$Q"O(59"]_@/S-F5,G/Q["K$RMZAN7*4R5L5&&B)";\635MDX
M8Y_LOTPYF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P&! W2?1U;<IU4ON*UA2@43126"PX
MI)"XH]3>4NLHLJ9L5?PMD9(O'DRQW=5[W+)(C2E@*+%O0C=;WX:UO>%DNJXC
MY:,ZEH[HF$M\ZK2:%&(%LED\)5,$M;72 SM@G4)DJJ&S&#2>!31&QRV/RV,R
MI$:@5H5*0LX!X=>70@C (0NFRXJ6$L[@ZY(F7HIE%%B%8_:BJ1:ED30H2*I1
MLP1.HVF4E+!DGOVS@"!\&$6U'FUO7D\=83#UE6# CR7=23-X@<GCZ8Q:_*"I
M*S&$LB,E8N;CE;N:!;L#:F*<&Q20(P[8 !.3F@WOS%BUH895VDD=8=-FWQ_9
M673TX)6EGV[.B%NT[.JW?@C;&S:P\G2]P5[U_5$E><PS_P#EUO QQ$\@ZD+J
M)-,XHH"Q.J=B>Q$2)H-"S/BP\"9(S.NRU@M-[JJ4FA++3G>0X8Q:"$.][UK
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M_%'N3H4XTVPEKE38@/4AUYQD%BWL.JYZKFVNB\(8# 8# 8# 8# 8# 8# 8#
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M4R>VM<\J9FM[=6YHE"'H3D)L0R5K0KU"9OD")M>KJ0/3<D>DA0%)9"P@A42
MW0#2P&:$'1=NG_KZIQJ^U+EF==3*63WE^<4[-8^-X#&:KD5CTS*WV>A0,9#D
MVF-4E@,YD<*9-/KJ8)N*TYKTFR3B]FG>0C83-F;)+PN7.8>K>S]A#L7M;7D
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MO8_61YW_ #]TO^E*#_EW!B]C]9'G?\_=+_I2@_Y=P8O8_61YW_/W2_Z4H/\
MEW!B]C]9'G?\_=+_ *4H/^7<&+V/UD>=_P _=+_I2@_Y=P8O8_61YW_/W2_Z
M4H/^7<&+V/UD>=_S]TO^E*#_ )=P8O8_61YW_/W2_P"E*#_EW!B]C]9'G?\
M/W2_Z4H/^7<&+V/UD>=_S]TO^E*#_EW!B]C]9'G?\_=+_I2@_P"7<&+V/UD>
M=_S]TO\ I2@_Y=P8O8_61YW_ #]TO^E*#_EW!B]C]9'G?\_=+_I2@_Y=P8O8
M_61YW_/W2_Z4H/\ EW!B]C]9'G?\_=+_ *4H/^7<&+V/UD>=_P _=+_I2@_Y
M=P8O8_61YW_/W2_Z4H/^7<&+V/UD>=_S]TO^E*#_ )=P8O8_61YW_/W2_P"E
M*#_EW!B]C]9'G?\ /W2_Z4H/^7<&+V/UD>=_S]TO^E*#_EW!B]C]9'G?\_=+
M_I2@_P"7<&+V/UD>=_S]TO\ I2@_Y=P8O8_61YW_ #]TO^E*#_EW!B]C]9'G
M?\_=+_I2@_Y=P8O8_61YW_/W2_Z4H/\ EW!B]C]9'G?\_=+_ *4H/^7<&+V/
MUD>=_P _=+_I2@_Y=P8O8_61YW_/W2_Z4H/^7<&+V/UD>=_S]TO^E*#_ )=P
M8O8_61YW_/W2_P"E*#_EW!B]C]9'G?\ /W2_Z4H/^7<&+V/UD>=_S]TO^E*#
M_EW!B]D%O#ER6^6"NL-9TO!@JU[E')"9'"+DK,$5!+H@S*V*+2[X$8S'!4[,
M217ZB<A0J.;-*R25(D@CRBS E_EC&$>+:U]OQ[VD52NX:SEKY]9'24O\A=;Q
MB3<OF;B\HY:@7II6WQ5[CL:6LQB6;+PA1$($R4'J^(0:V(S8QG4_&BO.%(W)
M&Z41GH.&L3DUOCW)D@B[W@ST,E^=W^928A>E<)2M?WIL*:7F=KS (T:I,WN!
M?HE.9"\DDLO3"YU7HVA.V<7(H;(8FBO^K$B^7)I(WRF<%V)29LN?6J8/BB02
MED4 5-JB)(6!Z7JC-C0HFI*D(\VQIRR3OZW&$_EV:NNKWA5[CTWBLHZ$ATK8
MYJ>I4!*>;W@I;M%1&PEQK=(5%Y:S+6F8@3-$#=#6M&4X.#@62F&9OPV:H4F'
MC^7-XO\ 6? ,K12-LDUV0!Z;'ANE34Q(3[\C"/\ L\0SD^1+9D5 U[4^M[LW
MF21QE*T]2:M4+S?ZP)(! 3  0$?RG)*L!=.**PF<IG<(N"I&5[F3,VLKZ5_;
MBR+VDXANDLOEVUB=J<Y:L2(W-RD$X<%"L\L(1J##/$7WWFV(7=>:9?UD>=_S
M]TO^E*#_ )=PF+V;O$K#@$_*5G02<PZ:DMXRRUYL2DS+)"D1ANMB*+5F,RU:
M!,,P(=[#H>P[WK7T83%C<<!@,!@,#^;_ *0IB)^Y;[T$DXYZC-?99R-Q[Q[7
MM[MO/J&1OK!!K7N6W)P\L0);:!+ X-BV1HXA'V\)*!",[1!9NO-X>0U26<=9
M=GX]T^ZUV)^X,]G+^'[0_P#_ &^1_:'#/N:^]/W!?LY?P_:(_$)']HL'N:^]
M/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)
M']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?L
MY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'
MN:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:
M(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/
MW!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)'
M]HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY
M?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N
M:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(
M_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W
M!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']
MHL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?
MP_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:
M^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_
M$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!
M?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']H
ML'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P
M_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^
M]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$
M)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?
MLY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL
M'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_
M:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]
M/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)
M']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?L
MY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'
MN:^]/W!?LY?P_:(_$)']HL'N:^]/W!?LY?P_:(_$)']HL'N:^]5H^Y;P5S)[
M4D(I'W!O;TKPKENWZDZ5H>%35AK=^DZ*O[SJ.VK%98%-*XLR'KGE>SNJ0],\
MA/2J@EEGIS"][\1#T0,@WHU77_#5QF']56'$P& P&!0W1O\ V*>[?]NKE?\
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M_P"\>5Y'2_U3YKY,KF8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# YF[.F5%5[R=T1,NGF,V3\[,513=1=<<(:%;^8_5H<QJD<O9],J
M],M= N3,H-)$248 8PCWK0M;^G"Z9;9CFCWC?L3G_H]-+ZMI^/636<DY\9*U
M;913=O5E**JF\,ADTCBE953NG8I,1H+G$9+'V(_Y>M1J%1(M)1A&((]>&RZM
M-G&\J[;PR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
MH?\ ^1Q_IK*_\4G'W^82#9*Z?B^_ROT7P97,P& P&!0W1O\ V*>[?]NKE?\
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M(Z)DYAA*@_:8)K5N_P!JM/PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M#9*Z?B^_ROT7P97,P& P&!0W1O\ V*>[?]NKE?\ O'E>1TO]4^:^3*YF P&
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ML%VGE.S@Q@_4NC^R9&),I$B4!83=.'D=]D+ [)'I/LSRFZV'?@+Z,&*WK"&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P&!0__P CC_365_XI./O\
MPD&R5T_%]_E?HO@RN9@,!@,"ANC?^Q3W;_MU<K_WCRO(Z7^J?-?)E<S 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _F+J6C^EXWW#'I[#Z1?"G1
ML[C]ZB;19\LF.32*5;LFT8/1"6IY#,9FT19^6LL&L9>SJ2V]R3)%6W'X4W24
M)PBQ:U':W3MQX1E^H.:NH'[K$=&*J8-<*E]U-'RA)>SI=4I4BD])U#+.1Y2-
M=T @<I@[1V.*T;9T11#!&XJW'.B%&I=3TIA>R][UO65)=.W/6<DDO5*6P9[9
MWOBP$FJ)Z.8VQ??N7NU8PPJ&/8I%9#1.FHTF%.4(80H/CY4WS#?@%L-1EG%K
MM_03L>#,WZ?E%<G5W)_4D<.]PBX*MHJX9LAZ3O'F7G:UZT9H=)U:N55I'J.X
MVE56=$PQ@+1"^L1%*6M')1&GQ2D+-"!N?5FS-Z$U[].-2SA+CO\ 5854L 8H
MU<?=L8N&B98G]QNU.CNE))R9T_-N>9U9L>/@,BBCZ3R@\5;T<@A$QA=00ZJX
M68E9EC6H>F0;2ZD*MG%;&LT8:9MX2R_QQR<55[1B%R@/'<5YKY$O"I.A:=X^
MZOB7N+2)ZHN?UZ\31PDO)<TB#I7-CV2^L#:V=16):O5*MJD4<4MCC*!^1*<X
MEFDE'>!IJWC;;,9F/CIP0% ^$NDHM6;%6CKR_&OKM.%_L8RQC;FCE^6,_+KS
M *]DCN78NNCZH;ESB)^NZJ9<YKBK37KG9(K=(T8A."0VD:. $MU3.9>'%W^;
MQ9"N+K:Y>B/9-<2;KWCJ#\O]*L,4W%^;II=%/U9U/</1"JV)"S-G.<.06TZP
M.+.%62(,2@"I2G<"FIO:3&_2T@Q3KSF=VZ6Z>&K/Q_E7%9W"'8<OIROBY/S?
M*I3NOO;5E"95&K JEVLR]HG4RGW Y-.8/2M!V6<[KDM8]I5KRLN;M- S"7QQ
M3'H H_A-&^526:FK3+Y_M]';-PQ?L*6=SN7N-L?)=GS&GZ*N^I.:81M^,>_[
M491PX7'WVJNG2DW-3]#-S.?,]E3^XCY@2N$8 PU)$$INTYA9>Q#,S;MV]<?K
M\V!O;ALB+<U^XB* <AH(T]NGNYT:\0@R)\G;G+@OYECDTX\D[PY1NM(E&T;]
M9]&,*J/.[@J8FT6FM>8B5EZ\INS!A$U9LX_Z]TK6?6]/G6]Q_*[DXUG'3_/*
M/@7L2LP1.L_;;LJ#M&[9E%_5(ZL;&T<YJXN]+N=91+&QA>C&UP=534 7B8X:
M7E%J=&Y29Q<7%S.JYSVS:[N^I>"N6ZXZ.&\:N2(U:UM4M02*0ZELBCQ(5K@?
M%HA(90%4N#('^&0X]O:5JO1YX3U2(8]&&:WYQ'/79=5LY.Z,,F P& P& P&
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M9@,!@,"ANC?^Q3W;_MU<K_WCRO(Z7^J?-?)E<S 8# 8# 8# 8# 8# 8# 8#
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MFIF\A.,!:$@T99&BP#%K8S<8SP>R5<M<RSJPT=NS;G:C)A:[<K8'!OLV45-
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MRA%K?AO0M^/AK>M_1_\ .!^^<'E"+SA\H]ZT$7FUY1;%] =!WX^&]BW]S^G
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M*-0(>EY3<X0E.9H]:J+JT+B=+1E&IUVTHTQCCL31X;U#3G$VXQU<D=<5]U]
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M@ &>/6QOU- <?9QY*>4;,Q/$AZ,7PU-051<QS*"%W].6:+V_2E&F23^SJ%7
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# H?_P"1Q_IK*_\
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M\ZC[;*X9(6:51EY*,.:G^/N21V:' LA0<D/VE7H33DQVTRM.82;K0O,6:6(
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M0F*4&F%J E"W,\;4>]E\@7O:">X)HEG@9VE QVP;6T#&GF#JJ)16%2"BJFV
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M*Z1_XN*K(Z^SR^;*=5#>VKF][-DMM7?*K-:20A]8Q":C:V"5F(UIIGF/4+"
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M$X]"8,:8D8C/"7P<JL'!4E1P>U6%UGL9<'ZR:GMR )'@ULE+]MB6VET):5Z
M5&O4LDC[*WY T:GZ5&:8J7#6+E+=\4,8=C"667<DJON5Y_#KJK^7K9?!5]<U
M6_\ 4S_%TI$9=PV.]&]/S=/8#BGD4@4NIS6F!$W<:E.,2<H>WHOX90=I.:1L
M!@MF/%\[[S/9BVUWN]"9A7)=B@NF-3J Q%Q:W\V$*HE#*?L6G4#-)%P5I;UJ
M9+H_9;FZ;<4:89+<K()) G/)]<PT9F,=&<-Y+>%W.\)Y\66*-L;-V<?8UJOT
M0: 1]2\$N%ER2[G&*5^B4FO*:*1_^TIP0)2"E/QN@QM,:C'Z@S?/H9XY8."\
M8.,%M!#*-6,IF4/9K$MFS61%.48'>8H9!==;-T/GB;3PC*;&4"!9)T:IX!Z*
M(D?F>%I(_,$0=X-V8U>'<(+X[7K9"5LV9AJR9KS;(G&0,S&H;70QLHWGRNZ/
M=4K<K&J4'I'5W%$%BQO/'LP"(M:$L0#-A'L9=W%*_*G-+OSO$'AM6*V!WFXX
M57E<HYD7)+5D9,ACE3,+LT0=2]LD_ETA+B@25+ZL/&ULIQ:0D*D98#3 A*],
MEN4/QOCRV(K*45KQQ^IR+3!AL[=A1RFXY'Y8DY_;CWFM)56\^=$*83AIXCTY
MGGUHTY*')N1$I2S46BAHU!JU>N4#,O"MP=^*P2QO<VF4O['MOE=X7O:TR+:6
M8\E2N:KMHB=TVH9$:PX_U-NK&.6IU %IH=^<A 6#0 "T#8!N0D?[>,DE+,Y,
M$^NUE6/$_IFQFRWW*.1M4UK9/U#-6>81U#=[<DW(=*$;4P5]:+XTZ:A&Z4F-
MX&X 5184VA;+NG2)?CW&;D!<?)WY7$T<K?(-T1'I><2]V=8Y;S)KGBM(09LE
M93]:TD?I&C+:HI31"-4B 8$D:8918-[V TTZ)N:.P<73M**"H6NRJT<ZTC]A
MJ+G4/)L;='&:.<L=.4Y#S@[-3<]EO7R9+&RG!WTZIEFPFJ]-@=-(@: 5I495
MW3S_ ,LT1PL<;5NH,NG+<,E=.HO,7A_C3(>F>%C(S\4,?)R],S*/C#1:?%'R
MTUR0J!B,++3&@3;"+PV/<3=QS\<\H(AW,5UW!*W"PW$:"#J:T(YB::Y&&*6M
M0:*?#IR!=(0B5)'=,VR-DM:.)0L]_ .0+"0_!HUZ7X1.!Q1E&*5-7,G!V)2-
M%/O/DG3IJ[CL3<X/8*VNF&4J43PYB_LQ@E0T(&$M"%N<Y(ZO,JGJIPL!C3)T
M8%1XQI&]:H-/-$:5X&DMSSYODL7EB82^Q+ 7-4PBJ"N[BL:@[/GHG!A<E%D1
MYYH);#5;8SP)Z2N!#66U27^SYM\AJHO1K&I/<%) 5)BL 4XSP\6[-M#SB(\B
MQ3GNNY\AA4XB-:PB$H9TQMBEL;S%49 R@D&T:9"I ZQY/,4:!6DVL2'?,&W2
M[:I./:DD&]C,W9Z.<H[P3*$,5MYK>IY'5KS:-1]55TF6&I)?)1QQ7TA/$\V3
M&G2&92)ZEDC01D28HE68J5:4N9I #_ZC6@DEEW<4H\S5*Y,MY=,V@LTL!#5<
MW70VF&ET;36Q4P-CBI)GM\N3<0<<(T3-/K[>'!228,HD1Q+<4(&AD>B<:2WA
M(BM9PC.W.'E5PML2'$Q2 5]>T$JAV11IV!+'4-Z2-K>5SG:9XW/X->9'T+;Y
M% $/A\]=MENAXDQA(4VR[NKM2WJ\D<W=*7?HLYLB!QJBX6^Q%*1_3+CD3XR'
MP.P*X?VHD]O,">@="V:PCUB,W8#2A*DA91@=%F"& S'%;OP ^F0>F8\QSUG:
MW2EZCHZ&-NFPB51%MDDJIFPVR<[5.+E#7UHDS+'Y&60K*")$I"N;UJ@M8$1_
MI#(.-;^+=&KA]*W-;F@2J(JTIGK]4U<L9]ZE<S3I'6@NGYSTM-O+(YP\.DH>
MTLU?9PHTC$L.V-&L$,[8?3V D!-W[IXIV$3^L)/*8<<VL[G7<ADMRVZ;-RUV
MD;@3+K4N1^ES1 T4;]12>:F8HTZ'&N+D:,DL]4:2$@O?]=Y"7C\W1^$4/_\
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MB/V,1IP4Z@ !MK&1_NNCY'&R9*C36&C)>F2O)% FIZ@[BROMH-%JOQ\6@RJ
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M2BB68D:I:7:D0K<V7,R6N[(E<VATKJ9D6PI"WL[<[.<<MBV4=1-L\935SO\
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M(2S3^1&22$3M%T)L!$E$:&QWYE2*HB:,.MR(.W L\6O2+V8 9T_OYO8R\_\
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MT5X[%%VA*E+6T,]<N)C,SG)W5Z,V@:])UBH)@]:,J9G+IEF)5SU>,5@\ND+
MX22,R&5PGK\RU9 [7&<UEN"%UZ.B4YJ5H"_NDL$W0Y6HI4N0-+ Z)=I"XL0N
M\AIR0.OHAF?1D:7!/)13G;,;YX8)M"3)M:D^8:-7+K&C\H:*X6M?,M+H= 12
MMOG<O;XHUNEDDNB9(".'O*9D>1*!F@(-+/ "EQF6_'%Z+"I:>/+6E^HG/UTL
M4.,J"P(U7]<EVU'8[*JPZ3<W!K.9KBE4@2W$XD.R%:D+)+2OY+F[N+28W+#0
MH1[<Q".$O>OD#R#<#VY!=9SJ:/KZ^O762J?.B*U7IH:)&8[)T>J#4D,;?+TR
M9K8T;V08Z,2%.42&/K#=G[ G.$(6XN9]$>6)ROT[9<).FDEAI[K;LP@%N0M\
M1.$IBQSLS,[3STBJJM6A:ZB>M-)XYK/]/TD,^&-,*2GR4>CQ ]/?EI-4EX<D
MX6GS/;S_ "WH"',D>^,ITR(WK=M0F!?V<O3OT-?54/58N$$VV+%I2ML3L#TY
MRF1F+5(2D)BN:I_3-V-&?Z9)?5\KU5-Q75(7J!3NKYS!&FO.>YY2U!2\U3 5
MD(+GD_I<F)3*ZY0Z,4]<I:G$(2PZ.1YM*:!C3)-+EJKQ&X)BT S(\#BNJX^E
ME\_@//DK@\KF-7<W\V)&A&Z5%(W:! KP5R/EA7FB806&W1B5,44*GB=IBR U
MR*6N;@668K2)F[1@\'#NF]EH@+$[<&'5U7+O%X;1J63,3XFEBF,?7:)0_=%3
M2&1IODRIL=G$MZ<CI&ZD:4Z0*%A7Q2@9^_ .QCT3/-S<_<W67-HT]T<RU=/F
M+E<-B\]+6NL;8DE;+7B)$LMZ(W:UD=5N,6ELF7DTZU5JFVK1HGAP.7(ENB4[
M.46E!\,27,G'_9]+'"+VK^R*^ZCZ"B#N^N=.12WJR?%D35M,ODK[ XK&XK$Z
M[>X^P-JL*Y=(>@Y_IWD&D(/ZQ"6X(DR_:<208@CA9B)ZZWK6RIK+&=Q;(5.[
M.@Y=/V5'8W%:^L%!7KE#KX>E\;-@]D/*Y=,88$21"TI5:=(ZD&KE<=/T,TE(
M9\6,PLFG#3:6Y]N^&V%7]A399('J='7M9G]K4K#.59[&_5*XT>^-;+M#%37W
M;4BB3C;[2TN*%J(1%J&]6<-1Z).C%.]EMF,>#WKX9=R"^9G?#56$V,C >A*\
M--A;;(X0CFDWKV%\ZVY4KE*T;:;-DD:5QPV?V"VKTB!S<DJ\Q&VC5B2EG 3E
M#)PQA%]6\W]!E((]-Y\SS1'9L:'QB./IS;<-=2HZGC]V/#IT<@(TBEFV!Q,5
M5<_GHG8TTLS3VC+*(*];910 Q;9RZ<4M<;U)?%=R>P)-<SG-%LB,979ID:+2
M9E,AUI2@4\DDA;+(8'A1;\R<5;O]75);>F+-9HBG2MAZ9&:G_P#2* FJ:K+R
M:*P5IT5=C59DSE%=K:GL^VY;5A%EQ"U%C$"&CYQK\^9KF#G>)RNK)?.G-<M$
MXORD^5.ZE$4G=MO[FE2@ D&DVE+F3Y)QX=#/J[JB#<^6U#!1RT(-!E,ND8XT
M#;E7C:T2NRIZCBC(ED_F*2JI.>A93E)R%, P"1-H AC!HTH(B:N-S.2 9/ K
MNNU^MVSI90\YC]AL;Y5)-10V1N57E1933%'](P:VW:%HY*SV"_EK[*OS<*"Y
M*3%Y"%H0$EMC<(\O:18K5ES)PZ/BFL-O=^CUAPAQY^L<BK>L+KFMAW"WQ9SJ
MERFL/IU!#:MKXNIU;<JLME9TDOO[ZHK%KFO0+7),R,JU:7ZOS4Y.(@<)QSQC
MM%#7+^FZ[7VLGCI"&'.G.;9#5CV68U$GJ9DEL(]T"W+49"C;B>H2QP!.M*!%
MB)T6 )03/O=!T9_UQURX7OJBNE[JM:ZD!M8I6Z!S*L^D*O./2OS83&+ CDAJ
M)L;*24R)Q7V4N='%W,G:+9@TP(RSIH^:$?@<HT::J5FI9)XNJ+;J=\G?'L4K
M^'UPH:).U$T4H98*_*(X4\1(,1G<$7OJ0;D![=&-.X,\;;%H1C3.!^CB]"++
M,,]36A$E_EFI(FM<OKEU'0UG-3"F,8(K7%\1R92(LQM(5IUDI55*=#&]26,T
MMT<23_D+H(KTP&E)MA'YM@V:'SD_UJ"K4@4YFSISA$X%6UUQ6*P.?4S.G9@D
M$BJ,=,:CL6GS+)WM'9OC,)/:3Y.8$A9!+(^2TG#1;DH&XX\U2C*4; 67GR8K
MF:G;:B4XI9HF$%711GYOJ>]ZT<YV>]11>V7&[699-<O4<?8JE9'E?(0MBQB@
M!KP[">$C8>0ZKRB %'B << 6S'S?-S#'^E(O<%ESNT*N=HQ'YW&((A=(G&76
M.*8ZGM!1:L[+E$G9_F=MRQQ?V9CA+^VJ%CZ<!F6.:!-HLAI"8G)0E%N+,=4$
MZY O(B'N+DG16%NQ-T)<KLB.'<[N/8^E/[8-R.FWX6AS;;9M\CT05'I6Q4+P
M0H&LS:$>PE>4G47=/++N#KV,3RW^7;IAD(ATL+F2HQ(WQQJ(60E)('T,<F;
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M73\7W^5^B^#*YF P& P*&Z-_[%/=O^W5RO\ WCRO(Z7^J?-?)E<W.W2\XD\
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M702L8E&G! Z#>TSDWMH/F87<<:W#-N9CD>(Y<H6AB/@UA,,,&(#> "<.]%
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MU2_ O?J \#=ZT5OSA\#-[#L>M%[\?O\ >PZWO7AX_1K \\!@>(!A&$(P"",
MM:$$8-Z$$6M_<V$6M[UO6\#RP& P& P& P/$0P \OG$$/F%H ?,+0?,,7_XA
M#X[UXB%_XU]W>!Y8# 8'B,8"P[&8(( :\/$0Q:"'7CO6M>(M[UK7CO?A@>6
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MHL276W4K"^6JLL]9*3;%.&T,3+&&>0,A!+*L2N"L2X?J$5G;ING/=&\3Z^Z
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M.*Q^*S*/5?Q! K4,9K'LFY83&&"0MO4,Q*(E4.9ZV.#&I587HHBB-I7_ $!
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M7HDOXD2<!FS0$"/\OJ[) :+8M!WORZ%OQ\/' ]^M:U]S6M?^/HUK7T?=\/\
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M\@XH9!Q!Q8#2323 [",DPL81 &4,.]ZV'>MZWK _2RBB@%EE%EE%E "6466
M( %@ '0  +"'6@@ $ =:UK7T:UKPP/B):&E-HC2=K;D^DIRA0ET2B3%:3*%>
MAA5'D: 4'T3E.C!:,$'P$/0M^.]^.\#VGMS>ITITI0HU&EJ<*19H]*0;I6E#
MZGE3*?4 +UTX?5%X 'XAUYM_1].\ %O0 &D,"A1A&@)&G0C"F)T-$G,  LPA
M(+0-;3$C++"'80> =Z#K6]>&M8'U^&M_=UK?A]S_ /;]W_[X'S&(4)RE,L.1
MI35:+1H4:HQ.2-2D">'0#PICQ V:1HX =:'H&]>;6O#>!^*T"%>4$A<B2+2
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M]NKE?^\>5Y'2_P!4^:^3*YF P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M\F_)X3)6N+]'RF+R^@-]0N<@A5$2N9I:YHTJ?2RMUD[L5MC G21,K>W2*%.
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M3@.,-3)G-.0?Y%!1I8":K+))TCOO#)@,!@,!@,!@,!@,!@,!@,!@,!@4/_\
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ME>1TO]4^:^3*YF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!
M0_\ \CC_ $UE?^*3C[_,)!LE=/Q??Y7Z+X,KF8# 8# H;HW_ +%/=O\ MU<K
M_P!X\KR.E_JGS7R97,P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MV_Y:K.3^JW#B8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
*8# 8# 8# 8'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g150472g09a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g09a01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[15 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %22^5!(X0DE-! 0      &$< 5H  QLE1QP"   "(  < E  "')R,S4Y
M,#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@5V%T<V]N7R!&;W)M
M(%,M-%]54T5?06-T:79E,#%?,S Y-#8P,#@T #A"24T$)0      $$H,XG.7
M)7[.$NR-6#5#)^XX0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q :XW>P         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    %HX0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _0      !( -0    $ +0    8       $X0DE- _<
M     !P  /____________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      S4
M   &              "&   "6@         !
M  $              EH   "&                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   "&     %)G:'1L;VYG   "6@    9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    A@    !29VAT;&]N9P   EH    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
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M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     4X0DE-! P     "R$    !    H    "0
M  '@  !#@   "P4 &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( "0 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
M 00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B
M,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8G
ME*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"
M! 0#! 4&!P<&!34!  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"
MDD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25
MQ-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _
M /2L_.Z?T?IUF7E.;CX>*P3 @ #V5UUL;^][:ZJV+R;KG^-+KW4;WU]*<.F8
MC20T-#7Y#F\--]H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      #_X3R_:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E
M4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE
M=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C8M8S V-R W.2XQ-3<W
M-#<L(#(P,34O,#,O,S M,C,Z-# Z-#(@(" @(" @("(^"B @(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P9&8O,2XS+R(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM
M;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@
M(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN
M<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E
M<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY!8W)O8F%T($1I<W1I;&QE<B Q,"XQ+C$V("A7:6YD;W=S
M*3PO<&1F.E!R;V1U8V5R/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/E!3
M8W)I<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X;7 Z0W)E871O<E1O;VP^"B @
M(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(Q+3 T+3(T5#$R.C4W.C Y*S U
M.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&5$871E
M/C(P,C$M,#0M,C14,3(Z,#8Z-#4K,#4Z,S \+WAM<#I#<F5A=&5$871E/@H@
M(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(Q+3 T+3(T5#$R.C4W.C Y
M*S U.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \9&,Z=&ET;&4^
M"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI
M('AM;#IL86YG/2)X+61E9F%U;'0B/DUI8W)O<V]F="!7;W)D("T@4')O:F5C
M="!7871S;VY?($9O<FT@4RTT7U5315]!8W1I=F4P,5\S,#DT-C P.#1?,30\
M+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C
M.G1I=&QE/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D
M9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^<G(S-3DP.3,\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T
M;W(^"B @(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T
M/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C)A8C<X,C V
M+34X,&(M,C$T92TY,&4X+6(P9CDT-35E8C-C.#PO>&UP34TZ26YS=&%N8V5)
M1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO
M=&]S:&]P.C<U.#DY-&,Q+6$T8V4M,3%E8BTY83,R+68V.#0V,S(T8F1A,3PO
M>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#YX;7 N9&ED.C8Q-#<S9#5C+39D,S(M.#8T,2TY-3@Y+6(R,C0P
M93!B8F9A9CPO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \
M>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI
M:60Z-C$T-S-D-6,M-F0S,BTX-C0Q+3DU.#DM8C(R-#!E,&)B9F%F/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(Q+3 T+3(T5#$R.C4W.C Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H
M;W @0T,@,C Q-2 H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG
M960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F
M<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O
M97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z,F%B-S@R,#8M-3@P8BTR,31E+3DP93@M8C!F.30U
M-65B,V,X/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#(Q+3 T+3(T5#$R.C4W.C Y*S U.C,P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!0:&]T;W-H;W @0T,@,C Q-2 H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI
M9#HV,30W,V0U8RTV9#,R+3@V-#$M.34X.2UB,C(T,&4P8F)F868\+W-T4F5F
M.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM
M<"YD:60Z-C$T-S-D-6,M-F0S,BTX-C0Q+3DU.#DM8C(R-#!E,&)B9F%F/"]S
M=%)E9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$
M;V-U;65N=$E$/GAM<"YD:60Z-C$T-S-D-6,M-F0S,BTX-C0Q+3DU.#DM8C(R
M-#!E,&)B9F%F/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L
M;W)-;V1E/C$\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^
M_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ .@$& 0$1 /_$ !\   $#
M!0$! 0             !"0H"!0<("P,&!/_$ $,0   & 0,"! 0#!@,##0
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M)B0WE]=0"(EY4X'7$O4%\6B8.2[6,E  ]PXV=0_U#Z_[+]OM]P_E4/4%\6B
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M5^'F@Y6,F8;?VHA+Q$DQDHMRAO3V\^LVD6+E-VR<H^2O^?U47**9R<<")P
M[B&IDL:FDE'LTT7!G:)&J!4G1U"K'<I D0"+G5( $5,J4 .90@>4XF\Q>PAK
MG>==LA#>(ZVMD,4HD/.['"F*)0$IRCE%,!*8H_NB!@Y*(" @(=A#[=$TA2^0
MH>4O !P <!P !V  #CC@ ]@^FK;.%+\FE.0#]V.?<=O;_*+>WV]OZ?;7/+\)
M(4ANI7NP$P%$0V\7/RB( (ASFO'9A ##SVY !X^X /VXZ)!P*)1 X%$OU P
M(#QWXX'M_?UUSJ,=%3+XOI^4I"%)_BKR<;RE*4"\FV]VU0X\%#RB8PF$3?\
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MSOQ^19 ?H'OR/?\ AJLWBL>I</;]G;CP/J(?A?/H@'</_< [?K^7;CMJW^*
MELJ[G-OG1_S$3&=B/:\C8*R#DF\UBH5BR2S2G6/(=(VW6>2@#HE;/9*/1CY-
MY(QS-*6,5\9./4(N8ZZ2PA)1RGTU,&=23I=[:<&9O@U8:U0^V;"[O&^2&<>F
M2[XBOB.)JNV3E8TKD$%G#([A%-E;*B]519S\<11FL+&3;QDM&0^]GV7^HGX=
M?>Q;-O\ EC%N1,M[;K%+LG][JU)A)^P4RZ55\L+*(S?AB3*R591=N08M#H/X
MIV,>:4^ <U*UI-7T?&RL/("\2->HK=-T9J%DC!;2?O\ 7;[GO#%H@$8>M3II
MXL>:!R$F\2E*V>/)-Q#^)>B:/F&,@R0=1D@DJT=D35+Y=1]M@/7DW]=/S:EC
M#:90-C<%>JGBX]V/%6>X4_,[>PR1KMD"TY">B^3A56<:4&<A:W3!J+=NF)F;
M5L*OG7,H<VY8^*RZEOM^SLQV _;\+Y]#_P#0_/[:<,I?4<W*]4+HX=6"R9MV
M\QV&[71L.WFDT^K5"#OR;NV-YO&DA+*NDV-M.[DWSM-X!&:"<404S>82G3.J
M)=?+^#YJ%MI^U_=VRMM6LE5>/<\5-PS:V2#DX-PY;DQZV2,NV2E&K51=$BH"
MF91(IR < *8P&[:PAXEWH[6*0E2=2W:+79E+(4"ZBW>X:H49H]-/OU8UPB6O
M9OJR$.F=^6Q01T&;"Z Q(595BWB;0B";B.FW#O4CPB=#R+6-]>Y&6NM*NE<2
MD=L4@0LE9JU-PJ#V07RGCYRHDFZE&39)=TH0BRXI$.94Q2**>42D,(2UNN!%
MR<WTGM\L1#1TA+RLAA21;L8R+9N)"0>KFG(,01:LFJ:KERJ( )@313.<0*(@
M' #IA7PP+'-F(>F#U!INJ8WGQR_"Y$OUHQ53K/7I:-4M=UA]OM==T^*)'ODX
MYT^:RUF9L8LQ6RJ?K&5.W(X35'S%="VL[C]U]@S;D6O56WAN(IC*$LJ\:WDW
M#=P=HSC+RV85>X6R:8I,(R@W:RPKYP@XQ45*O+BDP>R[>F0T=&MEG6=.MMTT
M8[J8;,K%C6O$8,<ZX[?.,EX$G7RH-FH7>.C7+=Y4)5V!3&;P%^B55Z^]6$ID
M(^5/!3[A)P6$*B?FT=/S=+/]*S?Q6\M98P.QN$UAZP6*BY&QG>H5!O<JBX,N
M:%L4A45)9,"5G)-;.BX"%D5R @;EW'++(-)([U')/5NZN&:NJ9F;YW/?'T3;
M[1I%\GA;"B+XJC* 9K!\.:V6T[4WPT]D*::$)\RDA]5I#MSGAH#T6 +K/I07
M0!$ \.]U#@]O^EV\8>X=O^RYBT/T]P]A[C].>=0G=I>[/.6R7.E-W#;>K@YJ
M&0::Z_=$0,Y@[-!.#IA,T^W1!E$T)RKS[=(&LG'+B0Y1]!\P<,I1DQ?M76.M
M)UH(3JMQ.WB+A=O$%BEYBFOJR-QN$L,?-W>5NT^R;H6*M5BPMB@Y8XI9.VXO
MXR/?",G+OC(/Y-NP68))KR.?"T=)FQ8+J4GU L_UA:$R1EFK*UO M4FVJJ$Q
M4<5RRS)W+7Q^Q=MTEXF<R&+1NU@0'_-(T=-5P"H-;:LU2F3 '  'V#C5!TR'
M$!,'/'MW[ /?N ?<.1X'2 DF7V*'\0YT&13,(#Y>!#G@0[#W#@?;\M(**0F\
MPD#GD!YX]^!Y#G[@ _3V[]P[!PIDDS@)3$*(#QVX#Z" A]/H( .@J9""(E#@
M1#CZ?40$?IS] _OG5/PZ//F],OFYY W "(#V[\CWY[>_N'?@0U[:\C(IF$3"
M4!$WOV#OVX[CQR/;@.XCP <!P&E*DF7G@H=^ [@ ^WM]/X?H ![ &JO(3_A+
M_H&D%,@AP)2_P  U05!(HB($ 1$..3  \ 'L <A]..W//]=5D(4@"!0X ?H
M '^@  !]Q_41UYBV1,;SB0.1#C[![<?3@>>.WO[=O;1\,CSSY?IQQ[AP(@(]
MA[=^ Y#V$.W' B&O7RE[?NE[>W( .D%-,1Y$A?\ 0-4"W1$PF$A>1]^  .>/
MR]A'["(<AR/ @ CRJ:*:0B)"@7S>_  '] #Z]_UTJB*:@AYPYX^@^W;V[>W;
MD?\ 7OSVX"HIE-YBE #!SWX#Z@ #].W/ =@[:4Z9%  #AR #SP/'O]!_A[A]
MAX'W !"GT2  @!0X, @//OP/T#CZ>X\#]1UY)LFR7G])$B?J'%102E !44$
M 5%! .3G$"E 3#R/!2A[  !^D0 0$!^PA_J'&F!.KMT#-O/4R;.LH5M^SP7N
MK81J+1EEF)B0>0=\;1S<&\7!98K[46JLVW;-TTH^.M;!=&S03,C=#F;B6#6!
MU 0W=]$SJ2[,IB31R)MNNMYIC!1R+;*>%HB5RE0'S%L)A^8N'U;CUYBM(G1#
MU10N4+77I"@H)D!!)4Y<$8FWQ;]=LN%\@[5L5Y<R;B_#V3G=B<W_ !:UKL6B
MC.O+C 1]7LBBQYFMNK$P4G*_$QT6[",D&(+-FR?E*503J&MNW?IR;Z=U4VR@
M\#[6<SWD'C@K<;"6DR\#28\3<B927O=D;P]/BD4@X,H=_-MS#YB$(4ZJB29Y
MIW2=\++3L%V*M9\Z@$O5<OY#A'+*:JN!JX"DIBBJRS1=-VUD+Y+OFR Y)E&:
MZ:7HUY%@TIK55-87ZEN060!I,?;MTFR9$DDR)D3(5,A$R@4A"% "E(0H  %(
M4I2@4H     &O?1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:_&Y /,F' <"(\A
MP' _NF'N'Z]_UU\X_IU1D'?S!_5:X^?F,!C/7D'&.79C$X\AA<K-3K"8O_=$
M3\E^@AJ_(%*F<B:92D3*0I2D( %(!2AY2E I0 H%*4 *  ' !V#MJX\ 'L !
;HT:-&C1HT:-&C1HT:-&C1HT:-&C1HT:-?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g150472g24a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g24a03.jpg
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MU9CG3E@U;R#]BDW9.5VJ.FB"RB>R^^1B>Z]BW*9\V2XMN:GR@/B@"GKZP 2
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M#?,C/%"!??+OT6[+@W>+N+\L<((<<FZB/#CIIZ?:N64.]-\W<<V8M[ZB'?\
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,EZ.CI>CHZ7HZ.O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g150472g34w73.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g34w73.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1" ,J G(# 1$  A$! Q$!_\0 K  !  (# 0$! 0$           <(
M!08)! ," 0H! 0$! 0                 ! @,0   & P ! @,""0P"  4
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MTQ&@K3FMFO%^5KS^R5W )O1<X3OK_<=/6/<M<21FLV/V<JJM7%US)6#DE<U
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M ].+:B&N<X6]2&-*0O#>C*7D_++#M@(5  9Z#0F%A,SI+?<(8# 8# 8# 8#
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M>5KY72:J-=$W*V/G/H7AC=8T^1"BW\$P&[5Q7#]'WI0C6QU&;]'4$>R$2?\
M]5+[ WS,WHL'9U0T*O9>=&6UOG%R6FK?K61T>MDLQEJMZ#<,:CS_ !""+G)^
M,=S'B9OREI?5X#?JYRP*\\X1RGW#M:'HD3.M*],GCLXTB,NBC/68IW4<T@[1
M)W)*S5+?]I0!_<*RGMO2"U76'25#'IHD<7FH-VT]NJMM;3M?3VDY8K2H/ER#
MCR!EW9<U2U'B@A<T[3>)K8?YEVRD1+NI;$,HF".%[*'FTC.KX YTY8[K-XU,
M[4>*KK(AS:9,XJ'I5!V9K421\,3JE T_L^V,UOG;4<5TJZ\<G(U62Z*2=K8I
MF_6+'YA +-8Y185SVA.Y:KDU+UM-J:@KP<;*9@X;7M\-KBV7)H DT5]/"4L)
M$:4(XLDP)G=,H02\ >,QPN">5UI4!WL5T9NB&I519_1EB*&VO&/K>*'*.C&V
MNZ?+GP&BNBK48I7]6<0M:!.<1M86L3[3A$4+"[LZODM8=PCRZH<5CH?7 SEC
MA<%,7PMV;*I>80IL_GZOHW5E5/QR4;Z),--'H-$T"(U!L'R"_1.S%9)QIA@Q
M&=TJ<\*^,QXY7Z+?KV>W.L6!D9:,<^=*BJ:H%MYO,3C<$>[4*M-T<C55ZV=8
MJV'I"5[:C2M,4C@4,=92MJAE:-&HU[1K+.XI8&<\P<0U_=!5P6(Z)8A/K,ON
M$7XQ,DEN24,44>>A*]@1]2M-C16NE,J21K<L.@S^0UNIB9'LE<7I)M6 9@"A
M82\IBN4/LF\='*  PHZODMB5LY5IJR8TBD-.7G:4"DJ^.V;:;I<MC5S-9%%9
M@D=I/%'2SWI4Z:;5YIOTQ0>,*/:8 Q@$-V7-.\\YJY\N:TX;;MC0.-65.*EC
M<TK^(ZE!HY/'(BBGZB)N\P "$+U*N(DR9U+C#7K:\]")R)1@T44: DXP)A(F
M8BH0O&?&EQ7#Y/1\OC]+HD+QS;8UR6I1P?M-,3VJN9;?3LJD%D:86,]_,9PQ
MU=(%IJ]O9S2#6MD6B]YN3I1ZUO1=^6NO%IAOB=XD5ZEB9RK^:.S)*V>XXT&*
M.-R6V?#XC%^@)VPVC;\:KZ*AF9;'!VB:V+'$SRI"W$$&A6:%[9@"MZ+T-^3,
M61XTN-)T:N72:*2F/'R:6] .TC71:XK.@2R9G==J(^&^84^N<=F#2O<X;:KE
M&6L:AC":!&$]$3I,65K8PC$99?'9$JKD#QD5IT%$'9TD[-%+99[$K&?MU8/G
M1\T3QQ\M>K:U@U44Q-)'4+O/1QAZFD#@X&-*Q*E*#9H5"M,?_.JCB#-EW9UV
M3HP^-3C6,L;5'&6JE*1H9&.A(XVIMSNP#Q)VCF6Z9)T)2Z;9ZB3FJ#11.V9:
MO<Q&#$(Q>$[Y=6(], !(2;LE=.J/%#7=[QO531 ;9&::M7L*.]=='-$MD5CR
MURW*&24IYI)TU",:B2?9*ME=TN1[H@E0M%:1'(GM8:%,8</0=1<<YC7G5+[]
M \QU-TM'H@Q6.@D2);7,O13^LYK7\PDU;6)6LT0-3JP%2*#3B%N;-(&!8HCS
MZM;U)99VTRM"K-(/*,+%Z<K,3,<&G5EQIS%13A1SC H45&':CXM:U=U2N62^
M4."\*2]9$PSVVS'8]\?EATYF%@RF&D.[@YN>USH<K >=HW6S3]B$Y3/'FE>(
MT76,&G=UV5&(\8WS+H=WBS[;;J)W>589.YPN#--;QQ06@6+U#>R:00YC3)=@
M0E)@&[+]TS0C1"'L7/!4Z5>+;CB4PBKJ\#"YQ$HU4M.N'.C""O;BM>!NT@YZ
M>C4*A^H^PY#&)>W/MB5H^*&XHQ0WNZA7_.>L0!@V:=LPN_+BV\[Q]\P-,_0W
M;"ZM;&6\8G)F:;5[. 26:-9L:=HC4AU+0^#I1,CXF,;:20P S;<?#DH 1TX!
MIJD2(2P>S\&Z>$\&$\=W$Z'B*GIW%59\176!<UXVKT':2J!-;JT0=#++/D!C
MBGA\$1OZYSD":"P..D(FEL+5J!&;+3"-]!6SME!&66Z>S$!\5'".FDMF_,@2
M)*3RS*>+RCQS2?#<BN<9G*%4QD4"+=!2?;@ U:_+SS NFC-.Y)1QA):D)(Q%
M[&_+KSM]G_C7BRO;P;[]DH'V/3H^VFV\&-F6VU9">OB+J>8S'^93K-05<1)=
M0DZ72Q@F[1&URLU ;I0)41L6@FC&8(7E5<FK)_'1QG2Z6G44?>+AJ8Z*GGT[
M6;G$^B[IB[ZXPR6R<Z<MG/:I[:YB6Z/=5MSXWFGLK"I-&E9P>^!%L@"A1HTN
M_*4R"Y+Y%<UHZE,B"-:OC5YNW<"F(&R>6&FI;7MM^LTAQL-:2-XWI0S2=Z=Y
M(2%J&(;2'^< !*$!9>@DO+CY(]K[Q8\:5N*,FLT*G3PHA?YATT/43*Y[<F(X
MJQ<P3ISL7G^(QXJ03-<E:(?5DD=S]MS:06!,8G'[*D)X-[UL3GE*<:$Y7ICG
MB9VW+H,IF4@M&YC(<YVE-[,LR76A8+^SPY,^,U=M*MWF;T[N**+19*N<4[80
M5HLK6S#_ ([,,]0M$F9GP0E)O%OQS(X77\$30V<PMFK>+6;7K(MK>X[6@$F<
MZNN>4G32UJIETLB\O;I',*XG,E.^;5M3BI4$%&AUM/[&]87?DLW4G-U+42_3
MN1U-"$4*76.@K)JE"=K6.>V<QJIR -=75NUM#$I6GM$>;HQ!65*@*)0$IRQ@
M)T(S0S/B+9)F9XHJ:^#.:FBQW*T4<5DGVA<.BBNL$[<?8D\/B#%T *!R6MW:
MQ(Y#3)#N.,CA*(O+5P'9.0G"C<5(P*#BA'%%# 7=/#LU%F\;'+41<X$[UTU6
M=5;C 6E;&B5587=;4(.F$-76?);D'"+'.9)>G/GL536-,G9P3)G$1VT@7-4F
M)&!*H-(&-^21NE^,:9ZW+:FRZU5INL.2-ZAED5:1BY;.@58V4P*G) ['1^U(
M)#)0R1^P&8Q8VE^HEQ)-]9&S"!;$0::6,1E./!5JJ_%)2;%;-QV]<I[A;[G/
MNG+NZ#AT'6R"<(J>BOYX:^15;_\ F*=42I=7$DL!CK\YT9P/XVTL_;>XB $
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M:'0P"T+6MX&4P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MV?\ 'MW:\]LV;U(<F*;&^M*Y;N93X1&MMAB.:0>36'4BA]N2O;%5C5#TJEL
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M91L'N@K,1CE%S4:]V53=YV!3_@IJKM"=R51.N@)=R14JB-O"QO1B=)[T5<3
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M.T3N;QR>.CM1P[/D+0Q1<9[WVE"'J8TE1:E_2+(\I0-@S45.R.QB4B(DE,H
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M>Z^A:-N);F\3<_.3&;IW>=&A]XI6N"D&'0D?Q$':7 8# 8# 8# 8# 8# 8#
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M[:R51DFH^4IYTD0\$.IKZLAEF4C7Q<1-1&( MZ9P*MV?0L]T&\@5'"+$@"H
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ML.]AW^#XZWO6&'ZP& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M!4]#])'G?^ONE_[4H/\ T[@J>A^DCSO_ %]TO_:E!_Z=P5/0_21YW_K[I?\
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M"IZ'Z2/._P#7W2_]J4'_ *=P5/0_21YW_K[I?^U*#_T[@J>A^DCSO_7W2_\
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ML0@BUH5-7R2#A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M0E&Q8#4M0-I[;&4<%A8'DOX$ATX.+ZL7"$:)3HS=3]DZU'XP[A8<S 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!__ )''^FLK_P 4G'W^
M82#9)=/U?GY3]'>#*YF P& P.#=&_P#8I[M_VZN5_P"\>5Y'2?ZH\7>3*YF
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M_P"*3C[_ #"0;)+I^K\_*?H[P97,P& P&!P;HW_L4]V_[=7*_P#>/*\CI/\
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M=CZ,L^E^<&>;!J>VJO3TO+J^D"9W8G>K8>2MM!U?GM%K>CTX4)C8@+]:K1H
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M P& P& P& P& P& P& P.#__ "./]-97_BDX^_S"0;)+I^K\_*?H[P97,P&
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M_%06BV2H$7;$\&U./<)D>CC<[RFK')B> 2U,V/\ &3]V>2Y&090LKM"=9T*
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MTS)('1Z;2W6.MC1%G)S4EIS#!BWLH*<I2H/(*&*FNS=B8C0,4$F@A;)5;"-
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M(,H.A[L\GQ:O%95E/C&BB\80N+U2+C)V6 R55/K)C[44=(IS'3$_U4UU^?\
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M>W&*R='[*,5"O[19EGW9-*.8S+)CDSA31=-/RF12R"P-X9(T_.#Q3MZ3B0U
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M6A_F1(A3Y,!8&(O$Y&D,99(6>"-L-A JAV4F%C9@[ N26*9II^1W\%PU7QT
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MVDC@9XG$\K;8>Z/)1A9))O8+.CHF<IXCJD[Z-\NC)2*Y"WIM+S1@;C%:],0
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M7\: BLD=3H(P31R98T\.?0?P6'J$IJIX2N81'I5>T@A#,J7'QXHVB=:W9#8
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M-NA341)94C2*MN]1DR1ZFS4M;FB.4<I-FE17HO0I7=2XJWJ_W7YA@DY823G
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MIZ"6\;,(RD0R<A.VL)37+S"S2W/92M1LLDM*68J/TF"-NG%G7'N:@&MSE2%
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M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!P?\
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MG<$C16W3T_3P&N%,(Y2INGG&'[YO,KQOA,XVV3*N5"5GD*AS(7)F/:87M!$
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M><R.J*1G&L4=D:'QX5_Q,[] 6!!B6EM6K[,V2W/J<A&)\7-H619K0 EJA[.
M/<X5UU];;[-.!>AN@U:.5](4GS><15?&PN5H;3547Y9<306W(7&U*8L9592F
MX6^FH_):-9:Y7TJW.,%:T#8^+FQZ-&:<M+"$(ADW1&D7QM$%I^+7R =15K55
M>7_T_712JFZ&OMHBDU>&ATNF8K+BN:Q'!17K@ZR(U!4&SI9SO4,6CC4WV!I#
MIR='=:Z*Q-1>Q>L\L9XQ-Q'-/3!RAUM(%?:K%T+SOSM<\)[B@--.=F-A'2,T
M@J BPX%RC6M33.&D%--'N#VB8)!94)4GM<A1+"%K:D/(4Z2>^5LK"7CI4S$Q
MV[K?\L\\7JQ<ERFE.O)2RW7('J1V*9$VN:2 =S&12LG%W&X5-7L[LZ30>'+K
MBD\"*)(V?)%S&E5J#P%[WHTP@*DTS,QNO%^>&H+T!SU2=$<JSJMXZH::!XUH
MV..5M-DZTI8)K>+8@>(O**]C+4:Q%/H(Y&6Z+)%I[XL3I_>V\$EDI3!%'[ ,
MJF;CG*(.0*9[7KMJ[/N>]8%3&^QK^ FD4??XI<#S(ZG7JH/%Y3'Z,IM SJ:H
MBKO7]7U:E4)P'.!XGUV>E[PZN!V@"$4F"7*<9J(_&'/./>&SK"OZOG]-"M6D
M[K@W0E0<UMU[$/L:=JW&XW-175$.N:32IY)),GI=E&VK Y/-&YV=S]-*E2:B
M:"3$GM;&81*:]R)F^$PD6O/&_P!HT)9#?/HE^:"Z$M5]YH;>J%EE]L2> .[W
MS!%>%99R+6,>G$L+JR=B16/"4CVVI%0BD*TER0M6U/N@//V5JDYXS'E_-KK5
M)R5>]!<&R*C6DJ,SFY+#LVW[0F375=W6!RO$86OOBY)7;4DCE)VO&H-,YW#V
M2 G2?2)M-TUISW$LDTPP*7W]E!,SE$Y7R]48/7 '2KAX[N/^$VV?4['ED+EM
M2F])3I-&%KS#U< J=\76F&+1Z [3Q<RRS)M84?C[2_&N"IA$\MIKFN4>@]3M
M-L;L=TY:JM$>);K/<9JF+K[$J8^3<>P3LYCY%MY >_M*MOD-AV]1-L\R#?H-
MML<]1>)-+!%Y1 I*VIG5PT3$SR2B!JMJ!Z*-;XOM-6QZ7Q;=FCIBPN8-H>=T
MD#Z'X[\=/.-F6PZ6'+W=XJ1QY/@J^-V@]5]6I-8%ESN0*5J[1T17JGUB+2+2
M"5B@ =E:*$-^-WK<3*V7D<\=_1?=%D(S(Q<$!JJMZJYQF$<I]3((HOL.5+NC
M+"DC4ZJK$-++=8N37Z^NT%:1T#&_$'.RP!CJZ?\ I!#Z?=)AE&,=[;C7G+G6
MC;VO7/2Q"6 4@SS&$Q=9W,EA5WS*>Q7IJ<-=#H8,VHD-%OE6LD9@\JKVP4:0
M*";('U,M<(NT$I5:(T1^RDI)G';7H\O6G"UU7>X^3M5#E\%()[ XCI7GBJ/K
M3^[(#4,[@"CHHQ_4R[Y2/K_HD?&&U6S:92FVM/&(!_J)![8/<&.417:54;P\
M4'0(IO9DFJ25/,^9WRW_ !XV<P"LGJNW66W5J;EY#T$FM)H0W>IC<WF%?'J1
MV:V;CYJ(2@!?Q5[T%+^#1AJ,XY]^2ZW3O$5E]6-?!;*]R>252STT[3TZ^U<6
MN%?)K43QJ;\NV13+A'HG:TE@2Q5.W1\>)>4B=WA:A:UZIM/5*RAD*]@WHS&4
M8W2EB_PVV$CNR:N\,E;1&J$D5AV'"(A6 )F_+FJIJ0F?C>A_'$1O" L2UB%[
M/2]7R..JF\K:IQ.(<8BY'ZVJ)6>@036^*[_YM);?Q=W&I;Z3>7F"\B,\OXWX
MEM[E*EV5DFDQ?H)?,PMJ,5A7H)3:+6ZU.QBK^C(O'ZX*=3(:4&0*EZ\X2;YP
MHLDM0:-V/?6;0*R>'?HBL*8C'+L$E5:3.M*DG/3\MKRU9@[KV6QIJW]+\ W/
M0:MNLYE;(DX(E3S!KQGZ=*WK +#P?8("-/H #6L!*@;XF;GC_E)3WP#U^Y<G
M4!"87&DE===4"K?FRH>BW?O>X9V[THI>JY@$3<I>TJ7JAW8NQ*EEBV-F$N]6
M.2(AG$B1I_85 ,.]:4;L=T_ZSV6I[KX5M[J"R^>K)ATMB#+-^>*-Z %!+!<A
M+VQ?'>H']]YXE%.R] PHD#D6*$."ZK'EMDI&E03?H;L<E+ ?H\>P&<<HB)B>
M$N>1_B0[J>:]I-Q3VS1$!LWCKE+D:K^;HP%KD4[9%]QT5(8Y<]DR05A*0QIQ
MJIJL2R8NW14]8E97P]=$4/Q.3EB.$1AK?CWUF7ZN3PY].68_]$*&R0U*T0KJ
M&;=>65;\)625_.#*);HJQ95P4:J7$1+V!!AED6VXFRD0R1>PE:$&TWS.]>@
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MSS)[HMP;JUB%F\;O[4!C4LUE2V!$1"[H?UM&6:2/[JF0N3PJ:V-I- E^1/&
MP%2<<8C7C''S_P"$MNO8/5LE\.71OD15STRO+(N!@0691<%AA<,D+;SO "Y%
M$:[8HG'GF11D#?,IA)1(G!Z<'!Z+4)0.#P%,6 I,D#L1-L>Y&*G?3O5WD]YX
M=X='YO;5F5VJ:*QOJX$#B^(N5GU? Z@1]?\ /]4T[:G<R>+Q20QB4,,)KZQG
M ,O2U:(M86D4IE7K":F6J2S41A,?'3DM&\]NWP18TRF .GTR2YXYY/HWR)&O
M'<"/5:%%*>=7&X(Q7H7[Z6IBIM[*9A**:=U-I)IH0]ACR5O*T7M() 2?ZHFV
M*X:5Q4^9^P?)87R<AZ ?[IGR&IK3OGGVK(S84J=^3(9*WJ92'MBR*PLM#24B
M*B#Q%J[IQ92C<SMXG"R&TQT22 !BE.'Y3W!C+MPW5S_PL!*NPNL(IVW1-?,=
MYV1JG-:\8L9F+_(G;FFQ:E3*>G)/?J2Q&FXY1"J^;Y1,)U<X*[21N%R&$[:H
MRBDNDXE7LD*@ -J;<9QOGJ_C7V_V(^\F\FW33W15?V/;=KV=/.*;>K^6J*^]
MB V3T%T'.*PYDZ)=6J+Q[ZNUO=,.T8)(5L!X4Z*3LQYH=@"K3Z/$-N.Z8GAQ
M]'0/KJW;"JBW^'.8Y%U0\\[539T%MXRTNM71%5#;-K!L>H8U7I,,K!!*[%A[
M[3]=RRTM2!ZDJPP3+LU:2PG(VLM/K9FPF8B)B9K51>UNX+WBJGJ:9L/8A9-K
M\W]$\_4]S/QVJ8J6<@=?U;,V.CU#3.WM&EA9-F6*_=1;GSTH:'N#KF=D8?I^
MAD)ME)%P1&HQC2*TF./3_P *B7OY*>\897_;M:QV\%Z*SG2Z^N+KYMLG4(@"
MPVJ^4>,K/Z-B%Z00O8XJ;&'8<7>*,BS.4J=$ZMP%JP@#V=L918@QJ,<;CP_X
M=:N(K^N*VN\>U(?8%O2I\A]3W//H#7M?[LCGM%$FJ/M$!H]\1(-4VWP5+T*L
M=&Y=+7!3J1*'LQF&$_V!%"&$'I,91$8QUIR4DODH['CR7R%'E]*NI2J&USY%
M'BJFY0HH"5'0]_YO[/B560)U8&2.P!/)J3:X=63\:W'"L0QX12]8>!4AV :,
MX)IN,<=-.GT7TA%W=:23J[E2K(=9MW6/"]\VV3?-G1EGO'CF6N+F[1;IIIA*
M,V?6?#Z9!%)_#"XVITVC9X<4RNY %>@FJ=JB1FX8F(VS?7NK81Y#^E$="4W<
M,;[#2VI=5^\R]KV#T7SP7$*E)2<8R2HN;[0L]BDT:CS%#D=BUP105O1=JA#L
MDG:Y\#(ECB'8M!5^C6ZUMBYBM(F/-H+?W9VMNKX)&Y3T%9L<DCCW+4%2OC++
M9?R'6U_M-;S;QWR/HA47(;<<:W=.<V^$67811$AA[AIL4+],I VM4JVNT801
M#;CQKE_+KSWH[W%'H7PF^5AU'<]5#M3I'FCG>;J(4MHJ1E3*)W"I&GD,J5.\
M@J&6M"R>!(;]"0N31I(T"$<88%$86(O0*QC6MQR5'K;M7L8ZZ:BK![5/;G5J
MKS$=(\KK[Q=7ZICEDYK"M8-T&ICE-N4$:(RW/S<L;ET(1JSGH@E*:<<V;ULS
MVS]E[-3&-7SVO1P]UIT'-_$[U%U).;NEDSN=@Y/GEK,DF>[ YRG".*2Q@J.Q
M9,UO\;@545_&UM8I1O364;MFF.G16,2(.OCZ 'A,&41OC&.%JWU3Y!NV)1:O
M&5//UR+-.=&2^14?VT\[A4*1ZO6T+4I'HNY.>G >_LV%.RE_F3IAHFAP&+3>
M68?(RRAA$2'1>19QQJ9Z\&LP[MOJ]WX;X0LA;TU9"J?]'=!U=';3?P7[PXB=
M%T=?>/+8M1P;(M+#:<_-S0#:]3B.IENVB7(5S\5I%\J%0'W?AL;8W3II$=^J
MX70MD]'5I<G4 HCV3>FXQ5_B1E_;L+B;@=SG)HZFM@E/:T4;!JWUGI!*ID4(
M0:B2-T* G6!*4N01FZ/$D,TFT9BIB-(XTKHP>1+L>/7<U1>96FK?*[N_R"\6
M\_4ZZ)8M"TXXXXHZTYCG_0]&/B\F.@3C3W=!KA5OS.L4" M2&M+J40>6'28)
M9J<<:TXU*RG 7>4RMNX^8D5SWS9DWMCJ>/WPNDM'1'7,[!2/-$ZK$R2.[]S]
M.*SVRE=;1F=U2PL1"83T[+CT3RN4;&/?MFE$DF<L:B:C2&NH>W[[-L%OF0NF
MB#+N6>4-3R"K\<^X]5NDB+G8NY55<[>--08H&]RYLCI8@-JBFHWO<=&W[]KY
M/Z>(.%VQ7#2KOX]&6\-'7_3%ZS"7H.C[DD4@8C^6:UO5E:+71TZC=9(HE5O7
M7%'FWZ==JGCD<(;:&1L\%1LZQLDQJF0-KX0(TW2=.H)VHI^R(CAU5-UY8NCW
M^O\ OV9[L>;PICNKECH;IGQZR"2TBKA+95S)04M>H0E;X!)YS FZ(7T9.ZC=
M(I9P5!"I_3)=+UI Q@(  K1=D:>.J:FWMSMIP8>^'Y78P4%L>+:N>4+!NJI%
M3)$VB$VRZUPW]&/G4,?)=U,75N[)&>HJ9BK-*HNXIS!;95Q[9HL6B +B3XFW
M'3O?^%D.BK;Z_K/ACCR6.-N6 XWUTQUS0B&>&T8WTJDE:"&]"2"1245$TH=<
M#&161">%QQ6@86QVD7P-6?3Q+%:D(U ]:J1&,Y3'*(53F'77<%?Q+H1FZR["
MC/*/1_)7%U06Q75=,L9I5>Q]4W#*F"P) ]N,B1RB*.RZT6Y3*V!J@*MCKE0T
M 3OQBDU(;L:MMT$UMQFML7$SZ+'5?TC?UD=DS+G6^KNLNKY)?E6+)E0D5YOD
M_-<@8J":X=6=.3"R()=$/DM;3&[:POZ(3%Y<2 .TB^?B;XW.84R8HA8624$S
M41C<1P4MCG0/DBFU+^-XJC.CKMM3H'KKEGI._#R5B/D]OB8;1@JCGEK@OVYU
M*ZYB:)%S?&#9@XFOJ%F$JEJG3C\$1II@2@E1JL;FXTB>ZQB+MWH44Y*ESET\
MW%7X3Y/&GCU9XZT<>K$+*=0AEP(:W<7Q&U*XIN_=RD^H#3K6(FHWS3"!KT$H
M23Y'0LJ;8KAI5W\>BDD7\GW<3?4">/SB[CC[&5\5^4/K>#6&BAD$3I)S7T&A
M+F=1#DM)!&QLH);SM:D4>VE6G)**+7-^VQ2M*4:5;R-;<;\X6-GG<G2M),/
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M8BS6BPH9M/Z)=53K CGN1QP4W@%;U3"H7*X) %;TBTB%J0[<SAK"/0!2$03
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MV3OT>PG&65Z?P>GX8+E\SJZKY26>4H@D-/*5))*@5%G1AD-+4H9HN Z3%&>
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M# 8(V:)TVPJ)-^DS JBB?2&.,Z31$77*M+EL;)T0C+]I@6+=>\:C#\$YAO\
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M&5S,!@,!@<&Z-_[%/=O^W5RO_>/*\CI/]4>+O)E<S 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# X/_\ (X_TUE?^*3C[_,)!LDNGZOS\I^CO
M!E<S 8# 8'!NC?\ L4]V_P"W5RO_ 'CRO(Z3_5'B[R97,P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MR2Z?J_/RGZ.\&5S,!@,!@<&Z-_[%/=O^W5RO_>/*\CI/]4>+O)E<S 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X/_\ (X_TUE?^*3C[_,)!
MLDNGZOS\I^CO!E<S 8# 8'!NC?\ L4]V_P"W5RO_ 'CRO(Z3_5'B[R97,P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M!LDNGZOS\I^CO!E<S 8# 8'!NC?^Q3W;_MU<K_WCRO(Z3_5'B[R97,P& P&
MP& P& P& P& P& P& P& P&!!%Y<P\_]*HXXCO2J(C9'V/6KG"(N#ZA&%^BJ
MMU2@0NYD:DC><AD#$!Z0EA(6@2J2BUA(0@."8#6M:+$S'!JH^*>33+=:KY,Y
M_K(RW614R.;;.3(VE,=27V-,I<<C<I-*'ZF]7,H]'B0(4+T<28ZHT@ DE* %
MAT'0W955Z,I&>1.9H;*:KF\6I2!L<OI!+:*&II(@: E/$#0W6\JI#:R)A7>X
M(\A).7Q:<J7%"V, SS!##H.][P7,L*Y<1<FN\&BM:.=#0!; H1$K4@D2BQ[8
M:)I88?=Y>RK:CS>3I3H13=/2]_!P!L6]FZ_\;UA=V5W>KTROBWE&<*[E7RZ@
MZV?UW0BBMEMT+'&/D'*K"<Z=2B1U6]OJC0@F[D%?I]ZTTN!.REJ+80B+-"(
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A@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g150472g40j37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g40j37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1#>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $,*^0I X0DE-! 0      !L< @   @  ' )0  ]-:6-H865L(%-C:'5E
M='H .$))300E       0F+I_;X) FZ[NO T@1X:%W#A"24T$.@      Y0
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M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M [_^-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))
M300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]       $@ U
M 0 M    !@       3A"24T#]P      '   ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              $8   $\
M  $                          0             !/    $8
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   $8     4F=H
M=&QO;F<   $\    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   !&     %)G:'1L;VYG   !/     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $     3A"24T$
M#      ' @    $   !L    &    40  !Y@   &Y@ 8  '_V/_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MK4VLQ_07'>BH _F-D(7,UYI2\.R23+:4M1+0H;FQ4G7+"EM959"8V@VL +J
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83DX5T)4%7C)H@5S#U$O#'OJ^:KZN/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g150472g43x34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g150472g43x34.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M<L8VMWB3478CQ& Q,<^F^5M+R&9/SLMG.J8N.3O#AR8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# Q%#X"UJ<7"B+<4EQ"G%1F5+4EW>U.I
M4K:-JVEU6][5K]Q6]_C@?NX,+?KZPXN_7>][]8[7X[5^*M[_ 'G[N_\ QP/O
M<6-O7IN.QO6T):WK;+?I\:5[<2WZ>W_T)7OW:U^YK?XX'WMIK?M]6V]^Q?RH
M]4)W[7/3:?D3^'[U?M5O7KK\?3> ^%GVJ1\3?L6I:EH]B?:M3F][<4I/IZ*4
MO>][WO?[OK^.!^MM-M)TAIM#2-;WO2&T)0G6]_CO>DIUK7KO>!]X# 8# 8#
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M3N3W\=^85VT@7EJ;4IM6V9XDK D(9(@K &EI5'G#YC3,N'(0IMUM*M>F!>6
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M.^_UKGBB8_REI,$;+F=(9;Y\28^"<JJ,%6.@V\+7GZTBW.';T H$8[)HT04
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MMLX2ZT4 \7H[CS!)7+:@63K;10G/GL,OV HSZ,RY$9F/&VJ-'^>4']+& P&
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M;<L5@:858+&\A6O73DZ5(7K?X^N!V7P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P.O7D ,XJ1@5?_*_;':8O4XS"KA@=:253,*CF L@9;H.B(E]
MF2W79E?D*23==]L:(WIN0IUAUMEY!9GHZTUD-XC2_P!)>1LB'-J;$RT6F)6#
M=L*Q8#30KFYP90XH>%4IZW?8#EE*,+^A8C0U%MJ8B:=<3O2&TEX\F\FV[Q#N
M%\Z=//&W/@F_H=9BP%#Q*-3;!-O59YW=M:K$=F1^^B1JIQBM3#4K3;<*(U&5
MIY;>]S?4>K#&;E^"(#F?^1W?0*LS0W"KY*(,8L,QE:55YPU5V8L4N(9CRYL
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MN_\ Y7X?_' ^M;UO7KK?KK?[F]?CK 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8'7COE9X?8$55'8[=!IZY>[#5 CS]U:ILBSA[=#A0[G1EK<EQE%P=E@0X
MVI[#>OE0AEMQ#C6TZ7A9GH@JV/$>9"H5>UT:C*C48X;LM.B,=*'I^$DQ=EFC
M#GO;+?\ OHT&V WFU-KVIMK<1]K6M):=TDOJYL5KB_BW9PKS86VQ%#68-EG$
MB-?Z5K2EU..%CTZ_CB,]H@]IJI30\AB,5WZMZ;5\+J7&GDMN:&:QVJIX>PQ
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M1Z.J5L9U991JR>*O:9_0V#EV!+(_4TCG5GB.W6&+E3&J=:G[+1GA,6$64Z]
M*'KWI464TG6YZ)+2?WR/9ZCU1!)%/\+.J^\=*LX1LR!O<40W'G6X<[,#]$M@
M#GQ^*,@)(2"]8.%"=8%B4:;9_,(RF93K._X5U:=#U1972J_P)(1-0ZQUN"%E
M4HD;+1)DJY@Z*;K-;Z(R>K[%.BI@:&-L51^H&5A([7Q*?5'9:=TYJ8AN1H3/
M1&$B?%(*Q?>+ +,B#%G\2/R;W&J=NW,_3G(Z99IMM*CI<N+-FS034[_+O*VU
MMM&GG1DE26W$?"SO!ZN?E53B?"YJJSNGNEK!-_7%/BV#="BW9@G9ZM3.Q"KO
MO3(ZGBK ^T!'3V.^E)KOQNN*C++L*]^D(B(07U++@TSQ$A\^Z_ST/TH!3*Y<
MD$['TB&+Z#7*R?JX=J04O%G&$"K*V2PZN,:?*J)QR#TEEB(_.C+VB/\ (TDG
MJRSNH3N'\Q?KU[M'9K5$.UX/; 5,5$,B"SC$;EH6'=NP Z^(8%,UV$?-TSFS
MT0IM_3>XS>W4Q/I9"_78F:WK]&\?>EW4Z;@]<EF;1UV+5[$&B ^D#)$B'OE1
M':*R>YRTRE\@':JIL$1<W'CN+@+F/E%OQW''I6\&;(B54KGB?68G1P$7J,2
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MEJ/*F(F%9Y/YI+$??TC4C:IV_>EA+,?2M;^%IEKV-();FY65A# 8# 8# 8#
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M7G-:UZ:WK\?[GK@?KQ""PR[(<E,_$S&=F+VVKYE_2L)4IUY#3/R.NH3I&_\
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MPXUWZGWGG/;.8UOG] 8LY\"3>I6SW3)%PN?/(W*#86(Y)!0%U+GD*AQ6XT&
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M+M9KE<.LUW;5FC4>%,K%:H;%2 S6Z#3K/309FV(!2HTKH%^APK0O<*RF%R3
MV-':AQW4QO<C99KP[G>#OA\CPWI5WI[=R=NZKK9:K:R1J7%=9*3[ "Y1S_F)
MVPFI+KSJB)^\S*#^?E'_ -[\A<I+4G26]MH2<ZM6ZY=V\.3 8# 8# 8# 8#
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M/&*;6N5OPC3;5<(5Z&S<9[E)#$7"6_K(\AJ2MI;+J%HVV-UZMM</#;B5ZWT
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MU#FQ93D3;"92([[3RH^Y49J9&T]IM2MM_41'T.H]?3W-JTK7X;UO S,#43;
M!&KG-D38@>X+',F";<TE"BK'"9#TF/'*3DOO-JB#GY$)YM#[GM:4ME:=*WM*
MM:#:;<;TXEK;B-.J0IQ+6U)^13:%(2MQ*/7W;0A3B=;WZ>FMJU_=U@8<DH,A
M3!H^80A19YAV0P)A2)3#,HF_$BNSI;(^.XM+LQV-"86\XEO2MH:0I6_1.M[P
M,_ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M'O<T!)ZK'V)=E+;DL)&U9^^=-$TS0.:_>I1\!*FUYX--9849L@LG&?9@Z?\
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M,&#DJORX;M?=9EM1&I<-3+ZH6G53%DF'6>W\>\V;+QX\",WZ6;M-FJ<FG3P
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M3]8;!==-G"E0H*.;=/LH2$#G"X35KNW(*UTF_5S?1^<OV8X/JEKLQQ(&(*B
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MYC(UV'\C$B.\EG2A>'65^G.HW'GEC#U*G?;D\CK=7^,225;YG<*C;O%B'6Y
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MH^&^Q @.S8TB0V\PC9=DLS.3/H7W2.A]!Y1TKJ==\?PYR/R3Q_\ '_R9M5?
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M4 %#[/SBM]+AHF'Y5?@1'+R9IHX;2;2:DB;O?&K= &W!QR>_/D*:(/:8<=U
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MWDRLS 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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ME_ZTGA]_O"4;)6GZOY_*_A[P969@,!@,#P;X;_W%/G;_ ,NKQ7_TCVO(TO\
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M[J48-MQEH*_YO>-YVY]*I$F^QJE.Y(X::O)N_-)I%0$N ND%^3RV_P!66-Z
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M"+/S$\(#W"SFPE:;H=#:(!5(@1XRI.YNUJVK2=>ASJU2\HZ@_P!HX_X:TO\
MUI/#[_>$HV2NOU?S^5_#W@RLS 8# 8'@WPW_ +BGSM_Y=7BO_I'M>1I?\I\7
MO)E9F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MS5J_5>@BJ2-K280\S9CU;$V]5A^I&&Y$.BA^B5U(02X"A6-R4?K!%]][ZV)
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ML3D/:I1&$]&1!TI<=3Q-K>="\LR%2'>-G2&0<6%RGI &P6WK39*++(6BH5E
M:M1 \P-('S6(*W!%UM\%HAMQA]+T#;KC>F]H]<&WGW5Y0O."_2HS=5M_&I!;
MI8]3$"Q?D!6-5ZO"LEC[',YI61#*; \4(N@H"%L,$3#"I6M%&7VDQ4I_% VS
MI6SA_<"AS#XJMQ^1EB14V3JS<*("NH G(@#;)NX;<'VA#\,<S5>D#FZ>[O\
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M-DK3]7\_E?P]X,K,P& P&!X-\-_[BGSM_P"75XK_ .D>UY&E_P I\7O)E9F
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M@5TY(F'1U3(^S<^;-<C_ %3RT-(5-+C3R71;XWD<Y9.5BX)I4$S.H=:@6BS
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MU)T\K25?%!+Z<LAFQ^>\\Q(B1!L 57%0%HK)8_4ZP]9R\"5<3H^45MPT880
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M9>M1LGY!>)FFISD;Q]59F;.5< 5)=.&4^TQ+R9K7Z<"D)->:K9J=)KRHT*?
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MS8%U<,Q2:^P-I95\Y58[,%#*@AB8_)E$"4*0WM,E,PK)F.N3%J6K<Q;JU/\
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M>)TBH$74B)E?2[.K066YH"0=6_/":7(A.*T(G/N*6]&]?A=6K>U)WO>\)FM
M*XOR<-&L\.%SRH[C70JX9M;,P$/(H/SE3_S-G\ST08D_518$WT7$CJ]6(?IK
M3*&]:UK1<UOG>>T%]\A*?H]/>E%I+\PK)=K05Q\E+DB)-?DRB#RX6W)DF0!F
M/05K<VI2XCJV=[VVI2=DS7,+HE(";>4%IM5$;DB6@,C8NO"(&WP3"GEL!7MQ
M(;6W1+*Y#FT1E>K*=K5O2?WV_4/MFDTR.+(@X]1K# 0O-62+!V0 IH64(N.L
M/.3R(]$1,2;-<>C-K4ZXA3FU-IWO?JG7H&4U5ZRPEI#%=!,H9VA3*&A ]M+6
MVW1;[>VDHCZTWM#X.$O7IZ>BX;&]?BTW[0BS_(^;O+J_Q4\&.CTZPM6L$.#P
M& PI@_&27W"(R1@M$2$0='RSLJ7'T^AQ#,YWZE.M/Z2YH99T#FE!&62RW&)4
M@6K5;R0XM8;"^/8EER$P0.KHL7ZSY2'I,>*/C50>IEAI2&&WXR7DHT]M2]ES
M>3/C4:DP_G^DI]6B_5%2)V3]-7Q+'U!LO DBBQA_XHB?F*E!<QZ-(D*]7GX[
MJVUJ4A2M;)FL%WF?-WW9S[W/J0\^3GCBA)YVJ 7'2!,.O;@DC.<7 VN7/%K5
MM49YS:G&-[]4;3@S6>S2*7&19&X]0J[#=R5(5;VV0 II%J5,U*3+59$HB)2<
M5*3->TYN5\OOT\OW>ON5ZAEBZO6@DDM,"UT$(EGG6'CDH6('CY)EZ*SN-&=+
M/Q([3I%V/'WMM"GMKVA&_;KTU^&!I8G,^;CVQ;,#GU(A,A)Q F%:B50#&;$$
MBS:62A$6AF A,"<2:1I,AYK2''DZUI>]ZPN:SI-&I,U^'*F4ZK2Y0],I$"3)
MKPE]^"B:*C@IJ(;SL1;D9,L'#9ANZ1M.G(C2&5>K:4IT1R_HVG_7DBOZ4K?Y
MH9^'\W)?D0OZ\K],-E!H_P"93/I?J)WP")S\1'RJ5[8SRVM>B%J3L/F12Z=+
M8=BRJG69,9\U%LCT>0!%O,/6*"B,W"/NM.15-N&H;<)E+4K>MOMI:1I*M:2G
MT#%WSR@;?<E;HU/W)>'&!#TC=9"[?=$V&7*GGQ;CWT7R+'')TY]Z8QO>VI+K
MRUN)4I:M[&61#H]*')AI'T^KP4CH[L0>F'7Q,9,&*_&1"?C0],Q$:BQWH;26
MEH1[4J:3I.]>W6M8'QJAT9+Y&4FF51,DPU&8+2-5T/I\HS"&R T-DB]J'\DY
MJ((ENQ&DN[5IN,ZMI/HA6T[#'A\XYX.4-4/H=,@J#0WQXA4.K@XJA4"5.T4D
MP1NV(*-P8<@GKZA;37M0M_\ A-ZVO\<&:WPD$$ -2V 084%8GD9A><R)'1!S
M4TL0<T[/)RVX;+*))&<[KW//+UMQU7XJ5O>!M<!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,#P?\ [1Q_PUI?^M)X??[PE&R5I^K^?ROX>\&5
MF8# 8# \&^&_]Q3YV_\ +J\5_P#2/:\C2_Y3XO>3*S,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,#P?_ +1Q_P -:7_K2>'W^\)1LE:?J_G\
MK^'O!E9F P& P/!OAO\ W%/G;_RZO%?_ $CVO(TO^4^+WDRLS 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \'_[1Q_PUI?\ K2>'W^\)1LE:
M?J_G\K^'O!E9F P& P/!OAO_ '%/G;_RZO%?_2/:\C2_Y3XO>3*S=&?/7E?D
M!UZ@<>KWCE<[%SVXA/([F-Y-W"OV)(!D/5:7&LIU6[9$40@[N% GVF**BG02
M4R=E!;SS7PKUZ[2=:;)S[/,7F? _N3$A_,"730780_5"JN$EZJ=%^2\*?R_Q
MR:C>2W1[MY453KU>@]-B:[&B[\<.0A824T'L^Y<'Z."VL(J!\^H[SI^7_832
MN>(GDISKM? 2T$)W YS,1Y1>8AZ_0GNZ73I,>'S<IV;G[GB<2*C++Y6<\D,@
M0?*A9'Z?TW9/RQK;B)]?G/R/:FINEEY9Q_\ EZ3W#F=UZ!5?'8R7C7B5;:TD
MI+OCQ^P!:58_27QJ^L1=7(-S*T-\^F$?\IRPCCL<:[-'QY:$N,*^G;4O1Q.:
M!<V&^:=:L?&J<?+0B'.08JOQ+;:"8RGE["?6S2.>R#XJP*&E!S\&+ -/G8@D
MC T[)<D14+G:EM[0Y)+=OS99X9Y<2^K';*%46V"HY&\M4YJ1OGHL%?Z]8KMQ
M&:/I\T Y(G$8$(-5P9YM)I^4DG+>UMYI<!#NX#@].$)02^X81&60I]#JN(B2
MHJP0*1%Y09L<D4:.<VV=;U-CICB2)JBAWK*V+]T>!')?"TY(TZKXD/#TKJ N
M^5,^J]"$EIVF;3NS\E9J%ZA Z*,%ZKI4I6&.KN5JG2B-DVW^EPR24B/),$)R
MISSZ-,QT?#\*R<%'1;7YXQ"%6!'6W'[2<D]#*-C@=3YYJLP7:N=X_ %P[5:)
MY;:G.7$8EC,NLOP&8]H4UK_TN+9_ ZQI;F,]Y\063"R9+174&CT8F,BB*OR]
MPA9[+,BT4G;P,(VX3C!JB9C6%RQ!_JI4$R.CAM0IJ&I,EMU4@GI;BLN>>,]2
M2%GDB!+D2R6 E+K(T)0UPGXL2T4M@/5HUAE$),DG32E2FEGV9:&()EN3%5IY
M_P!5LM:%V]$<KK/GB#U^3RB)4J"!UN%&<*&!G,35WM#OZ\EL7,L.*-3Q ")>
MH-9WMZM,RXB@DR#J.B:TF4I]31?2+J7E@&IG"IM>1>47D7#[XU:%3)_,R>FR
M]TZ$$-<YWTR$1L#X1==4%C.[GKK^Y,P8WI3,/XM*TC9,SBFPDEY(]-X&,L[I
M,N-MSO9:ZMB+1&:N)FV/D=.N(NFGR36[1#W!4'ZD."3[2AKW1Y;(HJS%97IQ
MK2%CA+X0X,%\TJ37Z(-;:G6Q^H5ZJ"WR"]\W7:+(TNO<+<L53DFYTO8D)#39
M&+4UHR\/)RTQH36G-ON.MSME]-3"Z6/RK.=GZ15N;RB8BD [!S\,R<FUWGNP
M >JF0-#+6T[7)9U_]16&^#91,AM*)+#P-N#IQ.TN3&VFU$FW'%&]E?.E4P<T
MXXV%!_F0]-^LQD;RMZ, @K?L\>TEN;QQ\[Y2]8":77)HS9EO1"2,T>U(U]6D
M8RD>E*X]H\O+QP'G-RJ<8%6>I]'G%M& 1<>"=&<SKEP%F&Z;97FR,F+(.N4-
M]D;/EP=>Z7/;E/L[;]6T)2/3+X09L;YTPXEVZ*(BL0;=T".%G;Y>3FT@L H:
M'>>;EOQ@A+ZQQ4VV5,U'9#-[^H_)R4]*Y+[3C#OU+8]/R7;Q]ORF:M@J5U4M
M'+567&*P"$1 &G 6H3$:D\UGUZP:C"9L\ZU8B-PDV*&09W+>@ZTPE3,:.W\*
MEBXQPYJ YW9/.NX4FM6R4X:@09E*%6&=%)5CD8RZF3A?7(D60<&%*E.AQH\0
M%(VR;5FY_P!/*D$HK#1A>F-(;D%].6$Q=_/(A,O@T*.F;*UH@P,C-V0)RP:)
M53YM>K)N&4A3(L_;Q7NR(17:Y$9OWTMN9M]G6_X)M.AC2Y;E-\TJ9!#]-(S&
M+39P3LVL@ZFT/K0 ':/UI#X!7@XQ=?&$24]-A)6R58R+LE^4^W T*VTU]-$>
MWM\3;>"Z^LK\Q8-RBP.6S I"LPN41=0B<H!5WHUGZUJ/;8DS=L^O*#B%6#:+
MZKLO2QZ)#?Y8LJTEMR5](I@DV]4 "%_.ATA.?M<9^+7F2%(ADQU1!\NF7!D&
MX"$.V0W22)8TY6W+"BW(FL$H)6-(92'=0_ _]PTE$D>EQV29YQE'V9H,81$E
MJ6U:H P<[(YFQ5>B6673>\1@)VP1VB,XNNAPS>Z3MM*'!DO4UQ:UL[:0^IL>
MEMJ+ \M"W6./O]*>/3*C73Y<V7E01_.ZT"75I_+.CAAZKW!&6&19YO1HUV,0
M8SD<<TNO.QFF9K;##VG-,CACRTA1/G6;;M-<.AJRZ'>C0&@<^"]3X<PE*J=V
M:IA%:4I-,RH>^D5E7ZYAN:TVL1]-H<KVNJ^+8]+YDT7R:K'%>0, &;POH]5Z
M7TPP=0%/T@\6_*3-%ZX/I6RV[T<W73-=7;30-,MCY'I,:,K;C*6EM?,R7,SX
MPL>I$O,EFH]H+7.'6)EZ$D627+Z4(@@88&PMU^QG"\FK5RTRBR7GQ70*1"'C
MVI)IJ+,%$Y,E]Q[XM(;C$]/1 B,?SBFO)'SB!EG0PW231HC4X_*Q@LD&%WSD
M!1P-272"9QR3.+5C]6QK*R40W'6RPT@<M"EH5+'I:*#%\Z;% Y] Z&W/_P#<
M7KFIBRQZ7!YR#:%N .K\N,WT5:R\BQ;G3^=Q:L*..@I 1+12>RY]*1;D*TC<
MHOIG)>CL'R:C]?/D!:HD+F#5\J#L(0W%I[S=JK)=X.)NI,M-EOO62%)K89AR
M3#1&7#6X^TG2D/H]6E'/#'E7$NF^6(_L%WMU>L%C)BH%D*MU(3:9E#<I!BIV
MFY<9>9!H9A1X]@@A*I5H]E>T]M#1=$MKVID/MK2Q)+F82 &CS,(\/K^C!B.+
M[#+M1218),:MT%B0' 1><'ID8.AB20+58I&E=6B18C,UEMN0H-);TM.G4.S%
M#TY\(7:R?GY 0( U,2P8F,MVO4^[3]<M1!(QRE))R 2Y=?2L<N$8J-\^E:B*
M9>3&G0G/9)8=VT[*4/3U;NSI\[!Z+.[3I8LX^&CV(+3XEBA\ZCQ;6TN7WQ86
MX620-;'R&+!'@CJ$EF/$2.'K>ER/GC>U;VX@]/5+ZNCRX;YWU@D<+L%;OJL"
M8_)1<NO4D'M4W0MV83*%(L&=,B.W3YY>HGQRI<8(Y,AH<2PQ&>7I(].?"C0H
M#SE"C+9,JC1"%)E/]3LXA5[5S,E:;&[,Z-U$C1:_85#B) $'>U4S8R4RP/1$
MAM2TMQW%1F=OMME]*>_3^89*,);-EKBR4"VSCYN,[4A/*:]6K51F2X)R\#;D
MT2D';)$N>W9<QLS%@.Q1CHF)IT=Z27=L))Z4/#PO.BQ+Y7%Z0DDIE-\Y18+,
MS4A_. $ <V"OP,IU 7=B6[+LJ0JP\4.6NMN D)D$8KSD<DS(6E+CQ?3.206T
M%YI5.9?E\QG[G"+ATZV'(WYK'IQZ?2*RX:',@W:=#*3XRRNC3+ZY$V$1?VB/
M!8=3$U%D?'IPGIO/L6&%YVOFYL+ZRO%ZR3A=#E:@HKE-0.<>:M-Z&5NM..?G
MD,R%AR:;#KA(9,<ESW=S)<]F?ZZ2RAD>EV)XN]W>#*+1.QI>-M%MBR 8E%B4
M^$U6Y<M5K=- 'VP,J.X^#%1!HI$5YQN9-=DSU_(ZMO6_@)<=%*<GI'D+SCGW
M9;&:;MMQZ8=$\]@4P.3M5.ERX# .E"!Q) 0M.ADX?J-L9,I-4V35+^L?1O2?
M73VMJ+;,^%?SKEYW4>A*Z#:8PTL='_30$<W_ "RB(9LLQIOF$&OP(DX"]+*L
M6CHE@+'HKNVWE0H;C3.TLL-:TXL>E<?8H?E>XH56.=F)KJI?-P0A^X H//QX
MMV]2%GH'1;!95V13QNO/0PNA\VIH$17HVS"W4$$+BITG0FU3>P?G'5*^0FTJ
M<;(R+@=02-Q[BUS4S9:A C ^-COS:NPV)3 F=8S<]%D=GP77UBT-,*W$:CO;
M9W)'I=AFQGE"_P ]=8F6MF-T QV/;<@D(K](CQ*OR./9'(?RUP:5V9ANO$:W
M!1+3LDZ3G,NS5)WI6VTHT."BC*_/R0)KU2CM2/S$I":W8^A07N4CDPOU+S*I
MIL ]D7J.^X,FT+I!$NH+-84[\K$5EN4V0TE4AXOI? V+YTASL2.))V(A7R+T
M4U*F]"'\N.S(TI'*>.1X]2=CUV97]BPTBT0+=J7*86XZP<7'?TI^"O;;X]*<
M$['Y447F/<IIQTQ:+)7./4\USZS(KU ;W)Z0NI:3<  JI@T^AV3&LZ-R$2YC
ML8>I,AN&AA*8KLV63TVQI)3_ )OI;GD/EL6@;<A8\*+&">'O=$?%ND.T/ACY
MW\PD(I>[%\D2CQ2[$9;$! R3-=BHU+4I<,>E" 5M^X%9H&I4*+#&(W?[ !M!
M";5Z,_%#+ W7K->BN<S"+*CBUCYK\8BNZ)R#3T<V_'<=>'N)TZIQ@OI2: YY
M:53JM*V:*ME9/8C0&L61A]BM*'4RM5JU=8NYL_7A8Q;S$:+7.>C1@%3TC3CQ
M C:(;KKKCD3339.%B>]$*>6;1ZZHJ8^S?E[5LE-UW=8@\AEC%4S=&GKILD"N
MYRF2LDS,Z/J.U;$E%MI8&[5^5H;_ /G>";4/EM_<#B!BIF"0KA2UO""CD*H2
MH%!8ID([/=[NRRQ!*LZC662+!1PE$='[E2=NOO%)7UBEHVMJ /3\FTO0ORMD
M5'@I\$Y82O10<[IB[8X-A<_!-N+, 3\;FL?H%=+']UY\(B?^6,'I ?WRT:T]
M(@LQ-KTED3"%,UGS@-DH-\MD[2;+36NK-!ZC78='BUV)+.$^>"HLT)LE.=3;
MY4>DKL"ZF\35"^&9_!%MK;?5K1?3RC=2'?/AUJ/,@SHT"%+O\05#C%ZYS8H>
M'<Z9#V"4$LUH&"","!,L!@RZ-C6B/ G1VXC;:]BT-:4MYLGI>BF')@,!@,!@
M,!@,!@,#P?\ [1Q_PUI?^M)X??[PE&R5I^K^?ROX>\&5F8# 8# \&^&_]Q3Y
MV_\ +J\5_P#2/:\C2_Y3XO>3*S4#Y$4.Z7^JU>#1R!*'/#7X&<+0QMGD5;1N
MO)'F@Y041DLH6T3$>AE$F1 >]&I2(WM_%>D:V67#K_S[D/E92[/QT#(Z=)D\
MHI,03"+,:=!&#D]$*G4%LM LC\J. 1-K\PY%.Q!^XS#\L>E;+ND:3M&V"VZ;
M\4)Z!S'R0KO0[(WQ@45K]=Z1?;8=F6&*=JC=K>L;],Z20$&++<$58G*WR$3<
M9@1Z '*K?)QE_40(ZE#$QX"RRS'%(H'-_-#YS/ZPOSEJ@D3M[0H0 FURKBVI
M<[1!/.[(.=G:,3YG/!XV2W&,5R3J*ZJ4RVZA,U/S_4$SIZ)!S?F?DXYVVO6K
MJ$JM:Y]4%ZV&%#3GURHL]=,O-1(DP[.H3"VH)V%*!//1-HA,19J96F&/8G4B
M4,S'#FH@=XG^5%:KM*&56V5L;-Y"F_'.83'[,4(NQ;'V2DWW70&RL>3!:CS$
MUFVDV8M<<>6ZB-$,O+4EM,-M"RYBR&..^8)*8ZFV=4LY:OCIG(C@,4)*@J<2
M)#JMT#F-EL59L)D,8G2&;3&& [!&>?94^//0Y[+4N5O>MI:)F->1HGES1:K$
M-F+Z:)#HTP?%N%3H3J'B#E3@,\CC01?-8%8Y_*D@3LXM'M#LF4EC>OI9.FU.
M,HVPY#'I7.&#]OO_ (W\X#VJ)=JYUNI%_'0M;Y;UI%UPQ>GZ@2Y==>G*T5K?
MTT/4,PUHN*?CO1X#4Z7&=0IEF*ZA6QPE\*NHG$/+6AN<;J\'J#J.<U9VIKM$
M5F0&-&6Y4<11$GAJ7)\:O,2>>-.B3T)J(GYY;/YFS(:;4ME&V!;IOQ<%PJWF
MG:K7UF11K4=JM:9Z 0'#&S,\+IP[1&)G-) QGF(UV $57"4*,Q8].D)I#;1#
MZE#?S?\ R:H(]../-(2?-O,6"S 6+Z44LQ0@_?-VI\D=K=<&0P+EI@/5U-+B
MB@#J15Y+T@8H>PW+8FB1<H@[,^H2_'1N2,Z4ZY%0_)H-<A=BZ+?99.O+,G8#
M]2EG!)5@;SQZK[>J4>>Y"K0[9CH(FS(88(DVWDHEI0\M'JVYZ;%LQP5Q.Y]Y
MNC H$:$O4,X3D6:F6@S835FA_5!YL9^.JYUY@?$!AALZB%8"76VV'&Y3L=[3
M?QL*^9Q^,/2U)/CWFX/KT;\C[05*EY*:VS9V2IL#*D.B45ODTRY,U!;%?K+
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M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>#_\
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M?C:)0F7GY6V4JVIM0Q>[L30;[5NG<YZ48:X;5:[(K8VPCQ-!M2JK((65(^B
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M321CCC+&H'?S-K[!7^36KE#S9DR*Z&JX&YT!<B/7BM'NUC:KL5LH]7A$>Q5
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M([26VVT)2A"$Z3K6M:UK S,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>#_\
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M 8'@_P#VCC_AK2_]:3P^_P!X2C9*T_5_/Y7\/>#*S,!@,!@>#?#?^XI\[?\
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M# 8'@WPW_N*?.W_EU>*_^D>UY&E_RGQ>\F5F8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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ML;.6#R(I<AAJ&S(T(YU08T(G$?2O3TU3C[;B6=-:7LZVK+?\[: ):=B'>?\
M56K&"J9RT7L((K0TVJEH!P+%-;8+$A9^8#0V?55Y*(<A,Q<5I;C"9;L93OHD
MFVK6(>2-<&TNO7(C6;4)B&K^?YD821;K_P!-0[37#9^KS=7$NQ8E5Z/ DV8#
MN!!=C37]$)LN*PSO;KZ$X3''"I!OG739S%=;B<[Z2>EV@(4+5N0)BT.!%LZ:
MHV6;NST."7Z(T2K[0"=7YJ/83TSN0EK6XZY"5)6HNUS2/.KFXS1F3.K]V)!1
M4E;6[(+#!(HSZDKKH<BG5_40A;]FGBYZ/S6>CZG<9F PXMA4E<5MQ>VAMJ<G
M_+>@U3E$CJ]F!6<)%@72^44I4Y+E6E6R,7YB7M(R].PHHRRSQAR&#C4V?.5N
M%*?<^A:^1:$>CB6QMN<,@[Y8<_K?++-U0R)L8^)5;;8*:3I\O0./?$F*U!F'
M2,/]-NFDOM%-U& Z::@.*3-<$^V5IKX%:<PFVYPK\/YH_F1X>(?XU<&6+#-N
M FGR8=GH<N39C(#KY'EH,>U#DV :P'_4D46Z54[.D,-PT(W&5M;ZFM.EVLX1
MYQ\X/(&D!-*Z5(KA&8PUNSNCZK&&PAJ87*9!D])B/6[1IP97Y?9@L1Y+$5Z2
M^_\ 4;C-/LLZ=6-M;7GGFAS;I!FG@A-6Z4*F=$F?%S]VQ5=L/"N8QD9'L!4_
M7Y,DCI,X37:S.CSB*DZ^2(A[32D[D:4TD;;C+FZ?YE\SY/9>BU^PU[HL^+R@
M**,WRS :LHA7 >BT8$1C#W)ZY<=3Y-8BR19+33:5*E;VMB/\LE&V<)MM^;XK
MWF+3+99=5*NT+IA T_:S-3&*<#A1P,S+J+UGBWZ2)M)(_$K9!%)F4^:B4PS*
M<F24;8>B,R([VG4EVM.[YLTQXN!C@Z3;C8(Q5(9Q\RU+JL&1#.62!X^D*)4T
MBIQ]I3LVSI\BPS+LIUZ/#'.H6I]SX/5](VU;O(N^UWL4B\M!J[9P$;G1)%>L
MQ.S:KL<:U:XS3[EAKL%\78"RISM64SI$N8E.ASNUI5%D2$>Y2268==R?G[19
M<(B[3*I9C#M;M7/X%NFS-UMD*(J-WN5!##K..EZM++EH9LM>NR90G\J3-UMQ
M*%2--LK0MPNV]6VF>=-+A0/S(M0^CU6/';*3U,FA=0*2C$*OTVOWLZ/#HK_0
M);<<K'KMU"NH<DJ3'6[-4RGW+9?VT-M;V;YCUV!(GLR*1<H\P>Y'"% T]FKP
M$56W.'^GUF*)M5QU;Y=4B-V2P<\2.&*:<<0_-G1FD..O2-,LC:P(7F_3$@JX
M3L%#N@&>=(<U!+$_64PH\@YT2I<NLSFANH-G5.*UZI2NRUT<2*?3,QFY9!&D
M^[7[HVU@B_.BKO52H'S'+NAPB5M9YZ(9!"9=&-K;Z3T>H52]!>=1IBK:,^JD
MHJUQARUEG&HX72/>WN2F2G;&#:L#J_EK1N0F#0<[5KP84 T!'D95=BUR0UJW
M6NOG;/5Z;&CE+*)GRBAH17)*DRTM?E3"]H0]+;W\GQ$FFUR];\I ?)WC0V51
M[8=-@J<)L1"+"DUF' @F[6,N\NCU&=/FG6Y"IMFG\_(153(4:; @*2EV0ZAK
M:EI$F560_.<0'&$7[_S.]#3$FV& %("U>&&M$BXI&EX0V0/&?EEAF.Z-!-ST
M)EJD-Q(TES6]0E/^J=;+M6'8?)0I+YQ7KY0>?6!35A[H&Y"RBXL!ADID6W>7
MJ=;;C^0JM8Z<F/ E"IT>-"E/PB6Y+:5NQM(UM*B8[]D+ >;E8,6OGXU=;-,5
M"Y5FTNMW"0R"A)GVVM.\Z1+C#POZMFEQ(* JVRV9+L]I'OD-,?2N2&5;>47;
M]6_:\RZ-/& K3!"V"/4K!),BZ^0)HJ\=ZWV$2,C.O5H&UNY-S!IA!V:T.91,
MBZ_,I:TIA_*VXR\X-MY/RB^;O,.@3JC&$UKH$*+T$P$KE")%18)B/;; 1"4.
MT&1(V)&L<LM'D4^JWYLF0W*CQT;A"R3D?;^HF_>+IL;+NGE8'Y$6LU1C5DR1
MLH>L@"T4S*0+U3$&K>/Z.3J@(EM@XW:_>2A\I,*<?8'KBL;0UI;NOD5M FG*
M-Q?/'E$P77R\>K]-<8M=F9K]8A;J[3)FRQ">@4>N6>NB)))B89KM@-V: +;>
M92I44I)3&E)9<WK6QMJ:\T\MN>=2L\^L  EU1^35;]16"P[!:(U2OD&@H.PS
MZ@4.A)).*Q:1PJP,?+'UZI^J:DQ-*W*C/,I)=-BN8?GISAV>U^:5:]UP:H''
M+>TD-JTZ1):LE9I%KY[)9F ;P5CQ/UJS>APJ'#?93+6;(QF'/A1O2W"[6]F>
M7+5FXQTOIG*^?V^:1II0&" 1;N%370]FE6"U1:DT8%SY1<?!*# \UQ]R7'3-
MC2DZCZ;5\2GFE;&..*U]U\Q1X\[2P%,"IG339(<P>U8T)A?00)_3++R]+D)
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M:4I3OTUK7X:UA&)L2*5%?A*&#U0I+BGI,3<.-N+(=6[]0MU^/MOXG7%O_O\
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MNIG_ .-JN_\ ^NKE_P#A+1,+T6+A# 8# 8# 8# 8# 8# 8# 8# 8# @%/_\
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9# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
